data_2ai6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ai6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 mt -52.21 -29.91 24.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.55 1.14 . . . . 0.0 113.469 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.71 -27.69 61.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 112.417 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.0 mt -83.25 -24.14 32.41 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 0.0 110.975 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.0 130.25 73.25 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.52 125.69 16.07 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.226 2.618 . . . . 0.0 109.78 171.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.77 -36.23 20.25 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.97 138.52 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -156.0 112.99 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.3 pt . . . . . 0 C--O 1.236 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 109.136 -172.652 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.5 p90 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -101.02 158.24 16.16 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.605 -0.684 . . . . 0.0 109.717 -173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.96 168.6 19.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.88 0.872 . . . . 0.0 109.446 -171.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.5 155.01 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.32 1.448 . . . . 0.0 108.335 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 tp -118.27 114.64 23.29 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 130.9 72.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -77.5 146.11 36.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.31 127.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.57 149.75 22.43 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 109.222 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -65.88 98.3 0.4 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.989 0.916 . . . . 0.0 110.75 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -148.52 18.02 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.281 -1.819 . . . . 0.0 115.123 169.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 55.8 Cg_exo -41.21 134.57 2.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 123.978 2.456 . . . . 0.0 114.5 171.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 47.23 21.54 0.2 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.021 2.528 . . . . 0.0 113.448 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.86 33.45 8.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.28 1.432 . . . . 0.0 112.659 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 113.82 -174.372 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 121.395 0.616 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.59 167.64 12.61 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -141.19 158.87 43.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.848 0.859 . . . . 0.0 110.412 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -151.52 166.08 32.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.845 1.658 . . . . 0.0 108.928 174.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -108.94 153.69 23.2 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.456 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 45.0 pt -129.82 155.28 41.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.854 1.262 . . . . 0.0 109.265 173.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.36 123.52 71.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -171.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -136.03 146.58 47.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.625 1.17 . . . . 0.0 108.478 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.13 129.84 1.44 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -150.78 151.92 33.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -60.19 -29.75 68.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.804 0.842 . . . . 0.0 112.479 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 -68.19 -28.03 66.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.33 0.968 . . . . 0.0 112.578 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.62 82.63 8.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.739 1.154 . . . . 0.0 108.913 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.12 -3.94 8.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.321 0.648 . . . . 0.0 112.355 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.33 142.95 26.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.818 1.647 . . . . 0.0 107.982 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 18.9 m-70 -60.92 -30.74 70.38 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 111.856 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.29 70.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.813 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.66 0.664 . . . . 0.0 110.431 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -41.57 86.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.216 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.93 -46.99 86.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.123 1.329 . . . . 0.0 110.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.88 -49.6 69.87 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.234 0.47 . . . . 0.0 111.331 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -58.84 -49.85 76.19 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.419 0.687 . . . . 0.0 110.839 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.1 t -73.47 -41.3 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.155 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m -62.36 -29.8 70.73 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 119.638 1.108 . . . . 0.0 110.895 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.6 -50.03 70.51 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -62.72 -47.77 82.15 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.194 0.997 . . . . 0.0 110.854 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.81 -43.99 90.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.965 -0.459 . . . . 0.0 111.302 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -68.78 -31.62 70.77 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.993 -1.067 . . . . 0.0 111.911 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -61.36 -43.69 98.44 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.421 1.01 . . . . 0.0 109.552 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -60.13 -43.04 95.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.513 1.052 . . . . 0.0 109.546 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.75 -7.17 1.69 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.333 1.92 . . . . 0.0 113.265 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.36 176.58 2.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.204 1.802 . . . . 0.0 113.216 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -130.03 140.51 50.85 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.4 m -146.45 163.34 35.98 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -153.58 128.71 9.69 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -66.75 116.71 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.4 -28.89 65.43 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.792 -0.568 . . . . 0.0 110.078 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.87 -169.37 42.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.1 -168.34 20.27 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.99 -161.22 26.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -121.37 153.53 37.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.445 1.098 . . . . 0.0 108.232 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 mt -125.28 135.04 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 123.526 0.73 . . . . 0.0 109.951 -172.547 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -128.11 122.42 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -173.04 3.96 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.41 -0.806 . . . . 0.0 111.21 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -160.15 53.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.02 153.77 35.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.45 1.1 . . . . 0.0 108.903 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.5 t -69.45 128.33 36.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.8 ttp -64.91 -17.24 64.16 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.355 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.69 -29.66 10.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.715 0.806 . . . . 0.0 112.638 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -127.4 0.08 6.3 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.75 -178.28 50.83 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.853 0.752 . . . . 0.0 112.144 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.1 131.04 19.96 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.635 2.223 . . . . 0.0 110.401 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.5 167.64 20.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.355 0.598 . . . . 0.0 109.557 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.14 77.7 5.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -57.76 -18.87 24.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.11 66.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.705 0.802 . . . . 0.0 111.21 169.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.44 -49.25 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -55.5 -48.32 74.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.001 0.521 . . . . 0.0 111.124 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.9 p -61.78 -44.83 96.11 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.476 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.43 -46.55 89.62 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.277 0.944 . . . . 0.0 110.571 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -62.27 -54.95 33.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.329 1.452 . . . . 0.0 110.684 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.735 0.814 . . . . 0.0 109.186 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -59.73 -40.2 87.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.287 0.949 . . . . 0.0 110.833 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.48 91.14 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.306 0.503 . . . . 0.0 111.201 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -81.71 -14.58 56.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.555 1.144 0 C-N-CA 124.848 1.259 . . . . 0.0 113.228 178.744 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--O 1.239 0.509 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.47 164.7 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.107 0.563 . . . . 0.0 111.184 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.9 p -137.69 172.67 12.61 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 108.758 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -142.73 169.55 17.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.768 0.427 . . . . 0.0 110.417 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 169.535 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.1 mt -55.51 -27.73 50.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.254 1.422 . . . . 0.0 113.524 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.0 -23.19 61.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.777 0.717 . . . . 0.0 112.564 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.52 -21.19 53.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.515 0.598 . . . . 0.0 111.315 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.07 134.97 96.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.278 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.74 106.95 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.27 2.647 . . . . 0.0 108.717 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.42 -33.51 73.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.9 t -142.6 138.2 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -150.64 103.35 3.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 pt . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 127.601 2.36 . . . . 0.0 106.641 177.819 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.05 155.09 17.29 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.931 0.492 . . . . 0.0 109.784 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.63 19.33 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.72 0.808 . . . . 0.0 108.966 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.86 153.59 17.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.767 1.227 . . . . 0.0 108.315 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.08 118.04 32.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.284 0.0 OUTLIER -130.02 130.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 118.373 0.533 . . . . 0.0 109.597 -172.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -80.63 147.33 30.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.792 1.637 . . . . 0.0 108.438 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.91 129.75 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -93.85 155.51 17.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.351 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 m -66.52 85.05 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.267 1.027 . . . . 0.0 111.555 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.45 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.19 13.14 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 116.23 -1.843 . . . . 0.0 114.041 169.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 52.0 Cg_exo -47.13 136.22 18.38 Favored 'Trans proline' 0 C--N 1.362 1.284 0 CA-C-N 124.02 2.472 . . . . 0.0 112.454 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 41.2 31.76 0.16 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.898 2.479 . . . . 0.0 113.847 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 32.0 12.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.897 1.679 . . . . 0.0 113.806 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.586 -175.633 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -69.41 167.89 15.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -142.8 159.34 42.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.722 0.809 . . . . 0.0 109.652 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.414 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -149.22 164.43 34.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 109.195 174.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 150.37 27.63 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -176.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.414 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 37.6 pt -127.68 155.55 39.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.486 1.115 . . . . 0.0 108.872 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 t -122.34 116.46 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -169.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -136.51 147.27 47.01 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.98 138.31 3.71 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -154.16 155.92 36.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -173.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.75 -33.03 72.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.779 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -65.87 -27.04 67.92 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.756 0.707 . . . . 0.0 112.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.51 78.92 9.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.593 1.088 . . . . 0.0 109.117 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.96 -6.9 9.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.697 0.799 . . . . 0.0 112.102 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 142.53 29.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.981 1.713 . . . . 0.0 107.604 174.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.463 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 13.7 m-70 -62.15 -29.66 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.637 1.175 . . . . 0.0 111.663 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -29.18 68.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.034 -0.507 . . . . 0.0 111.757 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.26 -44.67 78.79 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.807 0.73 . . . . 0.0 110.725 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -41.44 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.458 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.22 -45.12 94.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.54 1.064 . . . . 0.0 109.044 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.03 -48.11 80.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.163 0.892 . . . . 0.0 111.748 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -55.08 -56.78 15.94 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.974 0.909 . . . . 0.0 109.945 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.46 -43.62 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.599 -169.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 t -60.5 -35.58 76.28 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.075 1.307 . . . . 0.0 109.748 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.84 -48.16 86.78 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.165 0.893 . . . . 0.0 111.324 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.12 -46.66 83.15 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.143 0.972 . . . . 0.0 111.131 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.1 mmt -58.91 -43.77 91.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.694 0.679 . . . . 0.0 110.831 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -66.52 -33.37 75.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.859 -1.15 . . . . 0.0 111.27 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.94 -40.09 95.65 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.971 . . . . 0.0 110.389 169.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -64.59 -20.23 66.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.054 0.843 . . . . 0.0 111.49 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.47 -8.43 11.1 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.581 2.038 . . . . 0.0 112.723 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.24 178.55 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.826 1.65 . . . . 0.0 114.048 -169.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -132.31 145.1 51.03 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -147.57 165.57 29.98 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -168.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -150.51 130.95 13.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.658 1.183 . . . . 0.0 109.382 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -71.88 116.27 12.07 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -74.64 -24.96 58.91 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.97 -0.456 . . . . 0.0 110.418 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.49 -168.32 40.48 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.62 -167.87 22.69 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.31 -163.37 29.65 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.9 ttp-105 -119.49 154.43 33.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mt -113.19 126.98 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--N 1.331 -0.221 0 C-N-CA 123.837 0.855 . . . . 0.0 108.896 -176.025 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.3 t60 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 t -117.03 114.09 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.8 -173.23 4.0 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.637 -0.664 . . . . 0.0 111.945 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.7 -156.56 46.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -145.83 152.72 39.96 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.023 0.929 . . . . 0.0 109.084 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.2 t -69.32 130.46 42.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -64.81 -8.34 14.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.24 -27.71 6.37 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.153 0.981 . . . . 0.0 112.574 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -132.8 2.39 3.7 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.94 -177.27 48.17 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 119.246 0.93 . . . . 0.0 112.554 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 128.68 15.56 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.815 2.343 . . . . 0.0 110.902 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.87 167.24 22.25 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.499 0.666 . . . . 0.0 110.199 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -79.99 83.46 5.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 168.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -59.17 -14.82 11.75 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.37 84.47 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.154 0.982 . . . . 0.0 110.87 169.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.9 mm -62.19 -51.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -56.38 -51.18 69.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.801 0.84 . . . . 0.0 110.976 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 p -63.17 -42.78 99.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.337 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.67 -47.81 82.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.938 1.244 . . . . 0.0 110.74 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.259 0.481 . . . . 0.0 110.827 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.84 -51.17 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.18 -36.34 77.4 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.983 1.265 . . . . 0.0 110.846 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.36 68.33 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.406 0.548 . . . . 0.0 111.552 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -74.94 -19.32 60.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 126.558 1.943 . . . . 0.0 113.639 178.201 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.05 167.78 9.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.895 2.078 . . . . 0.0 107.862 173.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -142.45 170.11 16.31 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.657 1.583 . . . . 0.0 107.048 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -142.27 169.79 16.93 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.216 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.61 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.03 -28.24 64.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.622 0.769 . . . . 0.0 112.879 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.89 61.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.282 0.946 . . . . 0.0 112.363 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.13 -28.57 18.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.47 1.108 . . . . 0.0 110.957 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -55.91 129.09 71.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -50.44 133.24 36.93 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.273 2.649 . . . . 0.0 110.22 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.12 -42.35 9.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 137.09 43.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -156.42 118.18 3.9 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 169.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--O 1.235 0.3 0 C-N-CA 124.114 0.966 . . . . 0.0 109.131 -175.68 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -97.62 160.55 14.25 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.412 -0.805 . . . . 0.0 109.92 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 167.8 21.45 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.13 0.972 . . . . 0.0 108.791 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.12 155.17 15.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.351 1.06 . . . . 0.0 108.767 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -118.36 114.52 23.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -120.58 131.38 72.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.782 0.719 . . . . 0.0 109.231 -175.113 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -76.78 145.08 38.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.44 117.94 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.9 146.09 26.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.8 p -68.45 103.33 1.63 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.297 0.498 . . . . 0.0 109.853 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.66 25.02 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.655 -1.641 . . . . 0.0 114.753 169.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.428 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 49.9 Cg_exo -42.65 135.69 4.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 CA-C-N 123.827 2.402 . . . . 0.0 114.637 172.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 43.05 25.87 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.587 2.355 . . . . 0.0 114.518 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 51.47 33.35 10.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.814 1.245 . . . . 0.0 112.267 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.962 0 C-N-CA 124.339 0.971 . . . . 0.0 112.34 -173.426 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.3 0 CA-C-O 121.683 0.754 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.01 178.08 6.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.843 0.857 . . . . 0.0 109.341 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -141.17 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.532 0.733 . . . . 0.0 110.725 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.07 162.62 32.85 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.84 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.12 136.26 49.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 pt -116.79 155.03 18.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.704 0.802 . . . . 0.0 109.627 172.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.8 123.85 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -137.57 148.46 45.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.294 1.038 . . . . 0.0 108.502 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.76 133.15 1.93 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -150.3 156.5 41.65 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -60.1 -35.38 75.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 119.177 -0.439 . . . . 0.0 111.497 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -65.4 -26.38 67.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.4 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.59 80.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.626 1.103 . . . . 0.0 108.428 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.7 -13.32 21.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.777 0.831 . . . . 0.0 111.777 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.24 143.51 31.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.417 1.887 . . . . 0.0 107.683 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -58.48 -30.0 66.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.962 1.305 . . . . 0.0 112.926 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.68 -27.96 69.57 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.593 . . . . 0.0 111.476 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.53 -46.74 78.42 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.313 0.506 . . . . 0.0 110.63 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -40.83 80.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.473 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -59.66 -47.62 84.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.791 1.632 . . . . 0.0 109.741 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.82 -47.65 82.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.794 0.724 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -61.24 -50.07 74.56 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.151 0.58 . . . . 0.0 110.845 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.9 t -74.53 -44.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.452 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.1 p -62.11 -30.94 71.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.923 1.238 . . . . 0.0 110.341 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.49 -52.23 54.35 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.96 -42.3 85.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.681 1.241 . . . . 0.0 111.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.22 -43.33 82.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.406 1.003 . . . . 0.0 111.095 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -68.9 -29.89 68.27 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.966 -1.084 . . . . 0.0 112.285 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -62.36 -42.32 99.3 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.358 0.981 . . . . 0.0 109.071 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.09 -38.08 89.57 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.349 0.522 . . . . 0.0 110.314 172.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.65 -8.91 3.12 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.18 1.848 . . . . 0.0 113.459 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.9 m -66.69 171.28 5.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.678 1.591 . . . . 0.0 112.256 -169.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.35 136.6 54.22 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 169.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 54.2 m -142.27 165.36 27.64 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.2 131.71 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -68.32 109.56 3.68 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.6 mt -64.97 -28.17 69.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.722 0.409 . . . . 0.0 110.082 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.69 -167.55 40.7 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.76 -164.01 20.37 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.1 -159.65 23.64 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -125.5 154.13 42.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mt -129.83 139.49 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.351 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.12 129.65 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -159.77 -174.69 4.73 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.349 -0.844 . . . . 0.0 110.903 -170.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.81 -161.42 53.43 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.942 -0.474 . . . . 0.0 112.3 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -151.31 152.26 32.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 109.643 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 m -79.6 130.9 35.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 tpt -60.63 -35.26 75.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.903 0.481 . . . . 0.0 111.258 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.08 -16.89 24.46 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.73 -5.9 5.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -169.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.72 178.08 42.94 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.823 0.725 . . . . 0.0 112.098 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.55 135.38 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.671 2.248 . . . . 0.0 109.814 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.13 169.91 16.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 110.152 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -79.68 82.78 5.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -58.45 -18.28 27.34 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.66 -38.4 72.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.502 1.121 . . . . 0.0 111.846 169.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 14.6 mm -62.8 -49.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.9 m -56.58 -52.49 64.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.772 0.829 . . . . 0.0 111.325 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -62.08 -43.61 98.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.995 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.23 -47.93 83.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.499 1.045 . . . . 0.0 110.761 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -64.36 -47.11 80.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.303 0.501 . . . . 0.0 110.986 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -48.3 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -61.92 -38.81 89.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.34 1.427 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.29 97.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.552 0.615 . . . . 0.0 111.922 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -87.95 -12.95 43.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.632 0.651 . . . . 0.0 112.682 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.301 40.5 p90 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 128.56 2.744 . . . . 0.0 116.422 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 m -144.74 170.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.75 1.62 . . . . 0.0 108.143 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -141.39 171.59 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.253 1.421 . . . . 0.0 108.481 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -145.93 164.23 32.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.756 0.707 . . . . 0.0 111.735 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.268 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.8 mt -49.35 -34.25 15.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.181 1.392 . . . . 0.0 112.725 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.13 -24.51 67.19 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.4 mt -79.45 -19.95 48.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.097 0.559 . . . . 0.0 111.517 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mt -70.19 133.43 87.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.79 140.71 68.57 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.41 2.073 . . . . 0.0 108.973 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -86.33 -38.84 17.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.69 140.58 27.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -157.49 117.25 3.38 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 pt . . . . . 0 CA--C 1.538 0.495 0 C-N-CA 124.332 1.053 . . . . 0.0 109.918 -171.555 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 p90 . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.24 154.94 18.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.239 0.616 . . . . 0.0 109.778 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 169.79 16.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.488 0.715 . . . . 0.0 109.551 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.46 153.68 16.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.291 1.436 . . . . 0.0 108.319 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.7 tp -117.1 114.86 24.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.31 132.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.57 147.45 33.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.599 1.16 . . . . 0.0 107.895 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.22 125.85 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -97.11 146.23 25.23 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.679 1.192 . . . . 0.0 108.941 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 m -63.84 100.96 0.33 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.262 0.483 . . . . 0.0 111.025 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.504 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -147.85 9.76 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 116.094 -1.908 . . . . 0.0 114.602 169.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 88.4 Cg_exo -44.7 140.33 6.63 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 124.14 2.514 . . . . 0.0 114.58 174.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? 43.66 24.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.75 2.42 . . . . 0.0 114.117 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.17 30.26 4.17 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.158 1.383 . . . . 0.0 112.327 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.903 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.974 -170.825 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.404 ' C ' ' HG ' ' A' ' 40' ' ' SER . 53.3 mm-40 -77.25 -174.19 3.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.404 ' HG ' ' C ' ' A' ' 39' ' ' GLU . 14.3 m -150.8 160.52 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.778 -1.201 . . . . 0.0 109.974 170.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 165.11 33.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.643 1.577 . . . . 0.0 108.636 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.25 154.95 21.05 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 pt -134.39 155.44 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.9 1.28 . . . . 0.0 109.042 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -118.38 120.79 65.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -135.26 148.69 49.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.26 140.9 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 39.2 m-85 -151.99 152.82 32.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -60.05 -32.31 70.81 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.828 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.403 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.2 p-90 -65.84 -27.78 68.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.683 0.674 . . . . 0.0 112.41 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 78.07 9.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.565 1.075 . . . . 0.0 108.816 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.5 -5.59 8.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.414 0.686 . . . . 0.0 112.08 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 140.09 27.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.086 1.754 . . . . 0.0 107.472 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.5 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.7 m-70 -61.98 -31.12 71.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.596 1.158 . . . . 0.0 111.703 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 -29.39 67.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.728 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.86 -48.02 72.98 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.735 0.698 . . . . 0.0 110.466 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -40.6 82.33 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 117.473 -1.251 . . . . 0.0 110.013 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.1 -46.93 84.71 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.574 1.534 . . . . 0.0 110.137 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.45 -49.51 68.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.254 0.479 . . . . 0.0 111.45 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -60.83 -49.52 77.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.2 0.6 . . . . 0.0 110.955 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.73 -44.51 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.952 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -62.7 -28.29 69.84 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.637 1.108 . . . . 0.0 111.195 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.6 56.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.34 -45.78 86.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.194 0.997 . . . . 0.0 110.96 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.5 mmt -57.78 -45.09 86.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.702 0.683 . . . . 0.0 111.14 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.32 -32.12 72.87 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.946 -1.096 . . . . 0.0 111.814 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -63.72 -37.71 88.39 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.266 0.939 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -66.94 -34.86 78.69 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.216 0.916 . . . . 0.0 110.235 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.6 -6.46 3.86 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.548 2.023 . . . . 0.0 113.106 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.06 178.45 1.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.922 1.689 . . . . 0.0 113.001 -169.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -132.34 142.11 49.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.6 m -145.86 164.27 32.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.87 128.55 10.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 p -71.69 112.27 7.66 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 110.372 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.0 -166.85 39.73 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -163.82 -169.14 26.9 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.46 -160.86 24.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.17 156.82 32.89 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mt -126.36 146.93 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 125.608 1.563 . . . . 0.0 108.405 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t60 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.01 122.69 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -159.96 -176.36 5.64 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.61 -0.681 . . . . 0.0 111.488 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.66 -160.29 51.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -145.34 151.28 38.05 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.857 1.263 . . . . 0.0 108.057 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.1 p -69.85 147.88 49.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.027 0.441 . . . . 0.0 110.526 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.0 ttp -58.33 -22.47 53.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.478 1.111 . . . . 0.0 112.959 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.66 -14.89 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.0 4.78 3.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.214 1.37 . . . . 0.0 112.794 -170.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.69 -175.4 51.79 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 118.518 0.599 . . . . 0.0 112.251 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 136.73 28.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.73 2.287 . . . . 0.0 110.538 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.1 171.51 14.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.572 0.701 . . . . 0.0 110.27 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -77.74 74.67 4.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -58.31 -17.89 23.14 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.29 70.6 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.373 0.669 . . . . 0.0 111.479 169.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.6 -45.38 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.776 0.83 . . . . 0.0 108.794 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -59.39 -49.12 79.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.723 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 p -57.97 -46.16 85.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.718 0.69 . . . . 0.0 111.47 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -61.0 -48.83 79.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.087 0.858 . . . . 0.0 110.472 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -72.71 -42.96 63.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.942 -0.474 . . . . 0.0 111.534 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.3 mt -64.23 -42.32 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.82 -40.24 91.99 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.896 1.68 . . . . 0.0 111.058 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.4 -42.28 98.78 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.447 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.81 -28.18 64.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.226 1.011 . . . . 0.0 112.104 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 . . . . . 0 CA--C 1.549 0.917 0 C-N-CA 125.173 1.389 . . . . 0.0 113.263 -169.852 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.35 154.48 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.485 . . . . 0.0 107.873 -169.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -139.62 169.57 17.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 108.383 172.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -144.55 170.15 16.61 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.777 -0.577 . . . . 0.0 111.135 172.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.55 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.3 mt -50.93 -34.15 27.34 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.77 1.228 . . . . 0.0 112.859 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.52 -23.29 66.84 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.66 0.664 . . . . 0.0 112.579 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.0 mt -77.01 -19.93 56.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.115 0.566 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -69.61 129.72 91.15 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.13 2.553 . . . . 0.0 109.634 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 29.1 t70 -95.45 -40.24 9.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -169.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.73 134.32 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -157.48 119.2 3.7 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.7 pt . . . . . 0 C--O 1.236 0.388 0 C-N-CA 124.217 1.007 . . . . 0.0 109.407 -172.468 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 p90 . . . . . 0 C--O 1.235 0.308 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -107.88 156.52 19.09 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.48 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -143.73 170.61 15.53 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.47 0.708 . . . . 0.0 109.668 -172.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.83 153.51 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.541 1.536 . . . . 0.0 108.663 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.23 116.1 27.18 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 135.02 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 119.08 0.854 . . . . 0.0 109.411 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -82.18 149.29 28.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.751 1.22 . . . . 0.0 108.186 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.79 141.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -114.61 154.0 29.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.872 1.269 . . . . 0.0 109.59 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m -68.69 80.14 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.729 1.211 . . . . 0.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.422 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -134.84 11.1 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 116.028 -1.939 . . . . 0.0 115.179 169.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 77.9 Cg_exo -44.18 137.39 7.52 Favored 'Trans proline' 0 C--N 1.362 1.255 0 CA-C-N 124.248 2.553 . . . . 0.0 113.668 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 45.92 22.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.711 2.404 . . . . 0.0 114.205 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 49.89 30.71 4.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.962 1.305 . . . . 0.0 112.051 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.954 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.756 -170.905 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.01 166.24 16.26 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -139.23 158.29 44.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.972 0.909 . . . . 0.0 109.928 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.94 164.14 37.06 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.028 1.331 . . . . 0.0 109.047 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.32 154.94 21.09 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.52 155.42 38.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.264 1.426 . . . . 0.0 108.858 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.6 123.38 70.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -135.2 148.72 49.74 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.035 0.934 . . . . 0.0 108.619 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.47 136.86 3.82 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 171.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -150.46 151.05 32.14 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.14 -39.34 82.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.672 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -60.22 -30.25 69.27 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.106 0.866 . . . . 0.0 112.63 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.28 75.42 9.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.176 0.898 . . . . 0.0 108.767 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.59 -8.16 9.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.19 0.596 . . . . 0.0 112.081 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.66 138.43 36.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.59 1.956 . . . . 0.0 107.253 175.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.484 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.0 m-70 -60.66 -29.93 69.59 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.674 1.19 . . . . 0.0 112.027 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.76 69.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.439 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.63 -46.12 76.86 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.511 0.596 . . . . 0.0 110.919 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -42.01 83.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 117.288 -1.339 . . . . 0.0 110.243 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.97 -46.18 90.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 120.635 1.561 . . . . 0.0 109.901 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.36 -48.79 78.2 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.805 0.73 . . . . 0.0 111.365 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -62.17 -49.65 74.97 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.131 0.572 . . . . 0.0 111.045 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.48 -45.34 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.515 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -60.58 -36.1 77.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.678 1.126 . . . . 0.0 109.463 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.13 -50.36 66.91 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 118.899 0.772 . . . . 0.0 111.503 172.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.37 -46.93 84.24 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.544 1.172 . . . . 0.0 111.07 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.7 mmt -57.96 -45.93 85.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.774 0.715 . . . . 0.0 110.985 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -65.6 -32.59 74.25 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.027 -1.045 . . . . 0.0 111.459 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -63.42 -42.92 98.74 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 109.701 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -60.37 -40.16 89.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.295 0.952 . . . . 0.0 109.504 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.66 -7.08 1.94 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.415 1.959 . . . . 0.0 113.09 169.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.74 179.17 1.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.14 1.776 . . . . 0.0 113.672 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -131.86 144.74 51.1 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m -148.05 169.33 20.19 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.817 0.735 . . . . 0.0 112.641 -168.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.52 138.96 15.84 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.267 1.027 . . . . 0.0 109.012 169.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -70.96 118.1 13.3 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.9 -26.01 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.99 -0.444 . . . . 0.0 110.284 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.0 -166.95 38.45 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -160.6 -168.02 21.93 Favored Glycine 0 C--O 1.235 0.211 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.56 -155.37 15.57 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.81 153.01 52.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.844 1.258 . . . . 0.0 108.073 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.0 mt -136.07 141.49 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.234 0.277 0 C-N-CA 124.284 1.034 . . . . 0.0 111.238 -176.483 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.05 133.15 64.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -159.55 -175.05 4.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.14 -0.975 . . . . 0.0 110.249 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.87 -161.68 54.3 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 121.668 0.593 . . . . 0.0 112.32 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -150.83 153.15 34.86 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.605 1.562 . . . . 0.0 107.785 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 t -67.57 133.17 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.3 ttp -54.72 -27.01 37.65 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.696 1.198 . . . . 0.0 111.841 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.87 -24.7 8.53 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.665 0.786 . . . . 0.0 112.896 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.11 4.39 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.68 -175.75 40.39 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 118.957 0.799 . . . . 0.0 112.555 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.42 132.88 24.83 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.432 2.088 . . . . 0.0 110.33 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.22 173.6 8.39 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.478 0.656 . . . . 0.0 110.87 169.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -76.97 73.06 3.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.48 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 45.0 m80 -57.41 -19.08 21.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -173.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.32 65.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.454 0.701 . . . . 0.0 111.011 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -61.14 -50.39 80.71 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.2 m -56.01 -48.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.595 0.758 . . . . 0.0 110.776 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 p -59.19 -47.36 85.61 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.082 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.02 -46.59 89.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.528 1.058 . . . . 0.0 110.581 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 11' ' ' ASP . 23.4 mmtp -68.22 -47.27 68.31 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.562 0.745 . . . . 0.0 111.034 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.88 -37.31 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.934 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -63.06 -45.31 92.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 121.378 1.899 . . . . 0.0 110.819 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.5 89.0 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.454 0.57 . . . . 0.0 111.773 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.04 -17.17 28.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.254 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.253 30.6 p90 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 127.381 2.272 . . . . 0.0 114.093 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 C--O 1.237 0.427 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.03 158.31 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.819 1.647 . . . . 0.0 108.071 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 p -135.66 176.01 9.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.639 1.176 . . . . 0.0 108.617 169.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -139.37 166.65 23.98 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.865 -0.522 . . . . 0.0 111.282 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.395 0 C-N-CA 124.522 1.129 . . . . 0.0 108.115 169.886 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 mt -50.5 -34.87 26.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.32 1.048 . . . . 0.0 112.957 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.13 -24.13 64.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.699 0.681 . . . . 0.0 112.549 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.31 -19.63 42.47 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.633 0.773 . . . . 0.0 111.253 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.28 132.75 92.71 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.026 0.931 . . . . 0.0 108.694 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.4 109.91 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.489 2.793 . . . . 0.0 110.045 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -76.49 -38.19 55.67 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -169.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.09 124.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -146.21 102.49 3.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.8 pt . . . . . 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.02 -169.878 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -84.25 162.08 20.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.776 -0.578 . . . . 0.0 110.821 -175.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.16 171.86 13.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.356 1.063 . . . . 0.0 109.492 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.93 153.59 17.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.978 1.311 . . . . 0.0 108.035 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 tp -116.89 115.63 25.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.19 133.41 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 118.918 0.781 . . . . 0.0 110.007 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -77.96 147.66 34.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.014 1.326 . . . . 0.0 107.642 169.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.68 141.22 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -117.41 141.34 48.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.301 1.441 . . . . 0.0 108.16 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 m -64.16 106.97 1.17 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.574 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.549 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.01 17.39 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.935 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.0 Cg_exo -42.3 133.43 4.75 Favored 'Trans proline' 0 C--N 1.365 1.436 0 CA-C-N 123.733 2.369 . . . . 0.0 115.261 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 41.9 32.65 0.29 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.595 2.758 . . . . 0.0 113.179 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m 52.96 29.76 8.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.607 1.563 . . . . 0.0 113.0 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.304 -174.857 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.94 170.18 11.75 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -138.76 159.02 43.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.908 0.883 . . . . 0.0 110.543 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.55 36.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.722 1.609 . . . . 0.0 109.306 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -108.77 156.95 19.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 pt -137.02 159.02 36.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.961 1.705 . . . . 0.0 109.518 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.7 t -124.24 119.17 55.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.0 mmt85 -139.61 148.45 42.5 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.93 136.47 2.75 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.047 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 15.6 m-85 -153.0 156.01 38.02 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.259 0.623 . . . . 0.0 111.45 -169.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -35.61 61.34 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.418 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-90 -71.6 -25.44 62.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.215 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.71 80.38 9.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.317 0.962 . . . . 0.0 109.142 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.71 -9.15 17.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.418 0.687 . . . . 0.0 112.069 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.17 142.45 30.55 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.049 1.739 . . . . 0.0 107.604 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.421 ' CD2' ' HG ' ' A' ' 94' ' ' SER . 24.7 m-70 -61.98 -30.06 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.81 0.844 . . . . 0.0 111.735 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.38 68.16 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.749 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.49 -47.68 69.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.574 0.624 . . . . 0.0 110.655 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -38.56 79.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 117.456 -1.259 . . . . 0.0 110.243 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -58.95 -46.38 88.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.584 1.538 . . . . 0.0 109.932 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.69 -50.21 67.86 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.38 0.536 . . . . 0.0 111.418 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -61.29 -46.84 88.64 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 122.8 0.44 . . . . 0.0 111.158 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.74 -36.34 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.43 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.83 -29.89 70.47 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.137 1.335 . . . . 0.0 110.764 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.23 -49.0 55.89 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.405 1.002 . . . . 0.0 111.135 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -57.01 -44.71 83.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.823 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mmt -69.02 -41.64 77.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.724 -0.61 . . . . 0.0 112.231 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -69.24 -29.95 67.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.36 1.436 . . . . 0.0 111.714 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -61.5 -43.09 99.49 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.988 0.915 . . . . 0.0 109.167 169.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.84 -37.07 85.34 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.441 0.564 . . . . 0.0 110.287 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.98 -6.69 5.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 127.252 2.358 . . . . 0.0 112.944 172.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.46 177.32 4.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.514 1.925 . . . . 0.0 112.78 -169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -127.92 151.09 49.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 55.9 m -147.72 168.49 21.96 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.04 126.47 7.34 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.19 1.396 . . . . 0.0 108.002 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.08 118.79 11.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.38 -26.67 61.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.722 0.409 . . . . 0.0 110.252 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.67 -171.94 42.35 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.18 -173.75 20.09 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.88 -158.79 23.32 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -127.94 153.58 46.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.969 1.308 . . . . 0.0 108.725 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.53 130.55 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.33 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.883 -169.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.2 t60 . . . . . 0 C--O 1.233 0.19 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -134.29 114.91 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.25 172.9 17.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.206 1.002 . . . . 0.0 108.325 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.06 -165.39 24.33 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.91 1.232 . . . . 0.0 113.066 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -153.78 154.83 34.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.791 2.036 . . . . 0.0 107.388 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.421 ' HG ' ' CD2' ' A' ' 53' ' ' HIS . 24.2 m -139.1 106.17 5.46 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -56.45 -28.5 59.75 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.05 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.211 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -135.6 -7.89 2.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.02 171.32 45.97 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.018 0.818 . . . . 0.0 111.138 -169.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.51 144.77 36.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.626 2.218 . . . . 0.0 109.564 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 167.71 18.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 109.397 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -65.86 -31.54 72.54 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.53 0.732 . . . . 0.0 112.022 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.8 m80 58.21 -30.78 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.111 2.964 . . . . 0.0 115.983 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.86 75.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.776 1.171 . . . . 0.0 111.479 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 mm -58.98 -54.42 34.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.5 m -53.62 -50.55 65.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.294 1.038 . . . . 0.0 111.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 p -60.96 -41.69 96.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.232 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.1 -45.71 87.44 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.475 1.034 . . . . 0.0 110.053 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -64.7 -43.81 92.29 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 122.055 -0.403 . . . . 0.0 110.965 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 52.0 mt -62.9 -45.74 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.89 0.876 . . . . 0.0 108.956 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -62.78 -29.91 71.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.897 1.226 . . . . 0.0 111.566 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.58 -43.95 71.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.012 1.278 . . . . 0.0 111.193 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -71.62 -26.89 62.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.915 0.886 . . . . 0.0 112.595 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 CA--C 1.547 0.854 0 C-N-CA 125.558 1.543 . . . . 0.0 113.864 -170.871 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.48 167.94 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.575 0.75 . . . . 0.0 111.417 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -140.85 171.37 14.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.346 1.458 . . . . 0.0 109.277 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -142.6 171.93 13.38 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.228 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.352 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.0 mt -50.17 -33.97 20.93 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.763 1.225 . . . . 0.0 113.114 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.89 67.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.685 0.675 . . . . 0.0 112.558 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.21 -19.71 53.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.325 0.65 . . . . 0.0 111.341 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.46 133.01 92.95 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.16 111.32 0.71 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.647 2.898 . . . . 0.0 110.909 170.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.93 -34.88 64.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.235 0.614 . . . . 0.0 111.989 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.5 t -137.36 135.04 47.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.94 118.13 3.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 C--O 1.236 0.352 0 C-N-CA 124.708 1.203 . . . . 0.0 108.183 -176.661 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.0 p90 . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 121.084 0.469 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.82 159.56 15.33 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.72 166.51 23.79 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.976 1.31 . . . . 0.0 108.94 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.88 156.67 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.982 1.313 . . . . 0.0 107.776 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -122.06 121.07 36.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.77 135.82 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.458 0.572 . . . . 0.0 109.633 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -83.17 150.96 25.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.833 1.253 . . . . 0.0 107.65 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -137.37 140.68 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -113.32 146.82 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.419 1.487 . . . . 0.0 108.912 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.3 m -66.57 95.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.98 0.912 . . . . 0.0 110.805 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.477 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.17 11.78 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 115.905 -1.998 . . . . 0.0 114.069 168.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 71.0 Cg_exo -44.27 136.94 8.0 Favored 'Trans proline' 0 C--N 1.364 1.362 0 CA-C-N 124.146 2.516 . . . . 0.0 114.229 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mmt-85 47.65 22.07 0.3 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.802 2.441 . . . . 0.0 113.881 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 50.39 31.11 5.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.117 1.367 . . . . 0.0 112.217 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.904 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.925 -171.577 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -69.25 169.15 12.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 169.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -139.17 157.35 46.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.898 0.879 . . . . 0.0 109.851 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 165.91 32.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.401 1.481 . . . . 0.0 109.477 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -112.88 154.96 25.51 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.577 0.751 . . . . 0.0 109.092 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.6 pt -135.24 156.8 39.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.77 1.228 . . . . 0.0 109.749 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.86 124.26 72.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 125.868 1.667 . . . . 0.0 107.021 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -134.59 150.18 50.68 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.584 1.554 . . . . 0.0 108.689 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.79 131.63 1.48 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -154.55 151.24 28.65 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -64.54 -20.62 66.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -69.63 -26.22 64.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.634 1.107 . . . . 0.0 112.287 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.36 88.64 7.52 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.985 1.266 . . . . 0.0 109.076 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.32 -8.49 32.74 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.537 0.735 . . . . 0.0 112.101 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -147.9 145.62 28.71 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.669 1.588 . . . . 0.0 108.283 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -61.03 -31.8 71.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.241 1.016 . . . . 0.0 111.585 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.66 -26.06 68.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.824 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.0 -49.38 61.89 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.151 0.887 . . . . 0.0 110.418 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -39.86 85.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.254 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -62.06 -49.48 75.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.356 0.98 . . . . 0.0 110.081 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.81 -44.84 95.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.256 0.934 . . . . 0.0 111.169 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.48 -51.7 68.75 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.341 0.656 . . . . 0.0 110.78 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.4 t -82.12 -38.61 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.043 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.2 p -61.43 -31.75 71.7 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.857 1.662 . . . . 0.0 110.328 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.84 -51.06 59.83 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.05 -44.14 96.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.375 1.088 . . . . 0.0 111.202 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.35 -45.38 91.55 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.802 0.728 . . . . 0.0 110.563 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.41 -33.04 75.03 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.014 -1.054 . . . . 0.0 111.588 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -64.52 -39.64 94.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.962 0.801 . . . . 0.0 110.692 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.03 -32.12 73.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.264 0.938 . . . . 0.0 110.61 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.98 -8.05 4.47 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.114 2.292 . . . . 0.0 113.177 169.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -67.48 179.56 1.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.095 1.758 . . . . 0.0 113.539 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -131.14 143.14 50.41 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.0 m -147.15 167.44 24.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -168.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -153.09 134.37 14.23 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.524 1.53 . . . . 0.0 108.103 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 p -73.65 115.84 13.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.9 -24.92 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.952 -0.468 . . . . 0.0 110.772 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.0 43.48 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.44 -164.83 15.31 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.44 -155.61 22.67 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -138.52 155.02 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 109.127 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.8 136.63 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.234 0.244 0 C-N-CA 124.619 1.168 . . . . 0.0 109.62 -176.204 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.3 t60 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.15 123.0 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.23 -174.42 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.154 -0.966 . . . . 0.0 111.085 -169.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.79 -160.04 52.58 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -149.51 154.48 38.83 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.431 1.493 . . . . 0.0 107.863 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 t -69.74 131.83 45.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.8 ttt -59.02 -20.77 56.18 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.973 0.909 . . . . 0.0 111.814 170.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.32 -24.23 8.53 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 113.087 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -130.77 1.07 4.38 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -177.65 45.33 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.248 0.931 . . . . 0.0 112.381 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.25 130.22 17.2 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.739 2.293 . . . . 0.0 111.223 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.69 168.08 20.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.227 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.98 78.54 5.41 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 169.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -59.01 -15.88 15.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.01 66.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.387 0.675 . . . . 0.0 111.401 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.57 -44.17 96.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.728 0.811 . . . . 0.0 108.942 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.3 m -58.67 -53.03 62.91 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.268 0.627 . . . . 0.0 110.34 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 p -60.45 -44.6 95.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -58.98 -53.45 58.3 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.283 0.947 . . . . 0.0 110.931 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.4 -44.49 67.86 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.918 -0.489 . . . . 0.0 111.421 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.4 -42.25 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 118.087 -0.959 . . . . 0.0 108.639 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.72 -39.28 93.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.913 1.688 . . . . 0.0 111.029 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.94 89.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.475 0.58 . . . . 0.0 111.302 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -79.86 -24.66 41.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.224 0.465 . . . . 0.0 112.106 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 CA--C 1.546 0.807 0 C-N-CA 127.13 2.172 . . . . 0.0 111.967 -170.076 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 121.367 0.603 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.94 164.07 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.058 1.743 . . . . 0.0 110.033 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.3 p -141.42 172.06 13.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.324 1.849 . . . . 0.0 107.133 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.63 167.58 21.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.894 0.77 . . . . 0.0 112.39 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 125.323 1.449 . . . . 0.0 107.643 169.844 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -53.53 -28.98 34.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.828 1.251 . . . . 0.0 113.507 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.48 57.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.024 0.829 . . . . 0.0 112.451 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.0 mt -84.87 -19.72 31.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.017 0.927 . . . . 0.0 111.25 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.07 138.29 72.87 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.428 1.091 . . . . 0.0 109.265 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.41 99.35 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.517 2.811 . . . . 0.0 109.307 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.65 -32.09 67.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.938 1.295 . . . . 0.0 112.658 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t -140.99 128.67 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -152.28 108.14 3.36 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt . . . . . 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.258 . . . . 0.0 108.384 -172.209 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.2 p90 . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.46 157.92 16.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.97 172.07 13.29 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.684 0.794 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.45 153.23 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.225 1.41 . . . . 0.0 108.123 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.4 tp -117.76 115.62 25.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 131.95 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.85 147.16 39.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.01 131.04 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -100.08 151.2 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.455 1.102 . . . . 0.0 109.734 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 m -65.81 97.56 0.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.931 0.892 . . . . 0.0 110.827 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -151.07 22.6 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.451 -1.738 . . . . 0.0 114.449 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 81.8 Cg_exo -46.34 138.21 13.73 Favored 'Trans proline' 0 C--N 1.362 1.25 0 CA-C-N 123.906 2.431 . . . . 0.0 113.0 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 44.93 26.75 0.22 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 113.7 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m 50.18 33.04 6.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.347 1.459 . . . . 0.0 112.753 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 C-N-CA 123.556 0.598 . . . . 0.0 113.066 -172.659 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.125 0.488 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.74 168.72 14.38 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -142.03 159.56 41.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.038 0.935 . . . . 0.0 110.325 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.66 168.26 26.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.975 1.71 . . . . 0.0 108.835 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -108.39 156.77 19.05 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 pt -133.15 156.24 41.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.942 1.297 . . . . 0.0 109.245 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.59 116.7 50.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -137.81 147.43 44.59 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.7 134.99 2.02 Favored Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.435 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.0 m-85 -156.75 156.7 33.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -170.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -60.91 -33.09 72.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.242 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.435 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.7 p-90 -64.52 -28.62 69.77 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.84 0.746 . . . . 0.0 112.103 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 77.79 9.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.218 0.917 . . . . 0.0 108.705 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -65.89 -6.07 11.16 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.19 140.23 33.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.69 1.596 . . . . 0.0 107.55 174.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -61.46 -29.74 70.16 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.403 1.081 . . . . 0.0 111.873 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.58 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.759 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.0 -46.44 74.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.675 0.67 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -41.09 82.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.152 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -58.45 -44.66 89.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.004 1.729 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.25 -50.83 64.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.647 0.658 . . . . 0.0 111.542 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -60.77 -46.48 90.3 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.977 0.511 . . . . 0.0 111.089 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.8 -36.4 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.381 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -62.06 -28.95 69.96 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.244 1.384 . . . . 0.0 110.927 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.86 -52.06 45.69 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.321 0.964 . . . . 0.0 110.943 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -55.88 -47.54 77.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 110.445 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.242 -0.911 . . . . 0.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.3 -28.9 66.68 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.681 -1.262 . . . . 0.0 111.474 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -31.79 73.1 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.12 0.968 . . . . 0.0 110.057 169.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -70.76 -45.96 63.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.822 1.192 . . . . 0.0 108.332 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.26 -6.78 2.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.294 2.378 . . . . 0.0 112.502 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.84 171.39 11.76 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.149 1.78 . . . . 0.0 112.983 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.62 147.92 46.91 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.0 m -148.19 165.61 30.4 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -168.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.4 129.62 11.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.767 1.227 . . . . 0.0 107.997 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.5 114.45 5.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.5 -28.26 64.83 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.996 -0.44 . . . . 0.0 110.143 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.72 -167.02 40.07 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.99 -166.92 21.65 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 171.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.47 -161.2 26.45 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -127.12 151.15 49.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.626 1.17 . . . . 0.0 108.432 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.0 mt -132.66 135.13 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.232 0.164 0 C-N-CA 123.016 0.526 . . . . 0.0 111.535 -169.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.1 t60 . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.4 130.33 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -159.26 -172.14 3.63 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.5 -164.5 41.69 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 121.653 0.585 . . . . 0.0 111.676 170.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -148.23 153.32 38.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.173 1.389 . . . . 0.0 107.499 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 t -69.55 128.56 36.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.24 -20.58 55.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.212 0.605 . . . . 0.0 111.646 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.69 -27.33 9.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.911 0.884 . . . . 0.0 112.917 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -132.59 4.48 3.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.89 -178.74 50.63 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.229 0.922 . . . . 0.0 112.73 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.5 129.37 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.766 2.311 . . . . 0.0 110.47 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 169.16 17.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 111.079 169.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.13 75.41 4.67 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -56.86 -20.53 23.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.06 -38.75 65.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.64 0.776 . . . . 0.0 111.606 169.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mm -62.27 -45.6 98.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.998 0.919 . . . . 0.0 109.072 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.4 m -58.02 -52.66 64.59 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.413 0.685 . . . . 0.0 110.234 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -62.59 -41.42 98.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.26 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -60.99 -50.28 74.03 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 110.412 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.76 -46.11 73.0 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.09 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.3 mt -61.74 -44.52 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.833 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -62.66 -40.05 95.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.543 1.519 . . . . 0.0 111.216 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.34 84.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.782 0.719 . . . . 0.0 111.546 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -79.74 -21.11 44.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.299 0.64 . . . . 0.0 111.743 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 t80 . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 127.528 2.331 . . . . 0.0 112.419 -176.832 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.03 167.3 22.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.854 0.862 . . . . 0.0 110.586 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.8 p -139.01 171.39 14.39 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 109.363 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -146.95 163.21 36.91 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.73 -0.607 . . . . 0.0 110.599 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 169.265 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.3 mt -50.94 -35.35 32.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.319 1.048 . . . . 0.0 112.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.88 -23.73 66.04 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.808 0.731 . . . . 0.0 112.679 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.2 mt -84.7 -19.7 32.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.741 0.816 . . . . 0.0 111.305 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.5 138.48 94.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.95 111.32 1.35 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.088 2.525 . . . . 0.0 109.571 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.83 -37.15 70.36 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.399 1.08 . . . . 0.0 112.963 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.69 137.41 47.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -153.94 110.24 3.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 C--O 1.235 0.341 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 177.289 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 p90 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 160.39 14.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.74 166.55 24.33 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.382 1.073 . . . . 0.0 109.252 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.72 156.8 12.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.07 115.5 23.82 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.04 129.94 72.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -76.75 147.76 37.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -134.69 142.83 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -116.07 148.35 40.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.555 1.142 . . . . 0.0 108.733 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 m -61.51 101.24 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.834 0.854 . . . . 0.0 110.654 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.476 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.32 15.14 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.076 -1.916 . . . . 0.0 115.619 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.476 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 80.4 Cg_exo -42.84 137.24 4.37 Favored 'Trans proline' 0 C--N 1.362 1.288 0 CA-C-N 124.371 2.597 . . . . 0.0 114.244 171.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 45.84 25.62 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.35 2.26 . . . . 0.0 113.929 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.08 31.94 7.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.186 1.395 . . . . 0.0 112.355 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.83 0 C-N-CA 123.697 0.665 . . . . 0.0 112.872 -172.578 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.281 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.61 177.23 6.94 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -143.67 156.78 44.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.635 0.774 . . . . 0.0 110.146 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 165.37 36.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.512 1.525 . . . . 0.0 109.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.1 155.08 20.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.99 151.38 34.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.578 1.151 . . . . 0.0 109.166 171.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.12 120.95 64.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -131.28 147.49 52.59 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.859 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.73 132.87 1.81 Allowed Glycine 0 C--N 1.33 0.225 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.08 151.29 26.61 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -61.52 -28.18 69.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.442 0.697 . . . . 0.0 112.742 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -66.71 -26.96 67.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.143 0.883 . . . . 0.0 112.093 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 85.19 5.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 171.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.99 -10.89 43.77 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 173.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 141.09 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.896 1.278 . . . . 0.0 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.447 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.03 -32.22 70.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.572 1.549 . . . . 0.0 111.763 -173.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.18 -30.22 70.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.739 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.45 -47.88 66.01 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.89 0.768 . . . . 0.0 110.473 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -37.51 79.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.521 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.74 -47.41 86.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 110.323 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.24 -46.79 75.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.789 0.722 . . . . 0.0 111.393 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -52.76 -54.8 28.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.631 1.172 . . . . 0.0 110.056 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.4 t -80.57 -34.4 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.745 -169.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -62.35 -30.91 71.51 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 120.382 1.446 . . . . 0.0 110.835 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.9 -51.18 58.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 110.638 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.6 -44.87 92.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 111.187 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.43 -45.04 95.09 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.987 -0.445 . . . . 0.0 111.011 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.6 -31.2 71.07 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.086 -1.009 . . . . 0.0 111.834 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.39 -40.3 96.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.19 0.904 . . . . 0.0 110.033 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -59.42 -47.22 86.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.712 1.142 . . . . 0.0 108.907 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.68 -5.64 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 126.631 2.063 . . . . 0.0 112.709 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.1 m -66.33 176.05 1.96 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.116 1.766 . . . . 0.0 112.728 -170.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -129.86 143.34 50.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -147.63 164.06 34.68 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -169.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -154.9 128.54 8.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 108.306 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -68.25 114.28 6.6 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.4 mt -70.3 -27.62 64.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.932 0.493 . . . . 0.0 110.638 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.85 -173.58 45.57 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.4 -179.08 28.57 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.59 -162.14 28.57 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -137.65 167.21 22.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.226 1.013 . . . . 0.0 110.785 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.12 143.11 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -169.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.236 0.395 0 O-C-N 121.67 -0.644 . . . . 0.0 111.458 178.563 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.2 t60 . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.39 127.8 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.504 1.522 . . . . 0.0 107.322 -174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -162.15 -175.58 4.67 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.532 -0.73 . . . . 0.0 110.69 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.76 -167.57 48.37 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.266 0.46 . . . . 0.0 112.168 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -151.33 147.04 26.45 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.522 0.729 . . . . 0.0 109.943 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -73.42 139.47 45.88 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.82 -36.44 83.5 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.818 -0.551 . . . . 0.0 109.808 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.39 58.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.2 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -134.13 1.29 3.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.216 0.917 . . . . 0.0 113.35 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.02 55.13 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 118.93 0.787 . . . . 0.0 111.914 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 137.85 40.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.692 2.262 . . . . 0.0 110.181 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.6 169.84 16.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 169.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -79.05 72.4 5.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -56.85 -19.39 17.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.892 0.877 . . . . 0.0 113.276 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.94 -38.8 65.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.659 0.783 . . . . 0.0 111.388 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.1 mm -62.03 -43.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 C-N-CA 124.23 1.012 . . . . 0.0 109.028 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -57.52 -54.07 51.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.119 0.568 . . . . 0.0 110.082 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.1 p -60.6 -41.76 95.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.337 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.99 -50.71 72.29 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.419 1.009 . . . . 0.0 110.6 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -71.66 -42.23 67.77 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.906 -0.496 . . . . 0.0 111.423 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.14 -45.46 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.61 -36.08 81.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.168 1.349 . . . . 0.0 111.346 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.0 -42.54 94.38 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.44 1.018 . . . . 0.0 111.487 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -84.1 -17.84 38.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.586 0.754 . . . . 0.0 112.856 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 126.399 1.88 . . . . 0.0 115.595 -171.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.93 167.58 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.638 1.575 . . . . 0.0 108.727 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -140.85 169.57 17.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.68 1.192 . . . . 0.0 108.763 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -145.54 167.15 23.72 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 110.402 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.521 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.52 -28.43 65.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.49 -26.5 63.64 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.223 0.92 . . . . 0.0 112.055 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.74 -30.67 18.89 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.333 1.053 . . . . 0.0 110.654 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.3 127.76 81.31 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 144.42 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.46 2.107 . . . . 0.0 109.864 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -81.86 -44.05 17.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.137 0.575 . . . . 0.0 111.146 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 t -133.49 137.02 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -154.48 109.84 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 C--O 1.236 0.356 0 C-N-CA 123.812 0.845 . . . . 0.0 109.253 -172.79 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -85.62 157.47 20.35 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.32 168.75 19.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.038 0.935 . . . . 0.0 109.35 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 154.43 16.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 125.139 1.376 . . . . 0.0 107.548 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -118.36 118.23 31.22 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.31 134.63 65.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.94 0.791 . . . . 0.0 109.079 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -77.39 148.45 35.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' HA ' ' HG ' ' A' ' 71' ' ' CYS . 24.3 t -134.8 126.64 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.41 149.51 21.63 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.68 0.792 . . . . 0.0 109.566 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.9 m -65.59 100.76 0.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.484 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.505 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.02 19.32 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 116.282 -1.818 . . . . 0.0 114.776 169.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.505 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 84.8 Cg_exo -44.11 136.61 7.74 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 124.114 2.505 . . . . 0.0 113.846 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 46.13 25.76 0.37 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.738 2.015 . . . . 0.0 113.797 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.86 32.61 7.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.232 1.413 . . . . 0.0 112.448 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.901 0 C-N-CA 123.83 0.729 . . . . 0.0 112.842 -173.191 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -74.03 -176.48 2.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.714 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -142.25 159.67 41.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.685 0.794 . . . . 0.0 110.555 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.81 165.77 26.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.597 1.959 . . . . 0.0 107.573 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -111.94 146.99 36.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -126.45 154.8 36.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.312 1.045 . . . . 0.0 109.839 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.1 t -118.7 118.87 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -136.41 147.63 47.37 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.13 133.91 1.97 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.3 m-85 -156.33 155.01 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.9 0.88 . . . . 0.0 109.001 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.99 -31.56 71.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.457 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.1 p-90 -63.9 -30.15 71.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.29 0.95 . . . . 0.0 111.873 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.74 80.72 8.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.18 -14.54 38.69 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.005 0.522 . . . . 0.0 111.796 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.09 142.74 40.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.031 1.732 . . . . 0.0 108.26 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.482 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.8 -31.35 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.137 1.375 . . . . 0.0 111.879 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.33 -28.79 70.0 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.729 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.11 -46.98 72.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.997 0.817 . . . . 0.0 110.496 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -39.94 82.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.261 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -59.62 -48.04 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.778 1.626 . . . . 0.0 109.963 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -48.75 78.87 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.864 0.757 . . . . 0.0 111.324 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -60.62 -50.79 72.1 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.301 0.64 . . . . 0.0 110.891 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -75.07 -40.37 44.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 118.442 -0.79 . . . . 0.0 109.447 -171.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 t -59.09 -40.38 85.1 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.498 1.045 . . . . 0.0 109.082 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.95 -50.54 64.96 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 118.85 0.75 . . . . 0.0 111.952 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.51 -45.75 91.56 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.265 1.033 . . . . 0.0 111.283 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.86 -43.9 97.75 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.505 -0.747 . . . . 0.0 111.798 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.97 -32.36 73.81 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.645 -1.284 . . . . 0.0 111.152 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.37 90.76 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.947 0.899 . . . . 0.0 110.301 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -59.46 -46.42 88.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.878 1.217 . . . . 0.0 108.5 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.7 -5.99 1.59 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 126.951 2.215 . . . . 0.0 112.438 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.0 m -70.16 177.14 3.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.857 1.663 . . . . 0.0 112.114 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -129.46 142.56 50.75 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 169.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.402 ' HG ' ' HA ' ' A' ' 27' ' ' VAL . 91.3 m -143.05 165.09 28.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -168.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -154.94 130.77 10.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.48 112.67 4.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.7 mt -67.35 -28.46 67.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.796 -0.565 . . . . 0.0 110.219 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.66 42.18 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.036 -2.025 . . . . 0.0 108.036 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.34 -175.16 26.07 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.69 -159.86 24.66 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -135.7 163.03 31.09 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.4 1.1 . . . . 0.0 110.566 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.6 mt -123.85 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.451 -0.394 0 C-N-CA 123.241 0.616 . . . . 0.0 110.834 -169.434 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.2 t60 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.06 117.91 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -161.85 -168.61 1.98 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.053 0.541 . . . . 0.0 110.684 -173.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.87 -161.82 53.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -152.5 152.38 31.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.331 1.052 . . . . 0.0 108.67 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.3 p -77.94 137.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.7 tpt -65.05 -34.81 79.32 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.839 -0.538 . . . . 0.0 109.855 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.94 65.54 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.416 -0.802 . . . . 0.0 113.111 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -133.86 4.03 3.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.67 -175.26 55.07 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.806 0.73 . . . . 0.0 111.75 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.48 138.37 38.54 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.576 2.184 . . . . 0.0 110.685 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 176.29 5.25 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.54 -34.08 77.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.74 -0.6 . . . . 0.0 111.368 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.4 m80 58.51 -29.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.141 2.976 . . . . 0.0 115.87 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.72 81.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.474 1.11 . . . . 0.0 111.41 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.28 -46.36 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.4 m -56.29 -53.69 54.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.879 0.872 . . . . 0.0 110.538 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -47.21 77.99 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.931 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -64.83 -47.76 76.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.837 0.744 . . . . 0.0 110.519 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.75 -38.37 67.4 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 118.799 -0.619 . . . . 0.0 111.309 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.4 mt -61.61 -45.65 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 95.9 mttt -62.62 -40.33 96.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.573 1.533 . . . . 0.0 111.431 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.59 87.13 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.452 0.569 . . . . 0.0 111.224 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -79.45 -23.22 43.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 CA--C 1.543 0.675 0 C-N-CA 127.593 2.357 . . . . 0.0 111.943 -172.353 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' HG3' ' HE2' ' A' ' 110' ' ' LYS . 26.8 tt0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 121.666 0.746 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.65 162.89 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.038 1.335 . . . . 0.0 109.54 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 p -142.66 174.41 10.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.434 1.894 . . . . 0.0 108.514 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -145.67 167.29 23.47 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.422 -0.799 . . . . 0.0 111.14 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.456 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t70 . . . . . 0 C--O 1.232 0.172 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -53.85 -30.76 46.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.688 1.195 . . . . 0.0 113.349 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.25 -25.31 59.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.995 0.816 . . . . 0.0 112.434 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.85 -21.58 29.74 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.936 0.894 . . . . 0.0 111.135 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.85 131.75 82.97 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.59 119.76 5.57 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.763 2.976 . . . . 0.0 110.13 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.53 -41.14 12.9 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -169.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -138.58 135.03 43.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -156.14 116.3 3.66 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 pt . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 108.358 -176.332 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.2 p90 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -97.83 160.13 14.5 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.605 -0.684 . . . . 0.0 109.185 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 169.02 18.87 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 122.992 0.517 . . . . 0.0 110.126 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.0 153.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.322 . . . . 0.0 108.844 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 tp -118.81 116.87 27.42 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.52 132.62 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.416 1.007 . . . . 0.0 109.674 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -78.03 145.99 35.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.032 1.333 . . . . 0.0 108.503 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.14 128.73 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -93.79 154.07 17.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.984 0.913 . . . . 0.0 110.398 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.7 p -73.64 41.91 0.12 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.536 1.934 . . . . 0.0 114.963 -172.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.48 22.42 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 115.918 -1.991 . . . . 0.0 116.344 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.73 125.05 6.04 Favored 'Trans proline' 0 C--N 1.359 1.117 0 CA-C-N 124.553 2.662 . . . . 0.0 113.833 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 39.63 28.14 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.696 2.799 . . . . 0.0 114.419 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m 48.92 30.31 2.7 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.038 1.335 . . . . 0.0 112.551 -171.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.951 0 C-N-CA 124.129 0.871 . . . . 0.0 113.539 -170.177 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.503 0.668 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' C ' ' HG ' ' A' ' 40' ' ' SER . 57.5 mm-40 -74.08 168.06 20.3 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.434 ' HG ' ' C ' ' A' ' 39' ' ' GLU . 15.7 m -154.78 161.14 41.61 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.58 -1.325 . . . . 0.0 111.242 177.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.414 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -152.94 165.75 34.54 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.893 1.677 . . . . 0.0 108.477 173.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.25 151.17 26.31 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.414 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 48.6 pt -130.4 156.57 42.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.102 1.361 . . . . 0.0 109.32 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.6 122.71 66.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -128.69 153.32 47.44 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.33 132.26 2.46 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -151.21 151.08 31.38 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.2 1.0 . . . . 0.0 108.45 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.2 -29.13 68.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.192 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -65.54 -34.35 78.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.18 0.9 . . . . 0.0 110.979 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 71.13 8.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 169.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -62.62 -9.33 8.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.531 1.132 . . . . 0.0 111.696 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.34 37.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.236 1.815 . . . . 0.0 107.186 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.514 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 8.1 m-70 -58.48 -31.21 67.62 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.744 1.617 . . . . 0.0 112.078 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.93 -31.61 68.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.873 0.469 . . . . 0.0 111.633 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.94 -43.08 79.93 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.275 0.489 . . . . 0.0 110.6 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -40.21 72.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.449 175.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.35 -44.72 88.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.37 1.441 . . . . 0.0 109.876 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.67 -48.88 73.11 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 0.605 . . . . 0.0 111.606 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -56.87 -52.08 66.55 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.391 0.677 . . . . 0.0 110.086 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.19 -43.73 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.094 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -58.88 -37.13 75.86 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.625 1.102 . . . . 0.0 111.023 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.86 63.16 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.928 0.785 . . . . 0.0 111.199 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.25 -46.17 81.61 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.88 0.84 . . . . 0.0 111.019 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.6 mmt -59.12 -42.72 91.23 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.842 -0.536 . . . . 0.0 111.129 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -70.38 -30.7 67.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.342 0.974 . . . . 0.0 111.728 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -63.57 -43.07 98.07 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.327 0.967 . . . . 0.0 109.302 169.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -63.86 -27.04 68.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.451 0.569 . . . . 0.0 111.079 171.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.89 -7.22 9.43 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.137 2.304 . . . . 0.0 113.178 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 69.0 m -71.59 170.47 13.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.189 1.396 . . . . 0.0 111.721 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.59 140.73 52.21 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 m -144.28 163.16 34.51 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -149.08 128.89 13.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.04 0.936 . . . . 0.0 108.628 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -65.37 111.3 2.98 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.18 -27.53 66.49 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.707 -0.62 . . . . 0.0 110.1 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.15 -166.92 40.1 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.71 -165.94 17.63 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 170.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.35 -164.75 31.93 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -119.84 150.48 40.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.3 mt -128.27 138.46 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.7 m . . . . . 0 N--CA 1.451 -0.381 0 C-N-CA 123.855 0.862 . . . . 0.0 109.096 -171.231 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.1 t60 . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.87 129.23 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.766 1.626 . . . . 0.0 106.895 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.37 -169.13 2.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.036 0.835 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.84 -159.37 52.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.649 0.642 . . . . 0.0 112.526 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.7 154.22 39.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.24 1.416 . . . . 0.0 108.004 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 t -66.54 135.43 54.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 74.5 mtm -59.77 -16.46 27.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.638 1.175 . . . . 0.0 112.411 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.68 -23.14 4.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.117 0.967 . . . . 0.0 113.215 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -129.97 2.08 4.81 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.34 -175.59 45.88 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 119.09 0.859 . . . . 0.0 112.573 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.61 129.44 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.745 2.297 . . . . 0.0 110.968 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.86 167.76 20.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 110.304 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -78.97 76.66 5.46 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -57.06 -19.87 21.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.904 0.882 . . . . 0.0 113.166 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.39 -39.89 73.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.837 0.855 . . . . 0.0 110.987 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.9 mm -63.54 -49.15 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 m -62.63 -46.74 86.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 117.839 0.291 . . . . 0.0 110.843 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -62.01 -42.16 98.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.22 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.89 -49.94 75.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.979 1.263 . . . . 0.0 111.021 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -66.27 -45.12 81.6 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.935 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.87 -47.48 93.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -61.6 -39.15 90.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.307 1.412 . . . . 0.0 111.092 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.41 80.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 111.236 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -75.73 -21.6 57.34 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.349 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.4 t80 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 126.696 1.998 . . . . 0.0 111.671 -177.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.73 168.48 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.068 1.347 . . . . 0.0 109.414 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 p -139.38 171.38 14.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.472 1.109 . . . . 0.0 109.665 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -145.93 161.6 39.68 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.812 -0.555 . . . . 0.0 110.583 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.013 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 . . . . . 0 C--O 1.233 0.227 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -54.06 -34.0 58.93 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.586 0.754 . . . . 0.0 112.584 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.47 -24.42 66.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.192 0.906 . . . . 0.0 112.294 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.91 -20.18 23.67 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.95 . . . . 0.0 111.366 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.69 126.4 86.84 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.189 -1.386 . . . . 0.0 107.824 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.53 111.78 0.51 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.249 3.3 . . . . 0.0 110.421 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -71.38 -35.94 71.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.35 137.64 20.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -156.45 116.15 3.54 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.236 0.359 0 C-N-CA 124.391 1.076 . . . . 0.0 109.418 -174.481 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 N--CA 1.461 0.105 0 CA-C-O 121.246 0.546 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 156.06 27.45 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.886 0.474 . . . . 0.0 109.738 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.44 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -140.66 169.6 17.34 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.042 0.937 . . . . 0.0 108.687 179.122 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.43 150.67 19.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 108.013 174.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 tp -110.6 115.71 30.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.0 OUTLIER -127.32 128.13 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.53 0.681 . . . . 0.0 109.412 -172.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -79.27 149.53 31.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.43 1.492 . . . . 0.0 108.348 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.42 135.01 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -102.85 147.83 26.39 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.324 1.049 . . . . 0.0 108.464 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -62.23 99.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.282 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -149.66 17.97 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.163 -1.875 . . . . 0.0 114.776 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 51.1 Cg_exo -41.39 134.66 3.11 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 124.077 2.492 . . . . 0.0 114.31 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 38.17 31.89 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.692 2.797 . . . . 0.0 114.182 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m 51.59 32.58 9.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.149 1.379 . . . . 0.0 112.566 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.784 0 C-N-CA 123.998 0.809 . . . . 0.0 111.949 -174.119 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -176.33 4.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.0 m -140.95 156.52 46.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.572 0.749 . . . . 0.0 110.491 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.77 149.88 29.55 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.632 1.973 . . . . 0.0 106.742 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.43 150.55 27.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -128.8 154.05 39.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.26 1.024 . . . . 0.0 109.34 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.18 114.66 44.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -134.7 146.65 49.66 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.68 135.04 2.33 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.8 m-85 -157.06 152.6 26.67 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -60.32 -27.11 67.07 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.5 p-90 -66.86 -27.71 67.75 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 112.062 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.24 79.9 9.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.06 -6.29 8.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.005 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.98 142.03 29.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.226 1.811 . . . . 0.0 107.514 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.421 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 21.1 m-70 -62.04 -30.7 71.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.398 1.079 . . . . 0.0 111.543 -174.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -29.62 68.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.145 175.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.42 -47.5 73.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.781 0.719 . . . . 0.0 110.748 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -43.29 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.011 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.12 -47.13 84.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.102 0.864 . . . . 0.0 109.608 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.99 -48.29 71.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 0.483 . . . . 0.0 111.718 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -57.22 -53.75 54.59 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.366 0.666 . . . . 0.0 110.294 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.06 -45.19 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.864 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -64.29 -25.16 67.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 119.884 1.22 . . . . 0.0 111.471 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.32 -49.89 72.71 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 170.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.05 -41.93 85.63 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.185 0.992 . . . . 0.0 111.392 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.2 mmt -56.39 -44.85 80.66 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.367 0.985 . . . . 0.0 110.79 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.52 -29.08 66.62 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.246 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -63.41 -43.15 98.36 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.396 0.998 . . . . 0.0 109.193 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.53 -34.28 77.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.079 0.4 . . . . 0.0 110.306 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.83 5.07 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.535 2.017 . . . . 0.0 113.059 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -67.86 175.37 3.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.365 1.866 . . . . 0.0 113.434 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -128.2 148.82 50.63 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.4 163.57 32.69 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -168.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -149.35 128.04 12.45 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.089 1.356 . . . . 0.0 109.006 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.27 111.94 7.0 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 168.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.62 -26.41 64.42 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.237 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.18 -168.02 40.17 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.7 -175.54 30.78 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -158.43 20.38 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 -174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -128.57 154.02 46.62 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.839 -0.801 . . . . 0.0 108.869 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.1 mt -124.96 142.11 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 C--N 1.329 -0.309 0 C-N-CA 125.531 1.533 . . . . 0.0 108.366 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.0 t -130.34 128.07 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.52 -177.07 6.15 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 121.362 -0.836 . . . . 0.0 110.681 -173.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.01 -169.08 53.25 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -151.92 147.56 26.72 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.593 0.757 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.8 p -72.16 133.78 45.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -68.99 -27.18 65.47 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.782 -0.574 . . . . 0.0 110.09 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.49 -42.35 64.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.828 0.851 . . . . 0.0 112.384 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -133.65 3.15 3.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -168.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.51 -176.84 54.24 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.793 0.724 . . . . 0.0 111.848 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.22 132.02 23.29 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.674 2.249 . . . . 0.0 110.211 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.9 168.8 19.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -78.93 81.26 5.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 168.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.44 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 51.5 m80 -56.05 -21.25 20.63 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.568 0.747 . . . . 0.0 112.762 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -44.07 66.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.709 1.203 . . . . 0.0 111.484 169.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.02 -49.53 83.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -58.4 -50.56 73.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.747 0.819 . . . . 0.0 110.683 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -63.58 -40.01 95.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.072 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.28 -46.51 83.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.927 1.24 . . . . 0.0 110.538 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.17 -43.55 97.96 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.263 0.483 . . . . 0.0 110.437 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 52.5 mt -59.64 -51.58 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.009 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -60.98 -36.25 78.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.675 1.579 . . . . 0.0 111.283 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.92 99.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.922 0.783 . . . . 0.0 111.689 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.39 -18.09 37.25 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.264 35.8 p90 . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 127.16 2.184 . . . . 0.0 114.209 -173.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.6 m -140.18 169.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.127 0.971 . . . . 0.0 110.374 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -140.66 171.73 13.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.202 1.401 . . . . 0.0 108.885 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -143.5 170.76 15.21 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.65 -0.656 . . . . 0.0 109.623 170.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.514 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.233 0.202 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.0 mt -54.66 -32.3 58.94 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.769 0.828 . . . . 0.0 112.478 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.17 67.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.448 1.022 . . . . 0.0 112.289 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -90.08 -24.44 21.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.439 1.095 . . . . 0.0 111.307 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.32 130.17 89.43 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.2 116.63 3.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.23 2.62 . . . . 0.0 109.785 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.93 -35.84 64.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.822 0.849 . . . . 0.0 113.273 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.51 134.76 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -153.6 108.89 3.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 C--O 1.234 0.289 0 C-N-CA 124.155 0.982 . . . . 0.0 108.441 -176.932 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 p90 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.25 160.06 19.94 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.829 -0.545 . . . . 0.0 109.739 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.12 164.57 31.76 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.313 0.645 . . . . 0.0 109.378 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.67 156.02 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.604 1.161 . . . . 0.0 108.529 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -118.53 114.56 23.01 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.61 130.94 71.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -75.27 148.02 39.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.29 119.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -91.32 148.54 22.26 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 p -68.64 102.71 1.55 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.872 0.76 . . . . 0.0 109.712 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.429 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.12 23.75 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.003 0 CA-C-O 116.39 -1.767 . . . . 0.0 114.517 169.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.429 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 37.1 Cg_exo -41.85 124.36 2.69 Favored 'Trans proline' 0 C--N 1.361 1.187 0 CA-C-N 123.802 2.394 . . . . 0.0 114.521 173.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 34.22 38.24 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.341 3.056 . . . . 0.0 113.924 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m 52.97 30.31 9.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.224 1.409 . . . . 0.0 112.961 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 C-N-CA 124.797 1.189 . . . . 0.0 112.525 -177.035 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.327 0 CA-C-O 121.775 0.798 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.54 177.51 5.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.928 0.891 . . . . 0.0 109.045 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -139.34 160.58 39.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.717 0.77 . . . . 0.0 111.125 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -142.41 164.79 29.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 129.105 2.962 . . . . 0.0 105.566 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -128.31 149.57 50.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.09 147.77 33.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.496 0.718 . . . . 0.0 109.829 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.38 119.22 57.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -128.3 145.09 51.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.08 132.15 1.9 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 170.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -151.54 151.69 31.93 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -59.89 -29.37 68.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.7 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -66.28 -27.7 68.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.159 0.89 . . . . 0.0 111.836 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.91 81.97 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -62.06 -15.24 43.32 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 122.943 0.497 . . . . 0.0 111.583 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.76 142.16 38.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.137 1.775 . . . . 0.0 108.014 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -56.17 -31.37 63.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.441 1.496 . . . . 0.0 112.757 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.55 -27.09 68.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.73 -0.607 . . . . 0.0 111.557 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.33 -47.33 70.82 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.677 0.671 . . . . 0.0 110.693 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -39.71 83.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.467 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -61.95 -48.23 81.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.9 1.227 . . . . 0.0 109.927 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -45.81 91.79 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.347 0.976 . . . . 0.0 111.365 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -60.42 -51.18 70.59 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.391 0.677 . . . . 0.0 110.812 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.46 -33.91 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.15 -169.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p -61.16 -35.83 78.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.794 1.634 . . . . 0.0 110.169 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.8 -51.07 59.78 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.9 -44.21 96.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.208 1.004 . . . . 0.0 111.015 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.8 mmt -59.72 -44.4 93.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.696 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -66.69 -33.41 75.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.217 . . . . 0.0 111.976 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.27 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.216 0.916 . . . . 0.0 109.77 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.35 -35.78 80.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.571 0.623 . . . . 0.0 110.393 171.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.41 -8.12 5.32 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.633 2.54 . . . . 0.0 113.127 171.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 94.8 m -77.41 133.0 38.78 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.943 1.697 . . . . 0.0 111.711 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.39 137.3 33.47 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.9 m -144.71 163.96 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -155.69 133.85 11.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.653 1.181 . . . . 0.0 108.251 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.84 112.82 4.47 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.7 mt -67.87 -29.83 69.04 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.907 -0.495 . . . . 0.0 110.098 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.18 -171.0 42.87 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.28 -164.68 23.37 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.6 -147.52 8.85 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -171.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -133.63 155.59 49.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 108.217 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.7 mt -125.26 141.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.453 -0.323 0 C-N-CA 124.606 1.162 . . . . 0.0 108.219 -178.551 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t60 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.06 120.58 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.96 -164.98 1.39 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.532 0.733 . . . . 0.0 109.988 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.36 -167.91 54.56 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -153.04 144.43 23.26 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.957 0.503 . . . . 0.0 110.786 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.9 m -70.01 140.69 52.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -65.1 -49.61 69.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.14 -24.56 37.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -118.17 -6.74 10.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.94 -179.6 34.6 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.795 0.725 . . . . 0.0 112.408 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.09 136.48 37.92 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.713 2.275 . . . . 0.0 109.976 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.91 169.83 17.16 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.362 0.601 . . . . 0.0 110.078 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.09 82.42 6.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -58.44 -18.15 26.29 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.765 -0.584 . . . . 0.0 112.543 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.63 -39.68 68.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.57 1.148 . . . . 0.0 111.861 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 mm -61.7 -49.76 83.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 m -58.19 -51.46 69.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.908 0.883 . . . . 0.0 111.399 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.0 p -64.71 -41.01 96.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.382 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.7 -45.53 93.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 120.011 1.278 . . . . 0.0 110.468 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -65.13 -44.51 88.46 Favored 'General case' 0 N--CA 1.46 0.053 0 O-C-N 121.911 -0.493 . . . . 0.0 111.08 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.95 -42.12 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.374 0.67 . . . . 0.0 109.263 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -63.57 -38.0 89.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 120.111 1.323 . . . . 0.0 110.895 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.53 -44.88 85.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.84 0.745 . . . . 0.0 111.153 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -63.43 -36.28 83.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.256 1.022 . . . . 0.0 111.41 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.7 t80 . . . . . 0 CA--C 1.543 0.706 0 C-N-CA 126.945 2.098 . . . . 0.0 111.215 -169.644 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.2 166.43 18.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 -176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.6 p -139.5 172.54 12.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.565 1.146 . . . . 0.0 109.456 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -143.88 167.78 21.52 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.159 0.583 . . . . 0.0 110.315 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 169.467 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.88 -28.44 64.19 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.197 0.908 . . . . 0.0 112.848 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.7 63.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.294 0.952 . . . . 0.0 112.293 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.1 -28.1 19.22 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.513 1.125 . . . . 0.0 111.212 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.67 129.02 76.41 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.67 131.36 33.09 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.658 2.906 . . . . 0.0 110.707 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.21 -43.34 8.88 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.46 142.07 31.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -156.18 116.36 3.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 pt . . . . . 0 C--O 1.236 0.371 0 C-N-CA 125.279 1.432 . . . . 0.0 107.598 -179.236 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -86.77 158.77 19.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.428 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -142.36 166.58 24.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.901 0.88 . . . . 0.0 109.209 -176.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.06 154.74 21.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.108 0.963 . . . . 0.0 108.799 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.93 119.35 34.55 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.78 135.41 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 119.401 1.0 . . . . 0.0 110.423 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -79.99 146.62 31.94 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 124.84 33.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -93.76 153.28 18.4 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.509 0.724 . . . . 0.0 109.891 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m -67.85 87.92 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.297 1.039 . . . . 0.0 109.56 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.31 24.37 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 116.584 -1.674 . . . . 0.0 114.499 169.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.02 129.94 5.75 Favored 'Trans proline' 0 C--N 1.359 1.089 0 CA-C-N 123.551 2.304 . . . . 0.0 113.075 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 43.7 27.2 0.15 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.928 2.491 . . . . 0.0 113.901 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 50.1 32.38 5.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.401 1.481 . . . . 0.0 112.677 -175.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.55 -172.806 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 121.102 0.477 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -69.59 172.42 7.4 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.3 m -135.99 160.94 37.07 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.562 0.745 . . . . 0.0 110.361 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.11 162.81 30.74 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.547 1.539 . . . . 0.0 107.579 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.49 134.95 54.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 171.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 pt -121.57 161.64 21.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.667 1.187 . . . . 0.0 110.383 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.55 124.03 53.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.48 155.02 49.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.68 136.02 3.83 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -149.48 152.05 34.97 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -174.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.62 -33.47 72.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.53 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -64.91 -29.81 70.77 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.018 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.73 75.32 3.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 109.35 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.79 -10.46 37.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.536 173.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.51 142.57 35.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.667 1.587 . . . . 0.0 107.718 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -58.24 -33.79 69.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.968 1.307 . . . . 0.0 111.63 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.93 67.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.123 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.47 -42.34 87.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.097 0.862 . . . . 0.0 110.295 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -38.31 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 117.369 -1.301 . . . . 0.0 110.616 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.09 -43.01 95.83 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.259 1.391 . . . . 0.0 109.453 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.05 -50.57 72.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.128 0.876 . . . . 0.0 111.32 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -48.74 78.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.219 0.533 . . . . 0.0 109.8 -174.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -78.43 -44.75 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.385 -169.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.9 p -62.42 -31.38 72.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.577 1.535 . . . . 0.0 110.512 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.52 -52.17 48.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.19 -44.84 90.75 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.415 1.108 . . . . 0.0 111.384 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.6 mmt -57.04 -49.25 76.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.893 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.713 1.142 . . . . 0.0 111.988 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.74 -43.5 98.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.212 0.915 . . . . 0.0 109.756 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.66 -35.93 82.61 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.943 0.792 . . . . 0.0 110.379 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.2 -12.55 3.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.915 2.197 . . . . 0.0 112.98 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.3 m -74.34 121.46 21.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.959 1.703 . . . . 0.0 112.887 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.33 143.65 42.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 168.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.3 m -145.16 166.99 23.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.588 0.755 . . . . 0.0 112.498 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -149.48 134.01 17.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.67 1.188 . . . . 0.0 108.65 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -70.62 113.23 7.52 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.7 mt -70.72 -25.32 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.764 -0.585 . . . . 0.0 110.182 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.65 -169.74 42.26 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -170.73 23.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.16 -155.61 17.39 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.2 ttm105 -126.39 153.61 44.74 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.514 0.726 . . . . 0.0 109.174 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 mt -123.05 141.77 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--N 1.327 -0.37 0 C-N-CA 124.645 1.178 . . . . 0.0 108.459 -179.359 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.7 t60 . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 t -133.34 126.11 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.15 -179.8 8.33 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.81 -0.557 . . . . 0.0 110.757 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.68 -162.03 52.87 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -149.57 151.92 34.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.84 1.256 . . . . 0.0 108.64 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -73.58 131.07 41.31 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.91 -28.78 69.77 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.189 -0.32 . . . . 0.0 110.347 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.93 -35.74 17.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.638 0.775 . . . . 0.0 112.153 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.89 2.13 7.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.74 44.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 118.691 0.678 . . . . 0.0 111.988 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.92 136.55 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.225 1.95 . . . . 0.0 109.955 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.96 178.2 3.88 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -61.17 -34.37 74.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.704 -0.622 . . . . 0.0 111.375 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.428 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 41.3 m80 59.21 -32.85 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.07 2.948 . . . . 0.0 115.682 -173.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.49 81.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.785 1.175 . . . . 0.0 110.723 170.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -53.88 -50.6 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.344 1.058 . . . . 0.0 108.644 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -58.92 -50.26 74.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.315 1.046 . . . . 0.0 110.363 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -48.65 74.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.813 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.11 -44.83 91.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.343 0.974 . . . . 0.0 110.845 -175.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -67.13 -41.63 85.81 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.84 -0.538 . . . . 0.0 110.903 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.1 mt -59.84 -47.66 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 -33.88 75.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.01 1.277 . . . . 0.0 111.649 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.04 96.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.437 1.017 . . . . 0.0 111.324 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.4 -17.66 26.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 CA--C 1.547 0.833 0 C-N-CA 125.916 1.686 . . . . 0.0 114.208 -175.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.05 162.22 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.076 1.35 . . . . 0.0 108.031 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.5 p -138.26 171.82 13.82 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.709 1.603 . . . . 0.0 108.519 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -145.04 169.34 18.29 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.469 -0.769 . . . . 0.0 111.145 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.547 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 mt -53.74 -30.71 45.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.499 1.12 . . . . 0.0 113.484 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.59 -24.19 60.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.78 0.718 . . . . 0.0 112.266 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.31 -19.93 26.07 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.292 1.037 . . . . 0.0 111.108 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.09 131.01 80.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.51 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.348 2.699 . . . . 0.0 109.961 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.29 -34.71 70.9 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.564 0.746 . . . . 0.0 112.261 -169.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -142.56 135.26 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -154.61 105.57 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt . . . . . 0 C--O 1.236 0.351 0 C-N-CA 123.749 0.82 . . . . 0.0 109.588 -173.128 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.4 p90 . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.68 154.4 17.31 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.03 168.53 19.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 109.116 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.62 154.23 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.111 1.364 . . . . 0.0 108.002 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.6 tp -118.17 114.91 23.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.58 131.53 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -174.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -78.59 144.96 35.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.97 141.72 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -108.01 149.65 28.13 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.879 1.272 . . . . 0.0 109.633 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 m -63.68 99.95 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.365 0.666 . . . . 0.0 110.912 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -154.23 21.71 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.347 -1.787 . . . . 0.0 114.847 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.499 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.0 Cg_exo -46.99 136.85 17.29 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 124.327 2.581 . . . . 0.0 113.067 172.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? 46.41 25.05 0.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.153 2.181 . . . . 0.0 113.821 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 50.77 32.71 7.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.017 1.327 . . . . 0.0 112.351 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 C-N-CA 123.934 0.778 . . . . 0.0 112.586 -172.655 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' C ' ' HG ' ' A' ' 40' ' ' SER . 43.5 mt-10 -77.13 -178.14 4.88 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 171.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 39' ' ' GLU . 13.1 m -152.82 159.34 43.06 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.772 -1.205 . . . . 0.0 110.028 173.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.73 167.81 29.2 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.826 1.65 . . . . 0.0 108.785 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.01 152.74 24.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -129.85 153.41 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.752 1.221 . . . . 0.0 109.013 172.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.4 t -119.92 115.08 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -136.06 148.18 48.21 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.95 136.69 2.57 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.2 m-85 -156.29 152.31 27.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -172.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.53 -31.46 69.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.001 -0.524 . . . . 0.0 112.168 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.431 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -64.32 -27.54 69.1 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.828 0.74 . . . . 0.0 112.363 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 82.15 8.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.692 1.133 . . . . 0.0 108.267 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.52 -14.09 47.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.702 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.53 143.99 35.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.769 1.628 . . . . 0.0 108.418 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.419 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 21.2 m-70 -62.11 -30.7 71.2 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.736 1.214 . . . . 0.0 111.779 -174.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.01 -28.55 69.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.722 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.21 -47.79 72.72 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 110.549 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -40.37 82.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.262 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -58.61 -46.54 86.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.325 1.421 . . . . 0.0 110.02 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.31 -48.67 72.28 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.288 0.495 . . . . 0.0 111.451 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -60.18 -51.86 67.79 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.106 0.563 . . . . 0.0 110.864 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.32 -45.22 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.869 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -63.29 -28.37 69.97 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.731 1.15 . . . . 0.0 111.352 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.19 -49.38 75.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.57 -46.51 85.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.053 0.927 . . . . 0.0 110.708 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.3 mmt -58.36 -43.61 88.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.853 -0.529 . . . . 0.0 111.502 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.94 -33.31 73.52 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.103 -0.998 . . . . 0.0 111.875 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -61.22 -42.71 99.08 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.022 0.828 . . . . 0.0 109.617 170.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -60.71 -44.06 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.128 0.876 . . . . 0.0 109.706 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.71 -6.74 1.44 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.073 1.796 . . . . 0.0 113.28 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.63 177.99 4.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.645 1.578 . . . . 0.0 113.319 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.25 144.71 51.51 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 169.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.3 m -145.32 165.48 28.33 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -168.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.77 128.72 11.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.313 1.045 . . . . 0.0 108.525 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -67.47 115.33 6.96 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.6 mt -71.9 -26.51 62.35 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.005 -0.435 . . . . 0.0 110.451 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.05 -168.73 40.98 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.98 -172.0 28.81 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 173.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.13 -168.11 35.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -119.3 154.91 32.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 mt -128.79 133.77 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 108.595 -175.538 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.0 t -125.5 121.56 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.22 -176.32 5.57 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.461 -0.774 . . . . 0.0 111.586 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.75 -159.15 53.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.06 152.36 36.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.012 1.325 . . . . 0.0 108.188 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -77.03 130.54 37.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.6 mtp -64.32 -27.73 69.22 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.677 -0.639 . . . . 0.0 110.553 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.01 -38.03 45.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.159 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.9 3.33 3.2 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.75 -178.69 50.03 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.019 0.818 . . . . 0.0 112.038 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 133.96 23.95 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.653 2.235 . . . . 0.0 110.162 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.35 167.86 21.09 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.305 0.574 . . . . 0.0 110.027 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.29 82.15 6.39 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -59.04 -17.27 23.99 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.624 -0.673 . . . . 0.0 112.463 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.42 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.392 1.077 . . . . 0.0 111.934 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.78 -48.42 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.2 m -58.81 -50.03 75.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.752 0.821 . . . . 0.0 111.349 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 p -59.78 -44.16 94.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.945 0.793 . . . . 0.0 111.385 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.57 -48.24 80.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.784 0.72 . . . . 0.0 110.314 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.71 -47.83 76.87 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.158 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -62.21 -45.53 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -61.63 -38.49 87.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.426 1.466 . . . . 0.0 110.984 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.81 -47.71 68.31 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.792 0.723 . . . . 0.0 111.84 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -80.35 -15.08 57.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.791 0.836 . . . . 0.0 112.009 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 CA--C 1.552 1.05 0 C-N-CA 126.575 1.95 . . . . 0.0 115.519 176.322 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.49 163.55 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.205 . . . . 0.0 107.911 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -140.1 166.83 23.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.718 1.607 . . . . 0.0 108.562 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -147.82 168.57 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.285 -0.885 . . . . 0.0 112.61 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.456 0 C-N-CA 125.419 1.488 . . . . 0.0 107.098 168.875 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 C--O 1.232 0.164 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.72 -32.02 40.78 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.057 1.343 . . . . 0.0 113.595 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.61 58.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.795 0.725 . . . . 0.0 112.304 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.78 -20.18 27.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.175 0.99 . . . . 0.0 111.106 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.7 mt -58.53 133.76 85.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.98 111.19 0.55 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.841 3.028 . . . . 0.0 110.563 171.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.59 -35.73 52.61 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.3 t -137.86 136.47 45.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.9 101.01 2.86 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 pt . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 127.246 2.218 . . . . 0.0 107.184 -178.789 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 p90 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 121.281 0.563 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -77.11 160.47 29.0 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 122.059 -0.4 . . . . 0.0 110.149 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.04 167.13 22.79 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.706 1.202 . . . . 0.0 109.168 -174.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.33 155.62 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.4 tp -118.73 117.66 29.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.282 0.0 OUTLIER -128.28 128.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 118.724 0.693 . . . . 0.0 109.736 -173.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -76.72 146.93 37.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.54 1.536 . . . . 0.0 108.279 172.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.2 139.1 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -108.91 143.4 38.19 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.735 1.214 . . . . 0.0 107.882 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 p -67.95 106.03 2.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.581 0.628 . . . . 0.0 110.818 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.481 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.47 17.22 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 116.212 -1.851 . . . . 0.0 115.362 169.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 90.1 Cg_exo -43.94 135.91 7.6 Favored 'Trans proline' 0 C--N 1.362 1.27 0 CA-C-N 124.185 2.53 . . . . 0.0 114.427 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 45.15 27.47 0.32 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.956 2.102 . . . . 0.0 113.576 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.84 31.87 6.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.457 1.503 . . . . 0.0 112.545 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.864 0 C-N-CA 123.768 0.699 . . . . 0.0 112.974 -172.704 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -75.36 173.17 11.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.437 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -144.57 155.65 43.76 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.388 0.675 . . . . 0.0 110.691 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.67 166.54 33.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.696 1.598 . . . . 0.0 108.963 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.64 155.6 19.97 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -174.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.41 155.28 41.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.398 1.079 . . . . 0.0 108.836 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.07 121.5 67.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -131.52 148.83 52.66 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.879 1.271 . . . . 0.0 107.799 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.25 131.7 1.8 Allowed Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -154.54 152.84 30.54 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.41 -31.75 71.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.134 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -64.86 -25.85 68.08 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.53 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.38 88.21 7.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 119.632 1.105 . . . . 0.0 109.028 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.0 -5.5 22.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 0.0 112.187 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.59 147.93 28.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.588 1.555 . . . . 0.0 108.319 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -60.67 -34.25 74.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 111.437 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.5 -27.54 67.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 118.627 -0.701 . . . . 0.0 112.215 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.65 -49.14 61.5 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.243 0.929 . . . . 0.0 110.603 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -40.28 85.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.32 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -61.25 -49.84 75.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.095 0.861 . . . . 0.0 109.617 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.87 -46.37 89.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.393 0.997 . . . . 0.0 111.101 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -58.26 -52.62 64.8 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.566 0.747 . . . . 0.0 110.837 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.41 -34.37 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.457 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -59.48 -38.41 80.77 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.01 1.277 . . . . 0.0 109.245 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.89 87.34 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.821 0.737 . . . . 0.0 111.553 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.73 -45.31 90.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.257 1.029 . . . . 0.0 111.38 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -60.19 -44.65 94.93 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.862 -0.524 . . . . 0.0 110.795 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -65.65 -32.78 74.54 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.237 -0.915 . . . . 0.0 111.543 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -64.23 -39.1 93.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.464 171.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.26 -42.47 95.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.634 1.106 . . . . 0.0 109.262 169.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.41 -4.66 2.29 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.307 1.908 . . . . 0.0 112.939 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.9 m -69.11 178.46 2.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.484 1.513 . . . . 0.0 112.982 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -129.3 146.78 51.13 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.4 m -148.9 165.67 30.86 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -168.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -155.69 129.4 8.49 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.571 1.148 . . . . 0.0 109.585 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.75 115.66 10.16 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.0 mt -73.09 -25.2 60.79 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.179 0.591 . . . . 0.0 111.019 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.66 179.79 43.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.67 173.59 21.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.58 -158.9 24.52 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -136.02 153.09 51.47 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.118 1.367 . . . . 0.0 109.635 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mt -115.48 126.25 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.33 -0.273 0 C-N-CA 123.686 0.795 . . . . 0.0 108.867 -175.676 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t60 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -132.45 120.28 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -172.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -158.87 179.54 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.45 -163.33 15.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.459 1.027 . . . . 0.0 113.218 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -153.63 164.51 38.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.071 2.148 . . . . 0.0 107.251 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 t -135.55 127.45 29.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.8 tpp -62.84 -30.51 71.55 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.85 -35.93 32.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.404 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -131.24 -1.21 4.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.51 177.27 43.81 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 119.162 0.892 . . . . 0.0 111.686 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.01 138.09 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.472 2.115 . . . . 0.0 109.326 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.79 160.9 30.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.344 0.592 . . . . 0.0 110.813 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -82.05 78.0 8.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -54.61 -21.67 11.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.23 0.612 . . . . 0.0 112.403 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.89 65.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.15 1.38 . . . . 0.0 112.861 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.15 -47.71 92.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -61.38 -49.36 77.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.017 0.927 . . . . 0.0 111.201 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 p -59.29 -40.29 85.68 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.958 0.799 . . . . 0.0 111.783 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.63 -47.2 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.569 1.077 . . . . 0.0 110.375 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.75 -44.84 88.82 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.944 -0.472 . . . . 0.0 111.303 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.07 -47.44 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.38 -34.47 73.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.336 1.426 . . . . 0.0 111.569 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.83 89.22 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.522 1.056 . . . . 0.0 111.777 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -84.25 -16.07 44.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 CA--C 1.553 1.068 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -171.699 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 m -141.4 166.01 18.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.436 1.094 . . . . 0.0 109.164 169.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 p -134.13 171.47 14.18 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.943 1.297 . . . . 0.0 108.968 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -142.01 171.55 13.9 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.836 -0.54 . . . . 0.0 111.983 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.728 0 C-N-CA 124.768 1.227 . . . . 0.0 107.716 169.445 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.16 -27.58 62.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.787 0.835 . . . . 0.0 113.146 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.76 67.05 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.182 0.901 . . . . 0.0 112.61 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -77.6 -19.75 55.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.33 0.652 . . . . 0.0 111.649 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.88 139.88 97.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.03 110.59 1.19 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.917 2.412 . . . . 0.0 108.932 170.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.72 -33.36 64.33 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.986 0.914 . . . . 0.0 113.395 -169.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.9 t -136.81 133.4 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -157.85 110.55 2.4 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 170.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 124.109 0.963 . . . . 0.0 110.194 -171.819 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -78.81 163.4 25.37 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.886 -0.509 . . . . 0.0 110.129 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.34 166.67 24.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.559 1.143 . . . . 0.0 108.586 173.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.48 155.84 13.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.7 tp -118.44 116.65 27.13 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.28 0.0 OUTLIER -125.46 128.47 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-N 118.474 0.579 . . . . 0.0 109.671 -172.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -78.35 148.48 33.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.287 1.435 . . . . 0.0 108.415 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.2 139.37 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -108.67 146.66 33.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.387 1.475 . . . . 0.0 108.82 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -68.63 88.77 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.011 0.925 . . . . 0.0 112.457 -173.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -139.81 16.34 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 116.433 -1.746 . . . . 0.0 113.743 168.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 53.1 Cg_exo -47.85 143.45 13.17 Favored 'Trans proline' 0 C--N 1.362 1.258 0 CA-C-N 123.939 2.443 . . . . 0.0 113.33 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 41.26 31.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.636 2.374 . . . . 0.0 113.301 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.9 m 52.33 28.69 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.178 1.791 . . . . 0.0 113.374 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.857 0 CA-C-O 118.709 -1.05 . . . . 0.0 114.648 -173.438 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.195 0.522 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -67.53 165.72 16.27 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -140.55 155.94 46.46 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.014 0.926 . . . . 0.0 108.986 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.24 166.55 32.21 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.192 1.397 . . . . 0.0 108.694 176.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -108.4 156.28 19.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.7 pt -130.82 154.67 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.463 1.105 . . . . 0.0 108.826 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.79 119.85 63.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -132.07 147.61 52.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.231 1.412 . . . . 0.0 108.447 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.36 126.29 0.93 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -151.16 162.1 41.51 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.475 0.71 . . . . 0.0 109.842 -172.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -55.28 -43.38 74.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.833 0.853 . . . . 0.0 112.113 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -66.94 -27.32 67.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.457 -173.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.59 86.54 7.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.339 0.972 . . . . 0.0 108.516 172.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.42 -14.31 55.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.841 0.456 . . . . 0.0 111.664 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 144.5 33.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.03 1.732 . . . . 0.0 108.836 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.52 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 6.1 m-70 -58.14 -32.99 68.69 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.872 1.669 . . . . 0.0 112.079 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.39 -29.03 70.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.61 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.64 -49.23 63.97 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.76 0.709 . . . . 0.0 110.539 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -40.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.331 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.527 0.603 . . . . 0.0 110.017 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.08 -46.89 76.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.662 0.664 . . . . 0.0 111.507 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.99 -56.16 18.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.582 1.153 . . . . 0.0 110.002 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.2 t -78.47 -35.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 117.797 -1.097 . . . . 0.0 110.456 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.4 m -62.36 -31.65 72.33 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 120.314 1.415 . . . . 0.0 110.939 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.63 -47.97 87.25 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.176 0.898 . . . . 0.0 110.974 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.04 -46.28 85.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.074 0.937 . . . . 0.0 111.028 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.5 mmt -59.56 -42.83 93.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.525 0.602 . . . . 0.0 110.882 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -67.86 -32.57 73.17 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.91 -1.119 . . . . 0.0 111.339 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -64.17 -40.56 96.38 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.032 0.833 . . . . 0.0 110.143 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -62.35 -33.28 74.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.316 0.962 . . . . 0.0 110.619 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.99 -6.9 4.42 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.444 1.973 . . . . 0.0 113.164 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.1 m -70.64 -179.72 2.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.272 1.829 . . . . 0.0 114.446 -169.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -130.09 151.09 51.0 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.2 165.01 31.34 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.79 129.65 9.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.678 1.191 . . . . 0.0 109.443 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.7 113.48 8.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.6 mt -68.06 -29.74 68.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.912 -0.492 . . . . 0.0 110.129 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.01 -173.46 45.15 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.84 -177.1 24.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.95 -155.75 16.25 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -136.41 167.37 21.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.904 0.852 . . . . 0.0 110.752 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 mt -136.36 142.57 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.694 1.998 . . . . 0.0 107.273 -169.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.235 0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 109.142 179.638 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.6 t60 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.22 121.96 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -159.74 -175.19 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.324 -0.86 . . . . 0.0 111.169 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.05 30.85 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.837 0.687 . . . . 0.0 112.834 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -137.78 143.11 40.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 t -65.45 146.56 54.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.5 ptp -72.87 -12.86 61.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.283 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.74 -14.76 3.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.194 0.998 . . . . 0.0 113.388 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -134.79 -177.29 4.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.2 1.8 . . . . 0.0 108.443 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.67 173.39 44.27 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 170.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.94 139.32 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.094 1.862 . . . . 0.0 108.457 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 164.67 25.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.606 0.717 . . . . 0.0 111.081 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.37 74.03 7.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -56.37 -20.52 19.68 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.47 60.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.035 0.934 . . . . 0.0 111.618 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.87 -43.95 99.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.408 1.083 . . . . 0.0 109.284 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -59.43 -50.78 72.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.416 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -57.02 -44.32 82.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.48 0.582 . . . . 0.0 111.304 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.69 -50.61 71.78 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.809 0.731 . . . . 0.0 110.505 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.98 -43.13 72.11 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.899 -0.501 . . . . 0.0 111.361 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.45 -46.76 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.93 -32.79 74.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.283 1.402 . . . . 0.0 111.379 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.32 94.97 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.405 1.002 . . . . 0.0 111.537 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -86.88 -20.0 28.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 CA--C 1.548 0.885 0 C-N-CA 125.646 1.578 . . . . 0.0 113.307 -169.828 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' HG2' ' H ' ' A' ' 118' ' ' VAL . 26.7 tt0 . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.447 ' H ' ' HG2' ' A' ' 117' ' ' GLU . 7.1 p -158.06 162.36 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.593 1.557 . . . . 0.0 107.329 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -143.4 173.9 11.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 107.661 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.71 166.77 23.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.582 0.628 . . . . 0.0 111.068 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 169.736 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.232 0.168 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.9 mt -52.35 -34.67 48.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.833 0.853 . . . . 0.0 112.942 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.19 62.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.671 0.669 . . . . 0.0 112.236 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.15 -19.76 28.0 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.099 0.959 . . . . 0.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.1 mt -59.28 128.82 86.06 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 172.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.57 138.16 58.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.164 2.576 . . . . 0.0 111.035 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -86.56 -41.78 14.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.071 0.396 . . . . 0.0 111.55 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.78 140.56 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 124.721 1.208 . . . . 0.0 107.9 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -157.14 114.19 3.06 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt . . . . . 0 C--O 1.235 0.307 0 C-N-CA 124.258 1.023 . . . . 0.0 108.837 -173.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.9 p90 . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -113.38 152.36 30.1 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.694 0.797 . . . . 0.0 109.287 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.515 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -140.27 168.7 19.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.671 0.788 . . . . 0.0 109.085 -170.12 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.26 152.92 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.457 1.503 . . . . 0.0 108.811 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -114.75 114.81 26.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.47 133.94 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.819 0.736 . . . . 0.0 109.329 -175.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -81.38 147.39 29.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.21 143.3 34.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -114.52 146.83 40.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.331 1.452 . . . . 0.0 109.24 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 m -62.68 103.51 0.43 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.288 0.635 . . . . 0.0 111.526 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.84 18.55 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 116.076 -1.916 . . . . 0.0 114.791 169.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.499 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 32.7 Cg_exo -40.37 127.79 2.28 Favored 'Trans proline' 0 C--N 1.361 1.224 0 CA-C-N 124.216 2.541 . . . . 0.0 115.093 173.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 31.91 39.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.492 3.117 . . . . 0.0 113.926 -170.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 53.11 31.44 11.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.385 1.474 . . . . 0.0 112.961 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 C-N-CA 124.226 0.917 . . . . 0.0 112.748 -176.177 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.25 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' C ' ' HG ' ' A' ' 40' ' ' SER . 51.6 mm-40 -78.14 -176.35 4.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 172.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.414 ' HG ' ' C ' ' A' ' 39' ' ' GLU . 13.5 m -151.89 159.31 43.87 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 173.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 167.24 28.08 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.006 1.722 . . . . 0.0 108.282 174.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -108.2 157.51 18.25 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.9 pt -137.88 155.33 30.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.283 1.433 . . . . 0.0 108.58 174.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.6 t -119.03 123.77 72.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -135.96 149.26 48.83 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.311 1.044 . . . . 0.0 108.282 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.49 135.85 2.42 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 18.8 m-85 -153.92 155.29 35.39 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -60.14 -34.17 73.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.656 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.0 p-90 -64.28 -28.69 69.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.395 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 77.78 9.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.363 0.983 . . . . 0.0 108.799 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.07 -9.61 17.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.45 140.67 35.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.222 1.409 . . . . 0.0 107.456 174.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.483 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.8 m-70 -62.85 -29.86 71.07 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 111.428 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.77 67.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.942 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.4 -48.11 71.14 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.766 0.712 . . . . 0.0 110.501 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.16 -40.74 83.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 117.411 -1.28 . . . . 0.0 109.997 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.3 -46.7 85.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 120.608 1.549 . . . . 0.0 110.251 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.77 -49.17 69.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.239 0.472 . . . . 0.0 111.568 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -60.52 -49.3 78.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.349 0.66 . . . . 0.0 110.836 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.44 -44.42 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.056 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.71 -28.92 70.28 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.686 1.13 . . . . 0.0 111.092 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -49.28 72.28 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.365 0.984 . . . . 0.0 110.717 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.11 -46.88 85.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.127 0.963 . . . . 0.0 110.626 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.7 mmt -57.98 -43.41 86.5 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.836 -0.54 . . . . 0.0 111.198 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -68.59 -31.28 70.36 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.862 -1.149 . . . . 0.0 112.248 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.36 -42.47 98.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.489 1.041 . . . . 0.0 109.662 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -62.54 -30.59 71.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.703 0.683 . . . . 0.0 110.55 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.27 -8.55 5.96 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.05 2.262 . . . . 0.0 112.972 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.38 179.96 2.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.547 1.939 . . . . 0.0 113.185 -169.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.14 150.92 52.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.1 m -149.07 165.24 32.32 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.31 128.34 10.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 108.325 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.98 116.17 7.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.6 -28.37 64.8 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.008 -0.432 . . . . 0.0 109.993 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.56 -163.94 36.52 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.45 -164.33 22.93 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.35 -163.59 29.56 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.48 157.62 31.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -131.14 127.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.233 0.228 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -174.022 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 . . . . . 0 C--O 1.232 0.134 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -119.47 130.03 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -161.96 -179.53 7.22 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.155 -0.966 . . . . 0.0 110.828 -170.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -157.93 53.15 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -144.79 153.85 42.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.62 1.568 . . . . 0.0 107.647 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.1 p -70.78 133.9 46.94 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.6 mmt -73.86 32.45 0.08 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.09 1.356 . . . . 0.0 111.108 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.3 -39.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.611 1.565 . . . . 0.0 111.572 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -134.63 2.86 3.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 -175.76 53.62 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.086 0.857 . . . . 0.0 112.181 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.61 135.62 24.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.526 2.15 . . . . 0.0 110.642 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.79 172.43 12.68 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.458 0.647 . . . . 0.0 110.011 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -77.19 79.64 3.71 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.515 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 39.8 m80 -58.82 -17.77 26.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -174.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.46 82.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.204 0.602 . . . . 0.0 110.378 169.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mm -62.97 -49.7 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.8 m -57.79 -49.75 75.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.119 0.568 . . . . 0.0 109.716 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -65.82 -42.86 90.09 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.514 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.32 -46.4 86.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.2 1.364 . . . . 0.0 110.596 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -69.7 -42.79 73.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.054 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.45 -44.64 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.035 0.834 . . . . 0.0 108.944 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.79 -41.06 99.09 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.016 1.28 . . . . 0.0 111.303 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.65 75.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.624 0.647 . . . . 0.0 111.294 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -73.2 -29.27 62.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.015 0.526 . . . . 0.0 111.193 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 127.127 2.171 . . . . 0.0 111.764 -176.574 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 120.949 0.404 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.28 168.26 10.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.701 1.2 . . . . 0.0 110.784 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.6 p -138.7 171.15 14.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.364 1.466 . . . . 0.0 108.312 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -144.98 171.13 14.89 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.529 -0.732 . . . . 0.0 110.893 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 169.444 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.4 mt -50.62 -35.44 30.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.299 1.04 . . . . 0.0 112.84 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.93 -23.96 66.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.673 0.669 . . . . 0.0 112.479 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.65 -19.65 37.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.61 0.764 . . . . 0.0 111.212 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.92 131.65 94.67 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.52 111.78 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.301 2.667 . . . . 0.0 109.96 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.403 ' CG ' ' HZ3' ' A' ' 108' ' ' LYS . 23.5 t70 -73.5 -35.77 65.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -169.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.81 135.72 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -154.47 108.42 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--O 1.236 0.391 0 C-N-CA 124.128 0.971 . . . . 0.0 110.231 -170.686 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.2 p90 . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -107.12 151.46 25.35 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.75 169.18 17.96 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 109.179 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.63 152.87 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.107 1.363 . . . . 0.0 108.156 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -116.24 116.9 28.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.86 132.6 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.008 0.822 . . . . 0.0 109.615 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -77.85 147.98 34.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.31 140.42 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -112.05 146.81 37.27 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.618 1.167 . . . . 0.0 109.166 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 m -66.2 101.77 0.75 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.751 0.82 . . . . 0.0 109.598 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.519 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.67 16.27 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 115.839 -2.029 . . . . 0.0 115.004 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.519 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 63.6 Cg_exo -43.31 132.03 6.7 Favored 'Trans proline' 0 C--N 1.363 1.309 0 CA-C-N 124.258 2.557 . . . . 0.0 115.087 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 37.97 33.02 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.88 2.872 . . . . 0.0 114.049 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m 52.46 31.15 9.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.205 1.402 . . . . 0.0 112.846 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 C-N-CA 124.129 0.871 . . . . 0.0 112.877 -176.013 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 121.064 0.459 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -69.45 168.09 15.25 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.3 m -139.42 158.9 43.34 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.068 0.947 . . . . 0.0 110.526 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.52 165.67 35.89 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.696 1.598 . . . . 0.0 109.529 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.16 155.11 20.8 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.9 157.78 41.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.949 1.7 . . . . 0.0 109.052 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.72 117.53 51.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -137.78 150.4 47.19 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.53 138.27 2.68 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.1 m-85 -153.52 155.91 37.09 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -170.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.6 -33.88 72.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.402 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -65.7 -25.83 67.49 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.73 0.696 . . . . 0.0 112.536 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.42 82.06 8.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.677 1.126 . . . . 0.0 108.589 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -12.7 39.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.875 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.41 145.22 32.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.022 1.729 . . . . 0.0 108.381 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.44 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 15.2 m-70 -62.91 -31.27 72.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.384 1.074 . . . . 0.0 111.847 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -29.37 69.45 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.938 -0.477 . . . . 0.0 111.429 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.22 -45.44 84.69 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.48 0.582 . . . . 0.0 110.581 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -37.46 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.592 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.03 -45.96 86.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.483 1.492 . . . . 0.0 109.419 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.03 -48.34 71.43 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.763 0.425 . . . . 0.0 111.878 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -55.62 -54.97 37.5 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.683 0.793 . . . . 0.0 109.85 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.35 -43.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.022 -0.99 . . . . 0.0 108.664 -171.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.3 m -62.08 -29.03 70.03 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.008 1.276 . . . . 0.0 111.519 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.46 -51.09 55.33 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.43 1.014 . . . . 0.0 110.622 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.54 -44.89 92.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.972 0.886 . . . . 0.0 110.813 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -56.65 -45.72 81.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.294 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -70.33 -30.47 67.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.962 1.256 . . . . 0.0 112.327 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.18 -43.55 98.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.329 0.968 . . . . 0.0 109.694 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.44 -36.38 83.57 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.312 0.505 . . . . 0.0 110.368 171.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.32 -6.44 4.99 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.173 2.321 . . . . 0.0 113.281 170.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.6 171.88 9.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.724 1.61 . . . . 0.0 112.044 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -127.99 149.14 50.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -148.33 165.0 32.36 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -147.07 125.05 12.01 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.033 1.333 . . . . 0.0 108.263 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -67.73 111.59 4.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.9 mt -72.64 -24.61 61.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.934 -0.479 . . . . 0.0 110.62 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.34 -170.03 42.69 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.41 -174.01 28.6 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 171.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.0 -166.42 32.79 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -117.05 150.52 38.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.9 mt -118.97 136.69 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 123.608 0.763 . . . . 0.0 109.346 -169.863 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -121.71 126.64 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -166.07 1.51 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.611 -0.681 . . . . 0.0 110.509 -177.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.26 -160.9 53.44 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.84 -0.537 . . . . 0.0 111.804 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -154.04 155.13 34.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.366 1.467 . . . . 0.0 108.082 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.0 p -81.91 134.43 35.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -64.94 -29.26 70.18 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.835 -0.541 . . . . 0.0 110.647 170.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 -37.93 48.82 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.865 0.866 . . . . 0.0 112.756 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.32 1.38 3.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.61 -177.88 52.5 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 118.942 0.792 . . . . 0.0 111.921 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.67 134.44 28.19 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.641 2.228 . . . . 0.0 110.357 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 170.13 16.63 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.342 0.591 . . . . 0.0 110.225 169.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.03 79.05 3.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -58.89 -18.03 29.47 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.97 -39.19 74.14 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.668 0.787 . . . . 0.0 111.119 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.7 mm -61.8 -48.33 89.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -54.48 -52.03 63.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.735 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 p -60.46 -42.49 96.3 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.781 0.719 . . . . 0.0 111.822 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -60.94 -51.3 69.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.318 0.963 . . . . 0.0 110.825 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HZ3' ' CG ' ' A' ' 11' ' ' ASP . 18.0 mmtp -71.08 -43.83 66.95 Favored 'General case' 0 C--N 1.334 -0.109 0 C-N-CA 123.35 0.66 . . . . 0.0 111.121 -174.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.75 -43.26 97.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -63.02 -37.01 85.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 120.877 1.672 . . . . 0.0 111.228 176.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.6 93.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.098 0.863 . . . . 0.0 111.851 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -79.56 -20.06 47.93 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.24 0.616 . . . . 0.0 112.034 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.306 39.2 p90 . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 127.918 2.487 . . . . 0.0 115.969 -171.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.99 163.63 10.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.127 1.371 . . . . 0.0 107.752 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 p -137.39 171.84 13.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.744 1.218 . . . . 0.0 108.731 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -141.72 159.25 42.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.146 0.578 . . . . 0.0 110.173 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.685 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.54 -28.1 65.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.951 0.796 . . . . 0.0 112.706 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.68 66.53 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.829 1.195 . . . . 0.0 112.143 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.31 -31.07 17.09 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.633 1.173 . . . . 0.0 111.633 -175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.91 122.91 65.93 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.27 137.71 64.0 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.087 2.524 . . . . 0.0 111.141 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.63 -38.65 23.25 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 122.032 -0.417 . . . . 0.0 110.953 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.7 t -137.95 137.58 44.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -172.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -156.47 113.24 3.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 pt . . . . . 0 C--O 1.235 0.318 0 C-N-CA 124.294 1.038 . . . . 0.0 108.669 -173.224 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.39 163.24 12.96 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.804 0.842 . . . . 0.0 111.692 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.99 171.86 14.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.98 154.9 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.354 1.462 . . . . 0.0 108.477 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.2 tp -118.28 120.75 38.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.18 132.1 71.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 119.242 0.928 . . . . 0.0 109.411 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -76.08 146.22 39.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.9 121.16 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -90.45 149.26 22.3 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.734 0.814 . . . . 0.0 108.968 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -66.09 96.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.078 0.951 . . . . 0.0 109.911 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.25 19.3 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 116.254 -1.832 . . . . 0.0 115.229 169.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -39.36 132.52 1.49 Allowed 'Trans proline' 0 C--N 1.361 1.191 0 CA-C-N 123.927 2.438 . . . . 0.0 114.545 170.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 43.35 26.61 0.1 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.454 2.702 . . . . 0.0 114.154 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.68 32.1 8.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 112.358 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 C-N-CA 123.958 0.79 . . . . 0.0 112.923 -173.955 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 121.07 0.462 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.37 172.96 7.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -137.07 160.81 37.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.761 0.824 . . . . 0.0 110.619 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -139.34 165.11 28.07 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.613 1.565 . . . . 0.0 108.249 172.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.61 138.45 45.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 pt -115.6 155.08 16.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.132 0.973 . . . . 0.0 109.834 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.62 122.65 69.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -136.72 148.17 47.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 125.56 0.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -146.61 151.01 36.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -171.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -53.89 -31.26 49.33 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -74.54 -24.45 58.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.851 0.751 . . . . 0.0 112.951 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 83.4 8.06 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.974 1.261 . . . . 0.0 109.37 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.76 -6.24 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.636 0.775 . . . . 0.0 112.293 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.94 143.9 28.82 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 108.186 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -62.1 -31.38 71.83 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.104 0.962 . . . . 0.0 111.659 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.73 -27.46 69.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.785 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.779 0.718 . . . . 0.0 110.234 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -40.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.109 -1.424 . . . . 0.0 110.342 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.07 -48.61 80.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.868 1.667 . . . . 0.0 109.742 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.32 -47.11 83.6 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.888 0.767 . . . . 0.0 111.542 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -60.89 -50.13 74.65 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.96 0.504 . . . . 0.0 110.77 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.2 -44.69 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.32 -171.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.8 p -62.04 -30.41 70.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.789 1.177 . . . . 0.0 110.398 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.19 54.0 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.16 0.891 . . . . 0.0 111.007 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -64.08 -45.51 88.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.371 1.085 . . . . 0.0 111.169 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.54 -45.04 85.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.625 0.648 . . . . 0.0 111.179 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.42 -31.83 72.29 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.004 -1.06 . . . . 0.0 111.819 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.54 -39.8 95.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.101 0.864 . . . . 0.0 110.417 171.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.35 -33.9 77.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.226 0.921 . . . . 0.0 110.447 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.55 -9.88 4.03 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 126.416 1.96 . . . . 0.0 113.217 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -65.69 173.64 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.923 1.689 . . . . 0.0 112.503 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.14 135.1 49.31 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 169.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.0 m -142.48 164.49 29.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.9 130.43 11.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -66.23 109.24 2.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.2 mt -66.87 -28.16 68.1 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.926 -0.484 . . . . 0.0 110.472 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.02 -168.2 41.35 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.43 -169.15 20.87 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.88 -162.82 28.52 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 -128.88 153.7 47.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -128.86 140.38 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 124.259 1.024 . . . . 0.0 108.451 -177.077 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.7 t60 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.19 126.7 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.45 -177.51 6.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.598 0.759 . . . . 0.0 110.496 -173.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -161.05 53.22 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -150.61 155.64 39.8 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 108.421 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 t -69.61 131.85 45.29 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.6 ttm -62.51 -26.32 68.49 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.521 0.328 . . . . 0.0 110.844 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.24 -30.05 13.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 112.587 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.01 1.66 4.29 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -168.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.74 -176.56 48.54 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.092 0.86 . . . . 0.0 112.279 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.34 131.6 22.18 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.721 2.281 . . . . 0.0 110.663 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.87 170.02 16.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 110.231 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.03 74.14 4.58 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.41 -18.82 19.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 113.399 -175.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.47 -38.82 69.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.424 0.69 . . . . 0.0 111.199 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.65 -43.98 97.95 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.928 0.891 . . . . 0.0 108.828 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -57.0 -50.35 72.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.64 0.655 . . . . 0.0 110.617 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 -48.56 73.92 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.813 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.94 -50.08 72.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.018 0.826 . . . . 0.0 110.878 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -68.33 -46.12 71.08 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.575 0.75 . . . . 0.0 110.671 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.98 -39.24 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.983 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.06 -36.76 82.73 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.158 1.799 . . . . 0.0 111.572 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.99 89.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.963 0.801 . . . . 0.0 110.958 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -70.04 -39.17 75.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.162 0.585 . . . . 0.0 111.289 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 t80 . . . . . 0 CA--C 1.54 0.568 0 C-N-CA 126.965 2.106 . . . . 0.0 109.592 -168.468 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.0 p -149.21 155.03 8.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 120.755 -1.216 . . . . 0.0 108.587 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.9 p -140.97 170.98 14.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.547 1.539 . . . . 0.0 107.785 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -145.61 168.19 21.25 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.661 -0.649 . . . . 0.0 111.425 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.653 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.232 0.157 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 mt -53.65 -30.71 44.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 113.468 -178.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.58 -24.8 56.66 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.889 0.768 . . . . 0.0 112.283 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.0 -21.56 29.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.967 0.907 . . . . 0.0 110.954 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.37 129.91 80.41 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.91 112.57 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 172.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.61 -30.09 64.06 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.4 139.09 23.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.977 1.711 . . . . 0.0 106.386 177.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -155.03 109.28 2.94 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--O 1.236 0.359 0 C-N-CA 124.333 1.053 . . . . 0.0 108.815 -173.268 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 . . . . . 0 C--O 1.233 0.188 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -81.24 159.96 24.4 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.544 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -142.46 169.25 17.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.87 155.4 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.019 1.327 . . . . 0.0 108.727 177.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -122.57 111.47 16.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 -175.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.78 134.72 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 118.81 0.732 . . . . 0.0 109.812 -171.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -79.16 147.87 32.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.182 1.393 . . . . 0.0 108.462 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 t -137.05 128.93 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -97.3 150.98 20.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.813 1.245 . . . . 0.0 109.952 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m -66.29 100.36 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.195 176.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.51 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.8 19.51 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.171 169.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.51 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 86.6 Cg_exo -46.51 140.31 12.09 Favored 'Trans proline' 0 C--N 1.362 1.277 0 CA-C-N 124.317 2.578 . . . . 0.0 113.879 173.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 42.96 25.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 114.269 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 m 50.33 33.44 7.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.979 1.312 . . . . 0.0 112.226 -174.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.884 0 C-N-CA 124.143 0.878 . . . . 0.0 112.165 -172.437 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -70.09 170.39 11.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -141.8 158.26 44.02 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.993 0.917 . . . . 0.0 110.034 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.07 165.69 34.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.199 1.4 . . . . 0.0 109.142 174.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.26 158.04 17.81 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -175.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 pt -136.62 158.61 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.006 1.323 . . . . 0.0 109.358 175.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 t -123.36 119.16 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -171.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mmt85 -138.25 145.96 41.97 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.45 133.9 1.92 Allowed Glycine 0 C--N 1.332 0.326 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.421 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.6 m-85 -155.64 156.93 35.86 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.378 0.671 . . . . 0.0 109.294 -171.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -32.75 72.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.359 0.664 . . . . 0.0 111.485 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.421 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.5 p-90 -65.98 -29.09 69.42 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 112.207 178.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 81.21 8.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.289 0.949 . . . . 0.0 108.451 171.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -62.16 -15.45 46.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 111.919 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.15 144.76 36.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.891 1.676 . . . . 0.0 108.446 176.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.497 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 7.4 m-70 -59.49 -31.66 69.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.217 1.407 . . . . 0.0 111.895 -175.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.07 69.67 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.664 177.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.1 -47.75 70.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.747 0.703 . . . . 0.0 110.393 -178.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -39.99 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.476 -1.249 . . . . 0.0 110.3 176.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.5 -47.17 86.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.566 1.53 . . . . 0.0 109.786 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.75 -48.51 78.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.604 0.638 . . . . 0.0 111.41 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -60.84 -51.18 70.4 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.62 -44.77 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.33 -173.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -60.52 -37.01 79.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.727 1.149 . . . . 0.0 109.515 176.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.67 84.83 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.877 0.762 . . . . 0.0 111.601 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.04 -47.19 81.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.564 1.182 . . . . 0.0 110.817 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mmt -56.95 -44.34 82.47 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.968 -0.457 . . . . 0.0 111.19 175.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -67.87 -33.36 74.59 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.249 -0.907 . . . . 0.0 111.768 179.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -63.05 -40.98 99.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.059 0.845 . . . . 0.0 110.018 171.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -63.03 -37.83 88.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.032 0.833 . . . . 0.0 110.098 171.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 140.39 -8.93 2.92 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.323 1.916 . . . . 0.0 113.324 169.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.7 m -68.92 175.13 3.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.455 1.502 . . . . 0.0 112.436 -170.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.51 143.24 50.75 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.7 m -144.22 169.64 17.49 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.14 137.92 15.3 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.313 1.045 . . . . 0.0 108.777 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -70.9 112.48 7.11 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 169.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.2 -25.43 63.41 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.132 -0.355 . . . . 0.0 110.335 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.89 -164.23 37.65 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.92 23.09 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.39 -157.1 19.13 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -175.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -129.28 165.73 20.85 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 117.977 0.888 . . . . 0.0 109.594 173.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.4 mt -131.3 137.18 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -169.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 N--CA 1.455 -0.216 0 C-N-CA 123.665 0.786 . . . . 0.0 109.886 -175.611 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.2 t60 . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.08 119.07 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -174.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -159.88 -177.01 6.03 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.208 -0.933 . . . . 0.0 111.144 -169.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.84 -158.49 44.78 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 177.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -143.94 151.91 40.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.603 1.561 . . . . 0.0 107.398 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.6 p -72.84 139.68 47.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.8 mmm -64.51 -6.88 8.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.76 -19.74 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.802 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.57 2.55 2.96 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 112.7 -171.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.2 -176.14 54.82 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.845 0.748 . . . . 0.0 112.332 178.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -72.0 137.04 28.46 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.725 2.283 . . . . 0.0 110.692 -179.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 174.81 10.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.388 0.613 . . . . 0.0 110.306 169.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -79.4 80.84 5.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 168.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.544 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 42.6 m80 -58.37 -16.08 13.15 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -173.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.83 88.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.461 0.704 . . . . 0.0 110.869 171.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.2 mt -60.05 -47.49 91.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 175.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -56.05 -55.72 29.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.515 1.126 . . . . 0.0 110.876 -177.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 p -65.46 -41.08 93.78 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.078 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.57 -44.39 94.21 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.744 1.156 . . . . 0.0 110.23 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -66.09 -43.3 87.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.42 -49.41 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.88 -39.12 84.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.585 1.084 . . . . 0.0 111.239 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.54 78.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.473 0.578 . . . . 0.0 111.48 177.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -76.98 -18.38 58.26 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 CA--C 1.549 0.918 0 C-N-CA 126.088 1.755 . . . . 0.0 113.288 177.125 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.5 m -138.06 171.38 15.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.519 0.728 . . . . 0.0 110.791 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.9 p -142.18 166.49 24.55 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.028 1.331 . . . . 0.0 108.636 -174.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -144.18 170.36 16.12 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.691 171.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.645 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 169.541 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 tpp . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.95 146.3 38.99 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.858 1.263 . . . . 0.0 108.226 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.8 137.08 22.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.465 0.706 . . . . 0.0 109.723 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.81 176.75 6.05 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 168.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -145.66 155.52 43.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 mt -52.21 -29.91 24.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.55 1.14 . . . . 0.0 113.469 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.71 -27.69 61.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 112.417 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.0 mt -83.25 -24.14 32.41 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 0.0 110.975 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.0 130.25 73.25 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.52 125.69 16.07 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.226 2.618 . . . . 0.0 109.78 171.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.77 -36.23 20.25 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.97 138.52 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -156.0 112.99 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.3 pt -143.28 153.38 16.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 109.136 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -72.78 170.06 15.43 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -148.32 16.58 1.04 Allowed 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.926 -1.109 . . . . 0.0 112.575 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -115.39 26.91 9.71 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -168.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.91 -121.12 1.0 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 120.878 -1.139 . . . . 0.0 112.957 170.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.65 127.51 64.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -160.96 167.94 25.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.006 1.322 . . . . 0.0 108.424 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -101.02 158.24 16.16 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.605 -0.684 . . . . 0.0 109.717 -173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.96 168.6 19.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.88 0.872 . . . . 0.0 109.446 -171.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.5 155.01 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.32 1.448 . . . . 0.0 108.335 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 tp -118.27 114.64 23.29 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 130.9 72.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -77.5 146.11 36.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.31 127.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.57 149.75 22.43 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 109.222 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -65.88 98.3 0.4 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.989 0.916 . . . . 0.0 110.75 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -148.52 18.02 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.281 -1.819 . . . . 0.0 115.123 169.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 55.8 Cg_exo -41.21 134.57 2.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 123.978 2.456 . . . . 0.0 114.5 171.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 47.23 21.54 0.2 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.021 2.528 . . . . 0.0 113.448 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.86 33.45 8.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.28 1.432 . . . . 0.0 112.659 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.65 10.08 2.13 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 113.82 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.33 149.74 75.36 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 118.509 1.155 . . . . 0.0 111.007 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.95 -4.44 13.33 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.373 2.715 . . . . 0.0 114.847 -169.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.18 -176.64 5.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.285 1.034 . . . . 0.0 110.314 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.1 38.74 3.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.915 1.686 . . . . 0.0 109.815 174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.59 167.64 12.61 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -141.19 158.87 43.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.848 0.859 . . . . 0.0 110.412 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -151.52 166.08 32.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.845 1.658 . . . . 0.0 108.928 174.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -108.94 153.69 23.2 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.456 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 45.0 pt -129.82 155.28 41.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.854 1.262 . . . . 0.0 109.265 173.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.36 123.52 71.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -171.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -136.03 146.58 47.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.625 1.17 . . . . 0.0 108.478 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.13 129.84 1.44 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -150.78 151.92 33.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -60.19 -29.75 68.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.804 0.842 . . . . 0.0 112.479 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 -68.19 -28.03 66.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.33 0.968 . . . . 0.0 112.578 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.62 82.63 8.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.739 1.154 . . . . 0.0 108.913 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.12 -3.94 8.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.321 0.648 . . . . 0.0 112.355 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.33 142.95 26.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.818 1.647 . . . . 0.0 107.982 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 18.9 m-70 -60.92 -30.74 70.38 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 111.856 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.29 70.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.813 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.66 0.664 . . . . 0.0 110.431 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -41.57 86.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.216 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.93 -46.99 86.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.123 1.329 . . . . 0.0 110.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.88 -49.6 69.87 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.234 0.47 . . . . 0.0 111.331 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -58.84 -49.85 76.19 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.419 0.687 . . . . 0.0 110.839 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.1 t -73.47 -41.3 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.155 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m -62.36 -29.8 70.73 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 119.638 1.108 . . . . 0.0 110.895 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.6 -50.03 70.51 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -62.72 -47.77 82.15 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.194 0.997 . . . . 0.0 110.854 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.81 -43.99 90.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.965 -0.459 . . . . 0.0 111.302 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -68.78 -31.62 70.77 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.993 -1.067 . . . . 0.0 111.911 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -61.36 -43.69 98.44 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.421 1.01 . . . . 0.0 109.552 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -60.13 -43.04 95.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.513 1.052 . . . . 0.0 109.546 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.75 -7.17 1.69 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.333 1.92 . . . . 0.0 113.265 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.36 176.58 2.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.204 1.802 . . . . 0.0 113.216 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -130.03 140.51 50.85 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.4 m -146.45 163.34 35.98 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -153.58 128.71 9.69 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -66.75 116.71 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.4 -28.89 65.43 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.792 -0.568 . . . . 0.0 110.078 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.87 -169.37 42.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.1 -168.34 20.27 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.99 -161.22 26.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -121.37 153.53 37.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.445 1.098 . . . . 0.0 108.232 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 mt -125.28 135.04 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m -143.47 113.96 7.48 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.526 0.73 . . . . 0.0 109.951 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.33 133.13 35.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 168.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -118.17 133.36 55.97 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 m -59.56 -28.99 67.62 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -21.78 62.98 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.153 0.888 . . . . 0.0 113.389 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -153.54 140.89 19.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.918 1.235 . . . . 0.0 108.483 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -34.47 4.04 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.695 1.598 . . . . 0.0 112.978 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -46.16 140.11 4.15 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.119 2.168 . . . . 0.0 112.24 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 mt -97.28 158.36 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -130.63 150.43 51.82 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.31 -0.869 . . . . 0.0 108.93 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -128.11 122.42 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -173.04 3.96 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.41 -0.806 . . . . 0.0 111.21 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -160.15 53.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.02 153.77 35.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.45 1.1 . . . . 0.0 108.903 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.5 t -69.45 128.33 36.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.8 ttp -64.91 -17.24 64.16 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.355 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.69 -29.66 10.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.715 0.806 . . . . 0.0 112.638 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -127.4 0.08 6.3 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.75 -178.28 50.83 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.853 0.752 . . . . 0.0 112.144 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.1 131.04 19.96 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.635 2.223 . . . . 0.0 110.401 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.5 167.64 20.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.355 0.598 . . . . 0.0 109.557 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.14 77.7 5.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -57.76 -18.87 24.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.11 66.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.705 0.802 . . . . 0.0 111.21 169.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.44 -49.25 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -55.5 -48.32 74.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.001 0.521 . . . . 0.0 111.124 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.9 p -61.78 -44.83 96.11 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.476 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.43 -46.55 89.62 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.277 0.944 . . . . 0.0 110.571 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -62.27 -54.95 33.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.329 1.452 . . . . 0.0 110.684 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.735 0.814 . . . . 0.0 109.186 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -59.73 -40.2 87.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.287 0.949 . . . . 0.0 110.833 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.48 91.14 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.306 0.503 . . . . 0.0 111.201 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -81.71 -14.58 56.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 51.08 50.98 9.65 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.848 1.259 . . . . 0.0 113.228 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.75 -17.22 26.08 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.33 1.353 . . . . 0.0 112.101 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -143.74 -75.61 0.25 Allowed 'General case' 0 C--N 1.343 0.321 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.479 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.7 -74.08 0.09 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.75 1.159 . . . . 0.0 110.755 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -154.48 156.33 36.51 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.47 164.7 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.107 0.563 . . . . 0.0 111.184 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.9 p -137.69 172.67 12.61 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 108.758 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -142.73 169.55 17.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.768 0.427 . . . . 0.0 110.417 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.18 143.1 29.05 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.87 41.22 0.9 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.198 0.999 . . . . 0.0 110.33 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -155.37 -172.91 4.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.898 1.679 . . . . 0.0 108.048 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.26 -162.88 37.07 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.233 0.92 . . . . 0.0 111.26 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 C--O 1.246 0.897 0 C-N-CA 125.937 1.695 . . . . 0.0 107.305 178.263 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 tpp . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.27 162.14 39.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.479 1.512 . . . . 0.0 108.212 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.63 137.97 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.32 178.21 5.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.57 0.748 . . . . 0.0 109.487 170.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -152.31 153.69 34.19 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.058 -1.027 . . . . 0.0 109.559 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.1 mt -55.51 -27.73 50.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.254 1.422 . . . . 0.0 113.524 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.0 -23.19 61.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.777 0.717 . . . . 0.0 112.564 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.52 -21.19 53.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.515 0.598 . . . . 0.0 111.315 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.07 134.97 96.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.278 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.74 106.95 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.27 2.647 . . . . 0.0 108.717 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.42 -33.51 73.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.9 t -142.6 138.2 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -150.64 103.35 3.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 pt -144.16 166.39 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.601 2.36 . . . . 0.0 106.641 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -149.35 133.58 17.34 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -74.27 40.26 0.13 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.97 2.108 . . . . 0.0 113.623 -169.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.27 -30.43 69.45 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.926 1.291 . . . . 0.0 112.834 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.73 -155.32 25.22 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.8 t -71.72 135.68 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -159.41 168.04 27.27 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.53 1.132 . . . . 0.0 109.09 171.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.05 155.09 17.29 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.931 0.492 . . . . 0.0 109.784 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.63 19.33 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.72 0.808 . . . . 0.0 108.966 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.86 153.59 17.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.767 1.227 . . . . 0.0 108.315 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.08 118.04 32.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.284 0.0 OUTLIER -130.02 130.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 118.373 0.533 . . . . 0.0 109.597 -172.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -80.63 147.33 30.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.792 1.637 . . . . 0.0 108.438 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.91 129.75 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -93.85 155.51 17.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.351 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 m -66.52 85.05 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.267 1.027 . . . . 0.0 111.555 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.45 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.19 13.14 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 116.23 -1.843 . . . . 0.0 114.041 169.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 52.0 Cg_exo -47.13 136.22 18.38 Favored 'Trans proline' 0 C--N 1.362 1.284 0 CA-C-N 124.02 2.472 . . . . 0.0 112.454 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 41.2 31.76 0.16 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.898 2.479 . . . . 0.0 113.847 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 32.0 12.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.897 1.679 . . . . 0.0 113.806 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.27 21.41 0.56 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.586 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.57 148.13 81.86 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 118.053 0.926 . . . . 0.0 110.598 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.85 -1.67 11.6 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.455 2.77 . . . . 0.0 114.359 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.73 -173.45 4.48 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.758 1.223 . . . . 0.0 109.979 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.94 37.83 3.57 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.591 1.556 . . . . 0.0 110.129 174.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -69.41 167.89 15.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -142.8 159.34 42.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.722 0.809 . . . . 0.0 109.652 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.414 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -149.22 164.43 34.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 109.195 174.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 150.37 27.63 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -176.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.414 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 37.6 pt -127.68 155.55 39.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.486 1.115 . . . . 0.0 108.872 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 t -122.34 116.46 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -169.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -136.51 147.27 47.01 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.98 138.31 3.71 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -154.16 155.92 36.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -173.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.75 -33.03 72.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.779 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -65.87 -27.04 67.92 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.756 0.707 . . . . 0.0 112.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.51 78.92 9.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.593 1.088 . . . . 0.0 109.117 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.96 -6.9 9.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.697 0.799 . . . . 0.0 112.102 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 142.53 29.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.981 1.713 . . . . 0.0 107.604 174.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.463 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 13.7 m-70 -62.15 -29.66 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.637 1.175 . . . . 0.0 111.663 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -29.18 68.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.034 -0.507 . . . . 0.0 111.757 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.26 -44.67 78.79 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.807 0.73 . . . . 0.0 110.725 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -41.44 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.458 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.22 -45.12 94.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.54 1.064 . . . . 0.0 109.044 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.03 -48.11 80.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.163 0.892 . . . . 0.0 111.748 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -55.08 -56.78 15.94 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.974 0.909 . . . . 0.0 109.945 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.46 -43.62 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.599 -169.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 t -60.5 -35.58 76.28 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.075 1.307 . . . . 0.0 109.748 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.84 -48.16 86.78 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.165 0.893 . . . . 0.0 111.324 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.12 -46.66 83.15 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.143 0.972 . . . . 0.0 111.131 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.1 mmt -58.91 -43.77 91.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.694 0.679 . . . . 0.0 110.831 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -66.52 -33.37 75.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.859 -1.15 . . . . 0.0 111.27 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.94 -40.09 95.65 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.971 . . . . 0.0 110.389 169.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -64.59 -20.23 66.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.054 0.843 . . . . 0.0 111.49 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.47 -8.43 11.1 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.581 2.038 . . . . 0.0 112.723 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.24 178.55 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.826 1.65 . . . . 0.0 114.048 -169.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -132.31 145.1 51.03 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -147.57 165.57 29.98 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -168.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -150.51 130.95 13.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.658 1.183 . . . . 0.0 109.382 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -71.88 116.27 12.07 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -74.64 -24.96 58.91 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.97 -0.456 . . . . 0.0 110.418 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.49 -168.32 40.48 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.62 -167.87 22.69 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.31 -163.37 29.65 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.9 ttp-105 -119.49 154.43 33.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mt -113.19 126.98 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -150.06 152.47 34.87 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.837 0.855 . . . . 0.0 108.896 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.53 163.22 21.61 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.605 0.762 . . . . 0.0 110.647 171.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -130.65 151.73 50.79 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.242 1.017 . . . . 0.0 109.517 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -63.31 -16.82 61.51 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -170.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -60.34 -47.11 87.43 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.125 0.875 . . . . 0.0 111.14 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -162.53 21.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.084 0.954 . . . . 0.0 111.248 -173.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.8 mttp 56.62 18.36 3.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.57 1.548 . . . . 0.0 112.902 -169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -58.97 126.62 28.45 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.1 pt -63.5 150.06 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.88 0.848 . . . . 0.0 110.285 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -143.65 143.7 31.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.295 1.838 . . . . 0.0 106.702 -169.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 t -117.03 114.09 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.8 -173.23 4.0 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.637 -0.664 . . . . 0.0 111.945 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.7 -156.56 46.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -145.83 152.72 39.96 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.023 0.929 . . . . 0.0 109.084 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.2 t -69.32 130.46 42.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -64.81 -8.34 14.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.24 -27.71 6.37 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.153 0.981 . . . . 0.0 112.574 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -132.8 2.39 3.7 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.94 -177.27 48.17 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 119.246 0.93 . . . . 0.0 112.554 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 128.68 15.56 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.815 2.343 . . . . 0.0 110.902 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.87 167.24 22.25 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.499 0.666 . . . . 0.0 110.199 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -79.99 83.46 5.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 168.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -59.17 -14.82 11.75 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.37 84.47 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.154 0.982 . . . . 0.0 110.87 169.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.9 mm -62.19 -51.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -56.38 -51.18 69.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.801 0.84 . . . . 0.0 110.976 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 p -63.17 -42.78 99.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.337 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.67 -47.81 82.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.938 1.244 . . . . 0.0 110.74 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.259 0.481 . . . . 0.0 110.827 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.84 -51.17 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.18 -36.34 77.4 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.983 1.265 . . . . 0.0 110.846 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.36 68.33 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.406 0.548 . . . . 0.0 111.552 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -74.94 -19.32 60.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 t80 52.35 49.78 7.19 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.558 1.943 . . . . 0.0 113.639 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.93 -16.16 29.31 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.374 2.049 . . . . 0.0 111.36 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -145.5 169.82 17.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.398 2.279 . . . . 0.0 106.407 173.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -67.76 -38.64 83.72 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.863 0.865 . . . . 0.0 111.779 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -162.58 166.49 24.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 108.409 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.05 167.78 9.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.895 2.078 . . . . 0.0 107.862 173.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -142.45 170.11 16.31 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.657 1.583 . . . . 0.0 107.048 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -142.27 169.79 16.93 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.216 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.69 143.85 27.91 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -82.11 25.31 0.59 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.833 1.253 . . . . 0.0 111.852 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -154.18 -179.05 7.54 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.583 1.553 . . . . 0.0 107.725 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.7 175.52 15.95 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.631 1.586 . . . . 0.0 110.779 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 88.8 t80 . . . . . 0 C--O 1.246 0.916 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 175.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttm . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.1 158.27 7.09 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.43 0.692 . . . . 0.0 111.426 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 m -65.23 159.55 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.789 0.835 . . . . 0.0 110.656 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.62 171.4 4.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -147.96 156.52 42.76 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.097 0.959 . . . . 0.0 108.452 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.03 -28.24 64.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.622 0.769 . . . . 0.0 112.879 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.89 61.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.282 0.946 . . . . 0.0 112.363 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.13 -28.57 18.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.47 1.108 . . . . 0.0 110.957 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -55.91 129.09 71.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -50.44 133.24 36.93 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.273 2.649 . . . . 0.0 110.22 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.12 -42.35 9.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 137.09 43.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -156.42 118.18 3.9 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 169.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.9 pt -139.48 157.98 27.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.114 0.966 . . . . 0.0 109.131 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.02 90.07 3.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.696 1.599 . . . . 0.0 107.346 -176.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 m -72.31 54.18 0.3 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.834 2.453 . . . . 0.0 113.026 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -55.09 -45.84 75.44 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.759 1.223 . . . . 0.0 112.869 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.39 -39.34 0.86 Allowed Glycine 0 CA--C 1.524 0.624 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.466 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.2 t -149.08 120.15 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -160.32 164.95 32.13 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.438 1.095 . . . . 0.0 109.55 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -97.62 160.55 14.25 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.412 -0.805 . . . . 0.0 109.92 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 167.8 21.45 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.13 0.972 . . . . 0.0 108.791 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.12 155.17 15.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.351 1.06 . . . . 0.0 108.767 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -118.36 114.52 23.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -120.58 131.38 72.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.782 0.719 . . . . 0.0 109.231 -175.113 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -76.78 145.08 38.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.44 117.94 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.9 146.09 26.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.8 p -68.45 103.33 1.63 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.297 0.498 . . . . 0.0 109.853 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.66 25.02 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.655 -1.641 . . . . 0.0 114.753 169.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.428 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 49.9 Cg_exo -42.65 135.69 4.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 CA-C-N 123.827 2.402 . . . . 0.0 114.637 172.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 43.05 25.87 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.587 2.355 . . . . 0.0 114.518 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 51.47 33.35 10.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.814 1.245 . . . . 0.0 112.267 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.95 27.29 1.6 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.339 0.971 . . . . 0.0 112.34 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.59 87.67 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 117.638 0.719 . . . . 0.0 110.595 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.25 -10.34 19.2 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.072 2.515 . . . . 0.0 113.86 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.97 179.52 8.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.896 1.279 . . . . 0.0 109.88 -172.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.07 48.74 2.31 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.892 1.677 . . . . 0.0 109.156 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.01 178.08 6.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.843 0.857 . . . . 0.0 109.341 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -141.17 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.532 0.733 . . . . 0.0 110.725 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.07 162.62 32.85 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.84 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.12 136.26 49.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 pt -116.79 155.03 18.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.704 0.802 . . . . 0.0 109.627 172.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.8 123.85 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -137.57 148.46 45.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.294 1.038 . . . . 0.0 108.502 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.76 133.15 1.93 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -150.3 156.5 41.65 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -60.1 -35.38 75.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 119.177 -0.439 . . . . 0.0 111.497 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -65.4 -26.38 67.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.4 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.59 80.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.626 1.103 . . . . 0.0 108.428 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.7 -13.32 21.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.777 0.831 . . . . 0.0 111.777 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.24 143.51 31.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.417 1.887 . . . . 0.0 107.683 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -58.48 -30.0 66.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.962 1.305 . . . . 0.0 112.926 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.68 -27.96 69.57 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.593 . . . . 0.0 111.476 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.53 -46.74 78.42 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.313 0.506 . . . . 0.0 110.63 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -40.83 80.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.473 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -59.66 -47.62 84.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.791 1.632 . . . . 0.0 109.741 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.82 -47.65 82.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.794 0.724 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -61.24 -50.07 74.56 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.151 0.58 . . . . 0.0 110.845 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.9 t -74.53 -44.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.452 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.1 p -62.11 -30.94 71.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.923 1.238 . . . . 0.0 110.341 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.49 -52.23 54.35 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.96 -42.3 85.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.681 1.241 . . . . 0.0 111.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.22 -43.33 82.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.406 1.003 . . . . 0.0 111.095 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -68.9 -29.89 68.27 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.966 -1.084 . . . . 0.0 112.285 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -62.36 -42.32 99.3 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.358 0.981 . . . . 0.0 109.071 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.09 -38.08 89.57 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.349 0.522 . . . . 0.0 110.314 172.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.65 -8.91 3.12 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.18 1.848 . . . . 0.0 113.459 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.9 m -66.69 171.28 5.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.678 1.591 . . . . 0.0 112.256 -169.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.35 136.6 54.22 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 169.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 54.2 m -142.27 165.36 27.64 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.2 131.71 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -68.32 109.56 3.68 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.6 mt -64.97 -28.17 69.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.722 0.409 . . . . 0.0 110.082 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.69 -167.55 40.7 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.76 -164.01 20.37 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.1 -159.65 23.64 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -125.5 154.13 42.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mt -129.83 139.49 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.1 m -151.84 163.85 38.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -60.15 151.44 26.95 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 169.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -61.84 157.14 18.9 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 169.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.4 m -69.19 17.42 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.349 1.46 . . . . 0.0 113.648 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.66 -18.69 0.27 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.214 1.406 . . . . 0.0 113.037 -172.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -161.49 154.76 21.21 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.655 1.116 . . . . 0.0 109.259 -171.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.95 -20.34 63.71 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.008 -0.996 . . . . 0.0 113.419 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -44.17 122.5 2.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.098 1.359 . . . . 0.0 109.087 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.22 160.59 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 122.003 0.906 . . . . 0.0 111.479 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -141.44 140.64 33.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.921 2.088 . . . . 0.0 106.885 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.12 129.65 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -159.77 -174.69 4.73 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.349 -0.844 . . . . 0.0 110.903 -170.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.81 -161.42 53.43 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.942 -0.474 . . . . 0.0 112.3 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -151.31 152.26 32.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 109.643 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 m -79.6 130.9 35.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 tpt -60.63 -35.26 75.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.903 0.481 . . . . 0.0 111.258 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.08 -16.89 24.46 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.73 -5.9 5.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -169.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.72 178.08 42.94 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.823 0.725 . . . . 0.0 112.098 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.55 135.38 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.671 2.248 . . . . 0.0 109.814 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.13 169.91 16.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 110.152 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -79.68 82.78 5.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -58.45 -18.28 27.34 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.66 -38.4 72.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.502 1.121 . . . . 0.0 111.846 169.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 14.6 mm -62.8 -49.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.9 m -56.58 -52.49 64.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.772 0.829 . . . . 0.0 111.325 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -62.08 -43.61 98.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.995 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.23 -47.93 83.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.499 1.045 . . . . 0.0 110.761 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -64.36 -47.11 80.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.303 0.501 . . . . 0.0 110.986 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -48.3 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -61.92 -38.81 89.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.34 1.427 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.29 97.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.552 0.615 . . . . 0.0 111.922 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -87.95 -12.95 43.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.632 0.651 . . . . 0.0 112.682 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.301 40.5 p90 42.67 54.33 9.56 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 128.56 2.744 . . . . 0.0 116.422 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -56.34 -29.49 77.08 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.993 1.795 . . . . 0.0 110.89 168.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -138.68 161.22 37.7 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.11 2.564 . . . . 0.0 105.542 169.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -61.21 -33.26 73.19 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -158.49 161.38 37.38 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.828 1.251 . . . . 0.0 107.945 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 m -144.74 170.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.75 1.62 . . . . 0.0 108.143 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -141.39 171.59 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.253 1.421 . . . . 0.0 108.481 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -145.93 164.23 32.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.756 0.707 . . . . 0.0 111.735 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.39 25.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -81.98 42.14 0.7 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.984 1.314 . . . . 0.0 111.037 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -143.05 -160.78 1.15 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.951 1.7 . . . . 0.0 108.047 -170.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.27 -23.92 3.16 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 120.64 -1.287 . . . . 0.0 114.166 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 . . . . . 0 C--O 1.25 1.085 0 C-N-CA 128.763 2.825 . . . . 0.0 113.178 169.722 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 119.414 -0.326 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.91 166.5 30.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.111 1.364 . . . . 0.0 108.897 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.6 167.02 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.995 1.318 . . . . 0.0 107.709 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.82 174.54 10.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.722 1.609 . . . . 0.0 107.672 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -153.58 160.51 42.47 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.349 1.06 . . . . 0.0 108.84 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.8 mt -49.35 -34.25 15.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.181 1.392 . . . . 0.0 112.725 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.13 -24.51 67.19 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.4 mt -79.45 -19.95 48.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.097 0.559 . . . . 0.0 111.517 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mt -70.19 133.43 87.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.79 140.71 68.57 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.41 2.073 . . . . 0.0 108.973 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -86.33 -38.84 17.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.69 140.58 27.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -157.49 117.25 3.38 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 pt -139.02 175.03 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.332 1.053 . . . . 0.0 109.918 -171.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -123.95 53.03 1.41 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.039 1.336 . . . . 0.0 111.745 -168.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -53.99 3.18 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.355 3.062 . . . . 0.0 117.474 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -68.04 -19.69 64.91 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.964 1.305 . . . . 0.0 113.035 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.73 -158.41 11.22 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.795 0.712 . . . . 0.0 111.588 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.9 t -85.45 131.88 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -156.54 167.6 29.94 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.965 1.306 . . . . 0.0 109.014 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.24 154.94 18.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.239 0.616 . . . . 0.0 109.778 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 169.79 16.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.488 0.715 . . . . 0.0 109.551 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.46 153.68 16.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.291 1.436 . . . . 0.0 108.319 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.7 tp -117.1 114.86 24.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.31 132.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.57 147.45 33.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.599 1.16 . . . . 0.0 107.895 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.22 125.85 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -97.11 146.23 25.23 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.679 1.192 . . . . 0.0 108.941 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 m -63.84 100.96 0.33 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.262 0.483 . . . . 0.0 111.025 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.504 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -147.85 9.76 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 116.094 -1.908 . . . . 0.0 114.602 169.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 88.4 Cg_exo -44.7 140.33 6.63 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 124.14 2.514 . . . . 0.0 114.58 174.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? 43.66 24.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.75 2.42 . . . . 0.0 114.117 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.17 30.26 4.17 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.158 1.383 . . . . 0.0 112.327 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.73 5.47 0.42 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.974 -170.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.98 147.82 11.93 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 118.71 1.255 . . . . 0.0 110.548 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.37 -2.21 11.77 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.669 2.913 . . . . 0.0 116.422 -169.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 -173.8 4.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.907 1.231 . . . . 0.0 111.08 -170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.72 48.89 2.18 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.613 1.965 . . . . 0.0 108.518 170.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.404 ' C ' ' HG ' ' A' ' 40' ' ' SER . 53.3 mm-40 -77.25 -174.19 3.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.404 ' HG ' ' C ' ' A' ' 39' ' ' GLU . 14.3 m -150.8 160.52 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.778 -1.201 . . . . 0.0 109.974 170.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 165.11 33.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.643 1.577 . . . . 0.0 108.636 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.25 154.95 21.05 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 pt -134.39 155.44 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.9 1.28 . . . . 0.0 109.042 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -118.38 120.79 65.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -135.26 148.69 49.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.26 140.9 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 39.2 m-85 -151.99 152.82 32.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -60.05 -32.31 70.81 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.828 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.403 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.2 p-90 -65.84 -27.78 68.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.683 0.674 . . . . 0.0 112.41 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 78.07 9.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.565 1.075 . . . . 0.0 108.816 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.5 -5.59 8.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.414 0.686 . . . . 0.0 112.08 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 140.09 27.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.086 1.754 . . . . 0.0 107.472 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.5 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.7 m-70 -61.98 -31.12 71.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.596 1.158 . . . . 0.0 111.703 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 -29.39 67.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.728 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.86 -48.02 72.98 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.735 0.698 . . . . 0.0 110.466 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -40.6 82.33 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 117.473 -1.251 . . . . 0.0 110.013 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.1 -46.93 84.71 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.574 1.534 . . . . 0.0 110.137 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.45 -49.51 68.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.254 0.479 . . . . 0.0 111.45 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -60.83 -49.52 77.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.2 0.6 . . . . 0.0 110.955 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.73 -44.51 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.952 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -62.7 -28.29 69.84 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.637 1.108 . . . . 0.0 111.195 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.6 56.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.34 -45.78 86.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.194 0.997 . . . . 0.0 110.96 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.5 mmt -57.78 -45.09 86.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.702 0.683 . . . . 0.0 111.14 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.32 -32.12 72.87 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.946 -1.096 . . . . 0.0 111.814 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -63.72 -37.71 88.39 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.266 0.939 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -66.94 -34.86 78.69 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.216 0.916 . . . . 0.0 110.235 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.6 -6.46 3.86 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.548 2.023 . . . . 0.0 113.106 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.06 178.45 1.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.922 1.689 . . . . 0.0 113.001 -169.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -132.34 142.11 49.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.6 m -145.86 164.27 32.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.87 128.55 10.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 p -71.69 112.27 7.66 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 110.372 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.0 -166.85 39.73 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -163.82 -169.14 26.9 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.46 -160.86 24.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.17 156.82 32.89 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mt -126.36 146.93 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.6 m -149.91 165.79 31.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.608 1.563 . . . . 0.0 108.405 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -130.97 150.26 52.2 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.375 1.47 . . . . 0.0 108.634 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -141.19 147.52 38.49 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.685 1.194 . . . . 0.0 108.688 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 p -115.42 3.05 14.05 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.878 1.271 . . . . 0.0 112.321 -172.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -65.8 -33.7 76.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.327 0.651 . . . . 0.0 109.976 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -143.09 27.14 1.62 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.135 1.374 . . . . 0.0 110.876 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt 38.09 77.48 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.555 2.342 . . . . 0.0 112.86 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -136.88 154.32 50.52 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.559 0.695 . . . . 0.0 111.044 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mm -104.74 153.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -134.28 139.28 45.6 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.01 122.69 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -159.96 -176.36 5.64 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.61 -0.681 . . . . 0.0 111.488 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.66 -160.29 51.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -145.34 151.28 38.05 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.857 1.263 . . . . 0.0 108.057 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.1 p -69.85 147.88 49.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.027 0.441 . . . . 0.0 110.526 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.0 ttp -58.33 -22.47 53.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.478 1.111 . . . . 0.0 112.959 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.66 -14.89 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.0 4.78 3.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.214 1.37 . . . . 0.0 112.794 -170.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.69 -175.4 51.79 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 118.518 0.599 . . . . 0.0 112.251 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 136.73 28.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.73 2.287 . . . . 0.0 110.538 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.1 171.51 14.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.572 0.701 . . . . 0.0 110.27 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -77.74 74.67 4.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -58.31 -17.89 23.14 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.29 70.6 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.373 0.669 . . . . 0.0 111.479 169.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.6 -45.38 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.776 0.83 . . . . 0.0 108.794 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -59.39 -49.12 79.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.723 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 p -57.97 -46.16 85.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.718 0.69 . . . . 0.0 111.47 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -61.0 -48.83 79.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.087 0.858 . . . . 0.0 110.472 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -72.71 -42.96 63.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.942 -0.474 . . . . 0.0 111.534 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.3 mt -64.23 -42.32 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.82 -40.24 91.99 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.896 1.68 . . . . 0.0 111.058 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.4 -42.28 98.78 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.447 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.81 -28.18 64.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.226 1.011 . . . . 0.0 112.104 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 46.25 56.39 16.25 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.173 1.389 . . . . 0.0 113.263 -169.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.92 -17.63 28.61 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.462 2.108 . . . . 0.0 110.04 169.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.76 -177.63 5.82 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 128.279 2.632 . . . . 0.0 106.375 169.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -71.16 -45.17 64.05 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.039 0.836 . . . . 0.0 112.82 -169.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -156.48 170.87 21.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.042 0.837 . . . . 0.0 109.314 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.35 154.48 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.485 . . . . 0.0 107.873 -169.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -139.62 169.57 17.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 108.383 172.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -144.55 170.15 16.61 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.777 -0.577 . . . . 0.0 111.135 172.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.35 143.35 30.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.74 25.58 1.25 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.023 0.929 . . . . 0.0 111.459 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -155.34 178.18 10.51 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.693 1.597 . . . . 0.0 107.934 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.63 173.2 15.75 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.066 1.793 . . . . 0.0 110.761 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 82.0 t80 . . . . . 0 C--O 1.246 0.92 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.355 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.39 164.12 36.66 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.038 1.335 . . . . 0.0 108.831 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.1 t -137.75 157.6 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.73 174.84 10.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.885 1.674 . . . . 0.0 107.474 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.48 155.26 38.18 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.876 0.871 . . . . 0.0 109.098 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.3 mt -50.93 -34.15 27.34 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.77 1.228 . . . . 0.0 112.859 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.52 -23.29 66.84 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.66 0.664 . . . . 0.0 112.579 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.0 mt -77.01 -19.93 56.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.115 0.566 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -69.61 129.72 91.15 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.13 2.553 . . . . 0.0 109.634 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 29.1 t70 -95.45 -40.24 9.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -169.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.73 134.32 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -157.48 119.2 3.7 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.7 pt -140.76 158.4 23.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.217 1.007 . . . . 0.0 109.407 -172.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -65.1 172.96 2.65 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.829 1.252 . . . . 0.0 112.632 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -135.86 -1.23 2.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.225 1.81 . . . . 0.0 111.765 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -59.12 -42.67 91.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.336 0.971 . . . . 0.0 112.754 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.61 -58.25 0.34 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.29 133.34 39.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -161.76 173.01 15.23 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.798 1.239 . . . . 0.0 109.399 -173.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -107.88 156.52 19.09 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.48 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -143.73 170.61 15.53 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.47 0.708 . . . . 0.0 109.668 -172.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.83 153.51 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.541 1.536 . . . . 0.0 108.663 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.23 116.1 27.18 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 135.02 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 119.08 0.854 . . . . 0.0 109.411 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -82.18 149.29 28.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.751 1.22 . . . . 0.0 108.186 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.79 141.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -114.61 154.0 29.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.872 1.269 . . . . 0.0 109.59 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m -68.69 80.14 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.729 1.211 . . . . 0.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.422 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -134.84 11.1 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 116.028 -1.939 . . . . 0.0 115.179 169.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 77.9 Cg_exo -44.18 137.39 7.52 Favored 'Trans proline' 0 C--N 1.362 1.255 0 CA-C-N 124.248 2.553 . . . . 0.0 113.668 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 45.92 22.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.711 2.404 . . . . 0.0 114.205 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 49.89 30.71 4.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.962 1.305 . . . . 0.0 112.051 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.78 -7.75 0.23 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.756 -170.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.11 142.81 56.35 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 119.004 1.402 . . . . 0.0 110.314 170.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.17 164.55 35.37 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.692 2.261 . . . . 0.0 111.437 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 57.16 -167.96 0.12 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.835 2.054 . . . . 0.0 113.669 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.01 38.3 2.35 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.35 1.86 . . . . 0.0 108.995 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.01 166.24 16.26 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -139.23 158.29 44.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.972 0.909 . . . . 0.0 109.928 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.94 164.14 37.06 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.028 1.331 . . . . 0.0 109.047 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.32 154.94 21.09 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.52 155.42 38.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.264 1.426 . . . . 0.0 108.858 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.6 123.38 70.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -135.2 148.72 49.74 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.035 0.934 . . . . 0.0 108.619 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.47 136.86 3.82 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 171.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -150.46 151.05 32.14 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.14 -39.34 82.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.672 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -60.22 -30.25 69.27 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.106 0.866 . . . . 0.0 112.63 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.28 75.42 9.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.176 0.898 . . . . 0.0 108.767 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.59 -8.16 9.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.19 0.596 . . . . 0.0 112.081 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.66 138.43 36.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.59 1.956 . . . . 0.0 107.253 175.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.484 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.0 m-70 -60.66 -29.93 69.59 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.674 1.19 . . . . 0.0 112.027 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.76 69.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.439 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.63 -46.12 76.86 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.511 0.596 . . . . 0.0 110.919 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -42.01 83.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 117.288 -1.339 . . . . 0.0 110.243 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.97 -46.18 90.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 120.635 1.561 . . . . 0.0 109.901 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.36 -48.79 78.2 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.805 0.73 . . . . 0.0 111.365 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -62.17 -49.65 74.97 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.131 0.572 . . . . 0.0 111.045 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.48 -45.34 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.515 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -60.58 -36.1 77.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.678 1.126 . . . . 0.0 109.463 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.13 -50.36 66.91 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 118.899 0.772 . . . . 0.0 111.503 172.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.37 -46.93 84.24 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.544 1.172 . . . . 0.0 111.07 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.7 mmt -57.96 -45.93 85.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.774 0.715 . . . . 0.0 110.985 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -65.6 -32.59 74.25 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.027 -1.045 . . . . 0.0 111.459 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -63.42 -42.92 98.74 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 109.701 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -60.37 -40.16 89.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.295 0.952 . . . . 0.0 109.504 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.66 -7.08 1.94 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.415 1.959 . . . . 0.0 113.09 169.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.74 179.17 1.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.14 1.776 . . . . 0.0 113.672 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -131.86 144.74 51.1 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m -148.05 169.33 20.19 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.817 0.735 . . . . 0.0 112.641 -168.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.52 138.96 15.84 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.267 1.027 . . . . 0.0 109.012 169.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -70.96 118.1 13.3 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.9 -26.01 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.99 -0.444 . . . . 0.0 110.284 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.0 -166.95 38.45 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -160.6 -168.02 21.93 Favored Glycine 0 C--O 1.235 0.211 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.56 -155.37 15.57 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.81 153.01 52.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.844 1.258 . . . . 0.0 108.073 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.0 mt -136.07 141.49 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.7 m -145.01 154.42 42.51 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.284 1.034 . . . . 0.0 111.238 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.75 152.6 9.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.047 2.539 . . . . 0.0 106.16 168.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -146.61 169.89 18.04 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.43 0.692 . . . . 0.0 109.531 -172.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.7 m -59.05 -29.52 67.36 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.747 -0.595 . . . . 0.0 111.412 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -63.27 -38.53 91.52 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.25 1.02 . . . . 0.0 111.116 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -158.96 110.7 2.14 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.498 1.119 . . . . 0.0 108.982 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -78.08 -15.69 58.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.948 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 127.62 33.0 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 72.1 mt -66.6 159.85 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -141.28 149.8 41.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.05 133.15 64.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -159.55 -175.05 4.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.14 -0.975 . . . . 0.0 110.249 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.87 -161.68 54.3 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 121.668 0.593 . . . . 0.0 112.32 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -150.83 153.15 34.86 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.605 1.562 . . . . 0.0 107.785 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 t -67.57 133.17 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.3 ttp -54.72 -27.01 37.65 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.696 1.198 . . . . 0.0 111.841 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.87 -24.7 8.53 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.665 0.786 . . . . 0.0 112.896 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.11 4.39 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.68 -175.75 40.39 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 118.957 0.799 . . . . 0.0 112.555 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.42 132.88 24.83 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.432 2.088 . . . . 0.0 110.33 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.22 173.6 8.39 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.478 0.656 . . . . 0.0 110.87 169.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -76.97 73.06 3.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.48 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 45.0 m80 -57.41 -19.08 21.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -173.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.32 65.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.454 0.701 . . . . 0.0 111.011 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -61.14 -50.39 80.71 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.2 m -56.01 -48.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.595 0.758 . . . . 0.0 110.776 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 p -59.19 -47.36 85.61 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.082 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.02 -46.59 89.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.528 1.058 . . . . 0.0 110.581 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 11' ' ' ASP . 23.4 mmtp -68.22 -47.27 68.31 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.562 0.745 . . . . 0.0 111.034 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.88 -37.31 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.934 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -63.06 -45.31 92.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 121.378 1.899 . . . . 0.0 110.819 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.5 89.0 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.454 0.57 . . . . 0.0 111.773 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.04 -17.17 28.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.254 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.253 30.6 p90 38.84 64.7 3.55 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 127.381 2.272 . . . . 0.0 114.093 -175.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.41 -24.81 17.09 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.287 2.658 . . . . 0.0 114.058 169.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -129.68 -68.37 0.72 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.059 0.944 . . . . 0.0 109.368 169.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -165.07 -50.69 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.913 0.885 . . . . 0.0 109.996 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -152.9 167.52 28.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.517 1.127 . . . . 0.0 108.369 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.03 158.31 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.819 1.647 . . . . 0.0 108.071 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 p -135.66 176.01 9.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.639 1.176 . . . . 0.0 108.617 169.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -139.37 166.65 23.98 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.865 -0.522 . . . . 0.0 111.282 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.65 143.15 30.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.522 1.129 . . . . 0.0 108.115 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -90.24 47.89 1.5 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.303 1.041 . . . . 0.0 110.361 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -151.07 -179.42 7.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.549 1.14 . . . . 0.0 109.346 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.82 -163.33 53.7 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.991 1.282 . . . . 0.0 111.757 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 125.913 1.685 . . . . 0.0 106.984 -179.822 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.735 0.302 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.61 162.0 35.69 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.153 1.381 . . . . 0.0 108.154 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.9 m -66.41 167.49 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.173 0.989 . . . . 0.0 112.229 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.05 -176.96 4.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.902 2.081 . . . . 0.0 105.761 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -143.04 153.2 42.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 mt -50.5 -34.87 26.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.32 1.048 . . . . 0.0 112.957 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.13 -24.13 64.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.699 0.681 . . . . 0.0 112.549 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.31 -19.63 42.47 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.633 0.773 . . . . 0.0 111.253 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.28 132.75 92.71 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.026 0.931 . . . . 0.0 108.694 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.4 109.91 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.489 2.793 . . . . 0.0 110.045 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -76.49 -38.19 55.67 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -169.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.09 124.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -146.21 102.49 3.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.8 pt -134.18 150.68 31.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.02 -169.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -90.76 63.74 5.41 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.916 1.686 . . . . 0.0 110.249 -173.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -59.71 -2.84 0.41 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.708 1.603 . . . . 0.0 114.737 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.49 -22.42 66.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.789 1.236 . . . . 0.0 112.931 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.09 -175.82 38.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 118.735 0.698 . . . . 0.0 112.736 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.82 104.93 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -142.89 166.94 23.28 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.29 1.036 . . . . 0.0 109.51 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -84.25 162.08 20.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.776 -0.578 . . . . 0.0 110.821 -175.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.16 171.86 13.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.356 1.063 . . . . 0.0 109.492 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.93 153.59 17.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.978 1.311 . . . . 0.0 108.035 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 tp -116.89 115.63 25.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.19 133.41 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 118.918 0.781 . . . . 0.0 110.007 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -77.96 147.66 34.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.014 1.326 . . . . 0.0 107.642 169.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.68 141.22 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -117.41 141.34 48.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.301 1.441 . . . . 0.0 108.16 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 m -64.16 106.97 1.17 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.574 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.549 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.01 17.39 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.935 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.0 Cg_exo -42.3 133.43 4.75 Favored 'Trans proline' 0 C--N 1.365 1.436 0 CA-C-N 123.733 2.369 . . . . 0.0 115.261 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 41.9 32.65 0.29 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.595 2.758 . . . . 0.0 113.179 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m 52.96 29.76 8.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.607 1.563 . . . . 0.0 113.0 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.0 -0.28 0.66 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.304 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.35 145.59 57.19 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 118.954 1.377 . . . . 0.0 110.851 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -80.7 1.37 9.35 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.759 2.972 . . . . 0.0 115.899 -169.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.59 179.16 7.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.794 1.179 . . . . 0.0 111.331 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.89 35.68 2.85 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.228 1.811 . . . . 0.0 110.276 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.94 170.18 11.75 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -138.76 159.02 43.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.908 0.883 . . . . 0.0 110.543 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.55 36.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.722 1.609 . . . . 0.0 109.306 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -108.77 156.95 19.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 pt -137.02 159.02 36.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.961 1.705 . . . . 0.0 109.518 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.7 t -124.24 119.17 55.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.0 mmt85 -139.61 148.45 42.5 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.93 136.47 2.75 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.047 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 15.6 m-85 -153.0 156.01 38.02 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.259 0.623 . . . . 0.0 111.45 -169.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -35.61 61.34 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.418 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-90 -71.6 -25.44 62.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.215 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.71 80.38 9.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.317 0.962 . . . . 0.0 109.142 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.71 -9.15 17.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.418 0.687 . . . . 0.0 112.069 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.17 142.45 30.55 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.049 1.739 . . . . 0.0 107.604 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.421 ' CD2' ' HG ' ' A' ' 94' ' ' SER . 24.7 m-70 -61.98 -30.06 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.81 0.844 . . . . 0.0 111.735 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.38 68.16 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.749 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.49 -47.68 69.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.574 0.624 . . . . 0.0 110.655 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -38.56 79.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 117.456 -1.259 . . . . 0.0 110.243 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -58.95 -46.38 88.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.584 1.538 . . . . 0.0 109.932 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.69 -50.21 67.86 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.38 0.536 . . . . 0.0 111.418 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -61.29 -46.84 88.64 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 122.8 0.44 . . . . 0.0 111.158 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.74 -36.34 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.43 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.83 -29.89 70.47 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.137 1.335 . . . . 0.0 110.764 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.23 -49.0 55.89 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.405 1.002 . . . . 0.0 111.135 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -57.01 -44.71 83.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.823 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mmt -69.02 -41.64 77.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.724 -0.61 . . . . 0.0 112.231 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -69.24 -29.95 67.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.36 1.436 . . . . 0.0 111.714 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -61.5 -43.09 99.49 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.988 0.915 . . . . 0.0 109.167 169.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.84 -37.07 85.34 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.441 0.564 . . . . 0.0 110.287 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.98 -6.69 5.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 127.252 2.358 . . . . 0.0 112.944 172.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.46 177.32 4.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.514 1.925 . . . . 0.0 112.78 -169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -127.92 151.09 49.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 55.9 m -147.72 168.49 21.96 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.04 126.47 7.34 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.19 1.396 . . . . 0.0 108.002 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.08 118.79 11.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.38 -26.67 61.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.722 0.409 . . . . 0.0 110.252 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.67 -171.94 42.35 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.18 -173.75 20.09 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.88 -158.79 23.32 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -127.94 153.58 46.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.969 1.308 . . . . 0.0 108.725 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.53 130.55 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.3 m -131.91 150.85 52.03 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.883 -169.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -157.48 -50.56 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.813 0.845 . . . . 0.0 110.28 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 47.42 22.95 0.31 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.416 1.886 . . . . 0.0 113.621 -175.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m 49.54 27.85 2.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.72 1.608 . . . . 0.0 113.164 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -68.83 -34.11 74.95 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.778 -0.576 . . . . 0.0 112.153 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -169.58 175.15 5.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.627 1.971 . . . . 0.0 107.255 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.42 ' HE2' ' CG ' ' A' ' 116' ' ' TYR . 20.0 ptmt -72.02 59.46 0.37 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.751 1.22 . . . . 0.0 110.071 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -150.78 144.4 25.07 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.162 1.785 . . . . 0.0 107.588 -172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 mt -132.27 154.84 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -134.15 148.04 50.89 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.172 0.989 . . . . 0.0 108.746 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -134.29 114.91 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.25 172.9 17.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.206 1.002 . . . . 0.0 108.325 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.06 -165.39 24.33 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.91 1.232 . . . . 0.0 113.066 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -153.78 154.83 34.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.791 2.036 . . . . 0.0 107.388 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.421 ' HG ' ' CD2' ' A' ' 53' ' ' HIS . 24.2 m -139.1 106.17 5.46 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -56.45 -28.5 59.75 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.05 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.211 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -135.6 -7.89 2.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.02 171.32 45.97 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.018 0.818 . . . . 0.0 111.138 -169.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.51 144.77 36.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.626 2.218 . . . . 0.0 109.564 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 167.71 18.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 109.397 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -65.86 -31.54 72.54 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.53 0.732 . . . . 0.0 112.022 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.8 m80 58.21 -30.78 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.111 2.964 . . . . 0.0 115.983 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.86 75.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.776 1.171 . . . . 0.0 111.479 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 mm -58.98 -54.42 34.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.5 m -53.62 -50.55 65.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.294 1.038 . . . . 0.0 111.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 p -60.96 -41.69 96.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.232 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.1 -45.71 87.44 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.475 1.034 . . . . 0.0 110.053 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -64.7 -43.81 92.29 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 122.055 -0.403 . . . . 0.0 110.965 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 52.0 mt -62.9 -45.74 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.89 0.876 . . . . 0.0 108.956 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -62.78 -29.91 71.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.897 1.226 . . . . 0.0 111.566 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.58 -43.95 71.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.012 1.278 . . . . 0.0 111.193 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -71.62 -26.89 62.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.915 0.886 . . . . 0.0 112.595 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 46.42 55.85 16.08 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.558 1.543 . . . . 0.0 113.864 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.37 -18.14 30.1 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.037 1.825 . . . . 0.0 110.361 169.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -145.63 177.89 8.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.763 2.425 . . . . 0.0 106.462 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.42 ' CG ' ' HE2' ' A' ' 86' ' ' LYS . 81.5 t80 -67.5 -49.37 63.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.047 0.939 . . . . 0.0 112.319 -169.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -158.34 157.98 33.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.48 167.94 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.575 0.75 . . . . 0.0 111.417 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -140.85 171.37 14.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.346 1.458 . . . . 0.0 109.277 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -142.6 171.93 13.38 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.228 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.75 143.7 29.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -84.33 33.42 0.5 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.496 1.118 . . . . 0.0 111.337 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -154.74 -171.84 3.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.41 1.484 . . . . 0.0 108.461 -171.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.14 155.35 15.04 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.717 1.627 . . . . 0.0 110.608 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.011 1.724 . . . . 0.0 107.267 177.823 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.29 164.87 34.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.181 1.392 . . . . 0.0 108.537 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.67 161.52 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.577 1.151 . . . . 0.0 107.957 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.26 176.37 10.04 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.086 1.754 . . . . 0.0 107.162 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.1 155.77 40.44 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.023 0.929 . . . . 0.0 109.025 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.0 mt -50.17 -33.97 20.93 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.763 1.225 . . . . 0.0 113.114 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.89 67.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.685 0.675 . . . . 0.0 112.558 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.21 -19.71 53.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.325 0.65 . . . . 0.0 111.341 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.46 133.01 92.95 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.16 111.32 0.71 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.647 2.898 . . . . 0.0 110.909 170.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.93 -34.88 64.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.235 0.614 . . . . 0.0 111.989 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.5 t -137.36 135.04 47.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.94 118.13 3.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.6 pt -142.1 154.62 18.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.708 1.203 . . . . 0.0 108.183 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.85 140.62 58.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.07 0.548 . . . . 0.0 110.532 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -82.28 -16.56 49.0 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -158.91 101.13 1.61 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.983 1.265 . . . . 0.0 110.766 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.27 -172.42 38.38 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 121.609 0.561 . . . . 0.0 112.137 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -119.09 125.89 74.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -157.03 169.35 25.02 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.084 0.469 . . . . 0.0 111.67 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.82 159.56 15.33 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.72 166.51 23.79 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.976 1.31 . . . . 0.0 108.94 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.88 156.67 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.982 1.313 . . . . 0.0 107.776 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -122.06 121.07 36.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.77 135.82 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.458 0.572 . . . . 0.0 109.633 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -83.17 150.96 25.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.833 1.253 . . . . 0.0 107.65 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -137.37 140.68 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -113.32 146.82 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.419 1.487 . . . . 0.0 108.912 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.3 m -66.57 95.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.98 0.912 . . . . 0.0 110.805 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.477 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.17 11.78 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 115.905 -1.998 . . . . 0.0 114.069 168.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 71.0 Cg_exo -44.27 136.94 8.0 Favored 'Trans proline' 0 C--N 1.364 1.362 0 CA-C-N 124.146 2.516 . . . . 0.0 114.229 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mmt-85 47.65 22.07 0.3 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.802 2.441 . . . . 0.0 113.881 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 50.39 31.11 5.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.117 1.367 . . . . 0.0 112.217 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.89 5.6 0.81 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.925 -171.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.08 147.38 34.72 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 118.763 1.282 . . . . 0.0 110.457 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.6 -3.43 13.79 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.579 2.853 . . . . 0.0 115.831 -169.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.1 -176.3 5.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.573 1.079 . . . . 0.0 110.638 -170.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.51 37.12 3.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.874 1.669 . . . . 0.0 109.993 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -69.25 169.15 12.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 169.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -139.17 157.35 46.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.898 0.879 . . . . 0.0 109.851 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 165.91 32.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.401 1.481 . . . . 0.0 109.477 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -112.88 154.96 25.51 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.577 0.751 . . . . 0.0 109.092 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.6 pt -135.24 156.8 39.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.77 1.228 . . . . 0.0 109.749 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.86 124.26 72.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 125.868 1.667 . . . . 0.0 107.021 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -134.59 150.18 50.68 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.584 1.554 . . . . 0.0 108.689 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.79 131.63 1.48 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -154.55 151.24 28.65 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -64.54 -20.62 66.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -69.63 -26.22 64.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.634 1.107 . . . . 0.0 112.287 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.36 88.64 7.52 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.985 1.266 . . . . 0.0 109.076 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.32 -8.49 32.74 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.537 0.735 . . . . 0.0 112.101 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -147.9 145.62 28.71 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.669 1.588 . . . . 0.0 108.283 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -61.03 -31.8 71.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.241 1.016 . . . . 0.0 111.585 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.66 -26.06 68.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.824 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.0 -49.38 61.89 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.151 0.887 . . . . 0.0 110.418 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -39.86 85.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.254 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -62.06 -49.48 75.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.356 0.98 . . . . 0.0 110.081 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.81 -44.84 95.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.256 0.934 . . . . 0.0 111.169 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.48 -51.7 68.75 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.341 0.656 . . . . 0.0 110.78 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.4 t -82.12 -38.61 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.043 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.2 p -61.43 -31.75 71.7 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.857 1.662 . . . . 0.0 110.328 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.84 -51.06 59.83 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.05 -44.14 96.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.375 1.088 . . . . 0.0 111.202 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.35 -45.38 91.55 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.802 0.728 . . . . 0.0 110.563 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.41 -33.04 75.03 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.014 -1.054 . . . . 0.0 111.588 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -64.52 -39.64 94.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.962 0.801 . . . . 0.0 110.692 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.03 -32.12 73.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.264 0.938 . . . . 0.0 110.61 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.98 -8.05 4.47 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.114 2.292 . . . . 0.0 113.177 169.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -67.48 179.56 1.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.095 1.758 . . . . 0.0 113.539 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -131.14 143.14 50.41 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.0 m -147.15 167.44 24.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -168.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -153.09 134.37 14.23 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.524 1.53 . . . . 0.0 108.103 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 p -73.65 115.84 13.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.9 -24.92 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.952 -0.468 . . . . 0.0 110.772 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.0 43.48 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.44 -164.83 15.31 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.44 -155.61 22.67 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -138.52 155.02 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 109.127 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.8 136.63 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 m -145.69 164.43 31.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.619 1.168 . . . . 0.0 109.62 -176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.68 148.54 28.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -151.68 142.53 22.93 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.317 1.047 . . . . 0.0 108.422 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 m -63.63 -20.1 65.4 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.189 0.596 . . . . 0.0 111.278 169.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -66.96 -18.55 65.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.377 1.471 . . . . 0.0 112.161 172.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -125.37 -29.72 3.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.571 1.148 . . . . 0.0 111.839 -171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 mttm 74.08 13.56 4.02 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.41 2.284 . . . . 0.0 115.45 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.02 172.97 14.38 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.159 0.984 . . . . 0.0 108.532 168.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.2 156.83 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -140.14 149.26 42.8 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.199 1.0 . . . . 0.0 108.949 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.15 123.0 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.23 -174.42 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.154 -0.966 . . . . 0.0 111.085 -169.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.79 -160.04 52.58 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -149.51 154.48 38.83 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.431 1.493 . . . . 0.0 107.863 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 t -69.74 131.83 45.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.8 ttt -59.02 -20.77 56.18 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.973 0.909 . . . . 0.0 111.814 170.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.32 -24.23 8.53 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 113.087 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -130.77 1.07 4.38 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -177.65 45.33 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.248 0.931 . . . . 0.0 112.381 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.25 130.22 17.2 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.739 2.293 . . . . 0.0 111.223 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.69 168.08 20.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.227 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.98 78.54 5.41 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 169.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -59.01 -15.88 15.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.01 66.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.387 0.675 . . . . 0.0 111.401 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.57 -44.17 96.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.728 0.811 . . . . 0.0 108.942 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.3 m -58.67 -53.03 62.91 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.268 0.627 . . . . 0.0 110.34 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 p -60.45 -44.6 95.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -58.98 -53.45 58.3 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.283 0.947 . . . . 0.0 110.931 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.4 -44.49 67.86 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.918 -0.489 . . . . 0.0 111.421 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.4 -42.25 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 118.087 -0.959 . . . . 0.0 108.639 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.72 -39.28 93.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.913 1.688 . . . . 0.0 111.029 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.94 89.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.475 0.58 . . . . 0.0 111.302 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -79.86 -24.66 41.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.224 0.465 . . . . 0.0 112.106 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 t80 40.49 60.33 7.28 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.13 2.172 . . . . 0.0 111.967 -170.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.1 -22.56 34.93 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.105 2.537 . . . . 0.0 113.126 -171.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -153.76 -49.52 0.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.661 0.664 . . . . 0.0 111.859 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -157.62 174.61 15.08 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.526 0.73 . . . . 0.0 110.359 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.98 158.45 22.38 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.254 1.422 . . . . 0.0 110.765 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.94 164.07 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.058 1.743 . . . . 0.0 110.033 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.3 p -141.42 172.06 13.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.324 1.849 . . . . 0.0 107.133 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.63 167.58 21.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.894 0.77 . . . . 0.0 112.39 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.87 143.61 30.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.323 1.449 . . . . 0.0 107.643 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -88.22 33.15 0.74 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.112 0.965 . . . . 0.0 111.446 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -153.93 175.67 13.08 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.667 1.587 . . . . 0.0 107.624 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.11 -168.35 25.39 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.922 1.249 . . . . 0.0 111.96 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.248 0.995 0 C-N-CA 125.781 1.633 . . . . 0.0 107.665 179.043 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.13 151.86 35.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.849 1.26 . . . . 0.0 108.134 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.6 t -74.91 118.73 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.1 -176.7 1.84 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.064 0.546 . . . . 0.0 110.311 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -145.51 154.38 42.14 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.118 0.967 . . . . 0.0 108.839 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -53.53 -28.98 34.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.828 1.251 . . . . 0.0 113.507 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.48 57.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.024 0.829 . . . . 0.0 112.451 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.0 mt -84.87 -19.72 31.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.017 0.927 . . . . 0.0 111.25 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.07 138.29 72.87 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.428 1.091 . . . . 0.0 109.265 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.41 99.35 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.517 2.811 . . . . 0.0 109.307 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.65 -32.09 67.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.938 1.295 . . . . 0.0 112.658 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t -140.99 128.67 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -152.28 108.14 3.36 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -137.37 154.77 30.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.258 . . . . 0.0 108.384 -172.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.09 -34.23 76.02 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.6 m 54.95 -177.55 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.459 1.904 . . . . 0.0 113.463 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 47.31 43.97 15.6 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.956 1.703 . . . . 0.0 113.477 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.3 -157.64 22.55 Favored Glycine 0 C--N 1.337 0.61 0 O-C-N 121.366 -0.834 . . . . 0.0 111.375 -171.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.45 128.65 51.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -161.01 167.05 27.23 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.142 1.377 . . . . 0.0 109.95 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.46 157.92 16.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.97 172.07 13.29 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.684 0.794 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.45 153.23 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.225 1.41 . . . . 0.0 108.123 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.4 tp -117.76 115.62 25.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 131.95 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.85 147.16 39.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.01 131.04 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -100.08 151.2 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.455 1.102 . . . . 0.0 109.734 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 m -65.81 97.56 0.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.931 0.892 . . . . 0.0 110.827 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -151.07 22.6 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.451 -1.738 . . . . 0.0 114.449 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 81.8 Cg_exo -46.34 138.21 13.73 Favored 'Trans proline' 0 C--N 1.362 1.25 0 CA-C-N 123.906 2.431 . . . . 0.0 113.0 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 44.93 26.75 0.22 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 113.7 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m 50.18 33.04 6.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.347 1.459 . . . . 0.0 112.753 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.08 22.79 1.76 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 123.556 0.598 . . . . 0.0 113.066 -172.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.16 148.91 83.92 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.853 0.826 . . . . 0.0 111.124 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.15 -6.63 14.97 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.481 2.788 . . . . 0.0 113.787 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.45 -175.81 5.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.034 1.334 . . . . 0.0 109.906 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.92 37.51 3.43 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.764 1.626 . . . . 0.0 110.159 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.74 168.72 14.38 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -142.03 159.56 41.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.038 0.935 . . . . 0.0 110.325 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.66 168.26 26.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.975 1.71 . . . . 0.0 108.835 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -108.39 156.77 19.05 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 pt -133.15 156.24 41.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.942 1.297 . . . . 0.0 109.245 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.59 116.7 50.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -137.81 147.43 44.59 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.7 134.99 2.02 Favored Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.435 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.0 m-85 -156.75 156.7 33.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -170.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -60.91 -33.09 72.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.242 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.435 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.7 p-90 -64.52 -28.62 69.77 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.84 0.746 . . . . 0.0 112.103 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 77.79 9.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.218 0.917 . . . . 0.0 108.705 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -65.89 -6.07 11.16 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.19 140.23 33.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.69 1.596 . . . . 0.0 107.55 174.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -61.46 -29.74 70.16 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.403 1.081 . . . . 0.0 111.873 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.58 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.759 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.0 -46.44 74.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.675 0.67 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -41.09 82.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.152 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -58.45 -44.66 89.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.004 1.729 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.25 -50.83 64.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.647 0.658 . . . . 0.0 111.542 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -60.77 -46.48 90.3 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.977 0.511 . . . . 0.0 111.089 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.8 -36.4 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.381 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -62.06 -28.95 69.96 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.244 1.384 . . . . 0.0 110.927 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.86 -52.06 45.69 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.321 0.964 . . . . 0.0 110.943 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -55.88 -47.54 77.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 110.445 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.242 -0.911 . . . . 0.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.3 -28.9 66.68 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.681 -1.262 . . . . 0.0 111.474 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -31.79 73.1 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.12 0.968 . . . . 0.0 110.057 169.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -70.76 -45.96 63.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.822 1.192 . . . . 0.0 108.332 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.26 -6.78 2.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.294 2.378 . . . . 0.0 112.502 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.84 171.39 11.76 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.149 1.78 . . . . 0.0 112.983 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.62 147.92 46.91 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.0 m -148.19 165.61 30.4 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -168.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.4 129.62 11.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.767 1.227 . . . . 0.0 107.997 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.5 114.45 5.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.5 -28.26 64.83 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.996 -0.44 . . . . 0.0 110.143 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.72 -167.02 40.07 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.99 -166.92 21.65 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 171.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.47 -161.2 26.45 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -127.12 151.15 49.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.626 1.17 . . . . 0.0 108.432 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.0 mt -132.66 135.13 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.1 m -146.29 144.98 30.19 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.016 0.526 . . . . 0.0 111.535 -169.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -146.2 141.82 27.8 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.393 1.877 . . . . 0.0 106.287 169.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.64 163.63 32.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.1 1.76 . . . . 0.0 106.521 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 m -55.77 -22.11 22.53 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -171.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -63.72 -25.74 68.33 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.663 1.185 . . . . 0.0 112.159 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -152.32 113.73 4.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.666 1.121 . . . . 0.0 110.15 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -64.83 -26.76 68.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 117.933 -1.032 . . . . 0.0 112.324 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.6 122.54 18.71 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.5 mt -66.39 150.2 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 171.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -123.33 150.69 43.31 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.801 0.84 . . . . 0.0 108.77 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.4 130.33 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -159.26 -172.14 3.63 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.5 -164.5 41.69 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 121.653 0.585 . . . . 0.0 111.676 170.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -148.23 153.32 38.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.173 1.389 . . . . 0.0 107.499 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 t -69.55 128.56 36.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.24 -20.58 55.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.212 0.605 . . . . 0.0 111.646 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.69 -27.33 9.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.911 0.884 . . . . 0.0 112.917 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -132.59 4.48 3.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.89 -178.74 50.63 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.229 0.922 . . . . 0.0 112.73 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.5 129.37 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.766 2.311 . . . . 0.0 110.47 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 169.16 17.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 111.079 169.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.13 75.41 4.67 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -56.86 -20.53 23.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.06 -38.75 65.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.64 0.776 . . . . 0.0 111.606 169.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mm -62.27 -45.6 98.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.998 0.919 . . . . 0.0 109.072 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.4 m -58.02 -52.66 64.59 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.413 0.685 . . . . 0.0 110.234 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -62.59 -41.42 98.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.26 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -60.99 -50.28 74.03 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 110.412 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.76 -46.11 73.0 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.09 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.3 mt -61.74 -44.52 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.833 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -62.66 -40.05 95.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.543 1.519 . . . . 0.0 111.216 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.34 84.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.782 0.719 . . . . 0.0 111.546 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -79.74 -21.11 44.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.299 0.64 . . . . 0.0 111.743 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 t80 43.38 58.77 12.13 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.528 2.331 . . . . 0.0 112.419 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.01 -18.54 35.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.269 2.646 . . . . 0.0 112.87 -174.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.05 -52.16 0.13 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.708 0.803 . . . . 0.0 111.185 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -163.24 178.41 8.22 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.111 0.964 . . . . 0.0 109.414 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.54 155.86 24.66 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.03 167.3 22.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.854 0.862 . . . . 0.0 110.586 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.8 p -139.01 171.39 14.39 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 109.363 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -146.95 163.21 36.91 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.73 -0.607 . . . . 0.0 110.599 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.37 135.26 18.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 169.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.74 -20.08 54.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.754 0.422 . . . . 0.0 111.76 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.48 -33.62 72.85 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.142 0.977 . . . . 0.0 113.314 -171.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -84.19 123.67 6.32 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.944 2.098 . . . . 0.0 105.971 171.036 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.94 150.74 47.36 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 171.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.1 t -73.4 111.93 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.47 179.15 2.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.315 0.579 . . . . 0.0 110.465 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -145.07 155.01 43.09 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.638 1.175 . . . . 0.0 108.168 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.3 mt -50.94 -35.35 32.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.319 1.048 . . . . 0.0 112.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.88 -23.73 66.04 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.808 0.731 . . . . 0.0 112.679 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.2 mt -84.7 -19.7 32.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.741 0.816 . . . . 0.0 111.305 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.5 138.48 94.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.95 111.32 1.35 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.088 2.525 . . . . 0.0 109.571 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.83 -37.15 70.36 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.399 1.08 . . . . 0.0 112.963 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.69 137.41 47.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -153.94 110.24 3.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 pt -138.0 136.4 45.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -153.71 61.02 0.74 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.026 0.917 . . . . 0.0 109.543 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -156.59 174.86 14.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.845 1.658 . . . . 0.0 108.663 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -153.5 167.94 27.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.14 1.376 . . . . 0.0 108.911 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 -84.81 1.55 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.4 t -148.26 135.06 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 172.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -156.06 160.29 39.85 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.876 0.87 . . . . 0.0 109.16 171.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 160.39 14.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.74 166.55 24.33 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.382 1.073 . . . . 0.0 109.252 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.72 156.8 12.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.07 115.5 23.82 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.04 129.94 72.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -76.75 147.76 37.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -134.69 142.83 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -116.07 148.35 40.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.555 1.142 . . . . 0.0 108.733 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 m -61.51 101.24 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.834 0.854 . . . . 0.0 110.654 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.476 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.32 15.14 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.076 -1.916 . . . . 0.0 115.619 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.476 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 80.4 Cg_exo -42.84 137.24 4.37 Favored 'Trans proline' 0 C--N 1.362 1.288 0 CA-C-N 124.371 2.597 . . . . 0.0 114.244 171.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 45.84 25.62 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.35 2.26 . . . . 0.0 113.929 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.08 31.94 7.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.186 1.395 . . . . 0.0 112.355 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.83 20.75 1.45 Allowed Glycine 0 C--N 1.341 0.83 0 C-N-CA 123.697 0.665 . . . . 0.0 112.872 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.1 148.88 69.69 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.824 0.812 . . . . 0.0 110.64 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.79 -5.72 16.21 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.346 2.698 . . . . 0.0 114.017 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.84 -174.71 5.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.131 1.372 . . . . 0.0 109.473 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.87 49.65 2.04 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.029 1.732 . . . . 0.0 108.668 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.61 177.23 6.94 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -143.67 156.78 44.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.635 0.774 . . . . 0.0 110.146 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 165.37 36.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.512 1.525 . . . . 0.0 109.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.1 155.08 20.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.99 151.38 34.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.578 1.151 . . . . 0.0 109.166 171.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.12 120.95 64.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -131.28 147.49 52.59 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.859 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.73 132.87 1.81 Allowed Glycine 0 C--N 1.33 0.225 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.08 151.29 26.61 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -61.52 -28.18 69.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.442 0.697 . . . . 0.0 112.742 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -66.71 -26.96 67.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.143 0.883 . . . . 0.0 112.093 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 85.19 5.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 171.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.99 -10.89 43.77 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 173.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 141.09 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.896 1.278 . . . . 0.0 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.447 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.03 -32.22 70.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.572 1.549 . . . . 0.0 111.763 -173.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.18 -30.22 70.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.739 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.45 -47.88 66.01 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.89 0.768 . . . . 0.0 110.473 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -37.51 79.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.521 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.74 -47.41 86.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 110.323 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.24 -46.79 75.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.789 0.722 . . . . 0.0 111.393 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -52.76 -54.8 28.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.631 1.172 . . . . 0.0 110.056 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.4 t -80.57 -34.4 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.745 -169.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -62.35 -30.91 71.51 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 120.382 1.446 . . . . 0.0 110.835 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.9 -51.18 58.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 110.638 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.6 -44.87 92.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 111.187 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.43 -45.04 95.09 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.987 -0.445 . . . . 0.0 111.011 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.6 -31.2 71.07 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.086 -1.009 . . . . 0.0 111.834 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.39 -40.3 96.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.19 0.904 . . . . 0.0 110.033 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -59.42 -47.22 86.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.712 1.142 . . . . 0.0 108.907 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.68 -5.64 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 126.631 2.063 . . . . 0.0 112.709 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.1 m -66.33 176.05 1.96 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.116 1.766 . . . . 0.0 112.728 -170.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -129.86 143.34 50.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -147.63 164.06 34.68 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -169.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -154.9 128.54 8.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 108.306 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -68.25 114.28 6.6 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.4 mt -70.3 -27.62 64.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.932 0.493 . . . . 0.0 110.638 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.85 -173.58 45.57 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.4 -179.08 28.57 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.59 -162.14 28.57 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -137.65 167.21 22.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.226 1.013 . . . . 0.0 110.785 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.12 143.11 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -169.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.8 m -150.82 156.06 40.49 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 121.67 -0.644 . . . . 0.0 111.458 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -59.44 171.35 0.83 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.904 1.681 . . . . 0.0 111.698 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -143.26 157.01 44.86 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.129 1.372 . . . . 0.0 108.843 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.4 m -60.42 -37.86 82.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.59 0.756 . . . . 0.0 110.433 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -76.9 97.13 4.49 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -56.35 -26.82 54.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.934 0.893 . . . . 0.0 112.785 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -73.89 4.12 5.75 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 117.948 -1.025 . . . . 0.0 113.236 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -141.87 165.29 27.88 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 120.871 1.669 . . . . 0.0 112.203 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mm -125.46 163.78 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -130.06 150.05 51.5 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.412 -0.805 . . . . 0.0 110.078 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.39 127.8 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.504 1.522 . . . . 0.0 107.322 -174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -162.15 -175.58 4.67 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.532 -0.73 . . . . 0.0 110.69 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.76 -167.57 48.37 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.266 0.46 . . . . 0.0 112.168 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -151.33 147.04 26.45 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.522 0.729 . . . . 0.0 109.943 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -73.42 139.47 45.88 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.82 -36.44 83.5 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.818 -0.551 . . . . 0.0 109.808 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.39 58.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.2 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -134.13 1.29 3.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.216 0.917 . . . . 0.0 113.35 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.02 55.13 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 118.93 0.787 . . . . 0.0 111.914 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 137.85 40.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.692 2.262 . . . . 0.0 110.181 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.6 169.84 16.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 169.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -79.05 72.4 5.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -56.85 -19.39 17.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.892 0.877 . . . . 0.0 113.276 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.94 -38.8 65.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.659 0.783 . . . . 0.0 111.388 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.1 mm -62.03 -43.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 C-N-CA 124.23 1.012 . . . . 0.0 109.028 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -57.52 -54.07 51.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.119 0.568 . . . . 0.0 110.082 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.1 p -60.6 -41.76 95.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.337 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.99 -50.71 72.29 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.419 1.009 . . . . 0.0 110.6 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -71.66 -42.23 67.77 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.906 -0.496 . . . . 0.0 111.423 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.14 -45.46 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.61 -36.08 81.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.168 1.349 . . . . 0.0 111.346 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.0 -42.54 94.38 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.44 1.018 . . . . 0.0 111.487 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -84.1 -17.84 38.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.586 0.754 . . . . 0.0 112.856 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 46.11 52.36 11.2 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.399 1.88 . . . . 0.0 115.595 -171.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.44 -27.4 81.67 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.711 1.607 . . . . 0.0 111.178 168.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -143.23 168.54 19.52 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.377 2.271 . . . . 0.0 106.963 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -57.69 -42.6 84.0 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.943 1.297 . . . . 0.0 112.508 -172.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -155.38 172.15 18.69 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.189 0.996 . . . . 0.0 108.642 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.93 167.58 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.638 1.575 . . . . 0.0 108.727 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -140.85 169.57 17.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.68 1.192 . . . . 0.0 108.763 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -145.54 167.15 23.72 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 110.402 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.08 142.23 24.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -85.66 51.84 2.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.002 0.921 . . . . 0.0 109.324 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.36 -175.77 4.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.305 1.442 . . . . 0.0 108.906 -170.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.35 -161.33 50.55 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.7 p90 . . . . . 0 C--O 1.247 0.943 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 173.215 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.57 168.59 26.23 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.311 1.445 . . . . 0.0 108.769 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.06 106.57 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 170.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.3 179.08 1.7 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.502 0.668 . . . . 0.0 110.376 171.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -147.82 156.25 42.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.52 -28.43 65.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.49 -26.5 63.64 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.223 0.92 . . . . 0.0 112.055 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.74 -30.67 18.89 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.333 1.053 . . . . 0.0 110.654 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.3 127.76 81.31 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 144.42 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.46 2.107 . . . . 0.0 109.864 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -81.86 -44.05 17.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.137 0.575 . . . . 0.0 111.146 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 t -133.49 137.02 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -154.48 109.84 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.1 pt -140.5 154.89 22.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 123.812 0.845 . . . . 0.0 109.253 -172.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.57 174.13 3.69 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.995 0.918 . . . . 0.0 110.434 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -150.18 19.15 0.86 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.324 -1.485 . . . . 0.0 111.616 172.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.1 -30.32 67.51 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.01 -1.056 . . . . 0.0 112.015 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.97 -67.26 0.11 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 118.195 0.452 . . . . 0.0 112.846 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -142.38 135.61 27.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -163.05 163.36 25.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.229 1.012 . . . . 0.0 110.014 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -85.62 157.47 20.35 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.32 168.75 19.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.038 0.935 . . . . 0.0 109.35 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 154.43 16.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 125.139 1.376 . . . . 0.0 107.548 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -118.36 118.23 31.22 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.31 134.63 65.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.94 0.791 . . . . 0.0 109.079 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -77.39 148.45 35.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' HA ' ' HG ' ' A' ' 71' ' ' CYS . 24.3 t -134.8 126.64 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.41 149.51 21.63 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.68 0.792 . . . . 0.0 109.566 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.9 m -65.59 100.76 0.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.484 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.505 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.02 19.32 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 116.282 -1.818 . . . . 0.0 114.776 169.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.505 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 84.8 Cg_exo -44.11 136.61 7.74 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 124.114 2.505 . . . . 0.0 113.846 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 46.13 25.76 0.37 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.738 2.015 . . . . 0.0 113.797 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.86 32.61 7.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.232 1.413 . . . . 0.0 112.448 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.42 20.36 2.06 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.83 0.729 . . . . 0.0 112.842 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.06 149.53 81.57 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 117.905 0.852 . . . . 0.0 110.755 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.65 -9.37 18.47 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.312 2.675 . . . . 0.0 113.702 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.08 -176.98 6.11 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.477 1.511 . . . . 0.0 109.233 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.68 47.96 2.41 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.864 1.666 . . . . 0.0 109.196 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -74.03 -176.48 2.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.714 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -142.25 159.67 41.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.685 0.794 . . . . 0.0 110.555 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.81 165.77 26.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.597 1.959 . . . . 0.0 107.573 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -111.94 146.99 36.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -126.45 154.8 36.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.312 1.045 . . . . 0.0 109.839 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.1 t -118.7 118.87 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -136.41 147.63 47.37 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.13 133.91 1.97 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.3 m-85 -156.33 155.01 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.9 0.88 . . . . 0.0 109.001 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.99 -31.56 71.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.457 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.1 p-90 -63.9 -30.15 71.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.29 0.95 . . . . 0.0 111.873 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.74 80.72 8.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.18 -14.54 38.69 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.005 0.522 . . . . 0.0 111.796 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.09 142.74 40.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.031 1.732 . . . . 0.0 108.26 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.482 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.8 -31.35 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.137 1.375 . . . . 0.0 111.879 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.33 -28.79 70.0 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.729 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.11 -46.98 72.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.997 0.817 . . . . 0.0 110.496 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -39.94 82.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.261 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -59.62 -48.04 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.778 1.626 . . . . 0.0 109.963 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -48.75 78.87 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.864 0.757 . . . . 0.0 111.324 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -60.62 -50.79 72.1 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.301 0.64 . . . . 0.0 110.891 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -75.07 -40.37 44.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 118.442 -0.79 . . . . 0.0 109.447 -171.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 t -59.09 -40.38 85.1 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.498 1.045 . . . . 0.0 109.082 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.95 -50.54 64.96 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 118.85 0.75 . . . . 0.0 111.952 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.51 -45.75 91.56 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.265 1.033 . . . . 0.0 111.283 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.86 -43.9 97.75 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.505 -0.747 . . . . 0.0 111.798 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.97 -32.36 73.81 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.645 -1.284 . . . . 0.0 111.152 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.37 90.76 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.947 0.899 . . . . 0.0 110.301 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -59.46 -46.42 88.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.878 1.217 . . . . 0.0 108.5 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.7 -5.99 1.59 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 126.951 2.215 . . . . 0.0 112.438 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.0 m -70.16 177.14 3.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.857 1.663 . . . . 0.0 112.114 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -129.46 142.56 50.75 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 169.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.402 ' HG ' ' HA ' ' A' ' 27' ' ' VAL . 91.3 m -143.05 165.09 28.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -168.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -154.94 130.77 10.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.48 112.67 4.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.7 mt -67.35 -28.46 67.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.796 -0.565 . . . . 0.0 110.219 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.66 42.18 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.036 -2.025 . . . . 0.0 108.036 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.34 -175.16 26.07 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.69 -159.86 24.66 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -135.7 163.03 31.09 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.4 1.1 . . . . 0.0 110.566 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.6 mt -123.85 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 t -156.1 169.37 24.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.241 0.616 . . . . 0.0 110.834 -169.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -124.47 24.45 7.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.548 1.539 . . . . 0.0 109.249 169.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -61.42 2.37 0.16 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.788 1.235 . . . . 0.0 112.915 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -55.08 -13.55 1.23 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.561 2.744 . . . . 0.0 113.129 169.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 59.09 30.51 20.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.011 1.724 . . . . 0.0 110.607 -169.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -157.79 158.21 34.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.67 2.388 . . . . 0.0 106.211 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -60.7 -25.61 66.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.392 -0.813 . . . . 0.0 112.446 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -54.24 119.16 4.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.681 1.128 . . . . 0.0 109.818 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.07 159.36 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -138.35 149.06 45.23 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.256 1.022 . . . . 0.0 108.597 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.06 117.91 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -161.85 -168.61 1.98 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.053 0.541 . . . . 0.0 110.684 -173.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.87 -161.82 53.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -152.5 152.38 31.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.331 1.052 . . . . 0.0 108.67 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.3 p -77.94 137.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.7 tpt -65.05 -34.81 79.32 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.839 -0.538 . . . . 0.0 109.855 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.94 65.54 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.416 -0.802 . . . . 0.0 113.111 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -133.86 4.03 3.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.67 -175.26 55.07 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.806 0.73 . . . . 0.0 111.75 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.48 138.37 38.54 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.576 2.184 . . . . 0.0 110.685 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 176.29 5.25 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.54 -34.08 77.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.74 -0.6 . . . . 0.0 111.368 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.4 m80 58.51 -29.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.141 2.976 . . . . 0.0 115.87 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.72 81.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.474 1.11 . . . . 0.0 111.41 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.28 -46.36 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.4 m -56.29 -53.69 54.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.879 0.872 . . . . 0.0 110.538 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -47.21 77.99 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.931 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -64.83 -47.76 76.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.837 0.744 . . . . 0.0 110.519 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.75 -38.37 67.4 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 118.799 -0.619 . . . . 0.0 111.309 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.4 mt -61.61 -45.65 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 95.9 mttt -62.62 -40.33 96.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.573 1.533 . . . . 0.0 111.431 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.59 87.13 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.452 0.569 . . . . 0.0 111.224 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -79.45 -23.22 43.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.4 t80 41.41 62.9 6.62 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.593 2.357 . . . . 0.0 111.943 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.94 -23.43 40.83 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.903 2.402 . . . . 0.0 112.997 -172.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -155.99 -46.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.718 0.69 . . . . 0.0 112.463 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -158.51 173.53 16.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.487 0.715 . . . . 0.0 110.643 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' HG3' ' HE2' ' A' ' 110' ' ' LYS . 26.8 tt0 -67.51 161.25 25.89 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.345 1.058 . . . . 0.0 110.624 174.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.65 162.89 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.038 1.335 . . . . 0.0 109.54 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 p -142.66 174.41 10.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.434 1.894 . . . . 0.0 108.514 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -145.67 167.29 23.47 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.422 -0.799 . . . . 0.0 111.14 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.06 143.18 25.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -86.76 43.63 1.1 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.236 1.014 . . . . 0.0 110.262 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -152.49 -165.2 2.14 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.787 1.635 . . . . 0.0 107.974 -171.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.84 -176.4 52.1 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 119.279 0.945 . . . . 0.0 111.998 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 C--O 1.247 0.93 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 -178.558 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.41 164.29 31.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.594 1.558 . . . . 0.0 107.659 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.92 167.8 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.11 -174.26 4.14 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.609 1.564 . . . . 0.0 107.609 173.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -143.76 150.96 39.38 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -53.85 -30.76 46.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.688 1.195 . . . . 0.0 113.349 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.25 -25.31 59.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.995 0.816 . . . . 0.0 112.434 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.85 -21.58 29.74 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.936 0.894 . . . . 0.0 111.135 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.85 131.75 82.97 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.59 119.76 5.57 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.763 2.976 . . . . 0.0 110.13 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.53 -41.14 12.9 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -169.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -138.58 135.03 43.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -156.14 116.3 3.66 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 pt -137.23 154.29 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 108.358 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -131.47 91.98 3.1 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.836 0.854 . . . . 0.0 110.178 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 m -57.06 149.59 18.9 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.937 1.295 . . . . 0.0 111.408 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -156.52 -44.18 0.07 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.121 0.968 . . . . 0.0 110.42 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.01 -47.67 0.22 Allowed Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -149.21 140.24 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 169.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -155.83 166.3 33.9 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.797 1.239 . . . . 0.0 109.507 176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -97.83 160.13 14.5 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.605 -0.684 . . . . 0.0 109.185 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 169.02 18.87 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 122.992 0.517 . . . . 0.0 110.126 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.0 153.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.322 . . . . 0.0 108.844 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 tp -118.81 116.87 27.42 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.52 132.62 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.416 1.007 . . . . 0.0 109.674 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -78.03 145.99 35.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.032 1.333 . . . . 0.0 108.503 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.14 128.73 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -93.79 154.07 17.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.984 0.913 . . . . 0.0 110.398 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.7 p -73.64 41.91 0.12 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.536 1.934 . . . . 0.0 114.963 -172.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.48 22.42 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 115.918 -1.991 . . . . 0.0 116.344 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.73 125.05 6.04 Favored 'Trans proline' 0 C--N 1.359 1.117 0 CA-C-N 124.553 2.662 . . . . 0.0 113.833 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 39.63 28.14 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.696 2.799 . . . . 0.0 114.419 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m 48.92 30.31 2.7 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.038 1.335 . . . . 0.0 112.551 -171.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.22 -7.76 86.33 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.129 0.871 . . . . 0.0 113.539 -170.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.63 145.58 23.73 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 124.794 1.238 . . . . 0.0 108.908 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.52 9.34 4.14 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.831 3.021 . . . . 0.0 113.723 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.7 159.55 5.14 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.293 1.437 . . . . 0.0 112.059 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.12 39.52 2.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.864 1.266 . . . . 0.0 110.308 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' C ' ' HG ' ' A' ' 40' ' ' SER . 57.5 mm-40 -74.08 168.06 20.3 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.434 ' HG ' ' C ' ' A' ' 39' ' ' GLU . 15.7 m -154.78 161.14 41.61 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.58 -1.325 . . . . 0.0 111.242 177.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.414 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -152.94 165.75 34.54 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.893 1.677 . . . . 0.0 108.477 173.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.25 151.17 26.31 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.414 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 48.6 pt -130.4 156.57 42.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.102 1.361 . . . . 0.0 109.32 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.6 122.71 66.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -128.69 153.32 47.44 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.33 132.26 2.46 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -151.21 151.08 31.38 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.2 1.0 . . . . 0.0 108.45 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.2 -29.13 68.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.192 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -65.54 -34.35 78.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.18 0.9 . . . . 0.0 110.979 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 71.13 8.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 169.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -62.62 -9.33 8.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.531 1.132 . . . . 0.0 111.696 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.34 37.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.236 1.815 . . . . 0.0 107.186 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.514 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 8.1 m-70 -58.48 -31.21 67.62 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.744 1.617 . . . . 0.0 112.078 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.93 -31.61 68.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.873 0.469 . . . . 0.0 111.633 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.94 -43.08 79.93 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.275 0.489 . . . . 0.0 110.6 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -40.21 72.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.449 175.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.35 -44.72 88.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.37 1.441 . . . . 0.0 109.876 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.67 -48.88 73.11 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 0.605 . . . . 0.0 111.606 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -56.87 -52.08 66.55 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.391 0.677 . . . . 0.0 110.086 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.19 -43.73 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.094 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -58.88 -37.13 75.86 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.625 1.102 . . . . 0.0 111.023 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.86 63.16 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.928 0.785 . . . . 0.0 111.199 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.25 -46.17 81.61 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.88 0.84 . . . . 0.0 111.019 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.6 mmt -59.12 -42.72 91.23 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.842 -0.536 . . . . 0.0 111.129 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -70.38 -30.7 67.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.342 0.974 . . . . 0.0 111.728 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -63.57 -43.07 98.07 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.327 0.967 . . . . 0.0 109.302 169.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -63.86 -27.04 68.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.451 0.569 . . . . 0.0 111.079 171.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.89 -7.22 9.43 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.137 2.304 . . . . 0.0 113.178 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 69.0 m -71.59 170.47 13.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.189 1.396 . . . . 0.0 111.721 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.59 140.73 52.21 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 m -144.28 163.16 34.51 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -149.08 128.89 13.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.04 0.936 . . . . 0.0 108.628 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -65.37 111.3 2.98 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.18 -27.53 66.49 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.707 -0.62 . . . . 0.0 110.1 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.15 -166.92 40.1 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.71 -165.94 17.63 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 170.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.35 -164.75 31.93 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -119.84 150.48 40.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.3 mt -128.27 138.46 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.7 m -139.07 146.05 40.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.855 0.862 . . . . 0.0 109.096 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -124.75 27.3 6.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.026 1.73 . . . . 0.0 108.9 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -76.64 13.12 1.06 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.217 1.407 . . . . 0.0 111.732 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -59.87 -18.99 48.65 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.609 2.764 . . . . 0.0 114.095 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 53.76 33.41 16.79 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.891 1.276 . . . . 0.0 109.984 -169.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -161.36 160.49 29.63 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 127.635 2.374 . . . . 0.0 106.759 -172.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -21.54 64.53 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -57.5 156.21 8.39 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.462 1.105 . . . . 0.0 111.774 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.37 156.46 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -133.48 147.19 51.65 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.752 0.821 . . . . 0.0 109.735 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.87 129.23 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.766 1.626 . . . . 0.0 106.895 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.37 -169.13 2.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.036 0.835 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.84 -159.37 52.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.649 0.642 . . . . 0.0 112.526 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.7 154.22 39.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.24 1.416 . . . . 0.0 108.004 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 t -66.54 135.43 54.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 74.5 mtm -59.77 -16.46 27.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.638 1.175 . . . . 0.0 112.411 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.68 -23.14 4.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.117 0.967 . . . . 0.0 113.215 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -129.97 2.08 4.81 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.34 -175.59 45.88 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 119.09 0.859 . . . . 0.0 112.573 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.61 129.44 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.745 2.297 . . . . 0.0 110.968 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.86 167.76 20.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 110.304 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -78.97 76.66 5.46 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -57.06 -19.87 21.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.904 0.882 . . . . 0.0 113.166 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.39 -39.89 73.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.837 0.855 . . . . 0.0 110.987 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.9 mm -63.54 -49.15 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 m -62.63 -46.74 86.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 117.839 0.291 . . . . 0.0 110.843 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -62.01 -42.16 98.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.22 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.89 -49.94 75.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.979 1.263 . . . . 0.0 111.021 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -66.27 -45.12 81.6 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.935 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.87 -47.48 93.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -61.6 -39.15 90.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.307 1.412 . . . . 0.0 111.092 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.41 80.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 111.236 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -75.73 -21.6 57.34 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.349 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.4 t80 44.97 60.91 12.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.696 1.998 . . . . 0.0 111.671 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.28 -21.8 47.28 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.941 2.427 . . . . 0.0 112.527 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -154.86 -46.84 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.378 0.671 . . . . 0.0 111.865 170.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -159.3 179.95 8.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.2 1.0 . . . . 0.0 109.79 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.45 154.61 20.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.411 1.085 . . . . 0.0 109.513 169.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.73 168.48 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.068 1.347 . . . . 0.0 109.414 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 p -139.38 171.38 14.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.472 1.109 . . . . 0.0 109.665 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -145.93 161.6 39.68 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.812 -0.555 . . . . 0.0 110.583 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.61 135.69 18.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -72.94 -25.1 60.91 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.88 -32.71 71.2 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.008 0.923 . . . . 0.0 112.999 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.17 167.86 53.63 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.347 0.498 . . . . 0.0 111.929 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 59.5 t80 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 125.312 1.445 . . . . 0.0 107.715 175.561 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmt? . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.67 169.02 20.57 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.223 1.409 . . . . 0.0 108.561 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.3 t -137.11 130.67 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.65 -179.14 2.93 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.601 0.715 . . . . 0.0 110.798 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -148.14 155.39 41.36 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.207 1.403 . . . . 0.0 107.279 175.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -54.06 -34.0 58.93 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.586 0.754 . . . . 0.0 112.584 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.47 -24.42 66.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.192 0.906 . . . . 0.0 112.294 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.91 -20.18 23.67 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.95 . . . . 0.0 111.366 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.69 126.4 86.84 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.189 -1.386 . . . . 0.0 107.824 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.53 111.78 0.51 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.249 3.3 . . . . 0.0 110.421 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -71.38 -35.94 71.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.35 137.64 20.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -156.45 116.15 3.54 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.73 156.87 35.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.391 1.076 . . . . 0.0 109.418 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -70.87 163.19 27.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.558 0.743 . . . . 0.0 111.964 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 m -66.52 177.31 1.58 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.605 1.962 . . . . 0.0 112.548 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -37.28 120.61 0.78 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.811 2.045 . . . . 0.0 112.544 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.92 -161.94 34.72 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -174.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.8 t -133.98 129.99 54.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 172.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -159.73 158.01 30.5 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 123.919 0.887 . . . . 0.0 110.122 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 156.06 27.45 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.886 0.474 . . . . 0.0 109.738 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.44 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -140.66 169.6 17.34 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.042 0.937 . . . . 0.0 108.687 179.122 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.43 150.67 19.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 108.013 174.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 tp -110.6 115.71 30.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.0 OUTLIER -127.32 128.13 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.53 0.681 . . . . 0.0 109.412 -172.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -79.27 149.53 31.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.43 1.492 . . . . 0.0 108.348 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.42 135.01 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -102.85 147.83 26.39 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.324 1.049 . . . . 0.0 108.464 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -62.23 99.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.282 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -149.66 17.97 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.163 -1.875 . . . . 0.0 114.776 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 51.1 Cg_exo -41.39 134.66 3.11 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 124.077 2.492 . . . . 0.0 114.31 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 38.17 31.89 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.692 2.797 . . . . 0.0 114.182 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m 51.59 32.58 9.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.149 1.379 . . . . 0.0 112.566 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.33 30.38 0.87 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.998 0.809 . . . . 0.0 111.949 -174.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.42 153.04 87.63 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.243 0.617 . . . . 0.0 110.912 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.07 -23.62 77.74 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.439 2.76 . . . . 0.0 115.463 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.19 -167.87 2.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.078 1.351 . . . . 0.0 109.995 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.12 50.74 2.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.317 1.847 . . . . 0.0 108.744 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -176.33 4.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.0 m -140.95 156.52 46.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.572 0.749 . . . . 0.0 110.491 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.77 149.88 29.55 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.632 1.973 . . . . 0.0 106.742 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.43 150.55 27.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -128.8 154.05 39.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.26 1.024 . . . . 0.0 109.34 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.18 114.66 44.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -134.7 146.65 49.66 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.68 135.04 2.33 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.8 m-85 -157.06 152.6 26.67 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -60.32 -27.11 67.07 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.5 p-90 -66.86 -27.71 67.75 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 112.062 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.24 79.9 9.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.06 -6.29 8.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.005 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.98 142.03 29.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.226 1.811 . . . . 0.0 107.514 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.421 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 21.1 m-70 -62.04 -30.7 71.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.398 1.079 . . . . 0.0 111.543 -174.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -29.62 68.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.145 175.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.42 -47.5 73.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.781 0.719 . . . . 0.0 110.748 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -43.29 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.011 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.12 -47.13 84.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.102 0.864 . . . . 0.0 109.608 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.99 -48.29 71.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 0.483 . . . . 0.0 111.718 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -57.22 -53.75 54.59 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.366 0.666 . . . . 0.0 110.294 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.06 -45.19 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.864 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -64.29 -25.16 67.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 119.884 1.22 . . . . 0.0 111.471 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.32 -49.89 72.71 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 170.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.05 -41.93 85.63 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.185 0.992 . . . . 0.0 111.392 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.2 mmt -56.39 -44.85 80.66 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.367 0.985 . . . . 0.0 110.79 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.52 -29.08 66.62 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.246 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -63.41 -43.15 98.36 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.396 0.998 . . . . 0.0 109.193 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.53 -34.28 77.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.079 0.4 . . . . 0.0 110.306 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.83 5.07 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.535 2.017 . . . . 0.0 113.059 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -67.86 175.37 3.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.365 1.866 . . . . 0.0 113.434 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -128.2 148.82 50.63 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.4 163.57 32.69 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -168.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -149.35 128.04 12.45 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.089 1.356 . . . . 0.0 109.006 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.27 111.94 7.0 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 168.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.62 -26.41 64.42 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.237 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.18 -168.02 40.17 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.7 -175.54 30.78 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -158.43 20.38 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 -174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -128.57 154.02 46.62 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.839 -0.801 . . . . 0.0 108.869 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.1 mt -124.96 142.11 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 m -140.08 164.56 29.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.531 1.533 . . . . 0.0 108.366 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -135.82 159.96 40.06 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.836 1.254 . . . . 0.0 108.547 174.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -144.47 97.95 3.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.202 1.401 . . . . 0.0 107.666 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 m -61.58 -10.68 8.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.001 0.921 . . . . 0.0 112.888 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -63.65 -27.02 68.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.867 1.267 . . . . 0.0 111.375 170.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -141.19 -0.45 1.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -172.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 mptt 51.0 55.18 9.96 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.836 1.655 . . . . 0.0 110.609 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -146.5 103.65 3.69 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.864 0.866 . . . . 0.0 109.065 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -58.01 151.76 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -134.63 153.72 51.84 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.563 1.145 . . . . 0.0 108.666 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.0 t -130.34 128.07 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.52 -177.07 6.15 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 121.362 -0.836 . . . . 0.0 110.681 -173.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.01 -169.08 53.25 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -151.92 147.56 26.72 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.593 0.757 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.8 p -72.16 133.78 45.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -68.99 -27.18 65.47 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.782 -0.574 . . . . 0.0 110.09 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.49 -42.35 64.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.828 0.851 . . . . 0.0 112.384 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -133.65 3.15 3.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -168.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.51 -176.84 54.24 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.793 0.724 . . . . 0.0 111.848 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.22 132.02 23.29 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.674 2.249 . . . . 0.0 110.211 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.9 168.8 19.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -78.93 81.26 5.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 168.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.44 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 51.5 m80 -56.05 -21.25 20.63 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.568 0.747 . . . . 0.0 112.762 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -44.07 66.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.709 1.203 . . . . 0.0 111.484 169.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.02 -49.53 83.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -58.4 -50.56 73.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.747 0.819 . . . . 0.0 110.683 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -63.58 -40.01 95.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.072 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.28 -46.51 83.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.927 1.24 . . . . 0.0 110.538 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.17 -43.55 97.96 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.263 0.483 . . . . 0.0 110.437 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 52.5 mt -59.64 -51.58 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.009 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -60.98 -36.25 78.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.675 1.579 . . . . 0.0 111.283 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.92 99.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.922 0.783 . . . . 0.0 111.689 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.39 -18.09 37.25 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.264 35.8 p90 40.62 56.35 7.76 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 127.16 2.184 . . . . 0.0 114.209 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.59 -15.49 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.622 2.215 . . . . 0.0 110.447 169.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -141.22 161.65 37.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.444 2.698 . . . . 0.0 105.97 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -59.03 -46.42 88.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.935 0.894 . . . . 0.0 112.759 -169.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -161.0 158.76 28.49 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.402 1.881 . . . . 0.0 106.12 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.6 m -140.18 169.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.127 0.971 . . . . 0.0 110.374 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -140.66 171.73 13.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.202 1.401 . . . . 0.0 108.885 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -143.5 170.76 15.21 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.65 -0.656 . . . . 0.0 109.623 170.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.46 142.33 30.2 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -86.62 47.36 1.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.423 1.089 . . . . 0.0 110.121 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -150.65 179.2 8.39 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.47 1.108 . . . . 0.0 109.666 -171.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.74 -177.32 51.91 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.141 1.353 . . . . 0.0 111.529 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 C--O 1.246 0.897 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 172.343 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.69 167.68 24.01 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.387 1.475 . . . . 0.0 108.678 175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.26 164.01 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.669 0.787 . . . . 0.0 110.875 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.74 174.85 1.27 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.296 0.57 . . . . 0.0 110.438 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -148.34 154.82 40.49 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.602 1.161 . . . . 0.0 107.911 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.0 mt -54.66 -32.3 58.94 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.769 0.828 . . . . 0.0 112.478 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.17 67.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.448 1.022 . . . . 0.0 112.289 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -90.08 -24.44 21.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.439 1.095 . . . . 0.0 111.307 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.32 130.17 89.43 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.2 116.63 3.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.23 2.62 . . . . 0.0 109.785 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.93 -35.84 64.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.822 0.849 . . . . 0.0 113.273 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.51 134.76 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -153.6 108.89 3.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.1 pt -135.75 134.6 51.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.155 0.982 . . . . 0.0 108.441 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -71.25 -19.25 62.38 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -169.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 m 55.77 32.22 19.06 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.154 1.382 . . . . 0.0 112.478 176.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.36 -44.26 91.98 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -169.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.68 -59.34 0.32 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -146.95 127.96 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 169.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -160.56 161.52 32.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.254 1.021 . . . . 0.0 109.393 -176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.25 160.06 19.94 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.829 -0.545 . . . . 0.0 109.739 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.12 164.57 31.76 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.313 0.645 . . . . 0.0 109.378 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.67 156.02 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.604 1.161 . . . . 0.0 108.529 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -118.53 114.56 23.01 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.61 130.94 71.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -75.27 148.02 39.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.29 119.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -91.32 148.54 22.26 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 p -68.64 102.71 1.55 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.872 0.76 . . . . 0.0 109.712 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.429 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.12 23.75 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.003 0 CA-C-O 116.39 -1.767 . . . . 0.0 114.517 169.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.429 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 37.1 Cg_exo -41.85 124.36 2.69 Favored 'Trans proline' 0 C--N 1.361 1.187 0 CA-C-N 123.802 2.394 . . . . 0.0 114.521 173.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 34.22 38.24 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.341 3.056 . . . . 0.0 113.924 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m 52.97 30.31 9.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.224 1.409 . . . . 0.0 112.961 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.22 14.24 5.66 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.797 1.189 . . . . 0.0 112.525 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.26 149.65 90.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.95 0.875 . . . . 0.0 110.793 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.89 -12.32 16.34 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.187 2.591 . . . . 0.0 113.718 -177.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.44 -179.5 8.01 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.874 1.269 . . . . 0.0 109.952 -170.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.65 49.75 2.0 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.823 1.649 . . . . 0.0 109.055 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.54 177.51 5.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.928 0.891 . . . . 0.0 109.045 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -139.34 160.58 39.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.717 0.77 . . . . 0.0 111.125 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -142.41 164.79 29.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 129.105 2.962 . . . . 0.0 105.566 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -128.31 149.57 50.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.09 147.77 33.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.496 0.718 . . . . 0.0 109.829 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.38 119.22 57.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -128.3 145.09 51.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.08 132.15 1.9 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 170.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -151.54 151.69 31.93 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -59.89 -29.37 68.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.7 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -66.28 -27.7 68.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.159 0.89 . . . . 0.0 111.836 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.91 81.97 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -62.06 -15.24 43.32 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 122.943 0.497 . . . . 0.0 111.583 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.76 142.16 38.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.137 1.775 . . . . 0.0 108.014 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -56.17 -31.37 63.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.441 1.496 . . . . 0.0 112.757 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.55 -27.09 68.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.73 -0.607 . . . . 0.0 111.557 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.33 -47.33 70.82 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.677 0.671 . . . . 0.0 110.693 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -39.71 83.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.467 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -61.95 -48.23 81.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.9 1.227 . . . . 0.0 109.927 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -45.81 91.79 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.347 0.976 . . . . 0.0 111.365 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -60.42 -51.18 70.59 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.391 0.677 . . . . 0.0 110.812 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.46 -33.91 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.15 -169.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p -61.16 -35.83 78.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.794 1.634 . . . . 0.0 110.169 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.8 -51.07 59.78 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.9 -44.21 96.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.208 1.004 . . . . 0.0 111.015 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.8 mmt -59.72 -44.4 93.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.696 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -66.69 -33.41 75.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.217 . . . . 0.0 111.976 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.27 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.216 0.916 . . . . 0.0 109.77 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.35 -35.78 80.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.571 0.623 . . . . 0.0 110.393 171.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.41 -8.12 5.32 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.633 2.54 . . . . 0.0 113.127 171.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 94.8 m -77.41 133.0 38.78 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.943 1.697 . . . . 0.0 111.711 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.39 137.3 33.47 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.9 m -144.71 163.96 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -155.69 133.85 11.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.653 1.181 . . . . 0.0 108.251 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.84 112.82 4.47 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.7 mt -67.87 -29.83 69.04 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.907 -0.495 . . . . 0.0 110.098 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.18 -171.0 42.87 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.28 -164.68 23.37 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.6 -147.52 8.85 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -171.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -133.63 155.59 49.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 108.217 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.7 mt -125.26 141.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.1 m -138.41 143.33 39.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.606 1.162 . . . . 0.0 108.219 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -122.44 26.96 8.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.484 1.913 . . . . 0.0 108.546 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -129.7 31.87 4.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.133 1.773 . . . . 0.0 109.079 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -63.83 7.52 0.12 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.231 2.612 . . . . 0.0 114.41 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 55.87 26.39 9.65 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.237 1.815 . . . . 0.0 110.647 -169.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -162.81 156.67 20.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.599 2.76 . . . . 0.0 106.104 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -63.27 -29.16 70.54 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -66.09 122.01 16.45 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.546 1.066 . . . . 0.0 109.67 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.434 ' H ' HD11 ' A' ' 88' ' ' ILE . 2.4 mp -64.77 149.67 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 169.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -128.12 147.73 50.55 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.588 -0.695 . . . . 0.0 109.727 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.06 120.58 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.96 -164.98 1.39 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.532 0.733 . . . . 0.0 109.988 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.36 -167.91 54.56 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -153.04 144.43 23.26 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.957 0.503 . . . . 0.0 110.786 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.9 m -70.01 140.69 52.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -65.1 -49.61 69.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.14 -24.56 37.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -118.17 -6.74 10.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.94 -179.6 34.6 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.795 0.725 . . . . 0.0 112.408 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.09 136.48 37.92 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.713 2.275 . . . . 0.0 109.976 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.91 169.83 17.16 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.362 0.601 . . . . 0.0 110.078 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.09 82.42 6.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -58.44 -18.15 26.29 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.765 -0.584 . . . . 0.0 112.543 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.63 -39.68 68.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.57 1.148 . . . . 0.0 111.861 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 mm -61.7 -49.76 83.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 m -58.19 -51.46 69.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.908 0.883 . . . . 0.0 111.399 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.0 p -64.71 -41.01 96.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.382 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.7 -45.53 93.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 120.011 1.278 . . . . 0.0 110.468 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -65.13 -44.51 88.46 Favored 'General case' 0 N--CA 1.46 0.053 0 O-C-N 121.911 -0.493 . . . . 0.0 111.08 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.95 -42.12 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.374 0.67 . . . . 0.0 109.263 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -63.57 -38.0 89.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 120.111 1.323 . . . . 0.0 110.895 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.53 -44.88 85.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.84 0.745 . . . . 0.0 111.153 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -63.43 -36.28 83.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.256 1.022 . . . . 0.0 111.41 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.7 t80 43.8 63.24 8.38 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.945 2.098 . . . . 0.0 111.215 -169.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.29 -23.62 32.73 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.831 2.354 . . . . 0.0 112.364 -173.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -157.2 -45.42 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.579 0.752 . . . . 0.0 111.806 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -157.4 179.44 9.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.394 1.078 . . . . 0.0 109.564 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -64.07 162.42 14.24 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.885 0.874 . . . . 0.0 109.583 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.2 166.43 18.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 -176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.6 p -139.5 172.54 12.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.565 1.146 . . . . 0.0 109.456 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -143.88 167.78 21.52 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.159 0.583 . . . . 0.0 110.315 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.17 143.12 25.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 169.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -84.36 52.4 2.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.773 0.829 . . . . 0.0 109.283 175.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -149.94 -166.83 2.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.25 1.82 . . . . 0.0 107.714 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.38 -166.8 54.8 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.591 1.087 . . . . 0.0 111.424 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.548 1.539 . . . . 0.0 107.149 -177.795 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.83 158.46 21.91 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.32 130.61 47.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.8 -177.41 4.32 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.077 0.951 . . . . 0.0 110.764 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -148.44 155.41 41.17 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.217 1.807 . . . . 0.0 106.158 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.88 -28.44 64.19 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.197 0.908 . . . . 0.0 112.848 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.7 63.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.294 0.952 . . . . 0.0 112.293 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.1 -28.1 19.22 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.513 1.125 . . . . 0.0 111.212 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.67 129.02 76.41 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.67 131.36 33.09 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.658 2.906 . . . . 0.0 110.707 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.21 -43.34 8.88 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.46 142.07 31.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -156.18 116.36 3.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 pt -141.67 156.33 20.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.279 1.432 . . . . 0.0 107.598 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.27 139.8 58.65 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -65.93 -27.82 68.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -170.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -165.28 104.92 0.75 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.652 1.114 . . . . 0.0 109.84 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.62 -165.89 33.9 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -131.17 119.53 44.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -160.07 161.2 33.84 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.951 0.9 . . . . 0.0 109.41 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -86.77 158.77 19.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.428 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -142.36 166.58 24.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.901 0.88 . . . . 0.0 109.209 -176.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.06 154.74 21.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.108 0.963 . . . . 0.0 108.799 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.93 119.35 34.55 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.78 135.41 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 119.401 1.0 . . . . 0.0 110.423 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -79.99 146.62 31.94 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 124.84 33.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -93.76 153.28 18.4 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.509 0.724 . . . . 0.0 109.891 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m -67.85 87.92 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.297 1.039 . . . . 0.0 109.56 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.31 24.37 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 116.584 -1.674 . . . . 0.0 114.499 169.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.02 129.94 5.75 Favored 'Trans proline' 0 C--N 1.359 1.089 0 CA-C-N 123.551 2.304 . . . . 0.0 113.075 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 43.7 27.2 0.15 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.928 2.491 . . . . 0.0 113.901 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 50.1 32.38 5.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.401 1.481 . . . . 0.0 112.677 -175.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.24 15.1 1.48 Allowed Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.55 -172.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.93 151.58 89.17 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 118.251 1.025 . . . . 0.0 110.73 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.85 -0.38 10.64 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.581 2.854 . . . . 0.0 114.547 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.0 178.39 8.98 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.689 1.195 . . . . 0.0 110.032 -170.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.21 36.82 3.2 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.364 1.466 . . . . 0.0 110.466 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -69.59 172.42 7.4 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.3 m -135.99 160.94 37.07 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.562 0.745 . . . . 0.0 110.361 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.11 162.81 30.74 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.547 1.539 . . . . 0.0 107.579 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.49 134.95 54.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 171.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 pt -121.57 161.64 21.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.667 1.187 . . . . 0.0 110.383 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.55 124.03 53.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.48 155.02 49.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.68 136.02 3.83 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -149.48 152.05 34.97 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -174.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.62 -33.47 72.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.53 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -64.91 -29.81 70.77 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.018 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.73 75.32 3.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 109.35 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.79 -10.46 37.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.536 173.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.51 142.57 35.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.667 1.587 . . . . 0.0 107.718 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -58.24 -33.79 69.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.968 1.307 . . . . 0.0 111.63 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.93 67.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.123 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.47 -42.34 87.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.097 0.862 . . . . 0.0 110.295 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -38.31 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 117.369 -1.301 . . . . 0.0 110.616 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.09 -43.01 95.83 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.259 1.391 . . . . 0.0 109.453 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.05 -50.57 72.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.128 0.876 . . . . 0.0 111.32 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -48.74 78.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.219 0.533 . . . . 0.0 109.8 -174.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -78.43 -44.75 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.385 -169.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.9 p -62.42 -31.38 72.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.577 1.535 . . . . 0.0 110.512 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.52 -52.17 48.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.19 -44.84 90.75 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.415 1.108 . . . . 0.0 111.384 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.6 mmt -57.04 -49.25 76.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.893 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.713 1.142 . . . . 0.0 111.988 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.74 -43.5 98.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.212 0.915 . . . . 0.0 109.756 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.66 -35.93 82.61 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.943 0.792 . . . . 0.0 110.379 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.2 -12.55 3.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.915 2.197 . . . . 0.0 112.98 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.3 m -74.34 121.46 21.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.959 1.703 . . . . 0.0 112.887 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.33 143.65 42.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 168.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.3 m -145.16 166.99 23.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.588 0.755 . . . . 0.0 112.498 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -149.48 134.01 17.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.67 1.188 . . . . 0.0 108.65 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -70.62 113.23 7.52 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.7 mt -70.72 -25.32 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.764 -0.585 . . . . 0.0 110.182 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.65 -169.74 42.26 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -170.73 23.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.16 -155.61 17.39 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.2 ttm105 -126.39 153.61 44.74 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.514 0.726 . . . . 0.0 109.174 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 mt -123.05 141.77 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.7 m -158.4 161.28 37.51 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.645 1.178 . . . . 0.0 108.459 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.18 160.73 31.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 168.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -62.03 -20.97 64.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.05 1.34 . . . . 0.0 112.224 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.0 m 72.85 -47.19 0.67 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.804 2.441 . . . . 0.0 111.0 -175.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -67.99 -17.45 64.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.481 0.713 . . . . 0.0 110.376 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -152.79 163.72 39.18 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.514 1.926 . . . . 0.0 107.208 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -74.95 -14.96 60.69 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.184 -0.912 . . . . 0.0 112.11 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -42.82 132.21 3.9 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.3 1.44 . . . . 0.0 109.832 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.6 mm -74.23 159.91 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.617 0.722 . . . . 0.0 109.06 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -140.29 151.01 44.75 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.117 1.767 . . . . 0.0 107.917 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 t -133.34 126.11 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.15 -179.8 8.33 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.81 -0.557 . . . . 0.0 110.757 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.68 -162.03 52.87 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -149.57 151.92 34.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.84 1.256 . . . . 0.0 108.64 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -73.58 131.07 41.31 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.91 -28.78 69.77 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.189 -0.32 . . . . 0.0 110.347 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.93 -35.74 17.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.638 0.775 . . . . 0.0 112.153 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.89 2.13 7.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.74 44.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 118.691 0.678 . . . . 0.0 111.988 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.92 136.55 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.225 1.95 . . . . 0.0 109.955 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.96 178.2 3.88 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -61.17 -34.37 74.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.704 -0.622 . . . . 0.0 111.375 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.428 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 41.3 m80 59.21 -32.85 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.07 2.948 . . . . 0.0 115.682 -173.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.49 81.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.785 1.175 . . . . 0.0 110.723 170.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -53.88 -50.6 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.344 1.058 . . . . 0.0 108.644 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -58.92 -50.26 74.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.315 1.046 . . . . 0.0 110.363 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -48.65 74.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.813 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.11 -44.83 91.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.343 0.974 . . . . 0.0 110.845 -175.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -67.13 -41.63 85.81 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.84 -0.538 . . . . 0.0 110.903 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.1 mt -59.84 -47.66 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 -33.88 75.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.01 1.277 . . . . 0.0 111.649 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.04 96.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.437 1.017 . . . . 0.0 111.324 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.4 -17.66 26.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 46.32 57.1 16.74 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.916 1.686 . . . . 0.0 114.208 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.25 -19.19 44.55 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 121.773 1.649 . . . . 0.0 110.256 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -146.26 165.22 29.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.244 2.618 . . . . 0.0 106.067 169.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -59.82 -37.53 79.44 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.891 0.876 . . . . 0.0 113.207 -170.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -159.38 171.47 19.71 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.965 0.906 . . . . 0.0 108.63 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.05 162.22 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.076 1.35 . . . . 0.0 108.031 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.5 p -138.26 171.82 13.82 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.709 1.603 . . . . 0.0 108.519 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -145.04 169.34 18.29 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.469 -0.769 . . . . 0.0 111.145 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.42 143.24 31.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -87.61 32.34 0.73 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.209 1.004 . . . . 0.0 111.47 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -156.11 178.9 9.76 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.007 1.323 . . . . 0.0 108.399 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.16 178.83 16.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.939 1.733 . . . . 0.0 111.071 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.533 1.933 . . . . 0.0 106.145 174.172 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 tpp . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.72 148.33 46.94 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.1 0.56 . . . . 0.0 110.77 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.9 m -68.02 160.16 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.728 0.811 . . . . 0.0 110.367 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.25 173.66 4.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -146.52 155.26 42.39 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.035 0.934 . . . . 0.0 108.901 -175.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 mt -53.74 -30.71 45.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.499 1.12 . . . . 0.0 113.484 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.59 -24.19 60.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.78 0.718 . . . . 0.0 112.266 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.31 -19.93 26.07 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.292 1.037 . . . . 0.0 111.108 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.09 131.01 80.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.51 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.348 2.699 . . . . 0.0 109.961 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.29 -34.71 70.9 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.564 0.746 . . . . 0.0 112.261 -169.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -142.56 135.26 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -154.61 105.57 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt -133.94 149.79 30.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.749 0.82 . . . . 0.0 109.588 -173.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -69.81 172.22 7.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.244 1.818 . . . . 0.0 110.801 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -143.92 -2.6 0.91 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.284 1.834 . . . . 0.0 111.864 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.2 -28.36 69.32 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -169.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.44 -153.44 14.33 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -173.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.88 142.45 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -155.96 166.89 32.13 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.549 1.139 . . . . 0.0 109.963 172.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.68 154.4 17.31 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.03 168.53 19.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 109.116 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.62 154.23 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.111 1.364 . . . . 0.0 108.002 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.6 tp -118.17 114.91 23.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.58 131.53 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -174.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -78.59 144.96 35.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.97 141.72 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -108.01 149.65 28.13 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.879 1.272 . . . . 0.0 109.633 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 m -63.68 99.95 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.365 0.666 . . . . 0.0 110.912 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -154.23 21.71 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.347 -1.787 . . . . 0.0 114.847 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.499 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.0 Cg_exo -46.99 136.85 17.29 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 124.327 2.581 . . . . 0.0 113.067 172.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? 46.41 25.05 0.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.153 2.181 . . . . 0.0 113.821 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 50.77 32.71 7.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.017 1.327 . . . . 0.0 112.351 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.68 23.74 1.98 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.934 0.778 . . . . 0.0 112.586 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.99 150.21 83.85 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 117.769 0.784 . . . . 0.0 110.691 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.87 -8.04 17.72 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.308 2.672 . . . . 0.0 113.743 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.56 -174.95 5.14 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.305 1.442 . . . . 0.0 109.447 -171.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.07 51.91 2.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.031 1.733 . . . . 0.0 108.701 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.412 ' C ' ' HG ' ' A' ' 40' ' ' SER . 43.5 mt-10 -77.13 -178.14 4.88 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 171.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 39' ' ' GLU . 13.1 m -152.82 159.34 43.06 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.772 -1.205 . . . . 0.0 110.028 173.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.73 167.81 29.2 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.826 1.65 . . . . 0.0 108.785 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.01 152.74 24.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -129.85 153.41 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.752 1.221 . . . . 0.0 109.013 172.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.4 t -119.92 115.08 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -136.06 148.18 48.21 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.95 136.69 2.57 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.2 m-85 -156.29 152.31 27.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -172.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.53 -31.46 69.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.001 -0.524 . . . . 0.0 112.168 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.431 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -64.32 -27.54 69.1 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.828 0.74 . . . . 0.0 112.363 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 82.15 8.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.692 1.133 . . . . 0.0 108.267 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.52 -14.09 47.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.702 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.53 143.99 35.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.769 1.628 . . . . 0.0 108.418 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.419 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 21.2 m-70 -62.11 -30.7 71.2 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.736 1.214 . . . . 0.0 111.779 -174.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.01 -28.55 69.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.722 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.21 -47.79 72.72 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 110.549 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -40.37 82.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.262 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -58.61 -46.54 86.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.325 1.421 . . . . 0.0 110.02 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.31 -48.67 72.28 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.288 0.495 . . . . 0.0 111.451 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -60.18 -51.86 67.79 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.106 0.563 . . . . 0.0 110.864 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.32 -45.22 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.869 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -63.29 -28.37 69.97 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.731 1.15 . . . . 0.0 111.352 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.19 -49.38 75.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.57 -46.51 85.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.053 0.927 . . . . 0.0 110.708 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.3 mmt -58.36 -43.61 88.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.853 -0.529 . . . . 0.0 111.502 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.94 -33.31 73.52 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.103 -0.998 . . . . 0.0 111.875 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -61.22 -42.71 99.08 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.022 0.828 . . . . 0.0 109.617 170.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -60.71 -44.06 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.128 0.876 . . . . 0.0 109.706 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.71 -6.74 1.44 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.073 1.796 . . . . 0.0 113.28 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.63 177.99 4.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.645 1.578 . . . . 0.0 113.319 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.25 144.71 51.51 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 169.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.3 m -145.32 165.48 28.33 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -168.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.77 128.72 11.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.313 1.045 . . . . 0.0 108.525 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -67.47 115.33 6.96 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.6 mt -71.9 -26.51 62.35 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.005 -0.435 . . . . 0.0 110.451 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.05 -168.73 40.98 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.98 -172.0 28.81 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 173.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.13 -168.11 35.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -119.3 154.91 32.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 mt -128.79 133.77 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 m -141.59 140.77 33.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 108.595 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.34 156.83 33.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.396 0.678 . . . . 0.0 109.898 169.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -121.88 89.25 3.08 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.3 m -54.29 -16.98 2.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.115 1.366 . . . . 0.0 114.156 -172.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -59.03 -35.63 73.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.533 1.533 . . . . 0.0 111.416 172.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -149.58 15.1 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.975 0.91 . . . . 0.0 112.328 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.2 tttm 68.24 -52.99 0.54 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 129.011 2.924 . . . . 0.0 114.024 -172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -33.67 120.24 0.4 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.413 1.885 . . . . 0.0 112.099 -169.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.88 165.32 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.985 0.897 . . . . 0.0 110.861 172.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -134.09 149.75 51.13 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.398 1.879 . . . . 0.0 106.987 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.0 t -125.5 121.56 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.22 -176.32 5.57 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.461 -0.774 . . . . 0.0 111.586 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.75 -159.15 53.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.06 152.36 36.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.012 1.325 . . . . 0.0 108.188 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -77.03 130.54 37.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.6 mtp -64.32 -27.73 69.22 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.677 -0.639 . . . . 0.0 110.553 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.01 -38.03 45.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.159 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.9 3.33 3.2 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.75 -178.69 50.03 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.019 0.818 . . . . 0.0 112.038 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 133.96 23.95 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.653 2.235 . . . . 0.0 110.162 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.35 167.86 21.09 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.305 0.574 . . . . 0.0 110.027 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.29 82.15 6.39 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -59.04 -17.27 23.99 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.624 -0.673 . . . . 0.0 112.463 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.42 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.392 1.077 . . . . 0.0 111.934 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.78 -48.42 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.2 m -58.81 -50.03 75.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.752 0.821 . . . . 0.0 111.349 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 p -59.78 -44.16 94.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.945 0.793 . . . . 0.0 111.385 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.57 -48.24 80.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.784 0.72 . . . . 0.0 110.314 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.71 -47.83 76.87 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.158 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -62.21 -45.53 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -61.63 -38.49 87.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.426 1.466 . . . . 0.0 110.984 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.81 -47.71 68.31 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.792 0.723 . . . . 0.0 111.84 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -80.35 -15.08 57.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.791 0.836 . . . . 0.0 112.009 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.5 t80 57.52 43.28 1.01 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 126.575 1.95 . . . . 0.0 115.519 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -59.42 -26.08 80.73 Favored 'Trans proline' 0 C--N 1.36 1.165 0 CA-C-N 122.322 1.865 . . . . 0.0 112.412 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -143.62 166.34 25.11 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.169 2.187 . . . . 0.0 107.017 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -56.8 -38.36 72.43 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.162 0.985 . . . . 0.0 112.303 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -167.49 174.12 8.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.3 2.24 . . . . 0.0 105.568 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.49 163.55 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.205 . . . . 0.0 107.911 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -140.1 166.83 23.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.718 1.607 . . . . 0.0 108.562 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -147.82 168.57 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.285 -0.885 . . . . 0.0 112.61 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.34 143.63 31.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.419 1.488 . . . . 0.0 107.098 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -81.36 22.45 0.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.488 1.115 . . . . 0.0 112.132 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.21 164.18 33.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.52 1.528 . . . . 0.0 109.398 -171.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.75 172.73 17.32 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.452 1.025 . . . . 0.0 111.084 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.246 0.907 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.732 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.74 162.02 5.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.694 0.798 . . . . 0.0 111.547 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.28 159.72 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 110.794 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.51 167.79 10.21 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -144.61 151.84 39.62 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.674 0.79 . . . . 0.0 108.95 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.72 -32.02 40.78 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.057 1.343 . . . . 0.0 113.595 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.61 58.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.795 0.725 . . . . 0.0 112.304 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.78 -20.18 27.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.175 0.99 . . . . 0.0 111.106 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.7 mt -58.53 133.76 85.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.98 111.19 0.55 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.841 3.028 . . . . 0.0 110.563 171.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.59 -35.73 52.61 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.3 t -137.86 136.47 45.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.9 101.01 2.86 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 pt -144.85 172.48 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.246 2.218 . . . . 0.0 107.184 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -131.88 100.66 5.15 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.239 1.016 . . . . 0.0 109.606 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -60.69 -13.1 12.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.575 1.55 . . . . 0.0 114.178 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.0 -13.8 60.23 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.3 0.955 . . . . 0.0 111.973 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.22 177.27 17.18 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.459 1.028 . . . . 0.0 112.996 -172.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.0 t -138.04 123.93 25.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -169.26 168.67 9.63 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.687 0.795 . . . . 0.0 110.235 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -77.11 160.47 29.0 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 122.059 -0.4 . . . . 0.0 110.149 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.04 167.13 22.79 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.706 1.202 . . . . 0.0 109.168 -174.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.33 155.62 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.4 tp -118.73 117.66 29.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.282 0.0 OUTLIER -128.28 128.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 118.724 0.693 . . . . 0.0 109.736 -173.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -76.72 146.93 37.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.54 1.536 . . . . 0.0 108.279 172.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.2 139.1 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -108.91 143.4 38.19 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.735 1.214 . . . . 0.0 107.882 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 p -67.95 106.03 2.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.581 0.628 . . . . 0.0 110.818 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.481 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.47 17.22 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 116.212 -1.851 . . . . 0.0 115.362 169.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 90.1 Cg_exo -43.94 135.91 7.6 Favored 'Trans proline' 0 C--N 1.362 1.27 0 CA-C-N 124.185 2.53 . . . . 0.0 114.427 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 45.15 27.47 0.32 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.956 2.102 . . . . 0.0 113.576 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.84 31.87 6.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.457 1.503 . . . . 0.0 112.545 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.99 15.88 3.03 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 123.768 0.699 . . . . 0.0 112.974 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.53 148.24 86.68 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 118.178 0.989 . . . . 0.0 110.401 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.47 -11.46 17.23 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.058 2.506 . . . . 0.0 113.954 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.98 -178.95 7.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.855 1.262 . . . . 0.0 109.89 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.8 49.38 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.002 1.721 . . . . 0.0 108.944 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -75.36 173.17 11.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.437 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -144.57 155.65 43.76 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.388 0.675 . . . . 0.0 110.691 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.67 166.54 33.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.696 1.598 . . . . 0.0 108.963 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.64 155.6 19.97 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -174.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.41 155.28 41.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.398 1.079 . . . . 0.0 108.836 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.07 121.5 67.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -131.52 148.83 52.66 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.879 1.271 . . . . 0.0 107.799 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.25 131.7 1.8 Allowed Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -154.54 152.84 30.54 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.41 -31.75 71.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.134 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -64.86 -25.85 68.08 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.53 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.38 88.21 7.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 119.632 1.105 . . . . 0.0 109.028 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.0 -5.5 22.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 0.0 112.187 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.59 147.93 28.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.588 1.555 . . . . 0.0 108.319 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -60.67 -34.25 74.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 111.437 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.5 -27.54 67.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 118.627 -0.701 . . . . 0.0 112.215 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.65 -49.14 61.5 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.243 0.929 . . . . 0.0 110.603 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -40.28 85.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.32 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -61.25 -49.84 75.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.095 0.861 . . . . 0.0 109.617 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.87 -46.37 89.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.393 0.997 . . . . 0.0 111.101 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -58.26 -52.62 64.8 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.566 0.747 . . . . 0.0 110.837 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.41 -34.37 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.457 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -59.48 -38.41 80.77 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.01 1.277 . . . . 0.0 109.245 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.89 87.34 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.821 0.737 . . . . 0.0 111.553 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.73 -45.31 90.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.257 1.029 . . . . 0.0 111.38 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -60.19 -44.65 94.93 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.862 -0.524 . . . . 0.0 110.795 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -65.65 -32.78 74.54 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.237 -0.915 . . . . 0.0 111.543 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -64.23 -39.1 93.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.464 171.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.26 -42.47 95.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.634 1.106 . . . . 0.0 109.262 169.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.41 -4.66 2.29 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.307 1.908 . . . . 0.0 112.939 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.9 m -69.11 178.46 2.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.484 1.513 . . . . 0.0 112.982 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -129.3 146.78 51.13 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.4 m -148.9 165.67 30.86 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -168.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -155.69 129.4 8.49 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.571 1.148 . . . . 0.0 109.585 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.75 115.66 10.16 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.0 mt -73.09 -25.2 60.79 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.179 0.591 . . . . 0.0 111.019 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.66 179.79 43.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.67 173.59 21.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.58 -158.9 24.52 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -136.02 153.09 51.47 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.118 1.367 . . . . 0.0 109.635 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mt -115.48 126.25 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.5 m -153.02 162.58 41.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.686 0.795 . . . . 0.0 108.867 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -71.89 142.72 49.52 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -74.15 -14.28 60.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.414 0.686 . . . . 0.0 110.589 169.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m 63.28 4.1 1.56 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.021 2.128 . . . . 0.0 114.782 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -77.19 -43.0 35.36 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.795 0.725 . . . . 0.0 109.334 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -157.53 45.17 0.36 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.87 1.268 . . . . 0.0 109.732 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt 63.82 -16.3 0.07 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.289 2.236 . . . . 0.0 115.393 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -45.66 124.96 5.5 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.444 1.898 . . . . 0.0 110.74 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.2 mm -65.83 152.92 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 122.026 0.917 . . . . 0.0 109.321 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -139.63 150.96 45.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.991 2.116 . . . . 0.0 107.39 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -132.45 120.28 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -172.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -158.87 179.54 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.45 -163.33 15.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.459 1.027 . . . . 0.0 113.218 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -153.63 164.51 38.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.071 2.148 . . . . 0.0 107.251 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 t -135.55 127.45 29.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.8 tpp -62.84 -30.51 71.55 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.85 -35.93 32.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.404 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -131.24 -1.21 4.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.51 177.27 43.81 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 119.162 0.892 . . . . 0.0 111.686 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.01 138.09 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.472 2.115 . . . . 0.0 109.326 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.79 160.9 30.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.344 0.592 . . . . 0.0 110.813 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -82.05 78.0 8.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -54.61 -21.67 11.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.23 0.612 . . . . 0.0 112.403 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.89 65.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.15 1.38 . . . . 0.0 112.861 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.15 -47.71 92.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -61.38 -49.36 77.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.017 0.927 . . . . 0.0 111.201 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 p -59.29 -40.29 85.68 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.958 0.799 . . . . 0.0 111.783 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.63 -47.2 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.569 1.077 . . . . 0.0 110.375 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.75 -44.84 88.82 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.944 -0.472 . . . . 0.0 111.303 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.07 -47.44 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.38 -34.47 73.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.336 1.426 . . . . 0.0 111.569 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.83 89.22 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.522 1.056 . . . . 0.0 111.777 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -84.25 -16.07 44.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 49.27 47.06 4.32 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -59.43 -23.59 71.12 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 122.198 1.821 . . . . 0.0 111.417 168.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -138.41 162.65 33.91 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.996 2.118 . . . . 0.0 106.253 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -59.79 -38.77 82.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.877 0.871 . . . . 0.0 111.556 -173.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.88 166.26 34.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.569 1.948 . . . . 0.0 105.778 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 m -141.4 166.01 18.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.436 1.094 . . . . 0.0 109.164 169.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 p -134.13 171.47 14.18 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.943 1.297 . . . . 0.0 108.968 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -142.01 171.55 13.9 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.836 -0.54 . . . . 0.0 111.983 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.09 143.74 31.96 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.768 1.227 . . . . 0.0 107.716 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -85.21 25.59 0.97 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.627 1.171 . . . . 0.0 111.757 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -156.92 -179.83 8.59 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.88 1.272 . . . . 0.0 108.556 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 134.75 -178.29 18.6 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.227 1.87 . . . . 0.0 110.893 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.6 p90 . . . . . 0 C--O 1.247 0.97 0 C-N-CA 126.628 1.971 . . . . 0.0 106.54 169.927 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.54 155.94 36.32 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.92 0.488 . . . . 0.0 109.967 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.36 149.62 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.828 -0.545 . . . . 0.0 109.748 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.46 175.99 8.67 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -149.32 153.4 37.42 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.084 0.953 . . . . 0.0 108.923 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.16 -27.58 62.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.787 0.835 . . . . 0.0 113.146 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.76 67.05 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.182 0.901 . . . . 0.0 112.61 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -77.6 -19.75 55.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.33 0.652 . . . . 0.0 111.649 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.88 139.88 97.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.03 110.59 1.19 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.917 2.412 . . . . 0.0 108.932 170.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.72 -33.36 64.33 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.986 0.914 . . . . 0.0 113.395 -169.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.9 t -136.81 133.4 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -157.85 110.55 2.4 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 170.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt -144.68 169.98 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.109 0.963 . . . . 0.0 110.194 -171.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -133.31 158.23 43.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.296 1.838 . . . . 0.0 106.445 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.8 m -153.73 15.14 0.49 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.232 1.413 . . . . 0.0 111.346 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.89 -21.69 31.51 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.024 0.93 . . . . 0.0 112.944 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -149.91 -177.88 24.34 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.185 1.85 . . . . 0.0 108.959 171.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.18 115.16 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -133.6 158.96 41.88 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.392 1.077 . . . . 0.0 108.959 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -78.81 163.4 25.37 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.886 -0.509 . . . . 0.0 110.129 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.34 166.67 24.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.559 1.143 . . . . 0.0 108.586 173.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.48 155.84 13.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.7 tp -118.44 116.65 27.13 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.28 0.0 OUTLIER -125.46 128.47 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-N 118.474 0.579 . . . . 0.0 109.671 -172.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -78.35 148.48 33.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.287 1.435 . . . . 0.0 108.415 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.2 139.37 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -108.67 146.66 33.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.387 1.475 . . . . 0.0 108.82 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -68.63 88.77 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.011 0.925 . . . . 0.0 112.457 -173.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -139.81 16.34 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 116.433 -1.746 . . . . 0.0 113.743 168.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 53.1 Cg_exo -47.85 143.45 13.17 Favored 'Trans proline' 0 C--N 1.362 1.258 0 CA-C-N 123.939 2.443 . . . . 0.0 113.33 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 41.26 31.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.636 2.374 . . . . 0.0 113.301 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.9 m 52.33 28.69 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.178 1.791 . . . . 0.0 113.374 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.37 19.58 0.12 Allowed Glycine 0 C--N 1.341 0.857 0 CA-C-O 118.709 -1.05 . . . . 0.0 114.648 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.27 146.27 16.68 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 118.73 1.265 . . . . 0.0 110.57 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.45 4.21 4.65 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.858 3.039 . . . . 0.0 115.921 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.2 -177.87 6.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.331 1.052 . . . . 0.0 110.087 -172.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.91 38.21 4.06 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.621 1.568 . . . . 0.0 109.756 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -67.53 165.72 16.27 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -140.55 155.94 46.46 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.014 0.926 . . . . 0.0 108.986 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.24 166.55 32.21 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.192 1.397 . . . . 0.0 108.694 176.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -108.4 156.28 19.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.7 pt -130.82 154.67 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.463 1.105 . . . . 0.0 108.826 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.79 119.85 63.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -132.07 147.61 52.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.231 1.412 . . . . 0.0 108.447 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.36 126.29 0.93 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -151.16 162.1 41.51 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.475 0.71 . . . . 0.0 109.842 -172.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -55.28 -43.38 74.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.833 0.853 . . . . 0.0 112.113 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -66.94 -27.32 67.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.457 -173.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.59 86.54 7.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.339 0.972 . . . . 0.0 108.516 172.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.42 -14.31 55.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.841 0.456 . . . . 0.0 111.664 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 144.5 33.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.03 1.732 . . . . 0.0 108.836 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.52 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 6.1 m-70 -58.14 -32.99 68.69 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.872 1.669 . . . . 0.0 112.079 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.39 -29.03 70.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.61 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.64 -49.23 63.97 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.76 0.709 . . . . 0.0 110.539 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -40.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.331 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.527 0.603 . . . . 0.0 110.017 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.08 -46.89 76.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.662 0.664 . . . . 0.0 111.507 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.99 -56.16 18.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.582 1.153 . . . . 0.0 110.002 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.2 t -78.47 -35.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 117.797 -1.097 . . . . 0.0 110.456 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.4 m -62.36 -31.65 72.33 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 120.314 1.415 . . . . 0.0 110.939 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.63 -47.97 87.25 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.176 0.898 . . . . 0.0 110.974 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.04 -46.28 85.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.074 0.937 . . . . 0.0 111.028 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.5 mmt -59.56 -42.83 93.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.525 0.602 . . . . 0.0 110.882 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -67.86 -32.57 73.17 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.91 -1.119 . . . . 0.0 111.339 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -64.17 -40.56 96.38 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.032 0.833 . . . . 0.0 110.143 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -62.35 -33.28 74.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.316 0.962 . . . . 0.0 110.619 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.99 -6.9 4.42 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.444 1.973 . . . . 0.0 113.164 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.1 m -70.64 -179.72 2.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.272 1.829 . . . . 0.0 114.446 -169.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -130.09 151.09 51.0 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.2 165.01 31.34 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.79 129.65 9.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.678 1.191 . . . . 0.0 109.443 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.7 113.48 8.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.6 mt -68.06 -29.74 68.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.912 -0.492 . . . . 0.0 110.129 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.01 -173.46 45.15 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.84 -177.1 24.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.95 -155.75 16.25 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -136.41 167.37 21.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.904 0.852 . . . . 0.0 110.752 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 mt -136.36 142.57 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.694 1.998 . . . . 0.0 107.273 -169.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.7 m -149.52 162.51 40.01 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 109.142 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -101.67 127.02 48.6 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -76.01 171.57 14.23 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.121 0.968 . . . . 0.0 110.673 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 m -125.84 -28.44 3.22 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.126 0.971 . . . . 0.0 111.313 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -61.53 -27.86 68.9 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.731 0.812 . . . . 0.0 111.716 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -145.98 152.37 39.28 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 169.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -91.24 62.16 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.334 -0.854 . . . . 0.0 109.882 -169.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -147.45 170.75 16.72 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.559 0.744 . . . . 0.0 111.677 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.8 mm -80.38 166.92 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.581 0.753 . . . . 0.0 109.206 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -143.54 149.33 37.29 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.881 1.272 . . . . 0.0 107.988 169.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.22 121.96 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -159.74 -175.19 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.324 -0.86 . . . . 0.0 111.169 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.05 30.85 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.837 0.687 . . . . 0.0 112.834 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -137.78 143.11 40.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 t -65.45 146.56 54.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.5 ptp -72.87 -12.86 61.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.283 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.74 -14.76 3.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.194 0.998 . . . . 0.0 113.388 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -134.79 -177.29 4.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.2 1.8 . . . . 0.0 108.443 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.67 173.39 44.27 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 170.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.94 139.32 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.094 1.862 . . . . 0.0 108.457 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 164.67 25.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.606 0.717 . . . . 0.0 111.081 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.37 74.03 7.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -56.37 -20.52 19.68 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.47 60.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.035 0.934 . . . . 0.0 111.618 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.87 -43.95 99.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.408 1.083 . . . . 0.0 109.284 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -59.43 -50.78 72.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.416 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -57.02 -44.32 82.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.48 0.582 . . . . 0.0 111.304 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.69 -50.61 71.78 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.809 0.731 . . . . 0.0 110.505 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.98 -43.13 72.11 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.899 -0.501 . . . . 0.0 111.361 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.45 -46.76 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.93 -32.79 74.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.283 1.402 . . . . 0.0 111.379 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.32 94.97 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.405 1.002 . . . . 0.0 111.537 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -86.88 -20.0 28.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 41.97 57.88 10.05 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.646 1.578 . . . . 0.0 113.307 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.93 -15.8 32.69 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.01 1.807 . . . . 0.0 110.813 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -144.78 177.83 8.43 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.584 2.354 . . . . 0.0 106.7 170.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -64.04 -46.45 84.39 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.41 1.084 . . . . 0.0 111.838 -171.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' HG2' ' H ' ' A' ' 118' ' ' VAL . 26.7 tt0 -161.48 177.75 9.77 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.447 ' H ' ' HG2' ' A' ' 117' ' ' GLU . 7.1 p -158.06 162.36 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.593 1.557 . . . . 0.0 107.329 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -143.4 173.9 11.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 107.661 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.71 166.77 23.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.582 0.628 . . . . 0.0 111.068 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.16 143.5 26.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -87.26 27.59 1.04 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.97 1.308 . . . . 0.0 111.733 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -146.98 -165.08 2.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.661 1.584 . . . . 0.0 107.986 -170.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.11 -20.13 27.15 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.871 1.224 . . . . 0.0 113.479 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 127.688 2.395 . . . . 0.0 110.849 176.53 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.87 164.76 35.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 108.676 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.92 163.86 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.779 0.832 . . . . 0.0 110.687 174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.13 177.71 1.34 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.389 0.614 . . . . 0.0 109.996 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -146.36 155.19 42.43 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.9 mt -52.35 -34.67 48.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.833 0.853 . . . . 0.0 112.942 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.19 62.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.671 0.669 . . . . 0.0 112.236 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.15 -19.76 28.0 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.099 0.959 . . . . 0.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.1 mt -59.28 128.82 86.06 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 172.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.57 138.16 58.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.164 2.576 . . . . 0.0 111.035 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -86.56 -41.78 14.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.071 0.396 . . . . 0.0 111.55 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.78 140.56 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 124.721 1.208 . . . . 0.0 107.9 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -157.14 114.19 3.06 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt -142.38 159.66 19.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.258 1.023 . . . . 0.0 108.837 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -61.89 126.42 27.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 169.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 m -66.91 -30.0 70.03 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -169.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -159.27 127.43 5.04 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.193 0.997 . . . . 0.0 108.762 -170.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.42 -158.22 27.57 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 121.651 0.584 . . . . 0.0 112.32 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.0 t -129.2 112.06 24.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -158.69 172.48 18.19 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.378 1.071 . . . . 0.0 109.845 -173.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -113.38 152.36 30.1 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.694 0.797 . . . . 0.0 109.287 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.515 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -140.27 168.7 19.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.671 0.788 . . . . 0.0 109.085 -170.12 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.26 152.92 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.457 1.503 . . . . 0.0 108.811 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -114.75 114.81 26.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.47 133.94 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.819 0.736 . . . . 0.0 109.329 -175.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -81.38 147.39 29.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.21 143.3 34.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -114.52 146.83 40.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.331 1.452 . . . . 0.0 109.24 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 m -62.68 103.51 0.43 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.288 0.635 . . . . 0.0 111.526 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.84 18.55 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 116.076 -1.916 . . . . 0.0 114.791 169.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.499 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 32.7 Cg_exo -40.37 127.79 2.28 Favored 'Trans proline' 0 C--N 1.361 1.224 0 CA-C-N 124.216 2.541 . . . . 0.0 115.093 173.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 31.91 39.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.492 3.117 . . . . 0.0 113.926 -170.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 53.11 31.44 11.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.385 1.474 . . . . 0.0 112.961 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.97 17.39 3.42 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.226 0.917 . . . . 0.0 112.748 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.25 147.88 90.37 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.99 0.895 . . . . 0.0 110.725 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.94 -9.15 15.61 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.28 2.653 . . . . 0.0 113.822 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.07 -173.46 4.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.064 1.345 . . . . 0.0 109.712 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.2 52.87 1.96 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.156 1.782 . . . . 0.0 108.684 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' C ' ' HG ' ' A' ' 40' ' ' SER . 51.6 mm-40 -78.14 -176.35 4.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 172.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.414 ' HG ' ' C ' ' A' ' 39' ' ' GLU . 13.5 m -151.89 159.31 43.87 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 173.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 167.24 28.08 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.006 1.722 . . . . 0.0 108.282 174.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -108.2 157.51 18.25 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.9 pt -137.88 155.33 30.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.283 1.433 . . . . 0.0 108.58 174.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.6 t -119.03 123.77 72.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -135.96 149.26 48.83 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.311 1.044 . . . . 0.0 108.282 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.49 135.85 2.42 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 18.8 m-85 -153.92 155.29 35.39 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -60.14 -34.17 73.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.656 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.0 p-90 -64.28 -28.69 69.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.395 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 77.78 9.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.363 0.983 . . . . 0.0 108.799 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.07 -9.61 17.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.45 140.67 35.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.222 1.409 . . . . 0.0 107.456 174.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.483 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.8 m-70 -62.85 -29.86 71.07 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 111.428 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.77 67.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.942 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.4 -48.11 71.14 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.766 0.712 . . . . 0.0 110.501 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.16 -40.74 83.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 117.411 -1.28 . . . . 0.0 109.997 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.3 -46.7 85.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 120.608 1.549 . . . . 0.0 110.251 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.77 -49.17 69.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.239 0.472 . . . . 0.0 111.568 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -60.52 -49.3 78.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.349 0.66 . . . . 0.0 110.836 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.44 -44.42 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.056 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.71 -28.92 70.28 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.686 1.13 . . . . 0.0 111.092 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -49.28 72.28 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.365 0.984 . . . . 0.0 110.717 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.11 -46.88 85.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.127 0.963 . . . . 0.0 110.626 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.7 mmt -57.98 -43.41 86.5 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.836 -0.54 . . . . 0.0 111.198 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -68.59 -31.28 70.36 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.862 -1.149 . . . . 0.0 112.248 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.36 -42.47 98.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.489 1.041 . . . . 0.0 109.662 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -62.54 -30.59 71.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.703 0.683 . . . . 0.0 110.55 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.27 -8.55 5.96 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.05 2.262 . . . . 0.0 112.972 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.38 179.96 2.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.547 1.939 . . . . 0.0 113.185 -169.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.14 150.92 52.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.1 m -149.07 165.24 32.32 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.31 128.34 10.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 108.325 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.98 116.17 7.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.6 -28.37 64.8 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.008 -0.432 . . . . 0.0 109.993 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.56 -163.94 36.52 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.45 -164.33 22.93 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.35 -163.59 29.56 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.48 157.62 31.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -131.14 127.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.8 m -152.4 104.95 2.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -162.72 178.98 8.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.794 0.438 . . . . 0.0 110.082 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -118.27 88.27 2.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 170.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.82 -27.85 63.54 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.442 1.097 . . . . 0.0 110.531 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -54.02 -30.45 47.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.252 1.021 . . . . 0.0 112.033 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -86.98 -74.85 0.42 Allowed 'General case' 0 C--N 1.34 0.196 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.33 147.95 17.96 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.713 1.605 . . . . 0.0 107.71 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.0 pttt 47.13 -179.31 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.811 2.844 . . . . 0.0 116.432 170.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.07 171.02 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 171.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -140.53 139.56 35.07 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -119.47 130.03 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -161.96 -179.53 7.22 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.155 -0.966 . . . . 0.0 110.828 -170.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -157.93 53.15 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -144.79 153.85 42.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.62 1.568 . . . . 0.0 107.647 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.1 p -70.78 133.9 46.94 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.6 mmt -73.86 32.45 0.08 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.09 1.356 . . . . 0.0 111.108 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.3 -39.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.611 1.565 . . . . 0.0 111.572 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -134.63 2.86 3.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 -175.76 53.62 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.086 0.857 . . . . 0.0 112.181 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.61 135.62 24.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.526 2.15 . . . . 0.0 110.642 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.79 172.43 12.68 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.458 0.647 . . . . 0.0 110.011 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -77.19 79.64 3.71 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.515 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 39.8 m80 -58.82 -17.77 26.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -174.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.46 82.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.204 0.602 . . . . 0.0 110.378 169.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mm -62.97 -49.7 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.8 m -57.79 -49.75 75.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.119 0.568 . . . . 0.0 109.716 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -65.82 -42.86 90.09 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.514 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.32 -46.4 86.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.2 1.364 . . . . 0.0 110.596 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -69.7 -42.79 73.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.054 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.45 -44.64 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.035 0.834 . . . . 0.0 108.944 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.79 -41.06 99.09 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.016 1.28 . . . . 0.0 111.303 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.65 75.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.624 0.647 . . . . 0.0 111.294 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -73.2 -29.27 62.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.015 0.526 . . . . 0.0 111.193 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 t80 49.73 63.25 10.52 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.127 2.171 . . . . 0.0 111.764 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.01 -24.99 52.05 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.198 2.599 . . . . 0.0 113.0 -174.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -154.14 -47.67 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.258 0.623 . . . . 0.0 111.681 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -159.17 -174.77 4.88 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.023 0.929 . . . . 0.0 109.732 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.82 168.22 0.66 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.173 1.789 . . . . 0.0 111.01 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.28 168.26 10.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.701 1.2 . . . . 0.0 110.784 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.6 p -138.7 171.15 14.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.364 1.466 . . . . 0.0 108.312 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -144.98 171.13 14.89 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.529 -0.732 . . . . 0.0 110.893 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.85 143.43 30.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 169.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -84.73 37.34 0.64 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.382 1.073 . . . . 0.0 111.639 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -155.43 176.9 11.99 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.696 1.198 . . . . 0.0 108.647 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 136.58 165.56 10.56 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.252 1.882 . . . . 0.0 110.975 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 C--O 1.247 0.937 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 175.409 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.25 161.25 40.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.986 1.315 . . . . 0.0 108.066 171.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -157.92 168.0 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.511 1.525 . . . . 0.0 107.234 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.14 -173.97 4.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.301 1.441 . . . . 0.0 107.941 173.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -144.53 154.52 42.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.427 1.091 . . . . 0.0 108.205 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.4 mt -50.62 -35.44 30.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.299 1.04 . . . . 0.0 112.84 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.93 -23.96 66.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.673 0.669 . . . . 0.0 112.479 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.65 -19.65 37.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.61 0.764 . . . . 0.0 111.212 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.92 131.65 94.67 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.52 111.78 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.301 2.667 . . . . 0.0 109.96 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.403 ' CG ' ' HZ3' ' A' ' 108' ' ' LYS . 23.5 t70 -73.5 -35.77 65.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -169.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.81 135.72 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -154.47 108.42 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.7 pt -143.68 160.06 16.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.128 0.971 . . . . 0.0 110.231 -170.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -70.37 160.52 32.14 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 168.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -150.25 35.01 0.65 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.176 -1.577 . . . . 0.0 110.291 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.76 -14.48 2.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.235 1.014 . . . . 0.0 112.998 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.83 -171.24 22.06 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.11 0.868 . . . . 0.0 112.41 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.1 t -76.05 137.88 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 169.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -160.82 170.9 19.76 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.622 1.169 . . . . 0.0 109.13 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -107.12 151.46 25.35 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.75 169.18 17.96 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 109.179 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.63 152.87 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.107 1.363 . . . . 0.0 108.156 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -116.24 116.9 28.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.86 132.6 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.008 0.822 . . . . 0.0 109.615 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -77.85 147.98 34.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.31 140.42 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -112.05 146.81 37.27 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.618 1.167 . . . . 0.0 109.166 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 m -66.2 101.77 0.75 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.751 0.82 . . . . 0.0 109.598 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.519 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.67 16.27 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 115.839 -2.029 . . . . 0.0 115.004 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.519 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 63.6 Cg_exo -43.31 132.03 6.7 Favored 'Trans proline' 0 C--N 1.363 1.309 0 CA-C-N 124.258 2.557 . . . . 0.0 115.087 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 37.97 33.02 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.88 2.872 . . . . 0.0 114.049 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m 52.46 31.15 9.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.205 1.402 . . . . 0.0 112.846 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.96 13.47 3.35 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.129 0.871 . . . . 0.0 112.877 -176.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.65 149.08 85.55 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 117.935 0.868 . . . . 0.0 111.094 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.14 -8.53 15.33 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.294 2.663 . . . . 0.0 114.179 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.41 -176.79 5.85 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.761 1.224 . . . . 0.0 110.103 -169.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.68 37.28 3.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.867 1.667 . . . . 0.0 110.181 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -69.45 168.09 15.25 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.3 m -139.42 158.9 43.34 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.068 0.947 . . . . 0.0 110.526 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.52 165.67 35.89 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.696 1.598 . . . . 0.0 109.529 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.16 155.11 20.8 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.9 157.78 41.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.949 1.7 . . . . 0.0 109.052 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.72 117.53 51.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -137.78 150.4 47.19 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.53 138.27 2.68 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.1 m-85 -153.52 155.91 37.09 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -170.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.6 -33.88 72.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.402 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -65.7 -25.83 67.49 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.73 0.696 . . . . 0.0 112.536 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.42 82.06 8.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.677 1.126 . . . . 0.0 108.589 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -12.7 39.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.875 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.41 145.22 32.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.022 1.729 . . . . 0.0 108.381 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.44 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 15.2 m-70 -62.91 -31.27 72.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.384 1.074 . . . . 0.0 111.847 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -29.37 69.45 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.938 -0.477 . . . . 0.0 111.429 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.22 -45.44 84.69 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.48 0.582 . . . . 0.0 110.581 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -37.46 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.592 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.03 -45.96 86.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.483 1.492 . . . . 0.0 109.419 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.03 -48.34 71.43 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.763 0.425 . . . . 0.0 111.878 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -55.62 -54.97 37.5 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.683 0.793 . . . . 0.0 109.85 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.35 -43.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.022 -0.99 . . . . 0.0 108.664 -171.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.3 m -62.08 -29.03 70.03 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.008 1.276 . . . . 0.0 111.519 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.46 -51.09 55.33 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.43 1.014 . . . . 0.0 110.622 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.54 -44.89 92.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.972 0.886 . . . . 0.0 110.813 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -56.65 -45.72 81.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.294 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -70.33 -30.47 67.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.962 1.256 . . . . 0.0 112.327 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.18 -43.55 98.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.329 0.968 . . . . 0.0 109.694 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.44 -36.38 83.57 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.312 0.505 . . . . 0.0 110.368 171.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.32 -6.44 4.99 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.173 2.321 . . . . 0.0 113.281 170.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.6 171.88 9.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.724 1.61 . . . . 0.0 112.044 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -127.99 149.14 50.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -148.33 165.0 32.36 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -147.07 125.05 12.01 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.033 1.333 . . . . 0.0 108.263 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -67.73 111.59 4.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.9 mt -72.64 -24.61 61.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.934 -0.479 . . . . 0.0 110.62 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.34 -170.03 42.69 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.41 -174.01 28.6 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 171.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.0 -166.42 32.79 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -117.05 150.52 38.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.9 mt -118.97 136.69 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 m -156.05 165.16 37.27 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.608 0.763 . . . . 0.0 109.346 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -129.31 29.57 5.1 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.634 1.174 . . . . 0.0 108.581 169.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.64 -17.41 64.02 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.256 -0.902 . . . . 0.0 111.308 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 m -59.37 -24.95 63.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.971 1.708 . . . . 0.0 112.456 169.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 47.17 63.09 2.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.221 1.809 . . . . 0.0 110.575 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -115.18 -118.07 0.32 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.49 1.916 . . . . 0.0 106.232 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -136.73 11.21 3.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.062 1.301 . . . . 0.0 111.63 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -156.08 144.81 20.26 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.666 1.121 . . . . 0.0 111.329 -169.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 pt -64.11 161.05 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.727 0.775 . . . . 0.0 109.616 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -140.8 153.4 45.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.994 1.717 . . . . 0.0 107.557 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -121.71 126.64 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -166.07 1.51 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.611 -0.681 . . . . 0.0 110.509 -177.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.26 -160.9 53.44 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.84 -0.537 . . . . 0.0 111.804 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -154.04 155.13 34.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.366 1.467 . . . . 0.0 108.082 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.0 p -81.91 134.43 35.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -64.94 -29.26 70.18 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.835 -0.541 . . . . 0.0 110.647 170.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 -37.93 48.82 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.865 0.866 . . . . 0.0 112.756 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.32 1.38 3.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.61 -177.88 52.5 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 118.942 0.792 . . . . 0.0 111.921 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.67 134.44 28.19 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.641 2.228 . . . . 0.0 110.357 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 170.13 16.63 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.342 0.591 . . . . 0.0 110.225 169.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.03 79.05 3.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -58.89 -18.03 29.47 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.97 -39.19 74.14 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.668 0.787 . . . . 0.0 111.119 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.7 mm -61.8 -48.33 89.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -54.48 -52.03 63.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.735 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 p -60.46 -42.49 96.3 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.781 0.719 . . . . 0.0 111.822 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -60.94 -51.3 69.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.318 0.963 . . . . 0.0 110.825 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HZ3' ' CG ' ' A' ' 11' ' ' ASP . 18.0 mmtp -71.08 -43.83 66.95 Favored 'General case' 0 C--N 1.334 -0.109 0 C-N-CA 123.35 0.66 . . . . 0.0 111.121 -174.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.75 -43.26 97.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -63.02 -37.01 85.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 120.877 1.672 . . . . 0.0 111.228 176.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.6 93.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.098 0.863 . . . . 0.0 111.851 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -79.56 -20.06 47.93 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.24 0.616 . . . . 0.0 112.034 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.306 39.2 p90 41.94 54.25 8.47 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.918 2.487 . . . . 0.0 115.969 -171.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -58.69 -28.56 86.81 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.361 2.04 . . . . 0.0 110.817 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -131.08 156.76 44.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.88 2.472 . . . . 0.0 105.224 169.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -61.69 -32.59 72.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.037 0.935 . . . . 0.0 112.84 -169.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -157.7 163.91 37.69 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.847 2.059 . . . . 0.0 105.688 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.99 163.63 10.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.127 1.371 . . . . 0.0 107.752 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 p -137.39 171.84 13.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.744 1.218 . . . . 0.0 108.731 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -141.72 159.25 42.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.146 0.578 . . . . 0.0 110.173 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.75 125.79 10.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -63.7 -25.6 68.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.687 0.395 . . . . 0.0 111.862 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.39 -31.82 73.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.492 1.117 . . . . 0.0 112.967 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.96 151.96 46.5 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.2 p90 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.615 1.566 . . . . 0.0 109.178 -177.012 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.7 149.49 50.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.941 0.497 . . . . 0.0 110.081 175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.0 t -126.4 120.52 56.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.79 178.46 2.6 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.638 0.732 . . . . 0.0 110.467 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -149.65 157.02 42.85 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.54 -28.1 65.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.951 0.796 . . . . 0.0 112.706 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.68 66.53 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.829 1.195 . . . . 0.0 112.143 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.31 -31.07 17.09 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.633 1.173 . . . . 0.0 111.633 -175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.91 122.91 65.93 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.27 137.71 64.0 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.087 2.524 . . . . 0.0 111.141 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.63 -38.65 23.25 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 122.032 -0.417 . . . . 0.0 110.953 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.7 t -137.95 137.58 44.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -172.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -156.47 113.24 3.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.42 151.66 16.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.294 1.038 . . . . 0.0 108.669 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -154.08 112.21 3.56 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.809 0.844 . . . . 0.0 109.29 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.1 m -158.3 158.81 35.1 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.354 1.062 . . . . 0.0 109.69 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -150.4 158.54 44.27 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.621 1.968 . . . . 0.0 106.619 171.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.55 -106.89 1.88 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -170.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -146.26 132.16 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -152.37 171.37 18.13 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.412 1.485 . . . . 0.0 109.804 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.39 163.24 12.96 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.804 0.842 . . . . 0.0 111.692 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.99 171.86 14.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.98 154.9 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.354 1.462 . . . . 0.0 108.477 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.2 tp -118.28 120.75 38.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.18 132.1 71.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 119.242 0.928 . . . . 0.0 109.411 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -76.08 146.22 39.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.9 121.16 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -90.45 149.26 22.3 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.734 0.814 . . . . 0.0 108.968 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -66.09 96.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.078 0.951 . . . . 0.0 109.911 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.25 19.3 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 116.254 -1.832 . . . . 0.0 115.229 169.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -39.36 132.52 1.49 Allowed 'Trans proline' 0 C--N 1.361 1.191 0 CA-C-N 123.927 2.438 . . . . 0.0 114.545 170.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 43.35 26.61 0.1 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.454 2.702 . . . . 0.0 114.154 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.68 32.1 8.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 112.358 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.91 19.67 1.25 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.958 0.79 . . . . 0.0 112.923 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.41 151.0 88.55 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 117.925 0.862 . . . . 0.0 110.538 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -79.1 -5.1 14.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.293 2.662 . . . . 0.0 114.473 -171.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.17 -178.14 6.45 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.703 1.201 . . . . 0.0 109.9 -170.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.79 36.34 3.31 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.557 1.543 . . . . 0.0 110.404 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.37 172.96 7.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -137.07 160.81 37.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.761 0.824 . . . . 0.0 110.619 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -139.34 165.11 28.07 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.613 1.565 . . . . 0.0 108.249 172.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.61 138.45 45.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 pt -115.6 155.08 16.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.132 0.973 . . . . 0.0 109.834 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.62 122.65 69.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -136.72 148.17 47.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 125.56 0.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -146.61 151.01 36.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -171.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -53.89 -31.26 49.33 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -74.54 -24.45 58.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.851 0.751 . . . . 0.0 112.951 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 83.4 8.06 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.974 1.261 . . . . 0.0 109.37 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.76 -6.24 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.636 0.775 . . . . 0.0 112.293 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.94 143.9 28.82 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 108.186 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -62.1 -31.38 71.83 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.104 0.962 . . . . 0.0 111.659 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.73 -27.46 69.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.785 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.779 0.718 . . . . 0.0 110.234 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -40.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.109 -1.424 . . . . 0.0 110.342 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.07 -48.61 80.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.868 1.667 . . . . 0.0 109.742 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.32 -47.11 83.6 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.888 0.767 . . . . 0.0 111.542 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -60.89 -50.13 74.65 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.96 0.504 . . . . 0.0 110.77 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.2 -44.69 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.32 -171.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.8 p -62.04 -30.41 70.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.789 1.177 . . . . 0.0 110.398 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.19 54.0 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.16 0.891 . . . . 0.0 111.007 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -64.08 -45.51 88.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.371 1.085 . . . . 0.0 111.169 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.54 -45.04 85.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.625 0.648 . . . . 0.0 111.179 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.42 -31.83 72.29 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.004 -1.06 . . . . 0.0 111.819 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.54 -39.8 95.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.101 0.864 . . . . 0.0 110.417 171.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.35 -33.9 77.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.226 0.921 . . . . 0.0 110.447 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.55 -9.88 4.03 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 126.416 1.96 . . . . 0.0 113.217 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -65.69 173.64 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.923 1.689 . . . . 0.0 112.503 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.14 135.1 49.31 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 169.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.0 m -142.48 164.49 29.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.9 130.43 11.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -66.23 109.24 2.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.2 mt -66.87 -28.16 68.1 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.926 -0.484 . . . . 0.0 110.472 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.02 -168.2 41.35 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.43 -169.15 20.87 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.88 -162.82 28.52 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 -128.88 153.7 47.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -128.86 140.38 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.8 m -126.72 138.66 53.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.259 1.024 . . . . 0.0 108.451 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -134.88 4.48 3.29 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.316 1.847 . . . . 0.0 110.539 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -60.15 -20.41 58.35 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.475 1.034 . . . . 0.0 113.383 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 m -56.65 -31.79 64.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.493 1.117 . . . . 0.0 112.221 169.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 44.93 50.44 8.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.5 2.32 . . . . 0.0 111.306 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -134.95 48.95 2.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.113 1.365 . . . . 0.0 109.9 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? 55.3 28.35 11.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.637 1.575 . . . . 0.0 112.809 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -148.55 159.17 44.33 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.031 -1.043 . . . . 0.0 109.771 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.8 pt -131.44 169.77 21.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.713 1.605 . . . . 0.0 108.344 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -133.36 151.39 51.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.19 126.7 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.45 -177.51 6.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.598 0.759 . . . . 0.0 110.496 -173.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -161.05 53.22 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -150.61 155.64 39.8 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 108.421 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 t -69.61 131.85 45.29 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.6 ttm -62.51 -26.32 68.49 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.521 0.328 . . . . 0.0 110.844 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.24 -30.05 13.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 112.587 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.01 1.66 4.29 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -168.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.74 -176.56 48.54 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.092 0.86 . . . . 0.0 112.279 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.34 131.6 22.18 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.721 2.281 . . . . 0.0 110.663 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.87 170.02 16.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 110.231 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.03 74.14 4.58 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.41 -18.82 19.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 113.399 -175.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.47 -38.82 69.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.424 0.69 . . . . 0.0 111.199 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.65 -43.98 97.95 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.928 0.891 . . . . 0.0 108.828 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -57.0 -50.35 72.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.64 0.655 . . . . 0.0 110.617 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 -48.56 73.92 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.813 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.94 -50.08 72.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.018 0.826 . . . . 0.0 110.878 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -68.33 -46.12 71.08 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.575 0.75 . . . . 0.0 110.671 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.98 -39.24 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.983 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.06 -36.76 82.73 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.158 1.799 . . . . 0.0 111.572 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.99 89.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.963 0.801 . . . . 0.0 110.958 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -70.04 -39.17 75.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.162 0.585 . . . . 0.0 111.289 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 t80 46.44 67.15 4.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.965 2.106 . . . . 0.0 109.592 -168.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.24 -30.84 54.36 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.951 2.434 . . . . 0.0 111.987 -169.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -166.74 -30.65 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 111.298 170.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.54 167.16 22.71 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.249 1.419 . . . . 0.0 112.079 -168.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -77.49 175.0 10.23 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.0 p -149.21 155.03 8.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 120.755 -1.216 . . . . 0.0 108.587 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.9 p -140.97 170.98 14.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.547 1.539 . . . . 0.0 107.785 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -145.61 168.19 21.25 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.661 -0.649 . . . . 0.0 111.425 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.15 142.49 30.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -87.76 45.73 1.31 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.323 1.049 . . . . 0.0 110.018 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -153.51 -177.11 6.14 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.009 1.324 . . . . 0.0 108.948 -170.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.94 173.62 43.94 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.396 1.474 . . . . 0.0 111.529 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.9 p90 . . . . . 0 C--O 1.247 0.928 0 C-N-CA 126.685 1.994 . . . . 0.0 106.246 174.603 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.8 162.0 41.58 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.111 1.364 . . . . 0.0 108.379 175.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 p -155.1 148.59 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.61 176.24 3.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.301 0.572 . . . . 0.0 110.091 172.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -148.07 153.79 39.38 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 mt -53.65 -30.71 44.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 113.468 -178.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.58 -24.8 56.66 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.889 0.768 . . . . 0.0 112.283 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.0 -21.56 29.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.967 0.907 . . . . 0.0 110.954 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.37 129.91 80.41 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.91 112.57 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 172.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.61 -30.09 64.06 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.4 139.09 23.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.977 1.711 . . . . 0.0 106.386 177.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -155.03 109.28 2.94 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt -137.58 157.04 33.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.333 1.053 . . . . 0.0 108.815 -173.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -60.59 141.79 56.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.851 0.358 . . . . 0.0 110.188 172.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m -69.55 -30.71 68.58 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -169.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -170.1 115.92 0.52 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.745 1.157 . . . . 0.0 110.453 -169.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.55 -155.59 26.64 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 177.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -130.38 121.51 51.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 169.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -159.76 162.23 34.84 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.96 0.904 . . . . 0.0 110.045 -170.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -81.24 159.96 24.4 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.544 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -142.46 169.25 17.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.87 155.4 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.019 1.327 . . . . 0.0 108.727 177.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -122.57 111.47 16.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 -175.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.78 134.72 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 118.81 0.732 . . . . 0.0 109.812 -171.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -79.16 147.87 32.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.182 1.393 . . . . 0.0 108.462 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 t -137.05 128.93 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -97.3 150.98 20.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.813 1.245 . . . . 0.0 109.952 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m -66.29 100.36 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.195 176.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.8 19.51 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.171 169.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.51 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 86.6 Cg_exo -46.51 140.31 12.09 Favored 'Trans proline' 0 C--N 1.362 1.277 0 CA-C-N 124.317 2.578 . . . . 0.0 113.879 173.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 42.96 25.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 114.269 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 m 50.33 33.44 7.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.979 1.312 . . . . 0.0 112.226 -174.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.89 28.56 1.28 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.143 0.878 . . . . 0.0 112.165 -172.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.09 151.59 89.72 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 117.503 0.652 . . . . 0.0 110.537 175.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.85 -8.23 16.72 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.228 2.619 . . . . 0.0 113.915 -177.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.6 -175.08 5.2 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.05 1.34 . . . . 0.0 109.769 -170.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.85 37.64 3.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.653 1.581 . . . . 0.0 110.2 174.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -70.09 170.39 11.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -141.8 158.26 44.02 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.993 0.917 . . . . 0.0 110.034 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.07 165.69 34.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.199 1.4 . . . . 0.0 109.142 174.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.26 158.04 17.81 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -175.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 pt -136.62 158.61 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.006 1.323 . . . . 0.0 109.358 175.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 t -123.36 119.16 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -171.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mmt85 -138.25 145.96 41.97 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.45 133.9 1.92 Allowed Glycine 0 C--N 1.332 0.326 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.421 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.6 m-85 -155.64 156.93 35.86 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.378 0.671 . . . . 0.0 109.294 -171.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -32.75 72.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.359 0.664 . . . . 0.0 111.485 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.421 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.5 p-90 -65.98 -29.09 69.42 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 112.207 178.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 81.21 8.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.289 0.949 . . . . 0.0 108.451 171.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -62.16 -15.45 46.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 111.919 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.15 144.76 36.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.891 1.676 . . . . 0.0 108.446 176.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.497 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 7.4 m-70 -59.49 -31.66 69.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.217 1.407 . . . . 0.0 111.895 -175.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.07 69.67 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.664 177.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.1 -47.75 70.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.747 0.703 . . . . 0.0 110.393 -178.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -39.99 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.476 -1.249 . . . . 0.0 110.3 176.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.5 -47.17 86.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.566 1.53 . . . . 0.0 109.786 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.75 -48.51 78.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.604 0.638 . . . . 0.0 111.41 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -60.84 -51.18 70.4 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.62 -44.77 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.33 -173.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -60.52 -37.01 79.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.727 1.149 . . . . 0.0 109.515 176.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.67 84.83 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.877 0.762 . . . . 0.0 111.601 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.04 -47.19 81.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.564 1.182 . . . . 0.0 110.817 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mmt -56.95 -44.34 82.47 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.968 -0.457 . . . . 0.0 111.19 175.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -67.87 -33.36 74.59 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.249 -0.907 . . . . 0.0 111.768 179.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -63.05 -40.98 99.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.059 0.845 . . . . 0.0 110.018 171.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -63.03 -37.83 88.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.032 0.833 . . . . 0.0 110.098 171.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 140.39 -8.93 2.92 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.323 1.916 . . . . 0.0 113.324 169.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.7 m -68.92 175.13 3.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.455 1.502 . . . . 0.0 112.436 -170.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.51 143.24 50.75 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.7 m -144.22 169.64 17.49 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.14 137.92 15.3 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.313 1.045 . . . . 0.0 108.777 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -70.9 112.48 7.11 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 169.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.2 -25.43 63.41 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.132 -0.355 . . . . 0.0 110.335 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.89 -164.23 37.65 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.92 23.09 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.39 -157.1 19.13 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -175.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -129.28 165.73 20.85 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 117.977 0.888 . . . . 0.0 109.594 173.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.4 mt -131.3 137.18 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -169.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.9 m -147.1 136.27 22.51 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.665 0.786 . . . . 0.0 109.886 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -64.8 136.99 57.51 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 168.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -61.34 144.28 54.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.492 0.587 . . . . 0.0 109.429 177.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -63.0 -26.0 68.65 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -169.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -148.67 22.6 1.01 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.889 0.876 . . . . 0.0 111.553 -171.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -149.82 151.77 34.07 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.175 0.99 . . . . 0.0 109.029 -174.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -60.56 -28.24 68.3 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -68.71 173.13 5.46 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.362 1.077 . . . . 0.0 112.686 -169.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -121.0 156.1 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 170.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -129.82 147.52 51.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.27 1.428 . . . . 0.0 108.105 -172.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.08 119.07 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -174.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -159.88 -177.01 6.03 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.208 -0.933 . . . . 0.0 111.144 -169.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.84 -158.49 44.78 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 177.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -143.94 151.91 40.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.603 1.561 . . . . 0.0 107.398 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.6 p -72.84 139.68 47.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.8 mmm -64.51 -6.88 8.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.76 -19.74 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.802 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.57 2.55 2.96 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 112.7 -171.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.2 -176.14 54.82 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.845 0.748 . . . . 0.0 112.332 178.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -72.0 137.04 28.46 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.725 2.283 . . . . 0.0 110.692 -179.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 174.81 10.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.388 0.613 . . . . 0.0 110.306 169.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -79.4 80.84 5.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 168.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.544 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 42.6 m80 -58.37 -16.08 13.15 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -173.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.83 88.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.461 0.704 . . . . 0.0 110.869 171.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.2 mt -60.05 -47.49 91.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 175.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -56.05 -55.72 29.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.515 1.126 . . . . 0.0 110.876 -177.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 p -65.46 -41.08 93.78 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.078 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.57 -44.39 94.21 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.744 1.156 . . . . 0.0 110.23 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -66.09 -43.3 87.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.42 -49.41 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.88 -39.12 84.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.585 1.084 . . . . 0.0 111.239 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.54 78.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.473 0.578 . . . . 0.0 111.48 177.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -76.98 -18.38 58.26 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.9 t80 52.23 52.58 11.42 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 126.088 1.755 . . . . 0.0 113.288 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.31 -16.29 28.0 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.288 1.992 . . . . 0.0 111.286 170.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -150.27 165.31 33.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.061 2.145 . . . . 0.0 107.91 176.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -54.13 -51.69 63.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.669 1.587 . . . . 0.0 112.856 -171.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -163.82 159.55 21.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.5 m -138.06 171.38 15.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.519 0.728 . . . . 0.0 110.791 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.9 p -142.18 166.49 24.55 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.028 1.331 . . . . 0.0 108.636 -174.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -144.18 170.36 16.12 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.691 171.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.22 143.6 28.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 169.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -84.51 34.49 0.53 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.213 1.005 . . . . 0.0 111.601 -174.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -153.58 -179.3 7.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.875 1.67 . . . . 0.0 107.558 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 139.63 -154.51 23.7 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.302 0.953 . . . . 0.0 111.138 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 51.8 p90 . . . . . 0 C--O 1.247 0.925 0 C-N-CA 126.015 1.726 . . . . 0.0 107.906 177.172 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 mt -52.21 -29.91 24.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.55 1.14 . . . . 0.0 113.469 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.71 -27.69 61.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 112.417 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.0 mt -83.25 -24.14 32.41 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 0.0 110.975 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.0 130.25 73.25 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.52 125.69 16.07 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.226 2.618 . . . . 0.0 109.78 171.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.77 -36.23 20.25 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.97 138.52 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -156.0 112.99 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.3 pt . . . . . 0 C--O 1.236 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 109.136 -172.652 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.5 p90 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -101.02 158.24 16.16 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.605 -0.684 . . . . 0.0 109.717 -173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.96 168.6 19.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.88 0.872 . . . . 0.0 109.446 -171.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.5 155.01 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.32 1.448 . . . . 0.0 108.335 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 tp -118.27 114.64 23.29 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 130.9 72.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -77.5 146.11 36.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.31 127.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.57 149.75 22.43 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 109.222 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -65.88 98.3 0.4 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.989 0.916 . . . . 0.0 110.75 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -148.52 18.02 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.281 -1.819 . . . . 0.0 115.123 169.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 55.8 Cg_exo -41.21 134.57 2.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 123.978 2.456 . . . . 0.0 114.5 171.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 47.23 21.54 0.2 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.021 2.528 . . . . 0.0 113.448 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.86 33.45 8.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.28 1.432 . . . . 0.0 112.659 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 113.82 -174.372 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 121.395 0.616 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.59 167.64 12.61 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -141.19 158.87 43.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.848 0.859 . . . . 0.0 110.412 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -151.52 166.08 32.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.845 1.658 . . . . 0.0 108.928 174.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -108.94 153.69 23.2 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 45.0 pt -129.82 155.28 41.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.854 1.262 . . . . 0.0 109.265 173.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.36 123.52 71.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -171.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.605 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.8 mmp_? -136.03 146.58 47.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.625 1.17 . . . . 0.0 108.478 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.13 129.84 1.44 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -150.78 151.92 33.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -60.19 -29.75 68.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.804 0.842 . . . . 0.0 112.479 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 -68.19 -28.03 66.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.33 0.968 . . . . 0.0 112.578 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.62 82.63 8.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.739 1.154 . . . . 0.0 108.913 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.12 -3.94 8.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.321 0.648 . . . . 0.0 112.355 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.33 142.95 26.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.818 1.647 . . . . 0.0 107.982 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.437 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 18.9 m-70 -60.92 -30.74 70.38 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 111.856 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.29 70.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.813 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.66 0.664 . . . . 0.0 110.431 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -41.57 86.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.216 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.93 -46.99 86.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.123 1.329 . . . . 0.0 110.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.88 -49.6 69.87 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.234 0.47 . . . . 0.0 111.331 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -58.84 -49.85 76.19 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.419 0.687 . . . . 0.0 110.839 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.605 HG21 ' HG3' ' A' ' 45' ' ' ARG . 85.1 t -73.47 -41.3 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.155 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m -62.36 -29.8 70.73 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 119.638 1.108 . . . . 0.0 110.895 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.6 -50.03 70.51 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -62.72 -47.77 82.15 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.194 0.997 . . . . 0.0 110.854 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.81 -43.99 90.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.965 -0.459 . . . . 0.0 111.302 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -68.78 -31.62 70.77 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.993 -1.067 . . . . 0.0 111.911 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -61.36 -43.69 98.44 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.421 1.01 . . . . 0.0 109.552 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -60.13 -43.04 95.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.513 1.052 . . . . 0.0 109.546 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.75 -7.17 1.69 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.333 1.92 . . . . 0.0 113.265 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.36 176.58 2.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.204 1.802 . . . . 0.0 113.216 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -130.03 140.51 50.85 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.4 m -146.45 163.34 35.98 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -153.58 128.71 9.69 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -66.75 116.71 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.4 -28.89 65.43 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.792 -0.568 . . . . 0.0 110.078 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.87 -169.37 42.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.1 -168.34 20.27 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.99 -161.22 26.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -121.37 153.53 37.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.445 1.098 . . . . 0.0 108.232 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 mt -125.28 135.04 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 123.526 0.73 . . . . 0.0 109.951 -172.547 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -128.11 122.42 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -173.04 3.96 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.41 -0.806 . . . . 0.0 111.21 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -160.15 53.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.02 153.77 35.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.45 1.1 . . . . 0.0 108.903 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.5 t -69.45 128.33 36.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.8 ttp -64.91 -17.24 64.16 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.355 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.69 -29.66 10.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.715 0.806 . . . . 0.0 112.638 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -127.4 0.08 6.3 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.75 -178.28 50.83 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.853 0.752 . . . . 0.0 112.144 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.1 131.04 19.96 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.635 2.223 . . . . 0.0 110.401 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.5 167.64 20.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.355 0.598 . . . . 0.0 109.557 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.14 77.7 5.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -57.76 -18.87 24.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.11 66.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.705 0.802 . . . . 0.0 111.21 169.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.44 -49.25 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -55.5 -48.32 74.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.001 0.521 . . . . 0.0 111.124 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.9 p -61.78 -44.83 96.11 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.476 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.43 -46.55 89.62 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.277 0.944 . . . . 0.0 110.571 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -62.27 -54.95 33.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.329 1.452 . . . . 0.0 110.684 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.735 0.814 . . . . 0.0 109.186 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -59.73 -40.2 87.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.287 0.949 . . . . 0.0 110.833 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.48 91.14 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.306 0.503 . . . . 0.0 111.201 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -81.71 -14.58 56.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.555 1.144 0 C-N-CA 124.848 1.259 . . . . 0.0 113.228 178.744 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--O 1.239 0.509 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.47 164.7 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.107 0.563 . . . . 0.0 111.184 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.9 p -137.69 172.67 12.61 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 108.758 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -142.73 169.55 17.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.768 0.427 . . . . 0.0 110.417 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 169.535 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.1 mt -55.51 -27.73 50.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.254 1.422 . . . . 0.0 113.524 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.0 -23.19 61.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.777 0.717 . . . . 0.0 112.564 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.52 -21.19 53.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.515 0.598 . . . . 0.0 111.315 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.07 134.97 96.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.278 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.74 106.95 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.27 2.647 . . . . 0.0 108.717 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.42 -33.51 73.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.9 t -142.6 138.2 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -150.64 103.35 3.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 pt . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 127.601 2.36 . . . . 0.0 106.641 177.819 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.05 155.09 17.29 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.931 0.492 . . . . 0.0 109.784 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.63 19.33 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.72 0.808 . . . . 0.0 108.966 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.86 153.59 17.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.767 1.227 . . . . 0.0 108.315 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.08 118.04 32.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.284 0.0 OUTLIER -130.02 130.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 118.373 0.533 . . . . 0.0 109.597 -172.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -80.63 147.33 30.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.792 1.637 . . . . 0.0 108.438 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.91 129.75 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -93.85 155.51 17.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.351 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 m -66.52 85.05 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.267 1.027 . . . . 0.0 111.555 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.512 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.19 13.14 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 116.23 -1.843 . . . . 0.0 114.041 169.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 52.0 Cg_exo -47.13 136.22 18.38 Favored 'Trans proline' 0 C--N 1.362 1.284 0 CA-C-N 124.02 2.472 . . . . 0.0 112.454 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 41.2 31.76 0.16 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.898 2.479 . . . . 0.0 113.847 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 32.0 12.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.897 1.679 . . . . 0.0 113.806 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.586 -175.633 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -69.41 167.89 15.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -142.8 159.34 42.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.722 0.809 . . . . 0.0 109.652 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -149.22 164.43 34.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 109.195 174.17 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 150.37 27.63 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.432 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 37.6 pt -127.68 155.55 39.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.486 1.115 . . . . 0.0 108.872 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 t -122.34 116.46 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -169.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -136.51 147.27 47.01 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.98 138.31 3.71 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -154.16 155.92 36.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -173.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.75 -33.03 72.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.779 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -65.87 -27.04 67.92 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.756 0.707 . . . . 0.0 112.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.51 78.92 9.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.593 1.088 . . . . 0.0 109.117 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.96 -6.9 9.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.697 0.799 . . . . 0.0 112.102 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 142.53 29.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.981 1.713 . . . . 0.0 107.604 174.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.506 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 13.7 m-70 -62.15 -29.66 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.637 1.175 . . . . 0.0 111.663 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -29.18 68.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.034 -0.507 . . . . 0.0 111.757 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.26 -44.67 78.79 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.807 0.73 . . . . 0.0 110.725 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.415 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -70.53 -41.44 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.458 177.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.22 -45.12 94.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.54 1.064 . . . . 0.0 109.044 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.03 -48.11 80.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.163 0.892 . . . . 0.0 111.748 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -55.08 -56.78 15.94 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.974 0.909 . . . . 0.0 109.945 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.46 -43.62 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.599 -169.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 t -60.5 -35.58 76.28 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.075 1.307 . . . . 0.0 109.748 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.84 -48.16 86.78 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.165 0.893 . . . . 0.0 111.324 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.12 -46.66 83.15 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.143 0.972 . . . . 0.0 111.131 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.1 mmt -58.91 -43.77 91.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.694 0.679 . . . . 0.0 110.831 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -66.52 -33.37 75.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.859 -1.15 . . . . 0.0 111.27 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.94 -40.09 95.65 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.971 . . . . 0.0 110.389 169.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -64.59 -20.23 66.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.054 0.843 . . . . 0.0 111.49 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.47 -8.43 11.1 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.581 2.038 . . . . 0.0 112.723 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.24 178.55 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.826 1.65 . . . . 0.0 114.048 -169.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -132.31 145.1 51.03 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -147.57 165.57 29.98 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -168.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -150.51 130.95 13.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.658 1.183 . . . . 0.0 109.382 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -71.88 116.27 12.07 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -74.64 -24.96 58.91 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.97 -0.456 . . . . 0.0 110.418 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.49 -168.32 40.48 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.62 -167.87 22.69 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.31 -163.37 29.65 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.9 ttp-105 -119.49 154.43 33.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mt -113.19 126.98 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--N 1.331 -0.221 0 C-N-CA 123.837 0.855 . . . . 0.0 108.896 -176.025 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.3 t60 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 t -117.03 114.09 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.8 -173.23 4.0 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.637 -0.664 . . . . 0.0 111.945 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.7 -156.56 46.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -145.83 152.72 39.96 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.023 0.929 . . . . 0.0 109.084 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.2 t -69.32 130.46 42.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -64.81 -8.34 14.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.24 -27.71 6.37 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.153 0.981 . . . . 0.0 112.574 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -132.8 2.39 3.7 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.94 -177.27 48.17 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 119.246 0.93 . . . . 0.0 112.554 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 128.68 15.56 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.815 2.343 . . . . 0.0 110.902 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.87 167.24 22.25 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.499 0.666 . . . . 0.0 110.199 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -79.99 83.46 5.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 168.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -59.17 -14.82 11.75 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.37 84.47 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.154 0.982 . . . . 0.0 110.87 169.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.9 mm -62.19 -51.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -56.38 -51.18 69.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.801 0.84 . . . . 0.0 110.976 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 p -63.17 -42.78 99.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.337 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.67 -47.81 82.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.938 1.244 . . . . 0.0 110.74 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.259 0.481 . . . . 0.0 110.827 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.84 -51.17 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.18 -36.34 77.4 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.983 1.265 . . . . 0.0 110.846 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.36 68.33 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.406 0.548 . . . . 0.0 111.552 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -74.94 -19.32 60.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 126.558 1.943 . . . . 0.0 113.639 178.201 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.05 167.78 9.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.895 2.078 . . . . 0.0 107.862 173.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -142.45 170.11 16.31 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.657 1.583 . . . . 0.0 107.048 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -142.27 169.79 16.93 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.216 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.61 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.03 -28.24 64.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.622 0.769 . . . . 0.0 112.879 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.89 61.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.282 0.946 . . . . 0.0 112.363 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.13 -28.57 18.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.47 1.108 . . . . 0.0 110.957 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -55.91 129.09 71.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -50.44 133.24 36.93 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.273 2.649 . . . . 0.0 110.22 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.12 -42.35 9.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 137.09 43.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -156.42 118.18 3.9 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 169.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--O 1.235 0.3 0 C-N-CA 124.114 0.966 . . . . 0.0 109.131 -175.68 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -97.62 160.55 14.25 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.412 -0.805 . . . . 0.0 109.92 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 167.8 21.45 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.13 0.972 . . . . 0.0 108.791 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.12 155.17 15.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.351 1.06 . . . . 0.0 108.767 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -118.36 114.52 23.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -120.58 131.38 72.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.782 0.719 . . . . 0.0 109.231 -175.113 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -76.78 145.08 38.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.44 117.94 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.9 146.09 26.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.8 p -68.45 103.33 1.63 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.297 0.498 . . . . 0.0 109.853 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.455 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.66 25.02 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.655 -1.641 . . . . 0.0 114.753 169.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 49.9 Cg_exo -42.65 135.69 4.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 CA-C-N 123.827 2.402 . . . . 0.0 114.637 172.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 43.05 25.87 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.587 2.355 . . . . 0.0 114.518 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 51.47 33.35 10.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.814 1.245 . . . . 0.0 112.267 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.962 0 C-N-CA 124.339 0.971 . . . . 0.0 112.34 -173.426 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.3 0 CA-C-O 121.683 0.754 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.01 178.08 6.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.843 0.857 . . . . 0.0 109.341 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -141.17 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.532 0.733 . . . . 0.0 110.725 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.07 162.62 32.85 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.84 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.12 136.26 49.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 pt -116.79 155.03 18.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.704 0.802 . . . . 0.0 109.627 172.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.8 123.85 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.0 mmt85 -137.57 148.46 45.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.294 1.038 . . . . 0.0 108.502 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.76 133.15 1.93 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -150.3 156.5 41.65 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -60.1 -35.38 75.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 119.177 -0.439 . . . . 0.0 111.497 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -65.4 -26.38 67.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.4 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.59 80.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.626 1.103 . . . . 0.0 108.428 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.7 -13.32 21.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.777 0.831 . . . . 0.0 111.777 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.24 143.51 31.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.417 1.887 . . . . 0.0 107.683 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -58.48 -30.0 66.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.962 1.305 . . . . 0.0 112.926 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.68 -27.96 69.57 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.593 . . . . 0.0 111.476 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.53 -46.74 78.42 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.313 0.506 . . . . 0.0 110.63 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -40.83 80.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.473 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -59.66 -47.62 84.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.791 1.632 . . . . 0.0 109.741 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.82 -47.65 82.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.794 0.724 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -61.24 -50.07 74.56 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.151 0.58 . . . . 0.0 110.845 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 45' ' ' ARG . 66.9 t -74.53 -44.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.452 -170.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.1 p -62.11 -30.94 71.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.923 1.238 . . . . 0.0 110.341 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.49 -52.23 54.35 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.96 -42.3 85.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.681 1.241 . . . . 0.0 111.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.22 -43.33 82.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.406 1.003 . . . . 0.0 111.095 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -68.9 -29.89 68.27 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.966 -1.084 . . . . 0.0 112.285 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -62.36 -42.32 99.3 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.358 0.981 . . . . 0.0 109.071 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.09 -38.08 89.57 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.349 0.522 . . . . 0.0 110.314 172.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.65 -8.91 3.12 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.18 1.848 . . . . 0.0 113.459 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.9 m -66.69 171.28 5.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.678 1.591 . . . . 0.0 112.256 -169.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.35 136.6 54.22 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 169.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 54.2 m -142.27 165.36 27.64 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.2 131.71 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -68.32 109.56 3.68 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.6 mt -64.97 -28.17 69.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.722 0.409 . . . . 0.0 110.082 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.69 -167.55 40.7 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.76 -164.01 20.37 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.1 -159.65 23.64 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -125.5 154.13 42.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mt -129.83 139.49 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.351 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.12 129.65 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -159.77 -174.69 4.73 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.349 -0.844 . . . . 0.0 110.903 -170.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.81 -161.42 53.43 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.942 -0.474 . . . . 0.0 112.3 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -151.31 152.26 32.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 109.643 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 m -79.6 130.9 35.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 tpt -60.63 -35.26 75.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.903 0.481 . . . . 0.0 111.258 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.08 -16.89 24.46 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.73 -5.9 5.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -169.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.72 178.08 42.94 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.823 0.725 . . . . 0.0 112.098 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.55 135.38 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.671 2.248 . . . . 0.0 109.814 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.13 169.91 16.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 110.152 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -79.68 82.78 5.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -58.45 -18.28 27.34 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.66 -38.4 72.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.502 1.121 . . . . 0.0 111.846 169.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 14.6 mm -62.8 -49.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.9 m -56.58 -52.49 64.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.772 0.829 . . . . 0.0 111.325 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -62.08 -43.61 98.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.995 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.23 -47.93 83.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.499 1.045 . . . . 0.0 110.761 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -64.36 -47.11 80.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.303 0.501 . . . . 0.0 110.986 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -48.3 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -61.92 -38.81 89.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.34 1.427 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.29 97.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.552 0.615 . . . . 0.0 111.922 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -87.95 -12.95 43.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.632 0.651 . . . . 0.0 112.682 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.301 40.5 p90 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 128.56 2.744 . . . . 0.0 116.422 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 m -144.74 170.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.75 1.62 . . . . 0.0 108.143 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -141.39 171.59 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.253 1.421 . . . . 0.0 108.481 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -145.93 164.23 32.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.756 0.707 . . . . 0.0 111.735 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.268 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.8 mt -49.35 -34.25 15.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.181 1.392 . . . . 0.0 112.725 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.13 -24.51 67.19 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.4 mt -79.45 -19.95 48.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.097 0.559 . . . . 0.0 111.517 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mt -70.19 133.43 87.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.79 140.71 68.57 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.41 2.073 . . . . 0.0 108.973 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -86.33 -38.84 17.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.69 140.58 27.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -157.49 117.25 3.38 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 pt . . . . . 0 CA--C 1.538 0.495 0 C-N-CA 124.332 1.053 . . . . 0.0 109.918 -171.555 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 p90 . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.24 154.94 18.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.239 0.616 . . . . 0.0 109.778 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 169.79 16.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.488 0.715 . . . . 0.0 109.551 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.46 153.68 16.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.291 1.436 . . . . 0.0 108.319 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.7 tp -117.1 114.86 24.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.31 132.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.57 147.45 33.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.599 1.16 . . . . 0.0 107.895 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.22 125.85 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -97.11 146.23 25.23 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.679 1.192 . . . . 0.0 108.941 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 m -63.84 100.96 0.33 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.262 0.483 . . . . 0.0 111.025 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.592 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -147.85 9.76 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 116.094 -1.908 . . . . 0.0 114.602 169.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 88.4 Cg_exo -44.7 140.33 6.63 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 124.14 2.514 . . . . 0.0 114.58 174.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? 43.66 24.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.75 2.42 . . . . 0.0 114.117 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.17 30.26 4.17 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.158 1.383 . . . . 0.0 112.327 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.903 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.974 -170.825 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -77.25 -174.19 3.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.3 m -150.8 160.52 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.778 -1.201 . . . . 0.0 109.974 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 165.11 33.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.643 1.577 . . . . 0.0 108.636 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.25 154.95 21.05 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 pt -134.39 155.44 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.9 1.28 . . . . 0.0 109.042 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -118.38 120.79 65.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -135.26 148.69 49.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.26 140.9 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 39.2 m-85 -151.99 152.82 32.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -60.05 -32.31 70.81 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.828 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.403 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.2 p-90 -65.84 -27.78 68.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.683 0.674 . . . . 0.0 112.41 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 78.07 9.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.565 1.075 . . . . 0.0 108.816 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.5 -5.59 8.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.414 0.686 . . . . 0.0 112.08 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 140.09 27.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.086 1.754 . . . . 0.0 107.472 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.526 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.7 m-70 -61.98 -31.12 71.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.596 1.158 . . . . 0.0 111.703 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 -29.39 67.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.728 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.86 -48.02 72.98 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.735 0.698 . . . . 0.0 110.466 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -40.6 82.33 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 117.473 -1.251 . . . . 0.0 110.013 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.1 -46.93 84.71 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.574 1.534 . . . . 0.0 110.137 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.45 -49.51 68.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.254 0.479 . . . . 0.0 111.45 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -60.83 -49.52 77.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.2 0.6 . . . . 0.0 110.955 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.73 -44.51 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.952 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -62.7 -28.29 69.84 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.637 1.108 . . . . 0.0 111.195 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.6 56.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.34 -45.78 86.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.194 0.997 . . . . 0.0 110.96 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.5 mmt -57.78 -45.09 86.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.702 0.683 . . . . 0.0 111.14 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.32 -32.12 72.87 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.946 -1.096 . . . . 0.0 111.814 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -63.72 -37.71 88.39 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.266 0.939 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -66.94 -34.86 78.69 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.216 0.916 . . . . 0.0 110.235 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.6 -6.46 3.86 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.548 2.023 . . . . 0.0 113.106 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.06 178.45 1.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.922 1.689 . . . . 0.0 113.001 -169.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -132.34 142.11 49.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.6 m -145.86 164.27 32.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.87 128.55 10.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 p -71.69 112.27 7.66 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 110.372 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.0 -166.85 39.73 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -163.82 -169.14 26.9 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.46 -160.86 24.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.17 156.82 32.89 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mt -126.36 146.93 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 125.608 1.563 . . . . 0.0 108.405 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t60 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.01 122.69 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -159.96 -176.36 5.64 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.61 -0.681 . . . . 0.0 111.488 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.66 -160.29 51.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -145.34 151.28 38.05 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.857 1.263 . . . . 0.0 108.057 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.1 p -69.85 147.88 49.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.027 0.441 . . . . 0.0 110.526 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.0 ttp -58.33 -22.47 53.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.478 1.111 . . . . 0.0 112.959 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.66 -14.89 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.0 4.78 3.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.214 1.37 . . . . 0.0 112.794 -170.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.69 -175.4 51.79 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 118.518 0.599 . . . . 0.0 112.251 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 136.73 28.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.73 2.287 . . . . 0.0 110.538 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.1 171.51 14.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.572 0.701 . . . . 0.0 110.27 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -77.74 74.67 4.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -58.31 -17.89 23.14 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.29 70.6 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.373 0.669 . . . . 0.0 111.479 169.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.6 -45.38 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.776 0.83 . . . . 0.0 108.794 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -59.39 -49.12 79.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.723 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 p -57.97 -46.16 85.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.718 0.69 . . . . 0.0 111.47 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -61.0 -48.83 79.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.087 0.858 . . . . 0.0 110.472 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -72.71 -42.96 63.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.942 -0.474 . . . . 0.0 111.534 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.41 HG22 ' CG2' ' A' ' 118' ' ' VAL . 87.3 mt -64.23 -42.32 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.82 -40.24 91.99 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.896 1.68 . . . . 0.0 111.058 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.4 -42.28 98.78 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.447 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.81 -28.18 64.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.226 1.011 . . . . 0.0 112.104 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 . . . . . 0 CA--C 1.549 0.917 0 C-N-CA 125.173 1.389 . . . . 0.0 113.263 -169.852 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.41 ' CG2' HG22 ' A' ' 109' ' ' ILE . 2.5 t -141.35 154.48 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.485 . . . . 0.0 107.873 -169.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -139.62 169.57 17.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 108.383 172.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -144.55 170.15 16.61 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.777 -0.577 . . . . 0.0 111.135 172.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.55 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.3 mt -50.93 -34.15 27.34 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.77 1.228 . . . . 0.0 112.859 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.52 -23.29 66.84 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.66 0.664 . . . . 0.0 112.579 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.0 mt -77.01 -19.93 56.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.115 0.566 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -69.61 129.72 91.15 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.13 2.553 . . . . 0.0 109.634 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -95.45 -40.24 9.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -169.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.73 134.32 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -157.48 119.2 3.7 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.7 pt . . . . . 0 C--O 1.236 0.388 0 C-N-CA 124.217 1.007 . . . . 0.0 109.407 -172.468 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 p90 . . . . . 0 C--O 1.235 0.308 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -107.88 156.52 19.09 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.73 170.61 15.53 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.47 0.708 . . . . 0.0 109.668 -172.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.83 153.51 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.541 1.536 . . . . 0.0 108.663 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.23 116.1 27.18 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 135.02 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 119.08 0.854 . . . . 0.0 109.411 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -82.18 149.29 28.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.751 1.22 . . . . 0.0 108.186 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.79 141.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -114.61 154.0 29.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.872 1.269 . . . . 0.0 109.59 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m -68.69 80.14 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.729 1.211 . . . . 0.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.422 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -134.84 11.1 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 116.028 -1.939 . . . . 0.0 115.179 169.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 77.9 Cg_exo -44.18 137.39 7.52 Favored 'Trans proline' 0 C--N 1.362 1.255 0 CA-C-N 124.248 2.553 . . . . 0.0 113.668 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 45.92 22.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.711 2.404 . . . . 0.0 114.205 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 49.89 30.71 4.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.962 1.305 . . . . 0.0 112.051 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.954 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.756 -170.905 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.01 166.24 16.26 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -139.23 158.29 44.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.972 0.909 . . . . 0.0 109.928 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.94 164.14 37.06 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.028 1.331 . . . . 0.0 109.047 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.32 154.94 21.09 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.52 155.42 38.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.264 1.426 . . . . 0.0 108.858 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.6 123.38 70.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -135.2 148.72 49.74 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.035 0.934 . . . . 0.0 108.619 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.47 136.86 3.82 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 171.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -150.46 151.05 32.14 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.14 -39.34 82.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.672 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -60.22 -30.25 69.27 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.106 0.866 . . . . 0.0 112.63 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.28 75.42 9.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.176 0.898 . . . . 0.0 108.767 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.59 -8.16 9.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.19 0.596 . . . . 0.0 112.081 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.66 138.43 36.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.59 1.956 . . . . 0.0 107.253 175.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.506 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.0 m-70 -60.66 -29.93 69.59 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.674 1.19 . . . . 0.0 112.027 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.76 69.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.439 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.63 -46.12 76.86 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.511 0.596 . . . . 0.0 110.919 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -42.01 83.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 117.288 -1.339 . . . . 0.0 110.243 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.97 -46.18 90.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 120.635 1.561 . . . . 0.0 109.901 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.36 -48.79 78.2 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.805 0.73 . . . . 0.0 111.365 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -62.17 -49.65 74.97 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.131 0.572 . . . . 0.0 111.045 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.48 -45.34 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.515 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -60.58 -36.1 77.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.678 1.126 . . . . 0.0 109.463 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.13 -50.36 66.91 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 118.899 0.772 . . . . 0.0 111.503 172.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.37 -46.93 84.24 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.544 1.172 . . . . 0.0 111.07 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.7 mmt -57.96 -45.93 85.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.774 0.715 . . . . 0.0 110.985 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -65.6 -32.59 74.25 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.027 -1.045 . . . . 0.0 111.459 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -63.42 -42.92 98.74 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 109.701 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -60.37 -40.16 89.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.295 0.952 . . . . 0.0 109.504 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.66 -7.08 1.94 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.415 1.959 . . . . 0.0 113.09 169.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.74 179.17 1.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.14 1.776 . . . . 0.0 113.672 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -131.86 144.74 51.1 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m -148.05 169.33 20.19 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.817 0.735 . . . . 0.0 112.641 -168.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.52 138.96 15.84 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.267 1.027 . . . . 0.0 109.012 169.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -70.96 118.1 13.3 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.9 -26.01 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.99 -0.444 . . . . 0.0 110.284 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.0 -166.95 38.45 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -160.6 -168.02 21.93 Favored Glycine 0 C--O 1.235 0.211 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.56 -155.37 15.57 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.81 153.01 52.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.844 1.258 . . . . 0.0 108.073 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.0 mt -136.07 141.49 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.234 0.277 0 C-N-CA 124.284 1.034 . . . . 0.0 111.238 -176.483 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.05 133.15 64.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -159.55 -175.05 4.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.14 -0.975 . . . . 0.0 110.249 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.87 -161.68 54.3 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 121.668 0.593 . . . . 0.0 112.32 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -150.83 153.15 34.86 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.605 1.562 . . . . 0.0 107.785 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 t -67.57 133.17 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.3 ttp -54.72 -27.01 37.65 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.696 1.198 . . . . 0.0 111.841 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.87 -24.7 8.53 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.665 0.786 . . . . 0.0 112.896 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.11 4.39 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.68 -175.75 40.39 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 118.957 0.799 . . . . 0.0 112.555 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.42 132.88 24.83 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.432 2.088 . . . . 0.0 110.33 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.22 173.6 8.39 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.478 0.656 . . . . 0.0 110.87 169.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -76.97 73.06 3.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.41 -19.08 21.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.32 65.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.454 0.701 . . . . 0.0 111.011 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -61.14 -50.39 80.71 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.2 m -56.01 -48.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.595 0.758 . . . . 0.0 110.776 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 p -59.19 -47.36 85.61 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.082 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.02 -46.59 89.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.528 1.058 . . . . 0.0 110.581 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -68.22 -47.27 68.31 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.562 0.745 . . . . 0.0 111.034 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.88 -37.31 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.934 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -63.06 -45.31 92.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 121.378 1.899 . . . . 0.0 110.819 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.5 89.0 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.454 0.57 . . . . 0.0 111.773 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.04 -17.17 28.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.254 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.253 30.6 p90 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 127.381 2.272 . . . . 0.0 114.093 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 C--O 1.237 0.427 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.03 158.31 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.819 1.647 . . . . 0.0 108.071 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 p -135.66 176.01 9.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.639 1.176 . . . . 0.0 108.617 169.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -139.37 166.65 23.98 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.865 -0.522 . . . . 0.0 111.282 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.395 0 C-N-CA 124.522 1.129 . . . . 0.0 108.115 169.886 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 mt -50.5 -34.87 26.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.32 1.048 . . . . 0.0 112.957 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.13 -24.13 64.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.699 0.681 . . . . 0.0 112.549 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.31 -19.63 42.47 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.633 0.773 . . . . 0.0 111.253 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.28 132.75 92.71 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.026 0.931 . . . . 0.0 108.694 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.4 109.91 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.489 2.793 . . . . 0.0 110.045 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -76.49 -38.19 55.67 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -169.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.09 124.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -146.21 102.49 3.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.8 pt . . . . . 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.02 -169.878 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -84.25 162.08 20.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.776 -0.578 . . . . 0.0 110.821 -175.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.16 171.86 13.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.356 1.063 . . . . 0.0 109.492 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.93 153.59 17.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.978 1.311 . . . . 0.0 108.035 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 tp -116.89 115.63 25.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.19 133.41 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 118.918 0.781 . . . . 0.0 110.007 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -77.96 147.66 34.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.014 1.326 . . . . 0.0 107.642 169.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.68 141.22 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -117.41 141.34 48.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.301 1.441 . . . . 0.0 108.16 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 m -64.16 106.97 1.17 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.574 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.625 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.01 17.39 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.935 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.625 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.0 Cg_exo -42.3 133.43 4.75 Favored 'Trans proline' 0 C--N 1.365 1.436 0 CA-C-N 123.733 2.369 . . . . 0.0 115.261 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 41.9 32.65 0.29 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.595 2.758 . . . . 0.0 113.179 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m 52.96 29.76 8.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.607 1.563 . . . . 0.0 113.0 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.304 -174.857 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.94 170.18 11.75 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -138.76 159.02 43.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.908 0.883 . . . . 0.0 110.543 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.55 36.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.722 1.609 . . . . 0.0 109.306 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -108.77 156.95 19.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 pt -137.02 159.02 36.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.961 1.705 . . . . 0.0 109.518 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.7 t -124.24 119.17 55.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.0 mmt85 -139.61 148.45 42.5 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.93 136.47 2.75 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.047 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 15.6 m-85 -153.0 156.01 38.02 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.259 0.623 . . . . 0.0 111.45 -169.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -35.61 61.34 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.418 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-90 -71.6 -25.44 62.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.215 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.71 80.38 9.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.317 0.962 . . . . 0.0 109.142 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.71 -9.15 17.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.418 0.687 . . . . 0.0 112.069 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.17 142.45 30.55 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.049 1.739 . . . . 0.0 107.604 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -61.98 -30.06 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.81 0.844 . . . . 0.0 111.735 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.38 68.16 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.749 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.49 -47.68 69.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.574 0.624 . . . . 0.0 110.655 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -38.56 79.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 117.456 -1.259 . . . . 0.0 110.243 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -58.95 -46.38 88.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.584 1.538 . . . . 0.0 109.932 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.69 -50.21 67.86 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.38 0.536 . . . . 0.0 111.418 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -61.29 -46.84 88.64 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 122.8 0.44 . . . . 0.0 111.158 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.74 -36.34 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.43 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.83 -29.89 70.47 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.137 1.335 . . . . 0.0 110.764 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.23 -49.0 55.89 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.405 1.002 . . . . 0.0 111.135 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -57.01 -44.71 83.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.823 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mmt -69.02 -41.64 77.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.724 -0.61 . . . . 0.0 112.231 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -69.24 -29.95 67.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.36 1.436 . . . . 0.0 111.714 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -61.5 -43.09 99.49 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.988 0.915 . . . . 0.0 109.167 169.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.84 -37.07 85.34 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.441 0.564 . . . . 0.0 110.287 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.98 -6.69 5.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 127.252 2.358 . . . . 0.0 112.944 172.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.46 177.32 4.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.514 1.925 . . . . 0.0 112.78 -169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -127.92 151.09 49.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 55.9 m -147.72 168.49 21.96 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.04 126.47 7.34 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.19 1.396 . . . . 0.0 108.002 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.08 118.79 11.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.38 -26.67 61.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.722 0.409 . . . . 0.0 110.252 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.67 -171.94 42.35 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.18 -173.75 20.09 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.88 -158.79 23.32 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -127.94 153.58 46.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.969 1.308 . . . . 0.0 108.725 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.53 130.55 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.33 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.883 -169.992 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.2 t60 . . . . . 0 C--O 1.233 0.19 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -134.29 114.91 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.25 172.9 17.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.206 1.002 . . . . 0.0 108.325 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.06 -165.39 24.33 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.91 1.232 . . . . 0.0 113.066 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -153.78 154.83 34.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.791 2.036 . . . . 0.0 107.388 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.2 m -139.1 106.17 5.46 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -56.45 -28.5 59.75 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.05 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.211 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -135.6 -7.89 2.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.02 171.32 45.97 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.018 0.818 . . . . 0.0 111.138 -169.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.51 144.77 36.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.626 2.218 . . . . 0.0 109.564 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 167.71 18.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 109.397 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -65.86 -31.54 72.54 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.53 0.732 . . . . 0.0 112.022 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.8 m80 58.21 -30.78 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.111 2.964 . . . . 0.0 115.983 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.86 75.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.776 1.171 . . . . 0.0 111.479 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 mm -58.98 -54.42 34.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.5 m -53.62 -50.55 65.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.294 1.038 . . . . 0.0 111.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 p -60.96 -41.69 96.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.232 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.1 -45.71 87.44 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.475 1.034 . . . . 0.0 110.053 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -64.7 -43.81 92.29 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 122.055 -0.403 . . . . 0.0 110.965 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.405 HG21 HG11 ' A' ' 118' ' ' VAL . 52.0 mt -62.9 -45.74 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.89 0.876 . . . . 0.0 108.956 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -62.78 -29.91 71.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.897 1.226 . . . . 0.0 111.566 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.58 -43.95 71.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.012 1.278 . . . . 0.0 111.193 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -71.62 -26.89 62.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.915 0.886 . . . . 0.0 112.595 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 CA--C 1.547 0.854 0 C-N-CA 125.558 1.543 . . . . 0.0 113.864 -170.871 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.405 HG11 HG21 ' A' ' 109' ' ' ILE . 29.6 m -139.48 167.94 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.575 0.75 . . . . 0.0 111.417 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -140.85 171.37 14.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.346 1.458 . . . . 0.0 109.277 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -142.6 171.93 13.38 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.228 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.352 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.0 mt -50.17 -33.97 20.93 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.763 1.225 . . . . 0.0 113.114 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.89 67.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.685 0.675 . . . . 0.0 112.558 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.21 -19.71 53.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.325 0.65 . . . . 0.0 111.341 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.46 133.01 92.95 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.16 111.32 0.71 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.647 2.898 . . . . 0.0 110.909 170.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.93 -34.88 64.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.235 0.614 . . . . 0.0 111.989 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.5 t -137.36 135.04 47.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.94 118.13 3.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 C--O 1.236 0.352 0 C-N-CA 124.708 1.203 . . . . 0.0 108.183 -176.661 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.0 p90 . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 121.084 0.469 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.82 159.56 15.33 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.72 166.51 23.79 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.976 1.31 . . . . 0.0 108.94 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.88 156.67 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.982 1.313 . . . . 0.0 107.776 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -122.06 121.07 36.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.77 135.82 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.458 0.572 . . . . 0.0 109.633 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -83.17 150.96 25.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.833 1.253 . . . . 0.0 107.65 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -137.37 140.68 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -113.32 146.82 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.419 1.487 . . . . 0.0 108.912 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.3 m -66.57 95.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.98 0.912 . . . . 0.0 110.805 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.543 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.17 11.78 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 115.905 -1.998 . . . . 0.0 114.069 168.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.543 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 71.0 Cg_exo -44.27 136.94 8.0 Favored 'Trans proline' 0 C--N 1.364 1.362 0 CA-C-N 124.146 2.516 . . . . 0.0 114.229 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mmt-85 47.65 22.07 0.3 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.802 2.441 . . . . 0.0 113.881 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 50.39 31.11 5.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.117 1.367 . . . . 0.0 112.217 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.904 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.925 -171.577 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -69.25 169.15 12.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 169.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -139.17 157.35 46.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.898 0.879 . . . . 0.0 109.851 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 165.91 32.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.401 1.481 . . . . 0.0 109.477 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -112.88 154.96 25.51 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.577 0.751 . . . . 0.0 109.092 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.6 pt -135.24 156.8 39.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.77 1.228 . . . . 0.0 109.749 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.86 124.26 72.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 125.868 1.667 . . . . 0.0 107.021 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -134.59 150.18 50.68 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.584 1.554 . . . . 0.0 108.689 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.79 131.63 1.48 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -154.55 151.24 28.65 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -64.54 -20.62 66.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -69.63 -26.22 64.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.634 1.107 . . . . 0.0 112.287 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.36 88.64 7.52 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.985 1.266 . . . . 0.0 109.076 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.32 -8.49 32.74 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.537 0.735 . . . . 0.0 112.101 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -147.9 145.62 28.71 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.669 1.588 . . . . 0.0 108.283 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -61.03 -31.8 71.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.241 1.016 . . . . 0.0 111.585 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.66 -26.06 68.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.824 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.0 -49.38 61.89 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.151 0.887 . . . . 0.0 110.418 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -39.86 85.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.254 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -62.06 -49.48 75.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.356 0.98 . . . . 0.0 110.081 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.81 -44.84 95.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.256 0.934 . . . . 0.0 111.169 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.48 -51.7 68.75 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.341 0.656 . . . . 0.0 110.78 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.4 t -82.12 -38.61 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.043 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.2 p -61.43 -31.75 71.7 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.857 1.662 . . . . 0.0 110.328 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.84 -51.06 59.83 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.05 -44.14 96.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.375 1.088 . . . . 0.0 111.202 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.35 -45.38 91.55 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.802 0.728 . . . . 0.0 110.563 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.41 -33.04 75.03 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.014 -1.054 . . . . 0.0 111.588 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -64.52 -39.64 94.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.962 0.801 . . . . 0.0 110.692 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.03 -32.12 73.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.264 0.938 . . . . 0.0 110.61 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.98 -8.05 4.47 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.114 2.292 . . . . 0.0 113.177 169.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -67.48 179.56 1.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.095 1.758 . . . . 0.0 113.539 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -131.14 143.14 50.41 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.0 m -147.15 167.44 24.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -168.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -153.09 134.37 14.23 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.524 1.53 . . . . 0.0 108.103 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 p -73.65 115.84 13.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.9 -24.92 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.952 -0.468 . . . . 0.0 110.772 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.0 43.48 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.44 -164.83 15.31 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.44 -155.61 22.67 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -138.52 155.02 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 109.127 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.8 136.63 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.234 0.244 0 C-N-CA 124.619 1.168 . . . . 0.0 109.62 -176.204 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.3 t60 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.15 123.0 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.23 -174.42 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.154 -0.966 . . . . 0.0 111.085 -169.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.79 -160.04 52.58 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -149.51 154.48 38.83 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.431 1.493 . . . . 0.0 107.863 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 t -69.74 131.83 45.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.8 ttt -59.02 -20.77 56.18 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.973 0.909 . . . . 0.0 111.814 170.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.32 -24.23 8.53 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 113.087 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -130.77 1.07 4.38 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -177.65 45.33 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.248 0.931 . . . . 0.0 112.381 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.25 130.22 17.2 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.739 2.293 . . . . 0.0 111.223 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.69 168.08 20.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.227 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.98 78.54 5.41 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 169.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -59.01 -15.88 15.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.01 66.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.387 0.675 . . . . 0.0 111.401 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.57 -44.17 96.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.728 0.811 . . . . 0.0 108.942 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.3 m -58.67 -53.03 62.91 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.268 0.627 . . . . 0.0 110.34 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 p -60.45 -44.6 95.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -58.98 -53.45 58.3 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.283 0.947 . . . . 0.0 110.931 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.4 -44.49 67.86 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.918 -0.489 . . . . 0.0 111.421 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.4 -42.25 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 118.087 -0.959 . . . . 0.0 108.639 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.72 -39.28 93.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.913 1.688 . . . . 0.0 111.029 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.94 89.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.475 0.58 . . . . 0.0 111.302 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -79.86 -24.66 41.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.224 0.465 . . . . 0.0 112.106 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 CA--C 1.546 0.807 0 C-N-CA 127.13 2.172 . . . . 0.0 111.967 -170.076 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 121.367 0.603 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.94 164.07 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.058 1.743 . . . . 0.0 110.033 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.3 p -141.42 172.06 13.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.324 1.849 . . . . 0.0 107.133 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.63 167.58 21.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.894 0.77 . . . . 0.0 112.39 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 125.323 1.449 . . . . 0.0 107.643 169.844 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -53.53 -28.98 34.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.828 1.251 . . . . 0.0 113.507 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.48 57.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.024 0.829 . . . . 0.0 112.451 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.0 mt -84.87 -19.72 31.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.017 0.927 . . . . 0.0 111.25 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.07 138.29 72.87 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.428 1.091 . . . . 0.0 109.265 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.41 99.35 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.517 2.811 . . . . 0.0 109.307 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.65 -32.09 67.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.938 1.295 . . . . 0.0 112.658 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t -140.99 128.67 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -152.28 108.14 3.36 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt . . . . . 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.258 . . . . 0.0 108.384 -172.209 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.2 p90 . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.46 157.92 16.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.97 172.07 13.29 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.684 0.794 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.45 153.23 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.225 1.41 . . . . 0.0 108.123 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.4 tp -117.76 115.62 25.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 131.95 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.85 147.16 39.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.01 131.04 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -100.08 151.2 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.455 1.102 . . . . 0.0 109.734 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 m -65.81 97.56 0.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.931 0.892 . . . . 0.0 110.827 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.52 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -151.07 22.6 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.451 -1.738 . . . . 0.0 114.449 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.52 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 81.8 Cg_exo -46.34 138.21 13.73 Favored 'Trans proline' 0 C--N 1.362 1.25 0 CA-C-N 123.906 2.431 . . . . 0.0 113.0 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 44.93 26.75 0.22 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 113.7 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m 50.18 33.04 6.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.347 1.459 . . . . 0.0 112.753 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 C-N-CA 123.556 0.598 . . . . 0.0 113.066 -172.659 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.125 0.488 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.74 168.72 14.38 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -142.03 159.56 41.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.038 0.935 . . . . 0.0 110.325 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.66 168.26 26.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.975 1.71 . . . . 0.0 108.835 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -108.39 156.77 19.05 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 pt -133.15 156.24 41.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.942 1.297 . . . . 0.0 109.245 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.59 116.7 50.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -137.81 147.43 44.59 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.7 134.99 2.02 Favored Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.435 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.0 m-85 -156.75 156.7 33.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -170.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -60.91 -33.09 72.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.242 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.435 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.7 p-90 -64.52 -28.62 69.77 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.84 0.746 . . . . 0.0 112.103 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 77.79 9.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.218 0.917 . . . . 0.0 108.705 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -65.89 -6.07 11.16 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.19 140.23 33.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.69 1.596 . . . . 0.0 107.55 174.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.424 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 24.5 m-70 -61.46 -29.74 70.16 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.403 1.081 . . . . 0.0 111.873 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.58 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.759 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.0 -46.44 74.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.675 0.67 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -41.09 82.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.152 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -58.45 -44.66 89.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.004 1.729 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.25 -50.83 64.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.647 0.658 . . . . 0.0 111.542 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -60.77 -46.48 90.3 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.977 0.511 . . . . 0.0 111.089 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.8 -36.4 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.381 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -62.06 -28.95 69.96 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.244 1.384 . . . . 0.0 110.927 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.86 -52.06 45.69 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.321 0.964 . . . . 0.0 110.943 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -55.88 -47.54 77.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 110.445 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.242 -0.911 . . . . 0.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.3 -28.9 66.68 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.681 -1.262 . . . . 0.0 111.474 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -31.79 73.1 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.12 0.968 . . . . 0.0 110.057 169.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -70.76 -45.96 63.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.822 1.192 . . . . 0.0 108.332 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.26 -6.78 2.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.294 2.378 . . . . 0.0 112.502 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.84 171.39 11.76 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.149 1.78 . . . . 0.0 112.983 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.62 147.92 46.91 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.0 m -148.19 165.61 30.4 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -168.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.4 129.62 11.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.767 1.227 . . . . 0.0 107.997 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.5 114.45 5.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.5 -28.26 64.83 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.996 -0.44 . . . . 0.0 110.143 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.72 -167.02 40.07 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.99 -166.92 21.65 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 171.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.47 -161.2 26.45 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -127.12 151.15 49.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.626 1.17 . . . . 0.0 108.432 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.0 mt -132.66 135.13 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.232 0.164 0 C-N-CA 123.016 0.526 . . . . 0.0 111.535 -169.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.1 t60 . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.4 130.33 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -159.26 -172.14 3.63 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.5 -164.5 41.69 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 121.653 0.585 . . . . 0.0 111.676 170.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -148.23 153.32 38.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.173 1.389 . . . . 0.0 107.499 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 t -69.55 128.56 36.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.24 -20.58 55.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.212 0.605 . . . . 0.0 111.646 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.69 -27.33 9.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.911 0.884 . . . . 0.0 112.917 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -132.59 4.48 3.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.89 -178.74 50.63 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.229 0.922 . . . . 0.0 112.73 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.5 129.37 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.766 2.311 . . . . 0.0 110.47 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 169.16 17.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 111.079 169.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.13 75.41 4.67 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -56.86 -20.53 23.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.06 -38.75 65.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.64 0.776 . . . . 0.0 111.606 169.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mm -62.27 -45.6 98.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.998 0.919 . . . . 0.0 109.072 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.4 m -58.02 -52.66 64.59 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.413 0.685 . . . . 0.0 110.234 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -62.59 -41.42 98.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.26 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -60.99 -50.28 74.03 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 110.412 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.76 -46.11 73.0 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.09 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.3 mt -61.74 -44.52 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.833 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -62.66 -40.05 95.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.543 1.519 . . . . 0.0 111.216 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.34 84.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.782 0.719 . . . . 0.0 111.546 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -79.74 -21.11 44.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.299 0.64 . . . . 0.0 111.743 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 t80 . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 127.528 2.331 . . . . 0.0 112.419 -176.832 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.03 167.3 22.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.854 0.862 . . . . 0.0 110.586 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.8 p -139.01 171.39 14.39 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 109.363 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -146.95 163.21 36.91 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.73 -0.607 . . . . 0.0 110.599 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 169.265 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.3 mt -50.94 -35.35 32.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.319 1.048 . . . . 0.0 112.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.88 -23.73 66.04 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.808 0.731 . . . . 0.0 112.679 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.2 mt -84.7 -19.7 32.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.741 0.816 . . . . 0.0 111.305 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.5 138.48 94.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.95 111.32 1.35 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.088 2.525 . . . . 0.0 109.571 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.83 -37.15 70.36 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.399 1.08 . . . . 0.0 112.963 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.69 137.41 47.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -153.94 110.24 3.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 C--O 1.235 0.341 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 177.289 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 p90 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 160.39 14.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.74 166.55 24.33 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.382 1.073 . . . . 0.0 109.252 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.72 156.8 12.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.07 115.5 23.82 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.04 129.94 72.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -76.75 147.76 37.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -134.69 142.83 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -116.07 148.35 40.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.555 1.142 . . . . 0.0 108.733 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 m -61.51 101.24 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.834 0.854 . . . . 0.0 110.654 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.553 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.32 15.14 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.076 -1.916 . . . . 0.0 115.619 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 80.4 Cg_exo -42.84 137.24 4.37 Favored 'Trans proline' 0 C--N 1.362 1.288 0 CA-C-N 124.371 2.597 . . . . 0.0 114.244 171.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 45.84 25.62 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.35 2.26 . . . . 0.0 113.929 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.08 31.94 7.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.186 1.395 . . . . 0.0 112.355 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.83 0 C-N-CA 123.697 0.665 . . . . 0.0 112.872 -172.578 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.281 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.61 177.23 6.94 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -143.67 156.78 44.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.635 0.774 . . . . 0.0 110.146 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 165.37 36.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.512 1.525 . . . . 0.0 109.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.1 155.08 20.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.99 151.38 34.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.578 1.151 . . . . 0.0 109.166 171.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.12 120.95 64.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -131.28 147.49 52.59 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.859 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.73 132.87 1.81 Allowed Glycine 0 C--N 1.33 0.225 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.08 151.29 26.61 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -61.52 -28.18 69.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.442 0.697 . . . . 0.0 112.742 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -66.71 -26.96 67.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.143 0.883 . . . . 0.0 112.093 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 85.19 5.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 171.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.99 -10.89 43.77 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 173.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 141.09 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.896 1.278 . . . . 0.0 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.499 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.03 -32.22 70.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.572 1.549 . . . . 0.0 111.763 -173.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.18 -30.22 70.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.739 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.45 -47.88 66.01 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.89 0.768 . . . . 0.0 110.473 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -37.51 79.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.521 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.74 -47.41 86.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 110.323 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.24 -46.79 75.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.789 0.722 . . . . 0.0 111.393 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -52.76 -54.8 28.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.631 1.172 . . . . 0.0 110.056 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.4 t -80.57 -34.4 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.745 -169.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -62.35 -30.91 71.51 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 120.382 1.446 . . . . 0.0 110.835 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.9 -51.18 58.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 110.638 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.6 -44.87 92.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 111.187 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.43 -45.04 95.09 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.987 -0.445 . . . . 0.0 111.011 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.6 -31.2 71.07 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.086 -1.009 . . . . 0.0 111.834 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.39 -40.3 96.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.19 0.904 . . . . 0.0 110.033 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -59.42 -47.22 86.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.712 1.142 . . . . 0.0 108.907 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.68 -5.64 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 126.631 2.063 . . . . 0.0 112.709 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.1 m -66.33 176.05 1.96 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.116 1.766 . . . . 0.0 112.728 -170.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -129.86 143.34 50.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -147.63 164.06 34.68 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -169.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -154.9 128.54 8.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 108.306 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -68.25 114.28 6.6 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.4 mt -70.3 -27.62 64.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.932 0.493 . . . . 0.0 110.638 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.85 -173.58 45.57 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.4 -179.08 28.57 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.59 -162.14 28.57 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -137.65 167.21 22.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.226 1.013 . . . . 0.0 110.785 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.12 143.11 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -169.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.236 0.395 0 O-C-N 121.67 -0.644 . . . . 0.0 111.458 178.563 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.2 t60 . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.39 127.8 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.504 1.522 . . . . 0.0 107.322 -174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -162.15 -175.58 4.67 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.532 -0.73 . . . . 0.0 110.69 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.76 -167.57 48.37 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.266 0.46 . . . . 0.0 112.168 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -151.33 147.04 26.45 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.522 0.729 . . . . 0.0 109.943 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -73.42 139.47 45.88 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.82 -36.44 83.5 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.818 -0.551 . . . . 0.0 109.808 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.39 58.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.2 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -134.13 1.29 3.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.216 0.917 . . . . 0.0 113.35 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.02 55.13 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 118.93 0.787 . . . . 0.0 111.914 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 137.85 40.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.692 2.262 . . . . 0.0 110.181 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.6 169.84 16.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 169.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -79.05 72.4 5.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -56.85 -19.39 17.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.892 0.877 . . . . 0.0 113.276 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.94 -38.8 65.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.659 0.783 . . . . 0.0 111.388 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.1 mm -62.03 -43.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 C-N-CA 124.23 1.012 . . . . 0.0 109.028 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -57.52 -54.07 51.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.119 0.568 . . . . 0.0 110.082 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.1 p -60.6 -41.76 95.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.337 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.99 -50.71 72.29 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.419 1.009 . . . . 0.0 110.6 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -71.66 -42.23 67.77 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.906 -0.496 . . . . 0.0 111.423 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.14 -45.46 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.61 -36.08 81.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.168 1.349 . . . . 0.0 111.346 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.0 -42.54 94.38 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.44 1.018 . . . . 0.0 111.487 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -84.1 -17.84 38.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.586 0.754 . . . . 0.0 112.856 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 126.399 1.88 . . . . 0.0 115.595 -171.579 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.93 167.58 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.638 1.575 . . . . 0.0 108.727 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -140.85 169.57 17.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.68 1.192 . . . . 0.0 108.763 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -145.54 167.15 23.72 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 110.402 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.521 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.52 -28.43 65.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.49 -26.5 63.64 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.223 0.92 . . . . 0.0 112.055 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.74 -30.67 18.89 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.333 1.053 . . . . 0.0 110.654 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.3 127.76 81.31 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 144.42 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.46 2.107 . . . . 0.0 109.864 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -81.86 -44.05 17.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.137 0.575 . . . . 0.0 111.146 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 t -133.49 137.02 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -154.48 109.84 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 C--O 1.236 0.356 0 C-N-CA 123.812 0.845 . . . . 0.0 109.253 -172.79 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -85.62 157.47 20.35 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.32 168.75 19.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.038 0.935 . . . . 0.0 109.35 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 154.43 16.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 125.139 1.376 . . . . 0.0 107.548 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -118.36 118.23 31.22 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.31 134.63 65.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.94 0.791 . . . . 0.0 109.079 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -77.39 148.45 35.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.3 t -134.8 126.64 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.41 149.51 21.63 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.68 0.792 . . . . 0.0 109.566 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.9 m -65.59 100.76 0.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.484 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.554 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.02 19.32 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 116.282 -1.818 . . . . 0.0 114.776 169.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.554 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 84.8 Cg_exo -44.11 136.61 7.74 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 124.114 2.505 . . . . 0.0 113.846 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 46.13 25.76 0.37 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.738 2.015 . . . . 0.0 113.797 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.86 32.61 7.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.232 1.413 . . . . 0.0 112.448 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.901 0 C-N-CA 123.83 0.729 . . . . 0.0 112.842 -173.191 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -74.03 -176.48 2.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.714 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -142.25 159.67 41.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.685 0.794 . . . . 0.0 110.555 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.81 165.77 26.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.597 1.959 . . . . 0.0 107.573 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -111.94 146.99 36.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -126.45 154.8 36.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.312 1.045 . . . . 0.0 109.839 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.1 t -118.7 118.87 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.475 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.0 mmt85 -136.41 147.63 47.37 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.13 133.91 1.97 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.3 m-85 -156.33 155.01 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.9 0.88 . . . . 0.0 109.001 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.99 -31.56 71.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.457 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.1 p-90 -63.9 -30.15 71.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.29 0.95 . . . . 0.0 111.873 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.74 80.72 8.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.18 -14.54 38.69 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.005 0.522 . . . . 0.0 111.796 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.09 142.74 40.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.031 1.732 . . . . 0.0 108.26 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.491 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.8 -31.35 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.137 1.375 . . . . 0.0 111.879 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.33 -28.79 70.0 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.729 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.11 -46.98 72.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.997 0.817 . . . . 0.0 110.496 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -39.94 82.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.261 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -59.62 -48.04 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.778 1.626 . . . . 0.0 109.963 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -48.75 78.87 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.864 0.757 . . . . 0.0 111.324 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -60.62 -50.79 72.1 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.301 0.64 . . . . 0.0 110.891 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG21 ' HG3' ' A' ' 45' ' ' ARG . 60.5 t -75.07 -40.37 44.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 118.442 -0.79 . . . . 0.0 109.447 -171.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 t -59.09 -40.38 85.1 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.498 1.045 . . . . 0.0 109.082 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.95 -50.54 64.96 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 118.85 0.75 . . . . 0.0 111.952 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.51 -45.75 91.56 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.265 1.033 . . . . 0.0 111.283 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.86 -43.9 97.75 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.505 -0.747 . . . . 0.0 111.798 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.97 -32.36 73.81 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.645 -1.284 . . . . 0.0 111.152 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.37 90.76 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.947 0.899 . . . . 0.0 110.301 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -59.46 -46.42 88.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.878 1.217 . . . . 0.0 108.5 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.7 -5.99 1.59 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 126.951 2.215 . . . . 0.0 112.438 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.0 m -70.16 177.14 3.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.857 1.663 . . . . 0.0 112.114 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -129.46 142.56 50.75 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 169.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.3 m -143.05 165.09 28.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -168.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -154.94 130.77 10.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.48 112.67 4.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.7 mt -67.35 -28.46 67.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.796 -0.565 . . . . 0.0 110.219 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.66 42.18 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.036 -2.025 . . . . 0.0 108.036 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.34 -175.16 26.07 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.69 -159.86 24.66 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -135.7 163.03 31.09 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.4 1.1 . . . . 0.0 110.566 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.6 mt -123.85 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.451 -0.394 0 C-N-CA 123.241 0.616 . . . . 0.0 110.834 -169.434 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.2 t60 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.06 117.91 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -161.85 -168.61 1.98 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.053 0.541 . . . . 0.0 110.684 -173.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.87 -161.82 53.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -152.5 152.38 31.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.331 1.052 . . . . 0.0 108.67 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.3 p -77.94 137.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.7 tpt -65.05 -34.81 79.32 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.839 -0.538 . . . . 0.0 109.855 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.94 65.54 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.416 -0.802 . . . . 0.0 113.111 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -133.86 4.03 3.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.67 -175.26 55.07 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.806 0.73 . . . . 0.0 111.75 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.48 138.37 38.54 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.576 2.184 . . . . 0.0 110.685 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 176.29 5.25 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.54 -34.08 77.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.74 -0.6 . . . . 0.0 111.368 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.4 m80 58.51 -29.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.141 2.976 . . . . 0.0 115.87 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.72 81.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.474 1.11 . . . . 0.0 111.41 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.28 -46.36 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.4 m -56.29 -53.69 54.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.879 0.872 . . . . 0.0 110.538 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -47.21 77.99 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.931 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -64.83 -47.76 76.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.837 0.744 . . . . 0.0 110.519 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.75 -38.37 67.4 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 118.799 -0.619 . . . . 0.0 111.309 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.4 mt -61.61 -45.65 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.473 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 95.9 mttt -62.62 -40.33 96.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.573 1.533 . . . . 0.0 111.431 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.59 87.13 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.452 0.569 . . . . 0.0 111.224 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -79.45 -23.22 43.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 CA--C 1.543 0.675 0 C-N-CA 127.593 2.357 . . . . 0.0 111.943 -172.353 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' HG3' ' HE2' ' A' ' 110' ' ' LYS . 26.8 tt0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 121.666 0.746 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.65 162.89 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.038 1.335 . . . . 0.0 109.54 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 p -142.66 174.41 10.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.434 1.894 . . . . 0.0 108.514 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -145.67 167.29 23.47 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.422 -0.799 . . . . 0.0 111.14 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.456 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t70 . . . . . 0 C--O 1.232 0.172 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -53.85 -30.76 46.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.688 1.195 . . . . 0.0 113.349 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.25 -25.31 59.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.995 0.816 . . . . 0.0 112.434 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.85 -21.58 29.74 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.936 0.894 . . . . 0.0 111.135 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.85 131.75 82.97 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.59 119.76 5.57 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.763 2.976 . . . . 0.0 110.13 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.53 -41.14 12.9 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -169.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -138.58 135.03 43.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -156.14 116.3 3.66 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 pt . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 108.358 -176.332 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.2 p90 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -97.83 160.13 14.5 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.605 -0.684 . . . . 0.0 109.185 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 169.02 18.87 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 122.992 0.517 . . . . 0.0 110.126 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.0 153.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.322 . . . . 0.0 108.844 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 tp -118.81 116.87 27.42 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.52 132.62 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.416 1.007 . . . . 0.0 109.674 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -78.03 145.99 35.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.032 1.333 . . . . 0.0 108.503 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.14 128.73 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -93.79 154.07 17.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.984 0.913 . . . . 0.0 110.398 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.7 p -73.64 41.91 0.12 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.536 1.934 . . . . 0.0 114.963 -172.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.48 22.42 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 115.918 -1.991 . . . . 0.0 116.344 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.73 125.05 6.04 Favored 'Trans proline' 0 C--N 1.359 1.117 0 CA-C-N 124.553 2.662 . . . . 0.0 113.833 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 39.63 28.14 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.696 2.799 . . . . 0.0 114.419 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m 48.92 30.31 2.7 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.038 1.335 . . . . 0.0 112.551 -171.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.951 0 C-N-CA 124.129 0.871 . . . . 0.0 113.539 -170.177 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.503 0.668 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -74.08 168.06 20.3 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -154.78 161.14 41.61 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.58 -1.325 . . . . 0.0 111.242 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -152.94 165.75 34.54 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.893 1.677 . . . . 0.0 108.477 173.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.25 151.17 26.31 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.436 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 48.6 pt -130.4 156.57 42.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.102 1.361 . . . . 0.0 109.32 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.6 122.71 66.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -128.69 153.32 47.44 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.33 132.26 2.46 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -151.21 151.08 31.38 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.2 1.0 . . . . 0.0 108.45 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.2 -29.13 68.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.192 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -65.54 -34.35 78.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.18 0.9 . . . . 0.0 110.979 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 71.13 8.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 169.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -62.62 -9.33 8.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.531 1.132 . . . . 0.0 111.696 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.34 37.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.236 1.815 . . . . 0.0 107.186 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.558 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 8.1 m-70 -58.48 -31.21 67.62 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.744 1.617 . . . . 0.0 112.078 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.93 -31.61 68.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.873 0.469 . . . . 0.0 111.633 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.94 -43.08 79.93 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.275 0.489 . . . . 0.0 110.6 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -40.21 72.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.449 175.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.35 -44.72 88.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.37 1.441 . . . . 0.0 109.876 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.67 -48.88 73.11 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 0.605 . . . . 0.0 111.606 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -56.87 -52.08 66.55 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.391 0.677 . . . . 0.0 110.086 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.19 -43.73 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.094 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -58.88 -37.13 75.86 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.625 1.102 . . . . 0.0 111.023 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.86 63.16 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.928 0.785 . . . . 0.0 111.199 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.25 -46.17 81.61 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.88 0.84 . . . . 0.0 111.019 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.6 mmt -59.12 -42.72 91.23 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.842 -0.536 . . . . 0.0 111.129 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -70.38 -30.7 67.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.342 0.974 . . . . 0.0 111.728 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -63.57 -43.07 98.07 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.327 0.967 . . . . 0.0 109.302 169.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -63.86 -27.04 68.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.451 0.569 . . . . 0.0 111.079 171.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.89 -7.22 9.43 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.137 2.304 . . . . 0.0 113.178 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 69.0 m -71.59 170.47 13.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.189 1.396 . . . . 0.0 111.721 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.59 140.73 52.21 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 m -144.28 163.16 34.51 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -149.08 128.89 13.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.04 0.936 . . . . 0.0 108.628 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -65.37 111.3 2.98 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.18 -27.53 66.49 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.707 -0.62 . . . . 0.0 110.1 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.15 -166.92 40.1 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.71 -165.94 17.63 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 170.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.35 -164.75 31.93 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -119.84 150.48 40.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.3 mt -128.27 138.46 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.7 m . . . . . 0 N--CA 1.451 -0.381 0 C-N-CA 123.855 0.862 . . . . 0.0 109.096 -171.231 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.1 t60 . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.87 129.23 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.766 1.626 . . . . 0.0 106.895 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.37 -169.13 2.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.036 0.835 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.84 -159.37 52.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.649 0.642 . . . . 0.0 112.526 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.7 154.22 39.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.24 1.416 . . . . 0.0 108.004 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 t -66.54 135.43 54.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 74.5 mtm -59.77 -16.46 27.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.638 1.175 . . . . 0.0 112.411 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.68 -23.14 4.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.117 0.967 . . . . 0.0 113.215 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -129.97 2.08 4.81 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.34 -175.59 45.88 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 119.09 0.859 . . . . 0.0 112.573 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.61 129.44 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.745 2.297 . . . . 0.0 110.968 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.86 167.76 20.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 110.304 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -78.97 76.66 5.46 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -57.06 -19.87 21.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.904 0.882 . . . . 0.0 113.166 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.39 -39.89 73.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.837 0.855 . . . . 0.0 110.987 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.9 mm -63.54 -49.15 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 m -62.63 -46.74 86.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 117.839 0.291 . . . . 0.0 110.843 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -62.01 -42.16 98.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.22 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.89 -49.94 75.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.979 1.263 . . . . 0.0 111.021 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -66.27 -45.12 81.6 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.935 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.87 -47.48 93.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -61.6 -39.15 90.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.307 1.412 . . . . 0.0 111.092 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.41 80.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 111.236 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -75.73 -21.6 57.34 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.349 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.4 t80 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 126.696 1.998 . . . . 0.0 111.671 -177.957 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.73 168.48 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.068 1.347 . . . . 0.0 109.414 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 p -139.38 171.38 14.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.472 1.109 . . . . 0.0 109.665 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -145.93 161.6 39.68 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.812 -0.555 . . . . 0.0 110.583 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.013 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 . . . . . 0 C--O 1.233 0.227 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -54.06 -34.0 58.93 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.586 0.754 . . . . 0.0 112.584 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.47 -24.42 66.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.192 0.906 . . . . 0.0 112.294 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.91 -20.18 23.67 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.95 . . . . 0.0 111.366 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.69 126.4 86.84 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.189 -1.386 . . . . 0.0 107.824 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.53 111.78 0.51 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.249 3.3 . . . . 0.0 110.421 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -71.38 -35.94 71.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.35 137.64 20.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -156.45 116.15 3.54 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.236 0.359 0 C-N-CA 124.391 1.076 . . . . 0.0 109.418 -174.481 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 N--CA 1.461 0.105 0 CA-C-O 121.246 0.546 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 156.06 27.45 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.886 0.474 . . . . 0.0 109.738 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.66 169.6 17.34 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.042 0.937 . . . . 0.0 108.687 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.43 150.67 19.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 108.013 174.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 tp -110.6 115.71 30.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.0 OUTLIER -127.32 128.13 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.53 0.681 . . . . 0.0 109.412 -172.232 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -79.27 149.53 31.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.43 1.492 . . . . 0.0 108.348 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.42 135.01 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -102.85 147.83 26.39 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.324 1.049 . . . . 0.0 108.464 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -62.23 99.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.282 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.517 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -149.66 17.97 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.163 -1.875 . . . . 0.0 114.776 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.517 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 51.1 Cg_exo -41.39 134.66 3.11 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 124.077 2.492 . . . . 0.0 114.31 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 38.17 31.89 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.692 2.797 . . . . 0.0 114.182 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m 51.59 32.58 9.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.149 1.379 . . . . 0.0 112.566 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.784 0 C-N-CA 123.998 0.809 . . . . 0.0 111.949 -174.119 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -176.33 4.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.0 m -140.95 156.52 46.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.572 0.749 . . . . 0.0 110.491 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.77 149.88 29.55 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.632 1.973 . . . . 0.0 106.742 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.43 150.55 27.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -128.8 154.05 39.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.26 1.024 . . . . 0.0 109.34 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.18 114.66 44.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -134.7 146.65 49.66 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.68 135.04 2.33 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.8 m-85 -157.06 152.6 26.67 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -60.32 -27.11 67.07 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.5 p-90 -66.86 -27.71 67.75 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 112.062 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.24 79.9 9.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.06 -6.29 8.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.005 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.98 142.03 29.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.226 1.811 . . . . 0.0 107.514 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.434 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 21.1 m-70 -62.04 -30.7 71.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.398 1.079 . . . . 0.0 111.543 -174.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -29.62 68.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.145 175.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.42 -47.5 73.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.781 0.719 . . . . 0.0 110.748 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.03 -43.29 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.011 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.12 -47.13 84.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.102 0.864 . . . . 0.0 109.608 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.99 -48.29 71.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 0.483 . . . . 0.0 111.718 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -57.22 -53.75 54.59 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.366 0.666 . . . . 0.0 110.294 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.06 -45.19 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.864 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -64.29 -25.16 67.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 119.884 1.22 . . . . 0.0 111.471 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.32 -49.89 72.71 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 170.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.05 -41.93 85.63 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.185 0.992 . . . . 0.0 111.392 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.2 mmt -56.39 -44.85 80.66 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.367 0.985 . . . . 0.0 110.79 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.52 -29.08 66.62 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.246 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -63.41 -43.15 98.36 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.396 0.998 . . . . 0.0 109.193 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.53 -34.28 77.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.079 0.4 . . . . 0.0 110.306 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.83 5.07 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.535 2.017 . . . . 0.0 113.059 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -67.86 175.37 3.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.365 1.866 . . . . 0.0 113.434 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -128.2 148.82 50.63 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.4 163.57 32.69 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -168.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -149.35 128.04 12.45 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.089 1.356 . . . . 0.0 109.006 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.27 111.94 7.0 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 168.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.62 -26.41 64.42 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.237 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.18 -168.02 40.17 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.7 -175.54 30.78 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -158.43 20.38 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 -174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -128.57 154.02 46.62 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.839 -0.801 . . . . 0.0 108.869 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.1 mt -124.96 142.11 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 C--N 1.329 -0.309 0 C-N-CA 125.531 1.533 . . . . 0.0 108.366 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.0 t -130.34 128.07 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.52 -177.07 6.15 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 121.362 -0.836 . . . . 0.0 110.681 -173.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.01 -169.08 53.25 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -151.92 147.56 26.72 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.593 0.757 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.8 p -72.16 133.78 45.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -68.99 -27.18 65.47 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.782 -0.574 . . . . 0.0 110.09 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.49 -42.35 64.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.828 0.851 . . . . 0.0 112.384 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -133.65 3.15 3.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -168.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.51 -176.84 54.24 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.793 0.724 . . . . 0.0 111.848 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.22 132.02 23.29 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.674 2.249 . . . . 0.0 110.211 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.9 168.8 19.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -78.93 81.26 5.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 168.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.415 ' HB2' ' CE3' ' A' ' 120' ' ' TRP . 94.3 m-70 -56.05 -21.25 20.63 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.568 0.747 . . . . 0.0 112.762 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -44.07 66.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.709 1.203 . . . . 0.0 111.484 169.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.02 -49.53 83.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -58.4 -50.56 73.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.747 0.819 . . . . 0.0 110.683 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -63.58 -40.01 95.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.072 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.28 -46.51 83.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.927 1.24 . . . . 0.0 110.538 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.17 -43.55 97.96 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.263 0.483 . . . . 0.0 110.437 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.481 HG21 HG11 ' A' ' 118' ' ' VAL . 52.5 mt -59.64 -51.58 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.009 177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -60.98 -36.25 78.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.675 1.579 . . . . 0.0 111.283 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.92 99.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.922 0.783 . . . . 0.0 111.689 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.39 -18.09 37.25 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.264 35.8 p90 . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 127.16 2.184 . . . . 0.0 114.209 -173.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 109' ' ' ILE . 31.6 m -140.18 169.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.127 0.971 . . . . 0.0 110.374 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -140.66 171.73 13.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.202 1.401 . . . . 0.0 108.885 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 102' ' ' HIS . 9.9 p-90 -143.5 170.76 15.21 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.65 -0.656 . . . . 0.0 109.623 170.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.514 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.233 0.202 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.0 mt -54.66 -32.3 58.94 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.769 0.828 . . . . 0.0 112.478 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.17 67.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.448 1.022 . . . . 0.0 112.289 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -90.08 -24.44 21.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.439 1.095 . . . . 0.0 111.307 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.32 130.17 89.43 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.2 116.63 3.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.23 2.62 . . . . 0.0 109.785 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.93 -35.84 64.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.822 0.849 . . . . 0.0 113.273 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.51 134.76 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -153.6 108.89 3.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 C--O 1.234 0.289 0 C-N-CA 124.155 0.982 . . . . 0.0 108.441 -176.932 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 p90 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.25 160.06 19.94 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.829 -0.545 . . . . 0.0 109.739 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.12 164.57 31.76 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.313 0.645 . . . . 0.0 109.378 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.67 156.02 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.604 1.161 . . . . 0.0 108.529 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -118.53 114.56 23.01 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.61 130.94 71.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -75.27 148.02 39.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.29 119.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -91.32 148.54 22.26 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 p -68.64 102.71 1.55 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.872 0.76 . . . . 0.0 109.712 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.463 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.12 23.75 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.003 0 CA-C-O 116.39 -1.767 . . . . 0.0 114.517 169.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 37.1 Cg_exo -41.85 124.36 2.69 Favored 'Trans proline' 0 C--N 1.361 1.187 0 CA-C-N 123.802 2.394 . . . . 0.0 114.521 173.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 34.22 38.24 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.341 3.056 . . . . 0.0 113.924 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m 52.97 30.31 9.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.224 1.409 . . . . 0.0 112.961 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 C-N-CA 124.797 1.189 . . . . 0.0 112.525 -177.035 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.327 0 CA-C-O 121.775 0.798 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.54 177.51 5.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.928 0.891 . . . . 0.0 109.045 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -139.34 160.58 39.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.717 0.77 . . . . 0.0 111.125 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -142.41 164.79 29.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 129.105 2.962 . . . . 0.0 105.566 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -128.31 149.57 50.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.09 147.77 33.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.496 0.718 . . . . 0.0 109.829 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.38 119.22 57.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -128.3 145.09 51.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.08 132.15 1.9 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 170.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -151.54 151.69 31.93 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -59.89 -29.37 68.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.7 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -66.28 -27.7 68.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.159 0.89 . . . . 0.0 111.836 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.91 81.97 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -62.06 -15.24 43.32 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 122.943 0.497 . . . . 0.0 111.583 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.76 142.16 38.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.137 1.775 . . . . 0.0 108.014 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -56.17 -31.37 63.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.441 1.496 . . . . 0.0 112.757 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.55 -27.09 68.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.73 -0.607 . . . . 0.0 111.557 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.33 -47.33 70.82 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.677 0.671 . . . . 0.0 110.693 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -39.71 83.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.467 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -61.95 -48.23 81.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.9 1.227 . . . . 0.0 109.927 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -45.81 91.79 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.347 0.976 . . . . 0.0 111.365 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -60.42 -51.18 70.59 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.391 0.677 . . . . 0.0 110.812 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.46 -33.91 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.15 -169.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p -61.16 -35.83 78.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.794 1.634 . . . . 0.0 110.169 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.8 -51.07 59.78 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.9 -44.21 96.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.208 1.004 . . . . 0.0 111.015 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.8 mmt -59.72 -44.4 93.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.696 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -66.69 -33.41 75.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.217 . . . . 0.0 111.976 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.27 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.216 0.916 . . . . 0.0 109.77 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.35 -35.78 80.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.571 0.623 . . . . 0.0 110.393 171.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.41 -8.12 5.32 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.633 2.54 . . . . 0.0 113.127 171.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 94.8 m -77.41 133.0 38.78 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.943 1.697 . . . . 0.0 111.711 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.39 137.3 33.47 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.9 m -144.71 163.96 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -155.69 133.85 11.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.653 1.181 . . . . 0.0 108.251 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.84 112.82 4.47 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.7 mt -67.87 -29.83 69.04 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.907 -0.495 . . . . 0.0 110.098 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.18 -171.0 42.87 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.28 -164.68 23.37 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.6 -147.52 8.85 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -171.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -133.63 155.59 49.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 108.217 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.7 mt -125.26 141.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.453 -0.323 0 C-N-CA 124.606 1.162 . . . . 0.0 108.219 -178.551 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t60 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.06 120.58 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.96 -164.98 1.39 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.532 0.733 . . . . 0.0 109.988 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.36 -167.91 54.56 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -153.04 144.43 23.26 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.957 0.503 . . . . 0.0 110.786 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.9 m -70.01 140.69 52.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -65.1 -49.61 69.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.14 -24.56 37.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -118.17 -6.74 10.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.94 -179.6 34.6 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.795 0.725 . . . . 0.0 112.408 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.09 136.48 37.92 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.713 2.275 . . . . 0.0 109.976 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.91 169.83 17.16 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.362 0.601 . . . . 0.0 110.078 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.09 82.42 6.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -58.44 -18.15 26.29 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.765 -0.584 . . . . 0.0 112.543 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.63 -39.68 68.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.57 1.148 . . . . 0.0 111.861 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 mm -61.7 -49.76 83.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 m -58.19 -51.46 69.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.908 0.883 . . . . 0.0 111.399 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.0 p -64.71 -41.01 96.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.382 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.7 -45.53 93.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 120.011 1.278 . . . . 0.0 110.468 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -65.13 -44.51 88.46 Favored 'General case' 0 N--CA 1.46 0.053 0 O-C-N 121.911 -0.493 . . . . 0.0 111.08 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.439 HG21 HG11 ' A' ' 118' ' ' VAL . 54.8 mt -61.95 -42.12 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.374 0.67 . . . . 0.0 109.263 177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.415 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 93.2 mttt -63.57 -38.0 89.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 120.111 1.323 . . . . 0.0 110.895 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.53 -44.88 85.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.84 0.745 . . . . 0.0 111.153 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -63.43 -36.28 83.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.256 1.022 . . . . 0.0 111.41 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.7 t80 . . . . . 0 CA--C 1.543 0.706 0 C-N-CA 126.945 2.098 . . . . 0.0 111.215 -169.644 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.415 ' HG3' ' HE2' ' A' ' 110' ' ' LYS . 29.5 tt0 . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.439 HG11 HG21 ' A' ' 109' ' ' ILE . 18.8 m -141.2 166.43 18.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 -176.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.6 p -139.5 172.54 12.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.565 1.146 . . . . 0.0 109.456 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -143.88 167.78 21.52 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.159 0.583 . . . . 0.0 110.315 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 169.467 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.88 -28.44 64.19 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.197 0.908 . . . . 0.0 112.848 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.7 63.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.294 0.952 . . . . 0.0 112.293 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.1 -28.1 19.22 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.513 1.125 . . . . 0.0 111.212 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.67 129.02 76.41 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.67 131.36 33.09 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.658 2.906 . . . . 0.0 110.707 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.21 -43.34 8.88 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.46 142.07 31.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -156.18 116.36 3.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 pt . . . . . 0 C--O 1.236 0.371 0 C-N-CA 125.279 1.432 . . . . 0.0 107.598 -179.236 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -86.77 158.77 19.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.36 166.58 24.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.901 0.88 . . . . 0.0 109.209 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.06 154.74 21.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.108 0.963 . . . . 0.0 108.799 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.93 119.35 34.55 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.78 135.41 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 119.401 1.0 . . . . 0.0 110.423 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -79.99 146.62 31.94 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 124.84 33.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -93.76 153.28 18.4 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.509 0.724 . . . . 0.0 109.891 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m -67.85 87.92 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.297 1.039 . . . . 0.0 109.56 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.31 24.37 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 116.584 -1.674 . . . . 0.0 114.499 169.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.02 129.94 5.75 Favored 'Trans proline' 0 C--N 1.359 1.089 0 CA-C-N 123.551 2.304 . . . . 0.0 113.075 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 43.7 27.2 0.15 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.928 2.491 . . . . 0.0 113.901 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 50.1 32.38 5.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.401 1.481 . . . . 0.0 112.677 -175.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.55 -172.806 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 121.102 0.477 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -69.59 172.42 7.4 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.3 m -135.99 160.94 37.07 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.562 0.745 . . . . 0.0 110.361 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.11 162.81 30.74 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.547 1.539 . . . . 0.0 107.579 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.49 134.95 54.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 171.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 pt -121.57 161.64 21.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.667 1.187 . . . . 0.0 110.383 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.55 124.03 53.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.48 155.02 49.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.68 136.02 3.83 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -149.48 152.05 34.97 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -174.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.62 -33.47 72.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.53 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -64.91 -29.81 70.77 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.018 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.73 75.32 3.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 109.35 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.79 -10.46 37.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.536 173.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.51 142.57 35.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.667 1.587 . . . . 0.0 107.718 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -58.24 -33.79 69.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.968 1.307 . . . . 0.0 111.63 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.93 67.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.123 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.47 -42.34 87.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.097 0.862 . . . . 0.0 110.295 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -38.31 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 117.369 -1.301 . . . . 0.0 110.616 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.09 -43.01 95.83 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.259 1.391 . . . . 0.0 109.453 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.05 -50.57 72.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.128 0.876 . . . . 0.0 111.32 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -48.74 78.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.219 0.533 . . . . 0.0 109.8 -174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -78.43 -44.75 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.385 -169.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.9 p -62.42 -31.38 72.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.577 1.535 . . . . 0.0 110.512 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.52 -52.17 48.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.19 -44.84 90.75 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.415 1.108 . . . . 0.0 111.384 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.6 mmt -57.04 -49.25 76.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.893 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.713 1.142 . . . . 0.0 111.988 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.74 -43.5 98.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.212 0.915 . . . . 0.0 109.756 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.66 -35.93 82.61 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.943 0.792 . . . . 0.0 110.379 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.2 -12.55 3.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.915 2.197 . . . . 0.0 112.98 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.3 m -74.34 121.46 21.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.959 1.703 . . . . 0.0 112.887 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.33 143.65 42.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 168.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.3 m -145.16 166.99 23.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.588 0.755 . . . . 0.0 112.498 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -149.48 134.01 17.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.67 1.188 . . . . 0.0 108.65 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -70.62 113.23 7.52 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.7 mt -70.72 -25.32 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.764 -0.585 . . . . 0.0 110.182 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.65 -169.74 42.26 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -170.73 23.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.16 -155.61 17.39 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.2 ttm105 -126.39 153.61 44.74 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.514 0.726 . . . . 0.0 109.174 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 mt -123.05 141.77 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--N 1.327 -0.37 0 C-N-CA 124.645 1.178 . . . . 0.0 108.459 -179.359 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.7 t60 . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 t -133.34 126.11 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.15 -179.8 8.33 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.81 -0.557 . . . . 0.0 110.757 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.68 -162.03 52.87 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -149.57 151.92 34.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.84 1.256 . . . . 0.0 108.64 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -73.58 131.07 41.31 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.91 -28.78 69.77 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.189 -0.32 . . . . 0.0 110.347 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.93 -35.74 17.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.638 0.775 . . . . 0.0 112.153 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.89 2.13 7.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.74 44.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 118.691 0.678 . . . . 0.0 111.988 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.92 136.55 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.225 1.95 . . . . 0.0 109.955 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.96 178.2 3.88 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -61.17 -34.37 74.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.704 -0.622 . . . . 0.0 111.375 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 59.21 -32.85 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.07 2.948 . . . . 0.0 115.682 -173.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.49 81.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.785 1.175 . . . . 0.0 110.723 170.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -53.88 -50.6 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.344 1.058 . . . . 0.0 108.644 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -58.92 -50.26 74.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.315 1.046 . . . . 0.0 110.363 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -48.65 74.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.813 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.11 -44.83 91.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.343 0.974 . . . . 0.0 110.845 -175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -67.13 -41.63 85.81 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.84 -0.538 . . . . 0.0 110.903 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.1 mt -59.84 -47.66 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 -33.88 75.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.01 1.277 . . . . 0.0 111.649 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.04 96.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.437 1.017 . . . . 0.0 111.324 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.4 -17.66 26.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 CA--C 1.547 0.833 0 C-N-CA 125.916 1.686 . . . . 0.0 114.208 -175.992 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.05 162.22 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.076 1.35 . . . . 0.0 108.031 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.5 p -138.26 171.82 13.82 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.709 1.603 . . . . 0.0 108.519 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -145.04 169.34 18.29 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.469 -0.769 . . . . 0.0 111.145 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.547 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 mt -53.74 -30.71 45.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.499 1.12 . . . . 0.0 113.484 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.59 -24.19 60.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.78 0.718 . . . . 0.0 112.266 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.31 -19.93 26.07 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.292 1.037 . . . . 0.0 111.108 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.09 131.01 80.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.51 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.348 2.699 . . . . 0.0 109.961 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.29 -34.71 70.9 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.564 0.746 . . . . 0.0 112.261 -169.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -142.56 135.26 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -154.61 105.57 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt . . . . . 0 C--O 1.236 0.351 0 C-N-CA 123.749 0.82 . . . . 0.0 109.588 -173.128 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.4 p90 . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.68 154.4 17.31 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.03 168.53 19.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 109.116 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.62 154.23 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.111 1.364 . . . . 0.0 108.002 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.6 tp -118.17 114.91 23.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.58 131.53 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -174.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -78.59 144.96 35.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.97 141.72 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -108.01 149.65 28.13 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.879 1.272 . . . . 0.0 109.633 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 m -63.68 99.95 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.365 0.666 . . . . 0.0 110.912 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.547 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -154.23 21.71 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.347 -1.787 . . . . 0.0 114.847 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.0 Cg_exo -46.99 136.85 17.29 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 124.327 2.581 . . . . 0.0 113.067 172.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? 46.41 25.05 0.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.153 2.181 . . . . 0.0 113.821 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 50.77 32.71 7.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.017 1.327 . . . . 0.0 112.351 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 C-N-CA 123.934 0.778 . . . . 0.0 112.586 -172.655 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.13 -178.14 4.88 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.1 m -152.82 159.34 43.06 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.772 -1.205 . . . . 0.0 110.028 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.73 167.81 29.2 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.826 1.65 . . . . 0.0 108.785 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.01 152.74 24.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -129.85 153.41 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.752 1.221 . . . . 0.0 109.013 172.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.4 t -119.92 115.08 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -136.06 148.18 48.21 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.95 136.69 2.57 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.2 m-85 -156.29 152.31 27.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -172.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.53 -31.46 69.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.001 -0.524 . . . . 0.0 112.168 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.431 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -64.32 -27.54 69.1 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.828 0.74 . . . . 0.0 112.363 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 82.15 8.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.692 1.133 . . . . 0.0 108.267 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.52 -14.09 47.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.702 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.53 143.99 35.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.769 1.628 . . . . 0.0 108.418 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.45 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 21.2 m-70 -62.11 -30.7 71.2 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.736 1.214 . . . . 0.0 111.779 -174.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.01 -28.55 69.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.722 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.21 -47.79 72.72 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 110.549 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -40.37 82.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.262 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -58.61 -46.54 86.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.325 1.421 . . . . 0.0 110.02 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.31 -48.67 72.28 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.288 0.495 . . . . 0.0 111.451 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -60.18 -51.86 67.79 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.106 0.563 . . . . 0.0 110.864 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.32 -45.22 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.869 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -63.29 -28.37 69.97 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.731 1.15 . . . . 0.0 111.352 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.19 -49.38 75.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.57 -46.51 85.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.053 0.927 . . . . 0.0 110.708 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.3 mmt -58.36 -43.61 88.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.853 -0.529 . . . . 0.0 111.502 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.94 -33.31 73.52 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.103 -0.998 . . . . 0.0 111.875 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -61.22 -42.71 99.08 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.022 0.828 . . . . 0.0 109.617 170.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -60.71 -44.06 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.128 0.876 . . . . 0.0 109.706 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.71 -6.74 1.44 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.073 1.796 . . . . 0.0 113.28 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.63 177.99 4.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.645 1.578 . . . . 0.0 113.319 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.25 144.71 51.51 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 169.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.3 m -145.32 165.48 28.33 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -168.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.77 128.72 11.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.313 1.045 . . . . 0.0 108.525 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -67.47 115.33 6.96 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.6 mt -71.9 -26.51 62.35 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.005 -0.435 . . . . 0.0 110.451 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.05 -168.73 40.98 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.98 -172.0 28.81 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 173.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.13 -168.11 35.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -119.3 154.91 32.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 mt -128.79 133.77 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 108.595 -175.538 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.0 t -125.5 121.56 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.22 -176.32 5.57 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.461 -0.774 . . . . 0.0 111.586 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.75 -159.15 53.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.06 152.36 36.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.012 1.325 . . . . 0.0 108.188 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -77.03 130.54 37.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.6 mtp -64.32 -27.73 69.22 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.677 -0.639 . . . . 0.0 110.553 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.01 -38.03 45.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.159 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.9 3.33 3.2 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.75 -178.69 50.03 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.019 0.818 . . . . 0.0 112.038 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 133.96 23.95 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.653 2.235 . . . . 0.0 110.162 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.35 167.86 21.09 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.305 0.574 . . . . 0.0 110.027 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.29 82.15 6.39 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -59.04 -17.27 23.99 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.624 -0.673 . . . . 0.0 112.463 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.42 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.392 1.077 . . . . 0.0 111.934 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.78 -48.42 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.2 m -58.81 -50.03 75.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.752 0.821 . . . . 0.0 111.349 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 p -59.78 -44.16 94.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.945 0.793 . . . . 0.0 111.385 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.57 -48.24 80.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.784 0.72 . . . . 0.0 110.314 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.71 -47.83 76.87 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.158 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -62.21 -45.53 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -61.63 -38.49 87.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.426 1.466 . . . . 0.0 110.984 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.81 -47.71 68.31 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.792 0.723 . . . . 0.0 111.84 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -80.35 -15.08 57.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.791 0.836 . . . . 0.0 112.009 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 CA--C 1.552 1.05 0 C-N-CA 126.575 1.95 . . . . 0.0 115.519 176.322 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.49 163.55 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.205 . . . . 0.0 107.911 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -140.1 166.83 23.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.718 1.607 . . . . 0.0 108.562 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -147.82 168.57 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.285 -0.885 . . . . 0.0 112.61 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.456 0 C-N-CA 125.419 1.488 . . . . 0.0 107.098 168.875 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 C--O 1.232 0.164 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.72 -32.02 40.78 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.057 1.343 . . . . 0.0 113.595 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.61 58.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.795 0.725 . . . . 0.0 112.304 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.78 -20.18 27.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.175 0.99 . . . . 0.0 111.106 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.7 mt -58.53 133.76 85.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.98 111.19 0.55 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.841 3.028 . . . . 0.0 110.563 171.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.59 -35.73 52.61 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.3 t -137.86 136.47 45.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.9 101.01 2.86 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 pt . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 127.246 2.218 . . . . 0.0 107.184 -178.789 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 p90 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 121.281 0.563 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -77.11 160.47 29.0 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 122.059 -0.4 . . . . 0.0 110.149 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.04 167.13 22.79 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.706 1.202 . . . . 0.0 109.168 -174.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.33 155.62 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.4 tp -118.73 117.66 29.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.282 0.0 OUTLIER -128.28 128.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 118.724 0.693 . . . . 0.0 109.736 -173.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -76.72 146.93 37.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.54 1.536 . . . . 0.0 108.279 172.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.2 139.1 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -108.91 143.4 38.19 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.735 1.214 . . . . 0.0 107.882 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 p -67.95 106.03 2.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.581 0.628 . . . . 0.0 110.818 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.55 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.47 17.22 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 116.212 -1.851 . . . . 0.0 115.362 169.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.55 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 90.1 Cg_exo -43.94 135.91 7.6 Favored 'Trans proline' 0 C--N 1.362 1.27 0 CA-C-N 124.185 2.53 . . . . 0.0 114.427 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 45.15 27.47 0.32 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.956 2.102 . . . . 0.0 113.576 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.84 31.87 6.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.457 1.503 . . . . 0.0 112.545 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.864 0 C-N-CA 123.768 0.699 . . . . 0.0 112.974 -172.704 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -75.36 173.17 11.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.437 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -144.57 155.65 43.76 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.388 0.675 . . . . 0.0 110.691 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.67 166.54 33.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.696 1.598 . . . . 0.0 108.963 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.64 155.6 19.97 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -174.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.41 155.28 41.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.398 1.079 . . . . 0.0 108.836 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.07 121.5 67.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -131.52 148.83 52.66 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.879 1.271 . . . . 0.0 107.799 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.25 131.7 1.8 Allowed Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -154.54 152.84 30.54 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.41 -31.75 71.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.134 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -64.86 -25.85 68.08 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.53 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.38 88.21 7.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 119.632 1.105 . . . . 0.0 109.028 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.0 -5.5 22.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 0.0 112.187 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.59 147.93 28.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.588 1.555 . . . . 0.0 108.319 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -60.67 -34.25 74.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 111.437 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.5 -27.54 67.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 118.627 -0.701 . . . . 0.0 112.215 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.65 -49.14 61.5 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.243 0.929 . . . . 0.0 110.603 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.402 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.83 -40.28 85.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.32 177.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -61.25 -49.84 75.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.095 0.861 . . . . 0.0 109.617 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.87 -46.37 89.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.393 0.997 . . . . 0.0 111.101 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -58.26 -52.62 64.8 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.566 0.747 . . . . 0.0 110.837 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.41 -34.37 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.457 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -59.48 -38.41 80.77 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.01 1.277 . . . . 0.0 109.245 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.89 87.34 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.821 0.737 . . . . 0.0 111.553 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.73 -45.31 90.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.257 1.029 . . . . 0.0 111.38 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -60.19 -44.65 94.93 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.862 -0.524 . . . . 0.0 110.795 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -65.65 -32.78 74.54 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.237 -0.915 . . . . 0.0 111.543 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -64.23 -39.1 93.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.464 171.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -60.26 -42.47 95.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.634 1.106 . . . . 0.0 109.262 169.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.41 -4.66 2.29 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.307 1.908 . . . . 0.0 112.939 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.9 m -69.11 178.46 2.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.484 1.513 . . . . 0.0 112.982 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -129.3 146.78 51.13 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.4 m -148.9 165.67 30.86 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -168.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -155.69 129.4 8.49 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.571 1.148 . . . . 0.0 109.585 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.75 115.66 10.16 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.0 mt -73.09 -25.2 60.79 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.179 0.591 . . . . 0.0 111.019 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.66 179.79 43.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.67 173.59 21.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.58 -158.9 24.52 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -136.02 153.09 51.47 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.118 1.367 . . . . 0.0 109.635 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mt -115.48 126.25 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.33 -0.273 0 C-N-CA 123.686 0.795 . . . . 0.0 108.867 -175.676 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t60 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -132.45 120.28 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -172.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -158.87 179.54 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.45 -163.33 15.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.459 1.027 . . . . 0.0 113.218 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -153.63 164.51 38.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.071 2.148 . . . . 0.0 107.251 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 t -135.55 127.45 29.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.8 tpp -62.84 -30.51 71.55 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.85 -35.93 32.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.404 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -131.24 -1.21 4.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.51 177.27 43.81 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 119.162 0.892 . . . . 0.0 111.686 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.01 138.09 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.472 2.115 . . . . 0.0 109.326 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.79 160.9 30.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.344 0.592 . . . . 0.0 110.813 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -82.05 78.0 8.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -54.61 -21.67 11.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.23 0.612 . . . . 0.0 112.403 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.89 65.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.15 1.38 . . . . 0.0 112.861 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.15 -47.71 92.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -61.38 -49.36 77.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.017 0.927 . . . . 0.0 111.201 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 p -59.29 -40.29 85.68 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.958 0.799 . . . . 0.0 111.783 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.63 -47.2 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.569 1.077 . . . . 0.0 110.375 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.75 -44.84 88.82 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.944 -0.472 . . . . 0.0 111.303 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.07 -47.44 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.38 -34.47 73.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.336 1.426 . . . . 0.0 111.569 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.83 89.22 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.522 1.056 . . . . 0.0 111.777 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -84.25 -16.07 44.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 CA--C 1.553 1.068 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -171.699 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 m -141.4 166.01 18.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.436 1.094 . . . . 0.0 109.164 169.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 p -134.13 171.47 14.18 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.943 1.297 . . . . 0.0 108.968 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -142.01 171.55 13.9 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.836 -0.54 . . . . 0.0 111.983 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.728 0 C-N-CA 124.768 1.227 . . . . 0.0 107.716 169.445 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.16 -27.58 62.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.787 0.835 . . . . 0.0 113.146 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.76 67.05 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.182 0.901 . . . . 0.0 112.61 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -77.6 -19.75 55.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.33 0.652 . . . . 0.0 111.649 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.88 139.88 97.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.03 110.59 1.19 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.917 2.412 . . . . 0.0 108.932 170.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.72 -33.36 64.33 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.986 0.914 . . . . 0.0 113.395 -169.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.9 t -136.81 133.4 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -157.85 110.55 2.4 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 170.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 124.109 0.963 . . . . 0.0 110.194 -171.819 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -78.81 163.4 25.37 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.886 -0.509 . . . . 0.0 110.129 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.34 166.67 24.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.559 1.143 . . . . 0.0 108.586 173.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.48 155.84 13.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.7 tp -118.44 116.65 27.13 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.28 0.0 OUTLIER -125.46 128.47 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-N 118.474 0.579 . . . . 0.0 109.671 -172.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -78.35 148.48 33.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.287 1.435 . . . . 0.0 108.415 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.2 139.37 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -108.67 146.66 33.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.387 1.475 . . . . 0.0 108.82 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -68.63 88.77 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.011 0.925 . . . . 0.0 112.457 -173.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.464 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -139.81 16.34 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 116.433 -1.746 . . . . 0.0 113.743 168.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 53.1 Cg_exo -47.85 143.45 13.17 Favored 'Trans proline' 0 C--N 1.362 1.258 0 CA-C-N 123.939 2.443 . . . . 0.0 113.33 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 41.26 31.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.636 2.374 . . . . 0.0 113.301 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.9 m 52.33 28.69 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.178 1.791 . . . . 0.0 113.374 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.857 0 CA-C-O 118.709 -1.05 . . . . 0.0 114.648 -173.438 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.195 0.522 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -67.53 165.72 16.27 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -140.55 155.94 46.46 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.014 0.926 . . . . 0.0 108.986 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HE2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -153.24 166.55 32.21 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.192 1.397 . . . . 0.0 108.694 176.31 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -108.4 156.28 19.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.404 HG23 ' HE2' ' A' ' 41' ' ' LYS . 30.7 pt -130.82 154.67 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.463 1.105 . . . . 0.0 108.826 172.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.79 119.85 63.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -132.07 147.61 52.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.231 1.412 . . . . 0.0 108.447 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.36 126.29 0.93 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -151.16 162.1 41.51 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.475 0.71 . . . . 0.0 109.842 -172.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -55.28 -43.38 74.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.833 0.853 . . . . 0.0 112.113 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -66.94 -27.32 67.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.457 -173.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.59 86.54 7.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.339 0.972 . . . . 0.0 108.516 172.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.42 -14.31 55.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.841 0.456 . . . . 0.0 111.664 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 144.5 33.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.03 1.732 . . . . 0.0 108.836 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.556 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 6.1 m-70 -58.14 -32.99 68.69 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.872 1.669 . . . . 0.0 112.079 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.39 -29.03 70.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.61 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.64 -49.23 63.97 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.76 0.709 . . . . 0.0 110.539 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -64.86 -40.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.331 177.099 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.527 0.603 . . . . 0.0 110.017 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.08 -46.89 76.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.662 0.664 . . . . 0.0 111.507 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.99 -56.16 18.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.582 1.153 . . . . 0.0 110.002 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.2 t -78.47 -35.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 117.797 -1.097 . . . . 0.0 110.456 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.4 m -62.36 -31.65 72.33 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 120.314 1.415 . . . . 0.0 110.939 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.63 -47.97 87.25 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.176 0.898 . . . . 0.0 110.974 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.04 -46.28 85.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.074 0.937 . . . . 0.0 111.028 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.5 mmt -59.56 -42.83 93.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.525 0.602 . . . . 0.0 110.882 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -67.86 -32.57 73.17 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.91 -1.119 . . . . 0.0 111.339 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -64.17 -40.56 96.38 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.032 0.833 . . . . 0.0 110.143 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -62.35 -33.28 74.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.316 0.962 . . . . 0.0 110.619 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.99 -6.9 4.42 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.444 1.973 . . . . 0.0 113.164 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.1 m -70.64 -179.72 2.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.272 1.829 . . . . 0.0 114.446 -169.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -130.09 151.09 51.0 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.2 165.01 31.34 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.79 129.65 9.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.678 1.191 . . . . 0.0 109.443 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.7 113.48 8.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.6 mt -68.06 -29.74 68.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.912 -0.492 . . . . 0.0 110.129 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.01 -173.46 45.15 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.84 -177.1 24.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.95 -155.75 16.25 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -136.41 167.37 21.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.904 0.852 . . . . 0.0 110.752 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 mt -136.36 142.57 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.694 1.998 . . . . 0.0 107.273 -169.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.235 0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 109.142 179.638 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.6 t60 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.22 121.96 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -159.74 -175.19 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.324 -0.86 . . . . 0.0 111.169 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.05 30.85 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.837 0.687 . . . . 0.0 112.834 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -137.78 143.11 40.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 t -65.45 146.56 54.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.5 ptp -72.87 -12.86 61.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.283 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.74 -14.76 3.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.194 0.998 . . . . 0.0 113.388 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -134.79 -177.29 4.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.2 1.8 . . . . 0.0 108.443 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.67 173.39 44.27 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 170.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.94 139.32 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.094 1.862 . . . . 0.0 108.457 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 164.67 25.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.606 0.717 . . . . 0.0 111.081 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.37 74.03 7.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -56.37 -20.52 19.68 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.47 60.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.035 0.934 . . . . 0.0 111.618 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.87 -43.95 99.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.408 1.083 . . . . 0.0 109.284 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -59.43 -50.78 72.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.416 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -57.02 -44.32 82.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.48 0.582 . . . . 0.0 111.304 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.69 -50.61 71.78 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.809 0.731 . . . . 0.0 110.505 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.98 -43.13 72.11 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.899 -0.501 . . . . 0.0 111.361 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.45 -46.76 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.93 -32.79 74.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.283 1.402 . . . . 0.0 111.379 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.32 94.97 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.405 1.002 . . . . 0.0 111.537 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -86.88 -20.0 28.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 CA--C 1.548 0.885 0 C-N-CA 125.646 1.578 . . . . 0.0 113.307 -169.828 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 118' ' ' VAL . 26.7 tt0 . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.428 ' H ' ' HG2' ' A' ' 117' ' ' GLU . 7.1 p -158.06 162.36 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.593 1.557 . . . . 0.0 107.329 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -143.4 173.9 11.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 107.661 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.71 166.77 23.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.582 0.628 . . . . 0.0 111.068 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 169.736 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.232 0.168 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.9 mt -52.35 -34.67 48.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.833 0.853 . . . . 0.0 112.942 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.19 62.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.671 0.669 . . . . 0.0 112.236 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.15 -19.76 28.0 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.099 0.959 . . . . 0.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.1 mt -59.28 128.82 86.06 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 172.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.57 138.16 58.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.164 2.576 . . . . 0.0 111.035 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -86.56 -41.78 14.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.071 0.396 . . . . 0.0 111.55 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.78 140.56 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 124.721 1.208 . . . . 0.0 107.9 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -157.14 114.19 3.06 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt . . . . . 0 C--O 1.235 0.307 0 C-N-CA 124.258 1.023 . . . . 0.0 108.837 -173.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.9 p90 . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -113.38 152.36 30.1 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.694 0.797 . . . . 0.0 109.287 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.27 168.7 19.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.671 0.788 . . . . 0.0 109.085 -170.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.26 152.92 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.457 1.503 . . . . 0.0 108.811 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -114.75 114.81 26.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.47 133.94 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.819 0.736 . . . . 0.0 109.329 -175.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -81.38 147.39 29.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.21 143.3 34.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -114.52 146.83 40.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.331 1.452 . . . . 0.0 109.24 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 m -62.68 103.51 0.43 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.288 0.635 . . . . 0.0 111.526 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.84 18.55 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 116.076 -1.916 . . . . 0.0 114.791 169.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 32.7 Cg_exo -40.37 127.79 2.28 Favored 'Trans proline' 0 C--N 1.361 1.224 0 CA-C-N 124.216 2.541 . . . . 0.0 115.093 173.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 31.91 39.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.492 3.117 . . . . 0.0 113.926 -170.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 53.11 31.44 11.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.385 1.474 . . . . 0.0 112.961 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 C-N-CA 124.226 0.917 . . . . 0.0 112.748 -176.177 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.25 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -78.14 -176.35 4.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 172.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 m -151.89 159.31 43.87 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 167.24 28.08 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.006 1.722 . . . . 0.0 108.282 174.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -108.2 157.51 18.25 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.9 pt -137.88 155.33 30.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.283 1.433 . . . . 0.0 108.58 174.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.6 t -119.03 123.77 72.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.407 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.0 mmp_? -135.96 149.26 48.83 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.311 1.044 . . . . 0.0 108.282 176.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.49 135.85 2.42 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 18.8 m-85 -153.92 155.29 35.39 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -60.14 -34.17 73.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.656 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.0 p-90 -64.28 -28.69 69.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.395 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 77.78 9.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.363 0.983 . . . . 0.0 108.799 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.07 -9.61 17.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.45 140.67 35.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.222 1.409 . . . . 0.0 107.456 174.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.477 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.8 m-70 -62.85 -29.86 71.07 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 111.428 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.77 67.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.942 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.4 -48.11 71.14 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.766 0.712 . . . . 0.0 110.501 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.16 -40.74 83.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 117.411 -1.28 . . . . 0.0 109.997 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.3 -46.7 85.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 120.608 1.549 . . . . 0.0 110.251 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.77 -49.17 69.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.239 0.472 . . . . 0.0 111.568 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -60.52 -49.3 78.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.349 0.66 . . . . 0.0 110.836 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' HG3' ' A' ' 45' ' ' ARG . 61.2 t -69.44 -44.42 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.056 -175.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.71 -28.92 70.28 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.686 1.13 . . . . 0.0 111.092 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -49.28 72.28 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.365 0.984 . . . . 0.0 110.717 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.11 -46.88 85.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.127 0.963 . . . . 0.0 110.626 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.7 mmt -57.98 -43.41 86.5 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.836 -0.54 . . . . 0.0 111.198 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -68.59 -31.28 70.36 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.862 -1.149 . . . . 0.0 112.248 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.36 -42.47 98.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.489 1.041 . . . . 0.0 109.662 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -62.54 -30.59 71.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.703 0.683 . . . . 0.0 110.55 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.27 -8.55 5.96 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.05 2.262 . . . . 0.0 112.972 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.38 179.96 2.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.547 1.939 . . . . 0.0 113.185 -169.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.14 150.92 52.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.1 m -149.07 165.24 32.32 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.31 128.34 10.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 108.325 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.98 116.17 7.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.6 -28.37 64.8 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.008 -0.432 . . . . 0.0 109.993 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.56 -163.94 36.52 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.45 -164.33 22.93 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.35 -163.59 29.56 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.48 157.62 31.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -131.14 127.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.233 0.228 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -174.022 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 . . . . . 0 C--O 1.232 0.134 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -119.47 130.03 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -161.96 -179.53 7.22 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.155 -0.966 . . . . 0.0 110.828 -170.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -157.93 53.15 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -144.79 153.85 42.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.62 1.568 . . . . 0.0 107.647 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.1 p -70.78 133.9 46.94 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.6 mmt -73.86 32.45 0.08 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.09 1.356 . . . . 0.0 111.108 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.3 -39.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.611 1.565 . . . . 0.0 111.572 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -134.63 2.86 3.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 -175.76 53.62 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.086 0.857 . . . . 0.0 112.181 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.61 135.62 24.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.526 2.15 . . . . 0.0 110.642 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.79 172.43 12.68 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.458 0.647 . . . . 0.0 110.011 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -77.19 79.64 3.71 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -58.82 -17.77 26.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -174.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.46 82.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.204 0.602 . . . . 0.0 110.378 169.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mm -62.97 -49.7 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.8 m -57.79 -49.75 75.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.119 0.568 . . . . 0.0 109.716 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -65.82 -42.86 90.09 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.514 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.32 -46.4 86.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.2 1.364 . . . . 0.0 110.596 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -69.7 -42.79 73.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.054 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.45 -44.64 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.035 0.834 . . . . 0.0 108.944 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.79 -41.06 99.09 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.016 1.28 . . . . 0.0 111.303 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.65 75.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.624 0.647 . . . . 0.0 111.294 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -73.2 -29.27 62.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.015 0.526 . . . . 0.0 111.193 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 127.127 2.171 . . . . 0.0 111.764 -176.574 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 120.949 0.404 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.28 168.26 10.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.701 1.2 . . . . 0.0 110.784 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.6 p -138.7 171.15 14.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.364 1.466 . . . . 0.0 108.312 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -144.98 171.13 14.89 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.529 -0.732 . . . . 0.0 110.893 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 169.444 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.4 mt -50.62 -35.44 30.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.299 1.04 . . . . 0.0 112.84 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.93 -23.96 66.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.673 0.669 . . . . 0.0 112.479 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.65 -19.65 37.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.61 0.764 . . . . 0.0 111.212 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.92 131.65 94.67 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.52 111.78 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.301 2.667 . . . . 0.0 109.96 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.5 -35.77 65.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.81 135.72 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -154.47 108.42 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--O 1.236 0.391 0 C-N-CA 124.128 0.971 . . . . 0.0 110.231 -170.686 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.2 p90 . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -107.12 151.46 25.35 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.75 169.18 17.96 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 109.179 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.63 152.87 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.107 1.363 . . . . 0.0 108.156 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -116.24 116.9 28.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.86 132.6 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.008 0.822 . . . . 0.0 109.615 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -77.85 147.98 34.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.31 140.42 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -112.05 146.81 37.27 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.618 1.167 . . . . 0.0 109.166 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 m -66.2 101.77 0.75 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.751 0.82 . . . . 0.0 109.598 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.57 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.67 16.27 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 115.839 -2.029 . . . . 0.0 115.004 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 63.6 Cg_exo -43.31 132.03 6.7 Favored 'Trans proline' 0 C--N 1.363 1.309 0 CA-C-N 124.258 2.557 . . . . 0.0 115.087 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 37.97 33.02 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.88 2.872 . . . . 0.0 114.049 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m 52.46 31.15 9.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.205 1.402 . . . . 0.0 112.846 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 C-N-CA 124.129 0.871 . . . . 0.0 112.877 -176.013 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 121.064 0.459 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -69.45 168.09 15.25 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.3 m -139.42 158.9 43.34 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.068 0.947 . . . . 0.0 110.526 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.52 165.67 35.89 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.696 1.598 . . . . 0.0 109.529 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.16 155.11 20.8 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.9 157.78 41.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.949 1.7 . . . . 0.0 109.052 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.72 117.53 51.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -137.78 150.4 47.19 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.53 138.27 2.68 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.1 m-85 -153.52 155.91 37.09 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -170.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.6 -33.88 72.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.402 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -65.7 -25.83 67.49 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.73 0.696 . . . . 0.0 112.536 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.42 82.06 8.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.677 1.126 . . . . 0.0 108.589 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -12.7 39.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.875 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.41 145.22 32.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.022 1.729 . . . . 0.0 108.381 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.472 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 15.2 m-70 -62.91 -31.27 72.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.384 1.074 . . . . 0.0 111.847 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -29.37 69.45 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.938 -0.477 . . . . 0.0 111.429 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.22 -45.44 84.69 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.48 0.582 . . . . 0.0 110.581 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -37.46 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.592 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.03 -45.96 86.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.483 1.492 . . . . 0.0 109.419 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.03 -48.34 71.43 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.763 0.425 . . . . 0.0 111.878 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -55.62 -54.97 37.5 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.683 0.793 . . . . 0.0 109.85 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.35 -43.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.022 -0.99 . . . . 0.0 108.664 -171.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.3 m -62.08 -29.03 70.03 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.008 1.276 . . . . 0.0 111.519 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.46 -51.09 55.33 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.43 1.014 . . . . 0.0 110.622 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.54 -44.89 92.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.972 0.886 . . . . 0.0 110.813 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -56.65 -45.72 81.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.294 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -70.33 -30.47 67.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.962 1.256 . . . . 0.0 112.327 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.18 -43.55 98.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.329 0.968 . . . . 0.0 109.694 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.44 -36.38 83.57 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.312 0.505 . . . . 0.0 110.368 171.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.32 -6.44 4.99 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.173 2.321 . . . . 0.0 113.281 170.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.6 171.88 9.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.724 1.61 . . . . 0.0 112.044 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -127.99 149.14 50.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -148.33 165.0 32.36 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -147.07 125.05 12.01 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.033 1.333 . . . . 0.0 108.263 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -67.73 111.59 4.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.9 mt -72.64 -24.61 61.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.934 -0.479 . . . . 0.0 110.62 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.34 -170.03 42.69 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.41 -174.01 28.6 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 171.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.0 -166.42 32.79 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -117.05 150.52 38.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.9 mt -118.97 136.69 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 123.608 0.763 . . . . 0.0 109.346 -169.863 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -121.71 126.64 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -166.07 1.51 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.611 -0.681 . . . . 0.0 110.509 -177.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.26 -160.9 53.44 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.84 -0.537 . . . . 0.0 111.804 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -154.04 155.13 34.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.366 1.467 . . . . 0.0 108.082 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.0 p -81.91 134.43 35.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -64.94 -29.26 70.18 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.835 -0.541 . . . . 0.0 110.647 170.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 -37.93 48.82 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.865 0.866 . . . . 0.0 112.756 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.32 1.38 3.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.61 -177.88 52.5 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 118.942 0.792 . . . . 0.0 111.921 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.67 134.44 28.19 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.641 2.228 . . . . 0.0 110.357 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 170.13 16.63 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.342 0.591 . . . . 0.0 110.225 169.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.03 79.05 3.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -58.89 -18.03 29.47 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.97 -39.19 74.14 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.668 0.787 . . . . 0.0 111.119 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.7 mm -61.8 -48.33 89.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -54.48 -52.03 63.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.735 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 p -60.46 -42.49 96.3 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.781 0.719 . . . . 0.0 111.822 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -60.94 -51.3 69.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.318 0.963 . . . . 0.0 110.825 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -71.08 -43.83 66.95 Favored 'General case' 0 C--N 1.334 -0.109 0 C-N-CA 123.35 0.66 . . . . 0.0 111.121 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.75 -43.26 97.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -63.02 -37.01 85.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 120.877 1.672 . . . . 0.0 111.228 176.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.6 93.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.098 0.863 . . . . 0.0 111.851 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -79.56 -20.06 47.93 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.24 0.616 . . . . 0.0 112.034 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.306 39.2 p90 . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 127.918 2.487 . . . . 0.0 115.969 -171.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.99 163.63 10.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.127 1.371 . . . . 0.0 107.752 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 p -137.39 171.84 13.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.744 1.218 . . . . 0.0 108.731 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -141.72 159.25 42.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.146 0.578 . . . . 0.0 110.173 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.685 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.54 -28.1 65.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.951 0.796 . . . . 0.0 112.706 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.68 66.53 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.829 1.195 . . . . 0.0 112.143 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.31 -31.07 17.09 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.633 1.173 . . . . 0.0 111.633 -175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.91 122.91 65.93 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.27 137.71 64.0 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.087 2.524 . . . . 0.0 111.141 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.63 -38.65 23.25 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 122.032 -0.417 . . . . 0.0 110.953 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.7 t -137.95 137.58 44.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -172.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -156.47 113.24 3.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 pt . . . . . 0 C--O 1.235 0.318 0 C-N-CA 124.294 1.038 . . . . 0.0 108.669 -173.224 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.39 163.24 12.96 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.804 0.842 . . . . 0.0 111.692 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.99 171.86 14.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.98 154.9 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.354 1.462 . . . . 0.0 108.477 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.2 tp -118.28 120.75 38.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.18 132.1 71.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 119.242 0.928 . . . . 0.0 109.411 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -76.08 146.22 39.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.9 121.16 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -90.45 149.26 22.3 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.734 0.814 . . . . 0.0 108.968 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -66.09 96.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.078 0.951 . . . . 0.0 109.911 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.443 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.25 19.3 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 116.254 -1.832 . . . . 0.0 115.229 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 33.1 Cg_exo -39.36 132.52 1.49 Allowed 'Trans proline' 0 C--N 1.361 1.191 0 CA-C-N 123.927 2.438 . . . . 0.0 114.545 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 43.35 26.61 0.1 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.454 2.702 . . . . 0.0 114.154 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.68 32.1 8.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 112.358 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 C-N-CA 123.958 0.79 . . . . 0.0 112.923 -173.955 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 121.07 0.462 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.37 172.96 7.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -137.07 160.81 37.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.761 0.824 . . . . 0.0 110.619 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -139.34 165.11 28.07 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.613 1.565 . . . . 0.0 108.249 172.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.61 138.45 45.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 pt -115.6 155.08 16.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.132 0.973 . . . . 0.0 109.834 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.62 122.65 69.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.466 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.1 mmt85 -136.72 148.17 47.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 125.56 0.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -146.61 151.01 36.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -171.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -53.89 -31.26 49.33 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -74.54 -24.45 58.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.851 0.751 . . . . 0.0 112.951 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 83.4 8.06 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.974 1.261 . . . . 0.0 109.37 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.76 -6.24 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.636 0.775 . . . . 0.0 112.293 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.94 143.9 28.82 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 108.186 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -62.1 -31.38 71.83 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.104 0.962 . . . . 0.0 111.659 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.73 -27.46 69.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.785 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.779 0.718 . . . . 0.0 110.234 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -40.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.109 -1.424 . . . . 0.0 110.342 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.07 -48.61 80.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.868 1.667 . . . . 0.0 109.742 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.32 -47.11 83.6 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.888 0.767 . . . . 0.0 111.542 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -60.89 -50.13 74.65 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.96 0.504 . . . . 0.0 110.77 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.466 HG21 ' HG3' ' A' ' 45' ' ' ARG . 67.5 t -74.2 -44.69 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.32 -171.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.8 p -62.04 -30.41 70.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.789 1.177 . . . . 0.0 110.398 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.19 54.0 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.16 0.891 . . . . 0.0 111.007 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -64.08 -45.51 88.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.371 1.085 . . . . 0.0 111.169 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.54 -45.04 85.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.625 0.648 . . . . 0.0 111.179 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.42 -31.83 72.29 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.004 -1.06 . . . . 0.0 111.819 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.54 -39.8 95.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.101 0.864 . . . . 0.0 110.417 171.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.35 -33.9 77.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.226 0.921 . . . . 0.0 110.447 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.55 -9.88 4.03 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 126.416 1.96 . . . . 0.0 113.217 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -65.69 173.64 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.923 1.689 . . . . 0.0 112.503 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.14 135.1 49.31 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 169.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.0 m -142.48 164.49 29.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.9 130.43 11.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -66.23 109.24 2.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.2 mt -66.87 -28.16 68.1 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.926 -0.484 . . . . 0.0 110.472 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.02 -168.2 41.35 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.43 -169.15 20.87 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.88 -162.82 28.52 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 -128.88 153.7 47.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -128.86 140.38 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 124.259 1.024 . . . . 0.0 108.451 -177.077 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.7 t60 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.19 126.7 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.45 -177.51 6.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.598 0.759 . . . . 0.0 110.496 -173.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -161.05 53.22 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -150.61 155.64 39.8 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 108.421 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 t -69.61 131.85 45.29 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.6 ttm -62.51 -26.32 68.49 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.521 0.328 . . . . 0.0 110.844 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.24 -30.05 13.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 112.587 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.01 1.66 4.29 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -168.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.74 -176.56 48.54 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.092 0.86 . . . . 0.0 112.279 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.34 131.6 22.18 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.721 2.281 . . . . 0.0 110.663 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.87 170.02 16.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 110.231 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.03 74.14 4.58 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.41 -18.82 19.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 113.399 -175.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.47 -38.82 69.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.424 0.69 . . . . 0.0 111.199 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.65 -43.98 97.95 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.928 0.891 . . . . 0.0 108.828 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -57.0 -50.35 72.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.64 0.655 . . . . 0.0 110.617 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 -48.56 73.92 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.813 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.94 -50.08 72.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.018 0.826 . . . . 0.0 110.878 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -68.33 -46.12 71.08 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.575 0.75 . . . . 0.0 110.671 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.98 -39.24 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.983 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.06 -36.76 82.73 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.158 1.799 . . . . 0.0 111.572 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.99 89.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.963 0.801 . . . . 0.0 110.958 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -70.04 -39.17 75.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.162 0.585 . . . . 0.0 111.289 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 t80 . . . . . 0 CA--C 1.54 0.568 0 C-N-CA 126.965 2.106 . . . . 0.0 109.592 -168.468 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.0 p -149.21 155.03 8.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 120.755 -1.216 . . . . 0.0 108.587 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.9 p -140.97 170.98 14.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.547 1.539 . . . . 0.0 107.785 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -145.61 168.19 21.25 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.661 -0.649 . . . . 0.0 111.425 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.653 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.232 0.157 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 mt -53.65 -30.71 44.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 113.468 -178.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.58 -24.8 56.66 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.889 0.768 . . . . 0.0 112.283 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.0 -21.56 29.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.967 0.907 . . . . 0.0 110.954 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.37 129.91 80.41 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.91 112.57 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 172.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.61 -30.09 64.06 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.584 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.4 139.09 23.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.977 1.711 . . . . 0.0 106.386 177.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -155.03 109.28 2.94 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--O 1.236 0.359 0 C-N-CA 124.333 1.053 . . . . 0.0 108.815 -173.268 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 . . . . . 0 C--O 1.233 0.188 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -81.24 159.96 24.4 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.46 169.25 17.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.87 155.4 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.019 1.327 . . . . 0.0 108.727 177.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -122.57 111.47 16.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 -175.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.78 134.72 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 118.81 0.732 . . . . 0.0 109.812 -171.259 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -79.16 147.87 32.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.182 1.393 . . . . 0.0 108.462 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 t -137.05 128.93 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -97.3 150.98 20.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.813 1.245 . . . . 0.0 109.952 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m -66.29 100.36 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.195 176.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.8 19.51 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.171 169.338 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 86.6 Cg_exo -46.51 140.31 12.09 Favored 'Trans proline' 0 C--N 1.362 1.277 0 CA-C-N 124.317 2.578 . . . . 0.0 113.879 173.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 42.96 25.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 114.269 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 m 50.33 33.44 7.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.979 1.312 . . . . 0.0 112.226 -174.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.884 0 C-N-CA 124.143 0.878 . . . . 0.0 112.165 -172.437 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -70.09 170.39 11.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -141.8 158.26 44.02 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.993 0.917 . . . . 0.0 110.034 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -153.07 165.69 34.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.199 1.4 . . . . 0.0 109.142 174.696 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.26 158.04 17.81 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -175.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.412 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 43.9 pt -136.62 158.61 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.006 1.323 . . . . 0.0 109.358 175.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 t -123.36 119.16 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -171.204 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mmt85 -138.25 145.96 41.97 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.45 133.9 1.92 Allowed Glycine 0 C--N 1.332 0.326 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.421 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.6 m-85 -155.64 156.93 35.86 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.378 0.671 . . . . 0.0 109.294 -171.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -32.75 72.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.359 0.664 . . . . 0.0 111.485 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.421 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.5 p-90 -65.98 -29.09 69.42 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 112.207 178.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 81.21 8.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.289 0.949 . . . . 0.0 108.451 171.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -62.16 -15.45 46.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 111.919 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.15 144.76 36.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.891 1.676 . . . . 0.0 108.446 176.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.538 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 7.4 m-70 -59.49 -31.66 69.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.217 1.407 . . . . 0.0 111.895 -175.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.07 69.67 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.664 177.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.1 -47.75 70.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.747 0.703 . . . . 0.0 110.393 -178.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -39.99 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.476 -1.249 . . . . 0.0 110.3 176.162 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.5 -47.17 86.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.566 1.53 . . . . 0.0 109.786 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.75 -48.51 78.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.604 0.638 . . . . 0.0 111.41 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -60.84 -51.18 70.4 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.62 -44.77 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.33 -173.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -60.52 -37.01 79.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.727 1.149 . . . . 0.0 109.515 176.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.67 84.83 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.877 0.762 . . . . 0.0 111.601 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.04 -47.19 81.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.564 1.182 . . . . 0.0 110.817 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mmt -56.95 -44.34 82.47 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.968 -0.457 . . . . 0.0 111.19 175.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -67.87 -33.36 74.59 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.249 -0.907 . . . . 0.0 111.768 179.168 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -63.05 -40.98 99.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.059 0.845 . . . . 0.0 110.018 171.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -63.03 -37.83 88.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.032 0.833 . . . . 0.0 110.098 171.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 140.39 -8.93 2.92 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.323 1.916 . . . . 0.0 113.324 169.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.7 m -68.92 175.13 3.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.455 1.502 . . . . 0.0 112.436 -170.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.51 143.24 50.75 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.7 m -144.22 169.64 17.49 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.14 137.92 15.3 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.313 1.045 . . . . 0.0 108.777 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -70.9 112.48 7.11 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 169.546 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.2 -25.43 63.41 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.132 -0.355 . . . . 0.0 110.335 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.89 -164.23 37.65 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.92 23.09 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.39 -157.1 19.13 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -175.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -129.28 165.73 20.85 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 117.977 0.888 . . . . 0.0 109.594 173.051 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.4 mt -131.3 137.18 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -169.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 N--CA 1.455 -0.216 0 C-N-CA 123.665 0.786 . . . . 0.0 109.886 -175.611 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.2 t60 . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.08 119.07 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -174.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -159.88 -177.01 6.03 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.208 -0.933 . . . . 0.0 111.144 -169.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.84 -158.49 44.78 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 177.128 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -143.94 151.91 40.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.603 1.561 . . . . 0.0 107.398 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.6 p -72.84 139.68 47.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.8 mmm -64.51 -6.88 8.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.76 -19.74 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.802 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.57 2.55 2.96 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 112.7 -171.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.2 -176.14 54.82 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.845 0.748 . . . . 0.0 112.332 178.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -72.0 137.04 28.46 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.725 2.283 . . . . 0.0 110.692 -179.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 174.81 10.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.388 0.613 . . . . 0.0 110.306 169.496 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -79.4 80.84 5.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 168.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -58.37 -16.08 13.15 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.83 88.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.461 0.704 . . . . 0.0 110.869 171.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.2 mt -60.05 -47.49 91.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 175.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -56.05 -55.72 29.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.515 1.126 . . . . 0.0 110.876 -177.215 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 p -65.46 -41.08 93.78 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.078 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.57 -44.39 94.21 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.744 1.156 . . . . 0.0 110.23 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -66.09 -43.3 87.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.42 -49.41 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.88 -39.12 84.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.585 1.084 . . . . 0.0 111.239 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.54 78.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.473 0.578 . . . . 0.0 111.48 177.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -76.98 -18.38 58.26 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 CA--C 1.549 0.918 0 C-N-CA 126.088 1.755 . . . . 0.0 113.288 177.125 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.5 m -138.06 171.38 15.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.519 0.728 . . . . 0.0 110.791 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.9 p -142.18 166.49 24.55 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.028 1.331 . . . . 0.0 108.636 -174.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -144.18 170.36 16.12 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.691 171.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.645 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 169.541 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 tpp . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.95 146.3 38.99 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.858 1.263 . . . . 0.0 108.226 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.8 137.08 22.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.465 0.706 . . . . 0.0 109.723 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.81 176.75 6.05 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 168.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -145.66 155.52 43.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 mt -52.21 -29.91 24.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.55 1.14 . . . . 0.0 113.469 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.71 -27.69 61.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 112.417 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.0 mt -83.25 -24.14 32.41 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 0.0 110.975 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.0 130.25 73.25 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.52 125.69 16.07 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.226 2.618 . . . . 0.0 109.78 171.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.77 -36.23 20.25 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.97 138.52 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -156.0 112.99 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.3 pt -143.28 153.38 16.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 109.136 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -72.78 170.06 15.43 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -148.32 16.58 1.04 Allowed 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.926 -1.109 . . . . 0.0 112.575 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -115.39 26.91 9.71 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -168.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.91 -121.12 1.0 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 120.878 -1.139 . . . . 0.0 112.957 170.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.65 127.51 64.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -160.96 167.94 25.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.006 1.322 . . . . 0.0 108.424 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -101.02 158.24 16.16 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.605 -0.684 . . . . 0.0 109.717 -173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.96 168.6 19.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.88 0.872 . . . . 0.0 109.446 -171.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.5 155.01 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.32 1.448 . . . . 0.0 108.335 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 tp -118.27 114.64 23.29 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 130.9 72.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -77.5 146.11 36.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.31 127.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.57 149.75 22.43 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 109.222 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -65.88 98.3 0.4 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.989 0.916 . . . . 0.0 110.75 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.496 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -148.52 18.02 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.281 -1.819 . . . . 0.0 115.123 169.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 55.8 Cg_exo -41.21 134.57 2.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 123.978 2.456 . . . . 0.0 114.5 171.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 47.23 21.54 0.2 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.021 2.528 . . . . 0.0 113.448 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.86 33.45 8.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.28 1.432 . . . . 0.0 112.659 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.65 10.08 2.13 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 113.82 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.33 149.74 75.36 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 118.509 1.155 . . . . 0.0 111.007 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.95 -4.44 13.33 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.373 2.715 . . . . 0.0 114.847 -169.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.18 -176.64 5.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.285 1.034 . . . . 0.0 110.314 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.1 38.74 3.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.915 1.686 . . . . 0.0 109.815 174.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.59 167.64 12.61 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -141.19 158.87 43.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.848 0.859 . . . . 0.0 110.412 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -151.52 166.08 32.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.845 1.658 . . . . 0.0 108.928 174.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -108.94 153.69 23.2 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.477 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 45.0 pt -129.82 155.28 41.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.854 1.262 . . . . 0.0 109.265 173.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.36 123.52 71.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -171.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.605 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.8 mmp_? -136.03 146.58 47.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.625 1.17 . . . . 0.0 108.478 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.13 129.84 1.44 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -150.78 151.92 33.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -60.19 -29.75 68.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.804 0.842 . . . . 0.0 112.479 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 -68.19 -28.03 66.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.33 0.968 . . . . 0.0 112.578 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.62 82.63 8.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.739 1.154 . . . . 0.0 108.913 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.12 -3.94 8.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.321 0.648 . . . . 0.0 112.355 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.33 142.95 26.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.818 1.647 . . . . 0.0 107.982 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.437 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 18.9 m-70 -60.92 -30.74 70.38 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 111.856 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.29 70.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.813 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.66 0.664 . . . . 0.0 110.431 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -41.57 86.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.216 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.93 -46.99 86.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.123 1.329 . . . . 0.0 110.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.88 -49.6 69.87 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.234 0.47 . . . . 0.0 111.331 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -58.84 -49.85 76.19 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.419 0.687 . . . . 0.0 110.839 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.605 HG21 ' HG3' ' A' ' 45' ' ' ARG . 85.1 t -73.47 -41.3 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.155 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m -62.36 -29.8 70.73 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 119.638 1.108 . . . . 0.0 110.895 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.6 -50.03 70.51 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -62.72 -47.77 82.15 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.194 0.997 . . . . 0.0 110.854 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.81 -43.99 90.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.965 -0.459 . . . . 0.0 111.302 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -68.78 -31.62 70.77 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.993 -1.067 . . . . 0.0 111.911 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -61.36 -43.69 98.44 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.421 1.01 . . . . 0.0 109.552 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -60.13 -43.04 95.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.513 1.052 . . . . 0.0 109.546 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.75 -7.17 1.69 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.333 1.92 . . . . 0.0 113.265 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.36 176.58 2.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.204 1.802 . . . . 0.0 113.216 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -130.03 140.51 50.85 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.4 m -146.45 163.34 35.98 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -153.58 128.71 9.69 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -66.75 116.71 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.4 -28.89 65.43 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.792 -0.568 . . . . 0.0 110.078 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.87 -169.37 42.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.1 -168.34 20.27 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.99 -161.22 26.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -121.37 153.53 37.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.445 1.098 . . . . 0.0 108.232 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 mt -125.28 135.04 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m -143.47 113.96 7.48 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.526 0.73 . . . . 0.0 109.951 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.33 133.13 35.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 168.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -118.17 133.36 55.97 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 m -59.56 -28.99 67.62 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -21.78 62.98 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.153 0.888 . . . . 0.0 113.389 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -153.54 140.89 19.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.918 1.235 . . . . 0.0 108.483 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -34.47 4.04 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.695 1.598 . . . . 0.0 112.978 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -46.16 140.11 4.15 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.119 2.168 . . . . 0.0 112.24 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.482 ' HB ' HG12 ' A' ' 118' ' ' VAL . 1.9 mt -97.28 158.36 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -130.63 150.43 51.82 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.31 -0.869 . . . . 0.0 108.93 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -128.11 122.42 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -173.04 3.96 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.41 -0.806 . . . . 0.0 111.21 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -160.15 53.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.02 153.77 35.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.45 1.1 . . . . 0.0 108.903 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.5 t -69.45 128.33 36.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.8 ttp -64.91 -17.24 64.16 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.355 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.69 -29.66 10.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.715 0.806 . . . . 0.0 112.638 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -127.4 0.08 6.3 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.75 -178.28 50.83 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.853 0.752 . . . . 0.0 112.144 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.1 131.04 19.96 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.635 2.223 . . . . 0.0 110.401 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.5 167.64 20.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.355 0.598 . . . . 0.0 109.557 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.14 77.7 5.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -57.76 -18.87 24.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.11 66.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.705 0.802 . . . . 0.0 111.21 169.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.44 -49.25 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -55.5 -48.32 74.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.001 0.521 . . . . 0.0 111.124 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.9 p -61.78 -44.83 96.11 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.476 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.43 -46.55 89.62 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.277 0.944 . . . . 0.0 110.571 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -62.27 -54.95 33.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.329 1.452 . . . . 0.0 110.684 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.735 0.814 . . . . 0.0 109.186 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -59.73 -40.2 87.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.287 0.949 . . . . 0.0 110.833 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.48 91.14 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.306 0.503 . . . . 0.0 111.201 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -81.71 -14.58 56.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 51.08 50.98 9.65 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.848 1.259 . . . . 0.0 113.228 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.75 -17.22 26.08 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.33 1.353 . . . . 0.0 112.101 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -143.74 -75.61 0.25 Allowed 'General case' 0 C--N 1.343 0.321 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.479 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.7 -74.08 0.09 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.75 1.159 . . . . 0.0 110.755 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -154.48 156.33 36.51 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 88' ' ' ILE . 29.9 m -141.47 164.7 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.107 0.563 . . . . 0.0 111.184 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.9 p -137.69 172.67 12.61 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 108.758 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -142.73 169.55 17.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.768 0.427 . . . . 0.0 110.417 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.18 143.1 29.05 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.87 41.22 0.9 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.198 0.999 . . . . 0.0 110.33 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -155.37 -172.91 4.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.898 1.679 . . . . 0.0 108.048 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.26 -162.88 37.07 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.233 0.92 . . . . 0.0 111.26 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 C--O 1.246 0.897 0 C-N-CA 125.937 1.695 . . . . 0.0 107.305 178.263 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 tpp . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.27 162.14 39.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.479 1.512 . . . . 0.0 108.212 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.63 137.97 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.32 178.21 5.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.57 0.748 . . . . 0.0 109.487 170.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -152.31 153.69 34.19 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.058 -1.027 . . . . 0.0 109.559 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.1 mt -55.51 -27.73 50.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.254 1.422 . . . . 0.0 113.524 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.0 -23.19 61.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.777 0.717 . . . . 0.0 112.564 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.52 -21.19 53.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.515 0.598 . . . . 0.0 111.315 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.07 134.97 96.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.278 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.74 106.95 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.27 2.647 . . . . 0.0 108.717 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.42 -33.51 73.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.9 t -142.6 138.2 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -150.64 103.35 3.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 pt -144.16 166.39 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.601 2.36 . . . . 0.0 106.641 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -149.35 133.58 17.34 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -74.27 40.26 0.13 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.97 2.108 . . . . 0.0 113.623 -169.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.27 -30.43 69.45 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.926 1.291 . . . . 0.0 112.834 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.73 -155.32 25.22 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.8 t -71.72 135.68 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -159.41 168.04 27.27 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.53 1.132 . . . . 0.0 109.09 171.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.05 155.09 17.29 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.931 0.492 . . . . 0.0 109.784 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.63 19.33 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.72 0.808 . . . . 0.0 108.966 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.86 153.59 17.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.767 1.227 . . . . 0.0 108.315 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.08 118.04 32.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.284 0.0 OUTLIER -130.02 130.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 118.373 0.533 . . . . 0.0 109.597 -172.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -80.63 147.33 30.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.792 1.637 . . . . 0.0 108.438 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.91 129.75 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -93.85 155.51 17.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.351 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 m -66.52 85.05 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.267 1.027 . . . . 0.0 111.555 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.512 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.19 13.14 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 116.23 -1.843 . . . . 0.0 114.041 169.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 52.0 Cg_exo -47.13 136.22 18.38 Favored 'Trans proline' 0 C--N 1.362 1.284 0 CA-C-N 124.02 2.472 . . . . 0.0 112.454 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 41.2 31.76 0.16 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.898 2.479 . . . . 0.0 113.847 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 32.0 12.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.897 1.679 . . . . 0.0 113.806 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.27 21.41 0.56 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.586 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.57 148.13 81.86 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 118.053 0.926 . . . . 0.0 110.598 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.85 -1.67 11.6 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.455 2.77 . . . . 0.0 114.359 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.73 -173.45 4.48 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.758 1.223 . . . . 0.0 109.979 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.94 37.83 3.57 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.591 1.556 . . . . 0.0 110.129 174.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -69.41 167.89 15.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -142.8 159.34 42.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.722 0.809 . . . . 0.0 109.652 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -149.22 164.43 34.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 109.195 174.17 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 150.37 27.63 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.432 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 37.6 pt -127.68 155.55 39.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.486 1.115 . . . . 0.0 108.872 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 t -122.34 116.46 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -169.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -136.51 147.27 47.01 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.98 138.31 3.71 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -154.16 155.92 36.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -173.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.75 -33.03 72.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.779 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -65.87 -27.04 67.92 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.756 0.707 . . . . 0.0 112.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.51 78.92 9.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.593 1.088 . . . . 0.0 109.117 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.96 -6.9 9.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.697 0.799 . . . . 0.0 112.102 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 142.53 29.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.981 1.713 . . . . 0.0 107.604 174.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.506 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 13.7 m-70 -62.15 -29.66 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.637 1.175 . . . . 0.0 111.663 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -29.18 68.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.034 -0.507 . . . . 0.0 111.757 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.26 -44.67 78.79 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.807 0.73 . . . . 0.0 110.725 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.415 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -70.53 -41.44 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.458 177.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.22 -45.12 94.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.54 1.064 . . . . 0.0 109.044 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.03 -48.11 80.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.163 0.892 . . . . 0.0 111.748 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -55.08 -56.78 15.94 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.974 0.909 . . . . 0.0 109.945 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.46 -43.62 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.599 -169.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 t -60.5 -35.58 76.28 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.075 1.307 . . . . 0.0 109.748 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.84 -48.16 86.78 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.165 0.893 . . . . 0.0 111.324 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.12 -46.66 83.15 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.143 0.972 . . . . 0.0 111.131 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.1 mmt -58.91 -43.77 91.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.694 0.679 . . . . 0.0 110.831 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -66.52 -33.37 75.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.859 -1.15 . . . . 0.0 111.27 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.94 -40.09 95.65 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.971 . . . . 0.0 110.389 169.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -64.59 -20.23 66.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.054 0.843 . . . . 0.0 111.49 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.47 -8.43 11.1 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.581 2.038 . . . . 0.0 112.723 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.24 178.55 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.826 1.65 . . . . 0.0 114.048 -169.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -132.31 145.1 51.03 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -147.57 165.57 29.98 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -168.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -150.51 130.95 13.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.658 1.183 . . . . 0.0 109.382 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -71.88 116.27 12.07 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -74.64 -24.96 58.91 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.97 -0.456 . . . . 0.0 110.418 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.49 -168.32 40.48 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.62 -167.87 22.69 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.31 -163.37 29.65 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.9 ttp-105 -119.49 154.43 33.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mt -113.19 126.98 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -150.06 152.47 34.87 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.837 0.855 . . . . 0.0 108.896 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.53 163.22 21.61 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.605 0.762 . . . . 0.0 110.647 171.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -130.65 151.73 50.79 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.242 1.017 . . . . 0.0 109.517 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -63.31 -16.82 61.51 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -170.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -60.34 -47.11 87.43 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.125 0.875 . . . . 0.0 111.14 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -162.53 21.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.084 0.954 . . . . 0.0 111.248 -173.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.8 mttp 56.62 18.36 3.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.57 1.548 . . . . 0.0 112.902 -169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -58.97 126.62 28.45 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.1 pt -63.5 150.06 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.88 0.848 . . . . 0.0 110.285 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -143.65 143.7 31.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.295 1.838 . . . . 0.0 106.702 -169.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 t -117.03 114.09 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.8 -173.23 4.0 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.637 -0.664 . . . . 0.0 111.945 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.7 -156.56 46.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -145.83 152.72 39.96 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.023 0.929 . . . . 0.0 109.084 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.2 t -69.32 130.46 42.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -64.81 -8.34 14.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.24 -27.71 6.37 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.153 0.981 . . . . 0.0 112.574 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -132.8 2.39 3.7 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.94 -177.27 48.17 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 119.246 0.93 . . . . 0.0 112.554 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 128.68 15.56 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.815 2.343 . . . . 0.0 110.902 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.87 167.24 22.25 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.499 0.666 . . . . 0.0 110.199 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -79.99 83.46 5.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 168.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -59.17 -14.82 11.75 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.37 84.47 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.154 0.982 . . . . 0.0 110.87 169.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.9 mm -62.19 -51.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -56.38 -51.18 69.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.801 0.84 . . . . 0.0 110.976 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 p -63.17 -42.78 99.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.337 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.67 -47.81 82.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.938 1.244 . . . . 0.0 110.74 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.259 0.481 . . . . 0.0 110.827 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.84 -51.17 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.18 -36.34 77.4 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.983 1.265 . . . . 0.0 110.846 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.36 68.33 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.406 0.548 . . . . 0.0 111.552 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -74.94 -19.32 60.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 t80 52.35 49.78 7.19 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.558 1.943 . . . . 0.0 113.639 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.93 -16.16 29.31 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.374 2.049 . . . . 0.0 111.36 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -145.5 169.82 17.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.398 2.279 . . . . 0.0 106.407 173.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -67.76 -38.64 83.72 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.863 0.865 . . . . 0.0 111.779 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -162.58 166.49 24.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 108.409 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.05 167.78 9.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.895 2.078 . . . . 0.0 107.862 173.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -142.45 170.11 16.31 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.657 1.583 . . . . 0.0 107.048 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -142.27 169.79 16.93 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.216 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.69 143.85 27.91 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -82.11 25.31 0.59 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.833 1.253 . . . . 0.0 111.852 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -154.18 -179.05 7.54 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.583 1.553 . . . . 0.0 107.725 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.7 175.52 15.95 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.631 1.586 . . . . 0.0 110.779 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 88.8 t80 . . . . . 0 C--O 1.246 0.916 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 175.918 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttm . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.1 158.27 7.09 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.43 0.692 . . . . 0.0 111.426 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 m -65.23 159.55 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.789 0.835 . . . . 0.0 110.656 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.62 171.4 4.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -147.96 156.52 42.76 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.097 0.959 . . . . 0.0 108.452 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.03 -28.24 64.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.622 0.769 . . . . 0.0 112.879 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.89 61.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.282 0.946 . . . . 0.0 112.363 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.13 -28.57 18.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.47 1.108 . . . . 0.0 110.957 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -55.91 129.09 71.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -50.44 133.24 36.93 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.273 2.649 . . . . 0.0 110.22 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.12 -42.35 9.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 137.09 43.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -156.42 118.18 3.9 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 169.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.9 pt -139.48 157.98 27.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.114 0.966 . . . . 0.0 109.131 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.02 90.07 3.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.696 1.599 . . . . 0.0 107.346 -176.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 m -72.31 54.18 0.3 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.834 2.453 . . . . 0.0 113.026 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -55.09 -45.84 75.44 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.759 1.223 . . . . 0.0 112.869 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.39 -39.34 0.86 Allowed Glycine 0 CA--C 1.524 0.624 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.466 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.2 t -149.08 120.15 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -160.32 164.95 32.13 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.438 1.095 . . . . 0.0 109.55 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -97.62 160.55 14.25 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.412 -0.805 . . . . 0.0 109.92 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 167.8 21.45 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.13 0.972 . . . . 0.0 108.791 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.12 155.17 15.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.351 1.06 . . . . 0.0 108.767 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -118.36 114.52 23.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -120.58 131.38 72.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.782 0.719 . . . . 0.0 109.231 -175.113 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -76.78 145.08 38.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.44 117.94 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.9 146.09 26.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.8 p -68.45 103.33 1.63 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.297 0.498 . . . . 0.0 109.853 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.455 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.66 25.02 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.655 -1.641 . . . . 0.0 114.753 169.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 49.9 Cg_exo -42.65 135.69 4.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 CA-C-N 123.827 2.402 . . . . 0.0 114.637 172.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 43.05 25.87 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.587 2.355 . . . . 0.0 114.518 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 51.47 33.35 10.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.814 1.245 . . . . 0.0 112.267 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.95 27.29 1.6 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.339 0.971 . . . . 0.0 112.34 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.59 87.67 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 117.638 0.719 . . . . 0.0 110.595 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.25 -10.34 19.2 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.072 2.515 . . . . 0.0 113.86 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.97 179.52 8.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.896 1.279 . . . . 0.0 109.88 -172.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.07 48.74 2.31 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.892 1.677 . . . . 0.0 109.156 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.01 178.08 6.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.843 0.857 . . . . 0.0 109.341 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -141.17 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.532 0.733 . . . . 0.0 110.725 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.07 162.62 32.85 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.84 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.12 136.26 49.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 pt -116.79 155.03 18.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.704 0.802 . . . . 0.0 109.627 172.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.8 123.85 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.0 mmt85 -137.57 148.46 45.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.294 1.038 . . . . 0.0 108.502 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.76 133.15 1.93 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -150.3 156.5 41.65 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -60.1 -35.38 75.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 119.177 -0.439 . . . . 0.0 111.497 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -65.4 -26.38 67.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.4 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.59 80.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.626 1.103 . . . . 0.0 108.428 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.7 -13.32 21.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.777 0.831 . . . . 0.0 111.777 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.24 143.51 31.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.417 1.887 . . . . 0.0 107.683 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -58.48 -30.0 66.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.962 1.305 . . . . 0.0 112.926 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.68 -27.96 69.57 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.593 . . . . 0.0 111.476 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.53 -46.74 78.42 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.313 0.506 . . . . 0.0 110.63 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -40.83 80.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.473 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -59.66 -47.62 84.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.791 1.632 . . . . 0.0 109.741 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.82 -47.65 82.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.794 0.724 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -61.24 -50.07 74.56 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.151 0.58 . . . . 0.0 110.845 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 45' ' ' ARG . 66.9 t -74.53 -44.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.452 -170.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.1 p -62.11 -30.94 71.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.923 1.238 . . . . 0.0 110.341 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.49 -52.23 54.35 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.96 -42.3 85.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.681 1.241 . . . . 0.0 111.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.22 -43.33 82.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.406 1.003 . . . . 0.0 111.095 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -68.9 -29.89 68.27 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.966 -1.084 . . . . 0.0 112.285 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -62.36 -42.32 99.3 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.358 0.981 . . . . 0.0 109.071 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.09 -38.08 89.57 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.349 0.522 . . . . 0.0 110.314 172.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.65 -8.91 3.12 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.18 1.848 . . . . 0.0 113.459 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.9 m -66.69 171.28 5.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.678 1.591 . . . . 0.0 112.256 -169.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.35 136.6 54.22 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 169.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 54.2 m -142.27 165.36 27.64 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.2 131.71 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -68.32 109.56 3.68 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.6 mt -64.97 -28.17 69.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.722 0.409 . . . . 0.0 110.082 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.69 -167.55 40.7 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.76 -164.01 20.37 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.1 -159.65 23.64 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -125.5 154.13 42.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mt -129.83 139.49 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.1 m -151.84 163.85 38.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -60.15 151.44 26.95 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 169.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -61.84 157.14 18.9 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 169.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.4 m -69.19 17.42 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.349 1.46 . . . . 0.0 113.648 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.66 -18.69 0.27 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.214 1.406 . . . . 0.0 113.037 -172.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -161.49 154.76 21.21 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.655 1.116 . . . . 0.0 109.259 -171.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.95 -20.34 63.71 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.008 -0.996 . . . . 0.0 113.419 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -44.17 122.5 2.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.098 1.359 . . . . 0.0 109.087 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -83.22 160.59 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 122.003 0.906 . . . . 0.0 111.479 -176.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -141.44 140.64 33.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.921 2.088 . . . . 0.0 106.885 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.12 129.65 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -159.77 -174.69 4.73 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.349 -0.844 . . . . 0.0 110.903 -170.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.81 -161.42 53.43 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.942 -0.474 . . . . 0.0 112.3 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -151.31 152.26 32.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 109.643 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 m -79.6 130.9 35.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 tpt -60.63 -35.26 75.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.903 0.481 . . . . 0.0 111.258 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.08 -16.89 24.46 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.73 -5.9 5.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -169.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.72 178.08 42.94 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.823 0.725 . . . . 0.0 112.098 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.55 135.38 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.671 2.248 . . . . 0.0 109.814 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.13 169.91 16.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 110.152 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -79.68 82.78 5.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -58.45 -18.28 27.34 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.66 -38.4 72.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.502 1.121 . . . . 0.0 111.846 169.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 14.6 mm -62.8 -49.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.9 m -56.58 -52.49 64.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.772 0.829 . . . . 0.0 111.325 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -62.08 -43.61 98.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.995 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.23 -47.93 83.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.499 1.045 . . . . 0.0 110.761 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -64.36 -47.11 80.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.303 0.501 . . . . 0.0 110.986 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -48.3 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -61.92 -38.81 89.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.34 1.427 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.29 97.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.552 0.615 . . . . 0.0 111.922 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -87.95 -12.95 43.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.632 0.651 . . . . 0.0 112.682 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.301 40.5 p90 42.67 54.33 9.56 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 128.56 2.744 . . . . 0.0 116.422 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -56.34 -29.49 77.08 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.993 1.795 . . . . 0.0 110.89 168.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -138.68 161.22 37.7 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.11 2.564 . . . . 0.0 105.542 169.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -61.21 -33.26 73.19 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -158.49 161.38 37.38 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.828 1.251 . . . . 0.0 107.945 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 m -144.74 170.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.75 1.62 . . . . 0.0 108.143 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -141.39 171.59 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.253 1.421 . . . . 0.0 108.481 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -145.93 164.23 32.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.756 0.707 . . . . 0.0 111.735 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.39 25.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -81.98 42.14 0.7 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.984 1.314 . . . . 0.0 111.037 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -143.05 -160.78 1.15 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.951 1.7 . . . . 0.0 108.047 -170.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.27 -23.92 3.16 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 120.64 -1.287 . . . . 0.0 114.166 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 . . . . . 0 C--O 1.25 1.085 0 C-N-CA 128.763 2.825 . . . . 0.0 113.178 169.722 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 119.414 -0.326 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.91 166.5 30.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.111 1.364 . . . . 0.0 108.897 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.6 167.02 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.995 1.318 . . . . 0.0 107.709 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.82 174.54 10.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.722 1.609 . . . . 0.0 107.672 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -153.58 160.51 42.47 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.349 1.06 . . . . 0.0 108.84 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.8 mt -49.35 -34.25 15.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.181 1.392 . . . . 0.0 112.725 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.13 -24.51 67.19 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.4 mt -79.45 -19.95 48.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.097 0.559 . . . . 0.0 111.517 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mt -70.19 133.43 87.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.79 140.71 68.57 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.41 2.073 . . . . 0.0 108.973 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -86.33 -38.84 17.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.69 140.58 27.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -157.49 117.25 3.38 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 pt -139.02 175.03 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.332 1.053 . . . . 0.0 109.918 -171.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -123.95 53.03 1.41 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.039 1.336 . . . . 0.0 111.745 -168.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -53.99 3.18 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.355 3.062 . . . . 0.0 117.474 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -68.04 -19.69 64.91 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.964 1.305 . . . . 0.0 113.035 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.73 -158.41 11.22 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.795 0.712 . . . . 0.0 111.588 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.9 t -85.45 131.88 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -156.54 167.6 29.94 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.965 1.306 . . . . 0.0 109.014 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.24 154.94 18.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.239 0.616 . . . . 0.0 109.778 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 169.79 16.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.488 0.715 . . . . 0.0 109.551 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.46 153.68 16.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.291 1.436 . . . . 0.0 108.319 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.7 tp -117.1 114.86 24.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.31 132.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.57 147.45 33.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.599 1.16 . . . . 0.0 107.895 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.22 125.85 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -97.11 146.23 25.23 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.679 1.192 . . . . 0.0 108.941 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 m -63.84 100.96 0.33 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.262 0.483 . . . . 0.0 111.025 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.592 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -147.85 9.76 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 116.094 -1.908 . . . . 0.0 114.602 169.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 88.4 Cg_exo -44.7 140.33 6.63 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 124.14 2.514 . . . . 0.0 114.58 174.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? 43.66 24.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.75 2.42 . . . . 0.0 114.117 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.17 30.26 4.17 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.158 1.383 . . . . 0.0 112.327 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.73 5.47 0.42 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.974 -170.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.98 147.82 11.93 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 118.71 1.255 . . . . 0.0 110.548 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.37 -2.21 11.77 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.669 2.913 . . . . 0.0 116.422 -169.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 -173.8 4.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.907 1.231 . . . . 0.0 111.08 -170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.72 48.89 2.18 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.613 1.965 . . . . 0.0 108.518 170.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -77.25 -174.19 3.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.3 m -150.8 160.52 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.778 -1.201 . . . . 0.0 109.974 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 165.11 33.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.643 1.577 . . . . 0.0 108.636 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.25 154.95 21.05 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 pt -134.39 155.44 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.9 1.28 . . . . 0.0 109.042 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -118.38 120.79 65.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -135.26 148.69 49.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.26 140.9 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 39.2 m-85 -151.99 152.82 32.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -60.05 -32.31 70.81 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.828 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.403 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.2 p-90 -65.84 -27.78 68.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.683 0.674 . . . . 0.0 112.41 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 78.07 9.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.565 1.075 . . . . 0.0 108.816 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.5 -5.59 8.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.414 0.686 . . . . 0.0 112.08 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 140.09 27.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.086 1.754 . . . . 0.0 107.472 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.526 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.7 m-70 -61.98 -31.12 71.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.596 1.158 . . . . 0.0 111.703 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 -29.39 67.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.728 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.86 -48.02 72.98 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.735 0.698 . . . . 0.0 110.466 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -40.6 82.33 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 117.473 -1.251 . . . . 0.0 110.013 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.1 -46.93 84.71 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.574 1.534 . . . . 0.0 110.137 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.45 -49.51 68.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.254 0.479 . . . . 0.0 111.45 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -60.83 -49.52 77.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.2 0.6 . . . . 0.0 110.955 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.73 -44.51 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.952 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -62.7 -28.29 69.84 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.637 1.108 . . . . 0.0 111.195 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.6 56.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.34 -45.78 86.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.194 0.997 . . . . 0.0 110.96 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.5 mmt -57.78 -45.09 86.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.702 0.683 . . . . 0.0 111.14 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.32 -32.12 72.87 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.946 -1.096 . . . . 0.0 111.814 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -63.72 -37.71 88.39 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.266 0.939 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -66.94 -34.86 78.69 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.216 0.916 . . . . 0.0 110.235 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.6 -6.46 3.86 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.548 2.023 . . . . 0.0 113.106 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.06 178.45 1.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.922 1.689 . . . . 0.0 113.001 -169.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -132.34 142.11 49.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.6 m -145.86 164.27 32.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.87 128.55 10.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 p -71.69 112.27 7.66 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 110.372 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.0 -166.85 39.73 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -163.82 -169.14 26.9 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.46 -160.86 24.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.17 156.82 32.89 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mt -126.36 146.93 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.6 m -149.91 165.79 31.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.608 1.563 . . . . 0.0 108.405 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -130.97 150.26 52.2 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.375 1.47 . . . . 0.0 108.634 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -141.19 147.52 38.49 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.685 1.194 . . . . 0.0 108.688 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 p -115.42 3.05 14.05 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.878 1.271 . . . . 0.0 112.321 -172.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -65.8 -33.7 76.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.327 0.651 . . . . 0.0 109.976 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -143.09 27.14 1.62 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.135 1.374 . . . . 0.0 110.876 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt 38.09 77.48 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.555 2.342 . . . . 0.0 112.86 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -136.88 154.32 50.52 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.559 0.695 . . . . 0.0 111.044 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mm -104.74 153.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -134.28 139.28 45.6 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.01 122.69 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -159.96 -176.36 5.64 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.61 -0.681 . . . . 0.0 111.488 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.66 -160.29 51.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -145.34 151.28 38.05 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.857 1.263 . . . . 0.0 108.057 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.1 p -69.85 147.88 49.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.027 0.441 . . . . 0.0 110.526 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.0 ttp -58.33 -22.47 53.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.478 1.111 . . . . 0.0 112.959 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.66 -14.89 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.0 4.78 3.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.214 1.37 . . . . 0.0 112.794 -170.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.69 -175.4 51.79 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 118.518 0.599 . . . . 0.0 112.251 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 136.73 28.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.73 2.287 . . . . 0.0 110.538 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.1 171.51 14.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.572 0.701 . . . . 0.0 110.27 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -77.74 74.67 4.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -58.31 -17.89 23.14 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.29 70.6 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.373 0.669 . . . . 0.0 111.479 169.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.6 -45.38 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.776 0.83 . . . . 0.0 108.794 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -59.39 -49.12 79.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.723 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 p -57.97 -46.16 85.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.718 0.69 . . . . 0.0 111.47 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -61.0 -48.83 79.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.087 0.858 . . . . 0.0 110.472 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -72.71 -42.96 63.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.942 -0.474 . . . . 0.0 111.534 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.452 HG23 ' CG ' ' A' ' 114' ' ' PRO . 87.3 mt -64.23 -42.32 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.82 -40.24 91.99 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.896 1.68 . . . . 0.0 111.058 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.4 -42.28 98.78 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.447 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.81 -28.18 64.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.226 1.011 . . . . 0.0 112.104 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 46.25 56.39 16.25 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.173 1.389 . . . . 0.0 113.263 -169.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.452 ' CG ' HG23 ' A' ' 109' ' ' ILE . 67.1 Cg_endo -71.92 -17.63 28.61 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.462 2.108 . . . . 0.0 110.04 169.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.76 -177.63 5.82 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 128.279 2.632 . . . . 0.0 106.375 169.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -71.16 -45.17 64.05 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.039 0.836 . . . . 0.0 112.82 -169.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -156.48 170.87 21.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.042 0.837 . . . . 0.0 109.314 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.41 ' CG2' HG22 ' A' ' 109' ' ' ILE . 2.5 t -141.35 154.48 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.485 . . . . 0.0 107.873 -169.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -139.62 169.57 17.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 108.383 172.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -144.55 170.15 16.61 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.777 -0.577 . . . . 0.0 111.135 172.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.35 143.35 30.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.74 25.58 1.25 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.023 0.929 . . . . 0.0 111.459 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -155.34 178.18 10.51 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.693 1.597 . . . . 0.0 107.934 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.63 173.2 15.75 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.066 1.793 . . . . 0.0 110.761 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 82.0 t80 . . . . . 0 C--O 1.246 0.92 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.355 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.39 164.12 36.66 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.038 1.335 . . . . 0.0 108.831 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.1 t -137.75 157.6 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.73 174.84 10.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.885 1.674 . . . . 0.0 107.474 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.48 155.26 38.18 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.876 0.871 . . . . 0.0 109.098 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.3 mt -50.93 -34.15 27.34 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.77 1.228 . . . . 0.0 112.859 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.52 -23.29 66.84 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.66 0.664 . . . . 0.0 112.579 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.0 mt -77.01 -19.93 56.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.115 0.566 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -69.61 129.72 91.15 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.13 2.553 . . . . 0.0 109.634 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -95.45 -40.24 9.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -169.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.73 134.32 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -157.48 119.2 3.7 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.7 pt -140.76 158.4 23.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.217 1.007 . . . . 0.0 109.407 -172.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -65.1 172.96 2.65 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.829 1.252 . . . . 0.0 112.632 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -135.86 -1.23 2.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.225 1.81 . . . . 0.0 111.765 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -59.12 -42.67 91.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.336 0.971 . . . . 0.0 112.754 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.61 -58.25 0.34 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.29 133.34 39.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -161.76 173.01 15.23 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.798 1.239 . . . . 0.0 109.399 -173.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -107.88 156.52 19.09 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.73 170.61 15.53 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.47 0.708 . . . . 0.0 109.668 -172.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.83 153.51 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.541 1.536 . . . . 0.0 108.663 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.23 116.1 27.18 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 135.02 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 119.08 0.854 . . . . 0.0 109.411 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -82.18 149.29 28.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.751 1.22 . . . . 0.0 108.186 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.79 141.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -114.61 154.0 29.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.872 1.269 . . . . 0.0 109.59 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m -68.69 80.14 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.729 1.211 . . . . 0.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.422 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -134.84 11.1 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 116.028 -1.939 . . . . 0.0 115.179 169.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 77.9 Cg_exo -44.18 137.39 7.52 Favored 'Trans proline' 0 C--N 1.362 1.255 0 CA-C-N 124.248 2.553 . . . . 0.0 113.668 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 45.92 22.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.711 2.404 . . . . 0.0 114.205 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 49.89 30.71 4.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.962 1.305 . . . . 0.0 112.051 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.78 -7.75 0.23 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.756 -170.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.11 142.81 56.35 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 119.004 1.402 . . . . 0.0 110.314 170.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.17 164.55 35.37 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.692 2.261 . . . . 0.0 111.437 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 57.16 -167.96 0.12 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.835 2.054 . . . . 0.0 113.669 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.01 38.3 2.35 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.35 1.86 . . . . 0.0 108.995 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.01 166.24 16.26 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -139.23 158.29 44.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.972 0.909 . . . . 0.0 109.928 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.94 164.14 37.06 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.028 1.331 . . . . 0.0 109.047 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.32 154.94 21.09 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.52 155.42 38.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.264 1.426 . . . . 0.0 108.858 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.6 123.38 70.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -135.2 148.72 49.74 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.035 0.934 . . . . 0.0 108.619 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.47 136.86 3.82 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 171.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -150.46 151.05 32.14 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.14 -39.34 82.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.672 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -60.22 -30.25 69.27 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.106 0.866 . . . . 0.0 112.63 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.28 75.42 9.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.176 0.898 . . . . 0.0 108.767 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.59 -8.16 9.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.19 0.596 . . . . 0.0 112.081 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.66 138.43 36.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.59 1.956 . . . . 0.0 107.253 175.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.506 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.0 m-70 -60.66 -29.93 69.59 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.674 1.19 . . . . 0.0 112.027 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.76 69.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.439 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.63 -46.12 76.86 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.511 0.596 . . . . 0.0 110.919 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -42.01 83.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 117.288 -1.339 . . . . 0.0 110.243 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.97 -46.18 90.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 120.635 1.561 . . . . 0.0 109.901 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.36 -48.79 78.2 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.805 0.73 . . . . 0.0 111.365 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -62.17 -49.65 74.97 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.131 0.572 . . . . 0.0 111.045 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.48 -45.34 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.515 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -60.58 -36.1 77.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.678 1.126 . . . . 0.0 109.463 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.13 -50.36 66.91 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 118.899 0.772 . . . . 0.0 111.503 172.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.37 -46.93 84.24 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.544 1.172 . . . . 0.0 111.07 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.7 mmt -57.96 -45.93 85.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.774 0.715 . . . . 0.0 110.985 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -65.6 -32.59 74.25 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.027 -1.045 . . . . 0.0 111.459 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -63.42 -42.92 98.74 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 109.701 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -60.37 -40.16 89.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.295 0.952 . . . . 0.0 109.504 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.66 -7.08 1.94 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.415 1.959 . . . . 0.0 113.09 169.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.74 179.17 1.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.14 1.776 . . . . 0.0 113.672 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -131.86 144.74 51.1 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m -148.05 169.33 20.19 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.817 0.735 . . . . 0.0 112.641 -168.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.52 138.96 15.84 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.267 1.027 . . . . 0.0 109.012 169.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -70.96 118.1 13.3 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.9 -26.01 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.99 -0.444 . . . . 0.0 110.284 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.0 -166.95 38.45 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -160.6 -168.02 21.93 Favored Glycine 0 C--O 1.235 0.211 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.56 -155.37 15.57 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.81 153.01 52.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.844 1.258 . . . . 0.0 108.073 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.0 mt -136.07 141.49 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.7 m -145.01 154.42 42.51 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.284 1.034 . . . . 0.0 111.238 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.75 152.6 9.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.047 2.539 . . . . 0.0 106.16 168.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -146.61 169.89 18.04 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.43 0.692 . . . . 0.0 109.531 -172.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.7 m -59.05 -29.52 67.36 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.747 -0.595 . . . . 0.0 111.412 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -63.27 -38.53 91.52 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.25 1.02 . . . . 0.0 111.116 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -158.96 110.7 2.14 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.498 1.119 . . . . 0.0 108.982 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -78.08 -15.69 58.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.948 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 127.62 33.0 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 72.1 mt -66.6 159.85 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -141.28 149.8 41.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.05 133.15 64.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -159.55 -175.05 4.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.14 -0.975 . . . . 0.0 110.249 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.87 -161.68 54.3 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 121.668 0.593 . . . . 0.0 112.32 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -150.83 153.15 34.86 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.605 1.562 . . . . 0.0 107.785 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 t -67.57 133.17 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.3 ttp -54.72 -27.01 37.65 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.696 1.198 . . . . 0.0 111.841 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.87 -24.7 8.53 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.665 0.786 . . . . 0.0 112.896 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.11 4.39 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.68 -175.75 40.39 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 118.957 0.799 . . . . 0.0 112.555 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.42 132.88 24.83 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.432 2.088 . . . . 0.0 110.33 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.22 173.6 8.39 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.478 0.656 . . . . 0.0 110.87 169.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -76.97 73.06 3.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.41 -19.08 21.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.32 65.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.454 0.701 . . . . 0.0 111.011 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -61.14 -50.39 80.71 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.2 m -56.01 -48.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.595 0.758 . . . . 0.0 110.776 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 p -59.19 -47.36 85.61 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.082 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.02 -46.59 89.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.528 1.058 . . . . 0.0 110.581 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -68.22 -47.27 68.31 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.562 0.745 . . . . 0.0 111.034 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.88 -37.31 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.934 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -63.06 -45.31 92.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 121.378 1.899 . . . . 0.0 110.819 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.5 89.0 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.454 0.57 . . . . 0.0 111.773 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.04 -17.17 28.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.254 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.253 30.6 p90 38.84 64.7 3.55 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 127.381 2.272 . . . . 0.0 114.093 -175.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.41 -24.81 17.09 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.287 2.658 . . . . 0.0 114.058 169.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -129.68 -68.37 0.72 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.059 0.944 . . . . 0.0 109.368 169.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -165.07 -50.69 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.913 0.885 . . . . 0.0 109.996 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -152.9 167.52 28.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.517 1.127 . . . . 0.0 108.369 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.03 158.31 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.819 1.647 . . . . 0.0 108.071 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 p -135.66 176.01 9.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.639 1.176 . . . . 0.0 108.617 169.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -139.37 166.65 23.98 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.865 -0.522 . . . . 0.0 111.282 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.65 143.15 30.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.522 1.129 . . . . 0.0 108.115 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -90.24 47.89 1.5 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.303 1.041 . . . . 0.0 110.361 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -151.07 -179.42 7.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.549 1.14 . . . . 0.0 109.346 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.82 -163.33 53.7 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.991 1.282 . . . . 0.0 111.757 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 125.913 1.685 . . . . 0.0 106.984 -179.822 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.735 0.302 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.61 162.0 35.69 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.153 1.381 . . . . 0.0 108.154 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.9 m -66.41 167.49 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.173 0.989 . . . . 0.0 112.229 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.05 -176.96 4.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.902 2.081 . . . . 0.0 105.761 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -143.04 153.2 42.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 mt -50.5 -34.87 26.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.32 1.048 . . . . 0.0 112.957 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.13 -24.13 64.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.699 0.681 . . . . 0.0 112.549 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.31 -19.63 42.47 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.633 0.773 . . . . 0.0 111.253 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.28 132.75 92.71 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.026 0.931 . . . . 0.0 108.694 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.4 109.91 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.489 2.793 . . . . 0.0 110.045 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -76.49 -38.19 55.67 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -169.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.09 124.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -146.21 102.49 3.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.8 pt -134.18 150.68 31.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.02 -169.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -90.76 63.74 5.41 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.916 1.686 . . . . 0.0 110.249 -173.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -59.71 -2.84 0.41 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.708 1.603 . . . . 0.0 114.737 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.49 -22.42 66.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.789 1.236 . . . . 0.0 112.931 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.09 -175.82 38.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 118.735 0.698 . . . . 0.0 112.736 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.82 104.93 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -142.89 166.94 23.28 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.29 1.036 . . . . 0.0 109.51 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -84.25 162.08 20.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.776 -0.578 . . . . 0.0 110.821 -175.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.16 171.86 13.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.356 1.063 . . . . 0.0 109.492 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.93 153.59 17.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.978 1.311 . . . . 0.0 108.035 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 tp -116.89 115.63 25.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.19 133.41 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 118.918 0.781 . . . . 0.0 110.007 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -77.96 147.66 34.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.014 1.326 . . . . 0.0 107.642 169.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.68 141.22 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -117.41 141.34 48.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.301 1.441 . . . . 0.0 108.16 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 m -64.16 106.97 1.17 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.574 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.625 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.01 17.39 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.935 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.625 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.0 Cg_exo -42.3 133.43 4.75 Favored 'Trans proline' 0 C--N 1.365 1.436 0 CA-C-N 123.733 2.369 . . . . 0.0 115.261 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 41.9 32.65 0.29 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.595 2.758 . . . . 0.0 113.179 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m 52.96 29.76 8.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.607 1.563 . . . . 0.0 113.0 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.0 -0.28 0.66 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.304 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.35 145.59 57.19 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 118.954 1.377 . . . . 0.0 110.851 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -80.7 1.37 9.35 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.759 2.972 . . . . 0.0 115.899 -169.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.59 179.16 7.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.794 1.179 . . . . 0.0 111.331 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.89 35.68 2.85 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.228 1.811 . . . . 0.0 110.276 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.94 170.18 11.75 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -138.76 159.02 43.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.908 0.883 . . . . 0.0 110.543 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.55 36.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.722 1.609 . . . . 0.0 109.306 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -108.77 156.95 19.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 pt -137.02 159.02 36.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.961 1.705 . . . . 0.0 109.518 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.7 t -124.24 119.17 55.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.0 mmt85 -139.61 148.45 42.5 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.93 136.47 2.75 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.047 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 15.6 m-85 -153.0 156.01 38.02 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.259 0.623 . . . . 0.0 111.45 -169.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -35.61 61.34 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.418 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-90 -71.6 -25.44 62.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.215 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.71 80.38 9.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.317 0.962 . . . . 0.0 109.142 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.71 -9.15 17.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.418 0.687 . . . . 0.0 112.069 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.17 142.45 30.55 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.049 1.739 . . . . 0.0 107.604 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -61.98 -30.06 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.81 0.844 . . . . 0.0 111.735 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.38 68.16 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.749 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.49 -47.68 69.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.574 0.624 . . . . 0.0 110.655 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -38.56 79.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 117.456 -1.259 . . . . 0.0 110.243 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -58.95 -46.38 88.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.584 1.538 . . . . 0.0 109.932 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.69 -50.21 67.86 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.38 0.536 . . . . 0.0 111.418 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -61.29 -46.84 88.64 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 122.8 0.44 . . . . 0.0 111.158 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.74 -36.34 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.43 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.83 -29.89 70.47 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.137 1.335 . . . . 0.0 110.764 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.23 -49.0 55.89 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.405 1.002 . . . . 0.0 111.135 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -57.01 -44.71 83.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.823 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mmt -69.02 -41.64 77.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.724 -0.61 . . . . 0.0 112.231 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -69.24 -29.95 67.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.36 1.436 . . . . 0.0 111.714 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -61.5 -43.09 99.49 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.988 0.915 . . . . 0.0 109.167 169.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.84 -37.07 85.34 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.441 0.564 . . . . 0.0 110.287 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.98 -6.69 5.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 127.252 2.358 . . . . 0.0 112.944 172.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.46 177.32 4.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.514 1.925 . . . . 0.0 112.78 -169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -127.92 151.09 49.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 55.9 m -147.72 168.49 21.96 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.04 126.47 7.34 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.19 1.396 . . . . 0.0 108.002 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.08 118.79 11.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.38 -26.67 61.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.722 0.409 . . . . 0.0 110.252 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.67 -171.94 42.35 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.18 -173.75 20.09 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.88 -158.79 23.32 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -127.94 153.58 46.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.969 1.308 . . . . 0.0 108.725 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.53 130.55 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.3 m -131.91 150.85 52.03 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.883 -169.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -157.48 -50.56 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.813 0.845 . . . . 0.0 110.28 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 47.42 22.95 0.31 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.416 1.886 . . . . 0.0 113.621 -175.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m 49.54 27.85 2.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.72 1.608 . . . . 0.0 113.164 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -68.83 -34.11 74.95 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.778 -0.576 . . . . 0.0 112.153 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -169.58 175.15 5.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.627 1.971 . . . . 0.0 107.255 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.432 ' HE2' ' CG ' ' A' ' 116' ' ' TYR . 20.0 ptmt -72.02 59.46 0.37 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.751 1.22 . . . . 0.0 110.071 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -150.78 144.4 25.07 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.162 1.785 . . . . 0.0 107.588 -172.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.519 ' HB ' HG12 ' A' ' 118' ' ' VAL . 39.7 mt -132.27 154.84 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 173.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -134.15 148.04 50.89 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.172 0.989 . . . . 0.0 108.746 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -134.29 114.91 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.25 172.9 17.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.206 1.002 . . . . 0.0 108.325 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.06 -165.39 24.33 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.91 1.232 . . . . 0.0 113.066 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -153.78 154.83 34.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.791 2.036 . . . . 0.0 107.388 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.2 m -139.1 106.17 5.46 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -56.45 -28.5 59.75 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.05 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.211 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -135.6 -7.89 2.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.02 171.32 45.97 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.018 0.818 . . . . 0.0 111.138 -169.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.51 144.77 36.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.626 2.218 . . . . 0.0 109.564 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 167.71 18.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 109.397 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -65.86 -31.54 72.54 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.53 0.732 . . . . 0.0 112.022 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.8 m80 58.21 -30.78 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.111 2.964 . . . . 0.0 115.983 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.86 75.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.776 1.171 . . . . 0.0 111.479 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 mm -58.98 -54.42 34.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.5 m -53.62 -50.55 65.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.294 1.038 . . . . 0.0 111.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 p -60.96 -41.69 96.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.232 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.1 -45.71 87.44 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.475 1.034 . . . . 0.0 110.053 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -64.7 -43.81 92.29 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 122.055 -0.403 . . . . 0.0 110.965 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.405 HG21 HG11 ' A' ' 118' ' ' VAL . 52.0 mt -62.9 -45.74 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.89 0.876 . . . . 0.0 108.956 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -62.78 -29.91 71.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.897 1.226 . . . . 0.0 111.566 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.58 -43.95 71.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.012 1.278 . . . . 0.0 111.193 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -71.62 -26.89 62.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.915 0.886 . . . . 0.0 112.595 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 46.42 55.85 16.08 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.558 1.543 . . . . 0.0 113.864 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.37 -18.14 30.1 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.037 1.825 . . . . 0.0 110.361 169.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -145.63 177.89 8.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.763 2.425 . . . . 0.0 106.462 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.432 ' CG ' ' HE2' ' A' ' 86' ' ' LYS . 81.5 t80 -67.5 -49.37 63.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.047 0.939 . . . . 0.0 112.319 -169.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -158.34 157.98 33.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 88' ' ' ILE . 29.6 m -139.48 167.94 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.575 0.75 . . . . 0.0 111.417 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -140.85 171.37 14.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.346 1.458 . . . . 0.0 109.277 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -142.6 171.93 13.38 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.228 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.75 143.7 29.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -84.33 33.42 0.5 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.496 1.118 . . . . 0.0 111.337 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -154.74 -171.84 3.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.41 1.484 . . . . 0.0 108.461 -171.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.14 155.35 15.04 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.717 1.627 . . . . 0.0 110.608 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.011 1.724 . . . . 0.0 107.267 177.823 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.29 164.87 34.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.181 1.392 . . . . 0.0 108.537 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.67 161.52 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.577 1.151 . . . . 0.0 107.957 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.26 176.37 10.04 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.086 1.754 . . . . 0.0 107.162 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.1 155.77 40.44 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.023 0.929 . . . . 0.0 109.025 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.0 mt -50.17 -33.97 20.93 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.763 1.225 . . . . 0.0 113.114 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.89 67.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.685 0.675 . . . . 0.0 112.558 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.21 -19.71 53.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.325 0.65 . . . . 0.0 111.341 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.46 133.01 92.95 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.16 111.32 0.71 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.647 2.898 . . . . 0.0 110.909 170.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.93 -34.88 64.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.235 0.614 . . . . 0.0 111.989 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.5 t -137.36 135.04 47.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.94 118.13 3.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.6 pt -142.1 154.62 18.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.708 1.203 . . . . 0.0 108.183 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.85 140.62 58.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.07 0.548 . . . . 0.0 110.532 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -82.28 -16.56 49.0 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -158.91 101.13 1.61 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.983 1.265 . . . . 0.0 110.766 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.27 -172.42 38.38 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 121.609 0.561 . . . . 0.0 112.137 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -119.09 125.89 74.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -157.03 169.35 25.02 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.084 0.469 . . . . 0.0 111.67 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.82 159.56 15.33 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.72 166.51 23.79 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.976 1.31 . . . . 0.0 108.94 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.88 156.67 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.982 1.313 . . . . 0.0 107.776 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -122.06 121.07 36.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.77 135.82 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.458 0.572 . . . . 0.0 109.633 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -83.17 150.96 25.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.833 1.253 . . . . 0.0 107.65 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -137.37 140.68 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -113.32 146.82 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.419 1.487 . . . . 0.0 108.912 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.3 m -66.57 95.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.98 0.912 . . . . 0.0 110.805 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.543 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.17 11.78 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 115.905 -1.998 . . . . 0.0 114.069 168.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.543 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 71.0 Cg_exo -44.27 136.94 8.0 Favored 'Trans proline' 0 C--N 1.364 1.362 0 CA-C-N 124.146 2.516 . . . . 0.0 114.229 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mmt-85 47.65 22.07 0.3 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.802 2.441 . . . . 0.0 113.881 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 50.39 31.11 5.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.117 1.367 . . . . 0.0 112.217 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.89 5.6 0.81 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.925 -171.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.08 147.38 34.72 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 118.763 1.282 . . . . 0.0 110.457 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.6 -3.43 13.79 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.579 2.853 . . . . 0.0 115.831 -169.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.1 -176.3 5.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.573 1.079 . . . . 0.0 110.638 -170.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.51 37.12 3.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.874 1.669 . . . . 0.0 109.993 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -69.25 169.15 12.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 169.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -139.17 157.35 46.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.898 0.879 . . . . 0.0 109.851 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 165.91 32.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.401 1.481 . . . . 0.0 109.477 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -112.88 154.96 25.51 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.577 0.751 . . . . 0.0 109.092 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.6 pt -135.24 156.8 39.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.77 1.228 . . . . 0.0 109.749 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.86 124.26 72.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 125.868 1.667 . . . . 0.0 107.021 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -134.59 150.18 50.68 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.584 1.554 . . . . 0.0 108.689 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.79 131.63 1.48 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -154.55 151.24 28.65 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -64.54 -20.62 66.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -69.63 -26.22 64.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.634 1.107 . . . . 0.0 112.287 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.36 88.64 7.52 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.985 1.266 . . . . 0.0 109.076 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.32 -8.49 32.74 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.537 0.735 . . . . 0.0 112.101 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -147.9 145.62 28.71 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.669 1.588 . . . . 0.0 108.283 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -61.03 -31.8 71.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.241 1.016 . . . . 0.0 111.585 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.66 -26.06 68.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.824 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.0 -49.38 61.89 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.151 0.887 . . . . 0.0 110.418 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -39.86 85.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.254 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -62.06 -49.48 75.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.356 0.98 . . . . 0.0 110.081 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.81 -44.84 95.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.256 0.934 . . . . 0.0 111.169 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.48 -51.7 68.75 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.341 0.656 . . . . 0.0 110.78 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.4 t -82.12 -38.61 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.043 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.2 p -61.43 -31.75 71.7 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.857 1.662 . . . . 0.0 110.328 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.84 -51.06 59.83 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.05 -44.14 96.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.375 1.088 . . . . 0.0 111.202 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.35 -45.38 91.55 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.802 0.728 . . . . 0.0 110.563 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.41 -33.04 75.03 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.014 -1.054 . . . . 0.0 111.588 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -64.52 -39.64 94.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.962 0.801 . . . . 0.0 110.692 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.03 -32.12 73.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.264 0.938 . . . . 0.0 110.61 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.98 -8.05 4.47 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.114 2.292 . . . . 0.0 113.177 169.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -67.48 179.56 1.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.095 1.758 . . . . 0.0 113.539 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -131.14 143.14 50.41 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.0 m -147.15 167.44 24.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -168.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -153.09 134.37 14.23 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.524 1.53 . . . . 0.0 108.103 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 p -73.65 115.84 13.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.9 -24.92 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.952 -0.468 . . . . 0.0 110.772 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.0 43.48 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.44 -164.83 15.31 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.44 -155.61 22.67 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -138.52 155.02 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 109.127 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.8 136.63 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 m -145.69 164.43 31.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.619 1.168 . . . . 0.0 109.62 -176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.68 148.54 28.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -151.68 142.53 22.93 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.317 1.047 . . . . 0.0 108.422 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 m -63.63 -20.1 65.4 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.189 0.596 . . . . 0.0 111.278 169.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -66.96 -18.55 65.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.377 1.471 . . . . 0.0 112.161 172.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -125.37 -29.72 3.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.571 1.148 . . . . 0.0 111.839 -171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 mttm 74.08 13.56 4.02 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.41 2.284 . . . . 0.0 115.45 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.02 172.97 14.38 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.159 0.984 . . . . 0.0 108.532 168.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.2 156.83 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -140.14 149.26 42.8 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.199 1.0 . . . . 0.0 108.949 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.15 123.0 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.23 -174.42 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.154 -0.966 . . . . 0.0 111.085 -169.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.79 -160.04 52.58 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -149.51 154.48 38.83 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.431 1.493 . . . . 0.0 107.863 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 t -69.74 131.83 45.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.8 ttt -59.02 -20.77 56.18 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.973 0.909 . . . . 0.0 111.814 170.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.32 -24.23 8.53 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 113.087 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -130.77 1.07 4.38 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -177.65 45.33 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.248 0.931 . . . . 0.0 112.381 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.25 130.22 17.2 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.739 2.293 . . . . 0.0 111.223 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.69 168.08 20.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.227 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.98 78.54 5.41 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 169.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -59.01 -15.88 15.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.01 66.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.387 0.675 . . . . 0.0 111.401 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.57 -44.17 96.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.728 0.811 . . . . 0.0 108.942 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.3 m -58.67 -53.03 62.91 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.268 0.627 . . . . 0.0 110.34 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 p -60.45 -44.6 95.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -58.98 -53.45 58.3 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.283 0.947 . . . . 0.0 110.931 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.4 -44.49 67.86 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.918 -0.489 . . . . 0.0 111.421 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.4 -42.25 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 118.087 -0.959 . . . . 0.0 108.639 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.72 -39.28 93.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.913 1.688 . . . . 0.0 111.029 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.94 89.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.475 0.58 . . . . 0.0 111.302 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -79.86 -24.66 41.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.224 0.465 . . . . 0.0 112.106 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 t80 40.49 60.33 7.28 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.13 2.172 . . . . 0.0 111.967 -170.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.1 -22.56 34.93 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.105 2.537 . . . . 0.0 113.126 -171.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -153.76 -49.52 0.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.661 0.664 . . . . 0.0 111.859 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -157.62 174.61 15.08 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.526 0.73 . . . . 0.0 110.359 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.98 158.45 22.38 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.254 1.422 . . . . 0.0 110.765 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.94 164.07 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.058 1.743 . . . . 0.0 110.033 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.3 p -141.42 172.06 13.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.324 1.849 . . . . 0.0 107.133 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.63 167.58 21.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.894 0.77 . . . . 0.0 112.39 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.87 143.61 30.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.323 1.449 . . . . 0.0 107.643 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -88.22 33.15 0.74 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.112 0.965 . . . . 0.0 111.446 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -153.93 175.67 13.08 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.667 1.587 . . . . 0.0 107.624 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.11 -168.35 25.39 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.922 1.249 . . . . 0.0 111.96 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.248 0.995 0 C-N-CA 125.781 1.633 . . . . 0.0 107.665 179.043 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.13 151.86 35.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.849 1.26 . . . . 0.0 108.134 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.6 t -74.91 118.73 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.1 -176.7 1.84 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.064 0.546 . . . . 0.0 110.311 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -145.51 154.38 42.14 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.118 0.967 . . . . 0.0 108.839 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -53.53 -28.98 34.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.828 1.251 . . . . 0.0 113.507 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.48 57.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.024 0.829 . . . . 0.0 112.451 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.0 mt -84.87 -19.72 31.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.017 0.927 . . . . 0.0 111.25 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.07 138.29 72.87 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.428 1.091 . . . . 0.0 109.265 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.41 99.35 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.517 2.811 . . . . 0.0 109.307 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.65 -32.09 67.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.938 1.295 . . . . 0.0 112.658 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t -140.99 128.67 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -152.28 108.14 3.36 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -137.37 154.77 30.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.258 . . . . 0.0 108.384 -172.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.09 -34.23 76.02 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.6 m 54.95 -177.55 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.459 1.904 . . . . 0.0 113.463 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 47.31 43.97 15.6 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.956 1.703 . . . . 0.0 113.477 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.3 -157.64 22.55 Favored Glycine 0 C--N 1.337 0.61 0 O-C-N 121.366 -0.834 . . . . 0.0 111.375 -171.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.45 128.65 51.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -161.01 167.05 27.23 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.142 1.377 . . . . 0.0 109.95 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.46 157.92 16.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.97 172.07 13.29 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.684 0.794 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.45 153.23 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.225 1.41 . . . . 0.0 108.123 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.4 tp -117.76 115.62 25.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 131.95 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.85 147.16 39.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.01 131.04 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -100.08 151.2 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.455 1.102 . . . . 0.0 109.734 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 m -65.81 97.56 0.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.931 0.892 . . . . 0.0 110.827 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -151.07 22.6 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.451 -1.738 . . . . 0.0 114.449 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 81.8 Cg_exo -46.34 138.21 13.73 Favored 'Trans proline' 0 C--N 1.362 1.25 0 CA-C-N 123.906 2.431 . . . . 0.0 113.0 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 44.93 26.75 0.22 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 113.7 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m 50.18 33.04 6.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.347 1.459 . . . . 0.0 112.753 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.08 22.79 1.76 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 123.556 0.598 . . . . 0.0 113.066 -172.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.16 148.91 83.92 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.853 0.826 . . . . 0.0 111.124 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.15 -6.63 14.97 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.481 2.788 . . . . 0.0 113.787 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.45 -175.81 5.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.034 1.334 . . . . 0.0 109.906 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.92 37.51 3.43 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.764 1.626 . . . . 0.0 110.159 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.74 168.72 14.38 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -142.03 159.56 41.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.038 0.935 . . . . 0.0 110.325 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.66 168.26 26.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.975 1.71 . . . . 0.0 108.835 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -108.39 156.77 19.05 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 pt -133.15 156.24 41.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.942 1.297 . . . . 0.0 109.245 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.59 116.7 50.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -137.81 147.43 44.59 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.7 134.99 2.02 Favored Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.435 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.0 m-85 -156.75 156.7 33.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -170.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -60.91 -33.09 72.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.242 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.435 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.7 p-90 -64.52 -28.62 69.77 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.84 0.746 . . . . 0.0 112.103 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 77.79 9.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.218 0.917 . . . . 0.0 108.705 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -65.89 -6.07 11.16 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.19 140.23 33.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.69 1.596 . . . . 0.0 107.55 174.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.424 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 24.5 m-70 -61.46 -29.74 70.16 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.403 1.081 . . . . 0.0 111.873 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.58 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.759 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.0 -46.44 74.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.675 0.67 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -41.09 82.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.152 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -58.45 -44.66 89.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.004 1.729 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.25 -50.83 64.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.647 0.658 . . . . 0.0 111.542 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -60.77 -46.48 90.3 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.977 0.511 . . . . 0.0 111.089 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.8 -36.4 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.381 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -62.06 -28.95 69.96 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.244 1.384 . . . . 0.0 110.927 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.86 -52.06 45.69 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.321 0.964 . . . . 0.0 110.943 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -55.88 -47.54 77.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 110.445 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.242 -0.911 . . . . 0.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.3 -28.9 66.68 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.681 -1.262 . . . . 0.0 111.474 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -31.79 73.1 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.12 0.968 . . . . 0.0 110.057 169.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -70.76 -45.96 63.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.822 1.192 . . . . 0.0 108.332 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.26 -6.78 2.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.294 2.378 . . . . 0.0 112.502 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.84 171.39 11.76 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.149 1.78 . . . . 0.0 112.983 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.62 147.92 46.91 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.0 m -148.19 165.61 30.4 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -168.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.4 129.62 11.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.767 1.227 . . . . 0.0 107.997 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.5 114.45 5.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.5 -28.26 64.83 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.996 -0.44 . . . . 0.0 110.143 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.72 -167.02 40.07 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.99 -166.92 21.65 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 171.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.47 -161.2 26.45 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -127.12 151.15 49.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.626 1.17 . . . . 0.0 108.432 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.0 mt -132.66 135.13 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.1 m -146.29 144.98 30.19 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.016 0.526 . . . . 0.0 111.535 -169.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -146.2 141.82 27.8 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.393 1.877 . . . . 0.0 106.287 169.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.64 163.63 32.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.1 1.76 . . . . 0.0 106.521 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 m -55.77 -22.11 22.53 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -171.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -63.72 -25.74 68.33 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.663 1.185 . . . . 0.0 112.159 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -152.32 113.73 4.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.666 1.121 . . . . 0.0 110.15 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -64.83 -26.76 68.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 117.933 -1.032 . . . . 0.0 112.324 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.6 122.54 18.71 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.477 ' HB ' HG12 ' A' ' 118' ' ' VAL . 3.5 mt -66.39 150.2 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -123.33 150.69 43.31 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.801 0.84 . . . . 0.0 108.77 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.4 130.33 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -159.26 -172.14 3.63 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.5 -164.5 41.69 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 121.653 0.585 . . . . 0.0 111.676 170.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -148.23 153.32 38.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.173 1.389 . . . . 0.0 107.499 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 t -69.55 128.56 36.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.24 -20.58 55.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.212 0.605 . . . . 0.0 111.646 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.69 -27.33 9.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.911 0.884 . . . . 0.0 112.917 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -132.59 4.48 3.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.89 -178.74 50.63 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.229 0.922 . . . . 0.0 112.73 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.5 129.37 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.766 2.311 . . . . 0.0 110.47 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 169.16 17.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 111.079 169.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.13 75.41 4.67 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -56.86 -20.53 23.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.06 -38.75 65.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.64 0.776 . . . . 0.0 111.606 169.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mm -62.27 -45.6 98.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.998 0.919 . . . . 0.0 109.072 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.4 m -58.02 -52.66 64.59 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.413 0.685 . . . . 0.0 110.234 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -62.59 -41.42 98.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.26 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -60.99 -50.28 74.03 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 110.412 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.76 -46.11 73.0 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.09 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.3 mt -61.74 -44.52 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.833 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -62.66 -40.05 95.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.543 1.519 . . . . 0.0 111.216 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.34 84.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.782 0.719 . . . . 0.0 111.546 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -79.74 -21.11 44.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.299 0.64 . . . . 0.0 111.743 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 t80 43.38 58.77 12.13 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.528 2.331 . . . . 0.0 112.419 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.01 -18.54 35.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.269 2.646 . . . . 0.0 112.87 -174.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.05 -52.16 0.13 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.708 0.803 . . . . 0.0 111.185 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -163.24 178.41 8.22 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.111 0.964 . . . . 0.0 109.414 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.54 155.86 24.66 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.477 HG12 ' HB ' ' A' ' 88' ' ' ILE . 27.2 m -138.03 167.3 22.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.854 0.862 . . . . 0.0 110.586 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.8 p -139.01 171.39 14.39 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 109.363 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -146.95 163.21 36.91 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.73 -0.607 . . . . 0.0 110.599 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.37 135.26 18.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 169.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.74 -20.08 54.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.754 0.422 . . . . 0.0 111.76 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.48 -33.62 72.85 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.142 0.977 . . . . 0.0 113.314 -171.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -84.19 123.67 6.32 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.944 2.098 . . . . 0.0 105.971 171.036 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.94 150.74 47.36 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 171.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.1 t -73.4 111.93 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.47 179.15 2.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.315 0.579 . . . . 0.0 110.465 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -145.07 155.01 43.09 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.638 1.175 . . . . 0.0 108.168 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.3 mt -50.94 -35.35 32.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.319 1.048 . . . . 0.0 112.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.88 -23.73 66.04 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.808 0.731 . . . . 0.0 112.679 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.2 mt -84.7 -19.7 32.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.741 0.816 . . . . 0.0 111.305 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.5 138.48 94.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.95 111.32 1.35 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.088 2.525 . . . . 0.0 109.571 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.83 -37.15 70.36 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.399 1.08 . . . . 0.0 112.963 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.69 137.41 47.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -153.94 110.24 3.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 pt -138.0 136.4 45.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -153.71 61.02 0.74 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.026 0.917 . . . . 0.0 109.543 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -156.59 174.86 14.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.845 1.658 . . . . 0.0 108.663 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -153.5 167.94 27.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.14 1.376 . . . . 0.0 108.911 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 -84.81 1.55 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.4 t -148.26 135.06 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 172.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -156.06 160.29 39.85 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.876 0.87 . . . . 0.0 109.16 171.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 160.39 14.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.74 166.55 24.33 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.382 1.073 . . . . 0.0 109.252 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.72 156.8 12.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.07 115.5 23.82 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.04 129.94 72.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -76.75 147.76 37.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -134.69 142.83 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -116.07 148.35 40.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.555 1.142 . . . . 0.0 108.733 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 m -61.51 101.24 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.834 0.854 . . . . 0.0 110.654 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.553 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.32 15.14 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.076 -1.916 . . . . 0.0 115.619 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 80.4 Cg_exo -42.84 137.24 4.37 Favored 'Trans proline' 0 C--N 1.362 1.288 0 CA-C-N 124.371 2.597 . . . . 0.0 114.244 171.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 45.84 25.62 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.35 2.26 . . . . 0.0 113.929 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.08 31.94 7.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.186 1.395 . . . . 0.0 112.355 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.83 20.75 1.45 Allowed Glycine 0 C--N 1.341 0.83 0 C-N-CA 123.697 0.665 . . . . 0.0 112.872 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.1 148.88 69.69 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.824 0.812 . . . . 0.0 110.64 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.79 -5.72 16.21 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.346 2.698 . . . . 0.0 114.017 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.84 -174.71 5.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.131 1.372 . . . . 0.0 109.473 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.87 49.65 2.04 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.029 1.732 . . . . 0.0 108.668 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.61 177.23 6.94 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -143.67 156.78 44.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.635 0.774 . . . . 0.0 110.146 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 165.37 36.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.512 1.525 . . . . 0.0 109.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.1 155.08 20.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.99 151.38 34.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.578 1.151 . . . . 0.0 109.166 171.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.12 120.95 64.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -131.28 147.49 52.59 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.859 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.73 132.87 1.81 Allowed Glycine 0 C--N 1.33 0.225 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.08 151.29 26.61 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -61.52 -28.18 69.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.442 0.697 . . . . 0.0 112.742 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -66.71 -26.96 67.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.143 0.883 . . . . 0.0 112.093 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 85.19 5.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 171.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.99 -10.89 43.77 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 173.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 141.09 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.896 1.278 . . . . 0.0 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.499 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.03 -32.22 70.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.572 1.549 . . . . 0.0 111.763 -173.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.18 -30.22 70.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.739 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.45 -47.88 66.01 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.89 0.768 . . . . 0.0 110.473 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -37.51 79.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.521 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.74 -47.41 86.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 110.323 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.24 -46.79 75.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.789 0.722 . . . . 0.0 111.393 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -52.76 -54.8 28.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.631 1.172 . . . . 0.0 110.056 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.4 t -80.57 -34.4 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.745 -169.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -62.35 -30.91 71.51 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 120.382 1.446 . . . . 0.0 110.835 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.9 -51.18 58.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 110.638 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.6 -44.87 92.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 111.187 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.43 -45.04 95.09 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.987 -0.445 . . . . 0.0 111.011 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.6 -31.2 71.07 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.086 -1.009 . . . . 0.0 111.834 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.39 -40.3 96.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.19 0.904 . . . . 0.0 110.033 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -59.42 -47.22 86.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.712 1.142 . . . . 0.0 108.907 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.68 -5.64 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 126.631 2.063 . . . . 0.0 112.709 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.1 m -66.33 176.05 1.96 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.116 1.766 . . . . 0.0 112.728 -170.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -129.86 143.34 50.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -147.63 164.06 34.68 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -169.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -154.9 128.54 8.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 108.306 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -68.25 114.28 6.6 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.4 mt -70.3 -27.62 64.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.932 0.493 . . . . 0.0 110.638 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.85 -173.58 45.57 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.4 -179.08 28.57 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.59 -162.14 28.57 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -137.65 167.21 22.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.226 1.013 . . . . 0.0 110.785 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.12 143.11 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -169.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.8 m -150.82 156.06 40.49 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 121.67 -0.644 . . . . 0.0 111.458 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -59.44 171.35 0.83 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.904 1.681 . . . . 0.0 111.698 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -143.26 157.01 44.86 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.129 1.372 . . . . 0.0 108.843 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.4 m -60.42 -37.86 82.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.59 0.756 . . . . 0.0 110.433 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -76.9 97.13 4.49 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -56.35 -26.82 54.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.934 0.893 . . . . 0.0 112.785 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -73.89 4.12 5.75 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 117.948 -1.025 . . . . 0.0 113.236 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -141.87 165.29 27.88 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 120.871 1.669 . . . . 0.0 112.203 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mm -125.46 163.78 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -130.06 150.05 51.5 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.412 -0.805 . . . . 0.0 110.078 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.39 127.8 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.504 1.522 . . . . 0.0 107.322 -174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -162.15 -175.58 4.67 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.532 -0.73 . . . . 0.0 110.69 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.76 -167.57 48.37 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.266 0.46 . . . . 0.0 112.168 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -151.33 147.04 26.45 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.522 0.729 . . . . 0.0 109.943 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -73.42 139.47 45.88 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.82 -36.44 83.5 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.818 -0.551 . . . . 0.0 109.808 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.39 58.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.2 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -134.13 1.29 3.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.216 0.917 . . . . 0.0 113.35 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.02 55.13 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 118.93 0.787 . . . . 0.0 111.914 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 137.85 40.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.692 2.262 . . . . 0.0 110.181 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.6 169.84 16.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 169.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -79.05 72.4 5.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -56.85 -19.39 17.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.892 0.877 . . . . 0.0 113.276 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.94 -38.8 65.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.659 0.783 . . . . 0.0 111.388 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.1 mm -62.03 -43.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 C-N-CA 124.23 1.012 . . . . 0.0 109.028 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -57.52 -54.07 51.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.119 0.568 . . . . 0.0 110.082 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.1 p -60.6 -41.76 95.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.337 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.99 -50.71 72.29 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.419 1.009 . . . . 0.0 110.6 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -71.66 -42.23 67.77 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.906 -0.496 . . . . 0.0 111.423 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.14 -45.46 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.61 -36.08 81.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.168 1.349 . . . . 0.0 111.346 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.0 -42.54 94.38 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.44 1.018 . . . . 0.0 111.487 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -84.1 -17.84 38.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.586 0.754 . . . . 0.0 112.856 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 46.11 52.36 11.2 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.399 1.88 . . . . 0.0 115.595 -171.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.44 -27.4 81.67 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.711 1.607 . . . . 0.0 111.178 168.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -143.23 168.54 19.52 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.377 2.271 . . . . 0.0 106.963 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -57.69 -42.6 84.0 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.943 1.297 . . . . 0.0 112.508 -172.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -155.38 172.15 18.69 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.189 0.996 . . . . 0.0 108.642 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.93 167.58 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.638 1.575 . . . . 0.0 108.727 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -140.85 169.57 17.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.68 1.192 . . . . 0.0 108.763 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -145.54 167.15 23.72 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 110.402 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.08 142.23 24.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -85.66 51.84 2.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.002 0.921 . . . . 0.0 109.324 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.36 -175.77 4.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.305 1.442 . . . . 0.0 108.906 -170.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.35 -161.33 50.55 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.7 p90 . . . . . 0 C--O 1.247 0.943 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 173.215 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.57 168.59 26.23 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.311 1.445 . . . . 0.0 108.769 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.06 106.57 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 170.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.3 179.08 1.7 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.502 0.668 . . . . 0.0 110.376 171.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -147.82 156.25 42.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.52 -28.43 65.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.49 -26.5 63.64 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.223 0.92 . . . . 0.0 112.055 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.74 -30.67 18.89 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.333 1.053 . . . . 0.0 110.654 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.3 127.76 81.31 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 144.42 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.46 2.107 . . . . 0.0 109.864 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -81.86 -44.05 17.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.137 0.575 . . . . 0.0 111.146 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 t -133.49 137.02 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -154.48 109.84 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.1 pt -140.5 154.89 22.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 123.812 0.845 . . . . 0.0 109.253 -172.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.57 174.13 3.69 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.995 0.918 . . . . 0.0 110.434 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -150.18 19.15 0.86 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.324 -1.485 . . . . 0.0 111.616 172.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.1 -30.32 67.51 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.01 -1.056 . . . . 0.0 112.015 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.97 -67.26 0.11 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 118.195 0.452 . . . . 0.0 112.846 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -142.38 135.61 27.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -163.05 163.36 25.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.229 1.012 . . . . 0.0 110.014 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -85.62 157.47 20.35 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.32 168.75 19.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.038 0.935 . . . . 0.0 109.35 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 154.43 16.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 125.139 1.376 . . . . 0.0 107.548 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -118.36 118.23 31.22 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.31 134.63 65.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.94 0.791 . . . . 0.0 109.079 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -77.39 148.45 35.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.3 t -134.8 126.64 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.41 149.51 21.63 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.68 0.792 . . . . 0.0 109.566 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.9 m -65.59 100.76 0.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.484 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.554 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.02 19.32 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 116.282 -1.818 . . . . 0.0 114.776 169.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.554 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 84.8 Cg_exo -44.11 136.61 7.74 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 124.114 2.505 . . . . 0.0 113.846 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 46.13 25.76 0.37 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.738 2.015 . . . . 0.0 113.797 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.86 32.61 7.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.232 1.413 . . . . 0.0 112.448 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.42 20.36 2.06 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.83 0.729 . . . . 0.0 112.842 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.06 149.53 81.57 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 117.905 0.852 . . . . 0.0 110.755 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.65 -9.37 18.47 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.312 2.675 . . . . 0.0 113.702 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.08 -176.98 6.11 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.477 1.511 . . . . 0.0 109.233 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.68 47.96 2.41 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.864 1.666 . . . . 0.0 109.196 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -74.03 -176.48 2.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.714 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -142.25 159.67 41.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.685 0.794 . . . . 0.0 110.555 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.81 165.77 26.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.597 1.959 . . . . 0.0 107.573 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -111.94 146.99 36.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -126.45 154.8 36.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.312 1.045 . . . . 0.0 109.839 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.1 t -118.7 118.87 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.475 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.0 mmt85 -136.41 147.63 47.37 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.13 133.91 1.97 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.3 m-85 -156.33 155.01 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.9 0.88 . . . . 0.0 109.001 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.99 -31.56 71.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.457 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.1 p-90 -63.9 -30.15 71.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.29 0.95 . . . . 0.0 111.873 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.74 80.72 8.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.18 -14.54 38.69 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.005 0.522 . . . . 0.0 111.796 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.09 142.74 40.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.031 1.732 . . . . 0.0 108.26 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.491 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.8 -31.35 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.137 1.375 . . . . 0.0 111.879 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.33 -28.79 70.0 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.729 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.11 -46.98 72.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.997 0.817 . . . . 0.0 110.496 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -39.94 82.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.261 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -59.62 -48.04 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.778 1.626 . . . . 0.0 109.963 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -48.75 78.87 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.864 0.757 . . . . 0.0 111.324 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -60.62 -50.79 72.1 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.301 0.64 . . . . 0.0 110.891 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG21 ' HG3' ' A' ' 45' ' ' ARG . 60.5 t -75.07 -40.37 44.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 118.442 -0.79 . . . . 0.0 109.447 -171.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 t -59.09 -40.38 85.1 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.498 1.045 . . . . 0.0 109.082 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.95 -50.54 64.96 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 118.85 0.75 . . . . 0.0 111.952 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.51 -45.75 91.56 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.265 1.033 . . . . 0.0 111.283 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.86 -43.9 97.75 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.505 -0.747 . . . . 0.0 111.798 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.97 -32.36 73.81 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.645 -1.284 . . . . 0.0 111.152 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.37 90.76 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.947 0.899 . . . . 0.0 110.301 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -59.46 -46.42 88.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.878 1.217 . . . . 0.0 108.5 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.7 -5.99 1.59 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 126.951 2.215 . . . . 0.0 112.438 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.0 m -70.16 177.14 3.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.857 1.663 . . . . 0.0 112.114 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -129.46 142.56 50.75 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 169.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.3 m -143.05 165.09 28.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -168.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -154.94 130.77 10.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.48 112.67 4.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.7 mt -67.35 -28.46 67.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.796 -0.565 . . . . 0.0 110.219 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.66 42.18 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.036 -2.025 . . . . 0.0 108.036 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.34 -175.16 26.07 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.69 -159.86 24.66 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -135.7 163.03 31.09 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.4 1.1 . . . . 0.0 110.566 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.6 mt -123.85 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 t -156.1 169.37 24.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.241 0.616 . . . . 0.0 110.834 -169.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -124.47 24.45 7.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.548 1.539 . . . . 0.0 109.249 169.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -61.42 2.37 0.16 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.788 1.235 . . . . 0.0 112.915 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -55.08 -13.55 1.23 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.561 2.744 . . . . 0.0 113.129 169.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 59.09 30.51 20.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.011 1.724 . . . . 0.0 110.607 -169.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -157.79 158.21 34.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.67 2.388 . . . . 0.0 106.211 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -60.7 -25.61 66.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.392 -0.813 . . . . 0.0 112.446 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -54.24 119.16 4.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.681 1.128 . . . . 0.0 109.818 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.07 159.36 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -138.35 149.06 45.23 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.256 1.022 . . . . 0.0 108.597 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.06 117.91 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -161.85 -168.61 1.98 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.053 0.541 . . . . 0.0 110.684 -173.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.87 -161.82 53.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -152.5 152.38 31.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.331 1.052 . . . . 0.0 108.67 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.3 p -77.94 137.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.7 tpt -65.05 -34.81 79.32 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.839 -0.538 . . . . 0.0 109.855 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.94 65.54 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.416 -0.802 . . . . 0.0 113.111 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -133.86 4.03 3.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.67 -175.26 55.07 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.806 0.73 . . . . 0.0 111.75 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.48 138.37 38.54 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.576 2.184 . . . . 0.0 110.685 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 176.29 5.25 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.54 -34.08 77.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.74 -0.6 . . . . 0.0 111.368 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.4 m80 58.51 -29.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.141 2.976 . . . . 0.0 115.87 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.72 81.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.474 1.11 . . . . 0.0 111.41 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.28 -46.36 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.4 m -56.29 -53.69 54.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.879 0.872 . . . . 0.0 110.538 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -47.21 77.99 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.931 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -64.83 -47.76 76.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.837 0.744 . . . . 0.0 110.519 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.75 -38.37 67.4 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 118.799 -0.619 . . . . 0.0 111.309 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.4 mt -61.61 -45.65 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.473 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 95.9 mttt -62.62 -40.33 96.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.573 1.533 . . . . 0.0 111.431 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.59 87.13 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.452 0.569 . . . . 0.0 111.224 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -79.45 -23.22 43.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.4 t80 41.41 62.9 6.62 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.593 2.357 . . . . 0.0 111.943 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.94 -23.43 40.83 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.903 2.402 . . . . 0.0 112.997 -172.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -155.99 -46.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.718 0.69 . . . . 0.0 112.463 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -158.51 173.53 16.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.487 0.715 . . . . 0.0 110.643 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' HG3' ' HE2' ' A' ' 110' ' ' LYS . 26.8 tt0 -67.51 161.25 25.89 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.345 1.058 . . . . 0.0 110.624 174.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.65 162.89 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.038 1.335 . . . . 0.0 109.54 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 p -142.66 174.41 10.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.434 1.894 . . . . 0.0 108.514 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -145.67 167.29 23.47 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.422 -0.799 . . . . 0.0 111.14 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.06 143.18 25.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -86.76 43.63 1.1 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.236 1.014 . . . . 0.0 110.262 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -152.49 -165.2 2.14 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.787 1.635 . . . . 0.0 107.974 -171.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.84 -176.4 52.1 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 119.279 0.945 . . . . 0.0 111.998 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 C--O 1.247 0.93 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 -178.558 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.41 164.29 31.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.594 1.558 . . . . 0.0 107.659 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.92 167.8 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.11 -174.26 4.14 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.609 1.564 . . . . 0.0 107.609 173.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -143.76 150.96 39.38 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -53.85 -30.76 46.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.688 1.195 . . . . 0.0 113.349 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.25 -25.31 59.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.995 0.816 . . . . 0.0 112.434 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.85 -21.58 29.74 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.936 0.894 . . . . 0.0 111.135 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.85 131.75 82.97 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.59 119.76 5.57 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.763 2.976 . . . . 0.0 110.13 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.53 -41.14 12.9 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -169.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -138.58 135.03 43.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -156.14 116.3 3.66 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 pt -137.23 154.29 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 108.358 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -131.47 91.98 3.1 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.836 0.854 . . . . 0.0 110.178 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 m -57.06 149.59 18.9 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.937 1.295 . . . . 0.0 111.408 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -156.52 -44.18 0.07 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.121 0.968 . . . . 0.0 110.42 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.01 -47.67 0.22 Allowed Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -149.21 140.24 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 169.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -155.83 166.3 33.9 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.797 1.239 . . . . 0.0 109.507 176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -97.83 160.13 14.5 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.605 -0.684 . . . . 0.0 109.185 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 169.02 18.87 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 122.992 0.517 . . . . 0.0 110.126 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.0 153.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.322 . . . . 0.0 108.844 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 tp -118.81 116.87 27.42 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.52 132.62 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.416 1.007 . . . . 0.0 109.674 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -78.03 145.99 35.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.032 1.333 . . . . 0.0 108.503 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.14 128.73 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -93.79 154.07 17.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.984 0.913 . . . . 0.0 110.398 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.7 p -73.64 41.91 0.12 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.536 1.934 . . . . 0.0 114.963 -172.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.48 22.42 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 115.918 -1.991 . . . . 0.0 116.344 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.73 125.05 6.04 Favored 'Trans proline' 0 C--N 1.359 1.117 0 CA-C-N 124.553 2.662 . . . . 0.0 113.833 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 39.63 28.14 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.696 2.799 . . . . 0.0 114.419 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m 48.92 30.31 2.7 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.038 1.335 . . . . 0.0 112.551 -171.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.22 -7.76 86.33 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.129 0.871 . . . . 0.0 113.539 -170.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.63 145.58 23.73 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 124.794 1.238 . . . . 0.0 108.908 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.52 9.34 4.14 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.831 3.021 . . . . 0.0 113.723 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.7 159.55 5.14 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.293 1.437 . . . . 0.0 112.059 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.12 39.52 2.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.864 1.266 . . . . 0.0 110.308 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -74.08 168.06 20.3 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -154.78 161.14 41.61 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.58 -1.325 . . . . 0.0 111.242 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -152.94 165.75 34.54 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.893 1.677 . . . . 0.0 108.477 173.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.25 151.17 26.31 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.436 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 48.6 pt -130.4 156.57 42.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.102 1.361 . . . . 0.0 109.32 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.6 122.71 66.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -128.69 153.32 47.44 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.33 132.26 2.46 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -151.21 151.08 31.38 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.2 1.0 . . . . 0.0 108.45 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.2 -29.13 68.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.192 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -65.54 -34.35 78.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.18 0.9 . . . . 0.0 110.979 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 71.13 8.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 169.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -62.62 -9.33 8.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.531 1.132 . . . . 0.0 111.696 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.34 37.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.236 1.815 . . . . 0.0 107.186 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.558 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 8.1 m-70 -58.48 -31.21 67.62 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.744 1.617 . . . . 0.0 112.078 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.93 -31.61 68.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.873 0.469 . . . . 0.0 111.633 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.94 -43.08 79.93 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.275 0.489 . . . . 0.0 110.6 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -40.21 72.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.449 175.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.35 -44.72 88.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.37 1.441 . . . . 0.0 109.876 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.67 -48.88 73.11 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 0.605 . . . . 0.0 111.606 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -56.87 -52.08 66.55 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.391 0.677 . . . . 0.0 110.086 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.19 -43.73 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.094 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -58.88 -37.13 75.86 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.625 1.102 . . . . 0.0 111.023 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.86 63.16 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.928 0.785 . . . . 0.0 111.199 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.25 -46.17 81.61 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.88 0.84 . . . . 0.0 111.019 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.6 mmt -59.12 -42.72 91.23 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.842 -0.536 . . . . 0.0 111.129 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -70.38 -30.7 67.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.342 0.974 . . . . 0.0 111.728 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -63.57 -43.07 98.07 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.327 0.967 . . . . 0.0 109.302 169.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -63.86 -27.04 68.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.451 0.569 . . . . 0.0 111.079 171.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.89 -7.22 9.43 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.137 2.304 . . . . 0.0 113.178 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 69.0 m -71.59 170.47 13.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.189 1.396 . . . . 0.0 111.721 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.59 140.73 52.21 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 m -144.28 163.16 34.51 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -149.08 128.89 13.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.04 0.936 . . . . 0.0 108.628 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -65.37 111.3 2.98 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.18 -27.53 66.49 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.707 -0.62 . . . . 0.0 110.1 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.15 -166.92 40.1 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.71 -165.94 17.63 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 170.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.35 -164.75 31.93 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -119.84 150.48 40.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.3 mt -128.27 138.46 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.7 m -139.07 146.05 40.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.855 0.862 . . . . 0.0 109.096 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -124.75 27.3 6.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.026 1.73 . . . . 0.0 108.9 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -76.64 13.12 1.06 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.217 1.407 . . . . 0.0 111.732 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -59.87 -18.99 48.65 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.609 2.764 . . . . 0.0 114.095 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 53.76 33.41 16.79 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.891 1.276 . . . . 0.0 109.984 -169.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -161.36 160.49 29.63 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 127.635 2.374 . . . . 0.0 106.759 -172.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -61.68 -21.54 64.53 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 177.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -57.5 156.21 8.39 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.462 1.105 . . . . 0.0 111.774 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.37 156.46 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -133.48 147.19 51.65 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.752 0.821 . . . . 0.0 109.735 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.87 129.23 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.766 1.626 . . . . 0.0 106.895 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.37 -169.13 2.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.036 0.835 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.84 -159.37 52.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.649 0.642 . . . . 0.0 112.526 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.7 154.22 39.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.24 1.416 . . . . 0.0 108.004 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 t -66.54 135.43 54.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 74.5 mtm -59.77 -16.46 27.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.638 1.175 . . . . 0.0 112.411 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.68 -23.14 4.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.117 0.967 . . . . 0.0 113.215 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -129.97 2.08 4.81 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.34 -175.59 45.88 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 119.09 0.859 . . . . 0.0 112.573 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.61 129.44 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.745 2.297 . . . . 0.0 110.968 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.86 167.76 20.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 110.304 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -78.97 76.66 5.46 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -57.06 -19.87 21.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.904 0.882 . . . . 0.0 113.166 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.39 -39.89 73.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.837 0.855 . . . . 0.0 110.987 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.9 mm -63.54 -49.15 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 m -62.63 -46.74 86.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 117.839 0.291 . . . . 0.0 110.843 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -62.01 -42.16 98.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.22 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.89 -49.94 75.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.979 1.263 . . . . 0.0 111.021 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -66.27 -45.12 81.6 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.935 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.87 -47.48 93.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -61.6 -39.15 90.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.307 1.412 . . . . 0.0 111.092 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.41 80.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 111.236 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -75.73 -21.6 57.34 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.349 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.4 t80 44.97 60.91 12.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.696 1.998 . . . . 0.0 111.671 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.28 -21.8 47.28 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.941 2.427 . . . . 0.0 112.527 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -154.86 -46.84 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.378 0.671 . . . . 0.0 111.865 170.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -159.3 179.95 8.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.2 1.0 . . . . 0.0 109.79 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.45 154.61 20.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.411 1.085 . . . . 0.0 109.513 169.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.73 168.48 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.068 1.347 . . . . 0.0 109.414 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 p -139.38 171.38 14.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.472 1.109 . . . . 0.0 109.665 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -145.93 161.6 39.68 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.812 -0.555 . . . . 0.0 110.583 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.61 135.69 18.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -72.94 -25.1 60.91 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.88 -32.71 71.2 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.008 0.923 . . . . 0.0 112.999 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.17 167.86 53.63 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.347 0.498 . . . . 0.0 111.929 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 59.5 t80 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 125.312 1.445 . . . . 0.0 107.715 175.561 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmt? . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.67 169.02 20.57 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.223 1.409 . . . . 0.0 108.561 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.3 t -137.11 130.67 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.65 -179.14 2.93 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.601 0.715 . . . . 0.0 110.798 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -148.14 155.39 41.36 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.207 1.403 . . . . 0.0 107.279 175.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -54.06 -34.0 58.93 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.586 0.754 . . . . 0.0 112.584 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.47 -24.42 66.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.192 0.906 . . . . 0.0 112.294 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.91 -20.18 23.67 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.95 . . . . 0.0 111.366 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.69 126.4 86.84 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.189 -1.386 . . . . 0.0 107.824 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.53 111.78 0.51 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.249 3.3 . . . . 0.0 110.421 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -71.38 -35.94 71.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.35 137.64 20.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -156.45 116.15 3.54 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.73 156.87 35.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.391 1.076 . . . . 0.0 109.418 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -70.87 163.19 27.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.558 0.743 . . . . 0.0 111.964 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 m -66.52 177.31 1.58 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.605 1.962 . . . . 0.0 112.548 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -37.28 120.61 0.78 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.811 2.045 . . . . 0.0 112.544 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.92 -161.94 34.72 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -174.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.8 t -133.98 129.99 54.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 172.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -159.73 158.01 30.5 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 123.919 0.887 . . . . 0.0 110.122 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 156.06 27.45 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.886 0.474 . . . . 0.0 109.738 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.66 169.6 17.34 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.042 0.937 . . . . 0.0 108.687 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.43 150.67 19.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 108.013 174.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 tp -110.6 115.71 30.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.0 OUTLIER -127.32 128.13 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.53 0.681 . . . . 0.0 109.412 -172.232 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -79.27 149.53 31.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.43 1.492 . . . . 0.0 108.348 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.42 135.01 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -102.85 147.83 26.39 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.324 1.049 . . . . 0.0 108.464 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -62.23 99.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.282 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.517 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -149.66 17.97 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.163 -1.875 . . . . 0.0 114.776 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.517 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 51.1 Cg_exo -41.39 134.66 3.11 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 124.077 2.492 . . . . 0.0 114.31 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 38.17 31.89 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.692 2.797 . . . . 0.0 114.182 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m 51.59 32.58 9.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.149 1.379 . . . . 0.0 112.566 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.33 30.38 0.87 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.998 0.809 . . . . 0.0 111.949 -174.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.42 153.04 87.63 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.243 0.617 . . . . 0.0 110.912 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.07 -23.62 77.74 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.439 2.76 . . . . 0.0 115.463 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.19 -167.87 2.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.078 1.351 . . . . 0.0 109.995 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.12 50.74 2.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.317 1.847 . . . . 0.0 108.744 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -176.33 4.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.0 m -140.95 156.52 46.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.572 0.749 . . . . 0.0 110.491 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.77 149.88 29.55 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.632 1.973 . . . . 0.0 106.742 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.43 150.55 27.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -128.8 154.05 39.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.26 1.024 . . . . 0.0 109.34 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.18 114.66 44.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -134.7 146.65 49.66 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.68 135.04 2.33 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.8 m-85 -157.06 152.6 26.67 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -60.32 -27.11 67.07 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.5 p-90 -66.86 -27.71 67.75 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 112.062 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.24 79.9 9.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.06 -6.29 8.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.005 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.98 142.03 29.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.226 1.811 . . . . 0.0 107.514 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.434 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 21.1 m-70 -62.04 -30.7 71.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.398 1.079 . . . . 0.0 111.543 -174.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -29.62 68.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.145 175.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.42 -47.5 73.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.781 0.719 . . . . 0.0 110.748 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.03 -43.29 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.011 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.12 -47.13 84.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.102 0.864 . . . . 0.0 109.608 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.99 -48.29 71.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 0.483 . . . . 0.0 111.718 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -57.22 -53.75 54.59 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.366 0.666 . . . . 0.0 110.294 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.06 -45.19 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.864 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -64.29 -25.16 67.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 119.884 1.22 . . . . 0.0 111.471 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.32 -49.89 72.71 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 170.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.05 -41.93 85.63 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.185 0.992 . . . . 0.0 111.392 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.2 mmt -56.39 -44.85 80.66 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.367 0.985 . . . . 0.0 110.79 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.52 -29.08 66.62 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.246 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -63.41 -43.15 98.36 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.396 0.998 . . . . 0.0 109.193 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.53 -34.28 77.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.079 0.4 . . . . 0.0 110.306 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.83 5.07 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.535 2.017 . . . . 0.0 113.059 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -67.86 175.37 3.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.365 1.866 . . . . 0.0 113.434 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -128.2 148.82 50.63 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.4 163.57 32.69 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -168.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -149.35 128.04 12.45 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.089 1.356 . . . . 0.0 109.006 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.27 111.94 7.0 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 168.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.62 -26.41 64.42 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.237 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.18 -168.02 40.17 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.7 -175.54 30.78 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -158.43 20.38 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 -174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -128.57 154.02 46.62 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.839 -0.801 . . . . 0.0 108.869 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.1 mt -124.96 142.11 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 m -140.08 164.56 29.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.531 1.533 . . . . 0.0 108.366 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -135.82 159.96 40.06 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.836 1.254 . . . . 0.0 108.547 174.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -144.47 97.95 3.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.202 1.401 . . . . 0.0 107.666 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 m -61.58 -10.68 8.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.001 0.921 . . . . 0.0 112.888 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -63.65 -27.02 68.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.867 1.267 . . . . 0.0 111.375 170.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -141.19 -0.45 1.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -172.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 mptt 51.0 55.18 9.96 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.836 1.655 . . . . 0.0 110.609 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -146.5 103.65 3.69 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.864 0.866 . . . . 0.0 109.065 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.46 ' HB ' HG12 ' A' ' 118' ' ' VAL . 4.5 mt -58.01 151.76 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -134.63 153.72 51.84 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.563 1.145 . . . . 0.0 108.666 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.0 t -130.34 128.07 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.52 -177.07 6.15 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 121.362 -0.836 . . . . 0.0 110.681 -173.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.01 -169.08 53.25 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -151.92 147.56 26.72 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.593 0.757 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.8 p -72.16 133.78 45.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -68.99 -27.18 65.47 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.782 -0.574 . . . . 0.0 110.09 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.49 -42.35 64.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.828 0.851 . . . . 0.0 112.384 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -133.65 3.15 3.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -168.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.51 -176.84 54.24 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.793 0.724 . . . . 0.0 111.848 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.22 132.02 23.29 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.674 2.249 . . . . 0.0 110.211 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.9 168.8 19.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -78.93 81.26 5.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 168.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.415 ' HB2' ' CE3' ' A' ' 120' ' ' TRP . 94.3 m-70 -56.05 -21.25 20.63 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.568 0.747 . . . . 0.0 112.762 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -44.07 66.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.709 1.203 . . . . 0.0 111.484 169.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.02 -49.53 83.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -58.4 -50.56 73.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.747 0.819 . . . . 0.0 110.683 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -63.58 -40.01 95.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.072 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.28 -46.51 83.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.927 1.24 . . . . 0.0 110.538 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.17 -43.55 97.96 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.263 0.483 . . . . 0.0 110.437 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.481 HG21 HG11 ' A' ' 118' ' ' VAL . 52.5 mt -59.64 -51.58 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.009 177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -60.98 -36.25 78.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.675 1.579 . . . . 0.0 111.283 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.92 99.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.922 0.783 . . . . 0.0 111.689 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.39 -18.09 37.25 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.264 35.8 p90 40.62 56.35 7.76 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 127.16 2.184 . . . . 0.0 114.209 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.59 -15.49 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.622 2.215 . . . . 0.0 110.447 169.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -141.22 161.65 37.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.444 2.698 . . . . 0.0 105.97 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -59.03 -46.42 88.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.935 0.894 . . . . 0.0 112.759 -169.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -161.0 158.76 28.49 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.402 1.881 . . . . 0.0 106.12 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 109' ' ' ILE . 31.6 m -140.18 169.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.127 0.971 . . . . 0.0 110.374 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -140.66 171.73 13.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.202 1.401 . . . . 0.0 108.885 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 102' ' ' HIS . 9.9 p-90 -143.5 170.76 15.21 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.65 -0.656 . . . . 0.0 109.623 170.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.46 142.33 30.2 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -86.62 47.36 1.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.423 1.089 . . . . 0.0 110.121 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -150.65 179.2 8.39 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.47 1.108 . . . . 0.0 109.666 -171.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.74 -177.32 51.91 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.141 1.353 . . . . 0.0 111.529 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 C--O 1.246 0.897 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 172.343 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.69 167.68 24.01 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.387 1.475 . . . . 0.0 108.678 175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.26 164.01 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.669 0.787 . . . . 0.0 110.875 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.74 174.85 1.27 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.296 0.57 . . . . 0.0 110.438 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -148.34 154.82 40.49 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.602 1.161 . . . . 0.0 107.911 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.0 mt -54.66 -32.3 58.94 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.769 0.828 . . . . 0.0 112.478 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.17 67.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.448 1.022 . . . . 0.0 112.289 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -90.08 -24.44 21.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.439 1.095 . . . . 0.0 111.307 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.32 130.17 89.43 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.2 116.63 3.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.23 2.62 . . . . 0.0 109.785 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.93 -35.84 64.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.822 0.849 . . . . 0.0 113.273 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.51 134.76 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -153.6 108.89 3.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.1 pt -135.75 134.6 51.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.155 0.982 . . . . 0.0 108.441 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -71.25 -19.25 62.38 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -169.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 m 55.77 32.22 19.06 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.154 1.382 . . . . 0.0 112.478 176.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.36 -44.26 91.98 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -169.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.68 -59.34 0.32 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -146.95 127.96 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 169.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -160.56 161.52 32.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.254 1.021 . . . . 0.0 109.393 -176.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.25 160.06 19.94 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.829 -0.545 . . . . 0.0 109.739 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.12 164.57 31.76 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.313 0.645 . . . . 0.0 109.378 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.67 156.02 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.604 1.161 . . . . 0.0 108.529 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -118.53 114.56 23.01 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.61 130.94 71.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -75.27 148.02 39.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.29 119.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -91.32 148.54 22.26 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 p -68.64 102.71 1.55 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.872 0.76 . . . . 0.0 109.712 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.463 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.12 23.75 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.003 0 CA-C-O 116.39 -1.767 . . . . 0.0 114.517 169.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 37.1 Cg_exo -41.85 124.36 2.69 Favored 'Trans proline' 0 C--N 1.361 1.187 0 CA-C-N 123.802 2.394 . . . . 0.0 114.521 173.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 34.22 38.24 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.341 3.056 . . . . 0.0 113.924 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m 52.97 30.31 9.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.224 1.409 . . . . 0.0 112.961 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.22 14.24 5.66 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.797 1.189 . . . . 0.0 112.525 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.26 149.65 90.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.95 0.875 . . . . 0.0 110.793 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.89 -12.32 16.34 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.187 2.591 . . . . 0.0 113.718 -177.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.44 -179.5 8.01 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.874 1.269 . . . . 0.0 109.952 -170.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.65 49.75 2.0 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.823 1.649 . . . . 0.0 109.055 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.54 177.51 5.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.928 0.891 . . . . 0.0 109.045 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -139.34 160.58 39.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.717 0.77 . . . . 0.0 111.125 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -142.41 164.79 29.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 129.105 2.962 . . . . 0.0 105.566 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -128.31 149.57 50.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.09 147.77 33.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.496 0.718 . . . . 0.0 109.829 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.38 119.22 57.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -128.3 145.09 51.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.08 132.15 1.9 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 170.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -151.54 151.69 31.93 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -59.89 -29.37 68.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.7 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -66.28 -27.7 68.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.159 0.89 . . . . 0.0 111.836 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.91 81.97 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -62.06 -15.24 43.32 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 122.943 0.497 . . . . 0.0 111.583 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.76 142.16 38.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.137 1.775 . . . . 0.0 108.014 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -56.17 -31.37 63.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.441 1.496 . . . . 0.0 112.757 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.55 -27.09 68.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.73 -0.607 . . . . 0.0 111.557 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.33 -47.33 70.82 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.677 0.671 . . . . 0.0 110.693 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -39.71 83.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.467 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -61.95 -48.23 81.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.9 1.227 . . . . 0.0 109.927 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -45.81 91.79 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.347 0.976 . . . . 0.0 111.365 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -60.42 -51.18 70.59 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.391 0.677 . . . . 0.0 110.812 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.46 -33.91 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.15 -169.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p -61.16 -35.83 78.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.794 1.634 . . . . 0.0 110.169 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.8 -51.07 59.78 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.9 -44.21 96.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.208 1.004 . . . . 0.0 111.015 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.8 mmt -59.72 -44.4 93.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.696 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -66.69 -33.41 75.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.217 . . . . 0.0 111.976 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.27 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.216 0.916 . . . . 0.0 109.77 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.35 -35.78 80.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.571 0.623 . . . . 0.0 110.393 171.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.41 -8.12 5.32 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.633 2.54 . . . . 0.0 113.127 171.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 94.8 m -77.41 133.0 38.78 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.943 1.697 . . . . 0.0 111.711 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.39 137.3 33.47 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.9 m -144.71 163.96 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -155.69 133.85 11.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.653 1.181 . . . . 0.0 108.251 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.84 112.82 4.47 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.7 mt -67.87 -29.83 69.04 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.907 -0.495 . . . . 0.0 110.098 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.18 -171.0 42.87 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.28 -164.68 23.37 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.6 -147.52 8.85 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -171.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -133.63 155.59 49.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 108.217 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.7 mt -125.26 141.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.1 m -138.41 143.33 39.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.606 1.162 . . . . 0.0 108.219 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -122.44 26.96 8.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.484 1.913 . . . . 0.0 108.546 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -129.7 31.87 4.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.133 1.773 . . . . 0.0 109.079 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -63.83 7.52 0.12 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.231 2.612 . . . . 0.0 114.41 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 55.87 26.39 9.65 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.237 1.815 . . . . 0.0 110.647 -169.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -162.81 156.67 20.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.599 2.76 . . . . 0.0 106.104 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -63.27 -29.16 70.54 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -66.09 122.01 16.45 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.546 1.066 . . . . 0.0 109.67 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 88' ' ' ILE . 2.4 mp -64.77 149.67 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 169.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -128.12 147.73 50.55 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.588 -0.695 . . . . 0.0 109.727 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.06 120.58 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.96 -164.98 1.39 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.532 0.733 . . . . 0.0 109.988 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.36 -167.91 54.56 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -153.04 144.43 23.26 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.957 0.503 . . . . 0.0 110.786 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.9 m -70.01 140.69 52.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -65.1 -49.61 69.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.14 -24.56 37.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -118.17 -6.74 10.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.94 -179.6 34.6 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.795 0.725 . . . . 0.0 112.408 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.09 136.48 37.92 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.713 2.275 . . . . 0.0 109.976 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.91 169.83 17.16 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.362 0.601 . . . . 0.0 110.078 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.09 82.42 6.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -58.44 -18.15 26.29 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.765 -0.584 . . . . 0.0 112.543 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.63 -39.68 68.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.57 1.148 . . . . 0.0 111.861 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 mm -61.7 -49.76 83.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 m -58.19 -51.46 69.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.908 0.883 . . . . 0.0 111.399 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.0 p -64.71 -41.01 96.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.382 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.7 -45.53 93.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 120.011 1.278 . . . . 0.0 110.468 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -65.13 -44.51 88.46 Favored 'General case' 0 N--CA 1.46 0.053 0 O-C-N 121.911 -0.493 . . . . 0.0 111.08 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.439 HG21 HG11 ' A' ' 118' ' ' VAL . 54.8 mt -61.95 -42.12 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.374 0.67 . . . . 0.0 109.263 177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.415 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 93.2 mttt -63.57 -38.0 89.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 120.111 1.323 . . . . 0.0 110.895 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.53 -44.88 85.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.84 0.745 . . . . 0.0 111.153 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -63.43 -36.28 83.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.256 1.022 . . . . 0.0 111.41 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.7 t80 43.8 63.24 8.38 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.945 2.098 . . . . 0.0 111.215 -169.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.29 -23.62 32.73 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.831 2.354 . . . . 0.0 112.364 -173.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -157.2 -45.42 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.579 0.752 . . . . 0.0 111.806 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -157.4 179.44 9.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.394 1.078 . . . . 0.0 109.564 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.415 ' HG3' ' HE2' ' A' ' 110' ' ' LYS . 29.5 tt0 -64.07 162.42 14.24 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.885 0.874 . . . . 0.0 109.583 169.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.502 HG12 ' HB ' ' A' ' 88' ' ' ILE . 18.8 m -141.2 166.43 18.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 -176.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.6 p -139.5 172.54 12.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.565 1.146 . . . . 0.0 109.456 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -143.88 167.78 21.52 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.159 0.583 . . . . 0.0 110.315 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.17 143.12 25.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 169.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -84.36 52.4 2.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.773 0.829 . . . . 0.0 109.283 175.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -149.94 -166.83 2.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.25 1.82 . . . . 0.0 107.714 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.38 -166.8 54.8 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.591 1.087 . . . . 0.0 111.424 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.548 1.539 . . . . 0.0 107.149 -177.795 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.83 158.46 21.91 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.32 130.61 47.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.8 -177.41 4.32 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.077 0.951 . . . . 0.0 110.764 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -148.44 155.41 41.17 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.217 1.807 . . . . 0.0 106.158 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.88 -28.44 64.19 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.197 0.908 . . . . 0.0 112.848 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.7 63.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.294 0.952 . . . . 0.0 112.293 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.1 -28.1 19.22 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.513 1.125 . . . . 0.0 111.212 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.67 129.02 76.41 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.67 131.36 33.09 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.658 2.906 . . . . 0.0 110.707 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.21 -43.34 8.88 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.46 142.07 31.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -156.18 116.36 3.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 pt -141.67 156.33 20.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.279 1.432 . . . . 0.0 107.598 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.27 139.8 58.65 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -65.93 -27.82 68.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -170.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -165.28 104.92 0.75 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.652 1.114 . . . . 0.0 109.84 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.62 -165.89 33.9 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -131.17 119.53 44.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -160.07 161.2 33.84 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.951 0.9 . . . . 0.0 109.41 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -86.77 158.77 19.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.36 166.58 24.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.901 0.88 . . . . 0.0 109.209 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.06 154.74 21.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.108 0.963 . . . . 0.0 108.799 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.93 119.35 34.55 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.78 135.41 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 119.401 1.0 . . . . 0.0 110.423 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -79.99 146.62 31.94 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 124.84 33.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -93.76 153.28 18.4 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.509 0.724 . . . . 0.0 109.891 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m -67.85 87.92 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.297 1.039 . . . . 0.0 109.56 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.31 24.37 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 116.584 -1.674 . . . . 0.0 114.499 169.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.02 129.94 5.75 Favored 'Trans proline' 0 C--N 1.359 1.089 0 CA-C-N 123.551 2.304 . . . . 0.0 113.075 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 43.7 27.2 0.15 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.928 2.491 . . . . 0.0 113.901 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 50.1 32.38 5.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.401 1.481 . . . . 0.0 112.677 -175.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.24 15.1 1.48 Allowed Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.55 -172.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.93 151.58 89.17 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 118.251 1.025 . . . . 0.0 110.73 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.85 -0.38 10.64 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.581 2.854 . . . . 0.0 114.547 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.0 178.39 8.98 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.689 1.195 . . . . 0.0 110.032 -170.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.21 36.82 3.2 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.364 1.466 . . . . 0.0 110.466 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -69.59 172.42 7.4 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.3 m -135.99 160.94 37.07 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.562 0.745 . . . . 0.0 110.361 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.11 162.81 30.74 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.547 1.539 . . . . 0.0 107.579 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.49 134.95 54.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 171.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 pt -121.57 161.64 21.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.667 1.187 . . . . 0.0 110.383 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.55 124.03 53.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.48 155.02 49.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.68 136.02 3.83 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -149.48 152.05 34.97 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -174.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.62 -33.47 72.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.53 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -64.91 -29.81 70.77 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.018 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.73 75.32 3.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 109.35 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.79 -10.46 37.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.536 173.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.51 142.57 35.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.667 1.587 . . . . 0.0 107.718 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -58.24 -33.79 69.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.968 1.307 . . . . 0.0 111.63 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.93 67.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.123 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.47 -42.34 87.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.097 0.862 . . . . 0.0 110.295 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -38.31 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 117.369 -1.301 . . . . 0.0 110.616 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.09 -43.01 95.83 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.259 1.391 . . . . 0.0 109.453 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.05 -50.57 72.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.128 0.876 . . . . 0.0 111.32 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -48.74 78.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.219 0.533 . . . . 0.0 109.8 -174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -78.43 -44.75 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.385 -169.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.9 p -62.42 -31.38 72.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.577 1.535 . . . . 0.0 110.512 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.52 -52.17 48.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.19 -44.84 90.75 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.415 1.108 . . . . 0.0 111.384 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.6 mmt -57.04 -49.25 76.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.893 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.713 1.142 . . . . 0.0 111.988 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.74 -43.5 98.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.212 0.915 . . . . 0.0 109.756 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.66 -35.93 82.61 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.943 0.792 . . . . 0.0 110.379 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.2 -12.55 3.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.915 2.197 . . . . 0.0 112.98 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.3 m -74.34 121.46 21.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.959 1.703 . . . . 0.0 112.887 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.33 143.65 42.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 168.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.3 m -145.16 166.99 23.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.588 0.755 . . . . 0.0 112.498 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -149.48 134.01 17.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.67 1.188 . . . . 0.0 108.65 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -70.62 113.23 7.52 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.7 mt -70.72 -25.32 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.764 -0.585 . . . . 0.0 110.182 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.65 -169.74 42.26 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -170.73 23.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.16 -155.61 17.39 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.2 ttm105 -126.39 153.61 44.74 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.514 0.726 . . . . 0.0 109.174 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 mt -123.05 141.77 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.7 m -158.4 161.28 37.51 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.645 1.178 . . . . 0.0 108.459 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.18 160.73 31.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 168.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -62.03 -20.97 64.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.05 1.34 . . . . 0.0 112.224 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.0 m 72.85 -47.19 0.67 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.804 2.441 . . . . 0.0 111.0 -175.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -67.99 -17.45 64.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.481 0.713 . . . . 0.0 110.376 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -152.79 163.72 39.18 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.514 1.926 . . . . 0.0 107.208 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -74.95 -14.96 60.69 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.184 -0.912 . . . . 0.0 112.11 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -42.82 132.21 3.9 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.3 1.44 . . . . 0.0 109.832 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.6 mm -74.23 159.91 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.617 0.722 . . . . 0.0 109.06 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -140.29 151.01 44.75 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.117 1.767 . . . . 0.0 107.917 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 t -133.34 126.11 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.15 -179.8 8.33 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.81 -0.557 . . . . 0.0 110.757 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.68 -162.03 52.87 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -149.57 151.92 34.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.84 1.256 . . . . 0.0 108.64 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -73.58 131.07 41.31 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.91 -28.78 69.77 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.189 -0.32 . . . . 0.0 110.347 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.93 -35.74 17.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.638 0.775 . . . . 0.0 112.153 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.89 2.13 7.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.74 44.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 118.691 0.678 . . . . 0.0 111.988 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.92 136.55 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.225 1.95 . . . . 0.0 109.955 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.96 178.2 3.88 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -61.17 -34.37 74.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.704 -0.622 . . . . 0.0 111.375 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 59.21 -32.85 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.07 2.948 . . . . 0.0 115.682 -173.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.49 81.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.785 1.175 . . . . 0.0 110.723 170.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -53.88 -50.6 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.344 1.058 . . . . 0.0 108.644 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -58.92 -50.26 74.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.315 1.046 . . . . 0.0 110.363 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -48.65 74.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.813 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.11 -44.83 91.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.343 0.974 . . . . 0.0 110.845 -175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -67.13 -41.63 85.81 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.84 -0.538 . . . . 0.0 110.903 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.1 mt -59.84 -47.66 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 -33.88 75.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.01 1.277 . . . . 0.0 111.649 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.04 96.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.437 1.017 . . . . 0.0 111.324 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.4 -17.66 26.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 46.32 57.1 16.74 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.916 1.686 . . . . 0.0 114.208 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.25 -19.19 44.55 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 121.773 1.649 . . . . 0.0 110.256 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -146.26 165.22 29.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.244 2.618 . . . . 0.0 106.067 169.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -59.82 -37.53 79.44 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.891 0.876 . . . . 0.0 113.207 -170.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -159.38 171.47 19.71 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.965 0.906 . . . . 0.0 108.63 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.05 162.22 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.076 1.35 . . . . 0.0 108.031 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.5 p -138.26 171.82 13.82 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.709 1.603 . . . . 0.0 108.519 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -145.04 169.34 18.29 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.469 -0.769 . . . . 0.0 111.145 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.42 143.24 31.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -87.61 32.34 0.73 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.209 1.004 . . . . 0.0 111.47 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -156.11 178.9 9.76 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.007 1.323 . . . . 0.0 108.399 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.16 178.83 16.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.939 1.733 . . . . 0.0 111.071 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.533 1.933 . . . . 0.0 106.145 174.172 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 tpp . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.72 148.33 46.94 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.1 0.56 . . . . 0.0 110.77 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.9 m -68.02 160.16 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.728 0.811 . . . . 0.0 110.367 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.25 173.66 4.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -146.52 155.26 42.39 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.035 0.934 . . . . 0.0 108.901 -175.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 mt -53.74 -30.71 45.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.499 1.12 . . . . 0.0 113.484 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.59 -24.19 60.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.78 0.718 . . . . 0.0 112.266 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.31 -19.93 26.07 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.292 1.037 . . . . 0.0 111.108 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.09 131.01 80.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.51 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.348 2.699 . . . . 0.0 109.961 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.29 -34.71 70.9 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.564 0.746 . . . . 0.0 112.261 -169.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -142.56 135.26 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -154.61 105.57 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt -133.94 149.79 30.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.749 0.82 . . . . 0.0 109.588 -173.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -69.81 172.22 7.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.244 1.818 . . . . 0.0 110.801 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -143.92 -2.6 0.91 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.284 1.834 . . . . 0.0 111.864 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.2 -28.36 69.32 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -169.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.44 -153.44 14.33 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -173.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.88 142.45 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 169.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -155.96 166.89 32.13 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.549 1.139 . . . . 0.0 109.963 172.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.68 154.4 17.31 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.03 168.53 19.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 109.116 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.62 154.23 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.111 1.364 . . . . 0.0 108.002 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.6 tp -118.17 114.91 23.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.58 131.53 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -174.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -78.59 144.96 35.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.97 141.72 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -108.01 149.65 28.13 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.879 1.272 . . . . 0.0 109.633 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 m -63.68 99.95 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.365 0.666 . . . . 0.0 110.912 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.547 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -154.23 21.71 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.347 -1.787 . . . . 0.0 114.847 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.0 Cg_exo -46.99 136.85 17.29 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 124.327 2.581 . . . . 0.0 113.067 172.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? 46.41 25.05 0.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.153 2.181 . . . . 0.0 113.821 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 50.77 32.71 7.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.017 1.327 . . . . 0.0 112.351 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.68 23.74 1.98 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.934 0.778 . . . . 0.0 112.586 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.99 150.21 83.85 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 117.769 0.784 . . . . 0.0 110.691 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.87 -8.04 17.72 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.308 2.672 . . . . 0.0 113.743 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.56 -174.95 5.14 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.305 1.442 . . . . 0.0 109.447 -171.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.07 51.91 2.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.031 1.733 . . . . 0.0 108.701 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.13 -178.14 4.88 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.1 m -152.82 159.34 43.06 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.772 -1.205 . . . . 0.0 110.028 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.73 167.81 29.2 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.826 1.65 . . . . 0.0 108.785 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.01 152.74 24.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -129.85 153.41 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.752 1.221 . . . . 0.0 109.013 172.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.4 t -119.92 115.08 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -136.06 148.18 48.21 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.95 136.69 2.57 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.2 m-85 -156.29 152.31 27.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -172.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.53 -31.46 69.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.001 -0.524 . . . . 0.0 112.168 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.431 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -64.32 -27.54 69.1 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.828 0.74 . . . . 0.0 112.363 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 82.15 8.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.692 1.133 . . . . 0.0 108.267 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.52 -14.09 47.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.702 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.53 143.99 35.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.769 1.628 . . . . 0.0 108.418 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.45 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 21.2 m-70 -62.11 -30.7 71.2 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.736 1.214 . . . . 0.0 111.779 -174.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.01 -28.55 69.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.722 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.21 -47.79 72.72 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 110.549 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -40.37 82.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.262 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -58.61 -46.54 86.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.325 1.421 . . . . 0.0 110.02 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.31 -48.67 72.28 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.288 0.495 . . . . 0.0 111.451 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -60.18 -51.86 67.79 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.106 0.563 . . . . 0.0 110.864 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.32 -45.22 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.869 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -63.29 -28.37 69.97 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.731 1.15 . . . . 0.0 111.352 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.19 -49.38 75.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.57 -46.51 85.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.053 0.927 . . . . 0.0 110.708 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.3 mmt -58.36 -43.61 88.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.853 -0.529 . . . . 0.0 111.502 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.94 -33.31 73.52 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.103 -0.998 . . . . 0.0 111.875 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -61.22 -42.71 99.08 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.022 0.828 . . . . 0.0 109.617 170.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -60.71 -44.06 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.128 0.876 . . . . 0.0 109.706 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.71 -6.74 1.44 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.073 1.796 . . . . 0.0 113.28 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.63 177.99 4.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.645 1.578 . . . . 0.0 113.319 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.25 144.71 51.51 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 169.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.3 m -145.32 165.48 28.33 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -168.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.77 128.72 11.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.313 1.045 . . . . 0.0 108.525 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -67.47 115.33 6.96 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.6 mt -71.9 -26.51 62.35 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.005 -0.435 . . . . 0.0 110.451 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.05 -168.73 40.98 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.98 -172.0 28.81 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 173.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.13 -168.11 35.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -119.3 154.91 32.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 mt -128.79 133.77 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 m -141.59 140.77 33.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 108.595 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.34 156.83 33.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.396 0.678 . . . . 0.0 109.898 169.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -121.88 89.25 3.08 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.3 m -54.29 -16.98 2.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.115 1.366 . . . . 0.0 114.156 -172.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -59.03 -35.63 73.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.533 1.533 . . . . 0.0 111.416 172.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -149.58 15.1 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.975 0.91 . . . . 0.0 112.328 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.2 tttm 68.24 -52.99 0.54 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 129.011 2.924 . . . . 0.0 114.024 -172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -33.67 120.24 0.4 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.413 1.885 . . . . 0.0 112.099 -169.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.88 165.32 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.985 0.897 . . . . 0.0 110.861 172.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -134.09 149.75 51.13 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.398 1.879 . . . . 0.0 106.987 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.0 t -125.5 121.56 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.22 -176.32 5.57 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.461 -0.774 . . . . 0.0 111.586 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.75 -159.15 53.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.06 152.36 36.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.012 1.325 . . . . 0.0 108.188 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -77.03 130.54 37.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.6 mtp -64.32 -27.73 69.22 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.677 -0.639 . . . . 0.0 110.553 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.01 -38.03 45.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.159 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.9 3.33 3.2 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.75 -178.69 50.03 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.019 0.818 . . . . 0.0 112.038 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 133.96 23.95 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.653 2.235 . . . . 0.0 110.162 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.35 167.86 21.09 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.305 0.574 . . . . 0.0 110.027 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.29 82.15 6.39 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -59.04 -17.27 23.99 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.624 -0.673 . . . . 0.0 112.463 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.42 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.392 1.077 . . . . 0.0 111.934 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.78 -48.42 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.2 m -58.81 -50.03 75.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.752 0.821 . . . . 0.0 111.349 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 p -59.78 -44.16 94.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.945 0.793 . . . . 0.0 111.385 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.57 -48.24 80.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.784 0.72 . . . . 0.0 110.314 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.71 -47.83 76.87 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.158 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -62.21 -45.53 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -61.63 -38.49 87.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.426 1.466 . . . . 0.0 110.984 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.81 -47.71 68.31 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.792 0.723 . . . . 0.0 111.84 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -80.35 -15.08 57.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.791 0.836 . . . . 0.0 112.009 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.5 t80 57.52 43.28 1.01 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 126.575 1.95 . . . . 0.0 115.519 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -59.42 -26.08 80.73 Favored 'Trans proline' 0 C--N 1.36 1.165 0 CA-C-N 122.322 1.865 . . . . 0.0 112.412 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -143.62 166.34 25.11 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.169 2.187 . . . . 0.0 107.017 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -56.8 -38.36 72.43 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.162 0.985 . . . . 0.0 112.303 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -167.49 174.12 8.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.3 2.24 . . . . 0.0 105.568 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.49 163.55 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.205 . . . . 0.0 107.911 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -140.1 166.83 23.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.718 1.607 . . . . 0.0 108.562 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -147.82 168.57 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.285 -0.885 . . . . 0.0 112.61 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.34 143.63 31.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.419 1.488 . . . . 0.0 107.098 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -81.36 22.45 0.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.488 1.115 . . . . 0.0 112.132 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.21 164.18 33.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.52 1.528 . . . . 0.0 109.398 -171.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.75 172.73 17.32 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.452 1.025 . . . . 0.0 111.084 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.246 0.907 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.732 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.74 162.02 5.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.694 0.798 . . . . 0.0 111.547 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.28 159.72 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 110.794 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.51 167.79 10.21 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -144.61 151.84 39.62 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.674 0.79 . . . . 0.0 108.95 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.72 -32.02 40.78 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.057 1.343 . . . . 0.0 113.595 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.61 58.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.795 0.725 . . . . 0.0 112.304 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.78 -20.18 27.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.175 0.99 . . . . 0.0 111.106 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.7 mt -58.53 133.76 85.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.98 111.19 0.55 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.841 3.028 . . . . 0.0 110.563 171.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.59 -35.73 52.61 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.3 t -137.86 136.47 45.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.9 101.01 2.86 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 pt -144.85 172.48 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.246 2.218 . . . . 0.0 107.184 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -131.88 100.66 5.15 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.239 1.016 . . . . 0.0 109.606 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -60.69 -13.1 12.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.575 1.55 . . . . 0.0 114.178 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.0 -13.8 60.23 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.3 0.955 . . . . 0.0 111.973 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.22 177.27 17.18 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.459 1.028 . . . . 0.0 112.996 -172.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.0 t -138.04 123.93 25.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -169.26 168.67 9.63 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.687 0.795 . . . . 0.0 110.235 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -77.11 160.47 29.0 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 122.059 -0.4 . . . . 0.0 110.149 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.04 167.13 22.79 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.706 1.202 . . . . 0.0 109.168 -174.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.33 155.62 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.4 tp -118.73 117.66 29.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.282 0.0 OUTLIER -128.28 128.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 118.724 0.693 . . . . 0.0 109.736 -173.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -76.72 146.93 37.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.54 1.536 . . . . 0.0 108.279 172.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.2 139.1 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -108.91 143.4 38.19 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.735 1.214 . . . . 0.0 107.882 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 p -67.95 106.03 2.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.581 0.628 . . . . 0.0 110.818 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.55 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.47 17.22 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 116.212 -1.851 . . . . 0.0 115.362 169.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.55 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 90.1 Cg_exo -43.94 135.91 7.6 Favored 'Trans proline' 0 C--N 1.362 1.27 0 CA-C-N 124.185 2.53 . . . . 0.0 114.427 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 45.15 27.47 0.32 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.956 2.102 . . . . 0.0 113.576 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.84 31.87 6.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.457 1.503 . . . . 0.0 112.545 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.99 15.88 3.03 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 123.768 0.699 . . . . 0.0 112.974 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.53 148.24 86.68 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 118.178 0.989 . . . . 0.0 110.401 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.47 -11.46 17.23 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.058 2.506 . . . . 0.0 113.954 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.98 -178.95 7.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.855 1.262 . . . . 0.0 109.89 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.8 49.38 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.002 1.721 . . . . 0.0 108.944 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -75.36 173.17 11.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.437 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -144.57 155.65 43.76 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.388 0.675 . . . . 0.0 110.691 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.67 166.54 33.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.696 1.598 . . . . 0.0 108.963 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.64 155.6 19.97 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -174.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.41 155.28 41.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.398 1.079 . . . . 0.0 108.836 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.07 121.5 67.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -131.52 148.83 52.66 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.879 1.271 . . . . 0.0 107.799 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.25 131.7 1.8 Allowed Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -154.54 152.84 30.54 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.41 -31.75 71.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.134 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -64.86 -25.85 68.08 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.53 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.38 88.21 7.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 119.632 1.105 . . . . 0.0 109.028 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.0 -5.5 22.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 0.0 112.187 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.59 147.93 28.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.588 1.555 . . . . 0.0 108.319 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -60.67 -34.25 74.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 111.437 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.5 -27.54 67.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 118.627 -0.701 . . . . 0.0 112.215 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.65 -49.14 61.5 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.243 0.929 . . . . 0.0 110.603 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.402 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.83 -40.28 85.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.32 177.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -61.25 -49.84 75.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.095 0.861 . . . . 0.0 109.617 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.87 -46.37 89.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.393 0.997 . . . . 0.0 111.101 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -58.26 -52.62 64.8 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.566 0.747 . . . . 0.0 110.837 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.41 -34.37 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.457 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -59.48 -38.41 80.77 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.01 1.277 . . . . 0.0 109.245 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.89 87.34 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.821 0.737 . . . . 0.0 111.553 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.73 -45.31 90.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.257 1.029 . . . . 0.0 111.38 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -60.19 -44.65 94.93 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.862 -0.524 . . . . 0.0 110.795 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -65.65 -32.78 74.54 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.237 -0.915 . . . . 0.0 111.543 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -64.23 -39.1 93.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.464 171.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -60.26 -42.47 95.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.634 1.106 . . . . 0.0 109.262 169.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.41 -4.66 2.29 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.307 1.908 . . . . 0.0 112.939 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.9 m -69.11 178.46 2.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.484 1.513 . . . . 0.0 112.982 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -129.3 146.78 51.13 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.4 m -148.9 165.67 30.86 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -168.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -155.69 129.4 8.49 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.571 1.148 . . . . 0.0 109.585 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.75 115.66 10.16 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.0 mt -73.09 -25.2 60.79 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.179 0.591 . . . . 0.0 111.019 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.66 179.79 43.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.67 173.59 21.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.58 -158.9 24.52 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -136.02 153.09 51.47 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.118 1.367 . . . . 0.0 109.635 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mt -115.48 126.25 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.5 m -153.02 162.58 41.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.686 0.795 . . . . 0.0 108.867 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -71.89 142.72 49.52 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -74.15 -14.28 60.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.414 0.686 . . . . 0.0 110.589 169.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m 63.28 4.1 1.56 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.021 2.128 . . . . 0.0 114.782 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -77.19 -43.0 35.36 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.795 0.725 . . . . 0.0 109.334 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -157.53 45.17 0.36 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.87 1.268 . . . . 0.0 109.732 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt 63.82 -16.3 0.07 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.289 2.236 . . . . 0.0 115.393 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -45.66 124.96 5.5 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.444 1.898 . . . . 0.0 110.74 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.2 mm -65.83 152.92 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 122.026 0.917 . . . . 0.0 109.321 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -139.63 150.96 45.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.991 2.116 . . . . 0.0 107.39 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -132.45 120.28 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -172.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -158.87 179.54 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.45 -163.33 15.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.459 1.027 . . . . 0.0 113.218 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -153.63 164.51 38.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.071 2.148 . . . . 0.0 107.251 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 t -135.55 127.45 29.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.8 tpp -62.84 -30.51 71.55 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.85 -35.93 32.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.404 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -131.24 -1.21 4.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.51 177.27 43.81 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 119.162 0.892 . . . . 0.0 111.686 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.01 138.09 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.472 2.115 . . . . 0.0 109.326 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.79 160.9 30.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.344 0.592 . . . . 0.0 110.813 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -82.05 78.0 8.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -54.61 -21.67 11.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.23 0.612 . . . . 0.0 112.403 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.89 65.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.15 1.38 . . . . 0.0 112.861 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.15 -47.71 92.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -61.38 -49.36 77.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.017 0.927 . . . . 0.0 111.201 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 p -59.29 -40.29 85.68 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.958 0.799 . . . . 0.0 111.783 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.63 -47.2 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.569 1.077 . . . . 0.0 110.375 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.75 -44.84 88.82 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.944 -0.472 . . . . 0.0 111.303 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.07 -47.44 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.38 -34.47 73.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.336 1.426 . . . . 0.0 111.569 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.83 89.22 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.522 1.056 . . . . 0.0 111.777 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -84.25 -16.07 44.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 49.27 47.06 4.32 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -59.43 -23.59 71.12 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 122.198 1.821 . . . . 0.0 111.417 168.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -138.41 162.65 33.91 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.996 2.118 . . . . 0.0 106.253 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -59.79 -38.77 82.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.877 0.871 . . . . 0.0 111.556 -173.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.88 166.26 34.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.569 1.948 . . . . 0.0 105.778 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 m -141.4 166.01 18.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.436 1.094 . . . . 0.0 109.164 169.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 p -134.13 171.47 14.18 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.943 1.297 . . . . 0.0 108.968 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -142.01 171.55 13.9 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.836 -0.54 . . . . 0.0 111.983 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.09 143.74 31.96 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.768 1.227 . . . . 0.0 107.716 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -85.21 25.59 0.97 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.627 1.171 . . . . 0.0 111.757 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -156.92 -179.83 8.59 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.88 1.272 . . . . 0.0 108.556 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 134.75 -178.29 18.6 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.227 1.87 . . . . 0.0 110.893 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.6 p90 . . . . . 0 C--O 1.247 0.97 0 C-N-CA 126.628 1.971 . . . . 0.0 106.54 169.927 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.54 155.94 36.32 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.92 0.488 . . . . 0.0 109.967 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.36 149.62 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.828 -0.545 . . . . 0.0 109.748 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.46 175.99 8.67 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -149.32 153.4 37.42 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.084 0.953 . . . . 0.0 108.923 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.16 -27.58 62.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.787 0.835 . . . . 0.0 113.146 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.76 67.05 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.182 0.901 . . . . 0.0 112.61 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -77.6 -19.75 55.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.33 0.652 . . . . 0.0 111.649 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.88 139.88 97.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.03 110.59 1.19 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.917 2.412 . . . . 0.0 108.932 170.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.72 -33.36 64.33 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.986 0.914 . . . . 0.0 113.395 -169.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.9 t -136.81 133.4 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -157.85 110.55 2.4 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 170.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt -144.68 169.98 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.109 0.963 . . . . 0.0 110.194 -171.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -133.31 158.23 43.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.296 1.838 . . . . 0.0 106.445 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.8 m -153.73 15.14 0.49 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.232 1.413 . . . . 0.0 111.346 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.89 -21.69 31.51 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.024 0.93 . . . . 0.0 112.944 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -149.91 -177.88 24.34 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.185 1.85 . . . . 0.0 108.959 171.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.18 115.16 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -133.6 158.96 41.88 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.392 1.077 . . . . 0.0 108.959 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -78.81 163.4 25.37 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.886 -0.509 . . . . 0.0 110.129 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.34 166.67 24.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.559 1.143 . . . . 0.0 108.586 173.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.48 155.84 13.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.7 tp -118.44 116.65 27.13 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.28 0.0 OUTLIER -125.46 128.47 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-N 118.474 0.579 . . . . 0.0 109.671 -172.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -78.35 148.48 33.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.287 1.435 . . . . 0.0 108.415 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.2 139.37 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -108.67 146.66 33.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.387 1.475 . . . . 0.0 108.82 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -68.63 88.77 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.011 0.925 . . . . 0.0 112.457 -173.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.464 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -139.81 16.34 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 116.433 -1.746 . . . . 0.0 113.743 168.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 53.1 Cg_exo -47.85 143.45 13.17 Favored 'Trans proline' 0 C--N 1.362 1.258 0 CA-C-N 123.939 2.443 . . . . 0.0 113.33 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 41.26 31.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.636 2.374 . . . . 0.0 113.301 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.9 m 52.33 28.69 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.178 1.791 . . . . 0.0 113.374 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.37 19.58 0.12 Allowed Glycine 0 C--N 1.341 0.857 0 CA-C-O 118.709 -1.05 . . . . 0.0 114.648 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.27 146.27 16.68 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 118.73 1.265 . . . . 0.0 110.57 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.45 4.21 4.65 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.858 3.039 . . . . 0.0 115.921 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.2 -177.87 6.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.331 1.052 . . . . 0.0 110.087 -172.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.91 38.21 4.06 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.621 1.568 . . . . 0.0 109.756 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -67.53 165.72 16.27 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -140.55 155.94 46.46 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.014 0.926 . . . . 0.0 108.986 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HE2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -153.24 166.55 32.21 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.192 1.397 . . . . 0.0 108.694 176.31 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -108.4 156.28 19.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.404 HG23 ' HE2' ' A' ' 41' ' ' LYS . 30.7 pt -130.82 154.67 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.463 1.105 . . . . 0.0 108.826 172.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.79 119.85 63.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -132.07 147.61 52.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.231 1.412 . . . . 0.0 108.447 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.36 126.29 0.93 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -151.16 162.1 41.51 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.475 0.71 . . . . 0.0 109.842 -172.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -55.28 -43.38 74.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.833 0.853 . . . . 0.0 112.113 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -66.94 -27.32 67.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.457 -173.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.59 86.54 7.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.339 0.972 . . . . 0.0 108.516 172.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.42 -14.31 55.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.841 0.456 . . . . 0.0 111.664 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 144.5 33.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.03 1.732 . . . . 0.0 108.836 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.556 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 6.1 m-70 -58.14 -32.99 68.69 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.872 1.669 . . . . 0.0 112.079 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.39 -29.03 70.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.61 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.64 -49.23 63.97 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.76 0.709 . . . . 0.0 110.539 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -64.86 -40.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.331 177.099 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.527 0.603 . . . . 0.0 110.017 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.08 -46.89 76.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.662 0.664 . . . . 0.0 111.507 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.99 -56.16 18.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.582 1.153 . . . . 0.0 110.002 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.2 t -78.47 -35.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 117.797 -1.097 . . . . 0.0 110.456 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.4 m -62.36 -31.65 72.33 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 120.314 1.415 . . . . 0.0 110.939 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.63 -47.97 87.25 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.176 0.898 . . . . 0.0 110.974 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.04 -46.28 85.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.074 0.937 . . . . 0.0 111.028 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.5 mmt -59.56 -42.83 93.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.525 0.602 . . . . 0.0 110.882 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -67.86 -32.57 73.17 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.91 -1.119 . . . . 0.0 111.339 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -64.17 -40.56 96.38 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.032 0.833 . . . . 0.0 110.143 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -62.35 -33.28 74.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.316 0.962 . . . . 0.0 110.619 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.99 -6.9 4.42 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.444 1.973 . . . . 0.0 113.164 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.1 m -70.64 -179.72 2.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.272 1.829 . . . . 0.0 114.446 -169.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -130.09 151.09 51.0 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.2 165.01 31.34 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.79 129.65 9.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.678 1.191 . . . . 0.0 109.443 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.7 113.48 8.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.6 mt -68.06 -29.74 68.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.912 -0.492 . . . . 0.0 110.129 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.01 -173.46 45.15 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.84 -177.1 24.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.95 -155.75 16.25 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -136.41 167.37 21.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.904 0.852 . . . . 0.0 110.752 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 mt -136.36 142.57 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.694 1.998 . . . . 0.0 107.273 -169.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.7 m -149.52 162.51 40.01 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 109.142 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -101.67 127.02 48.6 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -76.01 171.57 14.23 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.121 0.968 . . . . 0.0 110.673 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 m -125.84 -28.44 3.22 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.126 0.971 . . . . 0.0 111.313 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -61.53 -27.86 68.9 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.731 0.812 . . . . 0.0 111.716 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -145.98 152.37 39.28 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 169.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -91.24 62.16 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.334 -0.854 . . . . 0.0 109.882 -169.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -147.45 170.75 16.72 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.559 0.744 . . . . 0.0 111.677 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.8 mm -80.38 166.92 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.581 0.753 . . . . 0.0 109.206 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -143.54 149.33 37.29 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.881 1.272 . . . . 0.0 107.988 169.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.22 121.96 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -159.74 -175.19 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.324 -0.86 . . . . 0.0 111.169 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.05 30.85 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.837 0.687 . . . . 0.0 112.834 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -137.78 143.11 40.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 t -65.45 146.56 54.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.5 ptp -72.87 -12.86 61.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.283 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.74 -14.76 3.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.194 0.998 . . . . 0.0 113.388 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -134.79 -177.29 4.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.2 1.8 . . . . 0.0 108.443 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.67 173.39 44.27 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 170.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.94 139.32 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.094 1.862 . . . . 0.0 108.457 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 164.67 25.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.606 0.717 . . . . 0.0 111.081 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.37 74.03 7.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -56.37 -20.52 19.68 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.47 60.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.035 0.934 . . . . 0.0 111.618 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.87 -43.95 99.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.408 1.083 . . . . 0.0 109.284 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -59.43 -50.78 72.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.416 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -57.02 -44.32 82.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.48 0.582 . . . . 0.0 111.304 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.69 -50.61 71.78 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.809 0.731 . . . . 0.0 110.505 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.98 -43.13 72.11 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.899 -0.501 . . . . 0.0 111.361 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.45 -46.76 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.93 -32.79 74.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.283 1.402 . . . . 0.0 111.379 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.32 94.97 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.405 1.002 . . . . 0.0 111.537 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -86.88 -20.0 28.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 41.97 57.88 10.05 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.646 1.578 . . . . 0.0 113.307 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.93 -15.8 32.69 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.01 1.807 . . . . 0.0 110.813 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -144.78 177.83 8.43 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.584 2.354 . . . . 0.0 106.7 170.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -64.04 -46.45 84.39 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.41 1.084 . . . . 0.0 111.838 -171.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 118' ' ' VAL . 26.7 tt0 -161.48 177.75 9.77 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.428 ' H ' ' HG2' ' A' ' 117' ' ' GLU . 7.1 p -158.06 162.36 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.593 1.557 . . . . 0.0 107.329 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -143.4 173.9 11.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 107.661 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.71 166.77 23.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.582 0.628 . . . . 0.0 111.068 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.16 143.5 26.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -87.26 27.59 1.04 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.97 1.308 . . . . 0.0 111.733 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -146.98 -165.08 2.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.661 1.584 . . . . 0.0 107.986 -170.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.11 -20.13 27.15 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.871 1.224 . . . . 0.0 113.479 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 127.688 2.395 . . . . 0.0 110.849 176.53 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.87 164.76 35.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 108.676 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.92 163.86 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.779 0.832 . . . . 0.0 110.687 174.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.13 177.71 1.34 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.389 0.614 . . . . 0.0 109.996 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -146.36 155.19 42.43 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.9 mt -52.35 -34.67 48.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.833 0.853 . . . . 0.0 112.942 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.19 62.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.671 0.669 . . . . 0.0 112.236 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.15 -19.76 28.0 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.099 0.959 . . . . 0.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.1 mt -59.28 128.82 86.06 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 172.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.57 138.16 58.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.164 2.576 . . . . 0.0 111.035 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -86.56 -41.78 14.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.071 0.396 . . . . 0.0 111.55 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.78 140.56 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 124.721 1.208 . . . . 0.0 107.9 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -157.14 114.19 3.06 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt -142.38 159.66 19.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.258 1.023 . . . . 0.0 108.837 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -61.89 126.42 27.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 169.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 m -66.91 -30.0 70.03 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -169.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -159.27 127.43 5.04 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.193 0.997 . . . . 0.0 108.762 -170.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.42 -158.22 27.57 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 121.651 0.584 . . . . 0.0 112.32 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.0 t -129.2 112.06 24.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -158.69 172.48 18.19 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.378 1.071 . . . . 0.0 109.845 -173.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -113.38 152.36 30.1 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.694 0.797 . . . . 0.0 109.287 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.27 168.7 19.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.671 0.788 . . . . 0.0 109.085 -170.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.26 152.92 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.457 1.503 . . . . 0.0 108.811 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -114.75 114.81 26.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.47 133.94 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.819 0.736 . . . . 0.0 109.329 -175.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -81.38 147.39 29.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.21 143.3 34.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -114.52 146.83 40.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.331 1.452 . . . . 0.0 109.24 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 m -62.68 103.51 0.43 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.288 0.635 . . . . 0.0 111.526 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.84 18.55 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 116.076 -1.916 . . . . 0.0 114.791 169.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 32.7 Cg_exo -40.37 127.79 2.28 Favored 'Trans proline' 0 C--N 1.361 1.224 0 CA-C-N 124.216 2.541 . . . . 0.0 115.093 173.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 31.91 39.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.492 3.117 . . . . 0.0 113.926 -170.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 53.11 31.44 11.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.385 1.474 . . . . 0.0 112.961 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.97 17.39 3.42 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.226 0.917 . . . . 0.0 112.748 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.25 147.88 90.37 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.99 0.895 . . . . 0.0 110.725 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.94 -9.15 15.61 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.28 2.653 . . . . 0.0 113.822 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.07 -173.46 4.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.064 1.345 . . . . 0.0 109.712 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.2 52.87 1.96 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.156 1.782 . . . . 0.0 108.684 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -78.14 -176.35 4.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 172.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 m -151.89 159.31 43.87 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 167.24 28.08 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.006 1.722 . . . . 0.0 108.282 174.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -108.2 157.51 18.25 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.9 pt -137.88 155.33 30.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.283 1.433 . . . . 0.0 108.58 174.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.6 t -119.03 123.77 72.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.407 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.0 mmp_? -135.96 149.26 48.83 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.311 1.044 . . . . 0.0 108.282 176.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.49 135.85 2.42 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 18.8 m-85 -153.92 155.29 35.39 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -60.14 -34.17 73.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.656 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.0 p-90 -64.28 -28.69 69.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.395 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 77.78 9.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.363 0.983 . . . . 0.0 108.799 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.07 -9.61 17.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.45 140.67 35.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.222 1.409 . . . . 0.0 107.456 174.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.477 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.8 m-70 -62.85 -29.86 71.07 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 111.428 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.77 67.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.942 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.4 -48.11 71.14 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.766 0.712 . . . . 0.0 110.501 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.16 -40.74 83.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 117.411 -1.28 . . . . 0.0 109.997 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.3 -46.7 85.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 120.608 1.549 . . . . 0.0 110.251 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.77 -49.17 69.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.239 0.472 . . . . 0.0 111.568 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -60.52 -49.3 78.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.349 0.66 . . . . 0.0 110.836 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' HG3' ' A' ' 45' ' ' ARG . 61.2 t -69.44 -44.42 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.056 -175.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.71 -28.92 70.28 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.686 1.13 . . . . 0.0 111.092 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -49.28 72.28 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.365 0.984 . . . . 0.0 110.717 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.11 -46.88 85.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.127 0.963 . . . . 0.0 110.626 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.7 mmt -57.98 -43.41 86.5 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.836 -0.54 . . . . 0.0 111.198 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -68.59 -31.28 70.36 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.862 -1.149 . . . . 0.0 112.248 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.36 -42.47 98.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.489 1.041 . . . . 0.0 109.662 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -62.54 -30.59 71.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.703 0.683 . . . . 0.0 110.55 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.27 -8.55 5.96 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.05 2.262 . . . . 0.0 112.972 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.38 179.96 2.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.547 1.939 . . . . 0.0 113.185 -169.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.14 150.92 52.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.1 m -149.07 165.24 32.32 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.31 128.34 10.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 108.325 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.98 116.17 7.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.6 -28.37 64.8 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.008 -0.432 . . . . 0.0 109.993 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.56 -163.94 36.52 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.45 -164.33 22.93 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.35 -163.59 29.56 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.48 157.62 31.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -131.14 127.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.8 m -152.4 104.95 2.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -162.72 178.98 8.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.794 0.438 . . . . 0.0 110.082 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -118.27 88.27 2.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 170.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.82 -27.85 63.54 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.442 1.097 . . . . 0.0 110.531 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -54.02 -30.45 47.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.252 1.021 . . . . 0.0 112.033 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -86.98 -74.85 0.42 Allowed 'General case' 0 C--N 1.34 0.196 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.33 147.95 17.96 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.713 1.605 . . . . 0.0 107.71 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.0 pttt 47.13 -179.31 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.811 2.844 . . . . 0.0 116.432 170.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.07 171.02 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 171.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -140.53 139.56 35.07 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -119.47 130.03 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -161.96 -179.53 7.22 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.155 -0.966 . . . . 0.0 110.828 -170.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -157.93 53.15 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -144.79 153.85 42.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.62 1.568 . . . . 0.0 107.647 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.1 p -70.78 133.9 46.94 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.6 mmt -73.86 32.45 0.08 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.09 1.356 . . . . 0.0 111.108 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.3 -39.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.611 1.565 . . . . 0.0 111.572 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -134.63 2.86 3.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 -175.76 53.62 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.086 0.857 . . . . 0.0 112.181 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.61 135.62 24.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.526 2.15 . . . . 0.0 110.642 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.79 172.43 12.68 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.458 0.647 . . . . 0.0 110.011 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -77.19 79.64 3.71 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -58.82 -17.77 26.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -174.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.46 82.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.204 0.602 . . . . 0.0 110.378 169.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mm -62.97 -49.7 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.8 m -57.79 -49.75 75.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.119 0.568 . . . . 0.0 109.716 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -65.82 -42.86 90.09 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.514 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.32 -46.4 86.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.2 1.364 . . . . 0.0 110.596 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -69.7 -42.79 73.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.054 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.45 -44.64 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.035 0.834 . . . . 0.0 108.944 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.79 -41.06 99.09 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.016 1.28 . . . . 0.0 111.303 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.65 75.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.624 0.647 . . . . 0.0 111.294 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -73.2 -29.27 62.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.015 0.526 . . . . 0.0 111.193 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 t80 49.73 63.25 10.52 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.127 2.171 . . . . 0.0 111.764 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.01 -24.99 52.05 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.198 2.599 . . . . 0.0 113.0 -174.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -154.14 -47.67 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.258 0.623 . . . . 0.0 111.681 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -159.17 -174.77 4.88 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.023 0.929 . . . . 0.0 109.732 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.82 168.22 0.66 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.173 1.789 . . . . 0.0 111.01 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.28 168.26 10.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.701 1.2 . . . . 0.0 110.784 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.6 p -138.7 171.15 14.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.364 1.466 . . . . 0.0 108.312 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -144.98 171.13 14.89 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.529 -0.732 . . . . 0.0 110.893 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.85 143.43 30.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 169.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -84.73 37.34 0.64 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.382 1.073 . . . . 0.0 111.639 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -155.43 176.9 11.99 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.696 1.198 . . . . 0.0 108.647 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 136.58 165.56 10.56 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.252 1.882 . . . . 0.0 110.975 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 C--O 1.247 0.937 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 175.409 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.25 161.25 40.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.986 1.315 . . . . 0.0 108.066 171.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -157.92 168.0 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.511 1.525 . . . . 0.0 107.234 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.14 -173.97 4.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.301 1.441 . . . . 0.0 107.941 173.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -144.53 154.52 42.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.427 1.091 . . . . 0.0 108.205 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.4 mt -50.62 -35.44 30.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.299 1.04 . . . . 0.0 112.84 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.93 -23.96 66.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.673 0.669 . . . . 0.0 112.479 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.65 -19.65 37.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.61 0.764 . . . . 0.0 111.212 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.92 131.65 94.67 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.52 111.78 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.301 2.667 . . . . 0.0 109.96 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.5 -35.77 65.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.81 135.72 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -154.47 108.42 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.7 pt -143.68 160.06 16.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.128 0.971 . . . . 0.0 110.231 -170.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -70.37 160.52 32.14 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 168.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -150.25 35.01 0.65 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.176 -1.577 . . . . 0.0 110.291 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.76 -14.48 2.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.235 1.014 . . . . 0.0 112.998 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.83 -171.24 22.06 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.11 0.868 . . . . 0.0 112.41 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.1 t -76.05 137.88 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 169.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -160.82 170.9 19.76 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.622 1.169 . . . . 0.0 109.13 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -107.12 151.46 25.35 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.75 169.18 17.96 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 109.179 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.63 152.87 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.107 1.363 . . . . 0.0 108.156 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -116.24 116.9 28.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.86 132.6 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.008 0.822 . . . . 0.0 109.615 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -77.85 147.98 34.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.31 140.42 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -112.05 146.81 37.27 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.618 1.167 . . . . 0.0 109.166 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 m -66.2 101.77 0.75 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.751 0.82 . . . . 0.0 109.598 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.57 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.67 16.27 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 115.839 -2.029 . . . . 0.0 115.004 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 63.6 Cg_exo -43.31 132.03 6.7 Favored 'Trans proline' 0 C--N 1.363 1.309 0 CA-C-N 124.258 2.557 . . . . 0.0 115.087 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 37.97 33.02 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.88 2.872 . . . . 0.0 114.049 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m 52.46 31.15 9.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.205 1.402 . . . . 0.0 112.846 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.96 13.47 3.35 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.129 0.871 . . . . 0.0 112.877 -176.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.65 149.08 85.55 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 117.935 0.868 . . . . 0.0 111.094 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.14 -8.53 15.33 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.294 2.663 . . . . 0.0 114.179 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.41 -176.79 5.85 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.761 1.224 . . . . 0.0 110.103 -169.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.68 37.28 3.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.867 1.667 . . . . 0.0 110.181 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -69.45 168.09 15.25 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.3 m -139.42 158.9 43.34 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.068 0.947 . . . . 0.0 110.526 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.52 165.67 35.89 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.696 1.598 . . . . 0.0 109.529 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.16 155.11 20.8 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.9 157.78 41.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.949 1.7 . . . . 0.0 109.052 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.72 117.53 51.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -137.78 150.4 47.19 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.53 138.27 2.68 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.1 m-85 -153.52 155.91 37.09 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -170.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.6 -33.88 72.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.402 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -65.7 -25.83 67.49 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.73 0.696 . . . . 0.0 112.536 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.42 82.06 8.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.677 1.126 . . . . 0.0 108.589 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -12.7 39.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.875 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.41 145.22 32.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.022 1.729 . . . . 0.0 108.381 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.472 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 15.2 m-70 -62.91 -31.27 72.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.384 1.074 . . . . 0.0 111.847 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -29.37 69.45 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.938 -0.477 . . . . 0.0 111.429 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.22 -45.44 84.69 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.48 0.582 . . . . 0.0 110.581 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -37.46 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.592 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.03 -45.96 86.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.483 1.492 . . . . 0.0 109.419 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.03 -48.34 71.43 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.763 0.425 . . . . 0.0 111.878 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -55.62 -54.97 37.5 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.683 0.793 . . . . 0.0 109.85 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.35 -43.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.022 -0.99 . . . . 0.0 108.664 -171.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.3 m -62.08 -29.03 70.03 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.008 1.276 . . . . 0.0 111.519 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.46 -51.09 55.33 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.43 1.014 . . . . 0.0 110.622 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.54 -44.89 92.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.972 0.886 . . . . 0.0 110.813 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -56.65 -45.72 81.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.294 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -70.33 -30.47 67.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.962 1.256 . . . . 0.0 112.327 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.18 -43.55 98.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.329 0.968 . . . . 0.0 109.694 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.44 -36.38 83.57 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.312 0.505 . . . . 0.0 110.368 171.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.32 -6.44 4.99 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.173 2.321 . . . . 0.0 113.281 170.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.6 171.88 9.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.724 1.61 . . . . 0.0 112.044 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -127.99 149.14 50.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -148.33 165.0 32.36 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -147.07 125.05 12.01 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.033 1.333 . . . . 0.0 108.263 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -67.73 111.59 4.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.9 mt -72.64 -24.61 61.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.934 -0.479 . . . . 0.0 110.62 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.34 -170.03 42.69 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.41 -174.01 28.6 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 171.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.0 -166.42 32.79 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -117.05 150.52 38.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.9 mt -118.97 136.69 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 m -156.05 165.16 37.27 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.608 0.763 . . . . 0.0 109.346 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -129.31 29.57 5.1 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.634 1.174 . . . . 0.0 108.581 169.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.64 -17.41 64.02 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.256 -0.902 . . . . 0.0 111.308 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 m -59.37 -24.95 63.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.971 1.708 . . . . 0.0 112.456 169.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 47.17 63.09 2.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.221 1.809 . . . . 0.0 110.575 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -115.18 -118.07 0.32 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.49 1.916 . . . . 0.0 106.232 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -136.73 11.21 3.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.062 1.301 . . . . 0.0 111.63 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -156.08 144.81 20.26 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.666 1.121 . . . . 0.0 111.329 -169.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 pt -64.11 161.05 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.727 0.775 . . . . 0.0 109.616 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -140.8 153.4 45.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.994 1.717 . . . . 0.0 107.557 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -121.71 126.64 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -166.07 1.51 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.611 -0.681 . . . . 0.0 110.509 -177.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.26 -160.9 53.44 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.84 -0.537 . . . . 0.0 111.804 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -154.04 155.13 34.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.366 1.467 . . . . 0.0 108.082 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.0 p -81.91 134.43 35.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -64.94 -29.26 70.18 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.835 -0.541 . . . . 0.0 110.647 170.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 -37.93 48.82 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.865 0.866 . . . . 0.0 112.756 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.32 1.38 3.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.61 -177.88 52.5 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 118.942 0.792 . . . . 0.0 111.921 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.67 134.44 28.19 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.641 2.228 . . . . 0.0 110.357 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 170.13 16.63 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.342 0.591 . . . . 0.0 110.225 169.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.03 79.05 3.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -58.89 -18.03 29.47 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.97 -39.19 74.14 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.668 0.787 . . . . 0.0 111.119 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.7 mm -61.8 -48.33 89.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -54.48 -52.03 63.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.735 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 p -60.46 -42.49 96.3 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.781 0.719 . . . . 0.0 111.822 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -60.94 -51.3 69.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.318 0.963 . . . . 0.0 110.825 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -71.08 -43.83 66.95 Favored 'General case' 0 C--N 1.334 -0.109 0 C-N-CA 123.35 0.66 . . . . 0.0 111.121 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.75 -43.26 97.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -63.02 -37.01 85.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 120.877 1.672 . . . . 0.0 111.228 176.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.6 93.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.098 0.863 . . . . 0.0 111.851 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -79.56 -20.06 47.93 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.24 0.616 . . . . 0.0 112.034 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.306 39.2 p90 41.94 54.25 8.47 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.918 2.487 . . . . 0.0 115.969 -171.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -58.69 -28.56 86.81 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.361 2.04 . . . . 0.0 110.817 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -131.08 156.76 44.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.88 2.472 . . . . 0.0 105.224 169.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -61.69 -32.59 72.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.037 0.935 . . . . 0.0 112.84 -169.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -157.7 163.91 37.69 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.847 2.059 . . . . 0.0 105.688 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.99 163.63 10.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.127 1.371 . . . . 0.0 107.752 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 p -137.39 171.84 13.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.744 1.218 . . . . 0.0 108.731 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -141.72 159.25 42.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.146 0.578 . . . . 0.0 110.173 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.75 125.79 10.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -63.7 -25.6 68.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.687 0.395 . . . . 0.0 111.862 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.39 -31.82 73.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.492 1.117 . . . . 0.0 112.967 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.96 151.96 46.5 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.2 p90 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.615 1.566 . . . . 0.0 109.178 -177.012 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.7 149.49 50.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.941 0.497 . . . . 0.0 110.081 175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.0 t -126.4 120.52 56.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.79 178.46 2.6 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.638 0.732 . . . . 0.0 110.467 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -149.65 157.02 42.85 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.54 -28.1 65.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.951 0.796 . . . . 0.0 112.706 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.68 66.53 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.829 1.195 . . . . 0.0 112.143 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.31 -31.07 17.09 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.633 1.173 . . . . 0.0 111.633 -175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.91 122.91 65.93 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.27 137.71 64.0 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.087 2.524 . . . . 0.0 111.141 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.63 -38.65 23.25 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 122.032 -0.417 . . . . 0.0 110.953 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.7 t -137.95 137.58 44.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -172.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -156.47 113.24 3.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.42 151.66 16.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.294 1.038 . . . . 0.0 108.669 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -154.08 112.21 3.56 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.809 0.844 . . . . 0.0 109.29 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.1 m -158.3 158.81 35.1 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.354 1.062 . . . . 0.0 109.69 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -150.4 158.54 44.27 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.621 1.968 . . . . 0.0 106.619 171.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.55 -106.89 1.88 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -170.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -146.26 132.16 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -152.37 171.37 18.13 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.412 1.485 . . . . 0.0 109.804 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.39 163.24 12.96 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.804 0.842 . . . . 0.0 111.692 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.99 171.86 14.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.98 154.9 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.354 1.462 . . . . 0.0 108.477 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.2 tp -118.28 120.75 38.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.18 132.1 71.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 119.242 0.928 . . . . 0.0 109.411 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -76.08 146.22 39.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.9 121.16 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -90.45 149.26 22.3 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.734 0.814 . . . . 0.0 108.968 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -66.09 96.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.078 0.951 . . . . 0.0 109.911 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.443 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.25 19.3 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 116.254 -1.832 . . . . 0.0 115.229 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 33.1 Cg_exo -39.36 132.52 1.49 Allowed 'Trans proline' 0 C--N 1.361 1.191 0 CA-C-N 123.927 2.438 . . . . 0.0 114.545 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 43.35 26.61 0.1 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.454 2.702 . . . . 0.0 114.154 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.68 32.1 8.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 112.358 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.91 19.67 1.25 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.958 0.79 . . . . 0.0 112.923 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.41 151.0 88.55 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 117.925 0.862 . . . . 0.0 110.538 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -79.1 -5.1 14.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.293 2.662 . . . . 0.0 114.473 -171.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.17 -178.14 6.45 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.703 1.201 . . . . 0.0 109.9 -170.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.79 36.34 3.31 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.557 1.543 . . . . 0.0 110.404 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.37 172.96 7.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -137.07 160.81 37.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.761 0.824 . . . . 0.0 110.619 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -139.34 165.11 28.07 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.613 1.565 . . . . 0.0 108.249 172.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.61 138.45 45.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 pt -115.6 155.08 16.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.132 0.973 . . . . 0.0 109.834 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.62 122.65 69.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.466 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.1 mmt85 -136.72 148.17 47.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 125.56 0.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -146.61 151.01 36.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -171.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -53.89 -31.26 49.33 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -74.54 -24.45 58.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.851 0.751 . . . . 0.0 112.951 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 83.4 8.06 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.974 1.261 . . . . 0.0 109.37 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.76 -6.24 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.636 0.775 . . . . 0.0 112.293 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.94 143.9 28.82 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 108.186 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -62.1 -31.38 71.83 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.104 0.962 . . . . 0.0 111.659 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.73 -27.46 69.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.785 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.779 0.718 . . . . 0.0 110.234 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -40.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.109 -1.424 . . . . 0.0 110.342 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.07 -48.61 80.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.868 1.667 . . . . 0.0 109.742 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.32 -47.11 83.6 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.888 0.767 . . . . 0.0 111.542 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -60.89 -50.13 74.65 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.96 0.504 . . . . 0.0 110.77 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.466 HG21 ' HG3' ' A' ' 45' ' ' ARG . 67.5 t -74.2 -44.69 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.32 -171.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.8 p -62.04 -30.41 70.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.789 1.177 . . . . 0.0 110.398 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.19 54.0 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.16 0.891 . . . . 0.0 111.007 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -64.08 -45.51 88.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.371 1.085 . . . . 0.0 111.169 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.54 -45.04 85.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.625 0.648 . . . . 0.0 111.179 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.42 -31.83 72.29 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.004 -1.06 . . . . 0.0 111.819 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.54 -39.8 95.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.101 0.864 . . . . 0.0 110.417 171.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.35 -33.9 77.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.226 0.921 . . . . 0.0 110.447 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.55 -9.88 4.03 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 126.416 1.96 . . . . 0.0 113.217 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -65.69 173.64 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.923 1.689 . . . . 0.0 112.503 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.14 135.1 49.31 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 169.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.0 m -142.48 164.49 29.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.9 130.43 11.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -66.23 109.24 2.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.2 mt -66.87 -28.16 68.1 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.926 -0.484 . . . . 0.0 110.472 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.02 -168.2 41.35 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.43 -169.15 20.87 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.88 -162.82 28.52 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 -128.88 153.7 47.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -128.86 140.38 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.8 m -126.72 138.66 53.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.259 1.024 . . . . 0.0 108.451 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -134.88 4.48 3.29 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.316 1.847 . . . . 0.0 110.539 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -60.15 -20.41 58.35 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.475 1.034 . . . . 0.0 113.383 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 m -56.65 -31.79 64.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.493 1.117 . . . . 0.0 112.221 169.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 44.93 50.44 8.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.5 2.32 . . . . 0.0 111.306 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -134.95 48.95 2.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.113 1.365 . . . . 0.0 109.9 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? 55.3 28.35 11.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.637 1.575 . . . . 0.0 112.809 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -148.55 159.17 44.33 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.031 -1.043 . . . . 0.0 109.771 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.8 pt -131.44 169.77 21.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.713 1.605 . . . . 0.0 108.344 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -133.36 151.39 51.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.19 126.7 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.45 -177.51 6.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.598 0.759 . . . . 0.0 110.496 -173.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -161.05 53.22 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -150.61 155.64 39.8 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 108.421 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 t -69.61 131.85 45.29 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.6 ttm -62.51 -26.32 68.49 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.521 0.328 . . . . 0.0 110.844 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.24 -30.05 13.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 112.587 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.01 1.66 4.29 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -168.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.74 -176.56 48.54 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.092 0.86 . . . . 0.0 112.279 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.34 131.6 22.18 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.721 2.281 . . . . 0.0 110.663 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.87 170.02 16.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 110.231 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.03 74.14 4.58 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.41 -18.82 19.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 113.399 -175.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.47 -38.82 69.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.424 0.69 . . . . 0.0 111.199 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.65 -43.98 97.95 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.928 0.891 . . . . 0.0 108.828 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -57.0 -50.35 72.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.64 0.655 . . . . 0.0 110.617 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 -48.56 73.92 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.813 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.94 -50.08 72.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.018 0.826 . . . . 0.0 110.878 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -68.33 -46.12 71.08 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.575 0.75 . . . . 0.0 110.671 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.98 -39.24 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.983 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.06 -36.76 82.73 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.158 1.799 . . . . 0.0 111.572 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.99 89.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.963 0.801 . . . . 0.0 110.958 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -70.04 -39.17 75.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.162 0.585 . . . . 0.0 111.289 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 t80 46.44 67.15 4.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.965 2.106 . . . . 0.0 109.592 -168.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.24 -30.84 54.36 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.951 2.434 . . . . 0.0 111.987 -169.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -166.74 -30.65 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 111.298 170.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.54 167.16 22.71 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.249 1.419 . . . . 0.0 112.079 -168.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -77.49 175.0 10.23 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.0 p -149.21 155.03 8.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 120.755 -1.216 . . . . 0.0 108.587 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.9 p -140.97 170.98 14.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.547 1.539 . . . . 0.0 107.785 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -145.61 168.19 21.25 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.661 -0.649 . . . . 0.0 111.425 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.15 142.49 30.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -87.76 45.73 1.31 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.323 1.049 . . . . 0.0 110.018 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -153.51 -177.11 6.14 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.009 1.324 . . . . 0.0 108.948 -170.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.94 173.62 43.94 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.396 1.474 . . . . 0.0 111.529 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.9 p90 . . . . . 0 C--O 1.247 0.928 0 C-N-CA 126.685 1.994 . . . . 0.0 106.246 174.603 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.8 162.0 41.58 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.111 1.364 . . . . 0.0 108.379 175.056 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 p -155.1 148.59 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.61 176.24 3.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.301 0.572 . . . . 0.0 110.091 172.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -148.07 153.79 39.38 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 mt -53.65 -30.71 44.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 113.468 -178.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.58 -24.8 56.66 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.889 0.768 . . . . 0.0 112.283 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.0 -21.56 29.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.967 0.907 . . . . 0.0 110.954 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.37 129.91 80.41 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.91 112.57 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 172.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.61 -30.09 64.06 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.584 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.4 139.09 23.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.977 1.711 . . . . 0.0 106.386 177.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -155.03 109.28 2.94 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt -137.58 157.04 33.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.333 1.053 . . . . 0.0 108.815 -173.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -60.59 141.79 56.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.851 0.358 . . . . 0.0 110.188 172.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m -69.55 -30.71 68.58 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -169.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -170.1 115.92 0.52 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.745 1.157 . . . . 0.0 110.453 -169.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.55 -155.59 26.64 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 177.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -130.38 121.51 51.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 169.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -159.76 162.23 34.84 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.96 0.904 . . . . 0.0 110.045 -170.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -81.24 159.96 24.4 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.46 169.25 17.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.87 155.4 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.019 1.327 . . . . 0.0 108.727 177.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -122.57 111.47 16.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 -175.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.78 134.72 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 118.81 0.732 . . . . 0.0 109.812 -171.259 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -79.16 147.87 32.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.182 1.393 . . . . 0.0 108.462 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 t -137.05 128.93 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -97.3 150.98 20.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.813 1.245 . . . . 0.0 109.952 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m -66.29 100.36 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.195 176.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.8 19.51 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.171 169.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 86.6 Cg_exo -46.51 140.31 12.09 Favored 'Trans proline' 0 C--N 1.362 1.277 0 CA-C-N 124.317 2.578 . . . . 0.0 113.879 173.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 42.96 25.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 114.269 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 m 50.33 33.44 7.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.979 1.312 . . . . 0.0 112.226 -174.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.89 28.56 1.28 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.143 0.878 . . . . 0.0 112.165 -172.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.09 151.59 89.72 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 117.503 0.652 . . . . 0.0 110.537 175.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.85 -8.23 16.72 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.228 2.619 . . . . 0.0 113.915 -177.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.6 -175.08 5.2 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.05 1.34 . . . . 0.0 109.769 -170.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.85 37.64 3.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.653 1.581 . . . . 0.0 110.2 174.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -70.09 170.39 11.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -141.8 158.26 44.02 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.993 0.917 . . . . 0.0 110.034 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -153.07 165.69 34.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.199 1.4 . . . . 0.0 109.142 174.696 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.26 158.04 17.81 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -175.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.412 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 43.9 pt -136.62 158.61 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.006 1.323 . . . . 0.0 109.358 175.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 t -123.36 119.16 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -171.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mmt85 -138.25 145.96 41.97 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.45 133.9 1.92 Allowed Glycine 0 C--N 1.332 0.326 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.421 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.6 m-85 -155.64 156.93 35.86 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.378 0.671 . . . . 0.0 109.294 -171.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -32.75 72.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.359 0.664 . . . . 0.0 111.485 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.421 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.5 p-90 -65.98 -29.09 69.42 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 112.207 178.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 81.21 8.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.289 0.949 . . . . 0.0 108.451 171.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -62.16 -15.45 46.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 111.919 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.15 144.76 36.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.891 1.676 . . . . 0.0 108.446 176.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.538 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 7.4 m-70 -59.49 -31.66 69.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.217 1.407 . . . . 0.0 111.895 -175.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.07 69.67 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.664 177.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.1 -47.75 70.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.747 0.703 . . . . 0.0 110.393 -178.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -39.99 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.476 -1.249 . . . . 0.0 110.3 176.162 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.5 -47.17 86.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.566 1.53 . . . . 0.0 109.786 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.75 -48.51 78.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.604 0.638 . . . . 0.0 111.41 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -60.84 -51.18 70.4 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.62 -44.77 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.33 -173.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -60.52 -37.01 79.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.727 1.149 . . . . 0.0 109.515 176.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.67 84.83 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.877 0.762 . . . . 0.0 111.601 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.04 -47.19 81.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.564 1.182 . . . . 0.0 110.817 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mmt -56.95 -44.34 82.47 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.968 -0.457 . . . . 0.0 111.19 175.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -67.87 -33.36 74.59 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.249 -0.907 . . . . 0.0 111.768 179.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -63.05 -40.98 99.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.059 0.845 . . . . 0.0 110.018 171.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -63.03 -37.83 88.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.032 0.833 . . . . 0.0 110.098 171.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 140.39 -8.93 2.92 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.323 1.916 . . . . 0.0 113.324 169.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.7 m -68.92 175.13 3.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.455 1.502 . . . . 0.0 112.436 -170.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.51 143.24 50.75 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.7 m -144.22 169.64 17.49 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.14 137.92 15.3 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.313 1.045 . . . . 0.0 108.777 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -70.9 112.48 7.11 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 169.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.2 -25.43 63.41 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.132 -0.355 . . . . 0.0 110.335 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.89 -164.23 37.65 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.92 23.09 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.39 -157.1 19.13 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -175.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -129.28 165.73 20.85 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 117.977 0.888 . . . . 0.0 109.594 173.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.4 mt -131.3 137.18 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -169.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.9 m -147.1 136.27 22.51 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.665 0.786 . . . . 0.0 109.886 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -64.8 136.99 57.51 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 168.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -61.34 144.28 54.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.492 0.587 . . . . 0.0 109.429 177.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -63.0 -26.0 68.65 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -169.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -148.67 22.6 1.01 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.889 0.876 . . . . 0.0 111.553 -171.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -149.82 151.77 34.07 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.175 0.99 . . . . 0.0 109.029 -174.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -60.56 -28.24 68.3 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -68.71 173.13 5.46 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.362 1.077 . . . . 0.0 112.686 -169.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -121.0 156.1 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 170.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -129.82 147.52 51.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.27 1.428 . . . . 0.0 108.105 -172.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.08 119.07 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -174.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -159.88 -177.01 6.03 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.208 -0.933 . . . . 0.0 111.144 -169.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.84 -158.49 44.78 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 177.128 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -143.94 151.91 40.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.603 1.561 . . . . 0.0 107.398 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.6 p -72.84 139.68 47.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.8 mmm -64.51 -6.88 8.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.76 -19.74 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.802 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.57 2.55 2.96 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 112.7 -171.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.2 -176.14 54.82 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.845 0.748 . . . . 0.0 112.332 178.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -72.0 137.04 28.46 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.725 2.283 . . . . 0.0 110.692 -179.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 174.81 10.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.388 0.613 . . . . 0.0 110.306 169.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -79.4 80.84 5.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 168.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -58.37 -16.08 13.15 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.83 88.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.461 0.704 . . . . 0.0 110.869 171.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.2 mt -60.05 -47.49 91.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 175.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -56.05 -55.72 29.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.515 1.126 . . . . 0.0 110.876 -177.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 p -65.46 -41.08 93.78 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.078 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.57 -44.39 94.21 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.744 1.156 . . . . 0.0 110.23 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -66.09 -43.3 87.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.42 -49.41 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.88 -39.12 84.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.585 1.084 . . . . 0.0 111.239 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.54 78.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.473 0.578 . . . . 0.0 111.48 177.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -76.98 -18.38 58.26 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.9 t80 52.23 52.58 11.42 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 126.088 1.755 . . . . 0.0 113.288 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.31 -16.29 28.0 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.288 1.992 . . . . 0.0 111.286 170.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -150.27 165.31 33.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.061 2.145 . . . . 0.0 107.91 176.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -54.13 -51.69 63.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.669 1.587 . . . . 0.0 112.856 -171.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -163.82 159.55 21.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.5 m -138.06 171.38 15.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.519 0.728 . . . . 0.0 110.791 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.9 p -142.18 166.49 24.55 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.028 1.331 . . . . 0.0 108.636 -174.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -144.18 170.36 16.12 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.691 171.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.22 143.6 28.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 169.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -84.51 34.49 0.53 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.213 1.005 . . . . 0.0 111.601 -174.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -153.58 -179.3 7.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.875 1.67 . . . . 0.0 107.558 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 139.63 -154.51 23.7 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.302 0.953 . . . . 0.0 111.138 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 51.8 p90 . . . . . 0 C--O 1.247 0.925 0 C-N-CA 126.015 1.726 . . . . 0.0 107.906 177.172 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 mt -52.21 -29.91 24.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.55 1.14 . . . . 0.0 113.469 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.71 -27.69 61.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 112.417 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.0 mt -83.25 -24.14 32.41 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 0.0 110.975 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.0 130.25 73.25 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.52 125.69 16.07 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.226 2.618 . . . . 0.0 109.78 171.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.77 -36.23 20.25 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.97 138.52 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -156.0 112.99 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.3 pt . . . . . 0 C--O 1.236 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 109.136 -172.652 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.5 p90 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -101.02 158.24 16.16 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.605 -0.684 . . . . 0.0 109.717 -173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.96 168.6 19.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.88 0.872 . . . . 0.0 109.446 -171.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.5 155.01 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.32 1.448 . . . . 0.0 108.335 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 tp -118.27 114.64 23.29 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 130.9 72.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -77.5 146.11 36.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.31 127.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.57 149.75 22.43 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 109.222 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -65.88 98.3 0.4 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.989 0.916 . . . . 0.0 110.75 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -148.52 18.02 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.281 -1.819 . . . . 0.0 115.123 169.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 55.8 Cg_exo -41.21 134.57 2.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 123.978 2.456 . . . . 0.0 114.5 171.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 47.23 21.54 0.2 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.021 2.528 . . . . 0.0 113.448 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.86 33.45 8.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.28 1.432 . . . . 0.0 112.659 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 113.82 -174.372 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 121.395 0.616 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.59 167.64 12.61 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -141.19 158.87 43.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.848 0.859 . . . . 0.0 110.412 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -151.52 166.08 32.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.845 1.658 . . . . 0.0 108.928 174.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -108.94 153.69 23.2 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 45.0 pt -129.82 155.28 41.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.854 1.262 . . . . 0.0 109.265 173.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.36 123.52 71.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -171.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.605 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.8 mmp_? -136.03 146.58 47.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.625 1.17 . . . . 0.0 108.478 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.13 129.84 1.44 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -150.78 151.92 33.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -60.19 -29.75 68.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.804 0.842 . . . . 0.0 112.479 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 -68.19 -28.03 66.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.33 0.968 . . . . 0.0 112.578 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.62 82.63 8.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.739 1.154 . . . . 0.0 108.913 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.12 -3.94 8.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.321 0.648 . . . . 0.0 112.355 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.33 142.95 26.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.818 1.647 . . . . 0.0 107.982 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.437 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 18.9 m-70 -60.92 -30.74 70.38 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 111.856 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.29 70.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.813 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.66 0.664 . . . . 0.0 110.431 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -41.57 86.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.216 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.93 -46.99 86.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.123 1.329 . . . . 0.0 110.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.88 -49.6 69.87 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.234 0.47 . . . . 0.0 111.331 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -58.84 -49.85 76.19 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.419 0.687 . . . . 0.0 110.839 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.605 HG21 ' HG3' ' A' ' 45' ' ' ARG . 85.1 t -73.47 -41.3 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.155 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m -62.36 -29.8 70.73 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 119.638 1.108 . . . . 0.0 110.895 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.6 -50.03 70.51 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -62.72 -47.77 82.15 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.194 0.997 . . . . 0.0 110.854 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.81 -43.99 90.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.965 -0.459 . . . . 0.0 111.302 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -68.78 -31.62 70.77 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.993 -1.067 . . . . 0.0 111.911 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -61.36 -43.69 98.44 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.421 1.01 . . . . 0.0 109.552 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -60.13 -43.04 95.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.513 1.052 . . . . 0.0 109.546 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.75 -7.17 1.69 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.333 1.92 . . . . 0.0 113.265 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.36 176.58 2.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.204 1.802 . . . . 0.0 113.216 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -130.03 140.51 50.85 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.4 m -146.45 163.34 35.98 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -153.58 128.71 9.69 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -66.75 116.71 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.4 -28.89 65.43 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.792 -0.568 . . . . 0.0 110.078 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.87 -169.37 42.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.1 -168.34 20.27 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.99 -161.22 26.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -121.37 153.53 37.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.445 1.098 . . . . 0.0 108.232 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 mt -125.28 135.04 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 123.526 0.73 . . . . 0.0 109.951 -172.547 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -128.11 122.42 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -173.04 3.96 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.41 -0.806 . . . . 0.0 111.21 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -160.15 53.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.02 153.77 35.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.45 1.1 . . . . 0.0 108.903 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.5 t -69.45 128.33 36.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.8 ttp -64.91 -17.24 64.16 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.355 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.69 -29.66 10.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.715 0.806 . . . . 0.0 112.638 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -127.4 0.08 6.3 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.75 -178.28 50.83 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.853 0.752 . . . . 0.0 112.144 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.1 131.04 19.96 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.635 2.223 . . . . 0.0 110.401 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.5 167.64 20.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.355 0.598 . . . . 0.0 109.557 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.14 77.7 5.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -57.76 -18.87 24.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.11 66.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.705 0.802 . . . . 0.0 111.21 169.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.44 -49.25 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -55.5 -48.32 74.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.001 0.521 . . . . 0.0 111.124 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.9 p -61.78 -44.83 96.11 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.476 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.43 -46.55 89.62 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.277 0.944 . . . . 0.0 110.571 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -62.27 -54.95 33.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.329 1.452 . . . . 0.0 110.684 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.735 0.814 . . . . 0.0 109.186 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -59.73 -40.2 87.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.287 0.949 . . . . 0.0 110.833 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.48 91.14 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.306 0.503 . . . . 0.0 111.201 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -81.71 -14.58 56.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.555 1.144 0 C-N-CA 124.848 1.259 . . . . 0.0 113.228 178.744 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--O 1.239 0.509 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.47 164.7 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.107 0.563 . . . . 0.0 111.184 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.9 p -137.69 172.67 12.61 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 108.758 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -142.73 169.55 17.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.768 0.427 . . . . 0.0 110.417 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 169.535 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.1 mt -55.51 -27.73 50.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.254 1.422 . . . . 0.0 113.524 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.0 -23.19 61.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.777 0.717 . . . . 0.0 112.564 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.52 -21.19 53.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.515 0.598 . . . . 0.0 111.315 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.07 134.97 96.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.278 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.74 106.95 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.27 2.647 . . . . 0.0 108.717 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.42 -33.51 73.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.9 t -142.6 138.2 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -150.64 103.35 3.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 pt . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 127.601 2.36 . . . . 0.0 106.641 177.819 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.05 155.09 17.29 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.931 0.492 . . . . 0.0 109.784 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.63 19.33 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.72 0.808 . . . . 0.0 108.966 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.86 153.59 17.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.767 1.227 . . . . 0.0 108.315 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.08 118.04 32.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.284 0.0 OUTLIER -130.02 130.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 118.373 0.533 . . . . 0.0 109.597 -172.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -80.63 147.33 30.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.792 1.637 . . . . 0.0 108.438 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.91 129.75 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -93.85 155.51 17.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.351 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 m -66.52 85.05 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.267 1.027 . . . . 0.0 111.555 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.512 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.19 13.14 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 116.23 -1.843 . . . . 0.0 114.041 169.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 52.0 Cg_exo -47.13 136.22 18.38 Favored 'Trans proline' 0 C--N 1.362 1.284 0 CA-C-N 124.02 2.472 . . . . 0.0 112.454 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 41.2 31.76 0.16 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.898 2.479 . . . . 0.0 113.847 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 32.0 12.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.897 1.679 . . . . 0.0 113.806 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.586 -175.633 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -69.41 167.89 15.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -142.8 159.34 42.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.722 0.809 . . . . 0.0 109.652 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -149.22 164.43 34.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 109.195 174.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 150.37 27.63 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.432 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 37.6 pt -127.68 155.55 39.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.486 1.115 . . . . 0.0 108.872 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 t -122.34 116.46 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -169.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -136.51 147.27 47.01 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.98 138.31 3.71 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -154.16 155.92 36.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -173.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.75 -33.03 72.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.779 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -65.87 -27.04 67.92 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.756 0.707 . . . . 0.0 112.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.51 78.92 9.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.593 1.088 . . . . 0.0 109.117 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.96 -6.9 9.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.697 0.799 . . . . 0.0 112.102 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 142.53 29.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.981 1.713 . . . . 0.0 107.604 174.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.506 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 13.7 m-70 -62.15 -29.66 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.637 1.175 . . . . 0.0 111.663 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -29.18 68.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.034 -0.507 . . . . 0.0 111.757 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.26 -44.67 78.79 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.807 0.73 . . . . 0.0 110.725 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.415 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -70.53 -41.44 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.458 177.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.22 -45.12 94.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.54 1.064 . . . . 0.0 109.044 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.03 -48.11 80.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.163 0.892 . . . . 0.0 111.748 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -55.08 -56.78 15.94 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.974 0.909 . . . . 0.0 109.945 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.46 -43.62 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.599 -169.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 t -60.5 -35.58 76.28 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.075 1.307 . . . . 0.0 109.748 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.84 -48.16 86.78 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.165 0.893 . . . . 0.0 111.324 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.12 -46.66 83.15 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.143 0.972 . . . . 0.0 111.131 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.1 mmt -58.91 -43.77 91.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.694 0.679 . . . . 0.0 110.831 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -66.52 -33.37 75.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.859 -1.15 . . . . 0.0 111.27 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.94 -40.09 95.65 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.971 . . . . 0.0 110.389 169.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -64.59 -20.23 66.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.054 0.843 . . . . 0.0 111.49 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.47 -8.43 11.1 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.581 2.038 . . . . 0.0 112.723 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.24 178.55 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.826 1.65 . . . . 0.0 114.048 -169.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -132.31 145.1 51.03 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -147.57 165.57 29.98 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -168.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -150.51 130.95 13.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.658 1.183 . . . . 0.0 109.382 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -71.88 116.27 12.07 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -74.64 -24.96 58.91 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.97 -0.456 . . . . 0.0 110.418 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.49 -168.32 40.48 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.62 -167.87 22.69 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.31 -163.37 29.65 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.9 ttp-105 -119.49 154.43 33.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mt -113.19 126.98 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--N 1.331 -0.221 0 C-N-CA 123.837 0.855 . . . . 0.0 108.896 -176.025 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.3 t60 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 t -117.03 114.09 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.8 -173.23 4.0 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.637 -0.664 . . . . 0.0 111.945 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.7 -156.56 46.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -145.83 152.72 39.96 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.023 0.929 . . . . 0.0 109.084 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.2 t -69.32 130.46 42.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -64.81 -8.34 14.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.24 -27.71 6.37 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.153 0.981 . . . . 0.0 112.574 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -132.8 2.39 3.7 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.94 -177.27 48.17 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 119.246 0.93 . . . . 0.0 112.554 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 128.68 15.56 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.815 2.343 . . . . 0.0 110.902 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.87 167.24 22.25 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.499 0.666 . . . . 0.0 110.199 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -79.99 83.46 5.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 168.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -59.17 -14.82 11.75 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.37 84.47 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.154 0.982 . . . . 0.0 110.87 169.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.9 mm -62.19 -51.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -56.38 -51.18 69.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.801 0.84 . . . . 0.0 110.976 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 p -63.17 -42.78 99.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.337 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.67 -47.81 82.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.938 1.244 . . . . 0.0 110.74 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.259 0.481 . . . . 0.0 110.827 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.84 -51.17 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.18 -36.34 77.4 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.983 1.265 . . . . 0.0 110.846 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.36 68.33 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.406 0.548 . . . . 0.0 111.552 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -74.94 -19.32 60.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 126.558 1.943 . . . . 0.0 113.639 178.201 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.05 167.78 9.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.895 2.078 . . . . 0.0 107.862 173.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -142.45 170.11 16.31 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.657 1.583 . . . . 0.0 107.048 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -142.27 169.79 16.93 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.216 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.61 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.03 -28.24 64.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.622 0.769 . . . . 0.0 112.879 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.89 61.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.282 0.946 . . . . 0.0 112.363 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.13 -28.57 18.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.47 1.108 . . . . 0.0 110.957 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -55.91 129.09 71.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -50.44 133.24 36.93 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.273 2.649 . . . . 0.0 110.22 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.12 -42.35 9.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 137.09 43.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -156.42 118.18 3.9 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 169.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--O 1.235 0.3 0 C-N-CA 124.114 0.966 . . . . 0.0 109.131 -175.68 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -97.62 160.55 14.25 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.412 -0.805 . . . . 0.0 109.92 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 167.8 21.45 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.13 0.972 . . . . 0.0 108.791 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.12 155.17 15.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.351 1.06 . . . . 0.0 108.767 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -118.36 114.52 23.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -120.58 131.38 72.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.782 0.719 . . . . 0.0 109.231 -175.113 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -76.78 145.08 38.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.44 117.94 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.9 146.09 26.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.8 p -68.45 103.33 1.63 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.297 0.498 . . . . 0.0 109.853 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.455 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.66 25.02 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.655 -1.641 . . . . 0.0 114.753 169.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 49.9 Cg_exo -42.65 135.69 4.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 CA-C-N 123.827 2.402 . . . . 0.0 114.637 172.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 43.05 25.87 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.587 2.355 . . . . 0.0 114.518 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 51.47 33.35 10.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.814 1.245 . . . . 0.0 112.267 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.962 0 C-N-CA 124.339 0.971 . . . . 0.0 112.34 -173.426 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.3 0 CA-C-O 121.683 0.754 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.01 178.08 6.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.843 0.857 . . . . 0.0 109.341 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -141.17 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.532 0.733 . . . . 0.0 110.725 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.07 162.62 32.85 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.84 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.12 136.26 49.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 pt -116.79 155.03 18.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.704 0.802 . . . . 0.0 109.627 172.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.8 123.85 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.0 mmt85 -137.57 148.46 45.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.294 1.038 . . . . 0.0 108.502 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.76 133.15 1.93 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -150.3 156.5 41.65 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -60.1 -35.38 75.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 119.177 -0.439 . . . . 0.0 111.497 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -65.4 -26.38 67.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.4 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.59 80.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.626 1.103 . . . . 0.0 108.428 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.7 -13.32 21.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.777 0.831 . . . . 0.0 111.777 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.24 143.51 31.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.417 1.887 . . . . 0.0 107.683 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -58.48 -30.0 66.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.962 1.305 . . . . 0.0 112.926 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.68 -27.96 69.57 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.593 . . . . 0.0 111.476 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.53 -46.74 78.42 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.313 0.506 . . . . 0.0 110.63 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -40.83 80.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.473 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -59.66 -47.62 84.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.791 1.632 . . . . 0.0 109.741 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.82 -47.65 82.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.794 0.724 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -61.24 -50.07 74.56 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.151 0.58 . . . . 0.0 110.845 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 45' ' ' ARG . 66.9 t -74.53 -44.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.452 -170.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.1 p -62.11 -30.94 71.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.923 1.238 . . . . 0.0 110.341 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.49 -52.23 54.35 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.96 -42.3 85.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.681 1.241 . . . . 0.0 111.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.22 -43.33 82.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.406 1.003 . . . . 0.0 111.095 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -68.9 -29.89 68.27 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.966 -1.084 . . . . 0.0 112.285 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -62.36 -42.32 99.3 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.358 0.981 . . . . 0.0 109.071 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.09 -38.08 89.57 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.349 0.522 . . . . 0.0 110.314 172.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.65 -8.91 3.12 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.18 1.848 . . . . 0.0 113.459 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.9 m -66.69 171.28 5.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.678 1.591 . . . . 0.0 112.256 -169.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.35 136.6 54.22 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 169.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 54.2 m -142.27 165.36 27.64 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.2 131.71 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -68.32 109.56 3.68 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.6 mt -64.97 -28.17 69.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.722 0.409 . . . . 0.0 110.082 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.69 -167.55 40.7 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.76 -164.01 20.37 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.1 -159.65 23.64 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -125.5 154.13 42.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mt -129.83 139.49 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.351 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.12 129.65 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -159.77 -174.69 4.73 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.349 -0.844 . . . . 0.0 110.903 -170.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.81 -161.42 53.43 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.942 -0.474 . . . . 0.0 112.3 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -151.31 152.26 32.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 109.643 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 m -79.6 130.9 35.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 tpt -60.63 -35.26 75.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.903 0.481 . . . . 0.0 111.258 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.08 -16.89 24.46 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.73 -5.9 5.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -169.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.72 178.08 42.94 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.823 0.725 . . . . 0.0 112.098 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.55 135.38 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.671 2.248 . . . . 0.0 109.814 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.13 169.91 16.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 110.152 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -79.68 82.78 5.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -58.45 -18.28 27.34 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.66 -38.4 72.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.502 1.121 . . . . 0.0 111.846 169.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 14.6 mm -62.8 -49.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.9 m -56.58 -52.49 64.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.772 0.829 . . . . 0.0 111.325 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -62.08 -43.61 98.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.995 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.23 -47.93 83.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.499 1.045 . . . . 0.0 110.761 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -64.36 -47.11 80.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.303 0.501 . . . . 0.0 110.986 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -48.3 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -61.92 -38.81 89.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.34 1.427 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.29 97.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.552 0.615 . . . . 0.0 111.922 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -87.95 -12.95 43.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.632 0.651 . . . . 0.0 112.682 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.301 40.5 p90 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 128.56 2.744 . . . . 0.0 116.422 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 m -144.74 170.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.75 1.62 . . . . 0.0 108.143 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -141.39 171.59 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.253 1.421 . . . . 0.0 108.481 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -145.93 164.23 32.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.756 0.707 . . . . 0.0 111.735 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.268 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.8 mt -49.35 -34.25 15.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.181 1.392 . . . . 0.0 112.725 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.13 -24.51 67.19 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.4 mt -79.45 -19.95 48.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.097 0.559 . . . . 0.0 111.517 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mt -70.19 133.43 87.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.79 140.71 68.57 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.41 2.073 . . . . 0.0 108.973 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -86.33 -38.84 17.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.69 140.58 27.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -157.49 117.25 3.38 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 pt . . . . . 0 CA--C 1.538 0.495 0 C-N-CA 124.332 1.053 . . . . 0.0 109.918 -171.555 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 p90 . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.24 154.94 18.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.239 0.616 . . . . 0.0 109.778 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 169.79 16.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.488 0.715 . . . . 0.0 109.551 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.46 153.68 16.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.291 1.436 . . . . 0.0 108.319 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.7 tp -117.1 114.86 24.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.31 132.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.57 147.45 33.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.599 1.16 . . . . 0.0 107.895 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.22 125.85 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -97.11 146.23 25.23 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.679 1.192 . . . . 0.0 108.941 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 m -63.84 100.96 0.33 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.262 0.483 . . . . 0.0 111.025 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.592 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -147.85 9.76 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 116.094 -1.908 . . . . 0.0 114.602 169.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 88.4 Cg_exo -44.7 140.33 6.63 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 124.14 2.514 . . . . 0.0 114.58 174.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? 43.66 24.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.75 2.42 . . . . 0.0 114.117 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.17 30.26 4.17 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.158 1.383 . . . . 0.0 112.327 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.903 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.974 -170.825 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -77.25 -174.19 3.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.3 m -150.8 160.52 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.778 -1.201 . . . . 0.0 109.974 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 165.11 33.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.643 1.577 . . . . 0.0 108.636 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.25 154.95 21.05 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 pt -134.39 155.44 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.9 1.28 . . . . 0.0 109.042 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -118.38 120.79 65.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -135.26 148.69 49.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.26 140.9 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 39.2 m-85 -151.99 152.82 32.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -60.05 -32.31 70.81 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.828 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.403 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.2 p-90 -65.84 -27.78 68.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.683 0.674 . . . . 0.0 112.41 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 78.07 9.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.565 1.075 . . . . 0.0 108.816 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.5 -5.59 8.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.414 0.686 . . . . 0.0 112.08 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 140.09 27.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.086 1.754 . . . . 0.0 107.472 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.526 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.7 m-70 -61.98 -31.12 71.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.596 1.158 . . . . 0.0 111.703 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 -29.39 67.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.728 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.86 -48.02 72.98 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.735 0.698 . . . . 0.0 110.466 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -40.6 82.33 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 117.473 -1.251 . . . . 0.0 110.013 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.1 -46.93 84.71 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.574 1.534 . . . . 0.0 110.137 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.45 -49.51 68.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.254 0.479 . . . . 0.0 111.45 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -60.83 -49.52 77.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.2 0.6 . . . . 0.0 110.955 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.73 -44.51 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.952 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -62.7 -28.29 69.84 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.637 1.108 . . . . 0.0 111.195 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.6 56.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.34 -45.78 86.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.194 0.997 . . . . 0.0 110.96 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.5 mmt -57.78 -45.09 86.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.702 0.683 . . . . 0.0 111.14 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.32 -32.12 72.87 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.946 -1.096 . . . . 0.0 111.814 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -63.72 -37.71 88.39 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.266 0.939 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -66.94 -34.86 78.69 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.216 0.916 . . . . 0.0 110.235 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.6 -6.46 3.86 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.548 2.023 . . . . 0.0 113.106 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.06 178.45 1.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.922 1.689 . . . . 0.0 113.001 -169.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -132.34 142.11 49.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.6 m -145.86 164.27 32.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.87 128.55 10.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 p -71.69 112.27 7.66 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 110.372 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.0 -166.85 39.73 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -163.82 -169.14 26.9 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.46 -160.86 24.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.17 156.82 32.89 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mt -126.36 146.93 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 125.608 1.563 . . . . 0.0 108.405 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t60 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.01 122.69 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -159.96 -176.36 5.64 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.61 -0.681 . . . . 0.0 111.488 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.66 -160.29 51.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -145.34 151.28 38.05 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.857 1.263 . . . . 0.0 108.057 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.1 p -69.85 147.88 49.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.027 0.441 . . . . 0.0 110.526 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.0 ttp -58.33 -22.47 53.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.478 1.111 . . . . 0.0 112.959 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.66 -14.89 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.0 4.78 3.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.214 1.37 . . . . 0.0 112.794 -170.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.69 -175.4 51.79 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 118.518 0.599 . . . . 0.0 112.251 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 136.73 28.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.73 2.287 . . . . 0.0 110.538 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.1 171.51 14.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.572 0.701 . . . . 0.0 110.27 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -77.74 74.67 4.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -58.31 -17.89 23.14 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.29 70.6 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.373 0.669 . . . . 0.0 111.479 169.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.6 -45.38 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.776 0.83 . . . . 0.0 108.794 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -59.39 -49.12 79.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.723 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 p -57.97 -46.16 85.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.718 0.69 . . . . 0.0 111.47 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -61.0 -48.83 79.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.087 0.858 . . . . 0.0 110.472 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -72.71 -42.96 63.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.942 -0.474 . . . . 0.0 111.534 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.41 HG22 ' CG2' ' A' ' 118' ' ' VAL . 87.3 mt -64.23 -42.32 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.82 -40.24 91.99 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.896 1.68 . . . . 0.0 111.058 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.4 -42.28 98.78 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.447 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.81 -28.18 64.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.226 1.011 . . . . 0.0 112.104 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 . . . . . 0 CA--C 1.549 0.917 0 C-N-CA 125.173 1.389 . . . . 0.0 113.263 -169.852 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.41 ' CG2' HG22 ' A' ' 109' ' ' ILE . 2.5 t -141.35 154.48 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.485 . . . . 0.0 107.873 -169.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -139.62 169.57 17.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 108.383 172.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -144.55 170.15 16.61 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.777 -0.577 . . . . 0.0 111.135 172.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.55 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.3 mt -50.93 -34.15 27.34 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.77 1.228 . . . . 0.0 112.859 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.52 -23.29 66.84 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.66 0.664 . . . . 0.0 112.579 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.0 mt -77.01 -19.93 56.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.115 0.566 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -69.61 129.72 91.15 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.13 2.553 . . . . 0.0 109.634 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -95.45 -40.24 9.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -169.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.73 134.32 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -157.48 119.2 3.7 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.7 pt . . . . . 0 C--O 1.236 0.388 0 C-N-CA 124.217 1.007 . . . . 0.0 109.407 -172.468 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 p90 . . . . . 0 C--O 1.235 0.308 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -107.88 156.52 19.09 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.73 170.61 15.53 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.47 0.708 . . . . 0.0 109.668 -172.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.83 153.51 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.541 1.536 . . . . 0.0 108.663 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.23 116.1 27.18 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 135.02 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 119.08 0.854 . . . . 0.0 109.411 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -82.18 149.29 28.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.751 1.22 . . . . 0.0 108.186 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.79 141.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -114.61 154.0 29.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.872 1.269 . . . . 0.0 109.59 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m -68.69 80.14 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.729 1.211 . . . . 0.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.422 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -134.84 11.1 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 116.028 -1.939 . . . . 0.0 115.179 169.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 77.9 Cg_exo -44.18 137.39 7.52 Favored 'Trans proline' 0 C--N 1.362 1.255 0 CA-C-N 124.248 2.553 . . . . 0.0 113.668 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 45.92 22.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.711 2.404 . . . . 0.0 114.205 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 49.89 30.71 4.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.962 1.305 . . . . 0.0 112.051 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.954 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.756 -170.905 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.01 166.24 16.26 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -139.23 158.29 44.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.972 0.909 . . . . 0.0 109.928 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.94 164.14 37.06 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.028 1.331 . . . . 0.0 109.047 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.32 154.94 21.09 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.52 155.42 38.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.264 1.426 . . . . 0.0 108.858 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.6 123.38 70.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -135.2 148.72 49.74 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.035 0.934 . . . . 0.0 108.619 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.47 136.86 3.82 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 171.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -150.46 151.05 32.14 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.14 -39.34 82.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.672 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -60.22 -30.25 69.27 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.106 0.866 . . . . 0.0 112.63 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.28 75.42 9.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.176 0.898 . . . . 0.0 108.767 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.59 -8.16 9.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.19 0.596 . . . . 0.0 112.081 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.66 138.43 36.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.59 1.956 . . . . 0.0 107.253 175.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.506 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.0 m-70 -60.66 -29.93 69.59 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.674 1.19 . . . . 0.0 112.027 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.76 69.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.439 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.63 -46.12 76.86 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.511 0.596 . . . . 0.0 110.919 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -42.01 83.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 117.288 -1.339 . . . . 0.0 110.243 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.97 -46.18 90.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 120.635 1.561 . . . . 0.0 109.901 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.36 -48.79 78.2 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.805 0.73 . . . . 0.0 111.365 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -62.17 -49.65 74.97 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.131 0.572 . . . . 0.0 111.045 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.48 -45.34 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.515 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -60.58 -36.1 77.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.678 1.126 . . . . 0.0 109.463 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.13 -50.36 66.91 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 118.899 0.772 . . . . 0.0 111.503 172.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.37 -46.93 84.24 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.544 1.172 . . . . 0.0 111.07 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.7 mmt -57.96 -45.93 85.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.774 0.715 . . . . 0.0 110.985 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -65.6 -32.59 74.25 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.027 -1.045 . . . . 0.0 111.459 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -63.42 -42.92 98.74 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 109.701 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -60.37 -40.16 89.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.295 0.952 . . . . 0.0 109.504 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.66 -7.08 1.94 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.415 1.959 . . . . 0.0 113.09 169.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.74 179.17 1.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.14 1.776 . . . . 0.0 113.672 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -131.86 144.74 51.1 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m -148.05 169.33 20.19 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.817 0.735 . . . . 0.0 112.641 -168.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.52 138.96 15.84 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.267 1.027 . . . . 0.0 109.012 169.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -70.96 118.1 13.3 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.9 -26.01 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.99 -0.444 . . . . 0.0 110.284 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.0 -166.95 38.45 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -160.6 -168.02 21.93 Favored Glycine 0 C--O 1.235 0.211 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.56 -155.37 15.57 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.81 153.01 52.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.844 1.258 . . . . 0.0 108.073 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.0 mt -136.07 141.49 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.234 0.277 0 C-N-CA 124.284 1.034 . . . . 0.0 111.238 -176.483 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.05 133.15 64.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -159.55 -175.05 4.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.14 -0.975 . . . . 0.0 110.249 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.87 -161.68 54.3 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 121.668 0.593 . . . . 0.0 112.32 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -150.83 153.15 34.86 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.605 1.562 . . . . 0.0 107.785 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 t -67.57 133.17 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.3 ttp -54.72 -27.01 37.65 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.696 1.198 . . . . 0.0 111.841 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.87 -24.7 8.53 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.665 0.786 . . . . 0.0 112.896 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.11 4.39 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.68 -175.75 40.39 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 118.957 0.799 . . . . 0.0 112.555 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.42 132.88 24.83 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.432 2.088 . . . . 0.0 110.33 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.22 173.6 8.39 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.478 0.656 . . . . 0.0 110.87 169.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -76.97 73.06 3.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.41 -19.08 21.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.32 65.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.454 0.701 . . . . 0.0 111.011 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -61.14 -50.39 80.71 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.2 m -56.01 -48.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.595 0.758 . . . . 0.0 110.776 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 p -59.19 -47.36 85.61 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.082 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.02 -46.59 89.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.528 1.058 . . . . 0.0 110.581 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -68.22 -47.27 68.31 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.562 0.745 . . . . 0.0 111.034 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.88 -37.31 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.934 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -63.06 -45.31 92.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 121.378 1.899 . . . . 0.0 110.819 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.5 89.0 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.454 0.57 . . . . 0.0 111.773 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.04 -17.17 28.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.254 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.253 30.6 p90 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 127.381 2.272 . . . . 0.0 114.093 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 C--O 1.237 0.427 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.03 158.31 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.819 1.647 . . . . 0.0 108.071 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 p -135.66 176.01 9.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.639 1.176 . . . . 0.0 108.617 169.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -139.37 166.65 23.98 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.865 -0.522 . . . . 0.0 111.282 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.395 0 C-N-CA 124.522 1.129 . . . . 0.0 108.115 169.886 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 mt -50.5 -34.87 26.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.32 1.048 . . . . 0.0 112.957 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.13 -24.13 64.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.699 0.681 . . . . 0.0 112.549 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.31 -19.63 42.47 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.633 0.773 . . . . 0.0 111.253 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.28 132.75 92.71 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.026 0.931 . . . . 0.0 108.694 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.4 109.91 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.489 2.793 . . . . 0.0 110.045 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -76.49 -38.19 55.67 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -169.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.09 124.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -146.21 102.49 3.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.8 pt . . . . . 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.02 -169.878 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -84.25 162.08 20.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.776 -0.578 . . . . 0.0 110.821 -175.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.16 171.86 13.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.356 1.063 . . . . 0.0 109.492 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.93 153.59 17.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.978 1.311 . . . . 0.0 108.035 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 tp -116.89 115.63 25.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.19 133.41 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 118.918 0.781 . . . . 0.0 110.007 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -77.96 147.66 34.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.014 1.326 . . . . 0.0 107.642 169.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.68 141.22 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -117.41 141.34 48.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.301 1.441 . . . . 0.0 108.16 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 m -64.16 106.97 1.17 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.574 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.625 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.01 17.39 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.935 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.625 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.0 Cg_exo -42.3 133.43 4.75 Favored 'Trans proline' 0 C--N 1.365 1.436 0 CA-C-N 123.733 2.369 . . . . 0.0 115.261 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 41.9 32.65 0.29 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.595 2.758 . . . . 0.0 113.179 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m 52.96 29.76 8.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.607 1.563 . . . . 0.0 113.0 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.304 -174.857 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.94 170.18 11.75 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -138.76 159.02 43.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.908 0.883 . . . . 0.0 110.543 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.55 36.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.722 1.609 . . . . 0.0 109.306 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -108.77 156.95 19.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 pt -137.02 159.02 36.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.961 1.705 . . . . 0.0 109.518 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.7 t -124.24 119.17 55.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.0 mmt85 -139.61 148.45 42.5 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.93 136.47 2.75 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.047 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 15.6 m-85 -153.0 156.01 38.02 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.259 0.623 . . . . 0.0 111.45 -169.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -35.61 61.34 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.418 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-90 -71.6 -25.44 62.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.215 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.71 80.38 9.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.317 0.962 . . . . 0.0 109.142 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.71 -9.15 17.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.418 0.687 . . . . 0.0 112.069 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.17 142.45 30.55 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.049 1.739 . . . . 0.0 107.604 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -61.98 -30.06 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.81 0.844 . . . . 0.0 111.735 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.38 68.16 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.749 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.49 -47.68 69.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.574 0.624 . . . . 0.0 110.655 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -38.56 79.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 117.456 -1.259 . . . . 0.0 110.243 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -58.95 -46.38 88.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.584 1.538 . . . . 0.0 109.932 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.69 -50.21 67.86 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.38 0.536 . . . . 0.0 111.418 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -61.29 -46.84 88.64 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 122.8 0.44 . . . . 0.0 111.158 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.74 -36.34 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.43 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.83 -29.89 70.47 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.137 1.335 . . . . 0.0 110.764 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.23 -49.0 55.89 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.405 1.002 . . . . 0.0 111.135 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -57.01 -44.71 83.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.823 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mmt -69.02 -41.64 77.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.724 -0.61 . . . . 0.0 112.231 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -69.24 -29.95 67.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.36 1.436 . . . . 0.0 111.714 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -61.5 -43.09 99.49 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.988 0.915 . . . . 0.0 109.167 169.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.84 -37.07 85.34 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.441 0.564 . . . . 0.0 110.287 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.98 -6.69 5.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 127.252 2.358 . . . . 0.0 112.944 172.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.46 177.32 4.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.514 1.925 . . . . 0.0 112.78 -169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -127.92 151.09 49.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 55.9 m -147.72 168.49 21.96 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.04 126.47 7.34 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.19 1.396 . . . . 0.0 108.002 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.08 118.79 11.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.38 -26.67 61.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.722 0.409 . . . . 0.0 110.252 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.67 -171.94 42.35 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.18 -173.75 20.09 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.88 -158.79 23.32 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -127.94 153.58 46.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.969 1.308 . . . . 0.0 108.725 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.53 130.55 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.33 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.883 -169.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.2 t60 . . . . . 0 C--O 1.233 0.19 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -134.29 114.91 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.25 172.9 17.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.206 1.002 . . . . 0.0 108.325 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.06 -165.39 24.33 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.91 1.232 . . . . 0.0 113.066 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -153.78 154.83 34.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.791 2.036 . . . . 0.0 107.388 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.2 m -139.1 106.17 5.46 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -56.45 -28.5 59.75 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.05 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.211 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -135.6 -7.89 2.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.02 171.32 45.97 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.018 0.818 . . . . 0.0 111.138 -169.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.51 144.77 36.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.626 2.218 . . . . 0.0 109.564 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 167.71 18.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 109.397 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -65.86 -31.54 72.54 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.53 0.732 . . . . 0.0 112.022 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.8 m80 58.21 -30.78 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.111 2.964 . . . . 0.0 115.983 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.86 75.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.776 1.171 . . . . 0.0 111.479 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 mm -58.98 -54.42 34.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.5 m -53.62 -50.55 65.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.294 1.038 . . . . 0.0 111.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 p -60.96 -41.69 96.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.232 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.1 -45.71 87.44 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.475 1.034 . . . . 0.0 110.053 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -64.7 -43.81 92.29 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 122.055 -0.403 . . . . 0.0 110.965 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.405 HG21 HG11 ' A' ' 118' ' ' VAL . 52.0 mt -62.9 -45.74 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.89 0.876 . . . . 0.0 108.956 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -62.78 -29.91 71.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.897 1.226 . . . . 0.0 111.566 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.58 -43.95 71.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.012 1.278 . . . . 0.0 111.193 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -71.62 -26.89 62.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.915 0.886 . . . . 0.0 112.595 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 CA--C 1.547 0.854 0 C-N-CA 125.558 1.543 . . . . 0.0 113.864 -170.871 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.405 HG11 HG21 ' A' ' 109' ' ' ILE . 29.6 m -139.48 167.94 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.575 0.75 . . . . 0.0 111.417 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -140.85 171.37 14.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.346 1.458 . . . . 0.0 109.277 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -142.6 171.93 13.38 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.228 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.352 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.0 mt -50.17 -33.97 20.93 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.763 1.225 . . . . 0.0 113.114 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.89 67.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.685 0.675 . . . . 0.0 112.558 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.21 -19.71 53.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.325 0.65 . . . . 0.0 111.341 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.46 133.01 92.95 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.16 111.32 0.71 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.647 2.898 . . . . 0.0 110.909 170.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.93 -34.88 64.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.235 0.614 . . . . 0.0 111.989 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.5 t -137.36 135.04 47.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.94 118.13 3.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 C--O 1.236 0.352 0 C-N-CA 124.708 1.203 . . . . 0.0 108.183 -176.661 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.0 p90 . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 121.084 0.469 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.82 159.56 15.33 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.72 166.51 23.79 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.976 1.31 . . . . 0.0 108.94 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.88 156.67 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.982 1.313 . . . . 0.0 107.776 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -122.06 121.07 36.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.77 135.82 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.458 0.572 . . . . 0.0 109.633 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -83.17 150.96 25.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.833 1.253 . . . . 0.0 107.65 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -137.37 140.68 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -113.32 146.82 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.419 1.487 . . . . 0.0 108.912 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.3 m -66.57 95.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.98 0.912 . . . . 0.0 110.805 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.543 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.17 11.78 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 115.905 -1.998 . . . . 0.0 114.069 168.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.543 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 71.0 Cg_exo -44.27 136.94 8.0 Favored 'Trans proline' 0 C--N 1.364 1.362 0 CA-C-N 124.146 2.516 . . . . 0.0 114.229 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mmt-85 47.65 22.07 0.3 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.802 2.441 . . . . 0.0 113.881 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 50.39 31.11 5.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.117 1.367 . . . . 0.0 112.217 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.904 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.925 -171.577 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -69.25 169.15 12.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 169.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -139.17 157.35 46.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.898 0.879 . . . . 0.0 109.851 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 165.91 32.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.401 1.481 . . . . 0.0 109.477 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -112.88 154.96 25.51 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.577 0.751 . . . . 0.0 109.092 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.6 pt -135.24 156.8 39.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.77 1.228 . . . . 0.0 109.749 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.86 124.26 72.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 125.868 1.667 . . . . 0.0 107.021 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -134.59 150.18 50.68 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.584 1.554 . . . . 0.0 108.689 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.79 131.63 1.48 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -154.55 151.24 28.65 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -64.54 -20.62 66.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -69.63 -26.22 64.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.634 1.107 . . . . 0.0 112.287 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.36 88.64 7.52 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.985 1.266 . . . . 0.0 109.076 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.32 -8.49 32.74 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.537 0.735 . . . . 0.0 112.101 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -147.9 145.62 28.71 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.669 1.588 . . . . 0.0 108.283 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -61.03 -31.8 71.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.241 1.016 . . . . 0.0 111.585 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.66 -26.06 68.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.824 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.0 -49.38 61.89 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.151 0.887 . . . . 0.0 110.418 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -39.86 85.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.254 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -62.06 -49.48 75.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.356 0.98 . . . . 0.0 110.081 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.81 -44.84 95.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.256 0.934 . . . . 0.0 111.169 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.48 -51.7 68.75 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.341 0.656 . . . . 0.0 110.78 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.4 t -82.12 -38.61 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.043 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.2 p -61.43 -31.75 71.7 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.857 1.662 . . . . 0.0 110.328 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.84 -51.06 59.83 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.05 -44.14 96.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.375 1.088 . . . . 0.0 111.202 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.35 -45.38 91.55 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.802 0.728 . . . . 0.0 110.563 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.41 -33.04 75.03 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.014 -1.054 . . . . 0.0 111.588 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -64.52 -39.64 94.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.962 0.801 . . . . 0.0 110.692 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.03 -32.12 73.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.264 0.938 . . . . 0.0 110.61 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.98 -8.05 4.47 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.114 2.292 . . . . 0.0 113.177 169.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -67.48 179.56 1.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.095 1.758 . . . . 0.0 113.539 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -131.14 143.14 50.41 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.0 m -147.15 167.44 24.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -168.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -153.09 134.37 14.23 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.524 1.53 . . . . 0.0 108.103 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 p -73.65 115.84 13.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.9 -24.92 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.952 -0.468 . . . . 0.0 110.772 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.0 43.48 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.44 -164.83 15.31 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.44 -155.61 22.67 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -138.52 155.02 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 109.127 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.8 136.63 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.234 0.244 0 C-N-CA 124.619 1.168 . . . . 0.0 109.62 -176.204 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.3 t60 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.15 123.0 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.23 -174.42 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.154 -0.966 . . . . 0.0 111.085 -169.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.79 -160.04 52.58 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -149.51 154.48 38.83 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.431 1.493 . . . . 0.0 107.863 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 t -69.74 131.83 45.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.8 ttt -59.02 -20.77 56.18 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.973 0.909 . . . . 0.0 111.814 170.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.32 -24.23 8.53 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 113.087 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -130.77 1.07 4.38 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -177.65 45.33 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.248 0.931 . . . . 0.0 112.381 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.25 130.22 17.2 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.739 2.293 . . . . 0.0 111.223 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.69 168.08 20.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.227 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.98 78.54 5.41 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 169.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -59.01 -15.88 15.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.01 66.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.387 0.675 . . . . 0.0 111.401 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.57 -44.17 96.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.728 0.811 . . . . 0.0 108.942 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.3 m -58.67 -53.03 62.91 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.268 0.627 . . . . 0.0 110.34 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 p -60.45 -44.6 95.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -58.98 -53.45 58.3 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.283 0.947 . . . . 0.0 110.931 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.4 -44.49 67.86 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.918 -0.489 . . . . 0.0 111.421 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.4 -42.25 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 118.087 -0.959 . . . . 0.0 108.639 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.72 -39.28 93.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.913 1.688 . . . . 0.0 111.029 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.94 89.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.475 0.58 . . . . 0.0 111.302 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -79.86 -24.66 41.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.224 0.465 . . . . 0.0 112.106 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 CA--C 1.546 0.807 0 C-N-CA 127.13 2.172 . . . . 0.0 111.967 -170.076 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 121.367 0.603 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.94 164.07 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.058 1.743 . . . . 0.0 110.033 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.3 p -141.42 172.06 13.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.324 1.849 . . . . 0.0 107.133 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.63 167.58 21.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.894 0.77 . . . . 0.0 112.39 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 125.323 1.449 . . . . 0.0 107.643 169.844 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -53.53 -28.98 34.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.828 1.251 . . . . 0.0 113.507 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.48 57.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.024 0.829 . . . . 0.0 112.451 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.0 mt -84.87 -19.72 31.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.017 0.927 . . . . 0.0 111.25 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.07 138.29 72.87 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.428 1.091 . . . . 0.0 109.265 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.41 99.35 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.517 2.811 . . . . 0.0 109.307 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.65 -32.09 67.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.938 1.295 . . . . 0.0 112.658 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t -140.99 128.67 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -152.28 108.14 3.36 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt . . . . . 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.258 . . . . 0.0 108.384 -172.209 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.2 p90 . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.46 157.92 16.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.97 172.07 13.29 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.684 0.794 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.45 153.23 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.225 1.41 . . . . 0.0 108.123 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.4 tp -117.76 115.62 25.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 131.95 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.85 147.16 39.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.01 131.04 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -100.08 151.2 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.455 1.102 . . . . 0.0 109.734 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 m -65.81 97.56 0.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.931 0.892 . . . . 0.0 110.827 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.52 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -151.07 22.6 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.451 -1.738 . . . . 0.0 114.449 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.52 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 81.8 Cg_exo -46.34 138.21 13.73 Favored 'Trans proline' 0 C--N 1.362 1.25 0 CA-C-N 123.906 2.431 . . . . 0.0 113.0 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 44.93 26.75 0.22 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 113.7 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m 50.18 33.04 6.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.347 1.459 . . . . 0.0 112.753 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 C-N-CA 123.556 0.598 . . . . 0.0 113.066 -172.659 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.125 0.488 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.74 168.72 14.38 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -142.03 159.56 41.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.038 0.935 . . . . 0.0 110.325 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.66 168.26 26.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.975 1.71 . . . . 0.0 108.835 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -108.39 156.77 19.05 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 pt -133.15 156.24 41.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.942 1.297 . . . . 0.0 109.245 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.59 116.7 50.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -137.81 147.43 44.59 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.7 134.99 2.02 Favored Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.435 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.0 m-85 -156.75 156.7 33.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -170.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -60.91 -33.09 72.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.242 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.435 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.7 p-90 -64.52 -28.62 69.77 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.84 0.746 . . . . 0.0 112.103 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 77.79 9.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.218 0.917 . . . . 0.0 108.705 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -65.89 -6.07 11.16 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.19 140.23 33.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.69 1.596 . . . . 0.0 107.55 174.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.424 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 24.5 m-70 -61.46 -29.74 70.16 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.403 1.081 . . . . 0.0 111.873 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.58 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.759 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.0 -46.44 74.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.675 0.67 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -41.09 82.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.152 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -58.45 -44.66 89.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.004 1.729 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.25 -50.83 64.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.647 0.658 . . . . 0.0 111.542 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -60.77 -46.48 90.3 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.977 0.511 . . . . 0.0 111.089 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.8 -36.4 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.381 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -62.06 -28.95 69.96 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.244 1.384 . . . . 0.0 110.927 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.86 -52.06 45.69 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.321 0.964 . . . . 0.0 110.943 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -55.88 -47.54 77.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 110.445 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.242 -0.911 . . . . 0.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.3 -28.9 66.68 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.681 -1.262 . . . . 0.0 111.474 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -31.79 73.1 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.12 0.968 . . . . 0.0 110.057 169.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -70.76 -45.96 63.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.822 1.192 . . . . 0.0 108.332 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.26 -6.78 2.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.294 2.378 . . . . 0.0 112.502 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.84 171.39 11.76 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.149 1.78 . . . . 0.0 112.983 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.62 147.92 46.91 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.0 m -148.19 165.61 30.4 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -168.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.4 129.62 11.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.767 1.227 . . . . 0.0 107.997 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.5 114.45 5.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.5 -28.26 64.83 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.996 -0.44 . . . . 0.0 110.143 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.72 -167.02 40.07 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.99 -166.92 21.65 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 171.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.47 -161.2 26.45 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -127.12 151.15 49.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.626 1.17 . . . . 0.0 108.432 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.0 mt -132.66 135.13 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.232 0.164 0 C-N-CA 123.016 0.526 . . . . 0.0 111.535 -169.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.1 t60 . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.4 130.33 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -159.26 -172.14 3.63 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.5 -164.5 41.69 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 121.653 0.585 . . . . 0.0 111.676 170.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -148.23 153.32 38.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.173 1.389 . . . . 0.0 107.499 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 t -69.55 128.56 36.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.24 -20.58 55.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.212 0.605 . . . . 0.0 111.646 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.69 -27.33 9.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.911 0.884 . . . . 0.0 112.917 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -132.59 4.48 3.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.89 -178.74 50.63 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.229 0.922 . . . . 0.0 112.73 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.5 129.37 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.766 2.311 . . . . 0.0 110.47 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 169.16 17.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 111.079 169.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.13 75.41 4.67 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -56.86 -20.53 23.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.06 -38.75 65.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.64 0.776 . . . . 0.0 111.606 169.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mm -62.27 -45.6 98.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.998 0.919 . . . . 0.0 109.072 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.4 m -58.02 -52.66 64.59 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.413 0.685 . . . . 0.0 110.234 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -62.59 -41.42 98.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.26 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -60.99 -50.28 74.03 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 110.412 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.76 -46.11 73.0 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.09 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.3 mt -61.74 -44.52 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.833 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -62.66 -40.05 95.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.543 1.519 . . . . 0.0 111.216 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.34 84.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.782 0.719 . . . . 0.0 111.546 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -79.74 -21.11 44.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.299 0.64 . . . . 0.0 111.743 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 t80 . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 127.528 2.331 . . . . 0.0 112.419 -176.832 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.03 167.3 22.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.854 0.862 . . . . 0.0 110.586 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.8 p -139.01 171.39 14.39 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 109.363 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -146.95 163.21 36.91 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.73 -0.607 . . . . 0.0 110.599 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 169.265 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.3 mt -50.94 -35.35 32.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.319 1.048 . . . . 0.0 112.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.88 -23.73 66.04 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.808 0.731 . . . . 0.0 112.679 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.2 mt -84.7 -19.7 32.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.741 0.816 . . . . 0.0 111.305 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.5 138.48 94.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.95 111.32 1.35 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.088 2.525 . . . . 0.0 109.571 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.83 -37.15 70.36 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.399 1.08 . . . . 0.0 112.963 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.69 137.41 47.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -153.94 110.24 3.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 C--O 1.235 0.341 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 177.289 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 p90 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 160.39 14.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.74 166.55 24.33 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.382 1.073 . . . . 0.0 109.252 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.72 156.8 12.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.07 115.5 23.82 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.04 129.94 72.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -76.75 147.76 37.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -134.69 142.83 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -116.07 148.35 40.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.555 1.142 . . . . 0.0 108.733 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 m -61.51 101.24 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.834 0.854 . . . . 0.0 110.654 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.553 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.32 15.14 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.076 -1.916 . . . . 0.0 115.619 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 80.4 Cg_exo -42.84 137.24 4.37 Favored 'Trans proline' 0 C--N 1.362 1.288 0 CA-C-N 124.371 2.597 . . . . 0.0 114.244 171.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 45.84 25.62 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.35 2.26 . . . . 0.0 113.929 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.08 31.94 7.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.186 1.395 . . . . 0.0 112.355 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.83 0 C-N-CA 123.697 0.665 . . . . 0.0 112.872 -172.578 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.281 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.61 177.23 6.94 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -143.67 156.78 44.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.635 0.774 . . . . 0.0 110.146 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 165.37 36.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.512 1.525 . . . . 0.0 109.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.1 155.08 20.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.99 151.38 34.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.578 1.151 . . . . 0.0 109.166 171.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.12 120.95 64.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -131.28 147.49 52.59 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.859 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.73 132.87 1.81 Allowed Glycine 0 C--N 1.33 0.225 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.08 151.29 26.61 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -61.52 -28.18 69.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.442 0.697 . . . . 0.0 112.742 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -66.71 -26.96 67.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.143 0.883 . . . . 0.0 112.093 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 85.19 5.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 171.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.99 -10.89 43.77 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 173.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 141.09 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.896 1.278 . . . . 0.0 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.499 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.03 -32.22 70.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.572 1.549 . . . . 0.0 111.763 -173.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.18 -30.22 70.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.739 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.45 -47.88 66.01 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.89 0.768 . . . . 0.0 110.473 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -37.51 79.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.521 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.74 -47.41 86.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 110.323 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.24 -46.79 75.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.789 0.722 . . . . 0.0 111.393 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -52.76 -54.8 28.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.631 1.172 . . . . 0.0 110.056 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.4 t -80.57 -34.4 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.745 -169.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -62.35 -30.91 71.51 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 120.382 1.446 . . . . 0.0 110.835 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.9 -51.18 58.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 110.638 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.6 -44.87 92.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 111.187 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.43 -45.04 95.09 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.987 -0.445 . . . . 0.0 111.011 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.6 -31.2 71.07 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.086 -1.009 . . . . 0.0 111.834 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.39 -40.3 96.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.19 0.904 . . . . 0.0 110.033 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -59.42 -47.22 86.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.712 1.142 . . . . 0.0 108.907 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.68 -5.64 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 126.631 2.063 . . . . 0.0 112.709 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.1 m -66.33 176.05 1.96 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.116 1.766 . . . . 0.0 112.728 -170.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -129.86 143.34 50.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -147.63 164.06 34.68 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -169.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -154.9 128.54 8.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 108.306 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -68.25 114.28 6.6 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.4 mt -70.3 -27.62 64.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.932 0.493 . . . . 0.0 110.638 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.85 -173.58 45.57 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.4 -179.08 28.57 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.59 -162.14 28.57 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -137.65 167.21 22.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.226 1.013 . . . . 0.0 110.785 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.12 143.11 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -169.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.236 0.395 0 O-C-N 121.67 -0.644 . . . . 0.0 111.458 178.563 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.2 t60 . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.39 127.8 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.504 1.522 . . . . 0.0 107.322 -174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -162.15 -175.58 4.67 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.532 -0.73 . . . . 0.0 110.69 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.76 -167.57 48.37 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.266 0.46 . . . . 0.0 112.168 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -151.33 147.04 26.45 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.522 0.729 . . . . 0.0 109.943 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -73.42 139.47 45.88 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.82 -36.44 83.5 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.818 -0.551 . . . . 0.0 109.808 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.39 58.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.2 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -134.13 1.29 3.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.216 0.917 . . . . 0.0 113.35 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.02 55.13 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 118.93 0.787 . . . . 0.0 111.914 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 137.85 40.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.692 2.262 . . . . 0.0 110.181 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.6 169.84 16.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 169.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -79.05 72.4 5.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -56.85 -19.39 17.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.892 0.877 . . . . 0.0 113.276 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.94 -38.8 65.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.659 0.783 . . . . 0.0 111.388 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.1 mm -62.03 -43.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 C-N-CA 124.23 1.012 . . . . 0.0 109.028 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -57.52 -54.07 51.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.119 0.568 . . . . 0.0 110.082 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.1 p -60.6 -41.76 95.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.337 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.99 -50.71 72.29 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.419 1.009 . . . . 0.0 110.6 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -71.66 -42.23 67.77 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.906 -0.496 . . . . 0.0 111.423 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.14 -45.46 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.61 -36.08 81.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.168 1.349 . . . . 0.0 111.346 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.0 -42.54 94.38 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.44 1.018 . . . . 0.0 111.487 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -84.1 -17.84 38.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.586 0.754 . . . . 0.0 112.856 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 126.399 1.88 . . . . 0.0 115.595 -171.579 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.93 167.58 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.638 1.575 . . . . 0.0 108.727 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -140.85 169.57 17.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.68 1.192 . . . . 0.0 108.763 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -145.54 167.15 23.72 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 110.402 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.521 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.52 -28.43 65.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.49 -26.5 63.64 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.223 0.92 . . . . 0.0 112.055 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.74 -30.67 18.89 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.333 1.053 . . . . 0.0 110.654 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.3 127.76 81.31 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 144.42 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.46 2.107 . . . . 0.0 109.864 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -81.86 -44.05 17.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.137 0.575 . . . . 0.0 111.146 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 t -133.49 137.02 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -154.48 109.84 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 C--O 1.236 0.356 0 C-N-CA 123.812 0.845 . . . . 0.0 109.253 -172.79 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -85.62 157.47 20.35 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.32 168.75 19.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.038 0.935 . . . . 0.0 109.35 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 154.43 16.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 125.139 1.376 . . . . 0.0 107.548 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -118.36 118.23 31.22 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.31 134.63 65.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.94 0.791 . . . . 0.0 109.079 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -77.39 148.45 35.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.3 t -134.8 126.64 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.41 149.51 21.63 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.68 0.792 . . . . 0.0 109.566 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.9 m -65.59 100.76 0.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.484 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.554 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.02 19.32 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 116.282 -1.818 . . . . 0.0 114.776 169.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.554 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 84.8 Cg_exo -44.11 136.61 7.74 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 124.114 2.505 . . . . 0.0 113.846 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 46.13 25.76 0.37 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.738 2.015 . . . . 0.0 113.797 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.86 32.61 7.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.232 1.413 . . . . 0.0 112.448 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.901 0 C-N-CA 123.83 0.729 . . . . 0.0 112.842 -173.191 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -74.03 -176.48 2.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.714 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -142.25 159.67 41.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.685 0.794 . . . . 0.0 110.555 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.81 165.77 26.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.597 1.959 . . . . 0.0 107.573 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -111.94 146.99 36.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -126.45 154.8 36.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.312 1.045 . . . . 0.0 109.839 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.1 t -118.7 118.87 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.475 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.0 mmt85 -136.41 147.63 47.37 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.13 133.91 1.97 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.3 m-85 -156.33 155.01 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.9 0.88 . . . . 0.0 109.001 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.99 -31.56 71.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.457 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.1 p-90 -63.9 -30.15 71.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.29 0.95 . . . . 0.0 111.873 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.74 80.72 8.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.18 -14.54 38.69 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.005 0.522 . . . . 0.0 111.796 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.09 142.74 40.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.031 1.732 . . . . 0.0 108.26 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.491 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.8 -31.35 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.137 1.375 . . . . 0.0 111.879 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.33 -28.79 70.0 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.729 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.11 -46.98 72.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.997 0.817 . . . . 0.0 110.496 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -39.94 82.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.261 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -59.62 -48.04 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.778 1.626 . . . . 0.0 109.963 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -48.75 78.87 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.864 0.757 . . . . 0.0 111.324 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -60.62 -50.79 72.1 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.301 0.64 . . . . 0.0 110.891 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG21 ' HG3' ' A' ' 45' ' ' ARG . 60.5 t -75.07 -40.37 44.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 118.442 -0.79 . . . . 0.0 109.447 -171.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 t -59.09 -40.38 85.1 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.498 1.045 . . . . 0.0 109.082 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.95 -50.54 64.96 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 118.85 0.75 . . . . 0.0 111.952 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.51 -45.75 91.56 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.265 1.033 . . . . 0.0 111.283 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.86 -43.9 97.75 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.505 -0.747 . . . . 0.0 111.798 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.97 -32.36 73.81 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.645 -1.284 . . . . 0.0 111.152 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.37 90.76 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.947 0.899 . . . . 0.0 110.301 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -59.46 -46.42 88.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.878 1.217 . . . . 0.0 108.5 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.7 -5.99 1.59 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 126.951 2.215 . . . . 0.0 112.438 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.0 m -70.16 177.14 3.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.857 1.663 . . . . 0.0 112.114 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -129.46 142.56 50.75 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 169.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.3 m -143.05 165.09 28.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -168.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -154.94 130.77 10.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.48 112.67 4.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.7 mt -67.35 -28.46 67.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.796 -0.565 . . . . 0.0 110.219 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.66 42.18 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.036 -2.025 . . . . 0.0 108.036 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.34 -175.16 26.07 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.69 -159.86 24.66 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -135.7 163.03 31.09 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.4 1.1 . . . . 0.0 110.566 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.6 mt -123.85 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.451 -0.394 0 C-N-CA 123.241 0.616 . . . . 0.0 110.834 -169.434 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.2 t60 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.06 117.91 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -161.85 -168.61 1.98 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.053 0.541 . . . . 0.0 110.684 -173.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.87 -161.82 53.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -152.5 152.38 31.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.331 1.052 . . . . 0.0 108.67 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.3 p -77.94 137.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.7 tpt -65.05 -34.81 79.32 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.839 -0.538 . . . . 0.0 109.855 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.94 65.54 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.416 -0.802 . . . . 0.0 113.111 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -133.86 4.03 3.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.67 -175.26 55.07 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.806 0.73 . . . . 0.0 111.75 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.48 138.37 38.54 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.576 2.184 . . . . 0.0 110.685 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 176.29 5.25 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.54 -34.08 77.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.74 -0.6 . . . . 0.0 111.368 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.4 m80 58.51 -29.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.141 2.976 . . . . 0.0 115.87 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.72 81.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.474 1.11 . . . . 0.0 111.41 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.28 -46.36 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.4 m -56.29 -53.69 54.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.879 0.872 . . . . 0.0 110.538 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -47.21 77.99 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.931 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -64.83 -47.76 76.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.837 0.744 . . . . 0.0 110.519 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.75 -38.37 67.4 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 118.799 -0.619 . . . . 0.0 111.309 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.4 mt -61.61 -45.65 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.473 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 95.9 mttt -62.62 -40.33 96.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.573 1.533 . . . . 0.0 111.431 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.59 87.13 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.452 0.569 . . . . 0.0 111.224 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -79.45 -23.22 43.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 CA--C 1.543 0.675 0 C-N-CA 127.593 2.357 . . . . 0.0 111.943 -172.353 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' HG3' ' HE2' ' A' ' 110' ' ' LYS . 26.8 tt0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 121.666 0.746 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.65 162.89 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.038 1.335 . . . . 0.0 109.54 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 p -142.66 174.41 10.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.434 1.894 . . . . 0.0 108.514 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -145.67 167.29 23.47 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.422 -0.799 . . . . 0.0 111.14 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.456 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t70 . . . . . 0 C--O 1.232 0.172 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -53.85 -30.76 46.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.688 1.195 . . . . 0.0 113.349 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.25 -25.31 59.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.995 0.816 . . . . 0.0 112.434 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.85 -21.58 29.74 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.936 0.894 . . . . 0.0 111.135 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.85 131.75 82.97 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.59 119.76 5.57 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.763 2.976 . . . . 0.0 110.13 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.53 -41.14 12.9 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -169.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -138.58 135.03 43.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -156.14 116.3 3.66 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 pt . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 108.358 -176.332 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.2 p90 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -97.83 160.13 14.5 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.605 -0.684 . . . . 0.0 109.185 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 169.02 18.87 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 122.992 0.517 . . . . 0.0 110.126 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.0 153.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.322 . . . . 0.0 108.844 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 tp -118.81 116.87 27.42 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.52 132.62 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.416 1.007 . . . . 0.0 109.674 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -78.03 145.99 35.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.032 1.333 . . . . 0.0 108.503 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.14 128.73 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -93.79 154.07 17.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.984 0.913 . . . . 0.0 110.398 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.7 p -73.64 41.91 0.12 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.536 1.934 . . . . 0.0 114.963 -172.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.48 22.42 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 115.918 -1.991 . . . . 0.0 116.344 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.73 125.05 6.04 Favored 'Trans proline' 0 C--N 1.359 1.117 0 CA-C-N 124.553 2.662 . . . . 0.0 113.833 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 39.63 28.14 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.696 2.799 . . . . 0.0 114.419 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m 48.92 30.31 2.7 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.038 1.335 . . . . 0.0 112.551 -171.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.951 0 C-N-CA 124.129 0.871 . . . . 0.0 113.539 -170.177 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.503 0.668 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -74.08 168.06 20.3 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -154.78 161.14 41.61 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.58 -1.325 . . . . 0.0 111.242 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -152.94 165.75 34.54 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.893 1.677 . . . . 0.0 108.477 173.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.25 151.17 26.31 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.436 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 48.6 pt -130.4 156.57 42.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.102 1.361 . . . . 0.0 109.32 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.6 122.71 66.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -128.69 153.32 47.44 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.33 132.26 2.46 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -151.21 151.08 31.38 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.2 1.0 . . . . 0.0 108.45 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.2 -29.13 68.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.192 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -65.54 -34.35 78.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.18 0.9 . . . . 0.0 110.979 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 71.13 8.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 169.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -62.62 -9.33 8.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.531 1.132 . . . . 0.0 111.696 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.34 37.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.236 1.815 . . . . 0.0 107.186 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.558 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 8.1 m-70 -58.48 -31.21 67.62 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.744 1.617 . . . . 0.0 112.078 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.93 -31.61 68.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.873 0.469 . . . . 0.0 111.633 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.94 -43.08 79.93 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.275 0.489 . . . . 0.0 110.6 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -40.21 72.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.449 175.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.35 -44.72 88.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.37 1.441 . . . . 0.0 109.876 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.67 -48.88 73.11 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 0.605 . . . . 0.0 111.606 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -56.87 -52.08 66.55 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.391 0.677 . . . . 0.0 110.086 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.19 -43.73 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.094 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -58.88 -37.13 75.86 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.625 1.102 . . . . 0.0 111.023 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.86 63.16 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.928 0.785 . . . . 0.0 111.199 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.25 -46.17 81.61 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.88 0.84 . . . . 0.0 111.019 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.6 mmt -59.12 -42.72 91.23 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.842 -0.536 . . . . 0.0 111.129 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -70.38 -30.7 67.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.342 0.974 . . . . 0.0 111.728 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -63.57 -43.07 98.07 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.327 0.967 . . . . 0.0 109.302 169.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -63.86 -27.04 68.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.451 0.569 . . . . 0.0 111.079 171.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.89 -7.22 9.43 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.137 2.304 . . . . 0.0 113.178 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 69.0 m -71.59 170.47 13.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.189 1.396 . . . . 0.0 111.721 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.59 140.73 52.21 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 m -144.28 163.16 34.51 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -149.08 128.89 13.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.04 0.936 . . . . 0.0 108.628 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -65.37 111.3 2.98 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.18 -27.53 66.49 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.707 -0.62 . . . . 0.0 110.1 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.15 -166.92 40.1 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.71 -165.94 17.63 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 170.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.35 -164.75 31.93 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -119.84 150.48 40.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.3 mt -128.27 138.46 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.7 m . . . . . 0 N--CA 1.451 -0.381 0 C-N-CA 123.855 0.862 . . . . 0.0 109.096 -171.231 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.1 t60 . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.87 129.23 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.766 1.626 . . . . 0.0 106.895 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.37 -169.13 2.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.036 0.835 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.84 -159.37 52.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.649 0.642 . . . . 0.0 112.526 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.7 154.22 39.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.24 1.416 . . . . 0.0 108.004 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 t -66.54 135.43 54.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 74.5 mtm -59.77 -16.46 27.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.638 1.175 . . . . 0.0 112.411 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.68 -23.14 4.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.117 0.967 . . . . 0.0 113.215 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -129.97 2.08 4.81 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.34 -175.59 45.88 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 119.09 0.859 . . . . 0.0 112.573 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.61 129.44 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.745 2.297 . . . . 0.0 110.968 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.86 167.76 20.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 110.304 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -78.97 76.66 5.46 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -57.06 -19.87 21.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.904 0.882 . . . . 0.0 113.166 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.39 -39.89 73.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.837 0.855 . . . . 0.0 110.987 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.9 mm -63.54 -49.15 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 m -62.63 -46.74 86.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 117.839 0.291 . . . . 0.0 110.843 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -62.01 -42.16 98.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.22 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.89 -49.94 75.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.979 1.263 . . . . 0.0 111.021 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -66.27 -45.12 81.6 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.935 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.87 -47.48 93.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -61.6 -39.15 90.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.307 1.412 . . . . 0.0 111.092 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.41 80.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 111.236 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -75.73 -21.6 57.34 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.349 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.4 t80 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 126.696 1.998 . . . . 0.0 111.671 -177.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.73 168.48 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.068 1.347 . . . . 0.0 109.414 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 p -139.38 171.38 14.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.472 1.109 . . . . 0.0 109.665 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -145.93 161.6 39.68 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.812 -0.555 . . . . 0.0 110.583 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.013 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 . . . . . 0 C--O 1.233 0.227 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -54.06 -34.0 58.93 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.586 0.754 . . . . 0.0 112.584 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.47 -24.42 66.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.192 0.906 . . . . 0.0 112.294 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.91 -20.18 23.67 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.95 . . . . 0.0 111.366 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.69 126.4 86.84 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.189 -1.386 . . . . 0.0 107.824 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.53 111.78 0.51 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.249 3.3 . . . . 0.0 110.421 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -71.38 -35.94 71.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.35 137.64 20.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -156.45 116.15 3.54 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.236 0.359 0 C-N-CA 124.391 1.076 . . . . 0.0 109.418 -174.481 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 N--CA 1.461 0.105 0 CA-C-O 121.246 0.546 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 156.06 27.45 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.886 0.474 . . . . 0.0 109.738 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.66 169.6 17.34 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.042 0.937 . . . . 0.0 108.687 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.43 150.67 19.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 108.013 174.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 tp -110.6 115.71 30.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.0 OUTLIER -127.32 128.13 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.53 0.681 . . . . 0.0 109.412 -172.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -79.27 149.53 31.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.43 1.492 . . . . 0.0 108.348 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.42 135.01 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -102.85 147.83 26.39 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.324 1.049 . . . . 0.0 108.464 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -62.23 99.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.282 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.517 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -149.66 17.97 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.163 -1.875 . . . . 0.0 114.776 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.517 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 51.1 Cg_exo -41.39 134.66 3.11 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 124.077 2.492 . . . . 0.0 114.31 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 38.17 31.89 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.692 2.797 . . . . 0.0 114.182 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m 51.59 32.58 9.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.149 1.379 . . . . 0.0 112.566 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.784 0 C-N-CA 123.998 0.809 . . . . 0.0 111.949 -174.119 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -176.33 4.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.0 m -140.95 156.52 46.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.572 0.749 . . . . 0.0 110.491 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.77 149.88 29.55 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.632 1.973 . . . . 0.0 106.742 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.43 150.55 27.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -128.8 154.05 39.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.26 1.024 . . . . 0.0 109.34 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.18 114.66 44.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -134.7 146.65 49.66 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.68 135.04 2.33 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.8 m-85 -157.06 152.6 26.67 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -60.32 -27.11 67.07 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.5 p-90 -66.86 -27.71 67.75 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 112.062 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.24 79.9 9.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.06 -6.29 8.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.005 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.98 142.03 29.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.226 1.811 . . . . 0.0 107.514 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.434 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 21.1 m-70 -62.04 -30.7 71.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.398 1.079 . . . . 0.0 111.543 -174.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -29.62 68.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.145 175.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.42 -47.5 73.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.781 0.719 . . . . 0.0 110.748 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.03 -43.29 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.011 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.12 -47.13 84.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.102 0.864 . . . . 0.0 109.608 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.99 -48.29 71.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 0.483 . . . . 0.0 111.718 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -57.22 -53.75 54.59 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.366 0.666 . . . . 0.0 110.294 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.06 -45.19 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.864 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -64.29 -25.16 67.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 119.884 1.22 . . . . 0.0 111.471 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.32 -49.89 72.71 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 170.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.05 -41.93 85.63 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.185 0.992 . . . . 0.0 111.392 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.2 mmt -56.39 -44.85 80.66 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.367 0.985 . . . . 0.0 110.79 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.52 -29.08 66.62 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.246 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -63.41 -43.15 98.36 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.396 0.998 . . . . 0.0 109.193 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.53 -34.28 77.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.079 0.4 . . . . 0.0 110.306 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.83 5.07 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.535 2.017 . . . . 0.0 113.059 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -67.86 175.37 3.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.365 1.866 . . . . 0.0 113.434 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -128.2 148.82 50.63 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.4 163.57 32.69 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -168.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -149.35 128.04 12.45 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.089 1.356 . . . . 0.0 109.006 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.27 111.94 7.0 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 168.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.62 -26.41 64.42 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.237 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.18 -168.02 40.17 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.7 -175.54 30.78 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -158.43 20.38 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 -174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -128.57 154.02 46.62 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.839 -0.801 . . . . 0.0 108.869 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.1 mt -124.96 142.11 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 C--N 1.329 -0.309 0 C-N-CA 125.531 1.533 . . . . 0.0 108.366 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.0 t -130.34 128.07 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.52 -177.07 6.15 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 121.362 -0.836 . . . . 0.0 110.681 -173.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.01 -169.08 53.25 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -151.92 147.56 26.72 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.593 0.757 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.8 p -72.16 133.78 45.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -68.99 -27.18 65.47 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.782 -0.574 . . . . 0.0 110.09 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.49 -42.35 64.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.828 0.851 . . . . 0.0 112.384 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -133.65 3.15 3.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -168.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.51 -176.84 54.24 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.793 0.724 . . . . 0.0 111.848 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.22 132.02 23.29 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.674 2.249 . . . . 0.0 110.211 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.9 168.8 19.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -78.93 81.26 5.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 168.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.415 ' HB2' ' CE3' ' A' ' 120' ' ' TRP . 51.5 m80 -56.05 -21.25 20.63 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.568 0.747 . . . . 0.0 112.762 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -44.07 66.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.709 1.203 . . . . 0.0 111.484 169.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.02 -49.53 83.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -58.4 -50.56 73.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.747 0.819 . . . . 0.0 110.683 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -63.58 -40.01 95.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.072 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.28 -46.51 83.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.927 1.24 . . . . 0.0 110.538 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.17 -43.55 97.96 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.263 0.483 . . . . 0.0 110.437 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.481 HG21 HG11 ' A' ' 118' ' ' VAL . 52.5 mt -59.64 -51.58 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.009 177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -60.98 -36.25 78.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.675 1.579 . . . . 0.0 111.283 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.92 99.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.922 0.783 . . . . 0.0 111.689 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.39 -18.09 37.25 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.264 35.8 p90 . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 127.16 2.184 . . . . 0.0 114.209 -173.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 109' ' ' ILE . 31.6 m -140.18 169.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.127 0.971 . . . . 0.0 110.374 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -140.66 171.73 13.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.202 1.401 . . . . 0.0 108.885 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 102' ' ' HIS . 9.9 p-90 -143.5 170.76 15.21 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.65 -0.656 . . . . 0.0 109.623 170.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.514 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.233 0.202 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.0 mt -54.66 -32.3 58.94 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.769 0.828 . . . . 0.0 112.478 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.17 67.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.448 1.022 . . . . 0.0 112.289 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -90.08 -24.44 21.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.439 1.095 . . . . 0.0 111.307 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.32 130.17 89.43 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.2 116.63 3.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.23 2.62 . . . . 0.0 109.785 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.93 -35.84 64.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.822 0.849 . . . . 0.0 113.273 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.51 134.76 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -153.6 108.89 3.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 C--O 1.234 0.289 0 C-N-CA 124.155 0.982 . . . . 0.0 108.441 -176.932 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 p90 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.25 160.06 19.94 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.829 -0.545 . . . . 0.0 109.739 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.12 164.57 31.76 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.313 0.645 . . . . 0.0 109.378 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.67 156.02 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.604 1.161 . . . . 0.0 108.529 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -118.53 114.56 23.01 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.61 130.94 71.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -75.27 148.02 39.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.29 119.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -91.32 148.54 22.26 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 p -68.64 102.71 1.55 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.872 0.76 . . . . 0.0 109.712 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.463 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.12 23.75 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.003 0 CA-C-O 116.39 -1.767 . . . . 0.0 114.517 169.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 37.1 Cg_exo -41.85 124.36 2.69 Favored 'Trans proline' 0 C--N 1.361 1.187 0 CA-C-N 123.802 2.394 . . . . 0.0 114.521 173.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 34.22 38.24 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.341 3.056 . . . . 0.0 113.924 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m 52.97 30.31 9.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.224 1.409 . . . . 0.0 112.961 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 C-N-CA 124.797 1.189 . . . . 0.0 112.525 -177.035 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.327 0 CA-C-O 121.775 0.798 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.54 177.51 5.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.928 0.891 . . . . 0.0 109.045 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -139.34 160.58 39.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.717 0.77 . . . . 0.0 111.125 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -142.41 164.79 29.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 129.105 2.962 . . . . 0.0 105.566 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -128.31 149.57 50.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.09 147.77 33.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.496 0.718 . . . . 0.0 109.829 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.38 119.22 57.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -128.3 145.09 51.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.08 132.15 1.9 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 170.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -151.54 151.69 31.93 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -59.89 -29.37 68.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.7 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -66.28 -27.7 68.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.159 0.89 . . . . 0.0 111.836 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.91 81.97 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -62.06 -15.24 43.32 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 122.943 0.497 . . . . 0.0 111.583 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.76 142.16 38.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.137 1.775 . . . . 0.0 108.014 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -56.17 -31.37 63.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.441 1.496 . . . . 0.0 112.757 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.55 -27.09 68.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.73 -0.607 . . . . 0.0 111.557 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.33 -47.33 70.82 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.677 0.671 . . . . 0.0 110.693 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -39.71 83.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.467 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -61.95 -48.23 81.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.9 1.227 . . . . 0.0 109.927 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -45.81 91.79 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.347 0.976 . . . . 0.0 111.365 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -60.42 -51.18 70.59 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.391 0.677 . . . . 0.0 110.812 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.46 -33.91 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.15 -169.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p -61.16 -35.83 78.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.794 1.634 . . . . 0.0 110.169 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.8 -51.07 59.78 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.9 -44.21 96.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.208 1.004 . . . . 0.0 111.015 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.8 mmt -59.72 -44.4 93.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.696 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -66.69 -33.41 75.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.217 . . . . 0.0 111.976 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.27 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.216 0.916 . . . . 0.0 109.77 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.35 -35.78 80.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.571 0.623 . . . . 0.0 110.393 171.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.41 -8.12 5.32 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.633 2.54 . . . . 0.0 113.127 171.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 94.8 m -77.41 133.0 38.78 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.943 1.697 . . . . 0.0 111.711 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.39 137.3 33.47 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.9 m -144.71 163.96 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -155.69 133.85 11.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.653 1.181 . . . . 0.0 108.251 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.84 112.82 4.47 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.7 mt -67.87 -29.83 69.04 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.907 -0.495 . . . . 0.0 110.098 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.18 -171.0 42.87 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.28 -164.68 23.37 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.6 -147.52 8.85 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -171.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -133.63 155.59 49.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 108.217 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.7 mt -125.26 141.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.453 -0.323 0 C-N-CA 124.606 1.162 . . . . 0.0 108.219 -178.551 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t60 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.06 120.58 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.96 -164.98 1.39 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.532 0.733 . . . . 0.0 109.988 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.36 -167.91 54.56 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -153.04 144.43 23.26 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.957 0.503 . . . . 0.0 110.786 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.9 m -70.01 140.69 52.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -65.1 -49.61 69.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.14 -24.56 37.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -118.17 -6.74 10.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.94 -179.6 34.6 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.795 0.725 . . . . 0.0 112.408 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.09 136.48 37.92 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.713 2.275 . . . . 0.0 109.976 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.91 169.83 17.16 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.362 0.601 . . . . 0.0 110.078 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.09 82.42 6.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -58.44 -18.15 26.29 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.765 -0.584 . . . . 0.0 112.543 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.63 -39.68 68.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.57 1.148 . . . . 0.0 111.861 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 mm -61.7 -49.76 83.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 m -58.19 -51.46 69.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.908 0.883 . . . . 0.0 111.399 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.0 p -64.71 -41.01 96.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.382 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.7 -45.53 93.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 120.011 1.278 . . . . 0.0 110.468 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -65.13 -44.51 88.46 Favored 'General case' 0 N--CA 1.46 0.053 0 O-C-N 121.911 -0.493 . . . . 0.0 111.08 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.439 HG21 HG11 ' A' ' 118' ' ' VAL . 54.8 mt -61.95 -42.12 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.374 0.67 . . . . 0.0 109.263 177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.415 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 93.2 mttt -63.57 -38.0 89.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 120.111 1.323 . . . . 0.0 110.895 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.53 -44.88 85.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.84 0.745 . . . . 0.0 111.153 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -63.43 -36.28 83.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.256 1.022 . . . . 0.0 111.41 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.7 t80 . . . . . 0 CA--C 1.543 0.706 0 C-N-CA 126.945 2.098 . . . . 0.0 111.215 -169.644 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.415 ' HG3' ' HE2' ' A' ' 110' ' ' LYS . 29.5 tt0 . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.439 HG11 HG21 ' A' ' 109' ' ' ILE . 18.8 m -141.2 166.43 18.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 -176.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.6 p -139.5 172.54 12.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.565 1.146 . . . . 0.0 109.456 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -143.88 167.78 21.52 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.159 0.583 . . . . 0.0 110.315 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 169.467 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.88 -28.44 64.19 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.197 0.908 . . . . 0.0 112.848 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.7 63.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.294 0.952 . . . . 0.0 112.293 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.1 -28.1 19.22 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.513 1.125 . . . . 0.0 111.212 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.67 129.02 76.41 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.67 131.36 33.09 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.658 2.906 . . . . 0.0 110.707 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.21 -43.34 8.88 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.46 142.07 31.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -156.18 116.36 3.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 pt . . . . . 0 C--O 1.236 0.371 0 C-N-CA 125.279 1.432 . . . . 0.0 107.598 -179.236 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -86.77 158.77 19.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.36 166.58 24.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.901 0.88 . . . . 0.0 109.209 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.06 154.74 21.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.108 0.963 . . . . 0.0 108.799 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.93 119.35 34.55 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.78 135.41 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 119.401 1.0 . . . . 0.0 110.423 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -79.99 146.62 31.94 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 124.84 33.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -93.76 153.28 18.4 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.509 0.724 . . . . 0.0 109.891 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m -67.85 87.92 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.297 1.039 . . . . 0.0 109.56 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.31 24.37 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 116.584 -1.674 . . . . 0.0 114.499 169.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.02 129.94 5.75 Favored 'Trans proline' 0 C--N 1.359 1.089 0 CA-C-N 123.551 2.304 . . . . 0.0 113.075 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 43.7 27.2 0.15 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.928 2.491 . . . . 0.0 113.901 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 50.1 32.38 5.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.401 1.481 . . . . 0.0 112.677 -175.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.55 -172.806 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 121.102 0.477 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -69.59 172.42 7.4 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.3 m -135.99 160.94 37.07 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.562 0.745 . . . . 0.0 110.361 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.11 162.81 30.74 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.547 1.539 . . . . 0.0 107.579 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.49 134.95 54.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 171.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 pt -121.57 161.64 21.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.667 1.187 . . . . 0.0 110.383 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.55 124.03 53.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.48 155.02 49.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.68 136.02 3.83 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -149.48 152.05 34.97 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -174.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.62 -33.47 72.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.53 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -64.91 -29.81 70.77 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.018 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.73 75.32 3.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 109.35 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.79 -10.46 37.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.536 173.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.51 142.57 35.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.667 1.587 . . . . 0.0 107.718 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -58.24 -33.79 69.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.968 1.307 . . . . 0.0 111.63 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.93 67.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.123 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.47 -42.34 87.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.097 0.862 . . . . 0.0 110.295 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -38.31 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 117.369 -1.301 . . . . 0.0 110.616 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.09 -43.01 95.83 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.259 1.391 . . . . 0.0 109.453 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.05 -50.57 72.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.128 0.876 . . . . 0.0 111.32 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -48.74 78.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.219 0.533 . . . . 0.0 109.8 -174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -78.43 -44.75 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.385 -169.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.9 p -62.42 -31.38 72.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.577 1.535 . . . . 0.0 110.512 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.52 -52.17 48.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.19 -44.84 90.75 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.415 1.108 . . . . 0.0 111.384 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.6 mmt -57.04 -49.25 76.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.893 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.713 1.142 . . . . 0.0 111.988 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.74 -43.5 98.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.212 0.915 . . . . 0.0 109.756 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.66 -35.93 82.61 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.943 0.792 . . . . 0.0 110.379 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.2 -12.55 3.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.915 2.197 . . . . 0.0 112.98 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.3 m -74.34 121.46 21.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.959 1.703 . . . . 0.0 112.887 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.33 143.65 42.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 168.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.3 m -145.16 166.99 23.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.588 0.755 . . . . 0.0 112.498 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -149.48 134.01 17.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.67 1.188 . . . . 0.0 108.65 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -70.62 113.23 7.52 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.7 mt -70.72 -25.32 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.764 -0.585 . . . . 0.0 110.182 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.65 -169.74 42.26 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -170.73 23.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.16 -155.61 17.39 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.2 ttm105 -126.39 153.61 44.74 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.514 0.726 . . . . 0.0 109.174 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 mt -123.05 141.77 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--N 1.327 -0.37 0 C-N-CA 124.645 1.178 . . . . 0.0 108.459 -179.359 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.7 t60 . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 t -133.34 126.11 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.15 -179.8 8.33 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.81 -0.557 . . . . 0.0 110.757 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.68 -162.03 52.87 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -149.57 151.92 34.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.84 1.256 . . . . 0.0 108.64 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -73.58 131.07 41.31 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.91 -28.78 69.77 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.189 -0.32 . . . . 0.0 110.347 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.93 -35.74 17.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.638 0.775 . . . . 0.0 112.153 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.89 2.13 7.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.74 44.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 118.691 0.678 . . . . 0.0 111.988 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.92 136.55 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.225 1.95 . . . . 0.0 109.955 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.96 178.2 3.88 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -61.17 -34.37 74.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.704 -0.622 . . . . 0.0 111.375 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.3 m80 59.21 -32.85 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.07 2.948 . . . . 0.0 115.682 -173.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.49 81.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.785 1.175 . . . . 0.0 110.723 170.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -53.88 -50.6 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.344 1.058 . . . . 0.0 108.644 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -58.92 -50.26 74.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.315 1.046 . . . . 0.0 110.363 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -48.65 74.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.813 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.11 -44.83 91.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.343 0.974 . . . . 0.0 110.845 -175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -67.13 -41.63 85.81 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.84 -0.538 . . . . 0.0 110.903 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.1 mt -59.84 -47.66 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 -33.88 75.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.01 1.277 . . . . 0.0 111.649 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.04 96.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.437 1.017 . . . . 0.0 111.324 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.4 -17.66 26.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 CA--C 1.547 0.833 0 C-N-CA 125.916 1.686 . . . . 0.0 114.208 -175.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.05 162.22 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.076 1.35 . . . . 0.0 108.031 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.5 p -138.26 171.82 13.82 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.709 1.603 . . . . 0.0 108.519 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -145.04 169.34 18.29 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.469 -0.769 . . . . 0.0 111.145 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.547 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 mt -53.74 -30.71 45.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.499 1.12 . . . . 0.0 113.484 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.59 -24.19 60.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.78 0.718 . . . . 0.0 112.266 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.31 -19.93 26.07 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.292 1.037 . . . . 0.0 111.108 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.09 131.01 80.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.51 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.348 2.699 . . . . 0.0 109.961 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.29 -34.71 70.9 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.564 0.746 . . . . 0.0 112.261 -169.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -142.56 135.26 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -154.61 105.57 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt . . . . . 0 C--O 1.236 0.351 0 C-N-CA 123.749 0.82 . . . . 0.0 109.588 -173.128 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.4 p90 . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.68 154.4 17.31 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.03 168.53 19.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 109.116 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.62 154.23 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.111 1.364 . . . . 0.0 108.002 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.6 tp -118.17 114.91 23.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.58 131.53 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -174.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -78.59 144.96 35.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.97 141.72 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -108.01 149.65 28.13 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.879 1.272 . . . . 0.0 109.633 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 m -63.68 99.95 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.365 0.666 . . . . 0.0 110.912 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.547 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -154.23 21.71 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.347 -1.787 . . . . 0.0 114.847 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.0 Cg_exo -46.99 136.85 17.29 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 124.327 2.581 . . . . 0.0 113.067 172.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? 46.41 25.05 0.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.153 2.181 . . . . 0.0 113.821 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 50.77 32.71 7.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.017 1.327 . . . . 0.0 112.351 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 C-N-CA 123.934 0.778 . . . . 0.0 112.586 -172.655 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.13 -178.14 4.88 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.1 m -152.82 159.34 43.06 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.772 -1.205 . . . . 0.0 110.028 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.73 167.81 29.2 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.826 1.65 . . . . 0.0 108.785 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.01 152.74 24.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -129.85 153.41 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.752 1.221 . . . . 0.0 109.013 172.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.4 t -119.92 115.08 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -136.06 148.18 48.21 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.95 136.69 2.57 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.2 m-85 -156.29 152.31 27.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -172.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.53 -31.46 69.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.001 -0.524 . . . . 0.0 112.168 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.431 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -64.32 -27.54 69.1 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.828 0.74 . . . . 0.0 112.363 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 82.15 8.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.692 1.133 . . . . 0.0 108.267 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.52 -14.09 47.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.702 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.53 143.99 35.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.769 1.628 . . . . 0.0 108.418 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.45 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 21.2 m-70 -62.11 -30.7 71.2 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.736 1.214 . . . . 0.0 111.779 -174.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.01 -28.55 69.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.722 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.21 -47.79 72.72 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 110.549 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -40.37 82.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.262 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -58.61 -46.54 86.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.325 1.421 . . . . 0.0 110.02 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.31 -48.67 72.28 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.288 0.495 . . . . 0.0 111.451 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -60.18 -51.86 67.79 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.106 0.563 . . . . 0.0 110.864 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.32 -45.22 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.869 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -63.29 -28.37 69.97 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.731 1.15 . . . . 0.0 111.352 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.19 -49.38 75.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.57 -46.51 85.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.053 0.927 . . . . 0.0 110.708 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.3 mmt -58.36 -43.61 88.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.853 -0.529 . . . . 0.0 111.502 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.94 -33.31 73.52 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.103 -0.998 . . . . 0.0 111.875 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -61.22 -42.71 99.08 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.022 0.828 . . . . 0.0 109.617 170.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -60.71 -44.06 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.128 0.876 . . . . 0.0 109.706 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.71 -6.74 1.44 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.073 1.796 . . . . 0.0 113.28 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.63 177.99 4.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.645 1.578 . . . . 0.0 113.319 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.25 144.71 51.51 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 169.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.3 m -145.32 165.48 28.33 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -168.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.77 128.72 11.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.313 1.045 . . . . 0.0 108.525 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -67.47 115.33 6.96 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.6 mt -71.9 -26.51 62.35 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.005 -0.435 . . . . 0.0 110.451 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.05 -168.73 40.98 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.98 -172.0 28.81 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 173.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.13 -168.11 35.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -119.3 154.91 32.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 mt -128.79 133.77 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 108.595 -175.538 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.0 t -125.5 121.56 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.22 -176.32 5.57 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.461 -0.774 . . . . 0.0 111.586 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.75 -159.15 53.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.06 152.36 36.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.012 1.325 . . . . 0.0 108.188 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -77.03 130.54 37.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.6 mtp -64.32 -27.73 69.22 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.677 -0.639 . . . . 0.0 110.553 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.01 -38.03 45.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.159 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.9 3.33 3.2 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.75 -178.69 50.03 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.019 0.818 . . . . 0.0 112.038 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 133.96 23.95 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.653 2.235 . . . . 0.0 110.162 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.35 167.86 21.09 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.305 0.574 . . . . 0.0 110.027 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.29 82.15 6.39 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -59.04 -17.27 23.99 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.624 -0.673 . . . . 0.0 112.463 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.42 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.392 1.077 . . . . 0.0 111.934 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.78 -48.42 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.2 m -58.81 -50.03 75.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.752 0.821 . . . . 0.0 111.349 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 p -59.78 -44.16 94.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.945 0.793 . . . . 0.0 111.385 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.57 -48.24 80.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.784 0.72 . . . . 0.0 110.314 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.71 -47.83 76.87 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.158 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -62.21 -45.53 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -61.63 -38.49 87.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.426 1.466 . . . . 0.0 110.984 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.81 -47.71 68.31 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.792 0.723 . . . . 0.0 111.84 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -80.35 -15.08 57.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.791 0.836 . . . . 0.0 112.009 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 CA--C 1.552 1.05 0 C-N-CA 126.575 1.95 . . . . 0.0 115.519 176.322 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.49 163.55 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.205 . . . . 0.0 107.911 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -140.1 166.83 23.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.718 1.607 . . . . 0.0 108.562 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -147.82 168.57 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.285 -0.885 . . . . 0.0 112.61 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.456 0 C-N-CA 125.419 1.488 . . . . 0.0 107.098 168.875 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 C--O 1.232 0.164 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.72 -32.02 40.78 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.057 1.343 . . . . 0.0 113.595 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.61 58.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.795 0.725 . . . . 0.0 112.304 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.78 -20.18 27.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.175 0.99 . . . . 0.0 111.106 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.7 mt -58.53 133.76 85.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.98 111.19 0.55 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.841 3.028 . . . . 0.0 110.563 171.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.59 -35.73 52.61 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.3 t -137.86 136.47 45.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.9 101.01 2.86 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 pt . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 127.246 2.218 . . . . 0.0 107.184 -178.789 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 p90 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 121.281 0.563 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -77.11 160.47 29.0 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 122.059 -0.4 . . . . 0.0 110.149 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.04 167.13 22.79 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.706 1.202 . . . . 0.0 109.168 -174.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.33 155.62 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.4 tp -118.73 117.66 29.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.282 0.0 OUTLIER -128.28 128.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 118.724 0.693 . . . . 0.0 109.736 -173.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -76.72 146.93 37.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.54 1.536 . . . . 0.0 108.279 172.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.2 139.1 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -108.91 143.4 38.19 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.735 1.214 . . . . 0.0 107.882 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 p -67.95 106.03 2.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.581 0.628 . . . . 0.0 110.818 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.55 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.47 17.22 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 116.212 -1.851 . . . . 0.0 115.362 169.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.55 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 90.1 Cg_exo -43.94 135.91 7.6 Favored 'Trans proline' 0 C--N 1.362 1.27 0 CA-C-N 124.185 2.53 . . . . 0.0 114.427 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 45.15 27.47 0.32 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.956 2.102 . . . . 0.0 113.576 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.84 31.87 6.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.457 1.503 . . . . 0.0 112.545 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.864 0 C-N-CA 123.768 0.699 . . . . 0.0 112.974 -172.704 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -75.36 173.17 11.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.437 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -144.57 155.65 43.76 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.388 0.675 . . . . 0.0 110.691 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.67 166.54 33.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.696 1.598 . . . . 0.0 108.963 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.64 155.6 19.97 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -174.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.41 155.28 41.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.398 1.079 . . . . 0.0 108.836 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.07 121.5 67.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -131.52 148.83 52.66 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.879 1.271 . . . . 0.0 107.799 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.25 131.7 1.8 Allowed Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -154.54 152.84 30.54 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.41 -31.75 71.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.134 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -64.86 -25.85 68.08 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.53 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.38 88.21 7.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 119.632 1.105 . . . . 0.0 109.028 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.0 -5.5 22.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 0.0 112.187 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.59 147.93 28.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.588 1.555 . . . . 0.0 108.319 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -60.67 -34.25 74.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 111.437 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.5 -27.54 67.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 118.627 -0.701 . . . . 0.0 112.215 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.65 -49.14 61.5 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.243 0.929 . . . . 0.0 110.603 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.402 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.83 -40.28 85.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.32 177.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -61.25 -49.84 75.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.095 0.861 . . . . 0.0 109.617 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.87 -46.37 89.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.393 0.997 . . . . 0.0 111.101 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -58.26 -52.62 64.8 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.566 0.747 . . . . 0.0 110.837 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.41 -34.37 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.457 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -59.48 -38.41 80.77 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.01 1.277 . . . . 0.0 109.245 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.89 87.34 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.821 0.737 . . . . 0.0 111.553 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.73 -45.31 90.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.257 1.029 . . . . 0.0 111.38 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -60.19 -44.65 94.93 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.862 -0.524 . . . . 0.0 110.795 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -65.65 -32.78 74.54 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.237 -0.915 . . . . 0.0 111.543 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -64.23 -39.1 93.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.464 171.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.26 -42.47 95.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.634 1.106 . . . . 0.0 109.262 169.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.41 -4.66 2.29 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.307 1.908 . . . . 0.0 112.939 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.9 m -69.11 178.46 2.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.484 1.513 . . . . 0.0 112.982 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -129.3 146.78 51.13 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.4 m -148.9 165.67 30.86 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -168.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -155.69 129.4 8.49 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.571 1.148 . . . . 0.0 109.585 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.75 115.66 10.16 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.0 mt -73.09 -25.2 60.79 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.179 0.591 . . . . 0.0 111.019 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.66 179.79 43.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.67 173.59 21.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.58 -158.9 24.52 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -136.02 153.09 51.47 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.118 1.367 . . . . 0.0 109.635 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mt -115.48 126.25 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.33 -0.273 0 C-N-CA 123.686 0.795 . . . . 0.0 108.867 -175.676 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t60 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -132.45 120.28 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -172.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -158.87 179.54 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.45 -163.33 15.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.459 1.027 . . . . 0.0 113.218 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -153.63 164.51 38.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.071 2.148 . . . . 0.0 107.251 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 t -135.55 127.45 29.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.8 tpp -62.84 -30.51 71.55 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.85 -35.93 32.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.404 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -131.24 -1.21 4.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.51 177.27 43.81 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 119.162 0.892 . . . . 0.0 111.686 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.01 138.09 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.472 2.115 . . . . 0.0 109.326 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.79 160.9 30.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.344 0.592 . . . . 0.0 110.813 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -82.05 78.0 8.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -54.61 -21.67 11.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.23 0.612 . . . . 0.0 112.403 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.89 65.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.15 1.38 . . . . 0.0 112.861 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.15 -47.71 92.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -61.38 -49.36 77.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.017 0.927 . . . . 0.0 111.201 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 p -59.29 -40.29 85.68 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.958 0.799 . . . . 0.0 111.783 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.63 -47.2 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.569 1.077 . . . . 0.0 110.375 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.75 -44.84 88.82 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.944 -0.472 . . . . 0.0 111.303 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.07 -47.44 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.38 -34.47 73.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.336 1.426 . . . . 0.0 111.569 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.83 89.22 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.522 1.056 . . . . 0.0 111.777 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -84.25 -16.07 44.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 CA--C 1.553 1.068 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -171.699 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 m -141.4 166.01 18.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.436 1.094 . . . . 0.0 109.164 169.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 p -134.13 171.47 14.18 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.943 1.297 . . . . 0.0 108.968 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -142.01 171.55 13.9 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.836 -0.54 . . . . 0.0 111.983 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.728 0 C-N-CA 124.768 1.227 . . . . 0.0 107.716 169.445 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.16 -27.58 62.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.787 0.835 . . . . 0.0 113.146 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.76 67.05 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.182 0.901 . . . . 0.0 112.61 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -77.6 -19.75 55.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.33 0.652 . . . . 0.0 111.649 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.88 139.88 97.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.03 110.59 1.19 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.917 2.412 . . . . 0.0 108.932 170.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.72 -33.36 64.33 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.986 0.914 . . . . 0.0 113.395 -169.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.9 t -136.81 133.4 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -157.85 110.55 2.4 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 170.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 124.109 0.963 . . . . 0.0 110.194 -171.819 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -78.81 163.4 25.37 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.886 -0.509 . . . . 0.0 110.129 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.34 166.67 24.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.559 1.143 . . . . 0.0 108.586 173.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.48 155.84 13.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.7 tp -118.44 116.65 27.13 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.28 0.0 OUTLIER -125.46 128.47 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-N 118.474 0.579 . . . . 0.0 109.671 -172.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -78.35 148.48 33.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.287 1.435 . . . . 0.0 108.415 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.2 139.37 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -108.67 146.66 33.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.387 1.475 . . . . 0.0 108.82 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -68.63 88.77 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.011 0.925 . . . . 0.0 112.457 -173.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.464 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -139.81 16.34 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 116.433 -1.746 . . . . 0.0 113.743 168.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 53.1 Cg_exo -47.85 143.45 13.17 Favored 'Trans proline' 0 C--N 1.362 1.258 0 CA-C-N 123.939 2.443 . . . . 0.0 113.33 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 41.26 31.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.636 2.374 . . . . 0.0 113.301 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.9 m 52.33 28.69 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.178 1.791 . . . . 0.0 113.374 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.857 0 CA-C-O 118.709 -1.05 . . . . 0.0 114.648 -173.438 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.195 0.522 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -67.53 165.72 16.27 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -140.55 155.94 46.46 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.014 0.926 . . . . 0.0 108.986 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HE2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -153.24 166.55 32.21 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.192 1.397 . . . . 0.0 108.694 176.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -108.4 156.28 19.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.404 HG23 ' HE2' ' A' ' 41' ' ' LYS . 30.7 pt -130.82 154.67 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.463 1.105 . . . . 0.0 108.826 172.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.79 119.85 63.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -132.07 147.61 52.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.231 1.412 . . . . 0.0 108.447 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.36 126.29 0.93 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -151.16 162.1 41.51 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.475 0.71 . . . . 0.0 109.842 -172.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -55.28 -43.38 74.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.833 0.853 . . . . 0.0 112.113 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -66.94 -27.32 67.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.457 -173.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.59 86.54 7.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.339 0.972 . . . . 0.0 108.516 172.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.42 -14.31 55.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.841 0.456 . . . . 0.0 111.664 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 144.5 33.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.03 1.732 . . . . 0.0 108.836 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.556 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 6.1 m-70 -58.14 -32.99 68.69 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.872 1.669 . . . . 0.0 112.079 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.39 -29.03 70.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.61 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.64 -49.23 63.97 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.76 0.709 . . . . 0.0 110.539 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -64.86 -40.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.331 177.099 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.527 0.603 . . . . 0.0 110.017 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.08 -46.89 76.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.662 0.664 . . . . 0.0 111.507 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.99 -56.16 18.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.582 1.153 . . . . 0.0 110.002 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.2 t -78.47 -35.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 117.797 -1.097 . . . . 0.0 110.456 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.4 m -62.36 -31.65 72.33 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 120.314 1.415 . . . . 0.0 110.939 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.63 -47.97 87.25 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.176 0.898 . . . . 0.0 110.974 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.04 -46.28 85.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.074 0.937 . . . . 0.0 111.028 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.5 mmt -59.56 -42.83 93.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.525 0.602 . . . . 0.0 110.882 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -67.86 -32.57 73.17 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.91 -1.119 . . . . 0.0 111.339 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -64.17 -40.56 96.38 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.032 0.833 . . . . 0.0 110.143 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -62.35 -33.28 74.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.316 0.962 . . . . 0.0 110.619 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.99 -6.9 4.42 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.444 1.973 . . . . 0.0 113.164 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.1 m -70.64 -179.72 2.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.272 1.829 . . . . 0.0 114.446 -169.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -130.09 151.09 51.0 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.2 165.01 31.34 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.79 129.65 9.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.678 1.191 . . . . 0.0 109.443 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.7 113.48 8.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.6 mt -68.06 -29.74 68.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.912 -0.492 . . . . 0.0 110.129 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.01 -173.46 45.15 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.84 -177.1 24.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.95 -155.75 16.25 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -136.41 167.37 21.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.904 0.852 . . . . 0.0 110.752 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 mt -136.36 142.57 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.694 1.998 . . . . 0.0 107.273 -169.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.235 0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 109.142 179.638 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.6 t60 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.22 121.96 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -159.74 -175.19 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.324 -0.86 . . . . 0.0 111.169 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.05 30.85 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.837 0.687 . . . . 0.0 112.834 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -137.78 143.11 40.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 t -65.45 146.56 54.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.5 ptp -72.87 -12.86 61.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.283 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.74 -14.76 3.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.194 0.998 . . . . 0.0 113.388 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -134.79 -177.29 4.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.2 1.8 . . . . 0.0 108.443 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.67 173.39 44.27 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 170.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.94 139.32 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.094 1.862 . . . . 0.0 108.457 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 164.67 25.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.606 0.717 . . . . 0.0 111.081 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.37 74.03 7.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -56.37 -20.52 19.68 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.47 60.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.035 0.934 . . . . 0.0 111.618 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.87 -43.95 99.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.408 1.083 . . . . 0.0 109.284 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -59.43 -50.78 72.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.416 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -57.02 -44.32 82.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.48 0.582 . . . . 0.0 111.304 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.69 -50.61 71.78 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.809 0.731 . . . . 0.0 110.505 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.98 -43.13 72.11 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.899 -0.501 . . . . 0.0 111.361 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.45 -46.76 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.93 -32.79 74.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.283 1.402 . . . . 0.0 111.379 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.32 94.97 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.405 1.002 . . . . 0.0 111.537 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -86.88 -20.0 28.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 CA--C 1.548 0.885 0 C-N-CA 125.646 1.578 . . . . 0.0 113.307 -169.828 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 118' ' ' VAL . 26.7 tt0 . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.428 ' H ' ' HG2' ' A' ' 117' ' ' GLU . 7.1 p -158.06 162.36 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.593 1.557 . . . . 0.0 107.329 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -143.4 173.9 11.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 107.661 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.71 166.77 23.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.582 0.628 . . . . 0.0 111.068 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 169.736 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.232 0.168 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.9 mt -52.35 -34.67 48.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.833 0.853 . . . . 0.0 112.942 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.19 62.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.671 0.669 . . . . 0.0 112.236 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.15 -19.76 28.0 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.099 0.959 . . . . 0.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.1 mt -59.28 128.82 86.06 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 172.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.57 138.16 58.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.164 2.576 . . . . 0.0 111.035 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -86.56 -41.78 14.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.071 0.396 . . . . 0.0 111.55 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.78 140.56 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 124.721 1.208 . . . . 0.0 107.9 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -157.14 114.19 3.06 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt . . . . . 0 C--O 1.235 0.307 0 C-N-CA 124.258 1.023 . . . . 0.0 108.837 -173.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.9 p90 . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -113.38 152.36 30.1 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.694 0.797 . . . . 0.0 109.287 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.27 168.7 19.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.671 0.788 . . . . 0.0 109.085 -170.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.26 152.92 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.457 1.503 . . . . 0.0 108.811 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -114.75 114.81 26.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.47 133.94 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.819 0.736 . . . . 0.0 109.329 -175.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -81.38 147.39 29.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.21 143.3 34.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -114.52 146.83 40.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.331 1.452 . . . . 0.0 109.24 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 m -62.68 103.51 0.43 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.288 0.635 . . . . 0.0 111.526 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.84 18.55 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 116.076 -1.916 . . . . 0.0 114.791 169.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 32.7 Cg_exo -40.37 127.79 2.28 Favored 'Trans proline' 0 C--N 1.361 1.224 0 CA-C-N 124.216 2.541 . . . . 0.0 115.093 173.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 31.91 39.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.492 3.117 . . . . 0.0 113.926 -170.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 53.11 31.44 11.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.385 1.474 . . . . 0.0 112.961 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 C-N-CA 124.226 0.917 . . . . 0.0 112.748 -176.177 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.25 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -78.14 -176.35 4.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 172.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 m -151.89 159.31 43.87 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 167.24 28.08 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.006 1.722 . . . . 0.0 108.282 174.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -108.2 157.51 18.25 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.9 pt -137.88 155.33 30.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.283 1.433 . . . . 0.0 108.58 174.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.6 t -119.03 123.77 72.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.407 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.0 mmp_? -135.96 149.26 48.83 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.311 1.044 . . . . 0.0 108.282 176.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.49 135.85 2.42 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 18.8 m-85 -153.92 155.29 35.39 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -60.14 -34.17 73.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.656 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.0 p-90 -64.28 -28.69 69.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.395 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 77.78 9.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.363 0.983 . . . . 0.0 108.799 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.07 -9.61 17.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.45 140.67 35.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.222 1.409 . . . . 0.0 107.456 174.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.477 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.8 m-70 -62.85 -29.86 71.07 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 111.428 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.77 67.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.942 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.4 -48.11 71.14 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.766 0.712 . . . . 0.0 110.501 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.16 -40.74 83.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 117.411 -1.28 . . . . 0.0 109.997 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.3 -46.7 85.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 120.608 1.549 . . . . 0.0 110.251 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.77 -49.17 69.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.239 0.472 . . . . 0.0 111.568 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -60.52 -49.3 78.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.349 0.66 . . . . 0.0 110.836 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' HG3' ' A' ' 45' ' ' ARG . 61.2 t -69.44 -44.42 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.056 -175.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.71 -28.92 70.28 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.686 1.13 . . . . 0.0 111.092 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -49.28 72.28 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.365 0.984 . . . . 0.0 110.717 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.11 -46.88 85.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.127 0.963 . . . . 0.0 110.626 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.7 mmt -57.98 -43.41 86.5 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.836 -0.54 . . . . 0.0 111.198 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -68.59 -31.28 70.36 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.862 -1.149 . . . . 0.0 112.248 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.36 -42.47 98.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.489 1.041 . . . . 0.0 109.662 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -62.54 -30.59 71.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.703 0.683 . . . . 0.0 110.55 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.27 -8.55 5.96 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.05 2.262 . . . . 0.0 112.972 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.38 179.96 2.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.547 1.939 . . . . 0.0 113.185 -169.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.14 150.92 52.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.1 m -149.07 165.24 32.32 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.31 128.34 10.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 108.325 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.98 116.17 7.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.6 -28.37 64.8 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.008 -0.432 . . . . 0.0 109.993 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.56 -163.94 36.52 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.45 -164.33 22.93 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.35 -163.59 29.56 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.48 157.62 31.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -131.14 127.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.233 0.228 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -174.022 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 . . . . . 0 C--O 1.232 0.134 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -119.47 130.03 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -161.96 -179.53 7.22 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.155 -0.966 . . . . 0.0 110.828 -170.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -157.93 53.15 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -144.79 153.85 42.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.62 1.568 . . . . 0.0 107.647 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.1 p -70.78 133.9 46.94 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.6 mmt -73.86 32.45 0.08 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.09 1.356 . . . . 0.0 111.108 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.3 -39.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.611 1.565 . . . . 0.0 111.572 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -134.63 2.86 3.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 -175.76 53.62 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.086 0.857 . . . . 0.0 112.181 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.61 135.62 24.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.526 2.15 . . . . 0.0 110.642 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.79 172.43 12.68 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.458 0.647 . . . . 0.0 110.011 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -77.19 79.64 3.71 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -58.82 -17.77 26.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -174.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.46 82.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.204 0.602 . . . . 0.0 110.378 169.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mm -62.97 -49.7 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.8 m -57.79 -49.75 75.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.119 0.568 . . . . 0.0 109.716 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -65.82 -42.86 90.09 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.514 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.32 -46.4 86.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.2 1.364 . . . . 0.0 110.596 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -69.7 -42.79 73.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.054 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.45 -44.64 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.035 0.834 . . . . 0.0 108.944 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.79 -41.06 99.09 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.016 1.28 . . . . 0.0 111.303 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.65 75.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.624 0.647 . . . . 0.0 111.294 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -73.2 -29.27 62.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.015 0.526 . . . . 0.0 111.193 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 127.127 2.171 . . . . 0.0 111.764 -176.574 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 120.949 0.404 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.28 168.26 10.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.701 1.2 . . . . 0.0 110.784 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.6 p -138.7 171.15 14.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.364 1.466 . . . . 0.0 108.312 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -144.98 171.13 14.89 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.529 -0.732 . . . . 0.0 110.893 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 169.444 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.4 mt -50.62 -35.44 30.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.299 1.04 . . . . 0.0 112.84 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.93 -23.96 66.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.673 0.669 . . . . 0.0 112.479 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.65 -19.65 37.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.61 0.764 . . . . 0.0 111.212 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.92 131.65 94.67 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.52 111.78 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.301 2.667 . . . . 0.0 109.96 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.5 -35.77 65.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.81 135.72 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -154.47 108.42 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--O 1.236 0.391 0 C-N-CA 124.128 0.971 . . . . 0.0 110.231 -170.686 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.2 p90 . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -107.12 151.46 25.35 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.75 169.18 17.96 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 109.179 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.63 152.87 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.107 1.363 . . . . 0.0 108.156 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -116.24 116.9 28.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.86 132.6 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.008 0.822 . . . . 0.0 109.615 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -77.85 147.98 34.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.31 140.42 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -112.05 146.81 37.27 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.618 1.167 . . . . 0.0 109.166 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 m -66.2 101.77 0.75 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.751 0.82 . . . . 0.0 109.598 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.57 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.67 16.27 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 115.839 -2.029 . . . . 0.0 115.004 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 63.6 Cg_exo -43.31 132.03 6.7 Favored 'Trans proline' 0 C--N 1.363 1.309 0 CA-C-N 124.258 2.557 . . . . 0.0 115.087 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 37.97 33.02 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.88 2.872 . . . . 0.0 114.049 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m 52.46 31.15 9.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.205 1.402 . . . . 0.0 112.846 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 C-N-CA 124.129 0.871 . . . . 0.0 112.877 -176.013 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 121.064 0.459 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -69.45 168.09 15.25 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.3 m -139.42 158.9 43.34 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.068 0.947 . . . . 0.0 110.526 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.52 165.67 35.89 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.696 1.598 . . . . 0.0 109.529 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.16 155.11 20.8 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.9 157.78 41.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.949 1.7 . . . . 0.0 109.052 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.72 117.53 51.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -137.78 150.4 47.19 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.53 138.27 2.68 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.1 m-85 -153.52 155.91 37.09 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -170.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.6 -33.88 72.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.402 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -65.7 -25.83 67.49 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.73 0.696 . . . . 0.0 112.536 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.42 82.06 8.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.677 1.126 . . . . 0.0 108.589 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -12.7 39.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.875 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.41 145.22 32.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.022 1.729 . . . . 0.0 108.381 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.472 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 15.2 m-70 -62.91 -31.27 72.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.384 1.074 . . . . 0.0 111.847 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -29.37 69.45 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.938 -0.477 . . . . 0.0 111.429 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.22 -45.44 84.69 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.48 0.582 . . . . 0.0 110.581 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -37.46 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.592 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.03 -45.96 86.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.483 1.492 . . . . 0.0 109.419 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.03 -48.34 71.43 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.763 0.425 . . . . 0.0 111.878 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -55.62 -54.97 37.5 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.683 0.793 . . . . 0.0 109.85 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.35 -43.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.022 -0.99 . . . . 0.0 108.664 -171.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.3 m -62.08 -29.03 70.03 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.008 1.276 . . . . 0.0 111.519 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.46 -51.09 55.33 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.43 1.014 . . . . 0.0 110.622 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.54 -44.89 92.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.972 0.886 . . . . 0.0 110.813 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -56.65 -45.72 81.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.294 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -70.33 -30.47 67.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.962 1.256 . . . . 0.0 112.327 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.18 -43.55 98.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.329 0.968 . . . . 0.0 109.694 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.44 -36.38 83.57 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.312 0.505 . . . . 0.0 110.368 171.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.32 -6.44 4.99 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.173 2.321 . . . . 0.0 113.281 170.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.6 171.88 9.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.724 1.61 . . . . 0.0 112.044 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -127.99 149.14 50.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -148.33 165.0 32.36 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -147.07 125.05 12.01 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.033 1.333 . . . . 0.0 108.263 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -67.73 111.59 4.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.9 mt -72.64 -24.61 61.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.934 -0.479 . . . . 0.0 110.62 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.34 -170.03 42.69 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.41 -174.01 28.6 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 171.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.0 -166.42 32.79 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -117.05 150.52 38.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.9 mt -118.97 136.69 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 123.608 0.763 . . . . 0.0 109.346 -169.863 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -121.71 126.64 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -166.07 1.51 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.611 -0.681 . . . . 0.0 110.509 -177.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.26 -160.9 53.44 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.84 -0.537 . . . . 0.0 111.804 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -154.04 155.13 34.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.366 1.467 . . . . 0.0 108.082 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.0 p -81.91 134.43 35.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -64.94 -29.26 70.18 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.835 -0.541 . . . . 0.0 110.647 170.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 -37.93 48.82 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.865 0.866 . . . . 0.0 112.756 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.32 1.38 3.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.61 -177.88 52.5 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 118.942 0.792 . . . . 0.0 111.921 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.67 134.44 28.19 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.641 2.228 . . . . 0.0 110.357 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 170.13 16.63 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.342 0.591 . . . . 0.0 110.225 169.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.03 79.05 3.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -58.89 -18.03 29.47 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.97 -39.19 74.14 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.668 0.787 . . . . 0.0 111.119 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.7 mm -61.8 -48.33 89.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -54.48 -52.03 63.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.735 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 p -60.46 -42.49 96.3 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.781 0.719 . . . . 0.0 111.822 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -60.94 -51.3 69.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.318 0.963 . . . . 0.0 110.825 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -71.08 -43.83 66.95 Favored 'General case' 0 C--N 1.334 -0.109 0 C-N-CA 123.35 0.66 . . . . 0.0 111.121 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.75 -43.26 97.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -63.02 -37.01 85.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 120.877 1.672 . . . . 0.0 111.228 176.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.6 93.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.098 0.863 . . . . 0.0 111.851 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -79.56 -20.06 47.93 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.24 0.616 . . . . 0.0 112.034 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.306 39.2 p90 . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 127.918 2.487 . . . . 0.0 115.969 -171.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.99 163.63 10.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.127 1.371 . . . . 0.0 107.752 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 p -137.39 171.84 13.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.744 1.218 . . . . 0.0 108.731 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -141.72 159.25 42.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.146 0.578 . . . . 0.0 110.173 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.685 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.54 -28.1 65.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.951 0.796 . . . . 0.0 112.706 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.68 66.53 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.829 1.195 . . . . 0.0 112.143 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.31 -31.07 17.09 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.633 1.173 . . . . 0.0 111.633 -175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.91 122.91 65.93 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.27 137.71 64.0 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.087 2.524 . . . . 0.0 111.141 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.63 -38.65 23.25 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 122.032 -0.417 . . . . 0.0 110.953 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.7 t -137.95 137.58 44.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -172.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -156.47 113.24 3.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 pt . . . . . 0 C--O 1.235 0.318 0 C-N-CA 124.294 1.038 . . . . 0.0 108.669 -173.224 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.39 163.24 12.96 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.804 0.842 . . . . 0.0 111.692 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.99 171.86 14.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.98 154.9 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.354 1.462 . . . . 0.0 108.477 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.2 tp -118.28 120.75 38.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.18 132.1 71.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 119.242 0.928 . . . . 0.0 109.411 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -76.08 146.22 39.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.9 121.16 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -90.45 149.26 22.3 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.734 0.814 . . . . 0.0 108.968 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -66.09 96.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.078 0.951 . . . . 0.0 109.911 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.443 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.25 19.3 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 116.254 -1.832 . . . . 0.0 115.229 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 33.1 Cg_exo -39.36 132.52 1.49 Allowed 'Trans proline' 0 C--N 1.361 1.191 0 CA-C-N 123.927 2.438 . . . . 0.0 114.545 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 43.35 26.61 0.1 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.454 2.702 . . . . 0.0 114.154 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.68 32.1 8.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 112.358 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 C-N-CA 123.958 0.79 . . . . 0.0 112.923 -173.955 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 121.07 0.462 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.37 172.96 7.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -137.07 160.81 37.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.761 0.824 . . . . 0.0 110.619 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -139.34 165.11 28.07 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.613 1.565 . . . . 0.0 108.249 172.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.61 138.45 45.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 pt -115.6 155.08 16.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.132 0.973 . . . . 0.0 109.834 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.62 122.65 69.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.466 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.1 mmt85 -136.72 148.17 47.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 125.56 0.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -146.61 151.01 36.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -171.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -53.89 -31.26 49.33 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -74.54 -24.45 58.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.851 0.751 . . . . 0.0 112.951 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 83.4 8.06 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.974 1.261 . . . . 0.0 109.37 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.76 -6.24 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.636 0.775 . . . . 0.0 112.293 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.94 143.9 28.82 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 108.186 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -62.1 -31.38 71.83 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.104 0.962 . . . . 0.0 111.659 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.73 -27.46 69.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.785 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.779 0.718 . . . . 0.0 110.234 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -40.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.109 -1.424 . . . . 0.0 110.342 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.07 -48.61 80.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.868 1.667 . . . . 0.0 109.742 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.32 -47.11 83.6 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.888 0.767 . . . . 0.0 111.542 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -60.89 -50.13 74.65 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.96 0.504 . . . . 0.0 110.77 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.466 HG21 ' HG3' ' A' ' 45' ' ' ARG . 67.5 t -74.2 -44.69 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.32 -171.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.8 p -62.04 -30.41 70.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.789 1.177 . . . . 0.0 110.398 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.19 54.0 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.16 0.891 . . . . 0.0 111.007 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -64.08 -45.51 88.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.371 1.085 . . . . 0.0 111.169 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.54 -45.04 85.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.625 0.648 . . . . 0.0 111.179 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.42 -31.83 72.29 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.004 -1.06 . . . . 0.0 111.819 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.54 -39.8 95.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.101 0.864 . . . . 0.0 110.417 171.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.35 -33.9 77.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.226 0.921 . . . . 0.0 110.447 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.55 -9.88 4.03 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 126.416 1.96 . . . . 0.0 113.217 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -65.69 173.64 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.923 1.689 . . . . 0.0 112.503 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.14 135.1 49.31 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 169.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.0 m -142.48 164.49 29.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.9 130.43 11.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -66.23 109.24 2.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.2 mt -66.87 -28.16 68.1 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.926 -0.484 . . . . 0.0 110.472 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.02 -168.2 41.35 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.43 -169.15 20.87 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.88 -162.82 28.52 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 -128.88 153.7 47.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -128.86 140.38 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 124.259 1.024 . . . . 0.0 108.451 -177.077 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.7 t60 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.19 126.7 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.45 -177.51 6.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.598 0.759 . . . . 0.0 110.496 -173.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -161.05 53.22 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -150.61 155.64 39.8 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 108.421 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 t -69.61 131.85 45.29 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.6 ttm -62.51 -26.32 68.49 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.521 0.328 . . . . 0.0 110.844 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.24 -30.05 13.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 112.587 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.01 1.66 4.29 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -168.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.74 -176.56 48.54 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.092 0.86 . . . . 0.0 112.279 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.34 131.6 22.18 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.721 2.281 . . . . 0.0 110.663 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.87 170.02 16.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 110.231 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.03 74.14 4.58 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.41 -18.82 19.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 113.399 -175.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.47 -38.82 69.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.424 0.69 . . . . 0.0 111.199 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.65 -43.98 97.95 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.928 0.891 . . . . 0.0 108.828 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -57.0 -50.35 72.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.64 0.655 . . . . 0.0 110.617 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 -48.56 73.92 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.813 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.94 -50.08 72.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.018 0.826 . . . . 0.0 110.878 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -68.33 -46.12 71.08 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.575 0.75 . . . . 0.0 110.671 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.98 -39.24 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.983 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.06 -36.76 82.73 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.158 1.799 . . . . 0.0 111.572 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.99 89.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.963 0.801 . . . . 0.0 110.958 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -70.04 -39.17 75.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.162 0.585 . . . . 0.0 111.289 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 t80 . . . . . 0 CA--C 1.54 0.568 0 C-N-CA 126.965 2.106 . . . . 0.0 109.592 -168.468 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.0 p -149.21 155.03 8.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 120.755 -1.216 . . . . 0.0 108.587 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.9 p -140.97 170.98 14.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.547 1.539 . . . . 0.0 107.785 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -145.61 168.19 21.25 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.661 -0.649 . . . . 0.0 111.425 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.653 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.232 0.157 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 mt -53.65 -30.71 44.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 113.468 -178.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.58 -24.8 56.66 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.889 0.768 . . . . 0.0 112.283 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.0 -21.56 29.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.967 0.907 . . . . 0.0 110.954 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.37 129.91 80.41 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.91 112.57 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 172.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.61 -30.09 64.06 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.4 139.09 23.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.977 1.711 . . . . 0.0 106.386 177.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -155.03 109.28 2.94 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--O 1.236 0.359 0 C-N-CA 124.333 1.053 . . . . 0.0 108.815 -173.268 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 . . . . . 0 C--O 1.233 0.188 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -81.24 159.96 24.4 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.46 169.25 17.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.87 155.4 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.019 1.327 . . . . 0.0 108.727 177.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -122.57 111.47 16.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 -175.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.78 134.72 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 118.81 0.732 . . . . 0.0 109.812 -171.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -79.16 147.87 32.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.182 1.393 . . . . 0.0 108.462 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 t -137.05 128.93 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -97.3 150.98 20.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.813 1.245 . . . . 0.0 109.952 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m -66.29 100.36 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.195 176.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.8 19.51 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.171 169.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 86.6 Cg_exo -46.51 140.31 12.09 Favored 'Trans proline' 0 C--N 1.362 1.277 0 CA-C-N 124.317 2.578 . . . . 0.0 113.879 173.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 42.96 25.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 114.269 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 m 50.33 33.44 7.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.979 1.312 . . . . 0.0 112.226 -174.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.884 0 C-N-CA 124.143 0.878 . . . . 0.0 112.165 -172.437 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -70.09 170.39 11.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -141.8 158.26 44.02 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.993 0.917 . . . . 0.0 110.034 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -153.07 165.69 34.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.199 1.4 . . . . 0.0 109.142 174.696 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.26 158.04 17.81 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -175.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.412 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 43.9 pt -136.62 158.61 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.006 1.323 . . . . 0.0 109.358 175.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 t -123.36 119.16 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -171.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mmt85 -138.25 145.96 41.97 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.45 133.9 1.92 Allowed Glycine 0 C--N 1.332 0.326 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.421 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.6 m-85 -155.64 156.93 35.86 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.378 0.671 . . . . 0.0 109.294 -171.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -32.75 72.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.359 0.664 . . . . 0.0 111.485 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.421 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.5 p-90 -65.98 -29.09 69.42 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 112.207 178.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 81.21 8.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.289 0.949 . . . . 0.0 108.451 171.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -62.16 -15.45 46.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 111.919 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.15 144.76 36.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.891 1.676 . . . . 0.0 108.446 176.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.538 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 7.4 m-70 -59.49 -31.66 69.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.217 1.407 . . . . 0.0 111.895 -175.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.07 69.67 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.664 177.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.1 -47.75 70.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.747 0.703 . . . . 0.0 110.393 -178.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -39.99 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.476 -1.249 . . . . 0.0 110.3 176.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.5 -47.17 86.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.566 1.53 . . . . 0.0 109.786 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.75 -48.51 78.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.604 0.638 . . . . 0.0 111.41 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -60.84 -51.18 70.4 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.62 -44.77 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.33 -173.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -60.52 -37.01 79.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.727 1.149 . . . . 0.0 109.515 176.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.67 84.83 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.877 0.762 . . . . 0.0 111.601 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.04 -47.19 81.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.564 1.182 . . . . 0.0 110.817 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mmt -56.95 -44.34 82.47 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.968 -0.457 . . . . 0.0 111.19 175.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -67.87 -33.36 74.59 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.249 -0.907 . . . . 0.0 111.768 179.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -63.05 -40.98 99.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.059 0.845 . . . . 0.0 110.018 171.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -63.03 -37.83 88.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.032 0.833 . . . . 0.0 110.098 171.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 140.39 -8.93 2.92 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.323 1.916 . . . . 0.0 113.324 169.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.7 m -68.92 175.13 3.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.455 1.502 . . . . 0.0 112.436 -170.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.51 143.24 50.75 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.7 m -144.22 169.64 17.49 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.14 137.92 15.3 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.313 1.045 . . . . 0.0 108.777 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -70.9 112.48 7.11 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 169.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.2 -25.43 63.41 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.132 -0.355 . . . . 0.0 110.335 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.89 -164.23 37.65 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.92 23.09 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.39 -157.1 19.13 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -175.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -129.28 165.73 20.85 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 117.977 0.888 . . . . 0.0 109.594 173.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.4 mt -131.3 137.18 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -169.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 N--CA 1.455 -0.216 0 C-N-CA 123.665 0.786 . . . . 0.0 109.886 -175.611 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.2 t60 . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.08 119.07 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -174.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -159.88 -177.01 6.03 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.208 -0.933 . . . . 0.0 111.144 -169.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.84 -158.49 44.78 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 177.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -143.94 151.91 40.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.603 1.561 . . . . 0.0 107.398 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.6 p -72.84 139.68 47.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.8 mmm -64.51 -6.88 8.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.76 -19.74 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.802 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.57 2.55 2.96 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 112.7 -171.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.2 -176.14 54.82 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.845 0.748 . . . . 0.0 112.332 178.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -72.0 137.04 28.46 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.725 2.283 . . . . 0.0 110.692 -179.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 174.81 10.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.388 0.613 . . . . 0.0 110.306 169.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -79.4 80.84 5.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 168.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -58.37 -16.08 13.15 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.83 88.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.461 0.704 . . . . 0.0 110.869 171.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.2 mt -60.05 -47.49 91.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 175.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -56.05 -55.72 29.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.515 1.126 . . . . 0.0 110.876 -177.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 p -65.46 -41.08 93.78 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.078 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.57 -44.39 94.21 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.744 1.156 . . . . 0.0 110.23 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -66.09 -43.3 87.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.42 -49.41 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.88 -39.12 84.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.585 1.084 . . . . 0.0 111.239 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.54 78.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.473 0.578 . . . . 0.0 111.48 177.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -76.98 -18.38 58.26 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 CA--C 1.549 0.918 0 C-N-CA 126.088 1.755 . . . . 0.0 113.288 177.125 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.5 m -138.06 171.38 15.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.519 0.728 . . . . 0.0 110.791 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.9 p -142.18 166.49 24.55 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.028 1.331 . . . . 0.0 108.636 -174.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -144.18 170.36 16.12 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.691 171.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.645 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 169.541 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 tpp . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.95 146.3 38.99 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.858 1.263 . . . . 0.0 108.226 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.8 137.08 22.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.465 0.706 . . . . 0.0 109.723 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.81 176.75 6.05 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 168.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -145.66 155.52 43.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 mt -52.21 -29.91 24.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.55 1.14 . . . . 0.0 113.469 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.71 -27.69 61.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 112.417 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.0 mt -83.25 -24.14 32.41 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 0.0 110.975 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.0 130.25 73.25 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.52 125.69 16.07 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.226 2.618 . . . . 0.0 109.78 171.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.77 -36.23 20.25 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.97 138.52 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -156.0 112.99 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.3 pt -143.28 153.38 16.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 109.136 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -72.78 170.06 15.43 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -148.32 16.58 1.04 Allowed 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.926 -1.109 . . . . 0.0 112.575 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -115.39 26.91 9.71 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -168.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.91 -121.12 1.0 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 120.878 -1.139 . . . . 0.0 112.957 170.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.65 127.51 64.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -160.96 167.94 25.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.006 1.322 . . . . 0.0 108.424 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -101.02 158.24 16.16 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.605 -0.684 . . . . 0.0 109.717 -173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.96 168.6 19.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.88 0.872 . . . . 0.0 109.446 -171.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.5 155.01 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.32 1.448 . . . . 0.0 108.335 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 tp -118.27 114.64 23.29 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 130.9 72.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -77.5 146.11 36.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.31 127.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -98.57 149.75 22.43 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 109.222 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -65.88 98.3 0.4 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.989 0.916 . . . . 0.0 110.75 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.496 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -148.52 18.02 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.281 -1.819 . . . . 0.0 115.123 169.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 55.8 Cg_exo -41.21 134.57 2.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 123.978 2.456 . . . . 0.0 114.5 171.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 47.23 21.54 0.2 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.021 2.528 . . . . 0.0 113.448 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.86 33.45 8.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.28 1.432 . . . . 0.0 112.659 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.65 10.08 2.13 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 113.82 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.33 149.74 75.36 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 118.509 1.155 . . . . 0.0 111.007 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.95 -4.44 13.33 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.373 2.715 . . . . 0.0 114.847 -169.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.18 -176.64 5.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.285 1.034 . . . . 0.0 110.314 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.1 38.74 3.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.915 1.686 . . . . 0.0 109.815 174.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.59 167.64 12.61 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -141.19 158.87 43.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.848 0.859 . . . . 0.0 110.412 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -151.52 166.08 32.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.845 1.658 . . . . 0.0 108.928 174.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -108.94 153.69 23.2 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.477 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 45.0 pt -129.82 155.28 41.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.854 1.262 . . . . 0.0 109.265 173.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.36 123.52 71.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -171.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.605 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.8 mmp_? -136.03 146.58 47.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.625 1.17 . . . . 0.0 108.478 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.13 129.84 1.44 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -150.78 151.92 33.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -60.19 -29.75 68.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.804 0.842 . . . . 0.0 112.479 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 -68.19 -28.03 66.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.33 0.968 . . . . 0.0 112.578 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.62 82.63 8.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.739 1.154 . . . . 0.0 108.913 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.12 -3.94 8.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.321 0.648 . . . . 0.0 112.355 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.33 142.95 26.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.818 1.647 . . . . 0.0 107.982 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.437 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 18.9 m-70 -60.92 -30.74 70.38 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 111.856 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.29 70.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.813 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.66 0.664 . . . . 0.0 110.431 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -41.57 86.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.216 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.93 -46.99 86.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.123 1.329 . . . . 0.0 110.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.88 -49.6 69.87 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.234 0.47 . . . . 0.0 111.331 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -58.84 -49.85 76.19 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.419 0.687 . . . . 0.0 110.839 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.605 HG21 ' HG3' ' A' ' 45' ' ' ARG . 85.1 t -73.47 -41.3 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.155 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m -62.36 -29.8 70.73 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 119.638 1.108 . . . . 0.0 110.895 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.6 -50.03 70.51 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -62.72 -47.77 82.15 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.194 0.997 . . . . 0.0 110.854 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.81 -43.99 90.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.965 -0.459 . . . . 0.0 111.302 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -68.78 -31.62 70.77 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.993 -1.067 . . . . 0.0 111.911 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -61.36 -43.69 98.44 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.421 1.01 . . . . 0.0 109.552 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -60.13 -43.04 95.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.513 1.052 . . . . 0.0 109.546 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.75 -7.17 1.69 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.333 1.92 . . . . 0.0 113.265 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.36 176.58 2.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.204 1.802 . . . . 0.0 113.216 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -130.03 140.51 50.85 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.4 m -146.45 163.34 35.98 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -153.58 128.71 9.69 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.277 1.031 . . . . 0.0 108.429 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -66.75 116.71 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.4 -28.89 65.43 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.792 -0.568 . . . . 0.0 110.078 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.87 -169.37 42.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.1 -168.34 20.27 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.99 -161.22 26.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -121.37 153.53 37.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.445 1.098 . . . . 0.0 108.232 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 mt -125.28 135.04 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m -143.47 113.96 7.48 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.526 0.73 . . . . 0.0 109.951 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.33 133.13 35.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 168.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -118.17 133.36 55.97 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 m -59.56 -28.99 67.62 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -21.78 62.98 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.153 0.888 . . . . 0.0 113.389 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -153.54 140.89 19.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.918 1.235 . . . . 0.0 108.483 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -34.47 4.04 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.695 1.598 . . . . 0.0 112.978 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -46.16 140.11 4.15 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.119 2.168 . . . . 0.0 112.24 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.482 ' HB ' HG12 ' A' ' 118' ' ' VAL . 1.9 mt -97.28 158.36 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -130.63 150.43 51.82 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.31 -0.869 . . . . 0.0 108.93 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -128.11 122.42 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -173.04 3.96 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.41 -0.806 . . . . 0.0 111.21 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -160.15 53.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.02 153.77 35.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.45 1.1 . . . . 0.0 108.903 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.5 t -69.45 128.33 36.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.8 ttp -64.91 -17.24 64.16 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.355 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.69 -29.66 10.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.715 0.806 . . . . 0.0 112.638 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -127.4 0.08 6.3 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.75 -178.28 50.83 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.853 0.752 . . . . 0.0 112.144 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.1 131.04 19.96 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.635 2.223 . . . . 0.0 110.401 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.5 167.64 20.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.355 0.598 . . . . 0.0 109.557 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.14 77.7 5.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -57.76 -18.87 24.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.11 66.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.705 0.802 . . . . 0.0 111.21 169.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.44 -49.25 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -55.5 -48.32 74.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.001 0.521 . . . . 0.0 111.124 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.9 p -61.78 -44.83 96.11 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.476 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.43 -46.55 89.62 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.277 0.944 . . . . 0.0 110.571 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -62.27 -54.95 33.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.329 1.452 . . . . 0.0 110.684 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.735 0.814 . . . . 0.0 109.186 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -59.73 -40.2 87.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.287 0.949 . . . . 0.0 110.833 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.48 91.14 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.306 0.503 . . . . 0.0 111.201 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -81.71 -14.58 56.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 51.08 50.98 9.65 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.848 1.259 . . . . 0.0 113.228 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.75 -17.22 26.08 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.33 1.353 . . . . 0.0 112.101 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -143.74 -75.61 0.25 Allowed 'General case' 0 C--N 1.343 0.321 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.479 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.7 -74.08 0.09 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.75 1.159 . . . . 0.0 110.755 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -154.48 156.33 36.51 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 88' ' ' ILE . 29.9 m -141.47 164.7 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.107 0.563 . . . . 0.0 111.184 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.9 p -137.69 172.67 12.61 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 108.758 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -142.73 169.55 17.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.768 0.427 . . . . 0.0 110.417 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.18 143.1 29.05 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.87 41.22 0.9 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.198 0.999 . . . . 0.0 110.33 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -155.37 -172.91 4.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.898 1.679 . . . . 0.0 108.048 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.26 -162.88 37.07 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.233 0.92 . . . . 0.0 111.26 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 C--O 1.246 0.897 0 C-N-CA 125.937 1.695 . . . . 0.0 107.305 178.263 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 tpp . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.27 162.14 39.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.479 1.512 . . . . 0.0 108.212 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.63 137.97 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.32 178.21 5.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.57 0.748 . . . . 0.0 109.487 170.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -152.31 153.69 34.19 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.058 -1.027 . . . . 0.0 109.559 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.1 mt -55.51 -27.73 50.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.254 1.422 . . . . 0.0 113.524 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.0 -23.19 61.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.777 0.717 . . . . 0.0 112.564 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.52 -21.19 53.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.515 0.598 . . . . 0.0 111.315 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.07 134.97 96.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.278 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.74 106.95 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.27 2.647 . . . . 0.0 108.717 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.42 -33.51 73.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.9 t -142.6 138.2 28.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -150.64 103.35 3.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 pt -144.16 166.39 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.601 2.36 . . . . 0.0 106.641 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -149.35 133.58 17.34 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -74.27 40.26 0.13 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.97 2.108 . . . . 0.0 113.623 -169.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.27 -30.43 69.45 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.926 1.291 . . . . 0.0 112.834 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.73 -155.32 25.22 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.8 t -71.72 135.68 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -159.41 168.04 27.27 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.53 1.132 . . . . 0.0 109.09 171.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.05 155.09 17.29 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.931 0.492 . . . . 0.0 109.784 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.63 19.33 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.72 0.808 . . . . 0.0 108.966 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.86 153.59 17.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.767 1.227 . . . . 0.0 108.315 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.08 118.04 32.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.284 0.0 OUTLIER -130.02 130.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 118.373 0.533 . . . . 0.0 109.597 -172.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -80.63 147.33 30.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.792 1.637 . . . . 0.0 108.438 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.91 129.75 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -93.85 155.51 17.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.351 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 m -66.52 85.05 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.267 1.027 . . . . 0.0 111.555 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.512 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.19 13.14 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 116.23 -1.843 . . . . 0.0 114.041 169.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 52.0 Cg_exo -47.13 136.22 18.38 Favored 'Trans proline' 0 C--N 1.362 1.284 0 CA-C-N 124.02 2.472 . . . . 0.0 112.454 170.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 41.2 31.76 0.16 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.898 2.479 . . . . 0.0 113.847 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 32.0 12.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.897 1.679 . . . . 0.0 113.806 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.27 21.41 0.56 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.586 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.57 148.13 81.86 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 118.053 0.926 . . . . 0.0 110.598 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.85 -1.67 11.6 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.455 2.77 . . . . 0.0 114.359 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.73 -173.45 4.48 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.758 1.223 . . . . 0.0 109.979 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.94 37.83 3.57 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.591 1.556 . . . . 0.0 110.129 174.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -69.41 167.89 15.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -142.8 159.34 42.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.722 0.809 . . . . 0.0 109.652 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -149.22 164.43 34.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 109.195 174.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 150.37 27.63 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.432 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 37.6 pt -127.68 155.55 39.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.486 1.115 . . . . 0.0 108.872 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 t -122.34 116.46 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -169.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -136.51 147.27 47.01 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.98 138.31 3.71 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -154.16 155.92 36.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -173.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.75 -33.03 72.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.779 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -65.87 -27.04 67.92 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.756 0.707 . . . . 0.0 112.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.51 78.92 9.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.593 1.088 . . . . 0.0 109.117 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.96 -6.9 9.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.697 0.799 . . . . 0.0 112.102 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 142.53 29.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.981 1.713 . . . . 0.0 107.604 174.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.506 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 13.7 m-70 -62.15 -29.66 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.637 1.175 . . . . 0.0 111.663 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -29.18 68.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.034 -0.507 . . . . 0.0 111.757 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.26 -44.67 78.79 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.807 0.73 . . . . 0.0 110.725 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.415 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -70.53 -41.44 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.458 177.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.22 -45.12 94.3 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.54 1.064 . . . . 0.0 109.044 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.03 -48.11 80.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.163 0.892 . . . . 0.0 111.748 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -55.08 -56.78 15.94 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.974 0.909 . . . . 0.0 109.945 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.46 -43.62 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.599 -169.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 t -60.5 -35.58 76.28 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.075 1.307 . . . . 0.0 109.748 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.84 -48.16 86.78 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.165 0.893 . . . . 0.0 111.324 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.12 -46.66 83.15 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.143 0.972 . . . . 0.0 111.131 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.1 mmt -58.91 -43.77 91.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.694 0.679 . . . . 0.0 110.831 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -66.52 -33.37 75.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.859 -1.15 . . . . 0.0 111.27 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.94 -40.09 95.65 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.971 . . . . 0.0 110.389 169.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -64.59 -20.23 66.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.054 0.843 . . . . 0.0 111.49 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.47 -8.43 11.1 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.581 2.038 . . . . 0.0 112.723 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.24 178.55 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.826 1.65 . . . . 0.0 114.048 -169.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -132.31 145.1 51.03 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -147.57 165.57 29.98 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -168.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -150.51 130.95 13.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.658 1.183 . . . . 0.0 109.382 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -71.88 116.27 12.07 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -74.64 -24.96 58.91 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.97 -0.456 . . . . 0.0 110.418 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.49 -168.32 40.48 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.62 -167.87 22.69 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.31 -163.37 29.65 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.9 ttp-105 -119.49 154.43 33.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mt -113.19 126.98 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -150.06 152.47 34.87 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.837 0.855 . . . . 0.0 108.896 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.53 163.22 21.61 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.605 0.762 . . . . 0.0 110.647 171.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -130.65 151.73 50.79 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.242 1.017 . . . . 0.0 109.517 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -63.31 -16.82 61.51 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -170.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -60.34 -47.11 87.43 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.125 0.875 . . . . 0.0 111.14 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -162.53 21.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.084 0.954 . . . . 0.0 111.248 -173.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.8 mttp 56.62 18.36 3.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.57 1.548 . . . . 0.0 112.902 -169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -58.97 126.62 28.45 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.1 pt -63.5 150.06 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.88 0.848 . . . . 0.0 110.285 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -143.65 143.7 31.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.295 1.838 . . . . 0.0 106.702 -169.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 t -117.03 114.09 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.8 -173.23 4.0 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.637 -0.664 . . . . 0.0 111.945 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.7 -156.56 46.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -145.83 152.72 39.96 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.023 0.929 . . . . 0.0 109.084 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.2 t -69.32 130.46 42.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -64.81 -8.34 14.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.24 -27.71 6.37 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.153 0.981 . . . . 0.0 112.574 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -132.8 2.39 3.7 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.94 -177.27 48.17 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 119.246 0.93 . . . . 0.0 112.554 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 128.68 15.56 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.815 2.343 . . . . 0.0 110.902 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.87 167.24 22.25 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.499 0.666 . . . . 0.0 110.199 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -79.99 83.46 5.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 168.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -59.17 -14.82 11.75 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.37 84.47 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.154 0.982 . . . . 0.0 110.87 169.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.9 mm -62.19 -51.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -56.38 -51.18 69.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.801 0.84 . . . . 0.0 110.976 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 p -63.17 -42.78 99.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.337 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.67 -47.81 82.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.938 1.244 . . . . 0.0 110.74 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.259 0.481 . . . . 0.0 110.827 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.84 -51.17 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.18 -36.34 77.4 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.983 1.265 . . . . 0.0 110.846 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.36 68.33 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.406 0.548 . . . . 0.0 111.552 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -74.94 -19.32 60.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 t80 52.35 49.78 7.19 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.558 1.943 . . . . 0.0 113.639 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.93 -16.16 29.31 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.374 2.049 . . . . 0.0 111.36 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -145.5 169.82 17.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.398 2.279 . . . . 0.0 106.407 173.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -67.76 -38.64 83.72 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.863 0.865 . . . . 0.0 111.779 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -162.58 166.49 24.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 108.409 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.05 167.78 9.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.895 2.078 . . . . 0.0 107.862 173.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -142.45 170.11 16.31 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.657 1.583 . . . . 0.0 107.048 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -142.27 169.79 16.93 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.216 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.69 143.85 27.91 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -82.11 25.31 0.59 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.833 1.253 . . . . 0.0 111.852 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -154.18 -179.05 7.54 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.583 1.553 . . . . 0.0 107.725 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.7 175.52 15.95 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.631 1.586 . . . . 0.0 110.779 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 88.8 t80 . . . . . 0 C--O 1.246 0.916 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 175.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttm . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.1 158.27 7.09 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.43 0.692 . . . . 0.0 111.426 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 m -65.23 159.55 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.789 0.835 . . . . 0.0 110.656 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.62 171.4 4.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -147.96 156.52 42.76 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.097 0.959 . . . . 0.0 108.452 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.03 -28.24 64.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.622 0.769 . . . . 0.0 112.879 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.89 61.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.282 0.946 . . . . 0.0 112.363 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.13 -28.57 18.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.47 1.108 . . . . 0.0 110.957 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -55.91 129.09 71.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -50.44 133.24 36.93 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.273 2.649 . . . . 0.0 110.22 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.12 -42.35 9.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 137.09 43.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -156.42 118.18 3.9 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 169.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.9 pt -139.48 157.98 27.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.114 0.966 . . . . 0.0 109.131 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.02 90.07 3.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.696 1.599 . . . . 0.0 107.346 -176.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 m -72.31 54.18 0.3 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.834 2.453 . . . . 0.0 113.026 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -55.09 -45.84 75.44 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.759 1.223 . . . . 0.0 112.869 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.39 -39.34 0.86 Allowed Glycine 0 CA--C 1.524 0.624 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.466 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.2 t -149.08 120.15 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -160.32 164.95 32.13 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.438 1.095 . . . . 0.0 109.55 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -97.62 160.55 14.25 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.412 -0.805 . . . . 0.0 109.92 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 167.8 21.45 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.13 0.972 . . . . 0.0 108.791 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.12 155.17 15.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.351 1.06 . . . . 0.0 108.767 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -118.36 114.52 23.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -120.58 131.38 72.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.782 0.719 . . . . 0.0 109.231 -175.113 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -76.78 145.08 38.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.44 117.94 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.9 146.09 26.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.8 p -68.45 103.33 1.63 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.297 0.498 . . . . 0.0 109.853 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.455 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.66 25.02 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.655 -1.641 . . . . 0.0 114.753 169.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 49.9 Cg_exo -42.65 135.69 4.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 CA-C-N 123.827 2.402 . . . . 0.0 114.637 172.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 43.05 25.87 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.587 2.355 . . . . 0.0 114.518 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 51.47 33.35 10.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.814 1.245 . . . . 0.0 112.267 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.95 27.29 1.6 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.339 0.971 . . . . 0.0 112.34 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.59 87.67 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 117.638 0.719 . . . . 0.0 110.595 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.25 -10.34 19.2 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.072 2.515 . . . . 0.0 113.86 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.97 179.52 8.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.896 1.279 . . . . 0.0 109.88 -172.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.07 48.74 2.31 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.892 1.677 . . . . 0.0 109.156 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.01 178.08 6.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.843 0.857 . . . . 0.0 109.341 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -141.17 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.532 0.733 . . . . 0.0 110.725 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.07 162.62 32.85 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.84 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.12 136.26 49.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 pt -116.79 155.03 18.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.704 0.802 . . . . 0.0 109.627 172.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.8 123.85 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.0 mmt85 -137.57 148.46 45.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.294 1.038 . . . . 0.0 108.502 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.76 133.15 1.93 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -150.3 156.5 41.65 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -60.1 -35.38 75.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 119.177 -0.439 . . . . 0.0 111.497 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -65.4 -26.38 67.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.4 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.59 80.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.626 1.103 . . . . 0.0 108.428 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.7 -13.32 21.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.777 0.831 . . . . 0.0 111.777 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.24 143.51 31.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.417 1.887 . . . . 0.0 107.683 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -58.48 -30.0 66.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.962 1.305 . . . . 0.0 112.926 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.68 -27.96 69.57 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.593 . . . . 0.0 111.476 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.53 -46.74 78.42 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.313 0.506 . . . . 0.0 110.63 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -40.83 80.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.473 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -59.66 -47.62 84.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.791 1.632 . . . . 0.0 109.741 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.82 -47.65 82.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.794 0.724 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -61.24 -50.07 74.56 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.151 0.58 . . . . 0.0 110.845 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 45' ' ' ARG . 66.9 t -74.53 -44.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.452 -170.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.1 p -62.11 -30.94 71.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.923 1.238 . . . . 0.0 110.341 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.49 -52.23 54.35 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.96 -42.3 85.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.681 1.241 . . . . 0.0 111.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.22 -43.33 82.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.406 1.003 . . . . 0.0 111.095 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -68.9 -29.89 68.27 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.966 -1.084 . . . . 0.0 112.285 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -62.36 -42.32 99.3 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.358 0.981 . . . . 0.0 109.071 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.09 -38.08 89.57 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.349 0.522 . . . . 0.0 110.314 172.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.65 -8.91 3.12 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.18 1.848 . . . . 0.0 113.459 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.9 m -66.69 171.28 5.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.678 1.591 . . . . 0.0 112.256 -169.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.35 136.6 54.22 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 169.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 54.2 m -142.27 165.36 27.64 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.2 131.71 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 p -68.32 109.56 3.68 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.6 mt -64.97 -28.17 69.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.722 0.409 . . . . 0.0 110.082 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.69 -167.55 40.7 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.76 -164.01 20.37 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.1 -159.65 23.64 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -125.5 154.13 42.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mt -129.83 139.49 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.1 m -151.84 163.85 38.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -60.15 151.44 26.95 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 169.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -61.84 157.14 18.9 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 169.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.4 m -69.19 17.42 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.349 1.46 . . . . 0.0 113.648 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.66 -18.69 0.27 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.214 1.406 . . . . 0.0 113.037 -172.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -161.49 154.76 21.21 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.655 1.116 . . . . 0.0 109.259 -171.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.95 -20.34 63.71 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.008 -0.996 . . . . 0.0 113.419 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -44.17 122.5 2.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.098 1.359 . . . . 0.0 109.087 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -83.22 160.59 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 122.003 0.906 . . . . 0.0 111.479 -176.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -141.44 140.64 33.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.921 2.088 . . . . 0.0 106.885 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.12 129.65 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -159.77 -174.69 4.73 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.349 -0.844 . . . . 0.0 110.903 -170.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.81 -161.42 53.43 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.942 -0.474 . . . . 0.0 112.3 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -151.31 152.26 32.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 109.643 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 m -79.6 130.9 35.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 tpt -60.63 -35.26 75.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.903 0.481 . . . . 0.0 111.258 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.08 -16.89 24.46 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.73 -5.9 5.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -169.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.72 178.08 42.94 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.823 0.725 . . . . 0.0 112.098 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.55 135.38 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.671 2.248 . . . . 0.0 109.814 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.13 169.91 16.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 110.152 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -79.68 82.78 5.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -58.45 -18.28 27.34 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.66 -38.4 72.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.502 1.121 . . . . 0.0 111.846 169.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 14.6 mm -62.8 -49.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.9 m -56.58 -52.49 64.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.772 0.829 . . . . 0.0 111.325 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -62.08 -43.61 98.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.995 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.23 -47.93 83.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.499 1.045 . . . . 0.0 110.761 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -64.36 -47.11 80.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.303 0.501 . . . . 0.0 110.986 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -48.3 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -61.92 -38.81 89.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.34 1.427 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.29 97.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.552 0.615 . . . . 0.0 111.922 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -87.95 -12.95 43.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.632 0.651 . . . . 0.0 112.682 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.301 40.5 p90 42.67 54.33 9.56 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 128.56 2.744 . . . . 0.0 116.422 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -56.34 -29.49 77.08 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.993 1.795 . . . . 0.0 110.89 168.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -138.68 161.22 37.7 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.11 2.564 . . . . 0.0 105.542 169.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -61.21 -33.26 73.19 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -158.49 161.38 37.38 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.828 1.251 . . . . 0.0 107.945 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 m -144.74 170.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.75 1.62 . . . . 0.0 108.143 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -141.39 171.59 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.253 1.421 . . . . 0.0 108.481 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -145.93 164.23 32.66 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.756 0.707 . . . . 0.0 111.735 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.39 25.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -81.98 42.14 0.7 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.984 1.314 . . . . 0.0 111.037 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -143.05 -160.78 1.15 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.951 1.7 . . . . 0.0 108.047 -170.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.27 -23.92 3.16 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 120.64 -1.287 . . . . 0.0 114.166 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 . . . . . 0 C--O 1.25 1.085 0 C-N-CA 128.763 2.825 . . . . 0.0 113.178 169.722 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 119.414 -0.326 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.91 166.5 30.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.111 1.364 . . . . 0.0 108.897 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.6 167.02 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.995 1.318 . . . . 0.0 107.709 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.82 174.54 10.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.722 1.609 . . . . 0.0 107.672 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -153.58 160.51 42.47 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.349 1.06 . . . . 0.0 108.84 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.8 mt -49.35 -34.25 15.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.181 1.392 . . . . 0.0 112.725 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.13 -24.51 67.19 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.4 mt -79.45 -19.95 48.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.097 0.559 . . . . 0.0 111.517 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mt -70.19 133.43 87.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.79 140.71 68.57 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.41 2.073 . . . . 0.0 108.973 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -86.33 -38.84 17.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.69 140.58 27.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -157.49 117.25 3.38 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 pt -139.02 175.03 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.332 1.053 . . . . 0.0 109.918 -171.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -123.95 53.03 1.41 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.039 1.336 . . . . 0.0 111.745 -168.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -53.99 3.18 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.355 3.062 . . . . 0.0 117.474 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -68.04 -19.69 64.91 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.964 1.305 . . . . 0.0 113.035 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.73 -158.41 11.22 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.795 0.712 . . . . 0.0 111.588 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.9 t -85.45 131.88 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -156.54 167.6 29.94 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.965 1.306 . . . . 0.0 109.014 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.24 154.94 18.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.239 0.616 . . . . 0.0 109.778 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 169.79 16.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.488 0.715 . . . . 0.0 109.551 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.46 153.68 16.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.291 1.436 . . . . 0.0 108.319 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.7 tp -117.1 114.86 24.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.31 132.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.57 147.45 33.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.599 1.16 . . . . 0.0 107.895 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.22 125.85 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -97.11 146.23 25.23 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.679 1.192 . . . . 0.0 108.941 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 m -63.84 100.96 0.33 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.262 0.483 . . . . 0.0 111.025 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.592 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -147.85 9.76 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 116.094 -1.908 . . . . 0.0 114.602 169.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 88.4 Cg_exo -44.7 140.33 6.63 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 124.14 2.514 . . . . 0.0 114.58 174.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? 43.66 24.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.75 2.42 . . . . 0.0 114.117 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.17 30.26 4.17 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.158 1.383 . . . . 0.0 112.327 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.73 5.47 0.42 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.974 -170.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.98 147.82 11.93 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 118.71 1.255 . . . . 0.0 110.548 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.37 -2.21 11.77 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.669 2.913 . . . . 0.0 116.422 -169.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 -173.8 4.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.907 1.231 . . . . 0.0 111.08 -170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.72 48.89 2.18 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.613 1.965 . . . . 0.0 108.518 170.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -77.25 -174.19 3.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.3 m -150.8 160.52 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.778 -1.201 . . . . 0.0 109.974 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 165.11 33.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.643 1.577 . . . . 0.0 108.636 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.25 154.95 21.05 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 pt -134.39 155.44 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.9 1.28 . . . . 0.0 109.042 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -118.38 120.79 65.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -135.26 148.69 49.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.26 140.9 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 39.2 m-85 -151.99 152.82 32.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -60.05 -32.31 70.81 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.828 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.403 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.2 p-90 -65.84 -27.78 68.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.683 0.674 . . . . 0.0 112.41 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 78.07 9.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.565 1.075 . . . . 0.0 108.816 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.5 -5.59 8.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.414 0.686 . . . . 0.0 112.08 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.2 140.09 27.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.086 1.754 . . . . 0.0 107.472 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.526 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.7 m-70 -61.98 -31.12 71.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.596 1.158 . . . . 0.0 111.703 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 -29.39 67.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.728 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.86 -48.02 72.98 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.735 0.698 . . . . 0.0 110.466 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -40.6 82.33 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 117.473 -1.251 . . . . 0.0 110.013 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.1 -46.93 84.71 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.574 1.534 . . . . 0.0 110.137 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.45 -49.51 68.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.254 0.479 . . . . 0.0 111.45 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -60.83 -49.52 77.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.2 0.6 . . . . 0.0 110.955 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.73 -44.51 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.952 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -62.7 -28.29 69.84 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.637 1.108 . . . . 0.0 111.195 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.6 56.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.34 -45.78 86.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.194 0.997 . . . . 0.0 110.96 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.5 mmt -57.78 -45.09 86.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.702 0.683 . . . . 0.0 111.14 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.32 -32.12 72.87 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.946 -1.096 . . . . 0.0 111.814 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -63.72 -37.71 88.39 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.266 0.939 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -66.94 -34.86 78.69 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.216 0.916 . . . . 0.0 110.235 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.6 -6.46 3.86 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.548 2.023 . . . . 0.0 113.106 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.06 178.45 1.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.922 1.689 . . . . 0.0 113.001 -169.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -132.34 142.11 49.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.6 m -145.86 164.27 32.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.87 128.55 10.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 p -71.69 112.27 7.66 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 110.372 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.0 -166.85 39.73 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -163.82 -169.14 26.9 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.46 -160.86 24.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.17 156.82 32.89 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mt -126.36 146.93 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.6 m -149.91 165.79 31.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.608 1.563 . . . . 0.0 108.405 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -130.97 150.26 52.2 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.375 1.47 . . . . 0.0 108.634 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -141.19 147.52 38.49 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.685 1.194 . . . . 0.0 108.688 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 p -115.42 3.05 14.05 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.878 1.271 . . . . 0.0 112.321 -172.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -65.8 -33.7 76.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.327 0.651 . . . . 0.0 109.976 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -143.09 27.14 1.62 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.135 1.374 . . . . 0.0 110.876 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt 38.09 77.48 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.555 2.342 . . . . 0.0 112.86 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -136.88 154.32 50.52 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.559 0.695 . . . . 0.0 111.044 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mm -104.74 153.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -134.28 139.28 45.6 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.01 122.69 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -159.96 -176.36 5.64 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.61 -0.681 . . . . 0.0 111.488 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.66 -160.29 51.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -145.34 151.28 38.05 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.857 1.263 . . . . 0.0 108.057 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.1 p -69.85 147.88 49.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.027 0.441 . . . . 0.0 110.526 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.0 ttp -58.33 -22.47 53.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.478 1.111 . . . . 0.0 112.959 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.66 -14.89 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.0 4.78 3.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.214 1.37 . . . . 0.0 112.794 -170.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.69 -175.4 51.79 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 118.518 0.599 . . . . 0.0 112.251 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 136.73 28.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.73 2.287 . . . . 0.0 110.538 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.1 171.51 14.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.572 0.701 . . . . 0.0 110.27 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -77.74 74.67 4.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -58.31 -17.89 23.14 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.29 70.6 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.373 0.669 . . . . 0.0 111.479 169.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.6 -45.38 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.776 0.83 . . . . 0.0 108.794 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -59.39 -49.12 79.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.723 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 p -57.97 -46.16 85.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.718 0.69 . . . . 0.0 111.47 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -61.0 -48.83 79.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.087 0.858 . . . . 0.0 110.472 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -72.71 -42.96 63.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.942 -0.474 . . . . 0.0 111.534 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.452 HG23 ' CG ' ' A' ' 114' ' ' PRO . 87.3 mt -64.23 -42.32 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.82 -40.24 91.99 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.896 1.68 . . . . 0.0 111.058 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.4 -42.28 98.78 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.447 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.81 -28.18 64.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.226 1.011 . . . . 0.0 112.104 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 46.25 56.39 16.25 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.173 1.389 . . . . 0.0 113.263 -169.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.452 ' CG ' HG23 ' A' ' 109' ' ' ILE . 67.1 Cg_endo -71.92 -17.63 28.61 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.462 2.108 . . . . 0.0 110.04 169.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.76 -177.63 5.82 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 128.279 2.632 . . . . 0.0 106.375 169.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -71.16 -45.17 64.05 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.039 0.836 . . . . 0.0 112.82 -169.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -156.48 170.87 21.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.042 0.837 . . . . 0.0 109.314 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.41 ' CG2' HG22 ' A' ' 109' ' ' ILE . 2.5 t -141.35 154.48 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.485 . . . . 0.0 107.873 -169.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -139.62 169.57 17.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 108.383 172.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -144.55 170.15 16.61 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.777 -0.577 . . . . 0.0 111.135 172.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.35 143.35 30.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.74 25.58 1.25 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.023 0.929 . . . . 0.0 111.459 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -155.34 178.18 10.51 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.693 1.597 . . . . 0.0 107.934 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.63 173.2 15.75 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.066 1.793 . . . . 0.0 110.761 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 82.0 t80 . . . . . 0 C--O 1.246 0.92 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.355 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.39 164.12 36.66 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.038 1.335 . . . . 0.0 108.831 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.1 t -137.75 157.6 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.73 174.84 10.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.885 1.674 . . . . 0.0 107.474 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.48 155.26 38.18 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.876 0.871 . . . . 0.0 109.098 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.3 mt -50.93 -34.15 27.34 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.77 1.228 . . . . 0.0 112.859 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.52 -23.29 66.84 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.66 0.664 . . . . 0.0 112.579 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.0 mt -77.01 -19.93 56.63 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.115 0.566 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -69.61 129.72 91.15 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.13 2.553 . . . . 0.0 109.634 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -95.45 -40.24 9.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -169.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.73 134.32 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -157.48 119.2 3.7 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.7 pt -140.76 158.4 23.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.217 1.007 . . . . 0.0 109.407 -172.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -65.1 172.96 2.65 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.829 1.252 . . . . 0.0 112.632 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -135.86 -1.23 2.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.225 1.81 . . . . 0.0 111.765 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -59.12 -42.67 91.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.336 0.971 . . . . 0.0 112.754 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.61 -58.25 0.34 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.29 133.34 39.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -161.76 173.01 15.23 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.798 1.239 . . . . 0.0 109.399 -173.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -107.88 156.52 19.09 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.73 170.61 15.53 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.47 0.708 . . . . 0.0 109.668 -172.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.83 153.51 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.541 1.536 . . . . 0.0 108.663 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.23 116.1 27.18 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 135.02 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 119.08 0.854 . . . . 0.0 109.411 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -82.18 149.29 28.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.751 1.22 . . . . 0.0 108.186 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.79 141.23 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -114.61 154.0 29.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.872 1.269 . . . . 0.0 109.59 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m -68.69 80.14 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.729 1.211 . . . . 0.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.422 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -134.84 11.1 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 116.028 -1.939 . . . . 0.0 115.179 169.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 77.9 Cg_exo -44.18 137.39 7.52 Favored 'Trans proline' 0 C--N 1.362 1.255 0 CA-C-N 124.248 2.553 . . . . 0.0 113.668 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 45.92 22.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.711 2.404 . . . . 0.0 114.205 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 49.89 30.71 4.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.962 1.305 . . . . 0.0 112.051 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.78 -7.75 0.23 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.756 -170.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.11 142.81 56.35 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 119.004 1.402 . . . . 0.0 110.314 170.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.17 164.55 35.37 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.692 2.261 . . . . 0.0 111.437 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 57.16 -167.96 0.12 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.835 2.054 . . . . 0.0 113.669 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.01 38.3 2.35 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.35 1.86 . . . . 0.0 108.995 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.01 166.24 16.26 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -139.23 158.29 44.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.972 0.909 . . . . 0.0 109.928 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.94 164.14 37.06 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.028 1.331 . . . . 0.0 109.047 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.32 154.94 21.09 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.52 155.42 38.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.264 1.426 . . . . 0.0 108.858 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.6 123.38 70.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -135.2 148.72 49.74 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.035 0.934 . . . . 0.0 108.619 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.47 136.86 3.82 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 171.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -150.46 151.05 32.14 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.14 -39.34 82.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.672 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -60.22 -30.25 69.27 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.106 0.866 . . . . 0.0 112.63 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.28 75.42 9.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.176 0.898 . . . . 0.0 108.767 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.59 -8.16 9.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.19 0.596 . . . . 0.0 112.081 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.66 138.43 36.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.59 1.956 . . . . 0.0 107.253 175.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.506 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 9.0 m-70 -60.66 -29.93 69.59 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.674 1.19 . . . . 0.0 112.027 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.76 69.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.439 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.63 -46.12 76.86 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.511 0.596 . . . . 0.0 110.919 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -42.01 83.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 117.288 -1.339 . . . . 0.0 110.243 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.97 -46.18 90.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 120.635 1.561 . . . . 0.0 109.901 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.36 -48.79 78.2 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.805 0.73 . . . . 0.0 111.365 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -62.17 -49.65 74.97 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.131 0.572 . . . . 0.0 111.045 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.48 -45.34 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.515 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -60.58 -36.1 77.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.678 1.126 . . . . 0.0 109.463 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.13 -50.36 66.91 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 118.899 0.772 . . . . 0.0 111.503 172.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.37 -46.93 84.24 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.544 1.172 . . . . 0.0 111.07 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.7 mmt -57.96 -45.93 85.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.774 0.715 . . . . 0.0 110.985 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -65.6 -32.59 74.25 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.027 -1.045 . . . . 0.0 111.459 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -63.42 -42.92 98.74 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 109.701 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -60.37 -40.16 89.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.295 0.952 . . . . 0.0 109.504 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.66 -7.08 1.94 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.415 1.959 . . . . 0.0 113.09 169.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.74 179.17 1.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.14 1.776 . . . . 0.0 113.672 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -131.86 144.74 51.1 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m -148.05 169.33 20.19 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.817 0.735 . . . . 0.0 112.641 -168.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.52 138.96 15.84 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.267 1.027 . . . . 0.0 109.012 169.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -70.96 118.1 13.3 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.9 -26.01 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.99 -0.444 . . . . 0.0 110.284 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.0 -166.95 38.45 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -160.6 -168.02 21.93 Favored Glycine 0 C--O 1.235 0.211 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.56 -155.37 15.57 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.81 153.01 52.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.844 1.258 . . . . 0.0 108.073 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.0 mt -136.07 141.49 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.7 m -145.01 154.42 42.51 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.284 1.034 . . . . 0.0 111.238 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.75 152.6 9.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.047 2.539 . . . . 0.0 106.16 168.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -146.61 169.89 18.04 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.43 0.692 . . . . 0.0 109.531 -172.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.7 m -59.05 -29.52 67.36 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.747 -0.595 . . . . 0.0 111.412 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -63.27 -38.53 91.52 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.25 1.02 . . . . 0.0 111.116 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -158.96 110.7 2.14 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.498 1.119 . . . . 0.0 108.982 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -78.08 -15.69 58.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.948 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 127.62 33.0 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 72.1 mt -66.6 159.85 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -141.28 149.8 41.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.05 133.15 64.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -159.55 -175.05 4.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.14 -0.975 . . . . 0.0 110.249 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.87 -161.68 54.3 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 121.668 0.593 . . . . 0.0 112.32 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -150.83 153.15 34.86 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.605 1.562 . . . . 0.0 107.785 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 t -67.57 133.17 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.3 ttp -54.72 -27.01 37.65 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.696 1.198 . . . . 0.0 111.841 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.87 -24.7 8.53 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.665 0.786 . . . . 0.0 112.896 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.11 4.39 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.68 -175.75 40.39 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 118.957 0.799 . . . . 0.0 112.555 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.42 132.88 24.83 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.432 2.088 . . . . 0.0 110.33 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.22 173.6 8.39 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.478 0.656 . . . . 0.0 110.87 169.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -76.97 73.06 3.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.41 -19.08 21.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.32 65.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.454 0.701 . . . . 0.0 111.011 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -61.14 -50.39 80.71 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.2 m -56.01 -48.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.595 0.758 . . . . 0.0 110.776 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 p -59.19 -47.36 85.61 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.082 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.02 -46.59 89.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.528 1.058 . . . . 0.0 110.581 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -68.22 -47.27 68.31 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.562 0.745 . . . . 0.0 111.034 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.0 mt -65.88 -37.31 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.934 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -63.06 -45.31 92.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 121.378 1.899 . . . . 0.0 110.819 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.5 89.0 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.454 0.57 . . . . 0.0 111.773 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.04 -17.17 28.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.254 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.253 30.6 p90 38.84 64.7 3.55 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 127.381 2.272 . . . . 0.0 114.093 -175.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.41 -24.81 17.09 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.287 2.658 . . . . 0.0 114.058 169.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -129.68 -68.37 0.72 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.059 0.944 . . . . 0.0 109.368 169.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -165.07 -50.69 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.913 0.885 . . . . 0.0 109.996 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -152.9 167.52 28.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.517 1.127 . . . . 0.0 108.369 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.03 158.31 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.819 1.647 . . . . 0.0 108.071 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 p -135.66 176.01 9.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.639 1.176 . . . . 0.0 108.617 169.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -139.37 166.65 23.98 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.865 -0.522 . . . . 0.0 111.282 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.65 143.15 30.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.522 1.129 . . . . 0.0 108.115 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -90.24 47.89 1.5 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.303 1.041 . . . . 0.0 110.361 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -151.07 -179.42 7.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.549 1.14 . . . . 0.0 109.346 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.82 -163.33 53.7 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.991 1.282 . . . . 0.0 111.757 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 125.913 1.685 . . . . 0.0 106.984 -179.822 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.735 0.302 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.61 162.0 35.69 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.153 1.381 . . . . 0.0 108.154 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.9 m -66.41 167.49 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.173 0.989 . . . . 0.0 112.229 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.05 -176.96 4.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.902 2.081 . . . . 0.0 105.761 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -143.04 153.2 42.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 mt -50.5 -34.87 26.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.32 1.048 . . . . 0.0 112.957 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.13 -24.13 64.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.699 0.681 . . . . 0.0 112.549 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.31 -19.63 42.47 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.633 0.773 . . . . 0.0 111.253 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.28 132.75 92.71 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.026 0.931 . . . . 0.0 108.694 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.4 109.91 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.489 2.793 . . . . 0.0 110.045 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -76.49 -38.19 55.67 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -169.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.09 124.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -146.21 102.49 3.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.8 pt -134.18 150.68 31.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.02 -169.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -90.76 63.74 5.41 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.916 1.686 . . . . 0.0 110.249 -173.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -59.71 -2.84 0.41 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.708 1.603 . . . . 0.0 114.737 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.49 -22.42 66.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.789 1.236 . . . . 0.0 112.931 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.09 -175.82 38.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 118.735 0.698 . . . . 0.0 112.736 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.82 104.93 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -142.89 166.94 23.28 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.29 1.036 . . . . 0.0 109.51 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -84.25 162.08 20.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.776 -0.578 . . . . 0.0 110.821 -175.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.16 171.86 13.71 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.356 1.063 . . . . 0.0 109.492 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.93 153.59 17.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.978 1.311 . . . . 0.0 108.035 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 tp -116.89 115.63 25.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.19 133.41 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 118.918 0.781 . . . . 0.0 110.007 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -77.96 147.66 34.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.014 1.326 . . . . 0.0 107.642 169.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.68 141.22 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -117.41 141.34 48.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.301 1.441 . . . . 0.0 108.16 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 m -64.16 106.97 1.17 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.574 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.625 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.01 17.39 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 116.257 -1.83 . . . . 0.0 113.935 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.625 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.0 Cg_exo -42.3 133.43 4.75 Favored 'Trans proline' 0 C--N 1.365 1.436 0 CA-C-N 123.733 2.369 . . . . 0.0 115.261 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 41.9 32.65 0.29 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.595 2.758 . . . . 0.0 113.179 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m 52.96 29.76 8.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.607 1.563 . . . . 0.0 113.0 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.0 -0.28 0.66 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.304 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.35 145.59 57.19 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 118.954 1.377 . . . . 0.0 110.851 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -80.7 1.37 9.35 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.759 2.972 . . . . 0.0 115.899 -169.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.59 179.16 7.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.794 1.179 . . . . 0.0 111.331 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.89 35.68 2.85 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.228 1.811 . . . . 0.0 110.276 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.94 170.18 11.75 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -138.76 159.02 43.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.908 0.883 . . . . 0.0 110.543 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.55 36.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.722 1.609 . . . . 0.0 109.306 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -108.77 156.95 19.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 pt -137.02 159.02 36.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.961 1.705 . . . . 0.0 109.518 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.7 t -124.24 119.17 55.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.0 mmt85 -139.61 148.45 42.5 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.93 136.47 2.75 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.047 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 15.6 m-85 -153.0 156.01 38.02 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.259 0.623 . . . . 0.0 111.45 -169.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -35.61 61.34 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.418 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-90 -71.6 -25.44 62.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.215 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.71 80.38 9.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.317 0.962 . . . . 0.0 109.142 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.71 -9.15 17.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.418 0.687 . . . . 0.0 112.069 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.17 142.45 30.55 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.049 1.739 . . . . 0.0 107.604 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -61.98 -30.06 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.81 0.844 . . . . 0.0 111.735 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.38 68.16 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.749 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.49 -47.68 69.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.574 0.624 . . . . 0.0 110.655 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -38.56 79.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 117.456 -1.259 . . . . 0.0 110.243 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -58.95 -46.38 88.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.584 1.538 . . . . 0.0 109.932 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.69 -50.21 67.86 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.38 0.536 . . . . 0.0 111.418 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -61.29 -46.84 88.64 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 122.8 0.44 . . . . 0.0 111.158 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.74 -36.34 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.43 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.83 -29.89 70.47 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.137 1.335 . . . . 0.0 110.764 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.23 -49.0 55.89 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.405 1.002 . . . . 0.0 111.135 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -57.01 -44.71 83.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.823 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mmt -69.02 -41.64 77.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.724 -0.61 . . . . 0.0 112.231 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -69.24 -29.95 67.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.36 1.436 . . . . 0.0 111.714 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -61.5 -43.09 99.49 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.988 0.915 . . . . 0.0 109.167 169.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.84 -37.07 85.34 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.441 0.564 . . . . 0.0 110.287 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.98 -6.69 5.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 127.252 2.358 . . . . 0.0 112.944 172.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.46 177.32 4.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.514 1.925 . . . . 0.0 112.78 -169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -127.92 151.09 49.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 55.9 m -147.72 168.49 21.96 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.04 126.47 7.34 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.19 1.396 . . . . 0.0 108.002 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.08 118.79 11.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.38 -26.67 61.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.722 0.409 . . . . 0.0 110.252 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.67 -171.94 42.35 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.18 -173.75 20.09 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.88 -158.79 23.32 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -127.94 153.58 46.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.969 1.308 . . . . 0.0 108.725 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.53 130.55 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.3 m -131.91 150.85 52.03 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.883 -169.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -157.48 -50.56 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.813 0.845 . . . . 0.0 110.28 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 47.42 22.95 0.31 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.416 1.886 . . . . 0.0 113.621 -175.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m 49.54 27.85 2.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.72 1.608 . . . . 0.0 113.164 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -68.83 -34.11 74.95 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.778 -0.576 . . . . 0.0 112.153 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -169.58 175.15 5.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.627 1.971 . . . . 0.0 107.255 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.432 ' HE2' ' CG ' ' A' ' 116' ' ' TYR . 20.0 ptmt -72.02 59.46 0.37 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.751 1.22 . . . . 0.0 110.071 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -150.78 144.4 25.07 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.162 1.785 . . . . 0.0 107.588 -172.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.519 ' HB ' HG12 ' A' ' 118' ' ' VAL . 39.7 mt -132.27 154.84 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 173.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -134.15 148.04 50.89 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.172 0.989 . . . . 0.0 108.746 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -134.29 114.91 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.25 172.9 17.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.206 1.002 . . . . 0.0 108.325 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.06 -165.39 24.33 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.91 1.232 . . . . 0.0 113.066 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -153.78 154.83 34.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.791 2.036 . . . . 0.0 107.388 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.2 m -139.1 106.17 5.46 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -56.45 -28.5 59.75 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.05 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.211 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -135.6 -7.89 2.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.02 171.32 45.97 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.018 0.818 . . . . 0.0 111.138 -169.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.51 144.77 36.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.626 2.218 . . . . 0.0 109.564 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 167.71 18.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 109.397 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -65.86 -31.54 72.54 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.53 0.732 . . . . 0.0 112.022 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.8 m80 58.21 -30.78 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.111 2.964 . . . . 0.0 115.983 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.86 75.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.776 1.171 . . . . 0.0 111.479 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 mm -58.98 -54.42 34.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.5 m -53.62 -50.55 65.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.294 1.038 . . . . 0.0 111.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 p -60.96 -41.69 96.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.232 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.1 -45.71 87.44 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.475 1.034 . . . . 0.0 110.053 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -64.7 -43.81 92.29 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 122.055 -0.403 . . . . 0.0 110.965 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.405 HG21 HG11 ' A' ' 118' ' ' VAL . 52.0 mt -62.9 -45.74 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.89 0.876 . . . . 0.0 108.956 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -62.78 -29.91 71.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.897 1.226 . . . . 0.0 111.566 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.58 -43.95 71.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.012 1.278 . . . . 0.0 111.193 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -71.62 -26.89 62.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.915 0.886 . . . . 0.0 112.595 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 46.42 55.85 16.08 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.558 1.543 . . . . 0.0 113.864 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.37 -18.14 30.1 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.037 1.825 . . . . 0.0 110.361 169.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -145.63 177.89 8.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.763 2.425 . . . . 0.0 106.462 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.432 ' CG ' ' HE2' ' A' ' 86' ' ' LYS . 81.5 t80 -67.5 -49.37 63.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.047 0.939 . . . . 0.0 112.319 -169.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -158.34 157.98 33.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 88' ' ' ILE . 29.6 m -139.48 167.94 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.575 0.75 . . . . 0.0 111.417 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p -140.85 171.37 14.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.346 1.458 . . . . 0.0 109.277 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -142.6 171.93 13.38 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.228 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.75 143.7 29.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -84.33 33.42 0.5 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.496 1.118 . . . . 0.0 111.337 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -154.74 -171.84 3.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.41 1.484 . . . . 0.0 108.461 -171.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.14 155.35 15.04 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.717 1.627 . . . . 0.0 110.608 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.011 1.724 . . . . 0.0 107.267 177.823 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.29 164.87 34.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.181 1.392 . . . . 0.0 108.537 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.67 161.52 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.577 1.151 . . . . 0.0 107.957 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.26 176.37 10.04 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.086 1.754 . . . . 0.0 107.162 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.1 155.77 40.44 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.023 0.929 . . . . 0.0 109.025 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.0 mt -50.17 -33.97 20.93 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.763 1.225 . . . . 0.0 113.114 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.89 67.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.685 0.675 . . . . 0.0 112.558 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.21 -19.71 53.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.325 0.65 . . . . 0.0 111.341 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.46 133.01 92.95 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.16 111.32 0.71 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.647 2.898 . . . . 0.0 110.909 170.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.93 -34.88 64.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.235 0.614 . . . . 0.0 111.989 -170.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.5 t -137.36 135.04 47.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.94 118.13 3.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.6 pt -142.1 154.62 18.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.708 1.203 . . . . 0.0 108.183 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.85 140.62 58.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.07 0.548 . . . . 0.0 110.532 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -82.28 -16.56 49.0 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -158.91 101.13 1.61 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.983 1.265 . . . . 0.0 110.766 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.27 -172.42 38.38 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 121.609 0.561 . . . . 0.0 112.137 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -119.09 125.89 74.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -157.03 169.35 25.02 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.084 0.469 . . . . 0.0 111.67 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.82 159.56 15.33 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.72 166.51 23.79 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.976 1.31 . . . . 0.0 108.94 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.88 156.67 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.982 1.313 . . . . 0.0 107.776 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -122.06 121.07 36.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.77 135.82 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.458 0.572 . . . . 0.0 109.633 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -83.17 150.96 25.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.833 1.253 . . . . 0.0 107.65 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -137.37 140.68 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -113.32 146.82 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.419 1.487 . . . . 0.0 108.912 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.3 m -66.57 95.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.98 0.912 . . . . 0.0 110.805 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.543 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.17 11.78 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 115.905 -1.998 . . . . 0.0 114.069 168.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.543 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 71.0 Cg_exo -44.27 136.94 8.0 Favored 'Trans proline' 0 C--N 1.364 1.362 0 CA-C-N 124.146 2.516 . . . . 0.0 114.229 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mmt-85 47.65 22.07 0.3 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.802 2.441 . . . . 0.0 113.881 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 50.39 31.11 5.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.117 1.367 . . . . 0.0 112.217 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.89 5.6 0.81 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.925 -171.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.08 147.38 34.72 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 118.763 1.282 . . . . 0.0 110.457 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.6 -3.43 13.79 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.579 2.853 . . . . 0.0 115.831 -169.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.1 -176.3 5.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.573 1.079 . . . . 0.0 110.638 -170.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.51 37.12 3.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.874 1.669 . . . . 0.0 109.993 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -69.25 169.15 12.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 169.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -139.17 157.35 46.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.898 0.879 . . . . 0.0 109.851 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 165.91 32.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.401 1.481 . . . . 0.0 109.477 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -112.88 154.96 25.51 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.577 0.751 . . . . 0.0 109.092 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.6 pt -135.24 156.8 39.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.77 1.228 . . . . 0.0 109.749 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.86 124.26 72.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 125.868 1.667 . . . . 0.0 107.021 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -134.59 150.18 50.68 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.584 1.554 . . . . 0.0 108.689 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.79 131.63 1.48 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -154.55 151.24 28.65 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -64.54 -20.62 66.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -69.63 -26.22 64.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.634 1.107 . . . . 0.0 112.287 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.36 88.64 7.52 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.985 1.266 . . . . 0.0 109.076 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.32 -8.49 32.74 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.537 0.735 . . . . 0.0 112.101 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -147.9 145.62 28.71 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.669 1.588 . . . . 0.0 108.283 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -61.03 -31.8 71.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.241 1.016 . . . . 0.0 111.585 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.66 -26.06 68.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.824 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.0 -49.38 61.89 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.151 0.887 . . . . 0.0 110.418 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -39.86 85.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.254 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -62.06 -49.48 75.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.356 0.98 . . . . 0.0 110.081 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.81 -44.84 95.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.256 0.934 . . . . 0.0 111.169 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.48 -51.7 68.75 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.341 0.656 . . . . 0.0 110.78 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.4 t -82.12 -38.61 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.043 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.2 p -61.43 -31.75 71.7 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.857 1.662 . . . . 0.0 110.328 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.84 -51.06 59.83 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.05 -44.14 96.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.375 1.088 . . . . 0.0 111.202 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.35 -45.38 91.55 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.802 0.728 . . . . 0.0 110.563 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.41 -33.04 75.03 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.014 -1.054 . . . . 0.0 111.588 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -64.52 -39.64 94.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.962 0.801 . . . . 0.0 110.692 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.03 -32.12 73.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.264 0.938 . . . . 0.0 110.61 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.98 -8.05 4.47 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.114 2.292 . . . . 0.0 113.177 169.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 37.9 m -67.48 179.56 1.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.095 1.758 . . . . 0.0 113.539 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -131.14 143.14 50.41 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.0 m -147.15 167.44 24.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -168.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -153.09 134.37 14.23 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.524 1.53 . . . . 0.0 108.103 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 p -73.65 115.84 13.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.9 -24.92 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.952 -0.468 . . . . 0.0 110.772 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.0 43.48 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.44 -164.83 15.31 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.44 -155.61 22.67 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -138.52 155.02 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 109.127 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.8 136.63 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 m -145.69 164.43 31.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.619 1.168 . . . . 0.0 109.62 -176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.68 148.54 28.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -151.68 142.53 22.93 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.317 1.047 . . . . 0.0 108.422 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 m -63.63 -20.1 65.4 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.189 0.596 . . . . 0.0 111.278 169.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -66.96 -18.55 65.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.377 1.471 . . . . 0.0 112.161 172.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -125.37 -29.72 3.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.571 1.148 . . . . 0.0 111.839 -171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 mttm 74.08 13.56 4.02 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.41 2.284 . . . . 0.0 115.45 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.02 172.97 14.38 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.159 0.984 . . . . 0.0 108.532 168.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.2 156.83 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -140.14 149.26 42.8 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.199 1.0 . . . . 0.0 108.949 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.15 123.0 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.23 -174.42 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.154 -0.966 . . . . 0.0 111.085 -169.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.79 -160.04 52.58 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -149.51 154.48 38.83 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.431 1.493 . . . . 0.0 107.863 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 t -69.74 131.83 45.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.8 ttt -59.02 -20.77 56.18 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.973 0.909 . . . . 0.0 111.814 170.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.32 -24.23 8.53 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 113.087 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -130.77 1.07 4.38 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -177.65 45.33 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.248 0.931 . . . . 0.0 112.381 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.25 130.22 17.2 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.739 2.293 . . . . 0.0 111.223 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.69 168.08 20.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.227 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.98 78.54 5.41 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 169.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -59.01 -15.88 15.4 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.01 66.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.387 0.675 . . . . 0.0 111.401 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.57 -44.17 96.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.728 0.811 . . . . 0.0 108.942 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.3 m -58.67 -53.03 62.91 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.268 0.627 . . . . 0.0 110.34 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 p -60.45 -44.6 95.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -58.98 -53.45 58.3 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.283 0.947 . . . . 0.0 110.931 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -70.4 -44.49 67.86 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.918 -0.489 . . . . 0.0 111.421 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.4 -42.25 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 118.087 -0.959 . . . . 0.0 108.639 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.72 -39.28 93.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.913 1.688 . . . . 0.0 111.029 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.94 89.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.475 0.58 . . . . 0.0 111.302 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -79.86 -24.66 41.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.224 0.465 . . . . 0.0 112.106 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 t80 40.49 60.33 7.28 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.13 2.172 . . . . 0.0 111.967 -170.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.1 -22.56 34.93 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.105 2.537 . . . . 0.0 113.126 -171.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -153.76 -49.52 0.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.661 0.664 . . . . 0.0 111.859 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -157.62 174.61 15.08 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.526 0.73 . . . . 0.0 110.359 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.98 158.45 22.38 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.254 1.422 . . . . 0.0 110.765 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.94 164.07 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.058 1.743 . . . . 0.0 110.033 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.3 p -141.42 172.06 13.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.324 1.849 . . . . 0.0 107.133 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.63 167.58 21.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.894 0.77 . . . . 0.0 112.39 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.87 143.61 30.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.323 1.449 . . . . 0.0 107.643 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -88.22 33.15 0.74 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.112 0.965 . . . . 0.0 111.446 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -153.93 175.67 13.08 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.667 1.587 . . . . 0.0 107.624 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.11 -168.35 25.39 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.922 1.249 . . . . 0.0 111.96 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.248 0.995 0 C-N-CA 125.781 1.633 . . . . 0.0 107.665 179.043 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.13 151.86 35.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.849 1.26 . . . . 0.0 108.134 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.6 t -74.91 118.73 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.1 -176.7 1.84 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.064 0.546 . . . . 0.0 110.311 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -145.51 154.38 42.14 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.118 0.967 . . . . 0.0 108.839 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -53.53 -28.98 34.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.828 1.251 . . . . 0.0 113.507 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.48 57.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.024 0.829 . . . . 0.0 112.451 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.0 mt -84.87 -19.72 31.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.017 0.927 . . . . 0.0 111.25 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.07 138.29 72.87 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.428 1.091 . . . . 0.0 109.265 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.41 99.35 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.517 2.811 . . . . 0.0 109.307 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.65 -32.09 67.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.938 1.295 . . . . 0.0 112.658 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t -140.99 128.67 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -152.28 108.14 3.36 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -137.37 154.77 30.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.258 . . . . 0.0 108.384 -172.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.09 -34.23 76.02 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.6 m 54.95 -177.55 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.459 1.904 . . . . 0.0 113.463 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 47.31 43.97 15.6 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.956 1.703 . . . . 0.0 113.477 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.3 -157.64 22.55 Favored Glycine 0 C--N 1.337 0.61 0 O-C-N 121.366 -0.834 . . . . 0.0 111.375 -171.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.45 128.65 51.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -161.01 167.05 27.23 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.142 1.377 . . . . 0.0 109.95 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.46 157.92 16.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.97 172.07 13.29 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.684 0.794 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.45 153.23 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.225 1.41 . . . . 0.0 108.123 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.4 tp -117.76 115.62 25.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 131.95 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.85 147.16 39.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.01 131.04 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -100.08 151.2 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.455 1.102 . . . . 0.0 109.734 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 m -65.81 97.56 0.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.931 0.892 . . . . 0.0 110.827 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -151.07 22.6 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.451 -1.738 . . . . 0.0 114.449 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 81.8 Cg_exo -46.34 138.21 13.73 Favored 'Trans proline' 0 C--N 1.362 1.25 0 CA-C-N 123.906 2.431 . . . . 0.0 113.0 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 44.93 26.75 0.22 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 113.7 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m 50.18 33.04 6.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.347 1.459 . . . . 0.0 112.753 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.08 22.79 1.76 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 123.556 0.598 . . . . 0.0 113.066 -172.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.16 148.91 83.92 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.853 0.826 . . . . 0.0 111.124 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.15 -6.63 14.97 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.481 2.788 . . . . 0.0 113.787 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.45 -175.81 5.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.034 1.334 . . . . 0.0 109.906 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.92 37.51 3.43 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.764 1.626 . . . . 0.0 110.159 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.74 168.72 14.38 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -142.03 159.56 41.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.038 0.935 . . . . 0.0 110.325 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.66 168.26 26.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.975 1.71 . . . . 0.0 108.835 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -108.39 156.77 19.05 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 pt -133.15 156.24 41.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.942 1.297 . . . . 0.0 109.245 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.59 116.7 50.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -137.81 147.43 44.59 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.7 134.99 2.02 Favored Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.435 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.0 m-85 -156.75 156.7 33.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -170.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -60.91 -33.09 72.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.242 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.435 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.7 p-90 -64.52 -28.62 69.77 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.84 0.746 . . . . 0.0 112.103 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 77.79 9.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.218 0.917 . . . . 0.0 108.705 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -65.89 -6.07 11.16 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.19 140.23 33.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.69 1.596 . . . . 0.0 107.55 174.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.424 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 24.5 m-70 -61.46 -29.74 70.16 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.403 1.081 . . . . 0.0 111.873 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.58 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.759 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.0 -46.44 74.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.675 0.67 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -41.09 82.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.152 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -58.45 -44.66 89.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.004 1.729 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.25 -50.83 64.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.647 0.658 . . . . 0.0 111.542 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -60.77 -46.48 90.3 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.977 0.511 . . . . 0.0 111.089 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.8 -36.4 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.381 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -62.06 -28.95 69.96 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.244 1.384 . . . . 0.0 110.927 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.86 -52.06 45.69 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.321 0.964 . . . . 0.0 110.943 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -55.88 -47.54 77.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 110.445 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.242 -0.911 . . . . 0.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.3 -28.9 66.68 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.681 -1.262 . . . . 0.0 111.474 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -31.79 73.1 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.12 0.968 . . . . 0.0 110.057 169.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -70.76 -45.96 63.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.822 1.192 . . . . 0.0 108.332 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.26 -6.78 2.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.294 2.378 . . . . 0.0 112.502 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.84 171.39 11.76 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.149 1.78 . . . . 0.0 112.983 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.62 147.92 46.91 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.0 m -148.19 165.61 30.4 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -168.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.4 129.62 11.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.767 1.227 . . . . 0.0 107.997 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.5 114.45 5.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.5 -28.26 64.83 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.996 -0.44 . . . . 0.0 110.143 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.72 -167.02 40.07 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.99 -166.92 21.65 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 171.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.47 -161.2 26.45 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -127.12 151.15 49.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.626 1.17 . . . . 0.0 108.432 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.0 mt -132.66 135.13 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.1 m -146.29 144.98 30.19 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.016 0.526 . . . . 0.0 111.535 -169.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -146.2 141.82 27.8 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.393 1.877 . . . . 0.0 106.287 169.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.64 163.63 32.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.1 1.76 . . . . 0.0 106.521 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 m -55.77 -22.11 22.53 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -171.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -63.72 -25.74 68.33 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.663 1.185 . . . . 0.0 112.159 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -152.32 113.73 4.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.666 1.121 . . . . 0.0 110.15 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -64.83 -26.76 68.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 117.933 -1.032 . . . . 0.0 112.324 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.6 122.54 18.71 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.477 ' HB ' HG12 ' A' ' 118' ' ' VAL . 3.5 mt -66.39 150.2 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -123.33 150.69 43.31 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.801 0.84 . . . . 0.0 108.77 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.4 130.33 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -159.26 -172.14 3.63 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.629 -0.669 . . . . 0.0 109.698 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.5 -164.5 41.69 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 121.653 0.585 . . . . 0.0 111.676 170.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -148.23 153.32 38.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.173 1.389 . . . . 0.0 107.499 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 t -69.55 128.56 36.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.24 -20.58 55.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.212 0.605 . . . . 0.0 111.646 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.69 -27.33 9.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.911 0.884 . . . . 0.0 112.917 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -132.59 4.48 3.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.89 -178.74 50.63 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.229 0.922 . . . . 0.0 112.73 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.5 129.37 16.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.766 2.311 . . . . 0.0 110.47 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 169.16 17.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 111.079 169.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.13 75.41 4.67 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -56.86 -20.53 23.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.06 -38.75 65.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.64 0.776 . . . . 0.0 111.606 169.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mm -62.27 -45.6 98.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.998 0.919 . . . . 0.0 109.072 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.4 m -58.02 -52.66 64.59 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.413 0.685 . . . . 0.0 110.234 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -62.59 -41.42 98.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.26 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -60.99 -50.28 74.03 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 110.412 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.76 -46.11 73.0 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.09 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.3 mt -61.74 -44.52 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.833 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -62.66 -40.05 95.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.543 1.519 . . . . 0.0 111.216 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.34 84.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.782 0.719 . . . . 0.0 111.546 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -79.74 -21.11 44.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.299 0.64 . . . . 0.0 111.743 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 t80 43.38 58.77 12.13 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.528 2.331 . . . . 0.0 112.419 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.01 -18.54 35.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.269 2.646 . . . . 0.0 112.87 -174.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.05 -52.16 0.13 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.708 0.803 . . . . 0.0 111.185 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -163.24 178.41 8.22 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.111 0.964 . . . . 0.0 109.414 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.54 155.86 24.66 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.477 HG12 ' HB ' ' A' ' 88' ' ' ILE . 27.2 m -138.03 167.3 22.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.854 0.862 . . . . 0.0 110.586 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.8 p -139.01 171.39 14.39 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 109.363 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -146.95 163.21 36.91 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.73 -0.607 . . . . 0.0 110.599 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.37 135.26 18.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 169.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.74 -20.08 54.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.754 0.422 . . . . 0.0 111.76 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.48 -33.62 72.85 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.142 0.977 . . . . 0.0 113.314 -171.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -84.19 123.67 6.32 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.944 2.098 . . . . 0.0 105.971 171.036 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.94 150.74 47.36 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 171.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.1 t -73.4 111.93 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.47 179.15 2.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.315 0.579 . . . . 0.0 110.465 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -145.07 155.01 43.09 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.638 1.175 . . . . 0.0 108.168 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.3 mt -50.94 -35.35 32.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.319 1.048 . . . . 0.0 112.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.88 -23.73 66.04 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.808 0.731 . . . . 0.0 112.679 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.2 mt -84.7 -19.7 32.36 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.741 0.816 . . . . 0.0 111.305 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.5 138.48 94.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.95 111.32 1.35 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.088 2.525 . . . . 0.0 109.571 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.83 -37.15 70.36 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.399 1.08 . . . . 0.0 112.963 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.69 137.41 47.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -153.94 110.24 3.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 pt -138.0 136.4 45.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -153.71 61.02 0.74 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.026 0.917 . . . . 0.0 109.543 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -156.59 174.86 14.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.845 1.658 . . . . 0.0 108.663 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -153.5 167.94 27.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.14 1.376 . . . . 0.0 108.911 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 -84.81 1.55 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.4 t -148.26 135.06 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 172.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -156.06 160.29 39.85 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.876 0.87 . . . . 0.0 109.16 171.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 160.39 14.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.74 166.55 24.33 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.382 1.073 . . . . 0.0 109.252 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.72 156.8 12.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.07 115.5 23.82 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.04 129.94 72.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -76.75 147.76 37.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -134.69 142.83 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -116.07 148.35 40.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.555 1.142 . . . . 0.0 108.733 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 m -61.51 101.24 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.834 0.854 . . . . 0.0 110.654 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.553 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.32 15.14 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.076 -1.916 . . . . 0.0 115.619 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 80.4 Cg_exo -42.84 137.24 4.37 Favored 'Trans proline' 0 C--N 1.362 1.288 0 CA-C-N 124.371 2.597 . . . . 0.0 114.244 171.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 45.84 25.62 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.35 2.26 . . . . 0.0 113.929 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.08 31.94 7.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.186 1.395 . . . . 0.0 112.355 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.83 20.75 1.45 Allowed Glycine 0 C--N 1.341 0.83 0 C-N-CA 123.697 0.665 . . . . 0.0 112.872 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.1 148.88 69.69 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.824 0.812 . . . . 0.0 110.64 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.79 -5.72 16.21 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.346 2.698 . . . . 0.0 114.017 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.84 -174.71 5.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.131 1.372 . . . . 0.0 109.473 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.87 49.65 2.04 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.029 1.732 . . . . 0.0 108.668 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.61 177.23 6.94 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -143.67 156.78 44.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.635 0.774 . . . . 0.0 110.146 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 165.37 36.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.512 1.525 . . . . 0.0 109.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.1 155.08 20.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.99 151.38 34.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.578 1.151 . . . . 0.0 109.166 171.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.12 120.95 64.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -131.28 147.49 52.59 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.859 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.73 132.87 1.81 Allowed Glycine 0 C--N 1.33 0.225 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.08 151.29 26.61 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -61.52 -28.18 69.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.442 0.697 . . . . 0.0 112.742 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -66.71 -26.96 67.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.143 0.883 . . . . 0.0 112.093 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 85.19 5.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 171.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.99 -10.89 43.77 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 173.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 141.09 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.896 1.278 . . . . 0.0 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.499 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.03 -32.22 70.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.572 1.549 . . . . 0.0 111.763 -173.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.18 -30.22 70.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.739 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.45 -47.88 66.01 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.89 0.768 . . . . 0.0 110.473 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -37.51 79.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.521 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.74 -47.41 86.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 110.323 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.24 -46.79 75.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.789 0.722 . . . . 0.0 111.393 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -52.76 -54.8 28.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.631 1.172 . . . . 0.0 110.056 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.4 t -80.57 -34.4 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.745 -169.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 m -62.35 -30.91 71.51 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 120.382 1.446 . . . . 0.0 110.835 170.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.9 -51.18 58.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 110.638 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.6 -44.87 92.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 111.187 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.43 -45.04 95.09 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.987 -0.445 . . . . 0.0 111.011 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -67.6 -31.2 71.07 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.086 -1.009 . . . . 0.0 111.834 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.39 -40.3 96.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.19 0.904 . . . . 0.0 110.033 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -59.42 -47.22 86.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.712 1.142 . . . . 0.0 108.907 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.68 -5.64 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 126.631 2.063 . . . . 0.0 112.709 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.1 m -66.33 176.05 1.96 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.116 1.766 . . . . 0.0 112.728 -170.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -129.86 143.34 50.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -147.63 164.06 34.68 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -169.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -154.9 128.54 8.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 108.306 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -68.25 114.28 6.6 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.4 mt -70.3 -27.62 64.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.932 0.493 . . . . 0.0 110.638 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.85 -173.58 45.57 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.4 -179.08 28.57 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.59 -162.14 28.57 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -137.65 167.21 22.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.226 1.013 . . . . 0.0 110.785 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.12 143.11 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -169.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.8 m -150.82 156.06 40.49 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 121.67 -0.644 . . . . 0.0 111.458 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -59.44 171.35 0.83 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.904 1.681 . . . . 0.0 111.698 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -143.26 157.01 44.86 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.129 1.372 . . . . 0.0 108.843 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.4 m -60.42 -37.86 82.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.59 0.756 . . . . 0.0 110.433 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -76.9 97.13 4.49 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -56.35 -26.82 54.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.934 0.893 . . . . 0.0 112.785 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -73.89 4.12 5.75 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 117.948 -1.025 . . . . 0.0 113.236 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -141.87 165.29 27.88 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 120.871 1.669 . . . . 0.0 112.203 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mm -125.46 163.78 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -130.06 150.05 51.5 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.412 -0.805 . . . . 0.0 110.078 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.39 127.8 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.504 1.522 . . . . 0.0 107.322 -174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -162.15 -175.58 4.67 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.532 -0.73 . . . . 0.0 110.69 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.76 -167.57 48.37 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.266 0.46 . . . . 0.0 112.168 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -151.33 147.04 26.45 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.522 0.729 . . . . 0.0 109.943 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -73.42 139.47 45.88 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.82 -36.44 83.5 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.818 -0.551 . . . . 0.0 109.808 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.39 58.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.2 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -134.13 1.29 3.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.216 0.917 . . . . 0.0 113.35 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.02 55.13 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 118.93 0.787 . . . . 0.0 111.914 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 137.85 40.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.692 2.262 . . . . 0.0 110.181 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.6 169.84 16.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 169.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -79.05 72.4 5.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -56.85 -19.39 17.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.892 0.877 . . . . 0.0 113.276 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.94 -38.8 65.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.659 0.783 . . . . 0.0 111.388 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.1 mm -62.03 -43.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 C-N-CA 124.23 1.012 . . . . 0.0 109.028 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -57.52 -54.07 51.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.119 0.568 . . . . 0.0 110.082 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.1 p -60.6 -41.76 95.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.337 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.99 -50.71 72.29 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.419 1.009 . . . . 0.0 110.6 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -71.66 -42.23 67.77 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.906 -0.496 . . . . 0.0 111.423 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.14 -45.46 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.61 -36.08 81.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.168 1.349 . . . . 0.0 111.346 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.0 -42.54 94.38 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.44 1.018 . . . . 0.0 111.487 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -84.1 -17.84 38.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.586 0.754 . . . . 0.0 112.856 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 46.11 52.36 11.2 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.399 1.88 . . . . 0.0 115.595 -171.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.44 -27.4 81.67 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.711 1.607 . . . . 0.0 111.178 168.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -143.23 168.54 19.52 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.377 2.271 . . . . 0.0 106.963 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -57.69 -42.6 84.0 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.943 1.297 . . . . 0.0 112.508 -172.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -155.38 172.15 18.69 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.189 0.996 . . . . 0.0 108.642 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.93 167.58 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.638 1.575 . . . . 0.0 108.727 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.3 p -140.85 169.57 17.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.68 1.192 . . . . 0.0 108.763 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -145.54 167.15 23.72 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 110.402 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.08 142.23 24.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -85.66 51.84 2.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.002 0.921 . . . . 0.0 109.324 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.36 -175.77 4.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.305 1.442 . . . . 0.0 108.906 -170.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.35 -161.33 50.55 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.7 p90 . . . . . 0 C--O 1.247 0.943 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 173.215 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.57 168.59 26.23 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.311 1.445 . . . . 0.0 108.769 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.06 106.57 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 170.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.3 179.08 1.7 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.502 0.668 . . . . 0.0 110.376 171.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -147.82 156.25 42.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.52 -28.43 65.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.49 -26.5 63.64 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.223 0.92 . . . . 0.0 112.055 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.74 -30.67 18.89 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.333 1.053 . . . . 0.0 110.654 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.3 127.76 81.31 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 144.42 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.46 2.107 . . . . 0.0 109.864 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -81.86 -44.05 17.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.137 0.575 . . . . 0.0 111.146 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 t -133.49 137.02 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -154.48 109.84 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.1 pt -140.5 154.89 22.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 123.812 0.845 . . . . 0.0 109.253 -172.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.57 174.13 3.69 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.995 0.918 . . . . 0.0 110.434 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -150.18 19.15 0.86 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.324 -1.485 . . . . 0.0 111.616 172.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.1 -30.32 67.51 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.01 -1.056 . . . . 0.0 112.015 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.97 -67.26 0.11 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 118.195 0.452 . . . . 0.0 112.846 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -142.38 135.61 27.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -163.05 163.36 25.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.229 1.012 . . . . 0.0 110.014 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -85.62 157.47 20.35 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.32 168.75 19.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.038 0.935 . . . . 0.0 109.35 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 154.43 16.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 125.139 1.376 . . . . 0.0 107.548 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -118.36 118.23 31.22 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.31 134.63 65.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.94 0.791 . . . . 0.0 109.079 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -77.39 148.45 35.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.3 t -134.8 126.64 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -96.41 149.51 21.63 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.68 0.792 . . . . 0.0 109.566 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.9 m -65.59 100.76 0.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.484 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.554 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.02 19.32 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 116.282 -1.818 . . . . 0.0 114.776 169.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.554 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 84.8 Cg_exo -44.11 136.61 7.74 Favored 'Trans proline' 0 C--N 1.362 1.263 0 CA-C-N 124.114 2.505 . . . . 0.0 113.846 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 46.13 25.76 0.37 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.738 2.015 . . . . 0.0 113.797 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 m 50.86 32.61 7.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.232 1.413 . . . . 0.0 112.448 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.42 20.36 2.06 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.83 0.729 . . . . 0.0 112.842 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.06 149.53 81.57 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 117.905 0.852 . . . . 0.0 110.755 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.65 -9.37 18.47 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.312 2.675 . . . . 0.0 113.702 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.08 -176.98 6.11 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.477 1.511 . . . . 0.0 109.233 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.68 47.96 2.41 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.864 1.666 . . . . 0.0 109.196 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -74.03 -176.48 2.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.714 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 m -142.25 159.67 41.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.685 0.794 . . . . 0.0 110.555 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.81 165.77 26.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.597 1.959 . . . . 0.0 107.573 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -111.94 146.99 36.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -126.45 154.8 36.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.312 1.045 . . . . 0.0 109.839 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.1 t -118.7 118.87 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.475 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.0 mmt85 -136.41 147.63 47.37 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.13 133.91 1.97 Allowed Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.3 m-85 -156.33 155.01 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.9 0.88 . . . . 0.0 109.001 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.99 -31.56 71.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.457 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.1 p-90 -63.9 -30.15 71.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.29 0.95 . . . . 0.0 111.873 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.74 80.72 8.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.18 -14.54 38.69 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.005 0.522 . . . . 0.0 111.796 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.09 142.74 40.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.031 1.732 . . . . 0.0 108.26 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.491 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.4 m-70 -60.8 -31.35 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.137 1.375 . . . . 0.0 111.879 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.33 -28.79 70.0 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.729 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.11 -46.98 72.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.997 0.817 . . . . 0.0 110.496 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -39.94 82.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.261 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -59.62 -48.04 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.778 1.626 . . . . 0.0 109.963 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -48.75 78.87 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.864 0.757 . . . . 0.0 111.324 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -60.62 -50.79 72.1 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.301 0.64 . . . . 0.0 110.891 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG21 ' HG3' ' A' ' 45' ' ' ARG . 60.5 t -75.07 -40.37 44.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 118.442 -0.79 . . . . 0.0 109.447 -171.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 t -59.09 -40.38 85.1 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.498 1.045 . . . . 0.0 109.082 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.95 -50.54 64.96 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 118.85 0.75 . . . . 0.0 111.952 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.51 -45.75 91.56 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.265 1.033 . . . . 0.0 111.283 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.1 mmt -60.86 -43.9 97.75 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.505 -0.747 . . . . 0.0 111.798 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.97 -32.36 73.81 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.645 -1.284 . . . . 0.0 111.152 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.37 90.76 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.947 0.899 . . . . 0.0 110.301 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -59.46 -46.42 88.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.878 1.217 . . . . 0.0 108.5 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.7 -5.99 1.59 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 126.951 2.215 . . . . 0.0 112.438 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.0 m -70.16 177.14 3.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.857 1.663 . . . . 0.0 112.114 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -129.46 142.56 50.75 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 169.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.3 m -143.05 165.09 28.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -168.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -154.94 130.77 10.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.48 112.67 4.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.7 mt -67.35 -28.46 67.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.796 -0.565 . . . . 0.0 110.219 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.66 42.18 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.036 -2.025 . . . . 0.0 108.036 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.34 -175.16 26.07 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.69 -159.86 24.66 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 107.399 -2.28 . . . . 0.0 107.399 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -135.7 163.03 31.09 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.4 1.1 . . . . 0.0 110.566 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.6 mt -123.85 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 t -156.1 169.37 24.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.241 0.616 . . . . 0.0 110.834 -169.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -124.47 24.45 7.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.548 1.539 . . . . 0.0 109.249 169.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -61.42 2.37 0.16 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.788 1.235 . . . . 0.0 112.915 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -55.08 -13.55 1.23 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.561 2.744 . . . . 0.0 113.129 169.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 59.09 30.51 20.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.011 1.724 . . . . 0.0 110.607 -169.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -157.79 158.21 34.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.67 2.388 . . . . 0.0 106.211 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -60.7 -25.61 66.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.392 -0.813 . . . . 0.0 112.446 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -54.24 119.16 4.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.681 1.128 . . . . 0.0 109.818 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.07 159.36 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -138.35 149.06 45.23 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.256 1.022 . . . . 0.0 108.597 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.06 117.91 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -161.85 -168.61 1.98 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.053 0.541 . . . . 0.0 110.684 -173.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.87 -161.82 53.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -152.5 152.38 31.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.331 1.052 . . . . 0.0 108.67 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.3 p -77.94 137.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.7 tpt -65.05 -34.81 79.32 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.839 -0.538 . . . . 0.0 109.855 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.94 65.54 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.416 -0.802 . . . . 0.0 113.111 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -133.86 4.03 3.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.67 -175.26 55.07 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.806 0.73 . . . . 0.0 111.75 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.48 138.37 38.54 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.576 2.184 . . . . 0.0 110.685 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 176.29 5.25 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.54 -34.08 77.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.74 -0.6 . . . . 0.0 111.368 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.4 m80 58.51 -29.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.141 2.976 . . . . 0.0 115.87 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.72 81.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.474 1.11 . . . . 0.0 111.41 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.28 -46.36 88.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.4 m -56.29 -53.69 54.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.879 0.872 . . . . 0.0 110.538 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -47.21 77.99 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.931 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -64.83 -47.76 76.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.837 0.744 . . . . 0.0 110.519 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.75 -38.37 67.4 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 118.799 -0.619 . . . . 0.0 111.309 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.4 mt -61.61 -45.65 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.473 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 95.9 mttt -62.62 -40.33 96.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.573 1.533 . . . . 0.0 111.431 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.59 87.13 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.452 0.569 . . . . 0.0 111.224 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -79.45 -23.22 43.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.4 t80 41.41 62.9 6.62 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.593 2.357 . . . . 0.0 111.943 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.94 -23.43 40.83 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.903 2.402 . . . . 0.0 112.997 -172.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -155.99 -46.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.718 0.69 . . . . 0.0 112.463 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -158.51 173.53 16.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.487 0.715 . . . . 0.0 110.643 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' HG3' ' HE2' ' A' ' 110' ' ' LYS . 26.8 tt0 -67.51 161.25 25.89 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.345 1.058 . . . . 0.0 110.624 174.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.65 162.89 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.038 1.335 . . . . 0.0 109.54 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 p -142.66 174.41 10.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.434 1.894 . . . . 0.0 108.514 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -145.67 167.29 23.47 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.422 -0.799 . . . . 0.0 111.14 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.06 143.18 25.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -86.76 43.63 1.1 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.236 1.014 . . . . 0.0 110.262 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -152.49 -165.2 2.14 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.787 1.635 . . . . 0.0 107.974 -171.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.84 -176.4 52.1 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 119.279 0.945 . . . . 0.0 111.998 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 C--O 1.247 0.93 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 -178.558 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.41 164.29 31.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.594 1.558 . . . . 0.0 107.659 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.92 167.8 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.11 -174.26 4.14 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.609 1.564 . . . . 0.0 107.609 173.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -143.76 150.96 39.38 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -53.85 -30.76 46.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.688 1.195 . . . . 0.0 113.349 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.25 -25.31 59.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.995 0.816 . . . . 0.0 112.434 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.85 -21.58 29.74 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.936 0.894 . . . . 0.0 111.135 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.85 131.75 82.97 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.59 119.76 5.57 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.763 2.976 . . . . 0.0 110.13 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.53 -41.14 12.9 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -169.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -138.58 135.03 43.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -156.14 116.3 3.66 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 pt -137.23 154.29 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 108.358 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -131.47 91.98 3.1 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.836 0.854 . . . . 0.0 110.178 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 m -57.06 149.59 18.9 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.937 1.295 . . . . 0.0 111.408 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -156.52 -44.18 0.07 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.121 0.968 . . . . 0.0 110.42 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.01 -47.67 0.22 Allowed Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -149.21 140.24 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 169.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -155.83 166.3 33.9 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.797 1.239 . . . . 0.0 109.507 176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -97.83 160.13 14.5 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.605 -0.684 . . . . 0.0 109.185 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 169.02 18.87 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 122.992 0.517 . . . . 0.0 110.126 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.0 153.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.322 . . . . 0.0 108.844 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 tp -118.81 116.87 27.42 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.52 132.62 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.416 1.007 . . . . 0.0 109.674 -174.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -78.03 145.99 35.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.032 1.333 . . . . 0.0 108.503 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.14 128.73 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -93.79 154.07 17.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.984 0.913 . . . . 0.0 110.398 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.7 p -73.64 41.91 0.12 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.536 1.934 . . . . 0.0 114.963 -172.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.48 22.42 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 115.918 -1.991 . . . . 0.0 116.344 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.73 125.05 6.04 Favored 'Trans proline' 0 C--N 1.359 1.117 0 CA-C-N 124.553 2.662 . . . . 0.0 113.833 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 39.63 28.14 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.696 2.799 . . . . 0.0 114.419 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m 48.92 30.31 2.7 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.038 1.335 . . . . 0.0 112.551 -171.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.22 -7.76 86.33 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.129 0.871 . . . . 0.0 113.539 -170.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.63 145.58 23.73 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 124.794 1.238 . . . . 0.0 108.908 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.52 9.34 4.14 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.831 3.021 . . . . 0.0 113.723 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.7 159.55 5.14 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.293 1.437 . . . . 0.0 112.059 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.12 39.52 2.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.864 1.266 . . . . 0.0 110.308 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -74.08 168.06 20.3 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -154.78 161.14 41.61 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.58 -1.325 . . . . 0.0 111.242 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -152.94 165.75 34.54 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.893 1.677 . . . . 0.0 108.477 173.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.25 151.17 26.31 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.436 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 48.6 pt -130.4 156.57 42.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.102 1.361 . . . . 0.0 109.32 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.6 122.71 66.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -128.69 153.32 47.44 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.33 132.26 2.46 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -151.21 151.08 31.38 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.2 1.0 . . . . 0.0 108.45 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.2 -29.13 68.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.192 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -65.54 -34.35 78.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.18 0.9 . . . . 0.0 110.979 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 71.13 8.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 169.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -62.62 -9.33 8.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.531 1.132 . . . . 0.0 111.696 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.34 37.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.236 1.815 . . . . 0.0 107.186 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.558 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 8.1 m-70 -58.48 -31.21 67.62 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.744 1.617 . . . . 0.0 112.078 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.93 -31.61 68.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.873 0.469 . . . . 0.0 111.633 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.94 -43.08 79.93 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.275 0.489 . . . . 0.0 110.6 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -40.21 72.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.449 175.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.35 -44.72 88.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.37 1.441 . . . . 0.0 109.876 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.67 -48.88 73.11 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 0.605 . . . . 0.0 111.606 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -56.87 -52.08 66.55 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.391 0.677 . . . . 0.0 110.086 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.19 -43.73 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.094 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -58.88 -37.13 75.86 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.625 1.102 . . . . 0.0 111.023 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.86 63.16 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.928 0.785 . . . . 0.0 111.199 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.25 -46.17 81.61 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.88 0.84 . . . . 0.0 111.019 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.6 mmt -59.12 -42.72 91.23 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.842 -0.536 . . . . 0.0 111.129 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -70.38 -30.7 67.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.342 0.974 . . . . 0.0 111.728 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -63.57 -43.07 98.07 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.327 0.967 . . . . 0.0 109.302 169.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -63.86 -27.04 68.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.451 0.569 . . . . 0.0 111.079 171.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.89 -7.22 9.43 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.137 2.304 . . . . 0.0 113.178 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 69.0 m -71.59 170.47 13.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.189 1.396 . . . . 0.0 111.721 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.59 140.73 52.21 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 m -144.28 163.16 34.51 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -149.08 128.89 13.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.04 0.936 . . . . 0.0 108.628 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -65.37 111.3 2.98 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.18 -27.53 66.49 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.707 -0.62 . . . . 0.0 110.1 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.15 -166.92 40.1 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.71 -165.94 17.63 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 170.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.35 -164.75 31.93 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -119.84 150.48 40.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.3 mt -128.27 138.46 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.7 m -139.07 146.05 40.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.855 0.862 . . . . 0.0 109.096 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -124.75 27.3 6.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.026 1.73 . . . . 0.0 108.9 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -76.64 13.12 1.06 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.217 1.407 . . . . 0.0 111.732 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -59.87 -18.99 48.65 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.609 2.764 . . . . 0.0 114.095 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 53.76 33.41 16.79 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.891 1.276 . . . . 0.0 109.984 -169.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -161.36 160.49 29.63 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 127.635 2.374 . . . . 0.0 106.759 -172.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -61.68 -21.54 64.53 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 177.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -57.5 156.21 8.39 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.462 1.105 . . . . 0.0 111.774 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.37 156.46 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -133.48 147.19 51.65 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.752 0.821 . . . . 0.0 109.735 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.87 129.23 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.766 1.626 . . . . 0.0 106.895 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.37 -169.13 2.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.036 0.835 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.84 -159.37 52.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.649 0.642 . . . . 0.0 112.526 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.7 154.22 39.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.24 1.416 . . . . 0.0 108.004 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 t -66.54 135.43 54.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 74.5 mtm -59.77 -16.46 27.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.638 1.175 . . . . 0.0 112.411 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.68 -23.14 4.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.117 0.967 . . . . 0.0 113.215 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -129.97 2.08 4.81 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.34 -175.59 45.88 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 119.09 0.859 . . . . 0.0 112.573 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.61 129.44 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.745 2.297 . . . . 0.0 110.968 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.86 167.76 20.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 110.304 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -78.97 76.66 5.46 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -57.06 -19.87 21.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.904 0.882 . . . . 0.0 113.166 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.39 -39.89 73.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.837 0.855 . . . . 0.0 110.987 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.9 mm -63.54 -49.15 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 m -62.63 -46.74 86.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 117.839 0.291 . . . . 0.0 110.843 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -62.01 -42.16 98.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.22 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.89 -49.94 75.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.979 1.263 . . . . 0.0 111.021 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -66.27 -45.12 81.6 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.935 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.87 -47.48 93.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -61.6 -39.15 90.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.307 1.412 . . . . 0.0 111.092 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.41 80.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 111.236 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -75.73 -21.6 57.34 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.349 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.4 t80 44.97 60.91 12.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.696 1.998 . . . . 0.0 111.671 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.28 -21.8 47.28 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.941 2.427 . . . . 0.0 112.527 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -154.86 -46.84 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.378 0.671 . . . . 0.0 111.865 170.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -159.3 179.95 8.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.2 1.0 . . . . 0.0 109.79 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.45 154.61 20.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.411 1.085 . . . . 0.0 109.513 169.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.73 168.48 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.068 1.347 . . . . 0.0 109.414 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 p -139.38 171.38 14.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.472 1.109 . . . . 0.0 109.665 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -145.93 161.6 39.68 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.812 -0.555 . . . . 0.0 110.583 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.61 135.69 18.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -72.94 -25.1 60.91 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.88 -32.71 71.2 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.008 0.923 . . . . 0.0 112.999 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.17 167.86 53.63 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.347 0.498 . . . . 0.0 111.929 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 59.5 t80 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 125.312 1.445 . . . . 0.0 107.715 175.561 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmt? . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.67 169.02 20.57 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.223 1.409 . . . . 0.0 108.561 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.3 t -137.11 130.67 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.65 -179.14 2.93 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.601 0.715 . . . . 0.0 110.798 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -148.14 155.39 41.36 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.207 1.403 . . . . 0.0 107.279 175.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -54.06 -34.0 58.93 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.586 0.754 . . . . 0.0 112.584 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.47 -24.42 66.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.192 0.906 . . . . 0.0 112.294 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.91 -20.18 23.67 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.95 . . . . 0.0 111.366 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.69 126.4 86.84 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.189 -1.386 . . . . 0.0 107.824 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.53 111.78 0.51 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.249 3.3 . . . . 0.0 110.421 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -71.38 -35.94 71.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.35 137.64 20.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -156.45 116.15 3.54 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.73 156.87 35.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.391 1.076 . . . . 0.0 109.418 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -70.87 163.19 27.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.558 0.743 . . . . 0.0 111.964 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 m -66.52 177.31 1.58 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.605 1.962 . . . . 0.0 112.548 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -37.28 120.61 0.78 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.811 2.045 . . . . 0.0 112.544 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.92 -161.94 34.72 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -174.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.8 t -133.98 129.99 54.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 172.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -159.73 158.01 30.5 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 123.919 0.887 . . . . 0.0 110.122 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 156.06 27.45 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.886 0.474 . . . . 0.0 109.738 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.66 169.6 17.34 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.042 0.937 . . . . 0.0 108.687 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.43 150.67 19.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 108.013 174.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 tp -110.6 115.71 30.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.0 OUTLIER -127.32 128.13 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.53 0.681 . . . . 0.0 109.412 -172.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -79.27 149.53 31.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.43 1.492 . . . . 0.0 108.348 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.42 135.01 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -102.85 147.83 26.39 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.324 1.049 . . . . 0.0 108.464 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -62.23 99.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.282 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.517 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -149.66 17.97 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.163 -1.875 . . . . 0.0 114.776 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.517 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 51.1 Cg_exo -41.39 134.66 3.11 Favored 'Trans proline' 0 C--N 1.361 1.196 0 CA-C-N 124.077 2.492 . . . . 0.0 114.31 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 38.17 31.89 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.692 2.797 . . . . 0.0 114.182 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m 51.59 32.58 9.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.149 1.379 . . . . 0.0 112.566 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.33 30.38 0.87 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.998 0.809 . . . . 0.0 111.949 -174.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.42 153.04 87.63 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.243 0.617 . . . . 0.0 110.912 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.07 -23.62 77.74 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.439 2.76 . . . . 0.0 115.463 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.19 -167.87 2.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.078 1.351 . . . . 0.0 109.995 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.12 50.74 2.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.317 1.847 . . . . 0.0 108.744 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -176.33 4.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.0 m -140.95 156.52 46.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.572 0.749 . . . . 0.0 110.491 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.77 149.88 29.55 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.632 1.973 . . . . 0.0 106.742 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.43 150.55 27.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -128.8 154.05 39.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.26 1.024 . . . . 0.0 109.34 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.18 114.66 44.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -134.7 146.65 49.66 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.68 135.04 2.33 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.8 m-85 -157.06 152.6 26.67 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -60.32 -27.11 67.07 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.5 p-90 -66.86 -27.71 67.75 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 112.062 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.24 79.9 9.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.06 -6.29 8.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.005 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.98 142.03 29.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.226 1.811 . . . . 0.0 107.514 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.434 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 21.1 m-70 -62.04 -30.7 71.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.398 1.079 . . . . 0.0 111.543 -174.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -29.62 68.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.145 175.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.42 -47.5 73.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.781 0.719 . . . . 0.0 110.748 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.03 -43.29 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.011 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.12 -47.13 84.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.102 0.864 . . . . 0.0 109.608 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.99 -48.29 71.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 0.483 . . . . 0.0 111.718 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -57.22 -53.75 54.59 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.366 0.666 . . . . 0.0 110.294 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.06 -45.19 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.864 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -64.29 -25.16 67.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 119.884 1.22 . . . . 0.0 111.471 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.32 -49.89 72.71 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 170.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.05 -41.93 85.63 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.185 0.992 . . . . 0.0 111.392 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.2 mmt -56.39 -44.85 80.66 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.367 0.985 . . . . 0.0 110.79 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.52 -29.08 66.62 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.246 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -63.41 -43.15 98.36 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.396 0.998 . . . . 0.0 109.193 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.53 -34.28 77.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.079 0.4 . . . . 0.0 110.306 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.83 5.07 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.535 2.017 . . . . 0.0 113.059 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -67.86 175.37 3.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.365 1.866 . . . . 0.0 113.434 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -128.2 148.82 50.63 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.4 163.57 32.69 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -168.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -149.35 128.04 12.45 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.089 1.356 . . . . 0.0 109.006 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.27 111.94 7.0 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 168.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.62 -26.41 64.42 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.237 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.18 -168.02 40.17 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.7 -175.54 30.78 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -158.43 20.38 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 -174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -128.57 154.02 46.62 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.839 -0.801 . . . . 0.0 108.869 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.1 mt -124.96 142.11 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 m -140.08 164.56 29.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.531 1.533 . . . . 0.0 108.366 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -135.82 159.96 40.06 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.836 1.254 . . . . 0.0 108.547 174.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -144.47 97.95 3.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.202 1.401 . . . . 0.0 107.666 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 m -61.58 -10.68 8.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.001 0.921 . . . . 0.0 112.888 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -63.65 -27.02 68.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.867 1.267 . . . . 0.0 111.375 170.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -141.19 -0.45 1.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -172.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 mptt 51.0 55.18 9.96 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.836 1.655 . . . . 0.0 110.609 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -146.5 103.65 3.69 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.864 0.866 . . . . 0.0 109.065 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.46 ' HB ' HG12 ' A' ' 118' ' ' VAL . 4.5 mt -58.01 151.76 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -134.63 153.72 51.84 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.563 1.145 . . . . 0.0 108.666 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.0 t -130.34 128.07 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.52 -177.07 6.15 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 121.362 -0.836 . . . . 0.0 110.681 -173.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.01 -169.08 53.25 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -151.92 147.56 26.72 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.593 0.757 . . . . 0.0 109.437 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.8 p -72.16 133.78 45.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -68.99 -27.18 65.47 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.782 -0.574 . . . . 0.0 110.09 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.49 -42.35 64.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.828 0.851 . . . . 0.0 112.384 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -133.65 3.15 3.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -168.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.51 -176.84 54.24 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.793 0.724 . . . . 0.0 111.848 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.22 132.02 23.29 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.674 2.249 . . . . 0.0 110.211 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.9 168.8 19.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -78.93 81.26 5.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 168.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.415 ' HB2' ' CE3' ' A' ' 120' ' ' TRP . 51.5 m80 -56.05 -21.25 20.63 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.568 0.747 . . . . 0.0 112.762 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -44.07 66.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.709 1.203 . . . . 0.0 111.484 169.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.02 -49.53 83.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.6 m -58.4 -50.56 73.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.747 0.819 . . . . 0.0 110.683 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -63.58 -40.01 95.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.072 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.28 -46.51 83.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.927 1.24 . . . . 0.0 110.538 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.17 -43.55 97.96 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.263 0.483 . . . . 0.0 110.437 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.481 HG21 HG11 ' A' ' 118' ' ' VAL . 52.5 mt -59.64 -51.58 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.009 177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -60.98 -36.25 78.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.675 1.579 . . . . 0.0 111.283 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.92 99.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.922 0.783 . . . . 0.0 111.689 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.39 -18.09 37.25 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.264 35.8 p90 40.62 56.35 7.76 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 127.16 2.184 . . . . 0.0 114.209 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.59 -15.49 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.622 2.215 . . . . 0.0 110.447 169.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -141.22 161.65 37.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.444 2.698 . . . . 0.0 105.97 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -59.03 -46.42 88.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.935 0.894 . . . . 0.0 112.759 -169.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -161.0 158.76 28.49 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.402 1.881 . . . . 0.0 106.12 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 109' ' ' ILE . 31.6 m -140.18 169.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.127 0.971 . . . . 0.0 110.374 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -140.66 171.73 13.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.202 1.401 . . . . 0.0 108.885 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 102' ' ' HIS . 9.9 p-90 -143.5 170.76 15.21 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.65 -0.656 . . . . 0.0 109.623 170.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.46 142.33 30.2 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -86.62 47.36 1.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.423 1.089 . . . . 0.0 110.121 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -150.65 179.2 8.39 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.47 1.108 . . . . 0.0 109.666 -171.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.74 -177.32 51.91 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.141 1.353 . . . . 0.0 111.529 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 C--O 1.246 0.897 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 172.343 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.69 167.68 24.01 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.387 1.475 . . . . 0.0 108.678 175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.26 164.01 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.669 0.787 . . . . 0.0 110.875 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.74 174.85 1.27 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.296 0.57 . . . . 0.0 110.438 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -148.34 154.82 40.49 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.602 1.161 . . . . 0.0 107.911 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.0 mt -54.66 -32.3 58.94 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.769 0.828 . . . . 0.0 112.478 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.17 67.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.448 1.022 . . . . 0.0 112.289 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -90.08 -24.44 21.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.439 1.095 . . . . 0.0 111.307 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.32 130.17 89.43 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.2 116.63 3.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.23 2.62 . . . . 0.0 109.785 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.93 -35.84 64.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.822 0.849 . . . . 0.0 113.273 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.51 134.76 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -153.6 108.89 3.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.1 pt -135.75 134.6 51.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.155 0.982 . . . . 0.0 108.441 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -71.25 -19.25 62.38 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -169.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 m 55.77 32.22 19.06 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.154 1.382 . . . . 0.0 112.478 176.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.36 -44.26 91.98 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -169.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.68 -59.34 0.32 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -146.95 127.96 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 169.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -160.56 161.52 32.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.254 1.021 . . . . 0.0 109.393 -176.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.25 160.06 19.94 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.829 -0.545 . . . . 0.0 109.739 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.12 164.57 31.76 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.313 0.645 . . . . 0.0 109.378 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.67 156.02 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.604 1.161 . . . . 0.0 108.529 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -118.53 114.56 23.01 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.61 130.94 71.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -75.27 148.02 39.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.29 119.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -91.32 148.54 22.26 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 p -68.64 102.71 1.55 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.872 0.76 . . . . 0.0 109.712 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.463 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.12 23.75 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.003 0 CA-C-O 116.39 -1.767 . . . . 0.0 114.517 169.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 37.1 Cg_exo -41.85 124.36 2.69 Favored 'Trans proline' 0 C--N 1.361 1.187 0 CA-C-N 123.802 2.394 . . . . 0.0 114.521 173.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 34.22 38.24 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.341 3.056 . . . . 0.0 113.924 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m 52.97 30.31 9.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.224 1.409 . . . . 0.0 112.961 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.22 14.24 5.66 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.797 1.189 . . . . 0.0 112.525 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.26 149.65 90.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.95 0.875 . . . . 0.0 110.793 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.89 -12.32 16.34 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.187 2.591 . . . . 0.0 113.718 -177.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.44 -179.5 8.01 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.874 1.269 . . . . 0.0 109.952 -170.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.65 49.75 2.0 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.823 1.649 . . . . 0.0 109.055 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.54 177.51 5.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.928 0.891 . . . . 0.0 109.045 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -139.34 160.58 39.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.717 0.77 . . . . 0.0 111.125 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -142.41 164.79 29.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 129.105 2.962 . . . . 0.0 105.566 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -128.31 149.57 50.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.09 147.77 33.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.496 0.718 . . . . 0.0 109.829 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.38 119.22 57.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -128.3 145.09 51.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.08 132.15 1.9 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 170.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -151.54 151.69 31.93 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -59.89 -29.37 68.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.7 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -66.28 -27.7 68.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.159 0.89 . . . . 0.0 111.836 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.91 81.97 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -62.06 -15.24 43.32 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 122.943 0.497 . . . . 0.0 111.583 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.76 142.16 38.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.137 1.775 . . . . 0.0 108.014 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -56.17 -31.37 63.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.441 1.496 . . . . 0.0 112.757 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.55 -27.09 68.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.73 -0.607 . . . . 0.0 111.557 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.33 -47.33 70.82 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.677 0.671 . . . . 0.0 110.693 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -39.71 83.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.467 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -61.95 -48.23 81.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.9 1.227 . . . . 0.0 109.927 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -45.81 91.79 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.347 0.976 . . . . 0.0 111.365 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -60.42 -51.18 70.59 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.391 0.677 . . . . 0.0 110.812 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.46 -33.91 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.15 -169.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p -61.16 -35.83 78.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.794 1.634 . . . . 0.0 110.169 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.8 -51.07 59.78 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.9 -44.21 96.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.208 1.004 . . . . 0.0 111.015 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.8 mmt -59.72 -44.4 93.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.696 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -66.69 -33.41 75.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.217 . . . . 0.0 111.976 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.27 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.216 0.916 . . . . 0.0 109.77 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.35 -35.78 80.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.571 0.623 . . . . 0.0 110.393 171.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.41 -8.12 5.32 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.633 2.54 . . . . 0.0 113.127 171.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 94.8 m -77.41 133.0 38.78 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.943 1.697 . . . . 0.0 111.711 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.39 137.3 33.47 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.9 m -144.71 163.96 32.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -155.69 133.85 11.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.653 1.181 . . . . 0.0 108.251 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.84 112.82 4.47 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.7 mt -67.87 -29.83 69.04 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.907 -0.495 . . . . 0.0 110.098 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.18 -171.0 42.87 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.28 -164.68 23.37 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.6 -147.52 8.85 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -171.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -133.63 155.59 49.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 108.217 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.7 mt -125.26 141.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.1 m -138.41 143.33 39.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.606 1.162 . . . . 0.0 108.219 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -122.44 26.96 8.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.484 1.913 . . . . 0.0 108.546 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -129.7 31.87 4.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.133 1.773 . . . . 0.0 109.079 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -63.83 7.52 0.12 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.231 2.612 . . . . 0.0 114.41 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 55.87 26.39 9.65 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.237 1.815 . . . . 0.0 110.647 -169.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -162.81 156.67 20.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.599 2.76 . . . . 0.0 106.104 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -63.27 -29.16 70.54 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -66.09 122.01 16.45 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.546 1.066 . . . . 0.0 109.67 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 88' ' ' ILE . 2.4 mp -64.77 149.67 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 169.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -128.12 147.73 50.55 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.588 -0.695 . . . . 0.0 109.727 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.06 120.58 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.96 -164.98 1.39 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.532 0.733 . . . . 0.0 109.988 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.36 -167.91 54.56 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -153.04 144.43 23.26 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 122.957 0.503 . . . . 0.0 110.786 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.9 m -70.01 140.69 52.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -65.1 -49.61 69.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.14 -24.56 37.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -118.17 -6.74 10.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.94 -179.6 34.6 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.795 0.725 . . . . 0.0 112.408 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.09 136.48 37.92 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.713 2.275 . . . . 0.0 109.976 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.91 169.83 17.16 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.362 0.601 . . . . 0.0 110.078 169.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.09 82.42 6.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -58.44 -18.15 26.29 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.765 -0.584 . . . . 0.0 112.543 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.63 -39.68 68.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.57 1.148 . . . . 0.0 111.861 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 mm -61.7 -49.76 83.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 m -58.19 -51.46 69.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.908 0.883 . . . . 0.0 111.399 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.0 p -64.71 -41.01 96.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.382 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.7 -45.53 93.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 120.011 1.278 . . . . 0.0 110.468 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -65.13 -44.51 88.46 Favored 'General case' 0 N--CA 1.46 0.053 0 O-C-N 121.911 -0.493 . . . . 0.0 111.08 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.439 HG21 HG11 ' A' ' 118' ' ' VAL . 54.8 mt -61.95 -42.12 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.374 0.67 . . . . 0.0 109.263 177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.415 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 93.2 mttt -63.57 -38.0 89.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 120.111 1.323 . . . . 0.0 110.895 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.53 -44.88 85.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.84 0.745 . . . . 0.0 111.153 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -63.43 -36.28 83.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.256 1.022 . . . . 0.0 111.41 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 24.7 t80 43.8 63.24 8.38 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.945 2.098 . . . . 0.0 111.215 -169.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.29 -23.62 32.73 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.831 2.354 . . . . 0.0 112.364 -173.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -157.2 -45.42 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.579 0.752 . . . . 0.0 111.806 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -157.4 179.44 9.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.394 1.078 . . . . 0.0 109.564 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.415 ' HG3' ' HE2' ' A' ' 110' ' ' LYS . 29.5 tt0 -64.07 162.42 14.24 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.885 0.874 . . . . 0.0 109.583 169.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.502 HG12 ' HB ' ' A' ' 88' ' ' ILE . 18.8 m -141.2 166.43 18.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 -176.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.6 p -139.5 172.54 12.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.565 1.146 . . . . 0.0 109.456 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -143.88 167.78 21.52 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.159 0.583 . . . . 0.0 110.315 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.17 143.12 25.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 169.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -84.36 52.4 2.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.773 0.829 . . . . 0.0 109.283 175.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -149.94 -166.83 2.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.25 1.82 . . . . 0.0 107.714 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.38 -166.8 54.8 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.591 1.087 . . . . 0.0 111.424 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.548 1.539 . . . . 0.0 107.149 -177.795 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.83 158.46 21.91 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.32 130.61 47.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.8 -177.41 4.32 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.077 0.951 . . . . 0.0 110.764 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -148.44 155.41 41.17 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.217 1.807 . . . . 0.0 106.158 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.88 -28.44 64.19 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.197 0.908 . . . . 0.0 112.848 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.7 63.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.294 0.952 . . . . 0.0 112.293 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.1 -28.1 19.22 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.513 1.125 . . . . 0.0 111.212 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.67 129.02 76.41 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.67 131.36 33.09 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.658 2.906 . . . . 0.0 110.707 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.21 -43.34 8.88 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.46 142.07 31.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -156.18 116.36 3.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 pt -141.67 156.33 20.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.279 1.432 . . . . 0.0 107.598 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.27 139.8 58.65 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -65.93 -27.82 68.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -170.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -165.28 104.92 0.75 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.652 1.114 . . . . 0.0 109.84 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.62 -165.89 33.9 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -131.17 119.53 44.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -160.07 161.2 33.84 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.951 0.9 . . . . 0.0 109.41 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -86.77 158.77 19.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.36 166.58 24.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.901 0.88 . . . . 0.0 109.209 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.06 154.74 21.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.108 0.963 . . . . 0.0 108.799 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.93 119.35 34.55 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.78 135.41 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 119.401 1.0 . . . . 0.0 110.423 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -79.99 146.62 31.94 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 124.84 33.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -93.76 153.28 18.4 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.509 0.724 . . . . 0.0 109.891 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m -67.85 87.92 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.297 1.039 . . . . 0.0 109.56 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.31 24.37 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 116.584 -1.674 . . . . 0.0 114.499 169.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.02 129.94 5.75 Favored 'Trans proline' 0 C--N 1.359 1.089 0 CA-C-N 123.551 2.304 . . . . 0.0 113.075 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 43.7 27.2 0.15 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.928 2.491 . . . . 0.0 113.901 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 50.1 32.38 5.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.401 1.481 . . . . 0.0 112.677 -175.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.24 15.1 1.48 Allowed Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.55 -172.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.93 151.58 89.17 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 118.251 1.025 . . . . 0.0 110.73 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.85 -0.38 10.64 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.581 2.854 . . . . 0.0 114.547 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.0 178.39 8.98 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.689 1.195 . . . . 0.0 110.032 -170.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.21 36.82 3.2 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.364 1.466 . . . . 0.0 110.466 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -69.59 172.42 7.4 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.3 m -135.99 160.94 37.07 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.562 0.745 . . . . 0.0 110.361 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.11 162.81 30.74 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.547 1.539 . . . . 0.0 107.579 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.49 134.95 54.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 171.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 pt -121.57 161.64 21.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.667 1.187 . . . . 0.0 110.383 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.55 124.03 53.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.48 155.02 49.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.68 136.02 3.83 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -149.48 152.05 34.97 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -174.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.62 -33.47 72.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.53 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -64.91 -29.81 70.77 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.018 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.73 75.32 3.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 109.35 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.79 -10.46 37.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.536 173.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.51 142.57 35.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.667 1.587 . . . . 0.0 107.718 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -58.24 -33.79 69.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.968 1.307 . . . . 0.0 111.63 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.93 67.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.123 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.47 -42.34 87.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.097 0.862 . . . . 0.0 110.295 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -38.31 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 117.369 -1.301 . . . . 0.0 110.616 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.09 -43.01 95.83 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.259 1.391 . . . . 0.0 109.453 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.05 -50.57 72.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.128 0.876 . . . . 0.0 111.32 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -48.74 78.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.219 0.533 . . . . 0.0 109.8 -174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -78.43 -44.75 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.385 -169.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.9 p -62.42 -31.38 72.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.577 1.535 . . . . 0.0 110.512 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.52 -52.17 48.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.19 -44.84 90.75 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.415 1.108 . . . . 0.0 111.384 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.6 mmt -57.04 -49.25 76.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.893 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.713 1.142 . . . . 0.0 111.988 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.74 -43.5 98.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.212 0.915 . . . . 0.0 109.756 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.66 -35.93 82.61 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.943 0.792 . . . . 0.0 110.379 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.2 -12.55 3.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.915 2.197 . . . . 0.0 112.98 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.3 m -74.34 121.46 21.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.959 1.703 . . . . 0.0 112.887 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.33 143.65 42.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 168.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.3 m -145.16 166.99 23.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.588 0.755 . . . . 0.0 112.498 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -149.48 134.01 17.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.67 1.188 . . . . 0.0 108.65 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -70.62 113.23 7.52 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.7 mt -70.72 -25.32 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.764 -0.585 . . . . 0.0 110.182 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.65 -169.74 42.26 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -170.73 23.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.16 -155.61 17.39 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.2 ttm105 -126.39 153.61 44.74 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.514 0.726 . . . . 0.0 109.174 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 mt -123.05 141.77 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.7 m -158.4 161.28 37.51 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.645 1.178 . . . . 0.0 108.459 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.18 160.73 31.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 168.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -62.03 -20.97 64.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.05 1.34 . . . . 0.0 112.224 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.0 m 72.85 -47.19 0.67 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.804 2.441 . . . . 0.0 111.0 -175.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -67.99 -17.45 64.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.481 0.713 . . . . 0.0 110.376 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -152.79 163.72 39.18 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.514 1.926 . . . . 0.0 107.208 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -74.95 -14.96 60.69 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.184 -0.912 . . . . 0.0 112.11 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -42.82 132.21 3.9 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.3 1.44 . . . . 0.0 109.832 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.6 mm -74.23 159.91 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.617 0.722 . . . . 0.0 109.06 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -140.29 151.01 44.75 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.117 1.767 . . . . 0.0 107.917 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 t -133.34 126.11 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.15 -179.8 8.33 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.81 -0.557 . . . . 0.0 110.757 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.68 -162.03 52.87 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -149.57 151.92 34.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.84 1.256 . . . . 0.0 108.64 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -73.58 131.07 41.31 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.91 -28.78 69.77 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.189 -0.32 . . . . 0.0 110.347 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.93 -35.74 17.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.638 0.775 . . . . 0.0 112.153 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.89 2.13 7.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.74 44.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 118.691 0.678 . . . . 0.0 111.988 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.92 136.55 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.225 1.95 . . . . 0.0 109.955 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.96 178.2 3.88 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -61.17 -34.37 74.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.704 -0.622 . . . . 0.0 111.375 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.3 m80 59.21 -32.85 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.07 2.948 . . . . 0.0 115.682 -173.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.49 81.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.785 1.175 . . . . 0.0 110.723 170.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.5 mm -53.88 -50.6 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.344 1.058 . . . . 0.0 108.644 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -58.92 -50.26 74.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.315 1.046 . . . . 0.0 110.363 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -48.65 74.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.813 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.11 -44.83 91.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.343 0.974 . . . . 0.0 110.845 -175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -67.13 -41.63 85.81 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.84 -0.538 . . . . 0.0 110.903 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.1 mt -59.84 -47.66 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 -33.88 75.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.01 1.277 . . . . 0.0 111.649 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.04 96.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.437 1.017 . . . . 0.0 111.324 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.4 -17.66 26.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 46.32 57.1 16.74 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.916 1.686 . . . . 0.0 114.208 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.25 -19.19 44.55 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 121.773 1.649 . . . . 0.0 110.256 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -146.26 165.22 29.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.244 2.618 . . . . 0.0 106.067 169.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -59.82 -37.53 79.44 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.891 0.876 . . . . 0.0 113.207 -170.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -159.38 171.47 19.71 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.965 0.906 . . . . 0.0 108.63 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.05 162.22 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.076 1.35 . . . . 0.0 108.031 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.5 p -138.26 171.82 13.82 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.709 1.603 . . . . 0.0 108.519 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -145.04 169.34 18.29 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.469 -0.769 . . . . 0.0 111.145 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.42 143.24 31.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -87.61 32.34 0.73 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.209 1.004 . . . . 0.0 111.47 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -156.11 178.9 9.76 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.007 1.323 . . . . 0.0 108.399 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.16 178.83 16.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.939 1.733 . . . . 0.0 111.071 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.533 1.933 . . . . 0.0 106.145 174.172 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 tpp . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.72 148.33 46.94 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.1 0.56 . . . . 0.0 110.77 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.9 m -68.02 160.16 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.728 0.811 . . . . 0.0 110.367 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.25 173.66 4.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -146.52 155.26 42.39 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.035 0.934 . . . . 0.0 108.901 -175.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 mt -53.74 -30.71 45.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.499 1.12 . . . . 0.0 113.484 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.59 -24.19 60.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.78 0.718 . . . . 0.0 112.266 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.31 -19.93 26.07 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.292 1.037 . . . . 0.0 111.108 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.09 131.01 80.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.51 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.348 2.699 . . . . 0.0 109.961 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.29 -34.71 70.9 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.564 0.746 . . . . 0.0 112.261 -169.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.0 t -142.56 135.26 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -154.61 105.57 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt -133.94 149.79 30.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.749 0.82 . . . . 0.0 109.588 -173.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -69.81 172.22 7.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.244 1.818 . . . . 0.0 110.801 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -143.92 -2.6 0.91 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.284 1.834 . . . . 0.0 111.864 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.2 -28.36 69.32 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -169.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.44 -153.44 14.33 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -173.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.88 142.45 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 169.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -155.96 166.89 32.13 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.549 1.139 . . . . 0.0 109.963 172.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.68 154.4 17.31 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.03 168.53 19.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 109.116 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.62 154.23 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.111 1.364 . . . . 0.0 108.002 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.6 tp -118.17 114.91 23.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.58 131.53 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -174.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -78.59 144.96 35.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.97 141.72 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -108.01 149.65 28.13 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.879 1.272 . . . . 0.0 109.633 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 m -63.68 99.95 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.365 0.666 . . . . 0.0 110.912 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.547 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -154.23 21.71 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 116.347 -1.787 . . . . 0.0 114.847 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.0 Cg_exo -46.99 136.85 17.29 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 124.327 2.581 . . . . 0.0 113.067 172.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? 46.41 25.05 0.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.153 2.181 . . . . 0.0 113.821 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 50.77 32.71 7.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.017 1.327 . . . . 0.0 112.351 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.68 23.74 1.98 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.934 0.778 . . . . 0.0 112.586 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.99 150.21 83.85 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 117.769 0.784 . . . . 0.0 110.691 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.87 -8.04 17.72 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.308 2.672 . . . . 0.0 113.743 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.56 -174.95 5.14 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.305 1.442 . . . . 0.0 109.447 -171.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.07 51.91 2.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.031 1.733 . . . . 0.0 108.701 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.13 -178.14 4.88 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.1 m -152.82 159.34 43.06 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.772 -1.205 . . . . 0.0 110.028 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.73 167.81 29.2 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.826 1.65 . . . . 0.0 108.785 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.01 152.74 24.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -129.85 153.41 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.752 1.221 . . . . 0.0 109.013 172.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.4 t -119.92 115.08 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -136.06 148.18 48.21 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.95 136.69 2.57 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 4.2 m-85 -156.29 152.31 27.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -172.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.53 -31.46 69.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.001 -0.524 . . . . 0.0 112.168 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.431 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -64.32 -27.54 69.1 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.828 0.74 . . . . 0.0 112.363 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 82.15 8.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.692 1.133 . . . . 0.0 108.267 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.52 -14.09 47.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.702 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.53 143.99 35.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.769 1.628 . . . . 0.0 108.418 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.45 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 21.2 m-70 -62.11 -30.7 71.2 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.736 1.214 . . . . 0.0 111.779 -174.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.01 -28.55 69.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.722 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.21 -47.79 72.72 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 110.549 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -40.37 82.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.262 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -58.61 -46.54 86.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.325 1.421 . . . . 0.0 110.02 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.31 -48.67 72.28 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.288 0.495 . . . . 0.0 111.451 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -60.18 -51.86 67.79 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.106 0.563 . . . . 0.0 110.864 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.32 -45.22 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.869 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -63.29 -28.37 69.97 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.731 1.15 . . . . 0.0 111.352 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.19 -49.38 75.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -63.57 -46.51 85.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.053 0.927 . . . . 0.0 110.708 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.3 mmt -58.36 -43.61 88.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.853 -0.529 . . . . 0.0 111.502 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.94 -33.31 73.52 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.103 -0.998 . . . . 0.0 111.875 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -61.22 -42.71 99.08 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.022 0.828 . . . . 0.0 109.617 170.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -60.71 -44.06 97.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.128 0.876 . . . . 0.0 109.706 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.71 -6.74 1.44 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.073 1.796 . . . . 0.0 113.28 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.63 177.99 4.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.645 1.578 . . . . 0.0 113.319 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.25 144.71 51.51 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 169.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.3 m -145.32 165.48 28.33 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -168.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.77 128.72 11.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.313 1.045 . . . . 0.0 108.525 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -67.47 115.33 6.96 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.6 mt -71.9 -26.51 62.35 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.005 -0.435 . . . . 0.0 110.451 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.05 -168.73 40.98 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.98 -172.0 28.81 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 173.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.13 -168.11 35.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -119.3 154.91 32.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 mt -128.79 133.77 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 m -141.59 140.77 33.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 108.595 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.34 156.83 33.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.396 0.678 . . . . 0.0 109.898 169.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -121.88 89.25 3.08 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.3 m -54.29 -16.98 2.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.115 1.366 . . . . 0.0 114.156 -172.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -59.03 -35.63 73.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.533 1.533 . . . . 0.0 111.416 172.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -149.58 15.1 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.975 0.91 . . . . 0.0 112.328 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.2 tttm 68.24 -52.99 0.54 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 129.011 2.924 . . . . 0.0 114.024 -172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -33.67 120.24 0.4 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.413 1.885 . . . . 0.0 112.099 -169.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.88 165.32 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.985 0.897 . . . . 0.0 110.861 172.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -134.09 149.75 51.13 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.398 1.879 . . . . 0.0 106.987 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.0 t -125.5 121.56 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.22 -176.32 5.57 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.461 -0.774 . . . . 0.0 111.586 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.75 -159.15 53.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.06 152.36 36.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.012 1.325 . . . . 0.0 108.188 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -77.03 130.54 37.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.6 mtp -64.32 -27.73 69.22 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.677 -0.639 . . . . 0.0 110.553 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.01 -38.03 45.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.159 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.9 3.33 3.2 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.75 -178.69 50.03 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.019 0.818 . . . . 0.0 112.038 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 133.96 23.95 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.653 2.235 . . . . 0.0 110.162 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.35 167.86 21.09 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.305 0.574 . . . . 0.0 110.027 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -80.29 82.15 6.39 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -59.04 -17.27 23.99 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.624 -0.673 . . . . 0.0 112.463 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.42 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.392 1.077 . . . . 0.0 111.934 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.78 -48.42 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.2 m -58.81 -50.03 75.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.752 0.821 . . . . 0.0 111.349 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 p -59.78 -44.16 94.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.945 0.793 . . . . 0.0 111.385 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.57 -48.24 80.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.784 0.72 . . . . 0.0 110.314 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.71 -47.83 76.87 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.158 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -62.21 -45.53 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -61.63 -38.49 87.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.426 1.466 . . . . 0.0 110.984 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.81 -47.71 68.31 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.792 0.723 . . . . 0.0 111.84 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -80.35 -15.08 57.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.791 0.836 . . . . 0.0 112.009 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.5 t80 57.52 43.28 1.01 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 126.575 1.95 . . . . 0.0 115.519 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -59.42 -26.08 80.73 Favored 'Trans proline' 0 C--N 1.36 1.165 0 CA-C-N 122.322 1.865 . . . . 0.0 112.412 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -143.62 166.34 25.11 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.169 2.187 . . . . 0.0 107.017 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -56.8 -38.36 72.43 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.162 0.985 . . . . 0.0 112.303 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -167.49 174.12 8.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.3 2.24 . . . . 0.0 105.568 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.49 163.55 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.205 . . . . 0.0 107.911 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -140.1 166.83 23.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.718 1.607 . . . . 0.0 108.562 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -147.82 168.57 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.285 -0.885 . . . . 0.0 112.61 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.34 143.63 31.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.419 1.488 . . . . 0.0 107.098 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -81.36 22.45 0.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.488 1.115 . . . . 0.0 112.132 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.21 164.18 33.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.52 1.528 . . . . 0.0 109.398 -171.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.75 172.73 17.32 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.452 1.025 . . . . 0.0 111.084 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.246 0.907 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.732 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.74 162.02 5.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.694 0.798 . . . . 0.0 111.547 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.28 159.72 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 110.794 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.51 167.79 10.21 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -144.61 151.84 39.62 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.674 0.79 . . . . 0.0 108.95 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.72 -32.02 40.78 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.057 1.343 . . . . 0.0 113.595 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.61 58.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.795 0.725 . . . . 0.0 112.304 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.78 -20.18 27.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.175 0.99 . . . . 0.0 111.106 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.7 mt -58.53 133.76 85.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.98 111.19 0.55 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.841 3.028 . . . . 0.0 110.563 171.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.59 -35.73 52.61 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.3 t -137.86 136.47 45.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.9 101.01 2.86 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 pt -144.85 172.48 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.246 2.218 . . . . 0.0 107.184 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -131.88 100.66 5.15 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.239 1.016 . . . . 0.0 109.606 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -60.69 -13.1 12.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.575 1.55 . . . . 0.0 114.178 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.0 -13.8 60.23 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.3 0.955 . . . . 0.0 111.973 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.22 177.27 17.18 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.459 1.028 . . . . 0.0 112.996 -172.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.0 t -138.04 123.93 25.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -169.26 168.67 9.63 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.687 0.795 . . . . 0.0 110.235 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -77.11 160.47 29.0 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 122.059 -0.4 . . . . 0.0 110.149 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.04 167.13 22.79 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.706 1.202 . . . . 0.0 109.168 -174.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.33 155.62 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.4 tp -118.73 117.66 29.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.282 0.0 OUTLIER -128.28 128.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 118.724 0.693 . . . . 0.0 109.736 -173.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -76.72 146.93 37.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.54 1.536 . . . . 0.0 108.279 172.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.2 139.1 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -108.91 143.4 38.19 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.735 1.214 . . . . 0.0 107.882 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 p -67.95 106.03 2.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.581 0.628 . . . . 0.0 110.818 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.55 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.47 17.22 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 116.212 -1.851 . . . . 0.0 115.362 169.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.55 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 90.1 Cg_exo -43.94 135.91 7.6 Favored 'Trans proline' 0 C--N 1.362 1.27 0 CA-C-N 124.185 2.53 . . . . 0.0 114.427 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 45.15 27.47 0.32 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.956 2.102 . . . . 0.0 113.576 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 50.84 31.87 6.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.457 1.503 . . . . 0.0 112.545 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.99 15.88 3.03 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 123.768 0.699 . . . . 0.0 112.974 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.53 148.24 86.68 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 118.178 0.989 . . . . 0.0 110.401 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.47 -11.46 17.23 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.058 2.506 . . . . 0.0 113.954 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.98 -178.95 7.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.855 1.262 . . . . 0.0 109.89 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.8 49.38 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.002 1.721 . . . . 0.0 108.944 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -75.36 173.17 11.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.437 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -144.57 155.65 43.76 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.388 0.675 . . . . 0.0 110.691 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.67 166.54 33.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.696 1.598 . . . . 0.0 108.963 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.64 155.6 19.97 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -174.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.41 155.28 41.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.398 1.079 . . . . 0.0 108.836 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.07 121.5 67.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -131.52 148.83 52.66 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.879 1.271 . . . . 0.0 107.799 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.25 131.7 1.8 Allowed Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -154.54 152.84 30.54 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.41 -31.75 71.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.134 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -64.86 -25.85 68.08 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.53 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.38 88.21 7.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 119.632 1.105 . . . . 0.0 109.028 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.0 -5.5 22.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 0.0 112.187 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.59 147.93 28.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.588 1.555 . . . . 0.0 108.319 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -60.67 -34.25 74.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 111.437 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.5 -27.54 67.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 118.627 -0.701 . . . . 0.0 112.215 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.65 -49.14 61.5 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.243 0.929 . . . . 0.0 110.603 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.402 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.83 -40.28 85.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.32 177.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -61.25 -49.84 75.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.095 0.861 . . . . 0.0 109.617 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.87 -46.37 89.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.393 0.997 . . . . 0.0 111.101 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -58.26 -52.62 64.8 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.566 0.747 . . . . 0.0 110.837 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.41 -34.37 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.457 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -59.48 -38.41 80.77 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.01 1.277 . . . . 0.0 109.245 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.89 87.34 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.821 0.737 . . . . 0.0 111.553 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.73 -45.31 90.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.257 1.029 . . . . 0.0 111.38 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -60.19 -44.65 94.93 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.862 -0.524 . . . . 0.0 110.795 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -65.65 -32.78 74.54 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.237 -0.915 . . . . 0.0 111.543 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -64.23 -39.1 93.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.464 171.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.26 -42.47 95.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.634 1.106 . . . . 0.0 109.262 169.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.41 -4.66 2.29 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.307 1.908 . . . . 0.0 112.939 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.9 m -69.11 178.46 2.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.484 1.513 . . . . 0.0 112.982 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -129.3 146.78 51.13 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.4 m -148.9 165.67 30.86 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -168.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -155.69 129.4 8.49 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.571 1.148 . . . . 0.0 109.585 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.75 115.66 10.16 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.0 mt -73.09 -25.2 60.79 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.179 0.591 . . . . 0.0 111.019 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.66 179.79 43.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.67 173.59 21.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.58 -158.9 24.52 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -136.02 153.09 51.47 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.118 1.367 . . . . 0.0 109.635 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 mt -115.48 126.25 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.5 m -153.02 162.58 41.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.686 0.795 . . . . 0.0 108.867 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -71.89 142.72 49.52 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -74.15 -14.28 60.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.414 0.686 . . . . 0.0 110.589 169.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m 63.28 4.1 1.56 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.021 2.128 . . . . 0.0 114.782 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -77.19 -43.0 35.36 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.795 0.725 . . . . 0.0 109.334 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -157.53 45.17 0.36 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.87 1.268 . . . . 0.0 109.732 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt 63.82 -16.3 0.07 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.289 2.236 . . . . 0.0 115.393 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -45.66 124.96 5.5 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.444 1.898 . . . . 0.0 110.74 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.2 mm -65.83 152.92 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 122.026 0.917 . . . . 0.0 109.321 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -139.63 150.96 45.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.991 2.116 . . . . 0.0 107.39 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -132.45 120.28 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -172.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -158.87 179.54 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.45 -163.33 15.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.459 1.027 . . . . 0.0 113.218 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -153.63 164.51 38.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.071 2.148 . . . . 0.0 107.251 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 t -135.55 127.45 29.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.8 tpp -62.84 -30.51 71.55 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 170.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.85 -35.93 32.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.404 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -131.24 -1.21 4.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.51 177.27 43.81 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 119.162 0.892 . . . . 0.0 111.686 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.01 138.09 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.472 2.115 . . . . 0.0 109.326 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.79 160.9 30.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.344 0.592 . . . . 0.0 110.813 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -82.05 78.0 8.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -54.61 -21.67 11.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.23 0.612 . . . . 0.0 112.403 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.89 65.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.15 1.38 . . . . 0.0 112.861 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.15 -47.71 92.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -61.38 -49.36 77.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.017 0.927 . . . . 0.0 111.201 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 p -59.29 -40.29 85.68 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.958 0.799 . . . . 0.0 111.783 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.63 -47.2 82.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.569 1.077 . . . . 0.0 110.375 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.75 -44.84 88.82 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.944 -0.472 . . . . 0.0 111.303 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.07 -47.44 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.38 -34.47 73.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.336 1.426 . . . . 0.0 111.569 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.83 89.22 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.522 1.056 . . . . 0.0 111.777 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -84.25 -16.07 44.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 49.27 47.06 4.32 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -59.43 -23.59 71.12 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 122.198 1.821 . . . . 0.0 111.417 168.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -138.41 162.65 33.91 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.996 2.118 . . . . 0.0 106.253 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -59.79 -38.77 82.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.877 0.871 . . . . 0.0 111.556 -173.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.88 166.26 34.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.569 1.948 . . . . 0.0 105.778 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 m -141.4 166.01 18.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.436 1.094 . . . . 0.0 109.164 169.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 p -134.13 171.47 14.18 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.943 1.297 . . . . 0.0 108.968 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -142.01 171.55 13.9 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.836 -0.54 . . . . 0.0 111.983 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.09 143.74 31.96 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.768 1.227 . . . . 0.0 107.716 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -85.21 25.59 0.97 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.627 1.171 . . . . 0.0 111.757 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -156.92 -179.83 8.59 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.88 1.272 . . . . 0.0 108.556 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 134.75 -178.29 18.6 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.227 1.87 . . . . 0.0 110.893 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.6 p90 . . . . . 0 C--O 1.247 0.97 0 C-N-CA 126.628 1.971 . . . . 0.0 106.54 169.927 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.54 155.94 36.32 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.92 0.488 . . . . 0.0 109.967 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.36 149.62 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.828 -0.545 . . . . 0.0 109.748 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.46 175.99 8.67 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -149.32 153.4 37.42 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.084 0.953 . . . . 0.0 108.923 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.16 -27.58 62.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.787 0.835 . . . . 0.0 113.146 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.76 67.05 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.182 0.901 . . . . 0.0 112.61 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -77.6 -19.75 55.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.33 0.652 . . . . 0.0 111.649 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.88 139.88 97.92 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.03 110.59 1.19 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.917 2.412 . . . . 0.0 108.932 170.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.72 -33.36 64.33 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.986 0.914 . . . . 0.0 113.395 -169.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.9 t -136.81 133.4 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -157.85 110.55 2.4 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 170.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt -144.68 169.98 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.109 0.963 . . . . 0.0 110.194 -171.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -133.31 158.23 43.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.296 1.838 . . . . 0.0 106.445 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.8 m -153.73 15.14 0.49 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.232 1.413 . . . . 0.0 111.346 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.89 -21.69 31.51 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.024 0.93 . . . . 0.0 112.944 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -149.91 -177.88 24.34 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.185 1.85 . . . . 0.0 108.959 171.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.18 115.16 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -133.6 158.96 41.88 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.392 1.077 . . . . 0.0 108.959 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -78.81 163.4 25.37 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.886 -0.509 . . . . 0.0 110.129 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.34 166.67 24.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.559 1.143 . . . . 0.0 108.586 173.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.48 155.84 13.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.7 tp -118.44 116.65 27.13 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.28 0.0 OUTLIER -125.46 128.47 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-N 118.474 0.579 . . . . 0.0 109.671 -172.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -78.35 148.48 33.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.287 1.435 . . . . 0.0 108.415 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.2 139.37 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -108.67 146.66 33.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.387 1.475 . . . . 0.0 108.82 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -68.63 88.77 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.011 0.925 . . . . 0.0 112.457 -173.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.464 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -139.81 16.34 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 116.433 -1.746 . . . . 0.0 113.743 168.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 53.1 Cg_exo -47.85 143.45 13.17 Favored 'Trans proline' 0 C--N 1.362 1.258 0 CA-C-N 123.939 2.443 . . . . 0.0 113.33 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 41.26 31.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.636 2.374 . . . . 0.0 113.301 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.9 m 52.33 28.69 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.178 1.791 . . . . 0.0 113.374 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.37 19.58 0.12 Allowed Glycine 0 C--N 1.341 0.857 0 CA-C-O 118.709 -1.05 . . . . 0.0 114.648 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.27 146.27 16.68 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 118.73 1.265 . . . . 0.0 110.57 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.45 4.21 4.65 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.858 3.039 . . . . 0.0 115.921 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.2 -177.87 6.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.331 1.052 . . . . 0.0 110.087 -172.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.91 38.21 4.06 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.621 1.568 . . . . 0.0 109.756 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -67.53 165.72 16.27 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -140.55 155.94 46.46 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.014 0.926 . . . . 0.0 108.986 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HE2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -153.24 166.55 32.21 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.192 1.397 . . . . 0.0 108.694 176.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -108.4 156.28 19.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.404 HG23 ' HE2' ' A' ' 41' ' ' LYS . 30.7 pt -130.82 154.67 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.463 1.105 . . . . 0.0 108.826 172.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.79 119.85 63.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -132.07 147.61 52.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.231 1.412 . . . . 0.0 108.447 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.36 126.29 0.93 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -151.16 162.1 41.51 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.475 0.71 . . . . 0.0 109.842 -172.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -55.28 -43.38 74.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.833 0.853 . . . . 0.0 112.113 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -66.94 -27.32 67.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.457 -173.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.59 86.54 7.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.339 0.972 . . . . 0.0 108.516 172.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.42 -14.31 55.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.841 0.456 . . . . 0.0 111.664 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 144.5 33.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.03 1.732 . . . . 0.0 108.836 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.556 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 6.1 m-70 -58.14 -32.99 68.69 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.872 1.669 . . . . 0.0 112.079 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.39 -29.03 70.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.61 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.64 -49.23 63.97 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.76 0.709 . . . . 0.0 110.539 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -64.86 -40.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.331 177.099 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.527 0.603 . . . . 0.0 110.017 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.08 -46.89 76.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.662 0.664 . . . . 0.0 111.507 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.99 -56.16 18.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.582 1.153 . . . . 0.0 110.002 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.2 t -78.47 -35.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 117.797 -1.097 . . . . 0.0 110.456 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.4 m -62.36 -31.65 72.33 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 120.314 1.415 . . . . 0.0 110.939 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.63 -47.97 87.25 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.176 0.898 . . . . 0.0 110.974 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.04 -46.28 85.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.074 0.937 . . . . 0.0 111.028 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.5 mmt -59.56 -42.83 93.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.525 0.602 . . . . 0.0 110.882 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -67.86 -32.57 73.17 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.91 -1.119 . . . . 0.0 111.339 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -64.17 -40.56 96.38 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.032 0.833 . . . . 0.0 110.143 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -62.35 -33.28 74.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.316 0.962 . . . . 0.0 110.619 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.99 -6.9 4.42 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.444 1.973 . . . . 0.0 113.164 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.1 m -70.64 -179.72 2.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.272 1.829 . . . . 0.0 114.446 -169.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -130.09 151.09 51.0 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.2 165.01 31.34 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.79 129.65 9.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.678 1.191 . . . . 0.0 109.443 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.7 113.48 8.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.6 mt -68.06 -29.74 68.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.912 -0.492 . . . . 0.0 110.129 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.01 -173.46 45.15 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.84 -177.1 24.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.95 -155.75 16.25 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -136.41 167.37 21.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.904 0.852 . . . . 0.0 110.752 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 mt -136.36 142.57 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.694 1.998 . . . . 0.0 107.273 -169.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.7 m -149.52 162.51 40.01 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 109.142 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -101.67 127.02 48.6 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -76.01 171.57 14.23 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.121 0.968 . . . . 0.0 110.673 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 m -125.84 -28.44 3.22 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.126 0.971 . . . . 0.0 111.313 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -61.53 -27.86 68.9 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.731 0.812 . . . . 0.0 111.716 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -145.98 152.37 39.28 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 169.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -91.24 62.16 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.334 -0.854 . . . . 0.0 109.882 -169.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -147.45 170.75 16.72 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.559 0.744 . . . . 0.0 111.677 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.8 mm -80.38 166.92 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.581 0.753 . . . . 0.0 109.206 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -143.54 149.33 37.29 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.881 1.272 . . . . 0.0 107.988 169.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.22 121.96 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -159.74 -175.19 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.324 -0.86 . . . . 0.0 111.169 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.05 30.85 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.837 0.687 . . . . 0.0 112.834 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -137.78 143.11 40.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 t -65.45 146.56 54.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.5 ptp -72.87 -12.86 61.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.283 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.74 -14.76 3.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.194 0.998 . . . . 0.0 113.388 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -134.79 -177.29 4.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.2 1.8 . . . . 0.0 108.443 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.67 173.39 44.27 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 170.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.94 139.32 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.094 1.862 . . . . 0.0 108.457 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.97 164.67 25.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.606 0.717 . . . . 0.0 111.081 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.37 74.03 7.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -56.37 -20.52 19.68 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.47 60.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.035 0.934 . . . . 0.0 111.618 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.87 -43.95 99.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.408 1.083 . . . . 0.0 109.284 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -59.43 -50.78 72.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.416 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -57.02 -44.32 82.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.48 0.582 . . . . 0.0 111.304 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.69 -50.61 71.78 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.809 0.731 . . . . 0.0 110.505 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.98 -43.13 72.11 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.899 -0.501 . . . . 0.0 111.361 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.45 -46.76 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.93 -32.79 74.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.283 1.402 . . . . 0.0 111.379 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.32 94.97 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.405 1.002 . . . . 0.0 111.537 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -86.88 -20.0 28.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 41.97 57.88 10.05 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.646 1.578 . . . . 0.0 113.307 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.93 -15.8 32.69 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.01 1.807 . . . . 0.0 110.813 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -144.78 177.83 8.43 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.584 2.354 . . . . 0.0 106.7 170.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -64.04 -46.45 84.39 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.41 1.084 . . . . 0.0 111.838 -171.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 118' ' ' VAL . 26.7 tt0 -161.48 177.75 9.77 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.428 ' H ' ' HG2' ' A' ' 117' ' ' GLU . 7.1 p -158.06 162.36 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.593 1.557 . . . . 0.0 107.329 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.9 p -143.4 173.9 11.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 107.661 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.71 166.77 23.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.582 0.628 . . . . 0.0 111.068 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.16 143.5 26.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -87.26 27.59 1.04 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.97 1.308 . . . . 0.0 111.733 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -146.98 -165.08 2.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.661 1.584 . . . . 0.0 107.986 -170.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.11 -20.13 27.15 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.871 1.224 . . . . 0.0 113.479 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 127.688 2.395 . . . . 0.0 110.849 176.53 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.87 164.76 35.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 108.676 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.92 163.86 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.779 0.832 . . . . 0.0 110.687 174.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.13 177.71 1.34 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.389 0.614 . . . . 0.0 109.996 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -146.36 155.19 42.43 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.9 mt -52.35 -34.67 48.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.833 0.853 . . . . 0.0 112.942 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.19 62.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.671 0.669 . . . . 0.0 112.236 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.15 -19.76 28.0 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.099 0.959 . . . . 0.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.1 mt -59.28 128.82 86.06 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 172.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.57 138.16 58.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.164 2.576 . . . . 0.0 111.035 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -86.56 -41.78 14.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.071 0.396 . . . . 0.0 111.55 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.78 140.56 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 124.721 1.208 . . . . 0.0 107.9 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -157.14 114.19 3.06 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt -142.38 159.66 19.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.258 1.023 . . . . 0.0 108.837 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -61.89 126.42 27.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 169.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 m -66.91 -30.0 70.03 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -169.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -159.27 127.43 5.04 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.193 0.997 . . . . 0.0 108.762 -170.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.42 -158.22 27.57 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 121.651 0.584 . . . . 0.0 112.32 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.0 t -129.2 112.06 24.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -158.69 172.48 18.19 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.378 1.071 . . . . 0.0 109.845 -173.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -113.38 152.36 30.1 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.694 0.797 . . . . 0.0 109.287 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.27 168.7 19.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.671 0.788 . . . . 0.0 109.085 -170.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.26 152.92 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.457 1.503 . . . . 0.0 108.811 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -114.75 114.81 26.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.47 133.94 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.819 0.736 . . . . 0.0 109.329 -175.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -81.38 147.39 29.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.21 143.3 34.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -114.52 146.83 40.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.331 1.452 . . . . 0.0 109.24 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 m -62.68 103.51 0.43 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.288 0.635 . . . . 0.0 111.526 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.84 18.55 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 116.076 -1.916 . . . . 0.0 114.791 169.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 32.7 Cg_exo -40.37 127.79 2.28 Favored 'Trans proline' 0 C--N 1.361 1.224 0 CA-C-N 124.216 2.541 . . . . 0.0 115.093 173.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 31.91 39.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.492 3.117 . . . . 0.0 113.926 -170.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 53.11 31.44 11.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.385 1.474 . . . . 0.0 112.961 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.97 17.39 3.42 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.226 0.917 . . . . 0.0 112.748 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.25 147.88 90.37 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.99 0.895 . . . . 0.0 110.725 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.94 -9.15 15.61 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.28 2.653 . . . . 0.0 113.822 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.07 -173.46 4.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.064 1.345 . . . . 0.0 109.712 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.2 52.87 1.96 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.156 1.782 . . . . 0.0 108.684 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -78.14 -176.35 4.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 172.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 m -151.89 159.31 43.87 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 167.24 28.08 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.006 1.722 . . . . 0.0 108.282 174.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -108.2 157.51 18.25 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.9 pt -137.88 155.33 30.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.283 1.433 . . . . 0.0 108.58 174.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.6 t -119.03 123.77 72.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.407 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.0 mmp_? -135.96 149.26 48.83 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.311 1.044 . . . . 0.0 108.282 176.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.49 135.85 2.42 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 18.8 m-85 -153.92 155.29 35.39 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -60.14 -34.17 73.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.656 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.408 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.0 p-90 -64.28 -28.69 69.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.395 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 77.78 9.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.363 0.983 . . . . 0.0 108.799 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.07 -9.61 17.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.45 140.67 35.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.222 1.409 . . . . 0.0 107.456 174.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.477 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 14.8 m-70 -62.85 -29.86 71.07 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 111.428 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.77 67.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.942 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.4 -48.11 71.14 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.766 0.712 . . . . 0.0 110.501 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.16 -40.74 83.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 117.411 -1.28 . . . . 0.0 109.997 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -58.3 -46.7 85.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 120.608 1.549 . . . . 0.0 110.251 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.77 -49.17 69.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.239 0.472 . . . . 0.0 111.568 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -60.52 -49.3 78.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.349 0.66 . . . . 0.0 110.836 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' HG3' ' A' ' 45' ' ' ARG . 61.2 t -69.44 -44.42 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.056 -175.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.71 -28.92 70.28 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.686 1.13 . . . . 0.0 111.092 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -49.28 72.28 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.365 0.984 . . . . 0.0 110.717 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.11 -46.88 85.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.127 0.963 . . . . 0.0 110.626 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.7 mmt -57.98 -43.41 86.5 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.836 -0.54 . . . . 0.0 111.198 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -68.59 -31.28 70.36 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.862 -1.149 . . . . 0.0 112.248 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.36 -42.47 98.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.489 1.041 . . . . 0.0 109.662 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -62.54 -30.59 71.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.703 0.683 . . . . 0.0 110.55 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.27 -8.55 5.96 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.05 2.262 . . . . 0.0 112.972 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.38 179.96 2.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.547 1.939 . . . . 0.0 113.185 -169.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.14 150.92 52.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.1 m -149.07 165.24 32.32 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.31 128.34 10.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 108.325 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -66.98 116.17 7.52 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.6 -28.37 64.8 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.008 -0.432 . . . . 0.0 109.993 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.56 -163.94 36.52 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.45 -164.33 22.93 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.35 -163.59 29.56 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -122.48 157.62 31.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -131.14 127.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.8 m -152.4 104.95 2.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -162.72 178.98 8.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.794 0.438 . . . . 0.0 110.082 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -118.27 88.27 2.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 170.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.82 -27.85 63.54 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.442 1.097 . . . . 0.0 110.531 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -54.02 -30.45 47.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.252 1.021 . . . . 0.0 112.033 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -86.98 -74.85 0.42 Allowed 'General case' 0 C--N 1.34 0.196 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.33 147.95 17.96 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.713 1.605 . . . . 0.0 107.71 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.0 pttt 47.13 -179.31 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.811 2.844 . . . . 0.0 116.432 170.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.07 171.02 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 171.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -140.53 139.56 35.07 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 t -119.47 130.03 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -161.96 -179.53 7.22 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.155 -0.966 . . . . 0.0 110.828 -170.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.08 -157.93 53.15 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -144.79 153.85 42.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.62 1.568 . . . . 0.0 107.647 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.1 p -70.78 133.9 46.94 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.6 mmt -73.86 32.45 0.08 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.09 1.356 . . . . 0.0 111.108 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.3 -39.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.611 1.565 . . . . 0.0 111.572 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -134.63 2.86 3.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 -175.76 53.62 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.086 0.857 . . . . 0.0 112.181 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.61 135.62 24.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.526 2.15 . . . . 0.0 110.642 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.79 172.43 12.68 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.458 0.647 . . . . 0.0 110.011 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -77.19 79.64 3.71 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 168.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -58.82 -17.77 26.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -174.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.46 82.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.204 0.602 . . . . 0.0 110.378 169.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mm -62.97 -49.7 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.8 m -57.79 -49.75 75.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.119 0.568 . . . . 0.0 109.716 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -65.82 -42.86 90.09 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.514 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.32 -46.4 86.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.2 1.364 . . . . 0.0 110.596 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -69.7 -42.79 73.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.054 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.45 -44.64 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.035 0.834 . . . . 0.0 108.944 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.79 -41.06 99.09 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.016 1.28 . . . . 0.0 111.303 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.65 75.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.624 0.647 . . . . 0.0 111.294 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -73.2 -29.27 62.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.015 0.526 . . . . 0.0 111.193 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 t80 49.73 63.25 10.52 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.127 2.171 . . . . 0.0 111.764 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.01 -24.99 52.05 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.198 2.599 . . . . 0.0 113.0 -174.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -154.14 -47.67 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.258 0.623 . . . . 0.0 111.681 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -159.17 -174.77 4.88 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.023 0.929 . . . . 0.0 109.732 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.82 168.22 0.66 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.173 1.789 . . . . 0.0 111.01 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.28 168.26 10.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.701 1.2 . . . . 0.0 110.784 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.6 p -138.7 171.15 14.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.364 1.466 . . . . 0.0 108.312 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -144.98 171.13 14.89 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.529 -0.732 . . . . 0.0 110.893 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.85 143.43 30.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 169.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -84.73 37.34 0.64 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.382 1.073 . . . . 0.0 111.639 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -155.43 176.9 11.99 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.696 1.198 . . . . 0.0 108.647 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 136.58 165.56 10.56 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.252 1.882 . . . . 0.0 110.975 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 C--O 1.247 0.937 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 175.409 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.25 161.25 40.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.986 1.315 . . . . 0.0 108.066 171.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -157.92 168.0 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.511 1.525 . . . . 0.0 107.234 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.14 -173.97 4.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.301 1.441 . . . . 0.0 107.941 173.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -144.53 154.52 42.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.427 1.091 . . . . 0.0 108.205 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.4 mt -50.62 -35.44 30.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.299 1.04 . . . . 0.0 112.84 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.93 -23.96 66.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.673 0.669 . . . . 0.0 112.479 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.65 -19.65 37.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.61 0.764 . . . . 0.0 111.212 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.92 131.65 94.67 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.52 111.78 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.301 2.667 . . . . 0.0 109.96 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.5 -35.77 65.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.81 135.72 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -154.47 108.42 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.7 pt -143.68 160.06 16.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.128 0.971 . . . . 0.0 110.231 -170.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -70.37 160.52 32.14 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 168.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -150.25 35.01 0.65 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.176 -1.577 . . . . 0.0 110.291 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.76 -14.48 2.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.235 1.014 . . . . 0.0 112.998 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.83 -171.24 22.06 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.11 0.868 . . . . 0.0 112.41 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.1 t -76.05 137.88 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 169.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -160.82 170.9 19.76 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.622 1.169 . . . . 0.0 109.13 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -107.12 151.46 25.35 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.75 169.18 17.96 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 109.179 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.63 152.87 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.107 1.363 . . . . 0.0 108.156 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -116.24 116.9 28.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.86 132.6 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.008 0.822 . . . . 0.0 109.615 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -77.85 147.98 34.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.31 140.42 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -112.05 146.81 37.27 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.618 1.167 . . . . 0.0 109.166 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 m -66.2 101.77 0.75 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.751 0.82 . . . . 0.0 109.598 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.57 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -150.67 16.27 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 115.839 -2.029 . . . . 0.0 115.004 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 63.6 Cg_exo -43.31 132.03 6.7 Favored 'Trans proline' 0 C--N 1.363 1.309 0 CA-C-N 124.258 2.557 . . . . 0.0 115.087 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 37.97 33.02 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.88 2.872 . . . . 0.0 114.049 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m 52.46 31.15 9.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.205 1.402 . . . . 0.0 112.846 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.96 13.47 3.35 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.129 0.871 . . . . 0.0 112.877 -176.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.65 149.08 85.55 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 117.935 0.868 . . . . 0.0 111.094 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.14 -8.53 15.33 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.294 2.663 . . . . 0.0 114.179 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.41 -176.79 5.85 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.761 1.224 . . . . 0.0 110.103 -169.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.68 37.28 3.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.867 1.667 . . . . 0.0 110.181 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -69.45 168.09 15.25 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.3 m -139.42 158.9 43.34 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.068 0.947 . . . . 0.0 110.526 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.52 165.67 35.89 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.696 1.598 . . . . 0.0 109.529 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.16 155.11 20.8 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.9 157.78 41.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.949 1.7 . . . . 0.0 109.052 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.72 117.53 51.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -137.78 150.4 47.19 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.53 138.27 2.68 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.1 m-85 -153.52 155.91 37.09 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -170.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.6 -33.88 72.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.402 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -65.7 -25.83 67.49 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.73 0.696 . . . . 0.0 112.536 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.42 82.06 8.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.677 1.126 . . . . 0.0 108.589 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -12.7 39.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.875 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.41 145.22 32.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.022 1.729 . . . . 0.0 108.381 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.472 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 15.2 m-70 -62.91 -31.27 72.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.384 1.074 . . . . 0.0 111.847 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -29.37 69.45 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.938 -0.477 . . . . 0.0 111.429 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.22 -45.44 84.69 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.48 0.582 . . . . 0.0 110.581 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -37.46 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.592 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.03 -45.96 86.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.483 1.492 . . . . 0.0 109.419 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.03 -48.34 71.43 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.763 0.425 . . . . 0.0 111.878 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -55.62 -54.97 37.5 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.683 0.793 . . . . 0.0 109.85 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.35 -43.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.022 -0.99 . . . . 0.0 108.664 -171.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.3 m -62.08 -29.03 70.03 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.008 1.276 . . . . 0.0 111.519 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.46 -51.09 55.33 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.43 1.014 . . . . 0.0 110.622 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.54 -44.89 92.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.972 0.886 . . . . 0.0 110.813 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.2 mmt -56.65 -45.72 81.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.294 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -70.33 -30.47 67.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.962 1.256 . . . . 0.0 112.327 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.18 -43.55 98.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.329 0.968 . . . . 0.0 109.694 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.44 -36.38 83.57 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.312 0.505 . . . . 0.0 110.368 171.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.32 -6.44 4.99 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.173 2.321 . . . . 0.0 113.281 170.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.6 171.88 9.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.724 1.61 . . . . 0.0 112.044 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -127.99 149.14 50.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.2 m -148.33 165.0 32.36 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -147.07 125.05 12.01 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.033 1.333 . . . . 0.0 108.263 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -67.73 111.59 4.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.9 mt -72.64 -24.61 61.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.934 -0.479 . . . . 0.0 110.62 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.34 -170.03 42.69 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.41 -174.01 28.6 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 171.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.0 -166.42 32.79 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -117.05 150.52 38.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.9 mt -118.97 136.69 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 m -156.05 165.16 37.27 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.608 0.763 . . . . 0.0 109.346 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -129.31 29.57 5.1 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.634 1.174 . . . . 0.0 108.581 169.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.64 -17.41 64.02 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.256 -0.902 . . . . 0.0 111.308 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 m -59.37 -24.95 63.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.971 1.708 . . . . 0.0 112.456 169.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 47.17 63.09 2.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.221 1.809 . . . . 0.0 110.575 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -115.18 -118.07 0.32 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.49 1.916 . . . . 0.0 106.232 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -136.73 11.21 3.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.062 1.301 . . . . 0.0 111.63 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -156.08 144.81 20.26 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.666 1.121 . . . . 0.0 111.329 -169.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 pt -64.11 161.05 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.727 0.775 . . . . 0.0 109.616 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -140.8 153.4 45.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.994 1.717 . . . . 0.0 107.557 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -121.71 126.64 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -166.07 1.51 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.611 -0.681 . . . . 0.0 110.509 -177.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.26 -160.9 53.44 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.84 -0.537 . . . . 0.0 111.804 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -154.04 155.13 34.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.366 1.467 . . . . 0.0 108.082 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.0 p -81.91 134.43 35.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -64.94 -29.26 70.18 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.835 -0.541 . . . . 0.0 110.647 170.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 -37.93 48.82 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.865 0.866 . . . . 0.0 112.756 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.32 1.38 3.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.61 -177.88 52.5 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 118.942 0.792 . . . . 0.0 111.921 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.67 134.44 28.19 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.641 2.228 . . . . 0.0 110.357 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 170.13 16.63 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.342 0.591 . . . . 0.0 110.225 169.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.03 79.05 3.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -58.89 -18.03 29.47 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.97 -39.19 74.14 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.668 0.787 . . . . 0.0 111.119 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.7 mm -61.8 -48.33 89.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -54.48 -52.03 63.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.735 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 p -60.46 -42.49 96.3 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.781 0.719 . . . . 0.0 111.822 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -60.94 -51.3 69.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.318 0.963 . . . . 0.0 110.825 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -71.08 -43.83 66.95 Favored 'General case' 0 C--N 1.334 -0.109 0 C-N-CA 123.35 0.66 . . . . 0.0 111.121 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.75 -43.26 97.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -63.02 -37.01 85.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 120.877 1.672 . . . . 0.0 111.228 176.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.6 93.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.098 0.863 . . . . 0.0 111.851 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -79.56 -20.06 47.93 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.24 0.616 . . . . 0.0 112.034 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.306 39.2 p90 41.94 54.25 8.47 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.918 2.487 . . . . 0.0 115.969 -171.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -58.69 -28.56 86.81 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.361 2.04 . . . . 0.0 110.817 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -131.08 156.76 44.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.88 2.472 . . . . 0.0 105.224 169.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -61.69 -32.59 72.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.037 0.935 . . . . 0.0 112.84 -169.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -157.7 163.91 37.69 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.847 2.059 . . . . 0.0 105.688 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.99 163.63 10.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.127 1.371 . . . . 0.0 107.752 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 p -137.39 171.84 13.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.744 1.218 . . . . 0.0 108.731 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -141.72 159.25 42.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.146 0.578 . . . . 0.0 110.173 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.75 125.79 10.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -63.7 -25.6 68.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.687 0.395 . . . . 0.0 111.862 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.39 -31.82 73.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.492 1.117 . . . . 0.0 112.967 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.96 151.96 46.5 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.2 p90 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.615 1.566 . . . . 0.0 109.178 -177.012 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.7 149.49 50.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.941 0.497 . . . . 0.0 110.081 175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.0 t -126.4 120.52 56.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.79 178.46 2.6 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.638 0.732 . . . . 0.0 110.467 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -149.65 157.02 42.85 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.54 -28.1 65.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.951 0.796 . . . . 0.0 112.706 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.68 66.53 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.829 1.195 . . . . 0.0 112.143 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.31 -31.07 17.09 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.633 1.173 . . . . 0.0 111.633 -175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.91 122.91 65.93 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.27 137.71 64.0 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.087 2.524 . . . . 0.0 111.141 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.63 -38.65 23.25 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 122.032 -0.417 . . . . 0.0 110.953 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.7 t -137.95 137.58 44.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -172.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -156.47 113.24 3.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.42 151.66 16.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.294 1.038 . . . . 0.0 108.669 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -154.08 112.21 3.56 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.809 0.844 . . . . 0.0 109.29 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.1 m -158.3 158.81 35.1 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.354 1.062 . . . . 0.0 109.69 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -150.4 158.54 44.27 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.621 1.968 . . . . 0.0 106.619 171.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.55 -106.89 1.88 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -170.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -146.26 132.16 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -152.37 171.37 18.13 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.412 1.485 . . . . 0.0 109.804 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.39 163.24 12.96 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.804 0.842 . . . . 0.0 111.692 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.99 171.86 14.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.98 154.9 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.354 1.462 . . . . 0.0 108.477 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.2 tp -118.28 120.75 38.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.18 132.1 71.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 119.242 0.928 . . . . 0.0 109.411 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -76.08 146.22 39.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.9 121.16 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -90.45 149.26 22.3 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.734 0.814 . . . . 0.0 108.968 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -66.09 96.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.078 0.951 . . . . 0.0 109.911 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.443 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -146.25 19.3 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 116.254 -1.832 . . . . 0.0 115.229 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 33.1 Cg_exo -39.36 132.52 1.49 Allowed 'Trans proline' 0 C--N 1.361 1.191 0 CA-C-N 123.927 2.438 . . . . 0.0 114.545 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 43.35 26.61 0.1 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.454 2.702 . . . . 0.0 114.154 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 51.68 32.1 8.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.042 1.337 . . . . 0.0 112.358 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.91 19.67 1.25 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.958 0.79 . . . . 0.0 112.923 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.41 151.0 88.55 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 117.925 0.862 . . . . 0.0 110.538 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -79.1 -5.1 14.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.293 2.662 . . . . 0.0 114.473 -171.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.17 -178.14 6.45 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.703 1.201 . . . . 0.0 109.9 -170.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.79 36.34 3.31 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.557 1.543 . . . . 0.0 110.404 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.37 172.96 7.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -137.07 160.81 37.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.761 0.824 . . . . 0.0 110.619 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -139.34 165.11 28.07 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.613 1.565 . . . . 0.0 108.249 172.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.61 138.45 45.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 pt -115.6 155.08 16.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.132 0.973 . . . . 0.0 109.834 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.62 122.65 69.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.466 ' HG3' HG21 ' A' ' 60' ' ' VAL . 5.1 mmt85 -136.72 148.17 47.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 125.56 0.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -146.61 151.01 36.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -171.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -53.89 -31.26 49.33 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -74.54 -24.45 58.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.851 0.751 . . . . 0.0 112.951 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.92 83.4 8.06 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.974 1.261 . . . . 0.0 109.37 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.76 -6.24 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.636 0.775 . . . . 0.0 112.293 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.94 143.9 28.82 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 108.186 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -62.1 -31.38 71.83 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.104 0.962 . . . . 0.0 111.659 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.73 -27.46 69.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.785 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.779 0.718 . . . . 0.0 110.234 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -40.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.109 -1.424 . . . . 0.0 110.342 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.07 -48.61 80.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.868 1.667 . . . . 0.0 109.742 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.32 -47.11 83.6 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.888 0.767 . . . . 0.0 111.542 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -60.89 -50.13 74.65 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.96 0.504 . . . . 0.0 110.77 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.466 HG21 ' HG3' ' A' ' 45' ' ' ARG . 67.5 t -74.2 -44.69 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.32 -171.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.8 p -62.04 -30.41 70.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.789 1.177 . . . . 0.0 110.398 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.19 54.0 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.16 0.891 . . . . 0.0 111.007 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -64.08 -45.51 88.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.371 1.085 . . . . 0.0 111.169 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -57.54 -45.04 85.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.625 0.648 . . . . 0.0 111.179 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.42 -31.83 72.29 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.004 -1.06 . . . . 0.0 111.819 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.54 -39.8 95.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.101 0.864 . . . . 0.0 110.417 171.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.35 -33.9 77.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.226 0.921 . . . . 0.0 110.447 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.55 -9.88 4.03 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 126.416 1.96 . . . . 0.0 113.217 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -65.69 173.64 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.923 1.689 . . . . 0.0 112.503 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.14 135.1 49.31 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 169.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.0 m -142.48 164.49 29.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.9 130.43 11.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -66.23 109.24 2.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.2 mt -66.87 -28.16 68.1 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.926 -0.484 . . . . 0.0 110.472 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.02 -168.2 41.35 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.43 -169.15 20.87 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.88 -162.82 28.52 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 -128.88 153.7 47.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -128.86 140.38 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.8 m -126.72 138.66 53.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.259 1.024 . . . . 0.0 108.451 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -134.88 4.48 3.29 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.316 1.847 . . . . 0.0 110.539 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -60.15 -20.41 58.35 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.475 1.034 . . . . 0.0 113.383 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 m -56.65 -31.79 64.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.493 1.117 . . . . 0.0 112.221 169.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 44.93 50.44 8.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.5 2.32 . . . . 0.0 111.306 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -134.95 48.95 2.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.113 1.365 . . . . 0.0 109.9 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? 55.3 28.35 11.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.637 1.575 . . . . 0.0 112.809 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -148.55 159.17 44.33 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.031 -1.043 . . . . 0.0 109.771 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.8 pt -131.44 169.77 21.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.713 1.605 . . . . 0.0 108.344 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -133.36 151.39 51.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.19 126.7 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.45 -177.51 6.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.598 0.759 . . . . 0.0 110.496 -173.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -161.05 53.22 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -150.61 155.64 39.8 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 108.421 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 t -69.61 131.85 45.29 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.6 ttm -62.51 -26.32 68.49 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.521 0.328 . . . . 0.0 110.844 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.24 -30.05 13.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 112.587 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -131.01 1.66 4.29 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -168.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.74 -176.56 48.54 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.092 0.86 . . . . 0.0 112.279 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.34 131.6 22.18 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.721 2.281 . . . . 0.0 110.663 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.87 170.02 16.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 110.231 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.03 74.14 4.58 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.41 -18.82 19.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 113.399 -175.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.47 -38.82 69.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.424 0.69 . . . . 0.0 111.199 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.65 -43.98 97.95 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 C-N-CA 123.928 0.891 . . . . 0.0 108.828 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -57.0 -50.35 72.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.64 0.655 . . . . 0.0 110.617 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 -48.56 73.92 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.813 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.94 -50.08 72.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.018 0.826 . . . . 0.0 110.878 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -68.33 -46.12 71.08 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.575 0.75 . . . . 0.0 110.671 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.98 -39.24 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.983 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.06 -36.76 82.73 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.158 1.799 . . . . 0.0 111.572 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.99 89.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.963 0.801 . . . . 0.0 110.958 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -70.04 -39.17 75.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.162 0.585 . . . . 0.0 111.289 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 t80 46.44 67.15 4.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.965 2.106 . . . . 0.0 109.592 -168.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.24 -30.84 54.36 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.951 2.434 . . . . 0.0 111.987 -169.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -166.74 -30.65 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 111.298 170.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.54 167.16 22.71 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.249 1.419 . . . . 0.0 112.079 -168.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -77.49 175.0 10.23 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.0 p -149.21 155.03 8.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 120.755 -1.216 . . . . 0.0 108.587 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.9 p -140.97 170.98 14.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.547 1.539 . . . . 0.0 107.785 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -145.61 168.19 21.25 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.661 -0.649 . . . . 0.0 111.425 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.15 142.49 30.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -87.76 45.73 1.31 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.323 1.049 . . . . 0.0 110.018 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -153.51 -177.11 6.14 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.009 1.324 . . . . 0.0 108.948 -170.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.94 173.62 43.94 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.396 1.474 . . . . 0.0 111.529 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.9 p90 . . . . . 0 C--O 1.247 0.928 0 C-N-CA 126.685 1.994 . . . . 0.0 106.246 174.603 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.8 162.0 41.58 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.111 1.364 . . . . 0.0 108.379 175.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 p -155.1 148.59 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.61 176.24 3.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.301 0.572 . . . . 0.0 110.091 172.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -148.07 153.79 39.38 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 mt -53.65 -30.71 44.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.384 1.074 . . . . 0.0 113.468 -178.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.58 -24.8 56.66 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.889 0.768 . . . . 0.0 112.283 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.0 -21.56 29.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.967 0.907 . . . . 0.0 110.954 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.37 129.91 80.41 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.91 112.57 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.497 2.798 . . . . 0.0 110.378 172.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -72.61 -30.09 64.06 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.4 139.09 23.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.977 1.711 . . . . 0.0 106.386 177.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -155.03 109.28 2.94 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt -137.58 157.04 33.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.333 1.053 . . . . 0.0 108.815 -173.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -60.59 141.79 56.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.851 0.358 . . . . 0.0 110.188 172.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m -69.55 -30.71 68.58 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -169.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -170.1 115.92 0.52 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.745 1.157 . . . . 0.0 110.453 -169.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.55 -155.59 26.64 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 177.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -130.38 121.51 51.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 169.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -159.76 162.23 34.84 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.96 0.904 . . . . 0.0 110.045 -170.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -81.24 159.96 24.4 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.46 169.25 17.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.87 155.4 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.019 1.327 . . . . 0.0 108.727 177.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -122.57 111.47 16.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 -175.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.78 134.72 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 118.81 0.732 . . . . 0.0 109.812 -171.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -79.16 147.87 32.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.182 1.393 . . . . 0.0 108.462 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 t -137.05 128.93 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -178.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -97.3 150.98 20.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.813 1.245 . . . . 0.0 109.952 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m -66.29 100.36 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.195 176.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -152.8 19.51 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.171 169.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 86.6 Cg_exo -46.51 140.31 12.09 Favored 'Trans proline' 0 C--N 1.362 1.277 0 CA-C-N 124.317 2.578 . . . . 0.0 113.879 173.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 42.96 25.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 114.269 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 m 50.33 33.44 7.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.979 1.312 . . . . 0.0 112.226 -174.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.89 28.56 1.28 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.143 0.878 . . . . 0.0 112.165 -172.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.09 151.59 89.72 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 117.503 0.652 . . . . 0.0 110.537 175.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.85 -8.23 16.72 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.228 2.619 . . . . 0.0 113.915 -177.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.6 -175.08 5.2 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.05 1.34 . . . . 0.0 109.769 -170.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.85 37.64 3.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.653 1.581 . . . . 0.0 110.2 174.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -70.09 170.39 11.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 m -141.8 158.26 44.02 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.993 0.917 . . . . 0.0 110.034 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HE2' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -153.07 165.69 34.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.199 1.4 . . . . 0.0 109.142 174.696 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.26 158.04 17.81 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -175.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.412 ' CG2' ' HE2' ' A' ' 41' ' ' LYS . 43.9 pt -136.62 158.61 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.006 1.323 . . . . 0.0 109.358 175.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 t -123.36 119.16 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -171.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mmt85 -138.25 145.96 41.97 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.45 133.9 1.92 Allowed Glycine 0 C--N 1.332 0.326 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.421 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 17.6 m-85 -155.64 156.93 35.86 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.378 0.671 . . . . 0.0 109.294 -171.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -32.75 72.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.359 0.664 . . . . 0.0 111.485 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.421 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 15.5 p-90 -65.98 -29.09 69.42 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 112.207 178.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 81.21 8.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.289 0.949 . . . . 0.0 108.451 171.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -62.16 -15.45 46.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 111.919 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.15 144.76 36.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.891 1.676 . . . . 0.0 108.446 176.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.538 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 7.4 m-70 -59.49 -31.66 69.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.217 1.407 . . . . 0.0 111.895 -175.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.07 69.67 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.664 177.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.1 -47.75 70.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.747 0.703 . . . . 0.0 110.393 -178.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -39.99 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.476 -1.249 . . . . 0.0 110.3 176.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.5 -47.17 86.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.566 1.53 . . . . 0.0 109.786 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.75 -48.51 78.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.604 0.638 . . . . 0.0 111.41 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -60.84 -51.18 70.4 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.62 -44.77 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.33 -173.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -60.52 -37.01 79.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.727 1.149 . . . . 0.0 109.515 176.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.67 84.83 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.877 0.762 . . . . 0.0 111.601 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.04 -47.19 81.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.564 1.182 . . . . 0.0 110.817 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mmt -56.95 -44.34 82.47 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.968 -0.457 . . . . 0.0 111.19 175.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -67.87 -33.36 74.59 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.249 -0.907 . . . . 0.0 111.768 179.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -63.05 -40.98 99.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.059 0.845 . . . . 0.0 110.018 171.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -63.03 -37.83 88.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.032 0.833 . . . . 0.0 110.098 171.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 140.39 -8.93 2.92 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.323 1.916 . . . . 0.0 113.324 169.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.7 m -68.92 175.13 3.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.455 1.502 . . . . 0.0 112.436 -170.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.51 143.24 50.75 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.7 m -144.22 169.64 17.49 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.14 137.92 15.3 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.313 1.045 . . . . 0.0 108.777 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -70.9 112.48 7.11 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 169.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.2 -25.43 63.41 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.132 -0.355 . . . . 0.0 110.335 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.89 -164.23 37.65 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.92 23.09 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.39 -157.1 19.13 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -175.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -129.28 165.73 20.85 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 117.977 0.888 . . . . 0.0 109.594 173.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.4 mt -131.3 137.18 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -169.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.9 m -147.1 136.27 22.51 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.665 0.786 . . . . 0.0 109.886 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -64.8 136.99 57.51 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 168.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -61.34 144.28 54.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.492 0.587 . . . . 0.0 109.429 177.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -63.0 -26.0 68.65 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -169.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -148.67 22.6 1.01 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.889 0.876 . . . . 0.0 111.553 -171.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -149.82 151.77 34.07 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.175 0.99 . . . . 0.0 109.029 -174.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -60.56 -28.24 68.3 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -68.71 173.13 5.46 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.362 1.077 . . . . 0.0 112.686 -169.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -121.0 156.1 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 170.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -129.82 147.52 51.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.27 1.428 . . . . 0.0 108.105 -172.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.08 119.07 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -174.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -159.88 -177.01 6.03 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.208 -0.933 . . . . 0.0 111.144 -169.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.84 -158.49 44.78 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 177.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -143.94 151.91 40.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.603 1.561 . . . . 0.0 107.398 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.6 p -72.84 139.68 47.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.8 mmm -64.51 -6.88 8.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.76 -19.74 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.802 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.57 2.55 2.96 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 112.7 -171.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.2 -176.14 54.82 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.845 0.748 . . . . 0.0 112.332 178.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -72.0 137.04 28.46 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.725 2.283 . . . . 0.0 110.692 -179.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.47 174.81 10.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.388 0.613 . . . . 0.0 110.306 169.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -79.4 80.84 5.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 168.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -58.37 -16.08 13.15 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.83 88.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.461 0.704 . . . . 0.0 110.869 171.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.2 mt -60.05 -47.49 91.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 175.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -56.05 -55.72 29.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.515 1.126 . . . . 0.0 110.876 -177.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 p -65.46 -41.08 93.78 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.078 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.57 -44.39 94.21 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.744 1.156 . . . . 0.0 110.23 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -66.09 -43.3 87.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.42 -49.41 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.88 -39.12 84.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.585 1.084 . . . . 0.0 111.239 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.54 78.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.473 0.578 . . . . 0.0 111.48 177.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -76.98 -18.38 58.26 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.9 t80 52.23 52.58 11.42 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 126.088 1.755 . . . . 0.0 113.288 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.31 -16.29 28.0 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.288 1.992 . . . . 0.0 111.286 170.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -150.27 165.31 33.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.061 2.145 . . . . 0.0 107.91 176.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -54.13 -51.69 63.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.669 1.587 . . . . 0.0 112.856 -171.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -163.82 159.55 21.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.5 m -138.06 171.38 15.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.519 0.728 . . . . 0.0 110.791 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.9 p -142.18 166.49 24.55 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.028 1.331 . . . . 0.0 108.636 -174.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -144.18 170.36 16.12 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.691 171.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.22 143.6 28.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 169.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -84.51 34.49 0.53 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.213 1.005 . . . . 0.0 111.601 -174.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -153.58 -179.3 7.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.875 1.67 . . . . 0.0 107.558 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 139.63 -154.51 23.7 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.302 0.953 . . . . 0.0 111.138 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 51.8 p90 . . . . . 0 C--O 1.247 0.925 0 C-N-CA 126.015 1.726 . . . . 0.0 107.906 177.172 . . . . . . . . 0 0 . 1 stop_ save_